1	ORIGINAL	JJ	O	original	amod	2	SENT_1	[p1l6t81r196b120],
2	RESEARCH	NN	O	research	_	0	SENT_1	[p1l285t82r474b120],
3	ARTICLE	NN	O	article	nn	4	SENT_1	[p1l563t82r714b120],
4	Clin	NN	O	clin	dep	2	SENT_1	[p1l6t134r42b150],
5	Phormcxcokinet	NNP	O	Phormcxcokinet	dep	4	SENT_1	[p1l51t134r204b150],
6	2008	CD	DATE	2008	num	5	SENT_1	[p1l210t134r261b152],
7	;	:	O	;	_	0	SENT_1	[p1l210t134r261b152],
8	47	CD	NUMBER	47	number	9	SENT_1	[p1l268t134r290b150],
9	(	CD	NUMBER	(	dep	4	SENT_1	[p1l299t134r328b152],
10	5	CD	NUMBER	5	num	11	SENT_1	[p1l299t134r328b152],
11	)	NN	O	)	dep	9	SENT_1	[p1l299t134r328b152],
12	:	:	O	:	_	0	SENT_1	[p1l299t134r328b152],
13	323	CD	NUMBER	323	dep	4	SENT_1	[p1l337t134r412b150],
14	—	CD	NUMBER	—	num	15	SENT_1	[p1l337t134r412b150],
15	332 0312-5963	CD	DURATION	332 0312-5963	dep	13	SENT_1	[p1l80t158r412b178],[p1l337t134r412b150],
16	/	:	O	/	punct	17	SENT_1	[p1l80t158r412b178],
17	08/0005-U	NN	O	08/0005-u	dep	15	SENT_1	[p1l80t158r412b178],
18	323	CD	NUMBER	323	num	17	SENT_1	[p1l80t158r412b178],
19	/	:	O	/	punct	20	SENT_1	[p1l80t158r412b178],
20	$	$	MONEY	$	dep	15	SENT_1	[p1l80t158r412b178],
21	48.00	CD	MONEY	48.00	num	20	SENT_1	[p1l80t158r412b178],
22	/	:	O	/	punct	20	SENT_1	[p1l80t158r412b178],
23	0	CD	NUMBER	0	dep	2	SENT_1	[p1l80t158r412b178],

1	©	RB	O	©	advmod	2	SENT_2	[p1l1640t210r1655b226],
2	2008	CD	DATE	2008	_	0	SENT_2	[p1l1662t209r1707b226],
3	Adis	NNP	ORGANIZATION	Adis	nn	5	SENT_2	[p1l1714t209r1756b226],
4	Data	NNP	ORGANIZATION	Data	nn	5	SENT_2	[p1l1764t209r1812b226],
5	Information	NNP	ORGANIZATION	Information	dep	2	SENT_2	[p1l1821t209r1934b226],
6	BV	NN	ORGANIZATION	bv	dep	5	SENT_2	[p1l1942t209r1972b225],
7	.	.	O	.	_	0	SENT_2	[p1l1942t209r1972b225],

1	All	DT	O	all	det	2	SENT_3	[p1l1980t209r2002b225],
2	rights	NNS	O	rights	nsubj	3	SENT_3	[p1l2011t209r2062b230],
3	resen/ed	VBD	O	resen/ed	_	0	SENT_3	[p1l2069t209r2154b226],

1	Determinants	NNS	O	determinant	_	0	SENT_4	[p1l7t306r576b373],
2	of	IN	O	of	_	0	SENT_4	[p1l611t305r693b373],
3	Steady-State	JJ	O	steady-state	amod	5	SENT_4	[p1l726t305r1242b396],
4	Torasemide	NNP	O	Torasemide	nn	5	SENT_4	[p1l6t420r495b488],
5	Pharmacokinetics	NNPS	O	Pharmacokinetics	prep_of	1	SENT_4	[p1l529t420r1266b488],

1	Impact	NN	O	impact	_	0	SENT_5	[p1l6t535r189b591],
2	of	IN	O	of	_	0	SENT_5	[p1l209t533r261b576],
3	Pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_5	[p1l281t533r731b591],
4	Factors	NNS	O	factor	nn	11	SENT_5	[p1l752t535r952b585],
5	,	,	O	,	_	0	SENT_5	[p1l752t535r952b585],
6	Gender	NN	O	gender	nn	11	SENT_5	[p1l973t533r1171b576],
7	and	CC	O	and	_	0	SENT_5	[p1l7t594r103b638],
8	Angiotensin	NN	O	angiotensin	nn	11	SENT_5	[p1l123t595r452b652],
9	II	CD	NUMBER	ii	num	11	SENT_5	[p1l472t596r514b637],
10	Receptor	NN	O	receptor	nn	11	SENT_5	[p1l535t596r770b652],
11	Blockers	NNS	O	blocker	prep_of	1	SENT_5	[p1l789t594r1015b638],

1	Dierk	NNP	PERSON	Dierk	nn	11	SENT_6	[p1l6t720r110b754],
2	Werner	NNP	PERSON	Werner	nn	11	SENT_6	[p1l126t717r288b760],
3	}	NNP	O	}	nn	11	SENT_6	[p1l126t717r288b760],
4	Ulrike	NNP	PERSON	Ulrike	nn	11	SENT_6	[p1l303t719r416b754],
5	Werner	NNP	PERSON	Werner	nn	11	SENT_6	[p1l433t717r596b760],
6	}	NNP	O	}	nn	11	SENT_6	[p1l433t717r596b760],
7	Annett	NNP	PERSON	Annett	nn	11	SENT_6	[p1l605t721r737b754],
8	Meybaum	NNP	PERSON	Meybaum	nn	11	SENT_6	[p1l751t717r963b766],
9	}	NNP	O	}	nn	11	SENT_6	[p1l751t717r963b766],
10	Boris	NNP	O	Boris	nn	11	SENT_6	[p1l976t720r1069b754],
11	Sch1nidt	NNP	O	Sch1nidt	dep	20	SENT_6	[p1l1087t717r1264b760],
12	,3	CD	NUMBER	,3	num	14	SENT_6	[p1l1087t717r1264b760],
13	Surnaira	NNP	O	Surnaira	nn	14	SENT_6	[p1l1276t720r1431b754],
14	LImbreen	NNP	O	LImbreen	dep	11	SENT_6	[p1l1450t717r1644b760],
15	,3	CD	NUMBER	,3	dep	20	SENT_6	[p1l1450t717r1644b760],
16	Anton	NNP	PERSON	Anton	nn	20	SENT_6	[p1l1652t721r1771b754],
17	Grosch/L	NNP	PERSON	Grosch/L	nn	20	SENT_6	[p1l1789t717r1944b760],
18	Heiko	NNP	PERSON	Heiko	nn	20	SENT_6	[p1l1961t719r2066b754],
19	G.	NNP	PERSON	G.	nn	20	SENT_6	[p1l2084t721r2122b754],
20	Lestin	NNP	PERSON	Lestin	dep	26	SENT_6	[p1l6t777r146b820],
21	,4	CD	NUMBER	,4	num	23	SENT_6	[p1l6t777r146b820],
22	Bernhard	NNP	PERSON	Bernhard	nn	23	SENT_6	[p1l157t779r328b814],
23	Graf	NNP	PERSON	Graf	dep	20	SENT_6	[p1l345t777r451b826],
24	,1	CD	NUMBER	,1	num	23	SENT_6	[p1l345t777r451b826],
25	Oliver	NNP	PERSON	Oliver	nn	26	SENT_6	[p1l465t780r582b814],
26	Zolkz	NNP	PERSON	Zolkz	_	0	SENT_6	[p1l597t777r694b814],
27	and	CC	O	and	_	0	SENT_6	[p1l721t780r797b814],
28	Martin	NNP	PERSON	Martin	nn	30	SENT_6	[p1l810t780r944b814],
29	F.	NNP	PERSON	F.	nn	30	SENT_6	[p1l960t781r993b813],
30	Frornmz	NNP	PERSON	Frornmz	conj_and	26	SENT_6	[p1l1011t777r1160b814],

1	1	CD	NUMBER	1	_	0	SENT_7	[p1l6t869r20b896],
2	Department	NNP	ORGANIZATION	Department	dep	1	SENT_7	[p1l61t869r260b906],
3	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l273t868r305b896],
4	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	2	SENT_7	[p1l317t868r512b906],
5	,	,	O	,	_	0	SENT_7	[p1l317t868r512b906],
6	Helios-Hospital	NNP	LOCATION	Helios-Hospital	nn	13	SENT_7	[p1l525t868r786b906],
7	Schwerin	NNP	LOCATION	Schwerin	nn	13	SENT_7	[p1l799t868r961b901],
8	,	,	O	,	_	0	SENT_7	[p1l799t868r961b901],
9	Schwerin	NNP	LOCATION	Schwerin	appos	13	SENT_7	[p1l975t868r1137b901],
10	,	,	O	,	_	0	SENT_7	[p1l975t868r1137b901],
11	Germany	NNP	LOCATION	Germany	appos	13	SENT_7	[p1l1150t868r1305b906],
12	2	CD	NUMBER	2	num	13	SENT_7	[p1l6t917r23b944],
13	Institute	NNP	ORGANIZATION	Institute	conj_and	4	SENT_7	[p1l62t917r199b944],
14	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l212t916r245b944],
15	Experimental	JJ	ORGANIZATION	experimental	amod	18	SENT_7	[p1l256t916r478b954],
16	and	CC	ORGANIZATION	and	_	0	SENT_7	[p1l491t916r553b944],
17	Clinical	JJ	ORGANIZATION	clinical	conj_and	15	SENT_7	[p1l566t916r692b944],
18	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	13	SENT_7	[p1l704t916r943b954],
19	and	CC	O	and	_	0	SENT_7	[p1l956t916r1017b944],
20	Toxicology	NN	O	toxicology	conj_and	4	SENT_7	[p1l1030t916r1222b954],
21	,	,	O	,	_	0	SENT_7	[p1l1030t916r1222b954],
22	Friedrich-Alexander-University	NN	O	friedrich-alexander-university	appos	20	SENT_7	[p1l1235t916r1760b954],

1	Erlangen-Nuremberg	NNP	LOCATION	Erlangen-Nuremberg	_	0	SENT_8	[p1l63t964r428b1002],
2	,	,	O	,	_	0	SENT_8	[p1l63t964r428b1002],
3	Erlangen	NNP	LOCATION	Erlangen	nn	5	SENT_8	[p1l441t964r598b1002],
4	,	,	O	,	_	0	SENT_8	[p1l441t964r598b1002],
5	Germany	NNP	LOCATION	Germany	appos	1	SENT_8	[p1l611t965r766b1002],

1	3	CD	NUMBER	3	_	0	SENT_9	[p1l6t1013r23b1040],
2	Technical	NNP	ORGANIZATION	Technical	nn	3	SENT_9	[p1l62t1012r220b1040],
3	University	NNP	ORGANIZATION	University	dep	1	SENT_9	[p1l232t1013r415b1050],
4	,	,	O	,	_	0	SENT_9	[p1l232t1013r415b1050],
5	Institute	NNP	ORGANIZATION	Institute	appos	3	SENT_9	[p1l428t1013r565b1040],
6	for	IN	ORGANIZATION	for	_	0	SENT_9	[p1l578t1012r625b1040],
7	Organic	NNP	ORGANIZATION	Organic	nn	8	SENT_9	[p1l637t1012r769b1050],
8	Chemistry	NNP	ORGANIZATION	Chemistry	prep_for	5	SENT_9	[p1l782t1012r955b1050],
9	and	CC	ORGANIZATION	and	_	0	SENT_9	[p1l968t1012r1029b1040],
10	Biochemistry	NNP	ORGANIZATION	Biochemistry	nn	16	SENT_9	[p1l1042t1012r1268b1050],
11	,	,	O	,	_	0	SENT_9	[p1l1042t1012r1268b1050],
12	Darmstadt	NNP	LOCATION	Darmstadt	appos	16	SENT_9	[p1l1281t1012r1467b1045],
13	,	,	O	,	_	0	SENT_9	[p1l1281t1012r1467b1045],
14	Germany	NNP	LOCATION	Germany	appos	16	SENT_9	[p1l1480t1012r1635b1050],
15	4	CD	NUMBER	4	num	16	SENT_9	[p1l6t1061r24b1088],
16	Department	NNP	ORGANIZATION	Department	conj_and	5	SENT_9	[p1l63t1061r262b1099],
17	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l275t1060r307b1089],
18	Laboratory	NNP	ORGANIZATION	Laboratory	nn	19	SENT_9	[p1l319t1060r503b1099],
19	Medicine	NNP	ORGANIZATION	Medicine	prep_of	16	SENT_9	[p1l514t1060r677b1094],
20	,	,	O	,	_	0	SENT_9	[p1l514t1060r677b1094],
21	Helios-Hospital	NNP	LOCATION	Helios-Hospital	nn	22	SENT_9	[p1l690t1060r952b1099],
22	Schwerin	NNP	LOCATION	Schwerin	appos	19	SENT_9	[p1l964t1060r1126b1094],
23	,	,	O	,	_	0	SENT_9	[p1l964t1060r1126b1094],
24	Schwerin	NNP	LOCATION	Schwerin	nn	26	SENT_9	[p1l1140t1060r1302b1094],
25	,	,	O	,	_	0	SENT_9	[p1l1140t1060r1302b1094],
26	Germany	NNP	LOCATION	Germany	dep	1	SENT_9	[p1l1315t1061r1470b1099],

1	AbSl	NN	O	absl	_	0	SENT_10	[p1l6t1222r208b1260],
2	'	''	O	'	_	0	SENT_10	[p1l6t1222r208b1260],
3	I	PRP	O	I	dep	1	SENT_10	[p1l6t1222r208b1260],
4	'	''	O	'	_	0	SENT_10	[p1l6t1222r208b1260],
5	GCl	NN	O	gcl	dep	3	SENT_10	[p1l6t1222r208b1260],
6	'	''	O	'	_	0	SENT_10	[p1l6t1222r208b1260],
7	Background	NNP	O	Background	nsubjpass	12	SENT_10	[p1l447t1230r666b1266],
8	:	:	O	:	_	0	SENT_10	[p1l447t1230r666b1266],
9	Torasemide	NNP	O	Torasemide	nsubjpass	12	SENT_10	[p1l681t1230r867b1258],
10	is	VBZ	O	be	auxpass	12	SENT_10	[p1l880t1230r904b1258],
11	frequently	RB	O	frequently	advmod	12	SENT_10	[p1l918t1230r1079b1266],
12	used	VBN	O	use	rcmod	5	SENT_10	[p1l1092t1230r1164b1258],
13	for	IN	O	for	_	0	SENT_10	[p1l1176t1230r1222b1258],
14	the	DT	O	the	det	15	SENT_10	[p1l1234t1230r1281b1258],
15	treatment	NN	O	treatment	prep_for	12	SENT_10	[p1l1294t1234r1443b1258],
16	of	IN	O	of	_	0	SENT_10	[p1l1455t1230r1490b1258],
17	hypertension	NN	O	hypertension	nn	20	SENT_10	[p1l1499t1230r1703b1266],
18	and	CC	O	and	_	0	SENT_10	[p1l1716t1230r1772b1258],
19	heart	NN	O	heart	nn	20	SENT_10	[p1l1784t1230r1863b1258],
20	failure	NN	O	failure	prep_of	15	SENT_10	[p1l1875t1230r1985b1258],
21	.	.	O	.	_	0	SENT_10	[p1l1875t1230r1985b1258],

1	However	RB	O	however	advmod	15	SENT_11	[p1l6t1280r159b1312],
2	,	,	O	,	_	0	SENT_11	[p1l6t1280r159b1312],
3	the	DT	O	the	det	4	SENT_11	[p1l173t1279r220b1307],
4	determinants	NNS	O	determinant	nsubj	15	SENT_11	[p1l30t1328r232b1356],
5	of	IN	O	of	_	0	SENT_11	[p1l243t1328r277b1356],
6	torasemide	NN	O	torasemide	nn	7	SENT_11	[p1l283t1328r456b1356],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	4	SENT_11	[p1l464t1328r742b1364],
8	in	IN	O	in	_	0	SENT_11	[p1l752t1328r782b1355],
9	patients	NNS	O	patient	prep_in	7	SENT_11	[p1l791t1328r912b1364],
10	during	IN	O	during	_	0	SENT_11	[p1l923t1328r1024b1364],
11	steady-state	JJ	O	steady-state	amod	12	SENT_11	[p1l1035t1328r1220b1364],
12	conditions	NNS	O	condition	prep_during	9	SENT_11	[p1l1229t1328r1392b1356],
13	are	VBP	O	be	cop	15	SENT_11	[p1l1403t1337r1449b1356],
14	largely	RB	O	largely	advmod	15	SENT_11	[p1l1458t1328r1567b1364],
15	unknown	JJ	O	unknown	_	0	SENT_11	[p1l1576t1328r1730b1356],
16	.	.	O	.	_	0	SENT_11	[p1l1576t1328r1730b1356],

1	We	PRP	O	we	nsubj	3	SENT_12	[p1l1741t1329r1795b1356],
2	therefore	RB	O	therefore	advmod	3	SENT_12	[p1l1808t1328r1950b1356],
3	explored	VBD	O	explore	_	0	SENT_12	[p1l1960t1328r2098b1364],
4	the	DT	O	the	det	5	SENT_12	[p1l2107t1328r2154b1356],
5	impact	NN	O	impact	dep	18	SENT_12	[p1l13t1377r120b1413],
6	of	IN	O	of	_	0	SENT_12	[p1l130t1377r164b1405],
7	genetic	JJ	O	genetic	amod	8	SENT_12	[p1l172t1377r284b1413],
8	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_12	[p1l294t1377r539b1413],
9	of	IN	O	of	_	0	SENT_12	[p1l550t1377r584b1405],
10	cytochrome	NN	O	cytochrome	nn	11	SENT_12	[p1l592t1377r777b1413],
11	P450	NN	O	p450	prep_of	8	SENT_12	[p1l787t1377r867b1405],
12	(	CD	NUMBER	(	num	11	SENT_12	[p1l879t1377r979b1411],
13	CYP	NN	O	cyp	dep	18	SENT_12	[p1l879t1377r979b1411],
14	)	CD	NUMBER	)	num	13	SENT_12	[p1l879t1377r979b1411],
15	2C9	NN	O	2c9	nn	18	SENT_12	[p1l990t1377r1054b1405],
16	(	CD	NUMBER	(	num	18	SENT_12	[p1l1066t1377r1227b1411],
17	CYP2C9	NN	O	cyp2c9	nn	18	SENT_12	[p1l1066t1377r1227b1411],
18	)	NN	O	)	dep	3	SENT_12	[p1l1066t1377r1227b1411],
19	and	CC	O	and	_	0	SENT_12	[p1l1239t1377r1295b1405],
20	organic	JJ	O	organic	amod	21	SENT_12	[p1l1305t1377r1421b1413],
21	anion	NN	O	anion	conj_and	18	SENT_12	[p1l1434t1377r1520b1405],
22	transporting	VBG	O	transport	xcomp	3	SENT_12	[p1l1537t1377r1727b1413],
23	polypeptide	NN	O	polypeptide	nn	25	SENT_12	[p1l1744t1377r1930b1413],
24	(	CD	NUMBER	(	num	25	SENT_12	[p1l1948t1377r2075b1411],
25	OATP	NN	O	oatp	dobj	22	SENT_12	[p1l1948t1377r2075b1411],
26	)	CD	NUMBER	)	num	27	SENT_12	[p1l1948t1377r2075b1411],
27	1B1	NN	O	1b1	dep	25	SENT_12	[p1l2097t1377r2154b1404],
28	(	CD	NUMBER	(	num	29	SENT_12	[p1l1131t1426r1324b1460],
29	SLCOIBI	NNP	O	SLCOIBI	dep	27	SENT_12	[p1l1131t1426r1324b1460],
30	)	CD	NUMBER	)	num	29	SENT_12	[p1l1131t1426r1324b1460],
31	,	,	O	,	_	0	SENT_12	[p1l1131t1426r1324b1460],
32	gender	NN	O	gender	appos	27	SENT_12	[p1l1343t1426r1458b1462],
33	,	,	O	,	_	0	SENT_12	[p1l1343t1426r1458b1462],
34	and	CC	O	and	_	0	SENT_12	[p1l1477t1426r1533b1454],
35	the	DT	O	the	det	36	SENT_12	[p1l1549t1426r1597b1454],
36	effects	NNS	O	effect	conj_and	25	SENT_12	[p1l1614t1426r1717b1454],
37	of	IN	O	of	_	0	SENT_12	[p1l1736t1426r1770b1454],
38	losartan	NN	O	losartan	nn	41	SENT_12	[p1l1784t1426r1909b1454],
39	and	CC	O	and	_	0	SENT_12	[p1l1926t1426r1982b1454],
40	irbesartan	NN	O	irbesartan	nn	41	SENT_12	[p1l1999t1426r2154b1454],
41	comedication	NN	O	comedication	prep_of	36	SENT_12	[p1l322t1475r534b1503],
42	on	IN	O	on	_	0	SENT_12	[p1l547t1484r585b1503],
43	the	DT	O	the	det	45	SENT_12	[p1l598t1475r645b1503],
44	interindividual	JJ	O	interindividual	amod	45	SENT_12	[p1l659t1475r890b1503],
45	variability	NN	O	variability	prep_on	22	SENT_12	[p1l903t1475r1065b1511],
46	of	IN	O	of	_	0	SENT_12	[p1l1078t1475r1113b1503],
47	steady-state	JJ	O	steady-state	amod	48	SENT_12	[p1l1124t1475r1308b1511],
48	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	45	SENT_12	[p1l1321t1475r1599b1511],
49	of	IN	O	of	_	0	SENT_12	[p1l1613t1475r1647b1503],
50	torasemide	NN	O	torasemide	prep_of	48	SENT_12	[p1l1657t1475r1838b1503],
51	.	.	O	.	_	0	SENT_12	[p1l1657t1475r1838b1503],

1	Patients	NNS	O	patient	_	0	SENT_13	[p1l29t1524r164b1552],
2	and	CC	O	and	_	0	SENT_13	[p1l175t1525r237b1552],
3	methods	NNS	O	method	conj_and	1	SENT_13	[p1l247t1525r400b1552],
4	:	:	O	:	_	0	SENT_13	[p1l247t1525r400b1552],
5	Twenty-four	CD	NUMBER	twenty-four	num	6	SENT_13	[p1l412t1524r612b1560],
6	patients	NNS	O	patient	dep	1	SENT_13	[p1l621t1524r743b1560],
7	receiving	VBG	O	receive	partmod	6	SENT_13	[p1l753t1524r900b1560],
8	stable	JJ	O	stable	amod	9	SENT_13	[p1l911t1524r1001b1552],
9	medication	NN	O	medication	dobj	7	SENT_13	[p1l1012t1524r1186b1552],
10	with	IN	O	with	_	0	SENT_13	[p1l1197t1524r1266b1552],
11	torasemide	NN	O	torasemide	nn	13	SENT_13	[p1l1276t1524r1448b1552],
12	10	CD	NUMBER	10	num	13	SENT_13	[p1l1462t1525r1497b1552],
13	mg	NN	O	mg	prep_with	7	SENT_13	[p1l1507t1533r1557b1560],
14	once	RB	DATE	once	advmod	15	SENT_13	[p1l1567t1533r1640b1552],
15	daily	JJ	SET	daily	advmod	7	SENT_13	[p1l1651t1524r1728b1560],
16	and	CC	O	and	_	0	SENT_13	[p1l1740t1524r1795b1552],
17	with	IN	O	with	_	0	SENT_13	[p1l1808t1524r1877b1552],
18	an	DT	O	a	det	19	SENT_13	[p1l1891t1533r1926b1552],
19	indication	NN	O	indication	prep_with	7	SENT_13	[p1l1939t1524r2096b1552],
20	for	IN	O	for	_	0	SENT_13	[p1l2108t1524r2154b1552],
21	additional	JJ	O	additional	amod	24	SENT_13	[p1l121t1573r277b1601],
22	angiotensin	NN	O	angiotensin	nn	24	SENT_13	[p1l291t1573r471b1609],
23	II	CD	NUMBER	ii	num	24	SENT_13	[p1l484t1573r509b1601],
24	receptor	NN	O	receptor	prep_for	19	SENT_13	[p1l521t1577r651b1609],
25	blocker	NN	O	blocker	nn	29	SENT_13	[p1l662t1573r781b1601],
26	(	NN	O	(	nn	29	SENT_13	[p1l794t1573r898b1607],
27	ARB	NN	O	arb	nn	29	SENT_13	[p1l794t1573r898b1607],
28	)	NN	O	)	nn	29	SENT_13	[p1l794t1573r898b1607],
29	treatment	NN	O	treatment	nsubjpass	39	SENT_13	[p1l912t1577r1061b1601],
30	to	TO	O	to	aux	31	SENT_13	[p1l1072t1577r1102b1601],
31	control	VB	O	control	rcmod	29	SENT_13	[p1l1115t1573r1225b1601],
32	hypertension	NN	O	hypertension	dobj	31	SENT_13	[p1l1238t1573r1441b1609],
33	or	CC	O	or	_	0	SENT_13	[p1l1454t1582r1486b1601],
34	to	TO	O	to	aux	35	SENT_13	[p1l1498t1577r1527b1601],
35	treat	VB	O	treat	rcmod	29	SENT_13	[p1l1540t1577r1610b1601],
36	heart	NN	O	heart	nn	37	SENT_13	[p1l1620t1573r1699b1601],
37	failure	NN	O	failure	dobj	35	SENT_13	[p1l1710t1573r1812b1601],
38	were	VBD	O	be	auxpass	39	SENT_13	[p1l1824t1582r1899b1601],
39	selected	VBN	O	select	dep	7	SENT_13	[p1l1912t1573r2045b1601],
40	.	.	O	.	_	0	SENT_13	[p1l1912t1573r2045b1601],

1	Blood	NN	O	blood	nn	2	SENT_14	[p1l2058t1573r2154b1601],
2	samples	NNS	O	sample	nsubjpass	4	SENT_14	[p1l109t1622r233b1658],
3	were	VBD	O	be	auxpass	4	SENT_14	[p1l246t1631r321b1650],
4	taken	VBN	O	take	_	0	SENT_14	[p1l332t1622r417b1650],
5	before	IN	O	before	_	0	SENT_14	[p1l428t1622r528b1650],
6	torasemide	NN	O	torasemide	nn	7	SENT_14	[p1l540t1622r712b1650],
7	administration	NN	O	administration	prep_before	4	SENT_14	[p1l724t1622r951b1650],
8	and	CC	O	and	_	0	SENT_14	[p1l963t1622r1019b1650],
9	0.5	CD	NUMBER	0.5	num	19	SENT_14	[p1l1030t1622r1087b1655],
10	,	,	O	,	_	0	SENT_14	[p1l1030t1622r1087b1655],
11	1	CD	NUMBER	1	num	19	SENT_14	[p1l1103t1623r1127b1655],
12	,	,	O	,	_	0	SENT_14	[p1l1103t1623r1127b1655],
13	2	CD	NUMBER	2	num	19	SENT_14	[p1l1140t1622r1167b1655],
14	,	,	O	,	_	0	SENT_14	[p1l1140t1622r1167b1655],
15	4	CD	NUMBER	4	num	19	SENT_14	[p1l1179t1622r1207b1655],
16	,	,	O	,	_	0	SENT_14	[p1l1179t1622r1207b1655],
17	8	CD	NUMBER	8	num	19	SENT_14	[p1l1221t1622r1246b1655],
18	,	,	O	,	_	0	SENT_14	[p1l1221t1622r1246b1655],
19	12	CD	NUMBER	12	conj_and	7	SENT_14	[p1l1258t1622r1293b1650],
20	and	CC	O	and	_	0	SENT_14	[p1l1303t1622r1359b1650],
21	24	CD	DURATION	24	num	22	SENT_14	[p1l1369t1622r1406b1650],
22	hours	NNS	NUMBER	hour	conj_and	7	SENT_14	[p1l1416t1622r1502b1650],
23	after	IN	O	after	_	0	SENT_14	[p1l1513t1622r1584b1650],
24	administration	NN	O	administration	prep_after	4	SENT_14	[p1l1594t1622r1829b1650],
25	.	.	O	.	_	0	SENT_14	[p1l1594t1622r1829b1650],

1	After	IN	O	after	_	0	SENT_15	[p1l1840t1622r1923b1650],
2	this	DT	O	this	det	5	SENT_15	[p1l1932t1622r1987b1650],
3	first	JJ	ORDINAL	first	amod	5	SENT_15	[p1l1997t1622r2061b1650],
4	study	NN	O	study	nn	5	SENT_15	[p1l2071t1622r2154b1658],
5	period	NN	O	period	prep_after	8	SENT_15	[p1l77t1671r186b1707],
6	,	,	O	,	_	0	SENT_15	[p1l77t1671r186b1707],
7	patients	NNS	O	patient	nsubj	8	SENT_15	[p1l196t1671r318b1707],
8	received	VBD	O	receive	_	0	SENT_15	[p1l328t1671r462b1699],
9	either	CC	O	either	prep	8	SENT_15	[p1l471t1671r561b1699],
10	irbesartan	NN	O	irbesartan	nn	12	SENT_15	[p1l569t1671r724b1699],
11	150	CD	NUMBER	150	num	12	SENT_15	[p1l737t1671r792b1699],
12	mg	NN	O	mg	dep	9	SENT_15	[p1l801t1680r850b1707],
13	(	CD	NUMBER	(	number	14	SENT_15	[p1l862t1671r934b1705],
14	five	CD	NUMBER	five	num	15	SENT_15	[p1l862t1671r934b1705],
15	female	NN	O	female	dep	12	SENT_15	[p1l946t1671r1053b1699],
16	and	CC	O	and	_	0	SENT_15	[p1l1066t1671r1122b1699],
17	seven	CD	NUMBER	seven	num	19	SENT_15	[p1l1135t1680r1223b1699],
18	male	JJ	O	male	amod	19	SENT_15	[p1l1236t1671r1311b1699],
19	patients	NNS	O	patient	conj_and	12	SENT_15	[p1l1323t1671r1445b1707],
20	aged	JJ	O	aged	amod	19	SENT_15	[p1l1459t1671r1533b1707],
21	69	CD	NUMBER	69	tmod	20	SENT_15	[p1l1546t1671r1582b1699],
22	i	FW	O	i	dep	19	SENT_15	[p1l1596t1673r1617b1699],
23	8	CD	DURATION	8	num	24	SENT_15	[p1l1631t1671r1646b1699],
24	years	NNS	NUMBER	year	dobj	8	SENT_15	[p1l1661t1672r1755b1707],
25	)	CD	NUMBER	)	dep	32	SENT_15	[p1l1661t1672r1755b1707],
26	or	CC	O	or	_	0	SENT_15	[p1l1769t1680r1801b1699],
27	losartan	NN	O	losartan	conj_or	25	SENT_15	[p1l1813t1671r1937b1699],
28	100	CD	NUMBER	100	num	29	SENT_15	[p1l1954t1671r2008b1699],
29	mg	NN	O	mg	dep	32	SENT_15	[p1l2021t1680r2070b1707],
30	(	CD	NUMBER	(	number	31	SENT_15	[p1l2084t1672r2154b1705],
31	two	CD	NUMBER	two	num	32	SENT_15	[p1l2084t1672r2154b1705],
32	female	JJ	O	female	dep	39	SENT_15	[p1l94t1720r200b1748],
33	and	CC	O	and	_	0	SENT_15	[p1l214t1720r270b1748],
34	ten	CD	NUMBER	ten	num	36	SENT_15	[p1l282t1725r329b1748],
35	male	JJ	O	male	amod	36	SENT_15	[p1l342t1720r418b1748],
36	patients	NNS	O	patient	dep	39	SENT_15	[p1l430t1720r551b1756],
37	aged	JJ	O	aged	amod	36	SENT_15	[p1l566t1720r639b1756],
38	61	CD	NUMBER	61	tmod	37	SENT_15	[p1l651t1720r686b1748],
39	i	FW	O	i	dep	24	SENT_15	[p1l704t1722r726b1748],
40	8	CD	DURATION	8	num	41	SENT_15	[p1l742t1720r758b1748],
41	years	NNS	NUMBER	year	dep	39	SENT_15	[p1l774t1721r869b1756],
42	)	RB	O	)	advmod	44	SENT_15	[p1l774t1721r869b1756],
43	once	RB	DATE	once	advmod	44	SENT_15	[p1l886t1729r959b1748],
44	daily	JJ	SET	daily	amod	41	SENT_15	[p1l975t1720r1060b1756],
45	.	.	O	.	_	0	SENT_15	[p1l975t1720r1060b1756],

1	After	IN	O	after	_	0	SENT_16	[p1l1078t1720r1161b1748],
2	3	CD	DURATION	3	num	3	SENT_16	[p1l1176t1720r1192b1748],
3	days	NNS	NUMBER	day	prep_after	13	SENT_16	[p1l1210t1720r1280b1756],
4	of	IN	O	of	_	0	SENT_16	[p1l1296t1720r1331b1748],
5	ARB	NN	O	arb	nn	6	SENT_16	[p1l1343t1721r1421b1748],
6	medication	NN	O	medication	prep_of	3	SENT_16	[p1l1439t1720r1622b1753],
7	,	,	O	,	_	0	SENT_16	[p1l1439t1720r1622b1753],
8	eight	CD	NUMBER	eight	num	10	SENT_16	[p1l1639t1720r1718b1756],
9	blood	NN	O	blood	nn	10	SENT_16	[p1l1732t1720r1822b1748],
10	samples	NNS	O	sample	nsubjpass	13	SENT_16	[p1l1838t1720r1962b1756],
11	were	VBD	O	be	auxpass	13	SENT_16	[p1l1979t1729r2054b1748],
12	again	RB	O	again	advmod	13	SENT_16	[p1l2070t1720r2154b1756],
13	collected	VBN	O	collect	_	0	SENT_16	[p1l130t1769r272b1797],
14	at	IN	O	at	_	0	SENT_16	[p1l287t1774r315b1797],
15	the	DT	O	the	det	16	SENT_16	[p1l329t1769r376b1797],
16	timepoints	NNS	O	timepoint	prep_at	13	SENT_16	[p1l389t1769r555b1805],
17	indicated	VBD	O	indicate	partmod	16	SENT_16	[p1l576t1769r720b1797],
18	above	IN	O	above	prep	17	SENT_16	[p1l741t1769r841b1797],
19	.	.	O	.	_	0	SENT_16	[p1l741t1769r841b1797],

1	The	DT	O	the	det	2	SENT_17	[p1l864t1769r924b1797],
2	patients	NNS	O	patient	nsubj	3	SENT_17	[p1l944t1769r1076b1805],
3	’	VBP	O	’	_	0	SENT_17	[p1l944t1769r1076b1805],
4	long-term	JJ	O	long-term	amod	5	SENT_17	[p1l1100t1769r1255b1805],
5	medications	NNS	O	medication	nsubjpass	16	SENT_17	[p1l1275t1769r1474b1802],
6	,	,	O	,	_	0	SENT_17	[p1l1275t1769r1474b1802],
7	which	WDT	O	which	nsubj	10	SENT_17	[p1l1496t1769r1591b1797],
8	did	VBD	O	do	aux	10	SENT_17	[p1l1611t1769r1661b1797],
9	not	RB	O	not	neg	10	SENT_17	[p1l1681t1773r1731b1797],
10	include	VB	O	include	rcmod	5	SENT_17	[p1l1751t1769r1866b1797],
11	known	VBN	O	know	amod	13	SENT_17	[p1l1886t1769r1993b1797],
12	CYP2C9	NN	O	cyp2c9	nn	13	SENT_17	[p1l2013t1769r2154b1797],
13	inhibitors	NNS	O	inhibitor	dobj	10	SENT_17	[p1l59t1818r218b1851],
14	,	,	O	,	_	0	SENT_17	[p1l59t1818r218b1851],
15	were	VBD	O	be	auxpass	16	SENT_17	[p1l230t1827r306b1846],
16	maintained	VBN	O	maintain	ccomp	3	SENT_17	[p1l317t1818r492b1846],
17	at	IN	O	at	_	0	SENT_17	[p1l502t1822r530b1846],
18	a	DT	O	a	det	20	SENT_17	[p1l540t1827r557b1846],
19	constant	JJ	O	constant	amod	20	SENT_17	[p1l567t1822r698b1846],
20	dose	NN	O	dose	prep_at	16	SENT_17	[p1l708t1818r779b1846],
21	during	IN	O	during	_	0	SENT_17	[p1l790t1818r892b1854],
22	the	DT	O	the	det	23	SENT_17	[p1l903t1818r950b1846],
23	study	NN	O	study	prep_during	16	SENT_17	[p1l962t1818r1053b1854],
24	.	.	O	.	_	0	SENT_17	[p1l962t1818r1053b1854],

1	All	DT	O	all	det	2	SENT_18	[p1l1066t1818r1115b1846],
2	patients	NNS	O	patient	nsubjpass	4	SENT_18	[p1l1125t1818r1247b1854],
3	were	VBD	O	be	auxpass	4	SENT_18	[p1l1258t1827r1334b1846],
4	genotyped	VBN	O	genotype	_	0	SENT_18	[p1l1345t1818r1509b1854],
5	for	IN	O	for	_	0	SENT_18	[p1l1519t1818r1565b1846],
6	CYP2	NN	O	cyp2	nn	7	SENT_18	[p1l1576t1818r1664b1846],
7	C9	NN	O	c9	prep_for	4	SENT_18	[p1l1669t1818r1712b1846],
8	(	CD	NUMBER	(	num	9	SENT_18	[p1l1723t1818r1752b1852],
9	*	NN	O	*	amod	63	SENT_18	[p1l1723t1818r1752b1852],
10	1	CD	NUMBER	1	dep	9	SENT_18	[p1l1759t1818r1786b1846],
11	/	:	O	/	punct	18	SENT_18	[p1l1759t1818r1786b1846],
12	*	CD	NUMBER	*	number	13	SENT_18	[p1l1788t1818r1821b1846],
13	1	CD	NUMBER	1	num	18	SENT_18	[p1l1788t1818r1821b1846],
14	[	NN	O	[	nn	18	SENT_18	[p1l1834t1819r1863b1852],
15	n	NN	O	n	nn	18	SENT_18	[p1l1834t1819r1863b1852],
16	=	JJ	O	=	amod	18	SENT_18	[p1l1877t1830r1897b1841],
17	15	CD	NUMBER	15	num	18	SENT_18	[p1l1914t1818r1972b1852],
18	]	NN	O	]	dep	9	SENT_18	[p1l1914t1818r1972b1852],
19	;	:	O	;	_	0	SENT_18	[p1l1914t1818r1972b1852],
20	*	CD	NUMBER	*	number	21	SENT_18	[p1l1988t1818r2003b1835],
21	1	CD	NUMBER	1	amod	57	SENT_18	[p1l2010t1818r2037b1846],
22	/	:	O	/	punct	54	SENT_18	[p1l2010t1818r2037b1846],
23	*	CD	NUMBER	*	number	24	SENT_18	[p1l2039t1818r2075b1846],
24	2	CD	NUMBER	2	num	29	SENT_18	[p1l2039t1818r2075b1846],
25	[	NN	O	[	nn	29	SENT_18	[p1l2091t1819r2120b1852],
26	n	NN	O	n	nn	29	SENT_18	[p1l2091t1819r2120b1852],
27	=	JJ	O	=	amod	29	SENT_18	[p1l2134t1830r2154b1841],
28	4	CD	NUMBER	4	num	29	SENT_18	[p1l155t1867r197b1901],
29	]	NN	O	]	dep	54	SENT_18	[p1l155t1867r197b1901],
30	;	:	O	;	_	0	SENT_18	[p1l155t1867r197b1901],
31	*	CD	NUMBER	*	number	32	SENT_18	[p1l213t1867r298b1896],
32	1	CD	NUMBER	1	dep	29	SENT_18	[p1l213t1867r298b1896],
33	/	:	O	/	punct	32	SENT_18	[p1l213t1867r298b1896],
34	*	CD	NUMBER	*	number	35	SENT_18	[p1l213t1867r298b1896],
35	3	CD	NUMBER	3	num	37	SENT_18	[p1l213t1867r298b1896],
36	[	NN	O	[	nn	37	SENT_18	[p1l316t1868r345b1901],
37	n	NN	O	n	npadvmod	38	SENT_18	[p1l316t1868r345b1901],
38	=	JJ	O	=	amod	29	SENT_18	[p1l359t1879r379b1890],
39	5	CD	NUMBER	5	dep	38	SENT_18	[p1l393t1867r436b1902],
40	]	CD	NUMBER	]	num	41	SENT_18	[p1l393t1867r436b1902],
41	)	NN	O	)	npadvmod	42	SENT_18	[p1l393t1867r436b1902],
42	as	RB	O	as	dep	39	SENT_18	[p1l451t1876r481b1895],
43	well	RB	O	well	advmod	42	SENT_18	[p1l496t1867r562b1895],
44	as	IN	O	as	_	0	SENT_18	[p1l576t1876r606b1895],
45	for	IN	O	for	_	0	SENT_18	[p1l620t1867r666b1895],
46	SLCOIBI	NNP	O	SLCOIBI	prep_as_for	51	SENT_18	[p1l678t1867r835b1896],
47	(	CD	NUMBER	(	num	46	SENT_18	[p1l852t1867r998b1902],
48	c.	NN	O	c.	nn	51	SENT_18	[p1l852t1867r998b1902],
49	521TT	NN	O	521tt	nn	51	SENT_18	[p1l852t1867r998b1902],
50	[	CD	NUMBER	[	num	51	SENT_18	[p1l1014t1868r1043b1901],
51	n	NN	O	n	pobj	42	SENT_18	[p1l1014t1868r1043b1901],
52	=	JJ	O	=	amod	54	SENT_18	[p1l1056t1879r1077b1890],
53	13	CD	NUMBER	13	num	54	SENT_18	[p1l1094t1867r1151b1901],
54	]	NN	O	]	dep	21	SENT_18	[p1l1094t1867r1151b1901],
55	;	:	O	;	_	0	SENT_18	[p1l1094t1867r1151b1901],
56	c.	NN	O	c.	nn	57	SENT_18	[p1l1166t1867r1301b1895],
57	521TC	NN	O	521tc	dep	18	SENT_18	[p1l1166t1867r1301b1895],
58	[	CD	NUMBER	[	num	59	SENT_18	[p1l1318t1868r1347b1901],
59	n	NN	O	n	dep	18	SENT_18	[p1l1318t1868r1347b1901],
60	=	JJ	O	=	amod	63	SENT_18	[p1l1360t1879r1381b1890],
61	11	CD	NUMBER	11	number	62	SENT_18	[p1l1398t1868r1467b1902],
62	]	CD	NUMBER	]	num	63	SENT_18	[p1l1398t1868r1467b1902],
63	)	NN	O	)	dep	4	SENT_18	[p1l1398t1868r1467b1902],
64	.	.	O	.	_	0	SENT_18	[p1l1398t1868r1467b1902],

1	Results	NNS	O	result	dep	121	SENT_19	[p1l1480t1868r1612b1896],
2	:	:	O	:	_	0	SENT_19	[p1l1480t1868r1612b1896],
3	Factorial	JJ	O	factorial	dep	121	SENT_19	[p1l1637t1867r1776b1896],
4	ANOVA	NNP	O	ANOVA	dep	121	SENT_19	[p1l1799t1868r1941b1896],
5	revealed	VBD	O	reveal	dep	121	SENT_19	[p1l1962t1867r2096b1896],
6	an	DT	O	a	dep	121	SENT_19	[p1l2119t1876r2154b1896],
7	independent	JJ	O	independent	dep	121	SENT_19	[p1l18t1917r211b1953],
8	impact	NN	O	impact	dep	121	SENT_19	[p1l232t1917r340b1953],
9	of	IN	O	of	dep	121	SENT_19	[p1l362t1917r396b1945],
10	the	DT	O	the	dep	121	SENT_19	[p1l415t1917r462b1945],
11	CYPZC9	NN	O	cypzc9	dep	121	SENT_19	[p1l487t1917r623b1945],
12	genotype	NN	O	genotype	dep	121	SENT_19	[p1l645t1921r788b1953],
13	(	CD	NUMBER	(	dep	121	SENT_19	[p1l812t1917r1087b1951],
14	dose-normalized	JJ	O	dose-normalized	dep	121	SENT_19	[p1l812t1917r1087b1951],
15	area	NN	O	area	dep	121	SENT_19	[p1l1099t1926r1164b1945],
16	under	IN	O	under	dep	121	SENT_19	[p1l1173t1917r1263b1945],
17	the	DT	O	the	dep	121	SENT_19	[p1l1273t1917r1320b1945],
18	plasma	NN	O	plasma	dep	121	SENT_19	[p1l1330t1917r1442b1953],
19	concentration-time	NN	O	concentration-time	dep	121	SENT_19	[p1l1453t1917r1750b1945],
20	curve	NN	O	curve	dep	121	SENT_19	[p1l1761t1926r1847b1945],
21	during	IN	O	during	dep	121	SENT_19	[p1l1859t1917r1960b1953],
22	the	DT	O	the	dep	121	SENT_19	[p1l1971t1917r2018b1945],
23	24-hour	JJ	DURATION	24-hour	dep	121	SENT_19	[p1l2029t1917r2154b1945],
24	dosing	NN	O	dosing	dep	121	SENT_19	[p1l18t1965r122b2001],
25	interval	NN	O	interval	dep	121	SENT_19	[p1l133t1965r252b1993],
26	at	IN	O	at	dep	121	SENT_19	[p1l264t1970r291b1993],
27	steady	JJ	O	steady	dep	121	SENT_19	[p1l303t1965r401b2001],
28	state	NN	O	state	dep	121	SENT_19	[p1l413t1970r483b1993],
29	[	CD	NUMBER	[	dep	121	SENT_19	[p1l497t1966r715b2001],
30	AUC24	NN	O	auc24	dep	121	SENT_19	[p1l497t1966r715b2001],
31	,	,	O	,	_	0	SENT_19	[p1l497t1966r715b2001],
32	ss/D	NN	O	ss/d	dep	121	SENT_19	[p1l497t1966r715b2001],
33	]	CD	NUMBER	]	dep	121	SENT_19	[p1l497t1966r715b2001],
34	:	:	O	:	_	0	SENT_19	[p1l497t1966r715b2001],
35	*	CD	NUMBER	*	dep	121	SENT_19	[p1l727t1965r811b1993],
36	1	CD	NUMBER	1	dep	121	SENT_19	[p1l727t1965r811b1993],
37	/	:	O	/	dep	121	SENT_19	[p1l727t1965r811b1993],
38	*	CD	NUMBER	*	dep	121	SENT_19	[p1l727t1965r811b1993],
39	1	CD	NUMBER	1	dep	121	SENT_19	[p1l727t1965r811b1993],
40	375.5	CD	NUMBER	375.5	dep	121	SENT_19	[p1l832t1965r917b1993],
41	i	FW	O	i	dep	121	SENT_19	[p1l935t1966r956b1992],
42	151.4	CD	NUMBER	151.4	dep	121	SENT_19	[p1l976t1965r1060b1993],
43	ug	NN	O	ug	dep	121	SENT_19	[p1l1077t1972r1117b2001],
44	o	NN	O	o	dep	121	SENT_19	[p1l1130t1976r1142b1989],
45	h/L/mg	NN	O	h/l/mg	dep	121	SENT_19	[p1l1154t1965r1269b2001],
46	vs	CC	O	vs	dep	121	SENT_19	[p1l1286t1974r1319b1993],
47	*	NN	O	*	dep	121	SENT_19	[p1l1338t1965r1423b1993],
48	1	CD	NUMBER	1	dep	121	SENT_19	[p1l1338t1965r1423b1993],
49	/	:	O	/	dep	121	SENT_19	[p1l1338t1965r1423b1993],
50	*	CD	NUMBER	*	dep	121	SENT_19	[p1l1338t1965r1423b1993],
51	3	CD	NUMBER	3	dep	121	SENT_19	[p1l1338t1965r1423b1993],
52	548.5	CD	NUMBER	548.5	dep	121	SENT_19	[p1l1442t1965r1528b1993],
53	i	FW	O	i	dep	121	SENT_19	[p1l1546t1966r1567b1992],
54	271.6	CD	NUMBER	271.6	dep	121	SENT_19	[p1l1584t1965r1671b1993],
55	ug	NN	O	ug	dep	121	SENT_19	[p1l1688t1972r1728b2001],
56	-	:	O	-	_	0	SENT_19	[p1l1741t1976r1753b1989],
57	h/L/mg	NN	O	h/l/mg	dep	121	SENT_19	[p1l1765t1965r1889b2001],
58	,	,	O	,	_	0	SENT_19	[p1l1765t1965r1889b2001],
59	p	NN	O	p	dep	121	SENT_19	[p1l1906t1974r1925b2001],
60	=	JJ	O	=	dep	121	SENT_19	[p1l1942t1977r1963b1988],
61	0.001	CD	NUMBER	0.001	dep	121	SENT_19	[p1l1980t1965r2089b1999],
62	)	NN	O	)	dep	121	SENT_19	[p1l1980t1965r2089b1999],
63	,	,	O	,	_	0	SENT_19	[p1l1980t1965r2089b1999],
64	the	DT	O	the	dep	121	SENT_19	[p1l2107t1965r2154b1993],
65	SLCOIBI	NNP	O	SLCOIBI	dep	121	SENT_19	[p1l60t2014r217b2042],
66	genotype	NN	O	genotype	dep	121	SENT_19	[p1l237t2018r380b2050],
67	(	CD	NUMBER	(	dep	121	SENT_19	[p1l392t2014r599b2049],
68	AUC24	NN	O	auc24	dep	121	SENT_19	[p1l392t2014r599b2049],
69	,	,	O	,	_	0	SENT_19	[p1l392t2014r599b2049],
70	ss/D	NN	O	ss/d	dep	121	SENT_19	[p1l392t2014r599b2049],
71	:	:	O	:	_	0	SENT_19	[p1l392t2014r599b2049],
72	TT	NN	O	tt	dep	121	SENT_19	[p1l612t2015r659b2041],
73	352.3	CD	NUMBER	352.3	dep	121	SENT_19	[p1l670t2014r755b2042],
74	i	FW	O	i	dep	121	SENT_19	[p1l766t2015r788b2041],
75	114	CD	NUMBER	114	dep	121	SENT_19	[p1l801t2014r856b2041],
76	ug	NN	O	ug	dep	121	SENT_19	[p1l867t2021r907b2050],
77	o	NN	O	o	dep	121	SENT_19	[p1l919t2025r932b2038],
78	h/L/mg	NN	O	h/l/mg	dep	121	SENT_19	[p1l943t2014r1059b2050],
79	vs	CC	O	vs	dep	121	SENT_19	[p1l1069t2023r1102b2042],
80	TC	NN	O	tc	dep	121	SENT_19	[p1l1113t2014r1162b2042],
81	487.6	CD	NUMBER	487.6	dep	121	SENT_19	[p1l1172t2014r1260b2042],
82	i	FW	O	i	dep	121	SENT_19	[p1l1270t2015r1292b2041],
83	218.4	CD	NUMBER	218.4	dep	121	SENT_19	[p1l1302t2014r1389b2042],
84	ug	NN	O	ug	dep	121	SENT_19	[p1l1400t2021r1440b2050],
85	-	:	O	-	_	0	SENT_19	[p1l1453t2025r1465b2038],
86	h/L/mg	NN	O	h/l/mg	dep	121	SENT_19	[p1l1477t2014r1601b2050],
87	,	,	O	,	_	0	SENT_19	[p1l1477t2014r1601b2050],
88	p	NN	O	p	dep	121	SENT_19	[p1l1612t2023r1631b2050],
89	<	JJR	O	<	dep	121	SENT_19	[p1l1641t2021r1662b2041],
90	0.05	CD	NUMBER	0.05	dep	121	SENT_19	[p1l1672t2014r1752b2048],
91	)	NN	O	)	dep	121	SENT_19	[p1l1672t2014r1752b2048],
92	and	CC	O	and	dep	121	SENT_19	[p1l1764t2014r1820b2042],
93	gender	NN	O	gender	dep	121	SENT_19	[p1l1830t2014r1937b2050],
94	(	NN	O	(	dep	121	SENT_19	[p1l1947t2014r2154b2049],
95	AUC24	NN	O	auc24	dep	121	SENT_19	[p1l1947t2014r2154b2049],
96	,	,	O	,	_	0	SENT_19	[p1l1947t2014r2154b2049],
97	ss/D2	NN	O	ss/d2	dep	121	SENT_19	[p1l1947t2014r2154b2049],
98	males	NNS	O	male	dep	121	SENT_19	[p1l55t2063r145b2091],
99	359.5	CD	NUMBER	359.5	dep	121	SENT_19	[p1l161t2063r246b2091],
100	i	FW	O	i	dep	121	SENT_19	[p1l261t2064r283b2090],
101	72.2	CD	NUMBER	72.2	dep	121	SENT_19	[p1l296t2063r363b2091],
102	ug	NN	O	ug	dep	121	SENT_19	[p1l378t2070r419b2099],
103	-	:	O	-	_	0	SENT_19	[p1l431t2074r443b2087],
104	h/L/mg	NN	O	h/l/mg	dep	121	SENT_19	[p1l455t2063r570b2099],
105	vs	CC	O	vs	dep	121	SENT_19	[p1l584t2072r617b2091],
106	females	NNS	O	female	dep	121	SENT_19	[p1l632t2063r753b2091],
107	547.3	CD	NUMBER	547.3	dep	121	SENT_19	[p1l768t2063r854b2091],
108	i	FW	O	i	dep	121	SENT_19	[p1l869t2064r890b2090],
109	284	CD	NUMBER	284	dep	121	SENT_19	[p1l904t2063r961b2091],
110	ug	NN	O	ug	dep	121	SENT_19	[p1l976t2070r1016b2099],
111	o	NN	O	o	dep	121	SENT_19	[p1l1029t2074r1041b2087],
112	h/L/mg	NN	O	h/l/mg	dep	121	SENT_19	[p1l1053t2063r1177b2099],
113	,	,	O	,	_	0	SENT_19	[p1l1053t2063r1177b2099],
114	p	NN	O	p	dep	121	SENT_19	[p1l1191t2072r1210b2099],
115	<	JJR	O	<	dep	121	SENT_19	[p1l1225t2070r1245b2091],
116	0.01	CD	NUMBER	0.01	dep	121	SENT_19	[p1l1259t2063r1339b2097],
117	)	NN	O	)	dep	121	SENT_19	[p1l1259t2063r1339b2097],
118	on	IN	O	on	dep	121	SENT_19	[p1l1355t2072r1393b2091],
119	disposition	NN	O	disposition	dep	121	SENT_19	[p1l1407t2063r1579b2099],
120	of	IN	O	of	dep	121	SENT_19	[p1l1593t2063r1627b2091],
121	torasemide	NN	O	torasemide	_	0	SENT_19	[p1l1638t2063r1819b2091],
122	.	.	O	.	_	0	SENT_19	[p1l1638t2063r1819b2091],

1	Coadministration	NN	O	coadministration	nsubj	4	SENT_20	[p1l1831t2063r2105b2091],
2	of	IN	O	of	_	0	SENT_20	[p1l2120t2063r2154b2091],
3	irbesartan	NN	O	irbesartan	prep_of	1	SENT_20	[p1l724t2112r879b2140],
4	caused	VBD	O	cause	_	0	SENT_20	[p1l894t2112r1001b2140],
5	a	DT	O	a	det	8	SENT_20	[p1l1016t2121r1033b2140],
6	13	CD	PERCENT	13	number	7	SENT_20	[p1l1051t2112r1117b2140],
7	%	NN	PERCENT	%	amod	8	SENT_20	[p1l1051t2112r1117b2140],
8	increase	NN	O	increase	dobj	4	SENT_20	[p1l1133t2112r1261b2140],
9	in	IN	O	in	_	0	SENT_20	[p1l1276t2112r1306b2139],
10	the	DT	O	the	det	11	SENT_20	[p1l1321t2112r1368b2140],
11	AUC24	NN	O	auc24	prep_in	4	SENT_20	[p1l1383t2112r1568b2147],
12	,	,	O	,	_	0	SENT_20	[p1l1383t2112r1568b2147],
13	ss/D	NN	O	ss/d	dobj	4	SENT_20	[p1l1383t2112r1568b2147],
14	of	IN	O	of	_	0	SENT_20	[p1l1584t2112r1619b2140],
15	torasemide	NN	O	torasemide	nn	17	SENT_20	[p1l1630t2112r1803b2140],
16	(	NN	O	(	nn	17	SENT_20	[p1l1819t2113r1849b2148],
17	p	NN	O	p	prep_of	13	SENT_20	[p1l1819t2113r1849b2148],
18	=	JJ	O	=	advmod	4	SENT_20	[p1l1865t2124r1886b2135],
19	0.002	CD	NUMBER	0.002	num	20	SENT_20	[p1l1901t2112r2010b2146],
20	)	NN	O	)	dep	18	SENT_20	[p1l1901t2112r2010b2146],
21	,	,	O	,	_	0	SENT_20	[p1l1901t2112r2010b2146],
22	whereas	IN	O	whereas	mark	24	SENT_20	[p1l2027t2112r2154b2140],
23	losartan	NN	O	losartan	nsubj	24	SENT_20	[p1l6t2161r131b2189],
24	had	VBD	O	have	dep	18	SENT_20	[p1l143t2161r200b2189],
25	no	DT	O	no	det	26	SENT_20	[p1l213t2170r251b2189],
26	effect	NN	O	effect	dobj	24	SENT_20	[p1l264t2161r361b2189],
27	.	.	O	.	_	0	SENT_20	[p1l264t2161r361b2189],

1	Conclusion	NN	O	conclusion	_	0	SENT_21	[p1l142t2210r339b2238],
2	:	:	O	:	_	0	SENT_21	[p1l142t2210r339b2238],
3	This	DT	O	this	det	4	SENT_21	[p1l357t2210r426b2238],
4	study	NN	O	study	nsubj	5	SENT_21	[p1l443t2210r526b2246],
5	shows	VBZ	O	show	dep	1	SENT_21	[p1l544t2210r639b2238],
6	that	IN	O	that	complm	13	SENT_21	[p1l656t2210r715b2238],
7	the	DT	O	the	det	9	SENT_21	[p1l729t2210r777b2238],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_21	[p1l794t2211r967b2238],
9	*	NN	O	*	nsubj	13	SENT_21	[p1l794t2211r967b2238],
10	3	CD	NUMBER	3	dep	9	SENT_21	[p1l794t2211r967b2238],
11	and	CC	O	and	_	0	SENT_21	[p1l986t2210r1041b2238],
12	SLCOIBI	NNP	O	SLCOIBI	conj_and	9	SENT_21	[p1l1057t2211r1213b2238],
13	c.	VBP	O	c.	ccomp	5	SENT_21	[p1l1232t2210r1367b2238],
14	521TC	NN	O	521tc	nn	15	SENT_21	[p1l1232t2210r1367b2238],
15	genotype	NN	O	genotype	nsubj	23	SENT_21	[p1l1384t2215r1527b2246],
16	and	CC	O	and	_	0	SENT_21	[p1l1544t2210r1599b2238],
17	female	JJ	O	female	amod	18	SENT_21	[p1l1615t2210r1721b2238],
18	gender	NN	O	gender	nsubj	23	SENT_21	[p1l1737t2210r1844b2246],
19	are	VBP	O	be	cop	23	SENT_21	[p1l1859t2219r1906b2238],
20	significant	JJ	O	significant	amod	23	SENT_21	[p1l1918t2210r2084b2246],
21	and	CC	O	and	_	0	SENT_21	[p1l2098t2210r2154b2238],
22	independent	JJ	O	independent	conj_and	20	SENT_21	[p1l132t2259r325b2295],
23	predictors	NNS	O	predictor	ccomp	13	SENT_21	[p1l339t2259r495b2295],
24	of	IN	O	of	_	0	SENT_21	[p1l511t2259r546b2287],
25	the	DT	O	the	det	26	SENT_21	[p1l558t2259r605b2287],
26	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	23	SENT_21	[p1l619t2259r897b2295],
27	of	IN	O	of	_	0	SENT_21	[p1l913t2259r947b2287],
28	torasemide	NN	O	torasemide	prep_of	26	SENT_21	[p1l959t2259r1139b2287],
29	.	.	O	.	_	0	SENT_21	[p1l959t2259r1139b2287],

1	Coadministration	NN	O	coadministration	_	0	SENT_22	[p1l1157t2259r1430b2287],
2	of	IN	O	of	_	0	SENT_22	[p1l1445t2259r1479b2287],
3	irbesartan	NN	O	irbesartan	nn	4	SENT_22	[p1l1491t2259r1646b2287],
4	yields	NNS	O	yield	prep_of	1	SENT_22	[p1l1659t2259r1752b2295],
5	moderate	JJ	O	moderate	amod	8	SENT_22	[p1l1766t2259r1912b2287],
6	but	CC	O	but	_	0	SENT_22	[p1l1925t2259r1975b2287],
7	significant	JJ	O	significant	conj_but	5	SENT_22	[p1l1989t2259r2154b2295],
8	increases	NNS	O	increase	dep	1	SENT_22	[p1l961t2308r1104b2336],
9	in	IN	O	in	_	0	SENT_22	[p1l1118t2308r1148b2336],
10	the	DT	O	the	det	13	SENT_22	[p1l1161t2308r1208b2336],
11	torasemide	NN	O	torasemide	nn	13	SENT_22	[p1l1221t2308r1394b2336],
12	plasma	NN	O	plasma	nn	13	SENT_22	[p1l1406t2308r1519b2344],
13	concentration	NN	O	concentration	prep_in	8	SENT_22	[p1l1531t2308r1745b2336],
14	and	CC	O	and	_	0	SENT_22	[p1l1759t2308r1815b2336],
15	elimination	NN	O	elimination	nn	16	SENT_22	[p1l1828t2308r2007b2336],
16	half-life	NN	O	half-life	conj_and	13	SENT_22	[p1l2019t2308r2154b2336],
17	.	.	O	.	_	0	SENT_22	[p1l2019t2308r2154b2336],

1	324	CD	NUMBER	324	num	2	SENT_23	[p1l6t2408r55b2432],
2	Werner	NNP	O	Werner	_	0	SENT_23	[p1l6t2443r105b2467],
3	et	FW	O	et	nn	4	SENT_23	[p1l116t2445r139b2467],
4	al.	FW	O	al.	dep	2	SENT_23	[p1l149t2442r179b2467],
5	.	.	O	.	_	0	SENT_23	[p1l149t2442r179b2467],

1	Background	NN	O	background	_	0	SENT_24	[p1l109t2645r582b2723],

1	In	IN	O	in	_	0	SENT_25	[p1l105t2871r170b2925],
2	accordance	NN	O	accordance	_	0	SENT_25	[p1l230t2869r590b2926],
3	with	IN	O	with	_	0	SENT_25	[p1l649t2869r790b2926],
4	current	JJ	DATE	current	amod	5	SENT_25	[p1l849t2878r1076b2926],
5	guidelines	NNS	O	guideline	prep_in_accordance_with	12	SENT_25	[p1l1134t2869r1481b2943],
6	,	,	O	,	_	0	SENT_25	[p1l1134t2869r1481b2943],
7	diuretics	NNS	O	diuretic	nsubjpass	12	SENT_25	[p1l1543t2869r1817b2926],
8	such	JJ	O	such	_	0	SENT_25	[p1l1880t2869r2024b2926],
9	as	IN	O	as	_	0	SENT_25	[p1l2083t2887r2144b2926],
10	torasemide	NN	O	torasemide	prep_such_as	7	SENT_25	[p1l8t2970r361b3027],
11	are	VBP	O	be	auxpass	12	SENT_25	[p1l388t2988r482b3027],
12	used	VBN	O	use	_	0	SENT_25	[p1l507t2970r655b3027],
13	for	IN	O	for	_	0	SENT_25	[p1l679t2970r773b3027],
14	the	DT	O	the	det	15	SENT_25	[p1l796t2970r893b3027],
15	treatment	NN	O	treatment	prep_for	12	SENT_25	[p1l918t2979r1223b3027],
16	of	IN	O	of	_	0	SENT_25	[p1l1248t2970r1318b3027],
17	arterial	JJ	O	arterial	amod	18	SENT_25	[p1l1339t2970r1564b3027],
18	hypertension	NN	O	hypertension	prep_of	15	SENT_25	[p1l1589t2970r2007b3044],
19	and	CC	O	and	_	0	SENT_25	[p1l2033t2970r2147b3027],
20	heart	NN	O	heart	nn	21	SENT_25	[p1l7t3072r169b3129],
21	failure	NN	O	failure	prep_of	15	SENT_25	[p1l200t3065r533b3129],
22	.	.	O	.	_	0	SENT_25	[p1l200t3065r533b3129],

1	[	NN	O	[	nsubj	16	SENT_26	[p1l200t3065r533b3129],
2	1	CD	NUMBER	1	num	1	SENT_26	[p1l200t3065r533b3129],
3	‘	CD	NUMBER	‘	number	4	SENT_26	[p1l200t3065r533b3129],
4	3	CD	NUMBER	3	num	5	SENT_26	[p1l200t3065r533b3129],
5	]	NN	O	]	dep	1	SENT_26	[p1l200t3065r533b3129],
6	Compared	VBN	O	compare	_	0	SENT_26	[p1l570t3072r905b3146],
7	with	IN	O	with	prepc_compared_with	1	SENT_26	[p1l938t3072r1080b3129],
8	other	JJ	O	other	amod	10	SENT_26	[p1l1113t3072r1278b3129],
9	loop	NN	O	loop	nn	10	SENT_26	[p1l1309t3072r1450b3146],
10	diuretics	NNS	O	diuretic	pobj	1	SENT_26	[p1l1484t3072r1777b3139],
11	,	,	O	,	_	0	SENT_26	[p1l1484t3072r1777b3139],
12	the	DT	O	the	det	13	SENT_26	[p1l1813t3072r1910b3129],
13	use	NN	O	use	appos	10	SENT_26	[p1l1942t3090r2048b3129],
14	of	IN	O	of	_	0	SENT_26	[p1l2082t3072r2152b3129],
15	torasemide	NN	O	torasemide	prep_of	13	SENT_26	[p1l8t3172r361b3229],
16	seems	VBZ	O	seem	_	0	SENT_26	[p1l408t3190r599b3229],
17	to	TO	O	to	aux	18	SENT_26	[p1l645t3181r705b3229],
18	provide	VB	O	provide	xcomp	16	SENT_26	[p1l748t3172r994b3246],
19	extra	JJ	O	extra	amod	20	SENT_26	[p1l1039t3181r1200b3229],
20	benefits	NNS	O	benefit	dobj	18	SENT_26	[p1l1241t3172r1514b3239],
21	,	,	O	,	_	0	SENT_26	[p1l1241t3172r1514b3239],
22	which	WDT	O	which	nsubjpass	25	SENT_26	[p1l1561t3172r1757b3229],
23	have	VBP	O	have	aux	25	SENT_26	[p1l1800t3172r1951b3229],
24	been	VBN	O	be	auxpass	25	SENT_26	[p1l1994t3172r2146b3229],
25	attributed	VBN	O	attribute	rcmod	20	SENT_26	[p1l9t3274r317b3331],
26	to	TO	O	to	_	0	SENT_26	[p1l375t3283r434b3331],
27	additional	JJ	O	additional	amod	31	SENT_26	[p1l495t3274r816b3331],
28	anti	JJ	O	anti	amod	31	SENT_26	[p1l876t3274r1394b3331],
29	—	NN	O	—	nn	31	SENT_26	[p1l876t3274r1394b3331],
30	aldosterone	NN	O	aldosterone	nn	31	SENT_26	[p1l876t3274r1394b3331],
31	effects	NNS	O	effect	prep_to	25	SENT_26	[p1l1454t3267r1747b3331],
32	.	.	O	.	_	0	SENT_26	[p1l1454t3267r1747b3331],

1	[	NN	O	[	nsubj	7	SENT_27	[p1l1454t3267r1747b3331],
2	4	CD	NUMBER	4	number	3	SENT_27	[p1l1454t3267r1747b3331],
3	]	CD	NUMBER	]	dep	1	SENT_27	[p1l1454t3267r1747b3331],
4	Moreover	RB	O	moreover	advmod	3	SENT_27	[p1l1808t3276r2143b3341],
5	,	,	O	,	_	0	SENT_27	[p1l1808t3276r2143b3341],
6	torasemide	NN	O	torasemide	appos	1	SENT_27	[p1l8t3374r361b3431],
7	differs	VBZ	O	differ	_	0	SENT_27	[p1l386t3374r593b3431],
8	from	IN	O	from	_	0	SENT_27	[p1l620t3374r776b3431],
9	other	JJ	O	other	amod	11	SENT_27	[p1l800t3374r965b3431],
10	loop	NN	O	loop	nn	11	SENT_27	[p1l989t3374r1129b3448],
11	diuretics	NNS	O	diuretic	prep_from	7	SENT_27	[p1l1155t3374r1430b3431],
12	in	IN	O	in	_	0	SENT_27	[p1l1456t3374r1517b3430],
13	that	IN	O	that	complm	15	SENT_27	[p1l1542t3374r1662b3431],
14	it	PRP	O	it	nsubj	15	SENT_27	[p1l1685t3374r1730b3431],
15	has	VBZ	O	have	prepc_in	11	SENT_27	[p1l1752t3374r1856b3431],
16	a	DT	O	a	det	19	SENT_27	[p1l1885t3392r1918b3431],
17	longer	JJR	O	longer	amod	19	SENT_27	[p1l1942t3374r2148b3448],
18	elimination	NN	O	elimination	nn	19	SENT_27	[p1l8t3477r375b3534],
19	half	NN	O	half	dobj	15	SENT_27	[p1l399t3477r658b3534],
20	—	CD	NUMBER	—	num	21	SENT_27	[p1l399t3477r658b3534],
21	life	NN	O	life	amod	19	SENT_27	[p1l399t3477r658b3534],
22	(	CD	NUMBER	(	num	24	SENT_27	[p1l687t3478r806b3547],
23	t1/2	NN	O	t1/2	nn	24	SENT_27	[p1l687t3478r806b3547],
24	)	NN	O	)	dep	21	SENT_27	[p1l687t3478r806b3547],
25	and	CC	O	and	_	0	SENT_27	[p1l835t3477r949b3534],
26	a	DT	O	a	det	28	SENT_27	[p1l975t3495r1009b3534],
27	longer	JJR	O	longer	amod	28	SENT_27	[p1l1033t3477r1239b3551],
28	duration	NN	O	duration	dep	21	SENT_27	[p1l1263t3477r1531b3534],
29	of	IN	O	of	_	0	SENT_27	[p1l1557t3477r1627b3534],
30	action	NN	O	action	prep_of	28	SENT_27	[p1l1648t3469r1922b3544],
31	,	,	O	,	_	0	SENT_27	[p1l1648t3469r1922b3544],
32	[	CD	NUMBER	[	number	33	SENT_27	[p1l1648t3469r1922b3544],
33	5	CD	NUMBER	5	num	34	SENT_27	[p1l1648t3469r1922b3544],
34	]	NN	O	]	appos	24	SENT_27	[p1l1648t3469r1922b3544],
35	which	WDT	O	which	nsubj	37	SENT_27	[p1l1951t3477r2146b3534],
36	may	MD	O	may	aux	37	SENT_27	[p1l8t3595r144b3651],
37	contribute	VB	O	contribute	rcmod	34	SENT_27	[p1l173t3577r498b3634],
38	to	TO	O	to	_	0	SENT_27	[p1l526t3586r586b3634],
39	better	JJR	O	better	amod	41	SENT_27	[p1l613t3577r798b3634],
40	patient	NN	O	patient	nn	41	SENT_27	[p1l822t3577r1043b3651],
41	compliance	NN	O	compliance	prep_to	37	SENT_27	[p1l1070t3577r1441b3651],
42	and	CC	O	and	_	0	SENT_27	[p1l1470t3577r1584b3634],
43	treatment	NN	O	treatment	nn	44	SENT_27	[p1l1610t3586r1915b3634],
44	adherence	NN	O	adherence	prep_to	37	SENT_27	[p1l1943t3577r2144b3634, p1l8t3696r170b3735],
45	.	.	O	.	_	0	SENT_27	[p1l1943t3577r2144b3634, p1l8t3696r170b3735],

1	Because	IN	O	because	_	0	SENT_28	[p1l201t3680r469b3735],
2	of	IN	O	of	prepc_because_of	8	SENT_28	[p1l497t3678r567b3735],
3	these	DT	O	these	det	4	SENT_28	[p1l589t3678r753b3735],
4	properties	NNS	O	property	pobj	8	SENT_28	[p1l779t3678r1120b3752],
5	,	,	O	,	_	0	SENT_28	[p1l779t3678r1120b3752],
6	torasemide	NN	O	torasemide	nsubj	8	SENT_28	[p1l1150t3678r1503b3735],
7	is	VBZ	O	be	cop	8	SENT_28	[p1l1531t3678r1581b3735],
8	one	CD	NUMBER	one	_	0	SENT_28	[p1l1611t3696r1724b3735],
9	of	IN	O	of	_	0	SENT_28	[p1l1753t3678r1822b3735],
10	the	DT	O	the	det	11	SENT_28	[p1l1844t3678r1941b3735],
11	drugs	NNS	O	drug	prep_of	8	SENT_28	[p1l1969t3678r2144b3752],
12	that	WDT	O	that	nsubjpass	15	SENT_28	[p2l8t20r128b77],
13	are	VBP	O	be	auxpass	15	SENT_28	[p2l151t38r246b77],
14	frequently	RB	O	frequently	advmod	15	SENT_28	[p2l269t20r599b94],
15	prescribed	VBN	O	prescribe	rcmod	11	SENT_28	[p2l621t20r973b94],
16	.	.	O	.	_	0	SENT_28	[p2l621t20r973b94],

1	Pharmacokinetic	JJ	MISC	pharmacokinetic	amod	2	SENT_29	[p2l1000t20r1541b77],
2	studies	NNS	O	study	nsubj	7	SENT_29	[p2l1568t20r1786b77],
3	performed	VBN	O	perform	partmod	2	SENT_29	[p2l1810t20r2147b94],
4	in	IN	O	in	_	0	SENT_29	[p2l8t121r68b177],
5	healthy	JJ	O	healthy	amod	6	SENT_29	[p2l97t121r333b195],
6	volunteers	NNS	O	volunteer	prep_in	3	SENT_29	[p2l364t121r697b178],
7	suggest	VBP	O	suggest	_	0	SENT_29	[p2l732t130r971b195],
8	that	IN	O	that	complm	11	SENT_29	[p2l999t121r1120b178],
9	torasemide	NN	O	torasemide	nn	10	SENT_29	[p2l1148t121r1501b178],
10	metabolism	NN	O	metabolism	nsubj	11	SENT_29	[p2l1531t121r1909b178],
11	differs	VBZ	O	differ	ccomp	7	SENT_29	[p2l1938t121r2144b178],
12	substantially	RB	O	substantially	advmod	11	SENT_29	[p2l10t222r415b296],
13	between	IN	O	between	_	0	SENT_29	[p2l437t222r707b279],
14	individuals	NNS	O	individual	prep_between	11	SENT_29	[p2l730t222r1104b279],
15	.	.	O	.	_	0	SENT_29	[p2l730t222r1104b279],

1	However	RB	O	however	advmod	22	SENT_30	[p2l1132t224r1444b289],
2	,	,	O	,	_	0	SENT_30	[p2l1132t224r1444b289],
3	data	NNS	O	datum	nsubj	22	SENT_30	[p2l1471t222r1604b279],
4	on	IN	O	on	_	0	SENT_30	[p2l1627t240r1705b279],
5	the	DT	O	the	det	6	SENT_30	[p2l1728t222r1825b279],
6	causes	NNS	O	cause	prep_on	3	SENT_30	[p2l1849t240r2056b279],
7	of	IN	O	of	_	0	SENT_30	[p2l2082t222r2151b279],
8	the	DT	O	the	det	11	SENT_30	[p2l7t323r104b380],
9	interindividual	JJ	O	interindividual	amod	11	SENT_30	[p2l135t323r610b380],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_30	[p2l639t323r1177b397],
11	variability	NN	O	variability	prep_of	6	SENT_30	[p2l1209t323r1539b397],
12	and	CC	O	and	_	0	SENT_30	[p2l1572t323r1685b380],
13	its	PRP$	O	its	poss	15	SENT_30	[p2l1715t323r1787b380],
14	functional	JJ	O	functional	amod	15	SENT_30	[p2l1820t323r2146b380],
15	consequences	NNS	O	consequence	prep_on	3	SENT_30	[p2l8t442r449b498],
16	in	IN	O	in	_	0	SENT_30	[p2l476t424r537b480],
17	patients	NNS	O	patient	prep_in	15	SENT_30	[p2l560t424r809b498],
18	under	IN	O	under	_	0	SENT_30	[p2l835t424r1020b481],
19	long-term	JJ	O	long-term	amod	20	SENT_30	[p2l1043t424r1362b498],
20	medication	NN	O	medication	prep_under	17	SENT_30	[p2l1385t424r1744b481],
21	are	VBP	O	be	aux	22	SENT_30	[p2l1770t442r1864b481],
22	lacking	VBG	O	lack	_	0	SENT_30	[p2l1890t424r2142b498],
23	.	.	O	.	_	0	SENT_30	[p2l1890t424r2142b498],

1	Torasemide	NNP	O	Torasemide	nsubjpass	3	SENT_31	[p2l105t526r485b582],
2	is	VBZ	O	be	auxpass	3	SENT_31	[p2l527t526r576b582],
3	cleared	VBN	O	clear	_	0	SENT_31	[p2l620t526r852b582],
4	from	IN	O	from	_	0	SENT_31	[p2l892t526r1048b582],
5	the	DT	O	the	det	6	SENT_31	[p2l1088t526r1185b582],
6	circulation	NN	O	circulation	prep_from	3	SENT_31	[p2l1227t526r1571b582],
7	by	IN	O	by	prep	3	SENT_31	[p2l1611t526r1690b599],
8	both	CC	O	both	dep	7	SENT_31	[p2l1730t526r1874b582],
9	hepatic	JJ	O	hepatic	amod	10	SENT_31	[p2l1914t526r2145b599],
10	metabolism	NN	O	metabolism	conj	7	SENT_31	[p2l8t627r401b693],
11	,	,	O	,	_	0	SENT_31	[p2l8t627r401b693],
12	which	WDT	O	which	nsubj	13	SENT_31	[p2l451t627r646b684],
13	constitutes	VBZ	O	constitute	rcmod	10	SENT_31	[p2l692t627r1034b683],
14	the	DT	O	the	det	16	SENT_31	[p2l1082t627r1179b683],
15	major	JJ	O	major	amod	16	SENT_31	[p2l1225t627r1413b700],
16	route	NN	O	route	nsubj	22	SENT_31	[p2l1457t635r1622b683],
17	of	IN	O	of	_	0	SENT_31	[p2l1669t627r1739b683],
18	elimination	NN	O	elimination	prep_of	16	SENT_31	[p2l1779t627r2146b683],
19	(	CD	NUMBER	(	num	18	SENT_31	[p2l10t728r500b801],
20	approximately	RB	O	approximately	quantmod	21	SENT_31	[p2l10t728r500b801],
21	80	CD	PERCENT	80	num	22	SENT_31	[p2l542t728r682b785],
22	%	NN	PERCENT	%	xcomp	13	SENT_31	[p2l542t728r682b785],
23	of	IN	O	of	_	0	SENT_31	[p2l725t728r794b784],
24	total	JJ	O	total	amod	26	SENT_31	[p2l827t728r969b784],
25	clearance	NN	O	clearance	nn	26	SENT_31	[p2l1008t728r1355b797],
26	)	NN	O	)	prep_of	22	SENT_31	[p2l1008t728r1355b797],
27	,	,	O	,	_	0	SENT_31	[p2l1008t728r1355b797],
28	and	CC	O	and	_	0	SENT_31	[p2l1398t728r1512b784],
29	excretion	NN	O	excretion	conj_and	3	SENT_31	[p2l1550t728r1849b784],
30	into	IN	O	into	_	0	SENT_31	[p2l1887t728r2010b784],
31	the	DT	O	the	det	32	SENT_31	[p2l2049t728r2146b784],
32	urine	NN	O	urine	prep_into	29	SENT_31	[p2l7t829r188b885],
33	.	.	O	.	_	0	SENT_31	[p2l7t829r188b885],

1	Previous	JJ	O	previous	amod	2	SENT_32	[p2l225t829r504b885],
2	studies	NNS	O	study	nsubj	4	SENT_32	[p2l542t829r760b885],
3	have	VBP	O	have	aux	4	SENT_32	[p2l794t829r945b885],
4	suggested	VBN	O	suggest	_	0	SENT_32	[p2l981t829r1296b902],
5	that	IN	O	that	complm	9	SENT_32	[p2l1328t829r1448b885],
6	organic	JJ	O	organic	amod	8	SENT_32	[p2l1481t829r1719b902],
7	anion	NN	O	anion	nn	8	SENT_32	[p2l1755t829r1931b885],
8	transporters	NNS	O	transporter	nsubj	9	SENT_32	[p2l1964t837r2144b885, p2l7t938r229b1003],
9	(	VBP	O	(	ccomp	4	SENT_32	[p2l263t930r528b999],
10	OATS	NNS	O	oats	nsubj	21	SENT_32	[p2l263t930r528b999],
11	)	CD	NUMBER	)	num	10	SENT_32	[p2l263t930r528b999],
12	,	,	O	,	_	0	SENT_32	[p2l263t930r528b999],
13	which	WDT	O	which	nsubjpass	15	SENT_32	[p2l561t930r757b986],
14	are	VBP	O	be	auxpass	15	SENT_32	[p2l788t947r883b986],
15	expressed	VBN	O	express	rcmod	10	SENT_32	[p2l914t930r1231b1003],
16	in	IN	O	in	_	0	SENT_32	[p2l1261t930r1322b986],
17	the	DT	O	the	det	18	SENT_32	[p2l1352t930r1448b986],
18	kidney	NN	O	kidney	prep_in	15	SENT_32	[p2l1477t930r1714b1003],
19	,	,	O	,	_	0	SENT_32	[p2l1477t930r1714b1003],
20	are	VBP	O	be	cop	21	SENT_32	[p2l1749t947r1844b986],
21	determinants	NNS	O	determinant	ccomp	9	SENT_32	[p2l1875t930r2144b986, p2l8t1041r175b1089],
22	of	IN	O	of	_	0	SENT_32	[p2l200t1032r269b1089],
23	torasemide	NN	O	torasemide	nn	25	SENT_32	[p2l286t1032r639b1089],
24	renal	JJ	O	renal	amod	25	SENT_32	[p2l661t1033r821b1089],
25	clearance	NN	O	clearance	prep_of	21	SENT_32	[p2l844t1024r1267b1089],
26	.	.	O	.	_	0	SENT_32	[p2l844t1024r1267b1089],

1	[	NN	O	[	nsubj	15	SENT_33	[p2l844t1024r1267b1089],
2	6	CD	NUMBER	6	num	3	SENT_33	[p2l844t1024r1267b1089],
3	’	NN	O	’	dep	1	SENT_33	[p2l844t1024r1267b1089],
4	7	CD	NUMBER	7	number	5	SENT_33	[p2l844t1024r1267b1089],
5	]	CD	NUMBER	]	num	7	SENT_33	[p2l844t1024r1267b1089],
6	The	DT	O	the	det	7	SENT_33	[p2l1292t1032r1415b1089],
7	mechanism	NN	O	mechanism	dep	1	SENT_33	[p2l1438t1032r1806b1089],
8	of	IN	O	of	_	0	SENT_33	[p2l1828t1032r1898b1089],
9	hepatic	JJ	O	hepatic	amod	10	SENT_33	[p2l1914t1032r2145b1106],
10	uptake	NN	O	uptake	prep_of	7	SENT_33	[p2l7t1133r221b1206],
11	is	VBZ	O	be	cop	15	SENT_33	[p2l240t1133r309b1199],
12	,	,	O	,	_	0	SENT_33	[p2l240t1133r309b1199],
13	however	RB	O	however	advmod	15	SENT_33	[p2l330t1133r625b1199],
14	,	,	O	,	_	0	SENT_33	[p2l330t1133r625b1199],
15	unclear	JJ	O	unclear	_	0	SENT_33	[p2l646t1133r899b1189],
16	.	.	O	.	_	0	SENT_33	[p2l646t1133r899b1189],

1	The	DT	O	the	det	3	SENT_34	[p2l922t1133r1045b1189],
2	liver	NN	O	liver	nn	3	SENT_34	[p2l1064t1133r1488b1206],
3	—	NN	O	—	_	0	SENT_34	[p2l1064t1133r1488b1206],
4	specific	JJ	O	specific	amod	6	SENT_34	[p2l1064t1133r1488b1206],
5	organic	JJ	O	organic	amod	6	SENT_34	[p2l1509t1133r1747b1206],
6	anion	NN	O	anion	nsubj	15	SENT_34	[p2l1769t1133r1946b1189],
7	transporting	VBG	O	transport	partmod	6	SENT_34	[p2l1964t1141r2144b1189, p2l7t1234r239b1307],
8	polypeptide	NN	O	polypeptide	dobj	7	SENT_34	[p2l292t1234r674b1307],
9	(	CD	NUMBER	(	num	8	SENT_34	[p2l731t1234r989b1303],
10	OATP	NN	O	oatp	nn	13	SENT_34	[p2l731t1234r989b1303],
11	)	CD	NUMBER	)	num	13	SENT_34	[p2l731t1234r989b1303],
12	1B1	NN	O	1b1	nn	13	SENT_34	[p2l1053t1234r1171b1290],
13	(	NN	O	(	dep	8	SENT_34	[p2l1235t1234r1387b1303],
14	also	RB	O	also	advmod	15	SENT_34	[p2l1235t1234r1387b1303],
15	known	VBN	O	know	rcmod	3	SENT_34	[p2l1441t1234r1660b1291],
16	as	IN	O	as	_	0	SENT_34	[p2l1716t1251r1777b1290],
17	OATP-C	NN	O	oatp-c	prep_as	15	SENT_34	[p2l1835t1234r2148b1291],
18	/	:	O	/	punct	3	SENT_34	[p2l1835t1234r2148b1291],
19	OATP2/LST	CD	NUMBER	oatp2/lst	number	20	SENT_34	[p2l9t1335r516b1404],
20	-1	CD	NUMBER	-1	num	21	SENT_34	[p2l9t1335r516b1404],
21	)	NN	O	)	nsubj	22	SENT_34	[p2l9t1335r516b1404],
22	mediates	VBZ	O	mediate	dep	3	SENT_34	[p2l557t1335r841b1391],
23	the	DT	O	the	det	24	SENT_34	[p2l881t1335r977b1391],
24	uptake	NN	O	uptake	nsubj	31	SENT_34	[p2l1015t1335r1229b1408],
25	of	IN	O	of	_	0	SENT_34	[p2l1269t1335r1338b1391],
26	a	DT	O	a	det	28	SENT_34	[p2l1372t1352r1406b1391],
27	broad	JJ	O	broad	amod	28	SENT_34	[p2l1441t1335r1626b1391],
28	range	NN	O	range	prep_of	24	SENT_34	[p2l1662t1352r1840b1408],
29	of	IN	O	of	_	0	SENT_34	[p2l1880t1335r1949b1391],
30	compounds	NNS	O	compound	prep_of	28	SENT_34	[p2l1983t1352r2144b1391, p2l7t1429r370b1510],
31	[	VBP	O	[	ccomp	22	SENT_34	[p2l1983t1352r2144b1391, p2l7t1429r370b1510],
32	8	CD	NUMBER	8	number	33	SENT_34	[p2l1983t1352r2144b1391, p2l7t1429r370b1510],
33	‘“	CD	NUMBER	‘“	num	34	SENT_34	[p2l1983t1352r2144b1391, p2l7t1429r370b1510],
34	]	NN	O	]	dobj	31	SENT_34	[p2l1983t1352r2144b1391, p2l7t1429r370b1510],
35	and	CC	O	and	_	0	SENT_34	[p2l405t1436r518b1493],
36	might	MD	O	might	aux	40	SENT_34	[p2l547t1436r735b1510],
37	therefore	RB	O	therefore	advmod	40	SENT_34	[p2l764t1436r1054b1493],
38	be	VB	O	be	cop	40	SENT_34	[p2l1083t1436r1158b1493],
39	a	DT	O	a	det	40	SENT_34	[p2l1189t1454r1223b1493],
40	candidate	NN	O	candidate	conj_and	31	SENT_34	[p2l1252t1436r1559b1493],
41	for	IN	O	for	_	0	SENT_34	[p2l1589t1436r1683b1493],
42	the	DT	O	the	det	43	SENT_34	[p2l1711t1436r1808b1493],
43	uptake	NN	O	uptake	prep_for	40	SENT_34	[p2l1837t1437r2051b1510],
44	of	IN	O	of	_	0	SENT_34	[p2l2082t1436r2151b1493],
45	torasemide	NN	O	torasemide	prep_of	43	SENT_34	[p2l7t1537r361b1593],
46	into	IN	O	into	_	0	SENT_34	[p2l396t1537r519b1593],
47	hepatocytes	NNS	O	hepatocyte	prep_into	40	SENT_34	[p2l555t1537r952b1610],
48	.	.	O	.	_	0	SENT_34	[p2l555t1537r952b1610],

1	Several	JJ	O	several	amod	5	SENT_35	[p2l993t1537r1232b1594],
2	common	JJ	O	common	amod	5	SENT_35	[p2l1268t1554r1549b1593],
3	single	JJ	O	single	amod	5	SENT_35	[p2l1587t1537r1775b1610],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_35	[p2l1811t1537r2146b1593],
5	polymorphisms	NNS	O	polymorphism	nsubj	6	SENT_35	[p2l7t1638r508b1711],
6	(	VBP	O	(	_	0	SENT_35	[p2l567t1638r794b1707],
7	SNPs	NNS	O	snp	nsubjpass	18	SENT_35	[p2l567t1638r794b1707],
8	)	CD	NUMBER	)	num	7	SENT_35	[p2l567t1638r794b1707],
9	in	IN	O	in	_	0	SENT_35	[p2l851t1638r912b1694],
10	the	DT	O	the	det	12	SENT_35	[p2l966t1638r1063b1694],
11	SLCOIBI	NN	O	slcoibus	nn	12	SENT_35	[p2l1118t1638r1439b1695],
12	gene	NN	O	gene	prep_in	7	SENT_35	[p2l1500t1655r1650b1711],
13	encoding	VBG	O	encode	partmod	12	SENT_35	[p2l1705t1638r1998b1711],
14	for	IN	O	for	_	0	SENT_35	[p2l2054t1638r2148b1694],
15	OATPIBI	NNP	O	OATPIBI	prep_for	13	SENT_35	[p2l9t1739r345b1796],
16	have	VBP	O	have	aux	18	SENT_35	[p2l372t1739r523b1795],
17	been	VBN	O	be	auxpass	18	SENT_35	[p2l542t1739r694b1795],
18	identified	VBN	O	identify	ccomp	6	SENT_35	[p2l714t1739r1039b1795],
19	.	.	O	.	_	0	SENT_35	[p2l714t1739r1039b1795],

1	In	IN	O	in	_	0	SENT_36	[p2l1063t1740r1128b1795],
2	particular	JJ	O	particular	prep_in	15	SENT_36	[p2l1148t1739r1474b1812],
3	,	,	O	,	_	0	SENT_36	[p2l1148t1739r1474b1812],
4	the	DT	O	the	det	6	SENT_36	[p2l1497t1739r1594b1795],
5	c.	NN	O	c.	nn	6	SENT_36	[p2l1615t1738r1938b1796],
6	521T	NN	O	521t	appos	2	SENT_36	[p2l1615t1738r1938b1796],
7	>	JJR	O	>	amod	9	SENT_36	[p2l1615t1738r1938b1796],
8	C	NN	O	c	nn	9	SENT_36	[p2l1615t1738r1938b1796],
9	mutation	NN	O	mutation	dep	6	SENT_36	[p2l1959t1747r2144b1795, p2l7t1840r132b1896],
10	(	CD	NUMBER	(	num	12	SENT_36	[p2l164t1840r567b1909],
11	Val174Ala	NN	O	val174alum	nn	12	SENT_36	[p2l164t1840r567b1909],
12	)	NN	O	)	nsubjpass	15	SENT_36	[p2l164t1840r567b1909],
13	has	VBZ	O	have	aux	15	SENT_36	[p2l599t1840r703b1896],
14	been	VBN	O	be	auxpass	15	SENT_36	[p2l734t1840r886b1896],
15	associated	VBN	O	associate	_	0	SENT_36	[p2l918t1840r1248b1896],
16	with	IN	O	with	_	0	SENT_36	[p2l1277t1840r1419b1897],
17	reduced	VBN	O	reduce	amod	19	SENT_36	[p2l1448t1840r1704b1896],
18	transport	NN	O	transport	nn	19	SENT_36	[p2l1733t1848r2021b1913],
19	activity	NN	O	activity	prep_with	15	SENT_36	[p2l2051t1857r2144b1896, p2l7t1941r176b2015],
20	of	IN	O	of	_	0	SENT_36	[p2l207t1941r276b1998],
21	OATPlBl	NN	O	oatplbl	prep_of	19	SENT_36	[p2l301t1942r637b1999],
22	in	IN	O	in	_	0	SENT_36	[p2l676t1944r733b1998],
23	vitr0	NN	O	vitr0	prep_in	21	SENT_36	[p2l764t1934r1041b1999],
24	[	CD	NUMBER	[	number	25	SENT_36	[p2l764t1934r1041b1999],
25	8	CD	NUMBER	8	num	26	SENT_36	[p2l764t1934r1041b1999],
26	’	NN	O	’	dep	23	SENT_36	[p2l764t1934r1041b1999],
27	12	CD	NUMBER	12	num	28	SENT_36	[p2l764t1934r1041b1999],
28	]	NN	O	]	dep	23	SENT_36	[p2l764t1934r1041b1999],
29	and	CC	O	and	_	0	SENT_36	[p2l1074t1942r1188b1998],
30	increased	VBN	O	increase	amod	32	SENT_36	[p2l1217t1941r1521b1998],
31	plasma	NN	O	plasma	nn	32	SENT_36	[p2l1549t1941r1778b2015],
32	concentrations	NNS	O	concentration	conj_and	23	SENT_36	[p2l1807t1950r2144b1998, p2l7t2042r161b2098],
33	of	IN	O	of	_	0	SENT_36	[p2l201t2042r271b2098],
34	drugs	NNS	O	drug	prep_of	32	SENT_36	[p2l303t2042r478b2115],
35	(	CD	NUMBER	(	num	34	SENT_36	[p2l519t2042r654b2115],
36	e.g.	FW	O	e.g.	dep	34	SENT_36	[p2l519t2042r654b2115],
37	HMG	NN	O	hmg	dep	36	SENT_36	[p2l695t2042r1062b2099],
38	.	.	O	.	_	0	SENT_36	[p2l695t2042r1062b2099],

1	—	NN	O	—	_	0	SENT_37	[p2l695t2042r1062b2099],
2	.	.	O	.	_	0	SENT_37	[p2l695t2042r1062b2099],

1	CoA	NN	O	coa	nn	3	SENT_38	[p2l695t2042r1062b2099],
2	reductase	NN	O	reductase	nn	3	SENT_38	[p2l1098t2042r1402b2098],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_38	[p2l1439t2042r1773b2111],
4	)	VBP	O	)	_	0	SENT_38	[p2l1439t2042r1773b2111],
5	in	IN	O	in	_	0	SENT_38	[p2l1812t2042r1873b2098],
6	healthy	JJ	O	healthy	amod	7	SENT_38	[p2l1909t2042r2145b2115],
7	volunteers	NNS	O	volunteer	prep_in	4	SENT_38	[p2l8t2136r556b2200],
8	.	.	O	.	_	0	SENT_38	[p2l8t2136r556b2200],

1	[	NN	O	[	_	0	SENT_39	[p2l8t2136r556b2200],
2	8	CD	NUMBER	8	number	3	SENT_39	[p2l8t2136r556b2200],
3	’	CD	NUMBER	’	dep	1	SENT_39	[p2l8t2136r556b2200],
4	13	CD	NUMBER	13	num	5	SENT_39	[p2l8t2136r556b2200],
5	’	NN	O	’	dep	3	SENT_39	[p2l8t2136r556b2200],
6	14	CD	NUMBER	14	num	7	SENT_39	[p2l8t2136r556b2200],
7	]	NN	O	]	dep	1	SENT_39	[p2l8t2136r556b2200],

1	In	IN	O	in	_	0	SENT_40	[p2l105t2245r170b2300],
2	the	DT	O	the	det	3	SENT_40	[p2l192t2244r288b2300],
3	liver	NN	O	liver	prep_in	7	SENT_40	[p2l311t2244r474b2311],
4	,	,	O	,	_	0	SENT_40	[p2l311t2244r474b2311],
5	torasemide	NN	O	torasemide	nsubjpass	7	SENT_40	[p2l499t2244r852b2300],
6	is	VBZ	O	be	auxpass	7	SENT_40	[p2l875t2244r925b2300],
7	metabolized	VBN	O	metabolize	_	0	SENT_40	[p2l948t2244r1343b2300],
8	mainly	RB	O	mainly	advmod	7	SENT_40	[p2l1365t2244r1587b2317],
9	by	IN	O	by	_	0	SENT_40	[p2l1608t2244r1687b2317],
10	the	DT	O	the	det	12	SENT_40	[p2l1710t2244r1806b2300],
11	genetically	RB	O	genetically	advmod	12	SENT_40	[p2l1830t2244r2144b2317, p2l8t2345r68b2418],
12	polymorphic	JJ	O	polymorphic	agent	7	SENT_40	[p2l121t2345r533b2418],
13	expressed	VBN	O	express	partmod	12	SENT_40	[p2l589t2345r906b2418],
14	cytochrome	NN	O	cytochrome	nn	15	SENT_40	[p2l961t2345r1340b2418],
15	P450	NN	O	p450	dobj	13	SENT_40	[p2l1394t2345r1558b2402],
16	(	CD	NUMBER	(	num	15	SENT_40	[p2l1615t2345r1820b2414],
17	CYP	NN	O	cyp	nn	19	SENT_40	[p2l1615t2345r1820b2414],
18	)	CD	NUMBER	)	num	19	SENT_40	[p2l1615t2345r1820b2414],
19	enzyme	NN	O	enzyme	tmod	13	SENT_40	[p2l1877t2363r2143b2418],
20	,	,	O	,	_	0	SENT_40	[p2l1877t2363r2143b2418],
21	CYP2C9	NN	O	cyp2c9	appos	19	SENT_40	[p2l9t2439r471b2504],
22	.	.	O	.	_	0	SENT_40	[p2l9t2439r471b2504],

1	“	NN	O	“	nsubj	10	SENT_41	[p2l9t2439r471b2504],
2	5	CD	NUMBER	5	num	1	SENT_41	[p2l9t2439r471b2504],
3	’	CD	NUMBER	’	number	4	SENT_41	[p2l9t2439r471b2504],
4	16	CD	NUMBER	16	num	5	SENT_41	[p2l9t2439r471b2504],
5	]	NN	O	]	dep	1	SENT_41	[p2l9t2439r471b2504],
6	In	FW	O	in	nn	8	SENT_41	[p2l502t2449r568b2503],
7	vitro	FW	O	vitro	nn	8	SENT_41	[p2l599t2449r748b2503],
8	studies	NNS	O	study	dep	1	SENT_41	[p2l781t2447r1000b2503],
9	have	VBP	O	have	aux	10	SENT_41	[p2l1031t2447r1181b2503],
10	demonstrated	VBN	O	demonstrate	_	0	SENT_41	[p2l1212t2447r1647b2503],
11	that	IN	O	that	complm	19	SENT_41	[p2l1675t2447r1796b2503],
12	the	DT	O	the	det	16	SENT_41	[p2l1824t2446r1920b2503],
13	allelic	JJ	O	allelic	amod	16	SENT_41	[p2l1952t2447r2145b2503],
14	variant	NN	O	variant	nn	16	SENT_41	[p2l8t2547r232b2603],
15	C	NN	O	c	nn	16	SENT_41	[p2l263t2548r314b2604],
16	YP2C9	NN	O	yp2c9	nsubj	19	SENT_41	[p2l318t2547r618b2604],
17	*	CD	NUMBER	*	num	18	SENT_41	[p2l318t2547r618b2604],
18	3	CD	NUMBER	3	dep	16	SENT_41	[p2l318t2547r618b2604],
19	confers	VBZ	O	confer	ccomp	10	SENT_41	[p2l651t2547r885b2603],
20	functional	JJ	O	functional	amod	21	SENT_41	[p2l916t2547r1242b2603],
21	differences	NNS	O	difference	dobj	19	SENT_41	[p2l1272t2547r1627b2603],
22	compared	VBN	O	compare	_	0	SENT_41	[p2l1659t2547r1976b2620],
23	with	IN	O	with	prepc_compared_with	19	SENT_41	[p2l2005t2547r2146b2604],
24	the	DT	O	the	det	27	SENT_41	[p2l7t2659r104b2715],
25	mutant	JJ	O	mutant	amod	27	SENT_41	[p2l139t2667r363b2715],
26	CYP2C9	NN	O	cyp2c9	nn	27	SENT_41	[p2l400t2659r758b2716],
27	*	NN	O	*	pobj	19	SENT_41	[p2l400t2659r758b2716],
28	2	CD	NUMBER	2	dep	27	SENT_41	[p2l400t2659r758b2716],
29	or	CC	O	or	_	0	SENT_41	[p2l794t2676r860b2715],
30	the	DT	O	the	det	35	SENT_41	[p2l893t2659r989b2715],
31	wild-type	JJ	O	wild-type	amod	35	SENT_41	[p2l1024t2659r1332b2732],
32	CYP2C9	NN	O	cyp2c9	nn	35	SENT_41	[p2l1371t2659r1722b2716],
33	*	NN	O	*	nn	35	SENT_41	[p2l1371t2659r1722b2716],
34	l	NN	O	l	nn	35	SENT_41	[p2l1371t2659r1722b2716],
35	allele	NN	O	allele	conj_or	27	SENT_41	[p2l1765t2651r2043b2715],
36	.	.	O	.	_	0	SENT_41	[p2l1765t2651r2043b2715],

1	“	NN	O	“	nn	3	SENT_42	[p2l1765t2651r2043b2715],
2	7	CD	NUMBER	7	num	3	SENT_42	[p2l1765t2651r2043b2715],
3	]	NN	O	]	npadvmod	18	SENT_42	[p2l1765t2651r2043b2715],
4	In	IN	O	in	_	0	SENT_42	[p2l2081t2660r2146b2715],
5	agreement	NN	O	agreement	prep_in	18	SENT_42	[p2l9t2767r344b2832],
6	with	IN	O	with	_	0	SENT_42	[p2l366t2759r508b2816],
7	these	DT	O	these	det	9	SENT_42	[p2l530t2759r694b2815],
8	experimental	JJ	O	experimental	amod	9	SENT_42	[p2l718t2759r1138b2832],
9	findings	NNS	O	finding	prep_with	5	SENT_42	[p2l1162t2759r1442b2832],
10	,	,	O	,	_	0	SENT_42	[p2l1162t2759r1442b2832],
11	the	DT	O	the	det	14	SENT_42	[p2l1468t2759r1564b2815],
12	C	NN	O	c	nn	14	SENT_42	[p2l1591t2760r1642b2816],
13	YP2	NN	O	yp2	nn	14	SENT_42	[p2l1647t2759r1772b2815],
14	C9	NN	O	c9	nsubj	18	SENT_42	[p2l1781t2759r1946b2816],
15	*	CD	NUMBER	*	num	17	SENT_42	[p2l1781t2759r1946b2816],
16	3	CD	NUMBER	3	num	17	SENT_42	[p2l1781t2759r1946b2816],
17	allele	NN	O	allele	dep	14	SENT_42	[p2l1975t2759r2146b2815],
18	had	VBD	O	have	_	0	SENT_42	[p2l7t2860r123b2916],
19	significant	JJ	O	significant	amod	20	SENT_42	[p2l157t2860r495b2933],
20	effects	NNS	O	effect	dobj	18	SENT_42	[p2l526t2860r737b2916],
21	on	IN	O	on	_	0	SENT_42	[p2l772t2878r850b2916],
22	torasemide	NN	O	torasemide	nn	23	SENT_42	[p2l881t2860r1234b2916],
23	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	20	SENT_42	[p2l1265t2860r1834b2933],
24	after	IN	O	after	_	0	SENT_42	[p2l1869t2860r2015b2916],
25	administration	NN	O	administration	prep_after	18	SENT_42	[p2l2047t2860r2144b2916, p2l8t2961r397b3017],
26	of	IN	O	of	_	0	SENT_42	[p2l434t2961r504b3017],
27	a	DT	O	a	det	30	SENT_42	[p2l536t2979r570b3017],
28	single	JJ	O	single	amod	30	SENT_42	[p2l607t2961r795b3034],
29	oral	JJ	O	oral	amod	30	SENT_42	[p2l832t2961r955b3017],
30	dose	NN	O	dose	prep_of	25	SENT_42	[p2l992t2961r1137b3017],
31	to	TO	O	to	_	0	SENT_42	[p2l1174t2969r1233b3017],
32	healthy	JJ	O	healthy	amod	33	SENT_42	[p2l1270t2961r1506b3034],
33	volunteers	NNS	O	volunteer	prep_to	30	SENT_42	[p2l1543t2961r1895b3028],
34	,	,	O	,	_	0	SENT_42	[p2l1543t2961r1895b3028],
35	with	IN	O	with	_	0	SENT_42	[p2l1935t2961r2077b3018],
36	a	DT	O	a	det	40	SENT_42	[p2l2114t2979r2147b3017],
37	1.7-fold	RB	O	1.7-fold	advmod	38	SENT_42	[p2l15t3063r265b3119],
38	lower	JJR	O	lower	amod	40	SENT_42	[p2l286t3063r470b3120],
39	hepatic	JJ	O	hepatic	amod	40	SENT_42	[p2l490t3063r721b3136],
40	clearance	NN	O	clearance	prep_with	18	SENT_42	[p2l745t3063r1048b3119],
41	in	IN	O	in	_	0	SENT_42	[p2l1071t3063r1131b3119],
42	carriers	NNS	O	carrier	prep_in	40	SENT_42	[p2l1154t3063r1392b3119],
43	of	IN	O	of	prep	42	SENT_42	[p2l1417t3063r1487b3119],
44	CYP2C9	NN	O	cyp2c9	nn	45	SENT_42	[p2l1507t3063r1821b3120],
45	*	NN	O	*	dep	43	SENT_42	[p2l1507t3063r1821b3120],
46	1	CD	NUMBER	1	dep	45	SENT_42	[p2l1836t3055r2143b3120],
47	/	:	O	/	punct	45	SENT_42	[p2l1836t3055r2143b3120],
48	*	CD	NUMBER	*	dep	45	SENT_42	[p2l1836t3055r2143b3120],
49	3	CD	NUMBER	3	dep	48	SENT_42	[p2l1836t3055r2143b3120],
50	.	.	O	.	_	0	SENT_42	[p2l1836t3055r2143b3120],

1	[	NN	O	[	nsubj	19	SENT_43	[p2l1836t3055r2143b3120],
2	18	CD	NUMBER	18	num	1	SENT_43	[p2l1836t3055r2143b3120],
3	’	CD	NUMBER	’	number	4	SENT_43	[p2l1836t3055r2143b3120],
4	19	CD	NUMBER	19	num	6	SENT_43	[p2l1836t3055r2143b3120],
5	]	NN	O	]	nn	6	SENT_43	[p2l1836t3055r2143b3120],
6	CYPZC9	NN	O	cypzc9	nsubjpass	9	SENT_43	[p2l106t3163r394b3221],
7	is	VBZ	O	be	auxpass	9	SENT_43	[p2l416t3163r466b3220],
8	also	RB	O	also	advmod	9	SENT_43	[p2l490t3163r616b3220],
9	involved	VBN	O	involve	rcmod	1	SENT_43	[p2l638t3163r920b3220],
10	in	IN	O	in	_	0	SENT_43	[p2l940t3163r1001b3219],
11	the	DT	O	the	det	12	SENT_43	[p2l1021t3163r1118b3220],
12	biotransformation	NN	O	biotransformation	prep_in	9	SENT_43	[p2l1138t3163r1718b3220],
13	of	IN	O	of	_	0	SENT_43	[p2l1739t3163r1809b3220],
14	the	DT	O	the	det	18	SENT_43	[p2l1824t3163r1920b3220],
15	angiotensin	NN	O	angiotensin	nn	18	SENT_43	[p2l1943t3163r2144b3236, p2l7t3264r199b3321],
16	II	CD	NUMBER	ii	num	18	SENT_43	[p2l235t3266r287b3320],
17	receptor	NN	O	receptor	nn	18	SENT_43	[p2l322t3273r587b3337],
18	blockers	NNS	O	blocker	prep_of	12	SENT_43	[p2l621t3264r893b3321],
19	(	VBP	O	(	_	0	SENT_43	[p2l933t3265r1178b3334],
20	ARBs	NNS	MISC	arb	nsubj	22	SENT_43	[p2l933t3265r1178b3334],
21	)	JJ	O	)	amod	22	SENT_43	[p2l933t3265r1178b3334],
22	irbesartan	NN	O	irbesartan	xcomp	19	SENT_43	[p2l1216t3264r1534b3321],
23	and	CC	O	and	_	0	SENT_43	[p2l1571t3264r1685b3321],
24	losartan	NN	O	losartan	conj_and	22	SENT_43	[p2l1721t3264r1991b3321],
25	.	.	O	.	_	0	SENT_43	[p2l1721t3264r1991b3321],

1	Because	IN	O	because	mark	7	SENT_44	[p2l2031t3266r2144b3321, p2l8t3383r185b3422],
2	ARBs	NNS	O	arb	nsubjpass	7	SENT_44	[p2l226t3366r420b3422],
3	and	CC	O	and	_	0	SENT_44	[p2l464t3365r578b3422],
4	torasemide	NN	O	torasemide	conj_and	2	SENT_44	[p2l617t3365r971b3422],
5	are	VBP	O	be	auxpass	7	SENT_44	[p2l1013t3383r1108b3422],
6	frequently	RB	O	frequently	advmod	7	SENT_44	[p2l1149t3365r1479b3438],
7	coadministered	VBN	O	coadminister	advcl	18	SENT_44	[p2l1521t3365r2014b3422],
8	for	IN	O	for	_	0	SENT_44	[p2l2054t3365r2148b3422],
9	treatment	NN	O	treatment	prep_for	7	SENT_44	[p2l7t3475r313b3523],
10	of	IN	O	of	_	0	SENT_44	[p2l343t3466r413b3523],
11	arterial	JJ	O	arterial	amod	12	SENT_44	[p2l440t3466r665b3523],
12	hypertension	NN	O	hypertension	prep_of	9	SENT_44	[p2l696t3466r1113b3539],
13	or	CC	O	or	_	0	SENT_44	[p2l1145t3484r1211b3523],
14	heart	NN	O	heart	nn	15	SENT_44	[p2l1239t3466r1401b3523],
15	failure	NN	O	failure	conj_or	12	SENT_44	[p2l1431t3466r1657b3533],
16	,	,	O	,	_	0	SENT_44	[p2l1431t3466r1657b3533],
17	this	DT	O	this	nsubj	18	SENT_44	[p2l1691t3466r1804b3523],
18	raises	VBZ	O	raise	_	0	SENT_44	[p2l1835t3466r2017b3523],
19	the	DT	O	the	dobj	18	SENT_44	[p2l2049t3466r2146b3523],

1	©	RB	O	©	advmod	2	SENT_45	[p2l9t3666r43b3700],
2	2008	CD	DATE	2008	_	0	SENT_45	[p2l61t3663r166b3700],
3	Adis	NNP	ORGANIZATION	Adis	nn	5	SENT_45	[p2l183t3663r279b3700],
4	Data	NNP	ORGANIZATION	Data	nn	5	SENT_45	[p2l298t3663r411b3700],
5	Information	NNP	ORGANIZATION	Information	dep	2	SENT_45	[p2l432t3663r694b3700],
6	BV	NN	ORGANIZATION	bv	dep	5	SENT_45	[p2l715t3663r783b3700],
7	.	.	O	.	_	0	SENT_45	[p2l715t3663r783b3700],

1	All	DT	O	all	det	2	SENT_46	[p2l803t3663r855b3700],
2	rights	NNS	O	rights	nsubj	3	SENT_46	[p2l875t3663r993b3710],
3	reserved	VBN	O	reserve	_	0	SENT_46	[p2l1012t3663r1221b3700],
4	.	.	O	.	_	0	SENT_46	[p2l1012t3663r1221b3700],

1	possibility	NN	O	possibility	_	0	SENT_47	[p3l8t91r344b165],
2	of	IN	O	of	_	0	SENT_47	[p3l378t91r447b148],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_47	[p3l473t91r1011b165],
4	interactions	NNS	O	interaction	prep_of	1	SENT_47	[p3l1045t91r1419b148],
5	between	IN	O	between	_	0	SENT_47	[p3l1452t91r1721b148],
6	these	DT	O	these	det	7	SENT_47	[p3l1753t91r1917b148],
7	drugs	NNS	O	drug	prep_between	1	SENT_47	[p3l1950t91r2143b165],
8	.	.	O	.	_	0	SENT_47	[p3l1950t91r2143b165],

1	In	FW	O	in	nn	2	SENT_48	[p3l7t195r73b249],
2	vitro	FW	O	vitro	amod	3	SENT_48	[p3l95t195r245b250],
3	studies	NNS	O	study	nsubj	5	SENT_48	[p3l270t192r488b249],
4	have	VBP	O	have	aux	5	SENT_48	[p3l510t192r661b249],
5	indicated	VBN	O	indicate	_	0	SENT_48	[p3l682t192r978b249],
6	that	IN	O	that	complm	9	SENT_48	[p3l999t192r1119b249],
7	irbesartan	NN	O	irbesartan	nsubjpass	9	SENT_48	[p3l1139t192r1456b249],
8	is	VBZ	O	be	auxpass	9	SENT_48	[p3l1477t192r1527b249],
9	oxidized	VBN	O	oxidize	ccomp	5	SENT_48	[p3l1551t192r1828b249],
10	primarily	RB	O	primarily	advmod	9	SENT_48	[p3l1847t192r2147b266],
11	by	IN	O	by	_	0	SENT_48	[p3l8t295r87b369],
12	CYP2C9	NN	O	cyp2c9	agent	9	SENT_48	[p3l113t287r482b353],
13	.	.	O	.	_	0	SENT_48	[p3l113t287r482b353],

1	[	NN	O	[	nsubj	19	SENT_49	[p3l113t287r482b353],
2	5	CD	NUMBER	5	number	3	SENT_49	[p3l113t287r482b353],
3	]	CD	NUMBER	]	num	4	SENT_49	[p3l113t287r482b353],
4	Metabolism	NN	O	metabolism	nsubj	9	SENT_49	[p3l510t295r897b352],
5	by	IN	O	by	_	0	SENT_49	[p3l919t295r999b369],
6	other	JJ	O	other	amod	7	SENT_49	[p3l1025t295r1190b352],
7	isoenzymes	NNS	O	isoenzyme	prep_by	4	SENT_49	[p3l1213t295r1587b369],
8	commonly	RB	O	commonly	advmod	9	SENT_49	[p3l1615t295r1958b369],
9	associated	VBN	O	associate	rcmod	1	SENT_49	[p3l1985t313r2145b352, p3l10t395r201b452],
10	with	IN	O	with	_	0	SENT_49	[p3l225t395r366b452],
11	drug	NN	O	drug	nn	12	SENT_49	[p3l391t395r536b469],
12	metabolism	NN	O	metabolism	prep_with	9	SENT_49	[p3l561t395r954b462],
13	,	,	O	,	_	0	SENT_49	[p3l561t395r954b462],
14	such	JJ	O	such	_	0	SENT_49	[p3l984t395r1128b452],
15	as	IN	O	as	_	0	SENT_49	[p3l1154t413r1215b452],
16	CYP3A4	NN	O	cyp3a4	prep_such_as	1	SENT_49	[p3l1243t396r1554b462],
17	,	,	O	,	_	0	SENT_49	[p3l1243t396r1554b462],
18	is	VBZ	O	be	cop	19	SENT_49	[p3l1581t395r1631b452],
19	negligible	JJ	O	negligible	_	0	SENT_49	[p3l1657t395r1995b469],
20	.	.	O	.	_	0	SENT_49	[p3l1657t395r1995b469],

1	The	DT	O	the	det	2	SENT_50	[p3l2023t395r2147b452],
2	metabolites	NNS	O	metabolite	nsubj	9	SENT_50	[p3l9t496r379b553],
3	derived	VBN	O	derive	partmod	2	SENT_50	[p3l409t496r649b553],
4	from	IN	O	from	_	0	SENT_50	[p3l676t496r832b553],
5	CYPZC9	NN	O	cypzc9	nn	6	SENT_50	[p3l859t497r1147b554],
6	oxidation	NN	O	oxidation	prep_from	3	SENT_50	[p3l1177t496r1481b553],
7	do	VBP	O	do	aux	9	SENT_50	[p3l1508t496r1586b553],
8	not	RB	O	not	neg	9	SENT_50	[p3l1614t505r1716b553],
9	add	VB	O	add	_	0	SENT_50	[p3l1744t496r1857b553],
10	appreciably	RB	O	appreciably	advmod	9	SENT_50	[p3l1886t496r2145b570, p3l11t597r145b671],
11	to	TO	O	to	_	0	SENT_50	[p3l203t606r263b654],
12	the	DT	O	the	det	14	SENT_50	[p3l321t597r417b654],
13	pharmacological	JJ	O	pharmacological	amod	14	SENT_50	[p3l473t597r1012b671],
14	activity	NN	O	activity	prep_to	9	SENT_50	[p3l1071t597r1310b671],
15	of	IN	O	of	_	0	SENT_50	[p3l1368t597r1438b654],
16	irbesartan	NN	O	irbesartan	prep_of	14	SENT_50	[p3l1489t597r1824b664],
17	,	,	O	,	_	0	SENT_50	[p3l1489t597r1824b664],
18	whereas	IN	O	whereas	mark	22	SENT_50	[p3l1885t597r2146b654],
19	CYPZC9	NN	O	cypzc9	nsubj	22	SENT_50	[p3l10t699r297b756],
20	is	VBZ	O	be	cop	22	SENT_50	[p3l321t698r371b755],
21	critically	RB	O	critically	advmod	22	SENT_50	[p3l395t698r680b772],
22	involved	VBN	O	involve	advcl	9	SENT_50	[p3l702t698r984b755],
23	in	IN	O	in	_	0	SENT_50	[p3l1005t698r1066b754],
24	the	DT	O	the	det	25	SENT_50	[p3l1087t698r1184b755],
25	biotransformation	NN	O	biotransformation	prep_in	22	SENT_50	[p3l1205t698r1785b755],
26	of	IN	O	of	_	0	SENT_50	[p3l1807t698r1877b755],
27	losartan	NN	O	losartan	prep_of	25	SENT_50	[p3l1893t698r2148b755],
28	to	TO	O	to	_	0	SENT_50	[p3l9t808r68b856],
29	its	PRP$	O	its	poss	32	SENT_50	[p3l96t799r169b856],
30	principal	JJ	O	principal	amod	32	SENT_50	[p3l197t799r484b873],
31	active	JJ	O	active	amod	32	SENT_50	[p3l512t799r702b856],
32	metabolite	NN	O	metabolite	prep_to	22	SENT_50	[p3l729t799r1086b866],
33	,	,	O	,	_	0	SENT_50	[p3l729t799r1086b866],
34	EXP3l74	NN	O	exp3l74	appos	32	SENT_50	[p3l1116t800r1446b856],
35	.	.	O	.	_	0	SENT_50	[p3l1116t800r1446b856],

1	In	FW	O	in	nn	2	SENT_51	[p3l1475t802r1541b856],
2	vitro	FW	O	vitro	amod	3	SENT_51	[p3l1569t802r1719b857],
3	studies	NNS	O	study	nsubj	5	SENT_51	[p3l1749t799r1968b856],
4	have	VBP	O	have	aux	5	SENT_51	[p3l1996t799r2147b856],
5	indicated	VBN	O	indicate	_	0	SENT_51	[p3l9t900r305b957],
6	that	IN	O	that	complm	10	SENT_51	[p3l333t900r454b957],
7	EXP3l74	NN	O	exp3l74	nsubjpass	10	SENT_51	[p3l481t901r794b957],
8	is	VBZ	O	be	auxpass	10	SENT_51	[p3l824t900r874b957],
9	also	RB	O	also	advmod	10	SENT_51	[p3l906t900r1032b957],
10	formed	VBN	O	form	ccomp	5	SENT_51	[p3l1063t900r1295b957],
11	by	IN	O	by	_	0	SENT_51	[p3l1322t900r1402b974],
12	CYP3A4	NN	O	cyp3a4	agent	10	SENT_51	[p3l1432t901r1742b957],
13	.	.	O	.	_	0	SENT_51	[p3l1432t901r1742b957],

1	The	DT	O	the	det	2	SENT_52	[p3l1776t900r1899b957],
2	role	NN	O	role	nsubj	9	SENT_52	[p3l1928t900r2053b957],
3	of	IN	O	of	_	0	SENT_52	[p3l2083t900r2153b957],
4	CYP3A4	NN	O	cyp3a4	prep_of	2	SENT_52	[p3l10t1002r303b1058],
5	is	VBZ	O	be	cop	9	SENT_52	[p3l348t1001r417b1068],
6	,	,	O	,	_	0	SENT_52	[p3l348t1001r417b1068],
7	however	RB	O	however	advmod	9	SENT_52	[p3l463t1001r757b1068],
8	,	,	O	,	_	0	SENT_52	[p3l463t1001r757b1068],
9	negligible	JJ	O	negligible	_	0	SENT_52	[p3l804t1001r1126b1075],
10	at	IN	O	at	_	0	SENT_52	[p3l1172t1010r1228b1058],
11	concentrations	NNS	O	concentration	prep_at	9	SENT_52	[p3l1270t1001r1739b1058],
12	of	IN	O	of	_	0	SENT_52	[p3l1785t1001r1855b1058],
13	losartan	NN	O	losartan	prep_of	11	SENT_52	[p3l1893t1001r2148b1058],
14	lower	JJR	O	lower	advmod	9	SENT_52	[p3l9t1102r193b1159],
15	than	IN	O	than	_	0	SENT_52	[p3l210t1103r348b1159],
16	1	CD	NUMBER	1	num	17	SENT_52	[p3l375t1103r398b1158],
17	umol/L	NN	O	umol/l	prep_than	14	SENT_52	[p3l426t1102r685b1176],
18	,	,	O	,	_	0	SENT_52	[p3l426t1102r685b1176],
19	corresponding	VBG	O	correspond	partmod	17	SENT_52	[p3l708t1102r1168b1176],
20	to	TO	O	to	_	0	SENT_52	[p3l1188t1111r1248b1159],
21	therapeutic	JJ	O	therapeutic	amod	23	SENT_52	[p3l1269t1102r1626b1176],
22	plasma	NN	O	plasma	nn	23	SENT_52	[p3l1645t1102r1875b1176],
23	concentrations	NNS	O	concentration	prep_to	19	SENT_52	[p3l1894t1120r2145b1159, p3l9t1197r356b1262],
24	.	.	O	.	_	0	SENT_52	[p3l1894t1120r2145b1159, p3l9t1197r356b1262],

1	[	NN	O	[	nsubj	11	SENT_53	[p3l1894t1120r2145b1159, p3l9t1197r356b1262],
2	2	CD	NUMBER	2	number	3	SENT_53	[p3l1894t1120r2145b1159, p3l9t1197r356b1262],
3	°	CD	NUMBER	°	num	4	SENT_53	[p3l1894t1120r2145b1159, p3l9t1197r356b1262],
4	]	NN	O	]	dep	1	SENT_53	[p3l1894t1120r2145b1159, p3l9t1197r356b1262],
5	Importantly	RB	O	importantly	advmod	1	SENT_53	[p3l418t1205r815b1279],
6	,	,	O	,	_	0	SENT_53	[p3l418t1205r815b1279],
7	both	DT	O	both	det	8	SENT_53	[p3l876t1205r1019b1262],
8	irbesartan	NN	O	irbesartan	conj_and	1	SENT_53	[p3l1077t1205r1394b1262],
9	and	CC	O	and	_	0	SENT_53	[p3l1454t1205r1568b1262],
10	losartan	NN	O	losartan	conj_and	1	SENT_53	[p3l1625t1205r1880b1262],
11	inhibit	VBP	O	inhibit	_	0	SENT_53	[p3l1938t1205r2149b1262],
12	CYPZC9-dependent	JJ	O	cypzc9-dependent	amod	13	SENT_53	[p3l10t1305r661b1379],
13	biotransformation	NN	O	biotransformation	dobj	11	SENT_53	[p3l687t1305r1267b1362],
14	of	IN	O	of	_	0	SENT_53	[p3l1296t1305r1366b1362],
15	other	JJ	O	other	amod	16	SENT_53	[p3l1390t1305r1555b1362],
16	drugs	NNS	O	drug	prep_of	13	SENT_53	[p3l1583t1305r1776b1379],
17	.	.	O	.	_	0	SENT_53	[p3l1583t1305r1776b1379],

1	For	IN	O	for	_	0	SENT_54	[p3l1808t1307r1920b1362],
2	example	NN	O	example	prep_for	12	SENT_54	[p3l1948t1323r2145b1362, p3l8t1406r123b1480],
3	,	,	O	,	_	0	SENT_54	[p3l1948t1323r2145b1362, p3l8t1406r123b1480],
4	the	DT	O	the	det	6	SENT_54	[p3l155t1406r251b1463],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_54	[p3l282t1406r933b1464],
6	—	NN	O	—	nsubjpass	12	SENT_54	[p3l282t1406r933b1464],
7	associated	VBN	O	associate	partmod	6	SENT_54	[p3l282t1406r933b1464],
8	methylhydroxylation	NN	O	methylhydroxylation	dobj	7	SENT_54	[p3l961t1406r1639b1480],
9	of	IN	O	of	_	0	SENT_54	[p3l1669t1406r1739b1463],
10	tolbutamide	NN	O	tolbutamide	prep_of	8	SENT_54	[p3l1762t1406r2147b1463],
11	is	VBZ	O	be	auxpass	12	SENT_54	[p3l9t1509r59b1566],
12	inhibited	VBN	O	inhibit	_	0	SENT_54	[p3l124t1509r410b1566],
13	by	IN	O	by	_	0	SENT_54	[p3l472t1509r551b1583],
14	losartan	NN	O	losartan	agent	12	SENT_54	[p3l615t1509r869b1566],
15	and	CC	O	and	_	0	SENT_54	[p3l934t1509r1048b1566],
16	irbesartan	NN	O	irbesartan	conj_and	14	SENT_54	[p3l1110t1501r1534b1566],
17	?	.	O	?	_	0	SENT_54	[p3l1110t1501r1534b1566],

1	”	NN	O	”	nsubjpass	20	SENT_55	[p3l1110t1501r1534b1566],
2	Conversely	RB	O	conversely	advmod	1	SENT_55	[p3l1601t1509r1985b1583],
3	,	,	O	,	_	0	SENT_55	[p3l1601t1509r1985b1583],
4	the	DT	O	the	det	6	SENT_55	[p3l2051t1509r2147b1566],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_55	[p3l10t1609r624b1667],
6	—	NN	O	—	nsubj	7	SENT_55	[p3l10t1609r624b1667],
7	mediated	VBD	O	mediate	parataxis	20	SENT_55	[p3l10t1609r624b1667],
8	conversion	NN	O	conversion	dobj	7	SENT_55	[p3l648t1609r1001b1666],
9	of	IN	O	of	_	0	SENT_55	[p3l1026t1609r1095b1666],
10	losartan	NN	O	losartan	prep_of	8	SENT_55	[p3l1114t1609r1368b1666],
11	to	TO	O	to	_	0	SENT_55	[p3l1392t1618r1452b1666],
12	its	PRP$	O	its	poss	14	SENT_55	[p3l1476t1609r1549b1666],
13	principal	JJ	O	principal	amod	14	SENT_55	[p3l1573t1609r1860b1683],
14	metabolite	NN	O	metabolite	prep_to	7	SENT_55	[p3l1884t1609r2145b1666, p3l9t1712r127b1779],
15	,	,	O	,	_	0	SENT_55	[p3l1884t1609r2145b1666, p3l9t1712r127b1779],
16	EXP3	NN	O	exp3	appos	14	SENT_55	[p3l150t1713r338b1769],
17	174	CD	NUMBER	174	num	16	SENT_55	[p3l352t1713r481b1779],
18	,	,	O	,	_	0	SENT_55	[p3l352t1713r481b1779],
19	is	VBZ	O	be	auxpass	20	SENT_55	[p3l504t1712r554b1769],
20	inhibited	VBN	O	inhibit	_	0	SENT_55	[p3l576t1712r863b1769],
21	by	IN	O	by	_	0	SENT_55	[p3l882t1712r961b1786],
22	the	DT	O	the	det	25	SENT_55	[p3l982t1712r1078b1769],
23	CYPZC9	NN	O	cypzc9	nn	25	SENT_55	[p3l1100t1713r1387b1770],
24	substrate	NN	O	substrate	nn	25	SENT_55	[p3l1412t1712r1695b1769],
25	phenytoin	NN	O	phenytoin	agent	20	SENT_55	[p3l1715t1704r2144b1786],
26	.	.	O	.	_	0	SENT_55	[p3l1715t1704r2144b1786],

1	[	NN	O	[	dobj	13	SENT_56	[p3l1715t1704r2144b1786],
2	22	CD	NUMBER	22	number	3	SENT_56	[p3l1715t1704r2144b1786],
3	]	CD	NUMBER	]	num	1	SENT_56	[p3l1715t1704r2144b1786],
4	Since	IN	O	since	_	0	SENT_56	[p3l11t1813r186b1870],
5	ARBs	NNS	O	arb	prep_since	1	SENT_56	[p3l207t1814r401b1870],
6	(	CD	NUMBER	(	num	7	SENT_56	[p3l426t1813r827b1883],
7	telmisartan	NN	O	telmisartan	nsubjpass	13	SENT_56	[p3l426t1813r827b1883],
8	,	,	O	,	_	0	SENT_56	[p3l426t1813r827b1883],
9	valsartan	NN	O	valsartan	nn	10	SENT_56	[p3l851t1813r1165b1883],
10	)	NN	O	)	appos	7	SENT_56	[p3l851t1813r1165b1883],
11	have	VBP	O	have	aux	13	SENT_56	[p3l1188t1813r1339b1870],
12	been	VBN	O	be	auxpass	13	SENT_56	[p3l1359t1813r1511b1870],
13	shown	VBN	O	show	dep	35	SENT_56	[p3l1534t1813r1741b1870],
14	to	TO	O	to	aux	17	SENT_56	[p3l1762t1822r1821b1870],
15	be	VB	O	be	cop	17	SENT_56	[p3l1842t1813r1917b1870],
16	OATP	JJ	O	oatp	amod	17	SENT_56	[p3l1940t1814r2148b1870],
17	substrates	NNS	O	substrate	xcomp	13	SENT_56	[p3l12t1913r324b1970],
18	in	FW	O	in	nn	19	SENT_56	[p3l360t1916r417b1970],
19	vitro	FW	O	vitro	advmod	17	SENT_56	[p3l450t1916r617b1980],
20	,	,	O	,	_	0	SENT_56	[p3l450t1916r617b1980],
21	inhibition	NN	O	inhibition	nsubj	35	SENT_56	[p3l652t1913r965b1970],
22	of	IN	O	of	_	0	SENT_56	[p3l997t1913r1067b1970],
23	OATP	NN	O	oatp	prep_of	21	SENT_56	[p3l1094t1913r1627b1970],
24	—	CD	NUMBER	—	num	23	SENT_56	[p3l1094t1913r1627b1970],
25	mediated	VBN	O	mediate	partmod	23	SENT_56	[p3l1094t1913r1627b1970],
26	torasemide	NN	O	torasemide	nn	27	SENT_56	[p3l1657t1913r2010b1970],
27	uptake	NN	O	uptake	dobj	25	SENT_56	[p3l2041t1931r2145b1987, p3l9t2014r141b2071],
28	into	IN	O	into	_	0	SENT_56	[p3l182t2014r305b2071],
29	the	DT	O	the	det	30	SENT_56	[p3l346t2014r442b2071],
30	liver	NN	O	liver	prep_into	25	SENT_56	[p3l483t2014r631b2071],
31	might	MD	O	might	aux	35	SENT_56	[p3l670t2014r858b2088],
32	be	VB	O	be	cop	35	SENT_56	[p3l896t2014r971b2071],
33	an	DT	O	a	det	35	SENT_56	[p3l1013t2032r1086b2071],
34	additional	JJ	O	additional	amod	35	SENT_56	[p3l1128t2014r1448b2071],
35	mechanism	NN	O	mechanism	_	0	SENT_56	[p3l1488t2014r1857b2071],
36	of	IN	O	of	_	0	SENT_56	[p3l1897t2014r1966b2071],
37	drug	NN	O	drug	nn	38	SENT_56	[p3l2002t2014r2147b2088],
38	interactions	NNS	O	interaction	prep_of	35	SENT_56	[p3l9t2116r383b2172],
39	between	IN	O	between	_	0	SENT_56	[p3l411t2116r680b2173],
40	torasemide	NN	O	torasemide	prep_between	38	SENT_56	[p3l706t2116r1059b2172],
41	and	CC	O	and	_	0	SENT_56	[p3l1088t2116r1202b2172],
42	ARBs	NNS	MISC	arb	prep_between	38	SENT_56	[p3l1227t2108r1597b2172],
43	.	.	O	.	_	0	SENT_56	[p3l1227t2108r1597b2172],

1	[	NN	O	[	_	0	SENT_57	[p3l1227t2108r1597b2172],
2	23	CD	NUMBER	23	number	3	SENT_57	[p3l1227t2108r1597b2172],
3	’	CD	NUMBER	’	dep	1	SENT_57	[p3l1227t2108r1597b2172],
4	24	CD	NUMBER	24	num	5	SENT_57	[p3l1227t2108r1597b2172],
5	]	NN	O	]	dep	3	SENT_57	[p3l1227t2108r1597b2172],

1	Because	IN	O	because	mark	9	SENT_58	[p3l106t2218r374b2273],
2	genetic	JJ	O	genetic	amod	3	SENT_58	[p3l418t2216r647b2290],
3	polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_58	[p3l690t2216r1192b2290],
4	in	IN	O	in	_	0	SENT_58	[p3l1236t2216r1297b2272],
5	CYPZC9	NN	O	cypzc9	prep_in	3	SENT_58	[p3l1343t2217r1622b2274],
6	and	CC	O	and	_	0	SENT_58	[p3l1665t2216r1779b2273],
7	SLCOIBI	NN	O	slcoibus	prep_in	3	SENT_58	[p3l1821t2217r2141b2274],
8	might	MD	O	might	aux	9	SENT_58	[p3l9t2317r197b2391],
9	contribute	VB	O	contribute	advcl	20	SENT_58	[p3l233t2317r559b2374],
10	to	TO	O	to	_	0	SENT_58	[p3l596t2326r655b2374],
11	interindividual	JJ	O	interindividual	amod	12	SENT_58	[p3l693t2317r1168b2374],
12	variability	NN	O	variability	prep_to	9	SENT_58	[p3l1205t2317r1535b2391],
13	in	IN	O	in	_	0	SENT_58	[p3l1572t2317r1633b2373],
14	the	DT	O	the	det	15	SENT_58	[p3l1669t2318r1766b2374],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	9	SENT_58	[p3l1802t2317r2145b2391, p3l8t2418r257b2475],
16	of	IN	O	of	_	0	SENT_58	[p3l292t2418r361b2475],
17	torasemide	NN	O	torasemide	prep_of	15	SENT_58	[p3l388t2418r758b2485],
18	,	,	O	,	_	0	SENT_58	[p3l388t2418r758b2485],
19	we	PRP	O	we	nsubj	20	SENT_58	[p3l794t2436r885b2475],
20	characterized	VBD	O	characterize	_	0	SENT_58	[p3l918t2418r1348b2475],
21	the	DT	O	the	det	22	SENT_58	[p3l1379t2418r1476b2475],
22	impact	NN	O	impact	dobj	20	SENT_58	[p3l1508t2418r1727b2492],
23	of	IN	O	of	_	0	SENT_58	[p3l1759t2418r1828b2475],
24	the	DT	O	the	det	27	SENT_58	[p3l1855t2418r1951b2475],
25	common	JJ	O	common	amod	27	SENT_58	[p3l1984t2436r2145b2475, p3l9t2538r151b2577],
26	CYP2C9	NN	O	cyp2c9	nn	27	SENT_58	[p3l240t2521r616b2587],
27	*	NN	O	*	prep_of	22	SENT_58	[p3l240t2521r616b2587],
28	l	NN	O	l	tmod	27	SENT_58	[p3l240t2521r616b2587],
29	,	,	O	,	_	0	SENT_58	[p3l240t2521r616b2587],
30	*	NN	O	*	conj_and	22	SENT_58	[p3l708t2521r782b2576],
31	2	CD	NUMBER	2	num	30	SENT_58	[p3l708t2521r782b2576],
32	and	CC	O	and	_	0	SENT_58	[p3l869t2520r983b2577],
33	*	CD	NUMBER	*	number	34	SENT_58	[p3l1071t2521r1142b2577],
34	3	CD	NUMBER	3	num	36	SENT_58	[p3l1071t2521r1142b2577],
35	allelic	JJ	O	allelic	amod	36	SENT_58	[p3l1232t2520r1425b2577],
36	variants	NNS	O	variant	conj_and	22	SENT_58	[p3l1512t2520r1764b2577],
37	and	CC	O	and	_	0	SENT_58	[p3l1853t2520r1966b2577],
38	the	DT	O	the	det	41	SENT_58	[p3l2051t2520r2147b2577],
39	OATPIBI	NNP	O	OATPIBI	nn	41	SENT_58	[p3l12t2621r334b2678],
40	c.	NN	O	c.	nn	41	SENT_58	[p3l386t2620r709b2677],
41	52lT	NN	O	52lt	conj_and	22	SENT_58	[p3l386t2620r709b2677],
42	>	JJR	O	>	amod	44	SENT_58	[p3l386t2620r709b2677],
43	C	NN	O	c	nn	44	SENT_58	[p3l386t2620r709b2677],
44	SNP	NN	O	snp	dep	41	SENT_58	[p3l758t2621r903b2677],
45	on	IN	O	on	_	0	SENT_58	[p3l949t2638r1027b2677],
46	torasemide	NN	O	torasemide	nn	47	SENT_58	[p3l1072t2620r1426b2677],
47	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	20	SENT_58	[p3l1471t2620r2039b2694],
48	in	IN	O	in	_	0	SENT_58	[p3l2087t2620r2148b2676],
49	humans	NNS	O	human	prep_in	47	SENT_58	[p3l8t2722r275b2778],
50	.	.	O	.	_	0	SENT_58	[p3l8t2722r275b2778],

1	Since	IN	O	since	_	0	SENT_59	[p3l314t2721r489b2778],
2	(	CD	NUMBER	(	prep_since	16	SENT_59	[p3l525t2722r609b2791],
3	to	TO	O	to	_	0	SENT_59	[p3l525t2722r609b2791],
4	the	DT	O	the	det	5	SENT_59	[p3l642t2722r739b2778],
5	best	JJS	O	best	prep_to	2	SENT_59	[p3l771t2721r901b2778],
6	of	IN	O	of	_	0	SENT_59	[p3l933t2721r1003b2778],
7	our	PRP$	O	we	poss	8	SENT_59	[p3l1031t2739r1138b2778],
8	knowledge	NN	O	knowledge	prep_of	5	SENT_59	[p3l1168t2721r1547b2795],
9	)	RB	O	)	advmod	5	SENT_59	[p3l1168t2721r1547b2795],
10	there	EX	O	there	expl	16	SENT_59	[p3l1582t2721r1741b2778],
11	have	VBP	O	have	aux	16	SENT_59	[p3l1773t2721r1924b2778],
12	so	RB	O	so	advmod	13	SENT_59	[p3l1960t2739r2026b2778],
13	far	RB	O	far	advmod	16	SENT_59	[p3l2060t2721r2149b2778],
14	been	VBN	O	be	cop	16	SENT_59	[p3l8t2822r160b2879],
15	no	DT	O	no	det	16	SENT_59	[p3l179t2840r257b2879],
16	studies	NNS	O	study	dep	33	SENT_59	[p3l280t2822r498b2879],
17	of	IN	O	of	_	0	SENT_59	[p3l521t2822r590b2879],
18	determinants	NNS	O	determinant	prep_of	16	SENT_59	[p3l605t2822r1019b2879],
19	of	IN	O	of	_	0	SENT_59	[p3l1041t2822r1111b2879],
20	torasemide	NN	O	torasemide	nn	21	SENT_59	[p3l1124t2822r1478b2879],
21	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	18	SENT_59	[p3l1497t2822r2066b2896],
22	in	IN	O	in	_	0	SENT_59	[p3l2087t2822r2148b2878],
23	patients	NNS	O	patient	prep_in	21	SENT_59	[p3l8t2923r257b2997],
24	during	IN	O	during	_	0	SENT_59	[p3l287t2923r495b2997],
25	steady	JJ	O	steady	amod	28	SENT_59	[p3l527t2923r904b2997],
26	—	JJ	O	—	amod	28	SENT_59	[p3l527t2923r904b2997],
27	state	NN	O	state	nn	28	SENT_59	[p3l527t2923r904b2997],
28	conditions	NNS	O	condition	prep_during	16	SENT_59	[p3l933t2923r1285b2990],
29	,	,	O	,	_	0	SENT_59	[p3l933t2923r1285b2990],
30	this	DT	O	this	det	31	SENT_59	[p3l1316t2923r1429b2980],
31	study	NN	O	study	appos	28	SENT_59	[p3l1462t2923r1632b2997],
32	was	VBD	O	be	auxpass	33	SENT_59	[p3l1661t2941r1782b2980],
33	performed	VBN	O	perform	_	0	SENT_59	[p3l1811t2923r2148b2997],
34	in	IN	O	in	_	0	SENT_59	[p3l9t3024r70b3080],
35	patients	NNS	O	patient	prep_in	33	SENT_59	[p3l107t3024r356b3098],
36	receiving	VBG	O	receive	partmod	35	SENT_59	[p3l396t3024r695b3098],
37	stable	JJ	O	stable	amod	38	SENT_59	[p3l737t3024r921b3081],
38	medication	NN	O	medication	dobj	36	SENT_59	[p3l960t3024r1318b3081],
39	with	IN	O	with	_	0	SENT_59	[p3l1357t3024r1499b3081],
40	torasemide	NN	O	torasemide	nn	42	SENT_59	[p3l1537t3024r1890b3081],
41	10	CD	NUMBER	10	num	42	SENT_59	[p3l1937t3025r2007b3081],
42	mg	NN	O	mg	prep_with	38	SENT_59	[p3l2046t3042r2147b3098],
43	once	RB	DATE	once	advmod	44	SENT_59	[p3l10t3143r159b3182],
44	daily	RB	SET	daily	advmod	36	SENT_59	[p3l191t3125r349b3199],
45	for	IN	O	for	_	0	SENT_59	[p3l380t3125r473b3182],
46	treatment	NN	O	treatment	prep_for	36	SENT_59	[p3l502t3134r807b3182],
47	of	IN	O	of	_	0	SENT_59	[p3l837t3125r907b3182],
48	arterial	JJ	O	arterial	amod	49	SENT_59	[p3l933t3125r1158b3182],
49	hypertension	NN	O	hypertension	prep_of	46	SENT_59	[p3l1188t3125r1606b3199],
50	or	CC	O	or	_	0	SENT_59	[p3l1636t3143r1702b3182],
51	symptomatic	JJ	O	symptomatic	amod	60	SENT_59	[p3l1733t3125r2146b3199],
52	heart	NN	O	heart	nn	60	SENT_59	[p3l8t3227r170b3284],
53	failure	NN	O	failure	nn	60	SENT_59	[p3l195t3227r403b3284],
54	(	CD	NUMBER	(	num	60	SENT_59	[p3l432t3228r607b3297],
55	New	NNP	ORGANIZATION	New	nn	60	SENT_59	[p3l432t3228r607b3297],
56	York	NNP	ORGANIZATION	York	nn	60	SENT_59	[p3l634t3227r799b3284],
57	Heart	NNP	ORGANIZATION	Heart	nn	60	SENT_59	[p3l824t3229r1003b3284],
58	Association	NNP	ORGANIZATION	Association	nn	60	SENT_59	[p3l1027t3227r1408b3284],
59	[	NN	O	[	nn	60	SENT_59	[p3l1440t3228r1714b3296],
60	NYHA	NN	O	nyha	conj_or	49	SENT_59	[p3l1440t3228r1714b3296],
61	]	CD	NUMBER	]	num	64	SENT_59	[p3l1440t3228r1714b3296],
62	class	NN	O	class	nn	64	SENT_59	[p3l1746t3227r1899b3284],
63	11-111	CD	NUMBER	11-111	num	64	SENT_59	[p3l1927t3228r2143b3297],
64	)	NN	O	)	nsubjpass	33	SENT_59	[p3l1927t3228r2143b3297],
65	.	.	O	.	_	0	SENT_59	[p3l1927t3228r2143b3297],

1	The	DT	O	the	det	3	SENT_60	[p3l9t3327r132b3384],
2	primary	JJ	O	primary	amod	3	SENT_60	[p3l157t3327r412b3401],
3	parameter	NN	O	parameter	nsubj	23	SENT_60	[p3l437t3336r761b3401],
4	of	IN	O	of	_	0	SENT_60	[p3l786t3327r856b3384],
5	interest	NN	O	interest	prep_of	3	SENT_60	[p3l876t3327r1113b3384],
6	was	VBD	O	be	cop	23	SENT_60	[p3l1138t3345r1260b3384],
7	a	DT	O	a	det	23	SENT_60	[p3l1289t3345r1322b3384],
8	change	NN	O	change	dep	23	SENT_60	[p3l1347t3327r1573b3401],
9	in	IN	O	in	_	0	SENT_60	[p3l1599t3327r1660b3383],
10	the	DT	O	the	det	11	SENT_60	[p3l1685t3327r1781b3384],
11	area	NN	O	area	prep_in	8	SENT_60	[p3l1809t3345r1941b3384],
12	under	IN	O	under	_	0	SENT_60	[p3l1965t3327r2149b3384],
13	the	DT	O	the	det	18	SENT_60	[p3l9t3428r105b3485],
14	plasma	NN	O	plasma	nn	18	SENT_60	[p3l140t3428r370b3502],
15	concentration	NN	O	concentration	nn	18	SENT_60	[p3l406t3428r1015b3485],
16	—	CD	NUMBER	—	num	18	SENT_60	[p3l406t3428r1015b3485],
17	time	NN	O	time	nn	18	SENT_60	[p3l406t3428r1015b3485],
18	curve	NN	O	curve	prep_under	11	SENT_60	[p3l1052t3446r1229b3485],
19	during	IN	O	during	_	0	SENT_60	[p3l1266t3428r1474b3502],
20	the	DT	O	the	det	22	SENT_60	[p3l1510t3428r1607b3485],
21	24-hour	JJ	DURATION	24-hour	amod	22	SENT_60	[p3l1644t3428r1899b3485],
22	dosing	NN	O	dosing	prep_during	18	SENT_60	[p3l1934t3428r2146b3502],
23	interval	NN	O	interval	_	0	SENT_60	[p3l9t3529r254b3586],
24	at	IN	O	at	_	0	SENT_60	[p3l281t3538r336b3586],
25	steady	JJ	O	steady	amod	28	SENT_60	[p3l363t3529r564b3603],
26	state	NN	O	state	nn	28	SENT_60	[p3l593t3538r736b3586],
27	(	CD	NUMBER	(	num	28	SENT_60	[p3l764t3530r1113b3602],
28	AUC24	NN	O	auc24	prep_at	23	SENT_60	[p3l764t3530r1113b3602],
29	,	,	O	,	_	0	SENT_60	[p3l764t3530r1113b3602],
30	ss	VBP	O	ss	dep	23	SENT_60	[p3l764t3530r1113b3602],
31	)	CD	NUMBER	)	dobj	30	SENT_60	[p3l764t3530r1113b3602],
32	Of	IN	O	of	_	0	SENT_60	[p3l1142t3529r1211b3586],
33	torasemide	NN	O	torasemide	prep_of	30	SENT_60	[p3l1231t3529r1584b3586],
34	in	IN	O	in	_	0	SENT_60	[p3l1609t3529r1670b3585],
35	relation	NN	O	relation	prep_in	33	SENT_60	[p3l1694t3529r1940b3586],
36	to	TO	O	to	_	0	SENT_60	[p3l1965t3538r2025b3586],
37	the	DT	O	the	det	39	SENT_60	[p3l2051t3529r2147b3586],
38	C	NN	O	c	nn	39	SENT_60	[p3l13t3632r64b3688],
39	YP2C9	NN	O	yp2c9	prep_to	35	SENT_60	[p3l68t3631r291b3688],
40	and	CC	O	and	_	0	SENT_60	[p3l316t3630r429b3687],
41	SLCOIBI	NN	O	slcoibus	nn	42	SENT_60	[p3l453t3631r773b3688],
42	genotype	NN	O	genotype	conj_and	39	SENT_60	[p3l803t3639r1114b3704],
43	.	.	O	.	_	0	SENT_60	[p3l803t3639r1114b3704],

1	Moreover	RB	O	moreover	advmod	6	SENT_61	[p3l1141t3632r1476b3697],
2	,	,	O	,	_	0	SENT_61	[p3l1141t3632r1476b3697],
3	torasemide	NN	O	torasemide	nn	4	SENT_61	[p3l1503t3630r1856b3687],
4	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	6	SENT_61	[p3l1878t3630r2145b3704, p3l10t3731r333b3787],
5	were	VBD	O	be	auxpass	6	SENT_61	[p3l362t3749r517b3788],
6	related	VBN	O	relate	_	0	SENT_61	[p3l543t3731r763b3787],
7	to	TO	O	to	_	0	SENT_61	[p3l789t3740r849b3787],
8	ARB	NN	O	arb	nn	9	SENT_61	[p3l876t3732r1036b3787],
9	comedication	NN	O	comedication	prep_to	6	SENT_61	[p3l1068t3731r1518b3787],
10	.	.	O	.	_	0	SENT_61	[p3l1068t3731r1518b3787],

1	Methods	NNS	O	method	_	0	SENT_62	[p4l110t130r443b191],

1	Study	NNP	O	Study	nn	2	SENT_63	[p4l106t338r299b407],
2	Design	NNP	O	Design	_	0	SENT_63	[p4l327t339r556b409],

1	An	DT	O	a	det	4	SENT_64	[p4l106t531r203b586],
2	open-label	JJ	O	open-label	amod	4	SENT_64	[p4l228t530r567b603],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_64	[p4l590t530r1128b603],
4	study	NN	O	study	nsubjpass	6	SENT_64	[p4l1156t530r1326b603],
5	was	VBD	O	be	auxpass	6	SENT_64	[p4l1351t548r1473b587],
6	performed	VBN	O	perform	_	0	SENT_64	[p4l1498t530r1835b603],
7	in	IN	O	in	_	0	SENT_64	[p4l1858t530r1919b586],
8	24	CD	NUMBER	24	num	9	SENT_64	[p4l1944t530r2021b586],
9	patients	NNS	O	patient	prep_in	6	SENT_64	[p4l2045t548r2145b603, p4l9t630r180b687],
10	with	IN	O	with	_	0	SENT_64	[p4l209t630r351b687],
11	arterial	JJ	O	arterial	amod	14	SENT_64	[p4l379t630r604b687],
12	hypertension	NN	O	hypertension	nn	14	SENT_64	[p4l630t630r1048b703],
13	(	NN	O	(	nn	14	SENT_64	[p4l1076t631r1139b700],
14	n	NN	O	n	prep_with	9	SENT_64	[p4l1076t631r1139b700],
15	=	JJ	O	=	amod	14	SENT_64	[p4l1167t654r1208b676],
16	18	CD	NUMBER	18	number	17	SENT_64	[p4l1243t631r1339b700],
17	)	CD	NUMBER	)	dep	15	SENT_64	[p4l1243t631r1339b700],
18	or	CC	O	or	_	0	SENT_64	[p4l1368t648r1434b687],
19	NYHA	NNP	O	NYHA	nn	20	SENT_64	[p4l1459t631r1691b687],
20	class	NN	O	class	conj_or	9	SENT_64	[p4l1718t630r1871b687],
21	II	CD	NUMBER	ii	num	20	SENT_64	[p4l1899t632r1951b686],
22	or	CC	O	or	_	0	SENT_64	[p4l1978t648r2044b687],
23	III	CD	NUMBER	iii	conj_or	9	SENT_64	[p4l2069t632r2148b686],
24	congestive	JJ	O	congestive	amod	31	SENT_64	[p4l10t730r353b803],
25	heart	NN	O	heart	nn	31	SENT_64	[p4l383t730r545b787],
26	failure	NN	O	failure	nn	31	SENT_64	[p4l574t730r783b787],
27	(	CD	NUMBER	(	num	31	SENT_64	[p4l817t731r879b800],
28	n	NN	O	n	nn	31	SENT_64	[p4l817t731r879b800],
29	=	JJ	O	=	amod	31	SENT_64	[p4l911t754r952b776],
30	6	CD	NUMBER	6	num	31	SENT_64	[p4l985t730r1065b800],
31	)	NN	O	)	dobj	6	SENT_64	[p4l985t730r1065b800],
32	.	.	O	.	_	0	SENT_64	[p4l985t730r1065b800],

1	The	DT	O	the	det	2	SENT_65	[p4l1099t730r1223b787],
2	study	NN	O	study	nsubjpass	4	SENT_65	[p4l1256t730r1426b803],
3	was	VBD	O	be	auxpass	4	SENT_65	[p4l1458t748r1579b787],
4	approved	VBN	O	approve	_	0	SENT_65	[p4l1613t730r1912b803],
5	by	IN	O	by	_	0	SENT_65	[p4l1940t730r2020b803],
6	the	DT	O	the	det	8	SENT_65	[p4l2051t730r2147b787],
7	Ethics	NNPS	ORGANIZATION	Ethics	nn	8	SENT_65	[p4l9t830r208b887],
8	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_65	[p4l257t830r614b887],
9	of	IN	O	of	_	0	SENT_65	[p4l662t830r732b887],
10	the	DT	O	the	det	12	SENT_65	[p4l773t830r870b887],
11	Federal	NNP	ORGANIZATION	Federal	nn	12	SENT_65	[p4l917t830r1158b887],
12	State	NNP	ORGANIZATION	State	prep_of	8	SENT_65	[p4l1207t830r1364b887],
13	of	IN	ORGANIZATION	of	_	0	SENT_65	[p4l1413t830r1482b887],
14	Mecklenburg-West	NNP	ORGANIZATION	Mecklenburg-West	prep_of	12	SENT_65	[p4l1523t830r2149b903],

1	Clin	NNP	O	Clin	nn	2	SENT_66	[p4l1405t1027r1489b1064],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_66	[p4l1510t1027r1867b1064],
3	2008	CD	DATE	2008	num	2	SENT_66	[p4l1883t1027r2000b1067],
4	;	:	O	;	_	0	SENT_66	[p4l1883t1027r2000b1067],
5	47	CD	NUMBER	47	number	6	SENT_66	[p4l2018t1027r2069b1064],
6	(	CD	NUMBER	(	dep	2	SENT_66	[p4l2089t1027r2146b1070],
7	5	CD	NUMBER	5	num	8	SENT_66	[p4l2089t1027r2146b1070],
8	)	NN	O	)	dep	6	SENT_66	[p4l2089t1027r2146b1070],

1	Determinants	NNS	O	determinant	_	0	SENT_67	[p4l6t1146r206b1170],
2	of	IN	O	of	_	0	SENT_67	[p4l217t1145r246b1170],
3	Torasemide	NNP	O	Torasemide	prep_of	1	SENT_67	[p4l256t1145r429b1170],
4	PK	NN	O	pk	dep	1	SENT_67	[p4l440t1146r484b1170],
5	325	CD	NUMBER	325	num	4	SENT_67	[p4l6t1181r54b1205],

1	Pomerania	NNP	LOCATION	Pomerania	nn	3	SENT_68	[p4l8t1384r355b1440],
2	(	NNP	O	(	nn	3	SENT_68	[p4l391t1384r697b1453],
3	Rostock	NNP	PERSON	Rostock	_	0	SENT_68	[p4l391t1384r697b1453],
4	,	,	O	,	_	0	SENT_68	[p4l391t1384r697b1453],
5	Germany	NNP	LOCATION	Germany	appos	3	SENT_68	[p4l736t1384r1078b1457],
6	)	CD	NUMBER	)	num	5	SENT_68	[p4l736t1384r1078b1457],
7	.	.	O	.	_	0	SENT_68	[p4l736t1384r1078b1457],

1	The	DT	O	the	det	2	SENT_69	[p4l1117t1384r1240b1440],
2	criteria	NNS	O	criterion	nsubj	8	SENT_69	[p4l1276t1384r1505b1440],
3	for	IN	O	for	_	0	SENT_69	[p4l1538t1384r1632b1440],
4	inclusion	NN	O	inclusion	prep_for	2	SENT_69	[p4l1665t1384r1961b1440],
5	were	VBD	O	be	cop	8	SENT_69	[p4l1996t1401r2151b1440],
6	stable	JJ	O	stable	amod	7	SENT_69	[p4l11t1485r195b1542],
7	diuretic	JJ	O	diuretic	amod	8	SENT_69	[p4l224t1485r468b1542],
8	therapy	NN	O	therapy	_	0	SENT_69	[p4l497t1485r738b1558],
9	with	IN	O	with	_	0	SENT_69	[p4l766t1485r909b1542],
10	torasemide	NN	O	torasemide	prep_with	8	SENT_69	[p4l936t1485r1290b1542],
11	(	CD	NUMBER	(	number	12	SENT_69	[p4l1320t1485r1423b1555],
12	10	CD	NUMBER	10	num	13	SENT_69	[p4l1320t1485r1423b1555],
13	mg	NN	O	mg	dep	10	SENT_69	[p4l1452t1503r1552b1558],
14	once	RB	DATE	once	advmod	13	SENT_69	[p4l1582t1503r1732b1542],
15	daily	JJ	SET	daily	amod	16	SENT_69	[p4l1760t1485r1944b1558],
16	)	NN	O	)	pobj	14	SENT_69	[p4l1760t1485r1944b1558],
17	for	IN	O	for	_	0	SENT_69	[p4l1975t1485r2068b1542],
18	at	IN	DURATION	at	quantmod	20	SENT_69	[p4l2096t1494r2152b1542],
19	least	JJS	DURATION	least	mwe	18	SENT_69	[p4l9t1586r156b1643],
20	1	CD	DURATION	1	prep_for	14	SENT_69	[p4l182t1587r206b1643],
21	week	NN	NUMBER	week	tmod	14	SENT_69	[p4l233t1586r404b1644],
22	and	CC	O	and	_	0	SENT_69	[p4l423t1586r537b1643],
23	a	DT	O	a	det	25	SENT_69	[p4l558t1605r591b1643],
24	clinical	JJ	O	clinical	amod	25	SENT_69	[p4l610t1586r846b1643],
25	indication	NN	O	indication	prep_with	8	SENT_69	[p4l866t1586r1189b1643],
26	for	IN	O	for	_	0	SENT_69	[p4l1208t1586r1302b1643],
27	additional	JJ	O	additional	amod	29	SENT_69	[p4l1321t1586r1642b1643],
28	ARB	NN	O	arb	nn	29	SENT_69	[p4l1662t1587r1822b1643],
29	treatment	NN	O	treatment	prep_for	25	SENT_69	[p4l1847t1595r2152b1643],
30	for	IN	O	for	_	0	SENT_69	[p4l9t1688r103b1744],
31	control	NN	O	control	prep_for	29	SENT_69	[p4l128t1688r355b1744],
32	of	IN	O	of	_	0	SENT_69	[p4l383t1688r453b1744],
33	hypertension	NN	O	hypertension	prep_of	31	SENT_69	[p4l473t1688r891b1761],
34	or	CC	O	or	_	0	SENT_69	[p4l919t1705r985b1744],
35	improvement	NN	O	improvement	conj_or	33	SENT_69	[p4l1010t1688r1442b1761],
36	of	IN	O	of	_	0	SENT_69	[p4l1468t1687r1538b1744],
37	heart	NN	O	heart	nn	39	SENT_69	[p4l1558t1688r1720b1744],
38	failure	NN	O	failure	nn	39	SENT_69	[p4l1746t1688r1955b1744],
39	treatment	NN	O	treatment	prep_of	25	SENT_69	[p4l1982t1696r2148b1744, p4l9t1797r185b1846],
40	.	.	O	.	_	0	SENT_69	[p4l1982t1696r2148b1744, p4l9t1797r185b1846],

1	For	IN	O	for	_	0	SENT_70	[p4l210t1791r322b1846],
2	clinical	JJ	O	clinical	amod	3	SENT_70	[p4l342t1789r578b1846],
3	reasons	NNS	O	reason	prep_for	9	SENT_70	[p4l599t1807r858b1856],
4	,	,	O	,	_	0	SENT_70	[p4l599t1807r858b1856],
5	one	CD	NUMBER	one	nsubj	9	SENT_70	[p4l883t1807r997b1846],
6	of	IN	O	of	_	0	SENT_70	[p4l1019t1789r1089b1846],
7	the	DT	O	the	det	8	SENT_70	[p4l1104t1789r1201b1846],
8	subjects	NNS	O	subject	prep_of	5	SENT_70	[p4l1225t1789r1480b1862],
9	received	VBD	O	receive	_	0	SENT_70	[p4l1502t1789r1777b1846],
10	torasemide	RB	O	torasemide	advmod	9	SENT_70	[p4l1797t1789r2150b1846],
11	20	CD	NUMBER	20	num	12	SENT_70	[p4l10t1890r87b1946],
12	mg	NN	O	mg	dobj	9	SENT_70	[p4l107t1907r207b1963],
13	once	RB	DATE	once	advmod	9	SENT_70	[p4l228t1907r378b1946],
14	daily	RB	SET	daily	advmod	9	SENT_70	[p4l398t1889r574b1963],
15	.	.	O	.	_	0	SENT_70	[p4l398t1889r574b1963],

1	After	IN	O	after	mark	6	SENT_71	[p4l597t1889r768b1946],
2	written	VBN	O	write	amod	4	SENT_71	[p4l786t1889r1013b1946],
3	informed	JJ	O	informed	amod	4	SENT_71	[p4l1032t1889r1328b1946],
4	consent	NN	O	consent	nsubjpass	6	SENT_71	[p4l1348t1898r1594b1946],
5	was	VBD	O	be	auxpass	6	SENT_71	[p4l1613t1907r1734b1946],
6	obtained	VBN	O	obtain	advcl	10	SENT_71	[p4l1756t1889r2050b1956],
7	,	,	O	,	_	0	SENT_71	[p4l1756t1889r2050b1956],
8	all	DT	O	all	det	9	SENT_71	[p4l2074t1889r2151b1946],
9	patients	NNS	O	patient	nsubj	10	SENT_71	[p4l8t1991r257b2064],
10	underwent	VBD	O	undergo	_	0	SENT_71	[p4l280t1991r622b2047],
11	a	DT	O	a	det	13	SENT_71	[p4l644t2008r678b2047],
12	screening	JJ	O	screening	amod	13	SENT_71	[p4l701t1991r1006b2064],
13	evaluation	NN	O	evaluation	dobj	10	SENT_71	[p4l1029t1991r1382b2057],
14	,	,	O	,	_	0	SENT_71	[p4l1029t1991r1382b2057],
15	which	WDT	O	which	nsubj	16	SENT_71	[p4l1407t1991r1603b2047],
16	included	VBD	O	include	rcmod	13	SENT_71	[p4l1624t1991r1903b2047],
17	laboratory	NN	O	laboratory	nn	18	SENT_71	[p4l1924t1991r2149b2047, p4l9t2101r137b2165],
18	tests	NNS	O	test	dobj	16	SENT_71	[p4l162t2101r320b2149],
19	.	.	O	.	_	0	SENT_71	[p4l162t2101r320b2149],

1	None	NN	O	none	nsubj	5	SENT_72	[p4l348t2094r522b2149],
2	of	IN	O	of	_	0	SENT_72	[p4l549t2092r618b2149],
3	the	DT	O	the	det	4	SENT_72	[p4l638t2092r734b2149],
4	patients	NNS	O	patient	prep_of	1	SENT_72	[p4l758t2092r1008b2165],
5	had	VBD	O	have	_	0	SENT_72	[p4l1034t2092r1151b2149],
6	a	DT	O	a	det	7	SENT_72	[p4l1176t2110r1209b2149],
7	history	NN	O	history	dobj	5	SENT_72	[p4l1232t2092r1456b2165],
8	of	IN	O	of	_	0	SENT_72	[p4l1482t2092r1552b2149],
9	additional	JJ	O	additional	amod	11	SENT_72	[p4l1573t2092r1894b2149],
10	hepatic	JJ	O	hepatic	amod	11	SENT_72	[p4l1918t2092r2150b2165],
11	disease	NN	O	disease	prep_of	7	SENT_72	[p4l9t2192r240b2249],
12	or	CC	O	or	_	0	SENT_72	[p4l264t2210r330b2249],
13	intrinsic	JJ	O	intrinsic	amod	15	SENT_72	[p4l351t2192r614b2249],
14	kidney	NN	O	kidney	nn	15	SENT_72	[p4l636t2192r855b2266],
15	disease	NN	O	disease	prep_of	7	SENT_72	[p4l879t2192r1127b2249],
16	.	.	O	.	_	0	SENT_72	[p4l879t2192r1127b2249],

1	Table	NNP	O	Table	nsubj	3	SENT_73	[p4l1153t2192r1335b2249],
2	1	CD	NUMBER	1	num	1	SENT_73	[p4l1358t2194r1383b2248],
3	summarizes	VBZ	O	summarize	_	0	SENT_73	[p4l1408t2192r1789b2249],
4	the	DT	O	the	det	6	SENT_73	[p4l1813t2192r1910b2249],
5	patient	NN	O	patient	nn	6	SENT_73	[p4l1931t2192r2152b2266],
6	characteristics	NNS	O	characteristic	dobj	3	SENT_73	[p4l9t2294r488b2360],
7	,	,	O	,	_	0	SENT_73	[p4l9t2294r488b2360],
8	including	VBG	O	include	_	0	SENT_73	[p4l528t2294r832b2367],
9	serum	NN	O	serum	nn	11	SENT_73	[p4l872t2311r1067b2350],
10	creatinine	NN	O	creatinine	nn	11	SENT_73	[p4l1103t2294r1420b2350],
11	levels	NNS	O	level	prep_including	6	SENT_73	[p4l1457t2294r1642b2351],
12	and	CC	O	and	_	0	SENT_73	[p4l1683t2294r1797b2350],
13	creatinine	NN	O	creatinine	nn	14	SENT_73	[p4l1834t2294r2151b2350],
14	clearance	NN	O	clearance	conj_and	11	SENT_73	[p4l9t2395r329b2452],
15	.	.	O	.	_	0	SENT_73	[p4l9t2395r329b2452],

1	All	DT	O	all	det	3	SENT_74	[p4l366t2395r467b2451],
2	long-term	JJ	O	long-term	amod	3	SENT_74	[p4l500t2395r819b2468],
3	medications	NNS	O	medication	nsubjpass	5	SENT_74	[p4l851t2395r1239b2452],
4	were	VBD	O	be	auxpass	5	SENT_74	[p4l1274t2413r1429b2452],
5	maintained	VBN	O	maintain	_	0	SENT_74	[p4l1462t2395r1822b2452],
6	at	IN	O	at	_	0	SENT_74	[p4l1855t2404r1911b2452],
7	a	DT	O	a	det	9	SENT_74	[p4l1944t2413r1978b2452],
8	constant	JJ	O	constant	amod	9	SENT_74	[p4l2010t2413r2148b2452, p4l11t2504r161b2552],
9	dose	NN	O	dose	prep_at	5	SENT_74	[p4l195t2495r341b2552],
10	during	IN	O	during	_	0	SENT_74	[p4l376t2495r585b2569],
11	the	DT	O	the	det	14	SENT_74	[p4l620t2495r717b2552],
12	entire	JJ	O	entire	amod	14	SENT_74	[p4l753t2495r934b2552],
13	study	NN	O	study	nn	14	SENT_74	[p4l972t2495r1142b2569],
14	phase	NN	O	phase	prep_during	5	SENT_74	[p4l1177t2495r1377b2569],
15	.	.	O	.	_	0	SENT_74	[p4l1177t2495r1377b2569],

1	These	DT	O	these	nsubj	4	SENT_75	[p4l1416t2495r1607b2552],
2	did	VBD	O	do	aux	4	SENT_75	[p4l1643t2495r1744b2552],
3	not	RB	O	not	neg	4	SENT_75	[p4l1778t2504r1881b2552],
4	include	VB	O	include	_	0	SENT_75	[p4l1914t2495r2151b2552],
5	known	VBN	O	know	amod	7	SENT_75	[p4l8t2598r228b2654],
6	CYPZC9	NN	O	cypzc9	nn	7	SENT_75	[p4l254t2598r542b2655],
7	inhibitors	NNS	O	inhibitor	dobj	4	SENT_75	[p4l570t2598r877b2654],
8	such	JJ	O	such	_	0	SENT_75	[p4l908t2598r1051b2654],
9	as	IN	O	as	_	0	SENT_75	[p4l1079t2615r1141b2654],
10	amiodarone	NN	O	amiodarone	prep_such_as	7	SENT_75	[p4l1170t2598r1567b2664],
11	,	,	O	,	_	0	SENT_75	[p4l1170t2598r1567b2664],
12	ﬂuconazole	NN	O	ﬂuconazole	nn	28	SENT_75	[p4l1596t2598r1989b2664],
13	,	,	O	,	_	0	SENT_75	[p4l1596t2598r1989b2664],
14	itraconazole	NN	O	itraconazole	nn	31	SENT_75	[p4l2018t2598r2149b2654, p4l9t2698r312b2765],
15	,	,	O	,	_	0	SENT_75	[p4l2018t2598r2149b2654, p4l9t2698r312b2765],
16	miconazole	NN	O	miconazole	nn	31	SENT_75	[p4l356t2698r745b2765],
17	,	,	O	,	_	0	SENT_75	[p4l356t2698r745b2765],
18	ﬂuvastatin	NN	O	ﬂuvastatin	nn	31	SENT_75	[p4l789t2698r1147b2765],
19	,	,	O	,	_	0	SENT_75	[p4l789t2698r1147b2765],
20	simvastatin	NN	O	simvastatin	conj_or	28	SENT_75	[p4l1193t2698r1575b2765],
21	,	,	O	,	_	0	SENT_75	[p4l1193t2698r1575b2765],
22	phenylbutazone	NN	O	phenylbutazone	conj_or	28	SENT_75	[p4l1617t2698r2148b2771],
23	,	,	O	,	_	0	SENT_75	[p4l1617t2698r2148b2771],
24	phenytoin	NN	O	phenytoin	conj_or	28	SENT_75	[p4l8t2798r348b2872],
25	,	,	O	,	_	0	SENT_75	[p4l8t2798r348b2872],
26	metronidazole	NN	O	metronidazole	conj_or	28	SENT_75	[p4l383t2798r863b2865],
27	,	,	O	,	_	0	SENT_75	[p4l383t2798r863b2865],
28	tamoxifen	NN	O	tamoxifen	nn	31	SENT_75	[p4l898t2798r1225b2855],
29	or	CC	O	or	_	0	SENT_75	[p4l1258t2816r1324b2855],
30	valproic	JJ	O	valproic	conj_or	28	SENT_75	[p4l1354t2798r1617b2872],
31	acid	NN	O	acid	appos	10	SENT_75	[p4l1652t2798r1799b2855],
32	.	.	O	.	_	0	SENT_75	[p4l1652t2798r1799b2855],

1	However	RB	O	however	advmod	8	SENT_76	[p4l1835t2800r2148b2865],
2	,	,	O	,	_	0	SENT_76	[p4l1835t2800r2148b2865],
3	15	CD	NUMBER	15	nsubj	8	SENT_76	[p4l16t2900r84b2957],
4	of	IN	O	of	_	0	SENT_76	[p4l108t2900r178b2956],
5	the	DT	O	the	det	7	SENT_76	[p4l191t2900r288b2956],
6	24	CD	NUMBER	24	num	7	SENT_76	[p4l309t2900r386b2956],
7	patients	NNS	O	patient	prep_of	3	SENT_76	[p4l405t2900r655b2973],
8	received	VBD	O	receive	_	0	SENT_76	[p4l675t2900r950b2957],
9	atorvastatin	NN	O	atorvastatin	dobj	8	SENT_76	[p4l970t2900r1362b2967],
10	,	,	O	,	_	0	SENT_76	[p4l970t2900r1362b2967],
11	recently	RB	DATE	recently	advmod	12	SENT_76	[p4l1384t2900r1644b2973],
12	described	VBN	O	describe	partmod	9	SENT_76	[p4l1664t2900r1973b2956],
13	as	IN	O	as	_	0	SENT_76	[p4l1994t2918r2056b2956],
14	an	DT	O	a	det	16	SENT_76	[p4l2078t2918r2151b2956],
15	OATPlBl	NN	O	oatplbl	nn	16	SENT_76	[p4l10t3025r347b3081],
16	substrate	NN	O	substrate	prep_as	12	SENT_76	[p4l383t3016r773b3080],
17	.	.	O	.	_	0	SENT_76	[p4l383t3016r773b3080],

1	[	NN	O	[	_	0	SENT_77	[p4l383t3016r773b3080],
2	25	CD	NUMBER	25	num	3	SENT_77	[p4l383t3016r773b3080],
3	]	NN	O	]	dep	1	SENT_77	[p4l383t3016r773b3080],

1	Table	NNP	O	Table	nn	3	SENT_78	[p4l8t3227r176b3276],
2	I.	NNP	O	I.	nn	3	SENT_78	[p4l204t3227r232b3275],
3	Patient	NNP	O	Patient	_	0	SENT_78	[p4l264t3227r460b3276],
4	characteristicsa	NN	O	characteristicsa	dep	3	SENT_78	[p4l486t3227r923b3276],

1	Parameter	NN	O	parameter	nn	3	SENT_79	[p4l13t3357r311b3405],
2	Losartan	NN	O	losartan	nn	3	SENT_79	[p4l941t3357r1185b3405],
3	group	NN	O	group	_	0	SENT_79	[p4l1214t3369r1376b3418],
4	Irbesarlan	JJ	O	irbesarlan	amod	5	SENT_79	[p4l1583t3357r1866b3405],
5	group	NN	O	group	dep	3	SENT_79	[p4l1895t3369r2056b3418],

1	(	NN	O	(	nn	2	SENT_80	[p4l940t3453r990b3515],
2	n	NN	O	n	_	0	SENT_80	[p4l940t3453r990b3515],
3	=	JJ	O	=	dep	2	SENT_80	[p4l1019t3475r1052b3494],
4	12	CD	NUMBER	12	number	5	SENT_80	[p4l1084t3453r1167b3515],
5	)	CD	NUMBER	)	num	10	SENT_80	[p4l1084t3453r1167b3515],
6	(	NN	O	(	nn	10	SENT_80	[p4l1581t3453r1631b3515],
7	n	NN	O	n	nn	10	SENT_80	[p4l1581t3453r1631b3515],
8	=	JJ	O	=	amod	10	SENT_80	[p4l1660t3475r1693b3494],
9	12	CD	NUMBER	12	num	10	SENT_80	[p4l1725t3453r1808b3515],
10	)	NN	O	)	dep	3	SENT_80	[p4l1725t3453r1808b3515],

1	Gender	NN	O	gender	nn	3	SENT_81	[p4l10t3566r225b3615],
2	(	NN	O	(	nn	3	SENT_81	[p4l251t3566r322b3627],
3	n	NN	O	n	_	0	SENT_81	[p4l251t3566r322b3627],
4	)	CD	NUMBER	)	dep	3	SENT_81	[p4l251t3566r322b3627],

1	male	JJ	O	male	amod	2	SENT_82	[p4l76t3657r211b3706],
2	10	CD	NUMBER	10	_	0	SENT_82	[p4l943t3658r1006b3706],
3	7	CD	NUMBER	7	num	4	SENT_82	[p4l1579t3659r1611b3705],
4	female	NN	O	female	dep	2	SENT_82	[p4l73t3748r265b3797],
5	2	CD	NUMBER	2	number	6	SENT_82	[p4l938t3749r970b3796],
6	5	CD	NUMBER	5	dep	4	SENT_82	[p4l1579t3750r1611b3797],

1	Diagnosis	NN	O	diagnosis	nn	3	SENT_83	[p5l13t30r291b91],
2	(	NN	O	(	nn	3	SENT_83	[p5l320t29r391b90],
3	n	NN	O	n	_	0	SENT_83	[p5l320t29r391b90],
4	)	CD	NUMBER	)	dep	3	SENT_83	[p5l320t29r391b90],

1	hypertension	NN	O	hypertension	_	0	SENT_84	[p5l76t121r441b181],
2	10	CD	NUMBER	10	number	3	SENT_84	[p5l943t122r1006b169],
3	8	CD	NUMBER	8	num	5	SENT_84	[p5l1579t122r1611b169],
4	heart	NN	O	heart	nn	5	SENT_84	[p5l76t211r220b259],
5	failure	NN	O	failure	dep	1	SENT_84	[p5l244t210r418b259],
6	2	CD	NUMBER	2	number	7	SENT_84	[p5l938t212r969b258],
7	4	CD	NUMBER	4	amod	5	SENT_84	[p5l1579t212r1611b258],

1	Torasemide	NNP	O	Torasemide	nn	2	SENT_85	[p5l8t302r348b350],
2	dose	NN	O	dose	dep	10	SENT_85	[p5l375t302r512b350],
3	0.134	CD	NUMBER	0.134	num	2	SENT_85	[p5l938t303r1097b350],
4	i	FW	O	i	dep	2	SENT_85	[p5l1122t307r1157b349],
5	0.044	CD	NUMBER	0.044	number	6	SENT_85	[p5l1182t303r1341b350],
6	0.119	CD	NUMBER	0.119	dep	4	SENT_85	[p5l1579t303r1737b350],
7	i	FW	O	i	dep	6	SENT_85	[p5l1763t307r1798b349],
8	0.016	CD	NUMBER	0.016	dep	10	SENT_85	[p5l1823t303r1981b350],
9	(	CD	NUMBER	(	num	10	SENT_85	[p5l12t391r346b453],
10	mg/day/kg	NN	O	mg/day/kg	dep	15	SENT_85	[p5l12t391r346b453],
11	)	CD	NUMBER	)	num	14	SENT_85	[p5l12t391r346b453],
12	CYP2C9	NN	O	cyp2c9	nn	14	SENT_85	[p5l14t481r264b530],
13	genotype	NN	O	genotype	nn	14	SENT_85	[p5l286t485r548b543],
14	(	NN	O	(	dep	10	SENT_85	[p5l577t481r649b542],
15	n	NN	O	n	_	0	SENT_85	[p5l577t481r649b542],
16	)	CD	NUMBER	)	num	15	SENT_85	[p5l577t481r649b542],

1	SLCO1B1	NN	O	slco1b1	nn	4	SENT_86	[p5l14t844r298b893],
2	genotype	NN	O	genotype	nn	4	SENT_86	[p5l326t848r588b906],
3	(	NN	O	(	nn	4	SENT_86	[p5l617t844r689b905],
4	n	NN	O	n	_	0	SENT_86	[p5l617t844r689b905],
5	)	CD	NUMBER	)	dep	4	SENT_86	[p5l617t844r689b905],

1	c.	NN	O	c.	nn	2	SENT_87	[p5l74t936r310b985],
2	521TT	NN	O	521tt	_	0	SENT_87	[p5l74t936r310b985],
3	6	CD	NUMBER	6	number	4	SENT_87	[p5l939t937r970b985],
4	7	CD	NUMBER	7	num	6	SENT_87	[p5l1580t938r1612b983],
5	c.	NN	O	c.	nn	6	SENT_87	[p5l74t1025r316b1075],
6	521TC	NN	O	521tc	dep	2	SENT_87	[p5l74t1025r316b1075],
7	6	CD	NUMBER	6	number	8	SENT_87	[p5l939t1027r970b1075],
8	5	CD	NUMBER	5	amod	6	SENT_87	[p5l1579t1028r1611b1075],

1	Age	NNP	O	Age	nn	3	SENT_88	[p5l9t1118r121b1178],
2	(	CD	NUMBER	(	num	3	SENT_88	[p5l150t1117r218b1178],
3	y	NN	O	y	dep	12	SENT_88	[p5l150t1117r218b1178],
4	)	CD	NUMBER	)	number	5	SENT_88	[p5l150t1117r218b1178],
5	61	CD	NUMBER	61	dep	3	SENT_88	[p5l939t1118r996b1166],
6	i	FW	O	i	dep	5	SENT_88	[p5l1032t1122r1067b1164],
7	8	CD	NUMBER	8	number	8	SENT_88	[p5l1092t1119r1124b1166],
8	(	CD	NUMBER	(	dep	5	SENT_88	[p5l1153t1117r1369b1178],
9	51-74	CD	NUMBER	51-74	dep	8	SENT_88	[p5l1153t1117r1369b1178],
10	)	NN	O	)	dep	12	SENT_88	[p5l1153t1117r1369b1178],
11	69	CD	NUMBER	69	num	10	SENT_88	[p5l1580t1119r1647b1166],
12	i	FW	O	i	dep	21	SENT_88	[p5l1673t1122r1708b1164],
13	8	CD	NUMBER	8	num	14	SENT_88	[p5l1733t1119r1765b1166],
14	(	CD	NUMBER	(	dep	12	SENT_88	[p5l1794t1117r2010b1178],
15	48-84	CD	NUMBER	48-84	number	16	SENT_88	[p5l1794t1117r2010b1178],
16	)	CD	NUMBER	)	num	20	SENT_88	[p5l1794t1117r2010b1178],
17	Bodyweight	NNP	O	Bodyweight	nn	20	SENT_88	[p5l12t1207r343b1268],
18	(	CD	NUMBER	(	num	20	SENT_88	[p5l371t1206r474b1268],
19	kg	NN	O	kg	nn	20	SENT_88	[p5l371t1206r474b1268],
20	)	NN	O	)	dep	14	SENT_88	[p5l371t1206r474b1268],
21	86	CD	NUMBER	86	dep	64	SENT_88	[p5l939t1208r1007b1255],
22	i	FW	O	i	dep	28	SENT_88	[p5l1032t1211r1067b1254],
23	11	CD	NUMBER	11	number	24	SENT_88	[p5l1096t1208r1150b1254],
24	(	CD	NUMBER	(	dep	22	SENT_88	[p5l1189t1206r1441b1267],
25	68-101	CD	NUMBER	68-101	dep	24	SENT_88	[p5l1189t1206r1441b1267],
26	)	NN	O	)	dep	28	SENT_88	[p5l1189t1206r1441b1267],
27	84	CD	NUMBER	84	num	26	SENT_88	[p5l1580t1208r1648b1255],
28	i	FW	O	i	dep	39	SENT_88	[p5l1673t1211r1708b1254],
29	16	CD	NUMBER	16	num	30	SENT_88	[p5l1737t1208r1801b1255],
30	(	CD	NUMBER	(	dep	28	SENT_88	[p5l1830t1206r2082b1267],
31	68-121	CD	NUMBER	68-121	number	32	SENT_88	[p5l1830t1206r2082b1267],
32	)	CD	NUMBER	)	num	36	SENT_88	[p5l1830t1206r2082b1267],
33	Serum	NN	O	serum	nn	36	SENT_88	[p5l11t1296r195b1345],
34	creatinine	NN	O	creatinine	nn	36	SENT_88	[p5l224t1297r501b1345],
35	(	CD	NUMBER	(	num	36	SENT_88	[p5l531t1296r762b1358],
36	umol/L	NN	O	umol/l	dep	30	SENT_88	[p5l531t1296r762b1358],
37	)	CD	NUMBER	)	number	38	SENT_88	[p5l531t1296r762b1358],
38	96	CD	NUMBER	96	num	36	SENT_88	[p5l939t1298r1007b1345],
39	i	FW	O	i	dep	43	SENT_88	[p5l1032t1302r1067b1344],
40	17	CD	NUMBER	17	number	41	SENT_88	[p5l1096t1298r1161b1344],
41	(	CD	NUMBER	(	dep	39	SENT_88	[p5l1189t1296r1441b1357],
42	70-125	CD	NUMBER	70-125	dep	41	SENT_88	[p5l1189t1296r1441b1357],
43	)	NN	O	)	dep	45	SENT_88	[p5l1189t1296r1441b1357],
44	103	CD	NUMBER	103	num	43	SENT_88	[p5l1584t1298r1684b1345],
45	i	FW	O	i	dep	50	SENT_88	[p5l1709t1302r1744b1344],
46	26	CD	NUMBER	26	number	47	SENT_88	[p5l1769t1298r1837b1345],
47	(	CD	NUMBER	(	dep	45	SENT_88	[p5l1866t1296r2118b1357],
48	70-142	CD	NUMBER	70-142	num	49	SENT_88	[p5l1866t1296r2118b1357],
49	)	CD	NUMBER	)	dep	47	SENT_88	[p5l1866t1296r2118b1357],
50	CLCR	NN	O	clcr	dep	52	SENT_88	[p5l10t1361r164b1416],
51	(	CD	NUMBER	(	num	50	SENT_88	[p5l192t1360r440b1422],
52	mL/min	NN	O	ml/min	dep	54	SENT_88	[p5l192t1360r440b1422],
53	)	CD	NUMBER	)	num	52	SENT_88	[p5l192t1360r440b1422],
54	89	CD	NUMBER	89	dep	55	SENT_88	[p5l938t1363r1006b1410],
55	i	FW	O	i	dep	59	SENT_88	[p5l1032t1366r1066b1409],
56	17	CD	NUMBER	17	number	57	SENT_88	[p5l1096t1362r1160b1409],
57	65	CD	NUMBER	65	dep	55	SENT_88	[p5l1579t1363r1647b1410],
58	i	FW	O	i	dep	57	SENT_88	[p5l1672t1366r1707b1409],
59	17	CD	NUMBER	17	dep	64	SENT_88	[p5l1737t1362r1801b1409],
60	a	DT	O	a	predet	62	SENT_88	[p5l10t1483r42b1520],
61	The	DT	O	the	det	62	SENT_88	[p5l122t1472r231b1520],
62	values	NNS	O	value	nsubjpass	64	SENT_88	[p5l256t1472r442b1520],
63	are	VBP	O	be	auxpass	64	SENT_88	[p5l469t1483r558b1520],
64	expressed	VBN	O	express	_	0	SENT_88	[p5l586t1472r880b1532],
65	as	IN	O	as	_	0	SENT_88	[p5l908t1483r972b1520],
66	the	DT	O	the	det	71	SENT_88	[p5l998t1472r1085b1520],
67	mean	JJ	O	mean	amod	71	SENT_88	[p5l1114t1483r1269b1520],
68	ir	JJ	O	ir	amod	71	SENT_88	[p5l1296t1476r1331b1519],
69	SD	NN	O	sd	nn	71	SENT_88	[p5l1357t1470r1441b1520],
70	(	NN	O	(	nn	71	SENT_88	[p5l1471t1471r1672b1533],
71	range	NN	O	range	prep_as	64	SENT_88	[p5l1471t1471r1672b1533],
72	)	CD	NUMBER	)	tmod	64	SENT_88	[p5l1471t1471r1672b1533],
73	unless	IN	O	unless	mark	74	SENT_88	[p5l1703t1472r1885b1520],
74	specified	VBN	O	specify	advcl	64	SENT_88	[p5l123t1561r374b1622],
75	othen/vise	NN	O	othen/vise	dobj	74	SENT_88	[p5l402t1562r691b1610],
76	.	.	O	.	_	0	SENT_88	[p5l402t1562r691b1610],

1	CLcn	NN	O	clcn	_	0	SENT_89	[p5l10t1651r167b1706],
2	=	JJ	O	=	amod	4	SENT_89	[p5l201t1673r234b1691],
3	creatinine	NN	O	creatinine	nn	4	SENT_89	[p5l268t1652r545b1700],
4	clearance	NN	O	clearance	dep	1	SENT_89	[p5l579t1652r872b1708],
5	;	:	O	;	_	0	SENT_89	[p5l579t1652r872b1708],
6	CYP	NN	O	cyp	dep	1	SENT_89	[p5l909t1651r1038b1700],
7	=	JJ	O	=	amod	9	SENT_89	[p5l1072t1673r1105b1691],
8	cytochrome	NN	O	cytochrome	nn	9	SENT_89	[p5l1139t1652r1470b1712],
9	P450	NN	O	p450	dep	6	SENT_89	[p5l1507t1652r1667b1708],
10	;	:	O	;	_	0	SENT_89	[p5l1507t1652r1667b1708],
11	SLCO	NN	O	slco	nn	14	SENT_89	[p5l1704t1651r1879b1700],
12	=	JJ	O	=	amod	14	SENT_89	[p5l1914t1673r1947b1691],
13	solute	JJ	O	solute	amod	14	SENT_89	[p5l1980t1652r2150b1700],
14	carrier	NN	O	carrier	dep	1	SENT_89	[p5l9t1741r192b1789],
15	organic	JJ	O	organic	amod	17	SENT_89	[p5l216t1741r426b1802],
16	anion	NN	O	anion	nn	17	SENT_89	[p5l452t1741r605b1789],
17	transporter	NN	O	transporter	dep	14	SENT_89	[p5l633t1744r959b1801],
18	.	.	O	.	_	0	SENT_89	[p5l633t1744r959b1801],

1	©	RB	O	©	advmod	2	SENT_90	[p5l10t1971r44b2005],
2	2008	CD	DATE	2008	_	0	SENT_90	[p5l62t1967r167b2005],
3	Adis	NNP	ORGANIZATION	Adis	nn	5	SENT_90	[p5l184t1967r280b2005],
4	Data	NNP	ORGANIZATION	Data	nn	5	SENT_90	[p5l299t1967r413b2005],
5	Information	NNP	ORGANIZATION	Information	dep	2	SENT_90	[p5l433t1967r697b2005],
6	BV	NN	ORGANIZATION	bv	dep	5	SENT_90	[p5l718t1967r785b2004],
7	.	.	O	.	_	0	SENT_90	[p5l718t1967r785b2004],

1	All	DT	O	all	det	2	SENT_91	[p5l805t1967r857b2004],
2	rights	NNS	O	rights	nsubj	3	SENT_91	[p5l878t1967r996b2014],
3	reserved	VBN	O	reserve	_	0	SENT_91	[p5l1015t1967r1224b2005],
4	.	.	O	.	_	0	SENT_91	[p5l1015t1967r1224b2005],

1	At	IN	O	at	_	0	SENT_92	[p5l105t2162r185b2218],
2	baseline	NN	O	baseline	prep_at	7	SENT_92	[p5l207t2162r489b2229],
3	,	,	O	,	_	0	SENT_92	[p5l207t2162r489b2229],
4	blood	NN	O	blood	nn	5	SENT_92	[p5l514t2162r698b2218],
5	samples	NNS	O	sample	nsubjpass	7	SENT_92	[p5l724t2162r979b2235],
6	were	VBD	O	be	auxpass	7	SENT_92	[p5l1005t2179r1159b2219],
7	collected	VBN	O	collect	_	0	SENT_92	[p5l1184t2162r1475b2218],
8	before	RB	O	before	advmod	7	SENT_92	[p5l1497t2162r1702b2218],
9	and	CC	O	and	_	0	SENT_92	[p5l1728t2162r1842b2218],
10	at	IN	O	at	conj_and	7	SENT_92	[p5l1867t2170r1922b2218],
11	0.5	CD	NUMBER	0.5	pobj	10	SENT_92	[p5l1946t2161r2061b2228],
12	,	,	O	,	_	0	SENT_92	[p5l1946t2161r2061b2228],
13	1	CD	NUMBER	1	conj_and	11	SENT_92	[p5l2096t2162r2144b2228],
14	,	,	O	,	_	0	SENT_92	[p5l2096t2162r2144b2228],
15	2	CD	NUMBER	2	conj_and	11	SENT_92	[p5l9t2264r63b2330],
16	,	,	O	,	_	0	SENT_92	[p5l9t2264r63b2330],
17	4	CD	NUMBER	4	conj_and	11	SENT_92	[p5l103t2264r159b2330],
18	,	,	O	,	_	0	SENT_92	[p5l103t2264r159b2330],
19	8	CD	NUMBER	8	conj_and	11	SENT_92	[p5l202t2264r254b2330],
20	,	,	O	,	_	0	SENT_92	[p5l202t2264r254b2330],
21	12	CD	NUMBER	12	conj_and	11	SENT_92	[p5l302t2264r372b2319],
22	and	CC	O	and	_	0	SENT_92	[p5l412t2264r526b2320],
23	24	CD	DURATION	24	num	24	SENT_92	[p5l563t2264r640b2319],
24	hours	NNS	NUMBER	hour	conj_and	11	SENT_92	[p5l677t2264r854b2320],
25	after	IN	O	after	_	0	SENT_92	[p5l894t2263r1041b2320],
26	torasemide	NN	O	torasemide	nn	27	SENT_92	[p5l1076t2264r1429b2320],
27	administration	NN	O	administration	prep_after	10	SENT_92	[p5l1469t2264r1933b2320],
28	in	IN	O	in	_	0	SENT_92	[p5l1970t2264r2031b2319],
29	all	DT	O	all	det	30	SENT_92	[p5l2069t2264r2146b2320],
30	patients	NNS	O	patient	prep_in	10	SENT_92	[p5l7t2364r274b2437],
31	.	.	O	.	_	0	SENT_92	[p5l7t2364r274b2437],

1	After	IN	O	after	_	0	SENT_93	[p5l321t2364r491b2420],
2	this	DT	O	this	det	4	SENT_93	[p5l532t2364r645b2420],
3	baseline	NN	O	baseline	nn	4	SENT_93	[p5l689t2364r953b2420],
4	analysis	NN	O	analysis	prep_after	11	SENT_93	[p5l998t2364r1253b2437],
5	of	IN	O	of	_	0	SENT_93	[p5l1299t2364r1369b2420],
6	torasemide	NN	O	torasemide	nn	7	SENT_93	[p5l1405t2364r1759b2420],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	4	SENT_93	[p5l1801t2364r2144b2437, p5l7t2465r275b2531],
8	,	,	O	,	_	0	SENT_93	[p5l1801t2364r2144b2437, p5l7t2465r275b2531],
9	12	CD	NUMBER	12	num	10	SENT_93	[p5l316t2465r387b2521],
10	patients	NNS	O	patient	nsubj	11	SENT_93	[p5l417t2465r666b2538],
11	received	VBD	O	receive	_	0	SENT_93	[p5l698t2465r971b2522],
12	irbesartan	NN	O	irbesartan	nn	14	SENT_93	[p5l1001t2465r1319b2521],
13	150	CD	NUMBER	150	num	14	SENT_93	[p5l1357t2464r1468b2522],
14	mg	NN	O	mg	dobj	11	SENT_93	[p5l1499t2482r1599b2538],
15	once	RB	DATE	once	advmod	16	SENT_93	[p5l1632t2482r1781b2521],
16	daily	RB	SET	daily	advmod	11	SENT_93	[p5l1813t2464r1988b2538],
17	.	.	O	.	_	0	SENT_93	[p5l1813t2464r1988b2538],

1	The	DT	O	the	det	4	SENT_94	[p5l2022t2465r2146b2521],
2	other	JJ	O	other	amod	4	SENT_94	[p5l9t2566r174b2622],
3	12	CD	NUMBER	12	num	4	SENT_94	[p5l217t2566r287b2622],
4	patients	NNS	O	patient	nsubj	5	SENT_94	[p5l324t2566r573b2639],
5	received	VBD	O	receive	_	0	SENT_94	[p5l611t2566r885b2622],
6	losartan	NN	O	losartan	nn	8	SENT_94	[p5l921t2566r1175b2622],
7	50	CD	NUMBER	50	num	8	SENT_94	[p5l1213t2565r1290b2623],
8	mg	NN	O	mg	dobj	5	SENT_94	[p5l1328t2583r1428b2639],
9	on	IN	O	on	_	0	SENT_94	[p5l1467t2583r1545b2622],
10	the	DT	DURATION	the	det	12	SENT_94	[p5l1581t2566r1678b2622],
11	first	JJ	DURATION	first	amod	12	SENT_94	[p5l1715t2566r1844b2622],
12	day	NN	DURATION	day	prep_on	5	SENT_94	[p5l1881t2566r1994b2639],
13	and	CC	O	and	_	0	SENT_94	[p5l2033t2566r2147b2622],
14	100	CD	NUMBER	100	num	15	SENT_94	[p5l16t2667r127b2724],
15	mg	NN	O	mg	conj_and	12	SENT_94	[p5l151t2684r251b2740],
16	on	IN	O	on	_	0	SENT_94	[p5l277t2684r355b2723],
17	the	DT	DATE	the	det	19	SENT_94	[p5l378t2667r475b2723],
18	following	JJ	DATE	following	amod	19	SENT_94	[p5l499t2667r811b2740],
19	days	NNS	DATE	day	prep_on	5	SENT_94	[p5l836t2667r998b2740],
20	.	.	O	.	_	0	SENT_94	[p5l836t2667r998b2740],

1	Comparative	JJ	O	comparative	amod	2	SENT_95	[p5l1027t2667r1442b2740],
2	studies	NNS	O	study	nsubj	4	SENT_95	[p5l1469t2667r1687b2723],
3	had	VBD	O	have	aux	4	SENT_95	[p5l1712t2667r1828b2723],
4	indicated	VBN	O	indicate	_	0	SENT_95	[p5l1851t2667r2147b2723],
5	that	IN	O	that	complm	14	SENT_95	[p5l8t2768r128b2824],
6	the	DT	O	the	det	8	SENT_95	[p5l147t2768r243b2824],
7	antihypertensive	JJ	O	antihypertensive	amod	8	SENT_95	[p5l265t2768r796b2841],
8	effect	NN	O	effect	nsubj	14	SENT_95	[p5l817t2768r1000b2824],
9	of	IN	O	of	_	0	SENT_95	[p5l1019t2768r1089b2824],
10	irbesartan	NN	O	irbesartan	nn	12	SENT_95	[p5l1103t2768r1421b2824],
11	150	CD	NUMBER	150	num	12	SENT_95	[p5l1448t2767r1559b2825],
12	mg	NN	O	mg	prep_of	8	SENT_95	[p5l1579t2785r1679b2841],
13	was	VBD	O	be	cop	14	SENT_95	[p5l1700t2785r1822b2825],
14	similar	JJ	O	similar	ccomp	4	SENT_95	[p5l1846t2768r2068b2824],
15	to	TO	O	to	_	0	SENT_95	[p5l2086t2776r2146b2824],
16	that	DT	O	that	prep_to	14	SENT_95	[p5l8t2870r128b2927],
17	of	IN	O	of	_	0	SENT_95	[p5l155t2870r225b2927],
18	losartan	NN	O	losartan	nn	20	SENT_95	[p5l246t2870r501b2927],
19	100	CD	NUMBER	100	num	20	SENT_95	[p5l535t2871r646b2927],
20	mg	NN	O	mg	prep_of	16	SENT_95	[p5l674t2862r881b2944],
21	,	,	O	,	_	0	SENT_95	[p5l674t2862r881b2944],
22	[	CD	NUMBER	[	number	23	SENT_95	[p5l674t2862r881b2944],
23	26	CD	NUMBER	26	num	24	SENT_95	[p5l674t2862r881b2944],
24	]	NN	O	]	appos	20	SENT_95	[p5l674t2862r881b2944],
25	and	CC	O	and	_	0	SENT_95	[p5l913t2870r1027b2927],
26	so	IN	O	so	mark	30	SENT_95	[p5l1056t2888r1122b2927],
27	these	DT	O	these	det	28	SENT_95	[p5l1150t2870r1314b2927],
28	dosages	NNS	O	dosage	nsubjpass	30	SENT_95	[p5l1342t2870r1594b2944],
29	were	VBD	O	be	auxpass	30	SENT_95	[p5l1623t2888r1777b2927],
30	chosen	VBN	O	choose	conj_and	14	SENT_95	[p5l1805t2870r2028b2927],
31	for	IN	O	for	_	0	SENT_95	[p5l2055t2870r2148b2927],
32	the	DT	O	the	det	34	SENT_95	[p5l8t2971r104b3027],
33	present	JJ	DATE	present	amod	34	SENT_95	[p5l126t2979r360b3044],
34	study	NN	O	study	prep_for	30	SENT_95	[p5l384t2971r571b3044],
35	.	.	O	.	_	0	SENT_95	[p5l384t2971r571b3044],

1	After	IN	O	after	_	0	SENT_96	[p5l598t2971r768b3027],
2	3	CD	DURATION	3	num	3	SENT_96	[p5l791t2971r823b3028],
3	days	NNS	NUMBER	day	prep_after	16	SENT_96	[p5l851t2971r994b3044],
4	of	IN	O	of	_	0	SENT_96	[p5l1020t2971r1089b3027],
5	irbesartan	NN	O	irbesartan	prep_of	3	SENT_96	[p5l1107t2971r1424b3027],
6	or	CC	O	or	_	0	SENT_96	[p5l1447t2988r1513b3027],
7	losartan	NN	O	losartan	nn	8	SENT_96	[p5l1534t2971r1789b3027],
8	comedica	NN	O	comedica	prep_after	16	SENT_96	[p5l1812t2971r2144b3027],
9	—	CD	NUMBER	—	num	10	SENT_96	[p5l1812t2971r2144b3027],
10	tion	NN	O	tion	dep	8	SENT_96	[p5l8t3072r149b3138],
11	,	,	O	,	_	0	SENT_96	[p5l8t3072r149b3138],
12	eight	CD	NUMBER	eight	num	14	SENT_96	[p5l176t3072r336b3145],
13	blood	NN	O	blood	nn	14	SENT_96	[p5l357t3072r541b3128],
14	samples	NNS	O	sample	nsubjpass	16	SENT_96	[p5l566t3072r821b3145],
15	were	VBD	O	be	auxpass	16	SENT_96	[p5l847t3089r1001b3129],
16	collected	VBN	O	collect	_	0	SENT_96	[p5l1025t3072r1316b3128],
17	at	IN	O	at	_	0	SENT_96	[p5l1340t3080r1396b3128],
18	the	DT	O	the	det	19	SENT_96	[p5l1418t3072r1514b3128],
19	timepoints	NNS	O	timepoint	prep_at	16	SENT_96	[p5l1538t3072r1876b3145],
20	indicated	VBD	O	indicate	partmod	19	SENT_96	[p5l1901t3072r2144b3128, p5l8t3173r83b3229],
21	above	IN	O	above	prep	20	SENT_96	[p5l110t3173r316b3229],
22	.	.	O	.	_	0	SENT_96	[p5l110t3173r316b3229],

1	Quantification	NN	O	quantification	_	0	SENT_97	[p5l107t3375r608b3431],
2	of	IN	O	of	_	0	SENT_97	[p5l637t3376r705b3431],
3	Drugs	NNS	O	drug	prep_of	1	SENT_97	[p5l732t3376r923b3446],
4	in	IN	O	in	_	0	SENT_97	[p5l951t3376r1001b3430],
5	Human	JJ	O	human	amod	6	SENT_97	[p5l1033t3376r1280b3431],
6	Plasma	NN	O	plasma	prep_in	1	SENT_97	[p5l1312t3376r1557b3431],

1	Plasma	NN	O	plasma	nn	2	SENT_98	[p5l105t3551r338b3607],
2	concentrations	NNS	O	concentration	nsubjpass	13	SENT_98	[p5l419t3551r888b3607],
3	of	IN	O	of	_	0	SENT_98	[p5l972t3551r1042b3607],
4	losartan	NN	O	losartan	prep_of	2	SENT_98	[p5l1118t3551r1373b3607],
5	and	CC	O	and	_	0	SENT_98	[p5l1456t3551r1569b3607],
6	its	PRP$	O	its	poss	8	SENT_98	[p5l1650t3551r1723b3607],
7	metabolite	NN	O	metabolite	nn	8	SENT_98	[p5l1806t3551r2146b3607],
8	EXP3l74	NN	O	exp3l74	nsubjpass	13	SENT_98	[p5l8t3644r407b3709],
9	[	CD	NUMBER	[	number	10	SENT_98	[p5l8t3644r407b3709],
10	27	CD	NUMBER	27	num	11	SENT_98	[p5l8t3644r407b3709],
11	]	NN	O	]	dep	8	SENT_98	[p5l8t3644r407b3709],
12	were	VBD	O	be	auxpass	13	SENT_98	[p5l442t3670r597b3709],
13	determined	VBN	O	determine	_	0	SENT_98	[p5l629t3652r992b3709],
14	by	IN	O	by	_	0	SENT_98	[p5l1021t3652r1101b3726],
15	liquid	JJ	O	liquid	amod	17	SENT_98	[p5l1133t3652r1321b3725],
16	chromatography	NN	O	chromatography	nn	17	SENT_98	[p5l1352t3652r2148b3726],
17	—	NN	O	—	agent	13	SENT_98	[p5l1352t3652r2148b3726],
18	tandem	JJ	O	tandem	amod	20	SENT_98	[p5l1352t3652r2148b3726],
19	mass	NN	O	mass	nn	20	SENT_98	[p6l8t37r166b76],
20	spectrometry	NN	O	spectrometry	tmod	13	SENT_98	[p6l210t28r627b93],
21	(	CD	NUMBER	(	num	22	SENT_98	[p6l670t20r1104b89],
22	LC	NN	O	lc	dep	20	SENT_98	[p6l670t20r1104b89],
23	.	.	O	.	_	0	SENT_98	[p6l670t20r1104b89],

1	—	NN	O	—	_	0	SENT_99	[p6l670t20r1104b89],
2	.	.	O	.	_	0	SENT_99	[p6l670t20r1104b89],

1	MS/MS	NN	O	ms/ms	nn	3	SENT_100	[p6l670t20r1104b89],
2	)	NN	O	)	nn	3	SENT_100	[p6l670t20r1104b89],
3	assays	NNS	O	assay	nsubj	5	SENT_100	[p6l1148t37r1349b93],
4	as	IN	O	as	advmod	5	SENT_100	[p6l1392t37r1454b76],
5	described	VBN	O	describe	_	0	SENT_100	[p6l1496t19r1804b76],
6	previously	RB	DATE	previously	advmod	5	SENT_100	[p6l1841t19r2144b92, p6l8t113r175b195],
7	.	.	O	.	_	0	SENT_100	[p6l1841t19r2144b92, p6l8t113r175b195],

1	[	NN	O	[	nsubjpass	6	SENT_101	[p6l1841t19r2144b92, p6l8t113r175b195],
2	28	CD	NUMBER	28	num	1	SENT_101	[p6l1841t19r2144b92, p6l8t113r175b195],
3	]	CD	NUMBER	]	num	4	SENT_101	[p6l1841t19r2144b92, p6l8t113r175b195],
4	EXP3174	NN	O	exp3174	dep	1	SENT_101	[p6l213t121r525b178],
5	was	VBD	O	be	auxpass	6	SENT_101	[p6l562t139r683b178],
6	synthesized	VBN	O	synthesize	_	0	SENT_101	[p6l722t121r1096b195],
7	as	IN	O	as	mark	8	SENT_101	[p6l1133t139r1194b178],
8	described	VBN	O	describe	advcl	6	SENT_101	[p6l1232t121r1540b178],
9	previously	RB	DATE	previously	advmod	8	SENT_101	[p6l1573t113r2021b195],
10	.	.	O	.	_	0	SENT_101	[p6l1573t113r2021b195],

1	[	NN	O	[	nsubj	3	SENT_102	[p6l1573t113r2021b195],
2	29	CD	NUMBER	29	num	3	SENT_102	[p6l1573t113r2021b195],
3	]	NN	O	]	_	0	SENT_102	[p6l1573t113r2021b195],
4	To	TO	O	to	aux	5	SENT_102	[p6l2059t123r2145b178],
5	evaluate	VB	O	evaluate	infmod	3	SENT_102	[p6l9t220r276b277],
6	the	DT	O	the	det	7	SENT_102	[p6l306t220r403b277],
7	pharmacokinetics	NNS	O	pharmacokinetic	dobj	5	SENT_102	[p6l432t220r1002b293],
8	of	IN	O	of	_	0	SENT_102	[p6l1035t220r1105b277],
9	torasemide	NN	O	torasemide	prep_of	7	SENT_102	[p6l1130t220r1483b277],
10	and	CC	O	and	_	0	SENT_102	[p6l1515t220r1629b277],
11	irbesartan	NN	O	irbesartan	prep_of	7	SENT_102	[p6l1659t220r1994b287],
12	,	,	O	,	_	0	SENT_102	[p6l1659t220r1994b287],
13	two	CD	NUMBER	two	npadvmod	14	SENT_102	[p6l2027t229r2145b277],
14	sensitive	JJ	O	sensitive	amod	15	SENT_102	[p6l11t320r289b377],
15	LC	NN	O	lc	dobj	3	SENT_102	[p6l322t321r705b377],
16	.	.	O	.	_	0	SENT_102	[p6l322t321r705b377],

1	—	NN	O	—	_	0	SENT_103	[p6l322t321r705b377],
2	.	.	O	.	_	0	SENT_103	[p6l322t321r705b377],

1	MS/MS	NN	O	ms/ms	nn	2	SENT_104	[p6l322t321r705b377],
2	assays	NNS	O	assay	nsubjpass	4	SENT_104	[p6l744t338r945b394],
3	were	VBD	O	be	auxpass	4	SENT_104	[p6l981t338r1135b377],
4	developed	VBN	O	develop	_	0	SENT_104	[p6l1170t320r1517b393],
5	.	.	O	.	_	0	SENT_104	[p6l1170t320r1517b393],

1	The	DT	O	the	det	2	SENT_105	[p6l1554t320r1678b377],
2	conditions	NNS	O	condition	nsubjpass	15	SENT_105	[p6l1713t320r2046b377],
3	of	IN	O	of	_	0	SENT_105	[p6l2082t320r2152b377],
4	sample	NN	O	sample	nn	5	SENT_105	[p6l11t420r235b493],
5	preparation	NN	O	preparation	prep_of	2	SENT_105	[p6l264t420r633b494],
6	and	CC	O	and	_	0	SENT_105	[p6l664t420r778b477],
7	chromatography	NN	O	chromatography	prep_of	2	SENT_105	[p6l808t420r1336b494],
8	and	CC	O	and	_	0	SENT_105	[p6l1368t420r1482b477],
9	the	DT	O	the	det	10	SENT_105	[p6l1511t420r1608b477],
10	results	NNS	O	result	conj_and	2	SENT_105	[p6l1637t420r1846b477],
11	of	IN	O	of	_	0	SENT_105	[p6l1879t420r1949b477],
12	assay	NN	O	assay	nn	13	SENT_105	[p6l1975t438r2146b494],
13	validations	NNS	O	validation	prep_of	10	SENT_105	[p6l8t520r359b576],
14	are	VBP	O	be	auxpass	15	SENT_105	[p6l386t538r481b576],
15	summarized	VBN	O	summarize	_	0	SENT_105	[p6l507t520r900b576],
16	in	IN	O	in	_	0	SENT_105	[p6l922t520r983b575],
17	table	NN	O	table	prep_in	15	SENT_105	[p6l1006t520r1161b576],
18	II	CD	NUMBER	ii	num	17	SENT_105	[p6l1185t522r1252b576],
19	.	.	O	.	_	0	SENT_105	[p6l1185t522r1252b576],

1	The	DT	O	the	det	2	SENT_106	[p6l1280t520r1403b576],
2	methods	NNS	O	method	nsubjpass	4	SENT_106	[p6l1427t520r1698b576],
3	were	VBD	O	be	auxpass	4	SENT_106	[p6l1723t538r1878b576],
4	validated	VBN	O	validate	_	0	SENT_106	[p6l1901t520r2144b576, p6l9t621r83b678],
5	according	VBG	O	accord	_	0	SENT_106	[p6l110t621r425b695],
6	to	TO	O	to	prepc_according_to	4	SENT_106	[p6l453t630r513b678],
7	the	DT	O	the	det	10	SENT_106	[p6l540t621r637b678],
8	US	NNP	LOCATION	US	nn	10	SENT_106	[p6l664t621r761b678],
9	FDA	NNP	ORGANIZATION	FDA	nn	10	SENT_106	[p6l791t622r952b677],
10	guideline	NN	O	guideline	pobj	4	SENT_106	[p6l979t613r1384b695],
11	.	.	O	.	_	0	SENT_106	[p6l979t613r1384b695],

1	[	NN	O	[	_	0	SENT_107	[p6l979t613r1384b695],
2	3	CD	NUMBER	3	num	4	SENT_107	[p6l979t613r1384b695],
3	°	NN	O	°	nn	4	SENT_107	[p6l979t613r1384b695],
4	]	NN	O	]	dep	1	SENT_107	[p6l979t613r1384b695],

1	Genotyping	VBG	O	genotype	_	0	SENT_108	[p6l107t826r525b897],

1	Genomic	JJ	O	genomic	amod	2	SENT_109	[p6l106t1003r399b1060],
2	DNA	NN	O	dna	nsubjpass	4	SENT_109	[p6l453t1003r627b1059],
3	was	VBD	O	be	auxpass	4	SENT_109	[p6l680t1020r802b1060],
4	extracted	VBN	O	extract	_	0	SENT_109	[p6l857t1003r1152b1059],
5	from	IN	O	from	_	0	SENT_109	[p6l1205t1003r1362b1059],
6	200	CD	NUMBER	200	num	8	SENT_109	[p6l1415t1003r1532b1060],
7	l.	NN	O	l.	nn	8	SENT_109	[p6l1587t1004r1680b1076],
8	tL	NN	O	tl	prep_from	4	SENT_109	[p6l1587t1004r1680b1076],
9	of	IN	O	of	_	0	SENT_109	[p6l1734t1003r1804b1059],
10	peripheral	JJ	O	peripheral	amod	11	SENT_109	[p6l1850t1003r2144b1076, p6l10t1104r64b1160],
11	blood	NN	O	blood	prep_of	8	SENT_109	[p6l115t1104r299b1160],
12	anticoagulated	VBN	O	anticoagulate	partmod	11	SENT_109	[p6l352t1104r822b1177],
13	with	IN	O	with	_	0	SENT_109	[p6l874t1104r1015b1161],
14	EDTA	NN	ORGANIZATION	edta	prep_with	12	SENT_109	[p6l1067t1104r1281b1160],
15	with	IN	O	with	_	0	SENT_109	[p6l1333t1104r1475b1160],
16	the	DT	O	the	det	18	SENT_109	[p6l1527t1104r1623b1160],
17	Flexigene	NNP	O	Flexigene	nn	18	SENT_109	[p6l1675t1104r1993b1177],
18	Kit	NN	O	kit	prep_with	14	SENT_109	[p6l2047t1104r2148b1160],
19	(	CD	NUMBER	(	num	18	SENT_109	[p6l11t1205r360b1275],
20	QIAGEN	NNP	ORGANIZATION	QIAGEN	nn	24	SENT_109	[p6l11t1205r360b1275],
21	,	,	O	,	_	0	SENT_109	[p6l11t1205r360b1275],
22	Hilden	NNP	PERSON	Hilden	appos	24	SENT_109	[p6l406t1205r642b1271],
23	,	,	O	,	_	0	SENT_109	[p6l406t1205r642b1271],
24	Germany	NNP	LOCATION	Germany	dep	18	SENT_109	[p6l688t1205r1011b1278],
25	)	CD	NUMBER	)	num	24	SENT_109	[p6l688t1205r1011b1278],
26	according	VBG	O	accord	_	0	SENT_109	[p6l1058t1205r1372b1278],
27	to	TO	O	to	prepc_according_to	12	SENT_109	[p6l1415t1213r1476b1261],
28	the	DT	O	the	det	29	SENT_109	[p6l1519t1205r1615b1261],
29	manufacturer	NN	O	manufacturer	poss	31	SENT_109	[p6l1658t1204r2145b1261],
30	’s	POS	O	’s	_	0	SENT_109	[p6l1658t1204r2145b1261],
31	instructions	NNS	O	instruction	pobj	12	SENT_109	[p6l8t1306r400b1362],
32	.	.	O	.	_	0	SENT_109	[p6l8t1306r400b1362],

1	Genotyping	VBG	O	genotype	partmod	17	SENT_110	[p6l487t1306r865b1379],
2	for	IN	O	for	_	0	SENT_110	[p6l948t1306r1042b1362],
3	the	DT	O	the	det	5	SENT_110	[p6l1121t1306r1218b1362],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_110	[p6l1303t1306r1679b1372],
5	*	NN	O	*	prep_for	1	SENT_110	[p6l1303t1306r1679b1372],
6	l	NN	O	l	tmod	5	SENT_110	[p6l1303t1306r1679b1372],
7	,	,	O	,	_	0	SENT_110	[p6l1303t1306r1679b1372],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_110	[p6l1767t1306r2143b1372],
9	*	NN	O	*	appos	5	SENT_110	[p6l1767t1306r2143b1372],
10	2	CD	NUMBER	2	dep	9	SENT_110	[p6l1767t1306r2143b1372],
11	,	,	O	,	_	0	SENT_110	[p6l1767t1306r2143b1372],
12	CYP2C9	NN	O	cyp2c9	appos	5	SENT_110	[p6l12t1408r388b1474],
13	*	CD	NUMBER	*	number	14	SENT_110	[p6l12t1408r388b1474],
14	3	CD	NUMBER	3	dep	12	SENT_110	[p6l12t1408r388b1474],
15	,	,	O	,	_	0	SENT_110	[p6l12t1408r388b1474],
16	SLCOIBI	NNP	PERSON	SLCOIBI	nsubj	17	SENT_110	[p6l474t1408r794b1465],
17	c.	VBD	O	c.	ccomp	21	SENT_110	[p6l884t1407r1175b1474],
18	521TT	NN	O	521tt	dobj	17	SENT_110	[p6l884t1407r1175b1474],
19	,	,	O	,	_	0	SENT_110	[p6l884t1407r1175b1474],
20	SLCOIBI	NNP	PERSON	SLCOIBI	nsubj	21	SENT_110	[p6l1261t1408r1581b1465],
21	c.	VBD	O	c.	_	0	SENT_110	[p6l1670t1407r1948b1464],
22	521TC	NN	O	521tc	nsubjpass	31	SENT_110	[p6l1670t1407r1948b1464],
23	and	CC	O	and	_	0	SENT_110	[p6l2033t1408r2147b1464],
24	SLCO	NN	ORGANIZATION	slco	nsubjpass	31	SENT_110	[p6l8t1508r238b1565],
25	]	CD	NUMBER	]	num	29	SENT_110	[p6l8t1508r238b1565],
26	B1	NN	O	b1	nn	29	SENT_110	[p6l245t1508r328b1564],
27	c.	NN	O	c.	nn	29	SENT_110	[p6l357t1507r639b1565],
28	52lCC	NN	O	52lcc	nn	29	SENT_110	[p6l357t1507r639b1565],
29	alleles	NNS	O	allele	dep	22	SENT_110	[p6l664t1508r865b1564],
30	was	VBD	O	be	auxpass	31	SENT_110	[p6l890t1525r1011b1564],
31	carried	VBN	O	carry	ccomp	21	SENT_110	[p6l1036t1508r1259b1564],
32	out	RP	O	out	prt	31	SENT_110	[p6l1281t1516r1383b1564],
33	using	VBG	O	use	xcomp	31	SENT_110	[p6l1403t1508r1576b1581],
34	the	DT	O	the	det	38	SENT_110	[p6l1599t1508r1696b1564],
35	TaqMan	NNP	O	TaqMan	nn	38	SENT_110	[p6l1718t1509r1991b1581],
36	PreDeveloped	NNP	O	PreDeveloped	nn	38	SENT_110	[p6l2013t1509r2143b1564, p6l8t1609r357b1682],
37	Assay	NN	O	assay	nn	38	SENT_110	[p6l393t1609r588b1682],
38	Reagents	NNS	O	reagent	dobj	33	SENT_110	[p6l625t1610r918b1682],
39	for	IN	O	for	_	0	SENT_110	[p6l957t1609r1050b1665],
40	Allelic	JJ	MISC	allelic	amod	44	SENT_110	[p6l1085t1609r1302b1665],
41	Discrimination	NN	MISC	discrimination	nn	44	SENT_110	[p6l1340t1609r1824b1665],
42	(	NN	O	(	nn	44	SENT_110	[p6l1863t1609r2147b1682],
43	Applied	NNP	O	Applied	nn	44	SENT_110	[p6l1863t1609r2147b1682],
44	Biosystems	NNP	O	Biosystems	prep_for	33	SENT_110	[p6l8t1710r397b1784],
45	,	,	O	,	_	0	SENT_110	[p6l8t1710r397b1784],
46	Weiterstadt	NNP	PERSON	Weiterstadt	nn	48	SENT_110	[p6l426t1710r816b1777],
47	,	,	O	,	_	0	SENT_110	[p6l426t1710r816b1777],
48	Germany	NNP	LOCATION	Germany	appos	44	SENT_110	[p6l848t1711r1171b1784],
49	)	CD	NUMBER	)	num	48	SENT_110	[p6l848t1711r1171b1784],
50	as	IN	O	as	mark	51	SENT_110	[p6l1203t1728r1264b1767],
51	described	VBN	O	describe	dep	48	SENT_110	[p6l1295t1710r1603b1767],
52	previously	RB	DATE	previously	advmod	51	SENT_110	[p6l1629t1703r2143b1784],
53	.	.	O	.	_	0	SENT_110	[p6l1629t1703r2143b1784],

1	[	NN	O	[	nsubjpass	8	SENT_111	[p6l1629t1703r2143b1784],
2	31	CD	NUMBER	31	dep	1	SENT_111	[p6l1629t1703r2143b1784],
3	’	CD	NUMBER	’	number	4	SENT_111	[p6l1629t1703r2143b1784],
4	32	CD	NUMBER	32	dep	1	SENT_111	[p6l1629t1703r2143b1784],
5	]	NN	O	]	nn	6	SENT_111	[p6l1629t1703r2143b1784],
6	Amplification	NN	O	amplification	dep	4	SENT_111	[p6l8t1811r461b1884],
7	was	VBD	O	be	auxpass	8	SENT_111	[p6l482t1828r603b1868],
8	performed	VBN	O	perform	_	0	SENT_111	[p6l625t1811r962b1884],
9	in	IN	O	in	_	0	SENT_111	[p6l982t1811r1043b1867],
10	a	DT	O	a	det	12	SENT_111	[p6l1065t1828r1098b1867],
11	final	JJ	O	final	amod	12	SENT_111	[p6l1118t1811r1264b1867],
12	volume	NN	O	volume	prep_in	8	SENT_111	[p6l1285t1811r1526b1867],
13	of	IN	O	of	_	0	SENT_111	[p6l1548t1811r1618b1867],
14	5	CD	NUMBER	5	num	15	SENT_111	[p6l1634t1810r1667b1868],
15	LLL	NN	O	lll	prep_of	12	SENT_111	[p6l1693t1812r1786b1884],
16	containing	VBG	O	contain	partmod	15	SENT_111	[p6l1807t1811r2146b1884],
17	1	CD	NUMBER	1	num	19	SENT_111	[p6l16t1912r39b1968],
18	l.	NN	O	l.	nn	19	SENT_111	[p6l66t1913r159b1985],
19	tL	NN	O	tl	dobj	16	SENT_111	[p6l66t1913r159b1985],
20	of	IN	O	of	_	0	SENT_111	[p6l179t1912r249b1968],
21	DNA	NN	O	dna	nn	22	SENT_111	[p6l262t1912r436b1968],
22	solution	NN	O	solution	prep_of	19	SENT_111	[p6l457t1912r714b1968],
23	(	CD	NUMBER	(	number	24	SENT_111	[p6l735t1911r794b1981],
24	5	CD	NUMBER	5	num	25	SENT_111	[p6l735t1911r794b1981],
25	ng/l	NN	O	ng/l	dep	22	SENT_111	[p6l817t1912r1059b1985],
26	.	.	O	.	_	0	SENT_111	[p6l817t1912r1059b1985],

1	LL	NN	O	ll	nn	2	SENT_112	[p6l817t1912r1059b1985],
2	)	NN	O	)	_	0	SENT_112	[p6l817t1912r1059b1985],
3	,	,	O	,	_	0	SENT_112	[p6l817t1912r1059b1985],
4	0.1	CD	NUMBER	0.1	num	5	SENT_112	[p6l1081t1912r1172b1969],
5	LLL	NN	O	lll	appos	2	SENT_112	[p6l1200t1913r1293b1985],
6	of	IN	O	of	_	0	SENT_112	[p6l1313t1912r1382b1968],
7	each	DT	O	each	det	11	SENT_112	[p6l1397t1912r1543b1968],
8	primer	NN	O	primer	nn	11	SENT_112	[p6l1560t1912r1777b1985],
9	(	NN	O	(	nn	11	SENT_112	[p6l1797t1912r1940b1981],
10	100	CD	NUMBER	100	num	11	SENT_112	[p6l1797t1912r1940b1981],
11	pmol	NN	O	pmol	prep_of	5	SENT_112	[p6l1958t1912r2148b1985],
12	/	:	O	/	punct	14	SENT_112	[p6l1958t1912r2148b1985],
13	LtL	NN	O	ltl	nn	14	SENT_112	[p6l9t2013r146b2086],
14	)	NN	O	)	dep	11	SENT_112	[p6l9t2013r146b2086],
15	,	,	O	,	_	0	SENT_112	[p6l9t2013r146b2086],
16	0.1	CD	NUMBER	0.1	num	17	SENT_112	[p6l174t2013r266b2070],
17	LLL	NN	O	lll	appos	2	SENT_112	[p6l300t2014r392b2086],
18	of	IN	O	of	_	0	SENT_112	[p6l418t2012r488b2069],
19	each	DT	O	each	det	24	SENT_112	[p6l508t2013r654b2069],
20	probe	NN	O	probe	nn	24	SENT_112	[p6l677t2013r860b2086],
21	(	NN	O	(	nn	24	SENT_112	[p6l888t2013r1032b2082],
22	100	CD	NUMBER	100	num	24	SENT_112	[p6l888t2013r1032b2082],
23	pII10l/LLL	NN	O	pii10l/lll	nn	24	SENT_112	[p6l1056t2013r1365b2086],
24	)	NN	O	)	prep_of	17	SENT_112	[p6l1056t2013r1365b2086],
25	and	CC	O	and	_	0	SENT_112	[p6l1394t2013r1508b2069],
26	2.5	CD	NUMBER	2.5	num	27	SENT_112	[p6l1533t2012r1627b2070],
27	uL	NN	O	ul	conj_and	24	SENT_112	[p6l1657t2014r1750b2086],
28	of	IN	O	of	_	0	SENT_112	[p6l1776t2013r1846b2069],
29	2	CD	NUMBER	2	num	32	SENT_112	[p6l1866t2013r1903b2069],
30	X	NN	O	x	nn	32	SENT_112	[p6l1929t2025r1970b2068],
31	PCR	NN	O	pcr	nn	32	SENT_112	[p6l1995t2013r2147b2070],
32	Master	NN	O	master	prep_of	27	SENT_112	[p6l8t2115r232b2170],
33	Mix	NNP	O	Mix	nn	34	SENT_112	[p6l255t2114r388b2170],
34	(	NNP	O	(	dep	2	SENT_112	[p6l416t2114r730b2183],
35	Absolute	JJ	O	absolute	amod	37	SENT_112	[p6l416t2114r730b2183],
36	PCR	NN	O	pcr	nn	37	SENT_112	[p6l755t2114r907b2171],
37	Master	NN	O	master	dep	34	SENT_112	[p6l930t2115r1156b2170],
38	Mix	NNP	O	Mix	nn	44	SENT_112	[p6l1178t2114r1329b2181],
39	,	,	O	,	_	0	SENT_112	[p6l1178t2114r1329b2181],
40	Abgene	NNP	PERSON	Abgene	appos	44	SENT_112	[p6l1356t2114r1624b2187],
41	,	,	O	,	_	0	SENT_112	[p6l1356t2114r1624b2187],
42	Hamburg	NNP	LOCATION	Hamburg	appos	44	SENT_112	[p6l1651t2114r1973b2187],
43	,	,	O	,	_	0	SENT_112	[p6l1651t2114r1973b2187],
44	Germany	NNP	LOCATION	Germany	dep	2	SENT_112	[p6l2002t2114r2144b2171, p6l8t2215r210b2288],
45	)	CD	NUMBER	)	num	44	SENT_112	[p6l2002t2114r2144b2171, p6l8t2215r210b2288],
46	by	IN	O	by	_	0	SENT_112	[p6l235t2215r314b2288],
47	use	NN	O	use	prep_by	44	SENT_112	[p6l337t2232r443b2271],
48	of	IN	O	of	_	0	SENT_112	[p6l468t2215r538b2271],
49	the	DT	O	the	det	53	SENT_112	[p6l555t2215r652b2271],
50	ABI	NNP	O	ABI	nn	53	SENT_112	[p6l675t2215r813b2271],
51	Prism	NNP	O	Prism	nn	53	SENT_112	[p6l836t2215r1024b2271],
52	Sequence	NN	O	sequence	nn	53	SENT_112	[p6l1048t2215r1354b2288],
53	Detector	NN	O	detector	prep_of	47	SENT_112	[p6l1377t2216r1656b2271],
54	7900	CD	NUMBER	7900	dep	2	SENT_112	[p6l1678t2215r1837b2272],
55	(	NNP	O	(	nn	61	SENT_112	[p6l1863t2215r2147b2288],
56	Applied	NNP	O	Applied	nn	61	SENT_112	[p6l1863t2215r2147b2288],
57	Biosystems	NNP	O	Biosystems	nn	61	SENT_112	[p6l8t2316r397b2389],
58	,	,	O	,	_	0	SENT_112	[p6l8t2316r397b2389],
59	Weiterstadt	NNP	O	Weiterstadt	appos	61	SENT_112	[p6l425t2316r815b2382],
60	,	,	O	,	_	0	SENT_112	[p6l425t2316r815b2382],
61	Germany	NNP	LOCATION	Germany	dep	54	SENT_112	[p6l846t2316r1188b2389],
62	)	CD	NUMBER	)	num	61	SENT_112	[p6l846t2316r1188b2389],
63	.	.	O	.	_	0	SENT_112	[p6l846t2316r1188b2389],

1	Phormocokinetic	JJ	PERSON	phormocokinetic	amod	2	SENT_113	[p6l109t2522r704b2577],
2	Ancilysis	NN	PERSON	ancilysis	_	0	SENT_113	[p6l730t2522r1000b2590],

1	Plasma	NN	O	plasma	nn	2	SENT_114	[p6l105t2696r338b2753],
2	concentration	NN	O	concentration	nsubjpass	17	SENT_114	[p6l380t2696r990b2753],
3	—	CD	NUMBER	—	num	4	SENT_114	[p6l380t2696r990b2753],
4	time	NN	O	time	tmod	17	SENT_114	[p6l380t2696r990b2753],
5	curves	NNS	O	curve	nsubjpass	17	SENT_114	[p6l1033t2714r1240b2753],
6	of	IN	O	of	_	0	SENT_114	[p6l1286t2696r1355b2753],
7	torasemide	NN	O	torasemide	prep_of	5	SENT_114	[p6l1392t2696r1763b2763],
8	,	,	O	,	_	0	SENT_114	[p6l1392t2696r1763b2763],
9	irbesartan	NN	O	irbesartan	prep_of	5	SENT_114	[p6l1809t2696r2143b2763],
10	,	,	O	,	_	0	SENT_114	[p6l1809t2696r2143b2763],
11	losartan	NN	O	losartan	prep_of	5	SENT_114	[p6l8t2796r263b2853],
12	and	CC	O	and	_	0	SENT_114	[p6l295t2796r409b2853],
13	the	DT	O	the	det	15	SENT_114	[p6l439t2796r536b2853],
14	losartan	NN	O	losartan	nn	15	SENT_114	[p6l567t2796r822b2853],
15	metabolite	NN	O	metabolite	prep_of	5	SENT_114	[p6l853t2796r1193b2853],
16	were	VBD	O	be	auxpass	17	SENT_114	[p6l1225t2814r1379b2853],
17	evaluated	VBN	O	evaluate	_	0	SENT_114	[p6l1411t2796r1720b2853],
18	by	IN	O	by	_	0	SENT_114	[p6l1749t2796r1829b2870],
19	noncompartmental	JJ	O	noncompartmental	amod	20	SENT_114	[p6l1861t2814r2144b2853, p6l7t2898r352b2972],
20	analysis	NN	O	analysis	agent	17	SENT_114	[p6l373t2898r629b2972],
21	using	VBG	O	use	xcomp	17	SENT_114	[p6l649t2898r823b2972],
22	WinNonlin	NNP	O	WinNonlin	dobj	21	SENT_114	[p6l842t2894r1255b2955],
23	®	CD	NUMBER	®	num	24	SENT_114	[p6l842t2894r1255b2955],
24	version	NN	O	version	dep	29	SENT_114	[p6l1276t2898r1512b2955],
25	3.3	CD	NUMBER	3.3	dep	24	SENT_114	[p6l1534t2899r1627b2955],
26	software	NN	O	software	dep	29	SENT_114	[p6l1653t2898r1926b2955],
27	(	CD	NUMBER	(	num	26	SENT_114	[p6l1948t2898r2144b2968, p6l11t2998r164b3072],
28	Pharsight	NNP	ORGANIZATION	Pharsight	nn	29	SENT_114	[p6l1948t2898r2144b2968, p6l11t2998r164b3072],
29	Corporation	NNP	ORGANIZATION	Corporation	dep	21	SENT_114	[p6l193t2998r599b3072],
30	,	,	O	,	_	0	SENT_114	[p6l193t2998r599b3072],
31	Mountain	NNP	ORGANIZATION	Mountain	nn	32	SENT_114	[p6l630t2998r943b3055],
32	View	NNP	ORGANIZATION	View	appos	29	SENT_114	[p6l971t2998r1162b3065],
33	,	,	O	,	_	0	SENT_114	[p6l971t2998r1162b3065],
34	CA	NNP	O	CA	appos	29	SENT_114	[p6l1194t2999r1321b3065],
35	,	,	O	,	_	0	SENT_114	[p6l1194t2999r1321b3065],
36	USA	NNP	LOCATION	USA	appos	29	SENT_114	[p6l1352t2999r1555b3068],
37	)	CD	NUMBER	)	num	36	SENT_114	[p6l1352t2999r1555b3068],
38	.	.	O	.	_	0	SENT_114	[p6l1352t2999r1555b3068],

1	The	DT	O	the	det	7	SENT_115	[p6l1588t2998r1711b3055],
2	peak	NN	O	peak	nn	7	SENT_115	[p6l1739t2998r1892b3072],
3	plasma	NN	O	plasma	nn	7	SENT_115	[p6l1918t2998r2148b3072],
4	concentration	NN	O	concentration	nn	7	SENT_115	[p6l9t3100r447b3157],
5	(	CD	NUMBER	(	num	7	SENT_115	[p6l479t3101r691b3170],
6	Cmax	NN	O	cmax	nn	7	SENT_115	[p6l479t3101r691b3170],
7	)	NN	O	)	nsubj	18	SENT_115	[p6l479t3101r691b3170],
8	and	CC	O	and	_	0	SENT_115	[p6l725t3100r838b3157],
9	the	DT	O	the	det	10	SENT_115	[p6l867t3100r964b3157],
10	time	NN	O	time	nsubj	18	SENT_115	[p6l993t3100r1135b3157],
11	to	TO	O	to	aux	12	SENT_115	[p6l1164t3109r1224b3157],
12	reach	VB	O	reach	infmod	10	SENT_115	[p6l1254t3100r1428b3157],
13	the	DT	O	the	det	17	SENT_115	[p6l1457t3100r1554b3157],
14	Cmax	NN	O	cmax	nn	17	SENT_115	[p6l1584t3101r1747b3165],
15	(	NN	O	(	nn	17	SENT_115	[p6l1778t3101r1959b3170],
16	tmax	NN	O	tmax	nn	17	SENT_115	[p6l1778t3101r1959b3170],
17	)	NN	O	)	dobj	12	SENT_115	[p6l1778t3101r1959b3170],
18	were	VBD	O	be	_	0	SENT_115	[p6l1992t3118r2146b3157],

1	Clin	NNP	O	Clin	nn	2	SENT_116	[p6l1404t3297r1488b3335],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_116	[p6l1509t3297r1866b3335],
3	2008	CD	DATE	2008	num	2	SENT_116	[p6l1882t3297r1999b3337],
4	;	:	O	;	_	0	SENT_116	[p6l1882t3297r1999b3337],
5	47	CD	NUMBER	47	number	6	SENT_116	[p6l2017t3297r2068b3334],
6	(	CD	NUMBER	(	dep	2	SENT_116	[p6l2088t3297r2145b3340],
7	5	CD	NUMBER	5	num	8	SENT_116	[p6l2088t3297r2145b3340],
8	)	NN	O	)	dep	6	SENT_116	[p6l2088t3297r2145b3340],

1	326	CD	NUMBER	326	num	2	SENT_117	[p6l6t3414r54b3438],
2	Werner	NNP	O	Werner	_	0	SENT_117	[p6l6t3449r106b3473],
3	et	FW	O	et	nn	4	SENT_117	[p6l116t3451r140b3473],
4	al.	FW	O	al.	dep	2	SENT_117	[p6l150t3448r180b3473],
5	.	.	O	.	_	0	SENT_117	[p6l150t3448r180b3473],

1	Table	NNP	O	Table	nn	2	SENT_118	[p6l6t3580r92b3605],
2	II	NNP	O	II	_	0	SENT_118	[p6l106t3580r130b3605],
3	.	.	O	.	_	0	SENT_118	[p6l106t3580r130b3605],

1	Main	NNP	O	Main	nn	2	SENT_119	[p6l146t3580r214b3605],
2	conditions	NNS	O	condition	_	0	SENT_119	[p6l229t3580r377b3605],
3	of	IN	O	of	_	0	SENT_119	[p6l391t3580r417b3605],
4	quantification	NN	O	quantification	prep_of	2	SENT_119	[p6l430t3580r624b3612],
5	of	IN	O	of	_	0	SENT_119	[p6l638t3580r665b3605],
6	analysed	VBN	O	analyse	prepc_of	4	SENT_119	[p6l678t3580r808b3612],
7	drugs	NNS	O	drug	dobj	6	SENT_119	[p6l823t3580r904b3612],
8	in	IN	O	in	_	0	SENT_119	[p6l919t3580r941b3605],
9	human	JJ	O	human	amod	10	SENT_119	[p6l956t3580r1054b3605],
10	plasma	NN	O	plasma	nn	17	SENT_119	[p6l1070t3580r1175b3612],
11	Parameter	NNP	O	Parameter	nn	17	SENT_119	[p6l6t3647r159b3672],
12	Torasemide	NNP	O	Torasemide	nn	17	SENT_119	[p6l533t3647r708b3672],
13	Irbesartan	NNP	O	Irbesartan	nn	17	SENT_119	[p6l1131t3647r1277b3672],
14	Losartan/EXP3174	NNP	O	Losartan/EXP3174	nn	17	SENT_119	[p6l1704t3646r1981b3672],
15	Internal	NNP	O	Internal	nn	17	SENT_119	[p6l12t3722r230b3773],
16	standard	JJ	O	standard	amod	17	SENT_119	[p6l260t3722r521b3773],
17	Clopamide	NN	O	clopamide	prep_in	7	SENT_119	[p6l1097t3721r1419b3786],

1	Extraction	NN	O	extraction	_	0	SENT_120	[p7l12t25r306b76],
2	Solid-liquid	JJ	O	solid-liquid	amod	4	SENT_120	[p7l1097t23r1425b89],
3	(	CD	NUMBER	(	tmod	2	SENT_120	[p7l1457t23r1626b89],
4	SPE	NN	O	spe	dep	1	SENT_120	[p7l1457t23r1626b89],
5	,	,	O	,	_	0	SENT_120	[p7l1457t23r1626b89],
6	methanol	NN	O	methanol	nn	7	SENT_120	[p7l1660t24r1956b89],
7	)	NN	O	)	appos	4	SENT_120	[p7l1660t24r1956b89],

1	HPLC	NN	O	hplc	_	0	SENT_121	[p7l11t244r186b295],

1	mobile	JJ	O	mobile	amod	2	SENT_122	[p7l79t344r274b395],
2	phase	NN	O	phase	_	0	SENT_122	[p7l304t344r484b408],
3	Acetonitrile/2	CD	PERCENT	acetonitrile/2	num	4	SENT_122	[p7l1095t343r1548b395],
4	%	NN	PERCENT	%	dep	2	SENT_122	[p7l1095t343r1548b395],
5	acetic	JJ	O	acetic	amod	6	SENT_122	[p7l1577t344r1752b395],
6	acid	NN	O	acid	dep	2	SENT_122	[p7l1780t344r1899b395],

1	(	NN	O	(	_	0	SENT_123	[p7l1098t443r1286b508],
2	90/10	CD	NUMBER	90/10	num	4	SENT_123	[p7l1098t443r1286b508],
3	v/v	NN	O	v/v	nn	4	SENT_123	[p7l1313t443r1418b508],
4	)	NN	O	)	dep	1	SENT_123	[p7l1313t443r1418b508],

1	stationary	JJ	O	stationary	amod	2	SENT_124	[p7l77t544r371b609],
2	phase	NN	O	phase	_	0	SENT_124	[p7l399t544r579b608],
3	8/3	CD	NUMBER	8/3	num	4	SENT_124	[p7l1096t543r1187b595],
4	nucleosil	NN	O	nucleosil	dep	2	SENT_124	[p7l1217t544r1475b595],
5	300-5	CD	NUMBER	300-5	num	6	SENT_124	[p7l1506t545r1691b595],
6	C4	NN	O	c4	dep	2	SENT_124	[p7l1721t543r1803b595],

1	flow	NN	O	flow	nn	2	SENT_125	[p7l75t764r195b815],
2	rate	NN	O	rate	_	0	SENT_125	[p7l225t768r336b815],
3	(	CD	NUMBER	(	num	5	SENT_125	[p7l366t763r628b828],
4	mL/min	NN	O	ml/min	nn	5	SENT_125	[p7l366t763r628b828],
5	)	NN	O	)	dep	2	SENT_125	[p7l366t763r628b828],
6	0.3	CD	NUMBER	0.3	dep	2	SENT_125	[p7l1096t765r1187b816],

1	MS	NN	O	m	nn	6	SENT_126	[p7l11t858r106b911],
2	instrumentation	NN	O	instrumentation	nn	6	SENT_126	[p7l137t860r596b911],
3	Finnigan	NNP	PERSON	Finnigan	nn	6	SENT_126	[p7l1100t860r1352b924],
4	MAT	NNP	O	MAT	nn	6	SENT_126	[p7l1385t860r1525b910],
5	LCQ	NNP	O	LCQ	nn	6	SENT_126	[p7l1554t858r1687b913],
6	ESI	NNP	ORGANIZATION	ESI	nsubj	7	SENT_126	[p7l1719t858r1818b911],
7	ion	NN	O	ion	_	0	SENT_126	[p7l1852t860r1935b910],
8	trap	NN	O	trap	nn	10	SENT_126	[p7l1964t863r2079b924],
9	mass	NN	O	mass	nn	10	SENT_126	[p7l1098t967r1255b1006],
10	spectrometer	NN	O	spectrometer	dobj	7	SENT_126	[p7l1284t958r1694b1019],
11	;	:	O	;	_	0	SENT_126	[p7l1284t958r1694b1019],
12	positive	JJ	O	positive	amod	10	SENT_126	[p7l1728t955r1954b1019],
13	scan	VB	O	scan	dep	7	SENT_126	[p7l1982t967r2120b1006],
14	mode-selected	JJ	O	mode-selected	amod	16	SENT_126	[p7l1098t1050r1539b1101],
15	reaction	NN	O	reaction	nn	16	SENT_126	[p7l1572t1050r1806b1101],
16	monitoring	NN	O	monitoring	dobj	13	SENT_126	[p7l1839t1050r2150b1114],

1	Parameter	NN	O	parameter	_	0	SENT_127	[p7l12t1145r326b1196],
2	Parent	NNP	O	Parent	nn	3	SENT_127	[p7l1100t1145r1295b1196],
3	mass	NN	O	mass	dep	1	SENT_127	[p7l1324t1157r1481b1196],
4	349.4	CD	NUMBER	349.4	number	5	SENT_127	[p7l1509t1146r1677b1196],
5	(	CD	NUMBER	(	num	7	SENT_127	[p7l1707t1144r1915b1209],
6	346.2	CD	NUMBER	346.2	num	7	SENT_127	[p7l1707t1144r1915b1209],
7	)	NN	O	)	dep	3	SENT_127	[p7l1707t1144r1915b1209],
8	amu	IN	O	amu	prep	7	SENT_127	[p7l1946t1157r2072b1196],

1	Daughter	NN	O	daughter	nn	2	SENT_128	[p7l1099t1240r1376b1305],
2	mass	NN	O	mass	dep	16	SENT_128	[p7l1404t1252r1561b1291],
3	264.1	CD	NUMBER	264.1	number	4	SENT_128	[p7l1589t1241r1745b1291],
4	(	CD	NUMBER	(	dep	2	SENT_128	[p7l1787t1239r1995b1304],
5	250.0	CD	NUMBER	250.0	num	7	SENT_128	[p7l1787t1239r1995b1304],
6	)	NN	O	)	nn	7	SENT_128	[p7l1787t1239r1995b1304],
7	amu	NN	O	amu	dep	4	SENT_128	[p7l2026t1252r2152b1291],
8	CE	NN	O	ce	dep	16	SENT_128	[p7l1097t1334r1186b1385],
9	20	CD	NUMBER	20	num	8	SENT_128	[p7l1214t1336r1287b1385],
10	eV	NN	O	ev	nn	16	SENT_128	[p7l1316t1335r1396b1385],
11	isolation	NN	O	isolation	nn	16	SENT_128	[p7l1425t1335r1668b1385],
12	width	NN	O	width	nn	16	SENT_128	[p7l1697t1335r1851b1385],
13	1	CD	NUMBER	1	num	16	SENT_128	[p7l1886t1336r1905b1384],
14	Da	NN	ORGANIZATION	da	nn	16	SENT_128	[p7l1947t1335r2028b1385],
15	Sheath	NN	ORGANIZATION	sheath	nn	16	SENT_128	[p7l1097t1428r1307b1480],
16	gas	NN	O	gas	dep	22	SENT_128	[p7l1338t1441r1443b1494],
17	45	CD	NUMBER	45	num	18	SENT_128	[p7l1471t1430r1543b1480],
18	psi	NNS	O	psus	dep	16	SENT_128	[p7l1573t1429r1653b1493],
19	Auxillary	JJ	O	auxillary	amod	22	SENT_128	[p7l1095t1525r1352b1589],
20	gas	NN	O	gas	nn	22	SENT_128	[p7l1379t1537r1485b1590],
21	o	NN	O	o	nn	22	SENT_128	[p7l1513t1526r1547b1576],
22	psi	NNS	O	psus	dep	31	SENT_128	[p7l1577t1525r1656b1589],
23	Spray	NNP	O	Spray	nn	24	SENT_128	[p7l1097t1618r1272b1683],
24	voltage	NN	O	voltage	dep	22	SENT_128	[p7l1298t1619r1515b1684],
25	5	CD	NUMBER	5	num	27	SENT_128	[p7l1544t1621r1577b1670],
26	kV	NN	O	kv	nn	27	SENT_128	[p7l1608t1619r1682b1669],
27	Capillary	NNP	O	Capillary	dep	24	SENT_128	[p7l1097t1713r1360b1778],
28	temperature	NN	O	temperature	nn	31	SENT_128	[p7l1385t1717r1751b1778],
29	180	CD	NUMBER	180	num	31	SENT_128	[p7l1784t1713r1966b1765],
30	°	NN	O	°	nn	31	SENT_128	[p7l1784t1713r1966b1765],
31	C	NN	O	c	_	0	SENT_128	[p7l1784t1713r1966b1765],
32	Capillary	JJ	O	capillary	amod	37	SENT_128	[p7l1097t1808r1360b1873],
33	voltage	NN	O	voltage	nn	37	SENT_128	[p7l1385t1809r1603b1874],
34	11	CD	NUMBER	11	num	37	SENT_128	[p7l1636t1810r1692b1859],
35	kV	NN	O	kv	nn	37	SENT_128	[p7l1733t1809r1808b1859],
36	Tube	NNP	O	Tube	nn	37	SENT_128	[p7l1095t1904r1248b1954],
37	lens	NN	O	lens	nsubj	38	SENT_128	[p7l1278t1904r1398b1954],
38	offset	VBD	O	offset	rcmod	31	SENT_128	[p7l1426t1903r1590b1954],
39	55	CD	NUMBER	55	num	40	SENT_128	[p7l1617t1906r1689b1954],
40	V	NN	O	v	dobj	38	SENT_128	[p7l1717t1904r1760b1953],

1	Calibration	NN	O	calibration	nn	3	SENT_129	[p7l9t2108r329b2160],
2	curve	NN	O	curve	nn	3	SENT_129	[p7l359t2121r522b2160],
3	range	NN	O	range	_	0	SENT_129	[p7l80t2220r247b2272],
4	(	CD	NUMBER	(	num	5	SENT_129	[p7l278t2206r449b2272],
5	ug/L	NN	O	ug/l	dep	3	SENT_129	[p7l278t2206r449b2272],
6	)	CD	NUMBER	)	num	7	SENT_129	[p7l278t2206r449b2272],
7	25-5000	CD	NUMBER	25-5000	dep	5	SENT_129	[p7l1096t2209r1358b2259],
8	R	NN	O	r	dep	3	SENT_129	[p7l80t2307r122b2356],
9	20.9956	CD	NUMBER	20.9956	num	8	SENT_129	[p7l1096t2308r1339b2357],

1	Precision	NN	O	precision	_	0	SENT_130	[p7l12t2512r283b2563],
2	(	CD	NUMBER	(	num	4	SENT_130	[p7l316t2511r859b2577],
3	intraday/interday	JJ	O	intraday/interday	amod	4	SENT_130	[p7l316t2511r859b2577],
4	)	NN	O	)	dep	1	SENT_130	[p7l316t2511r859b2577],
5	[	CD	NUMBER	[	number	6	SENT_130	[p7l891t2512r982b2576],
6	°	CD	NUMBER	°	dep	4	SENT_130	[p7l891t2512r982b2576],
7	/	:	O	/	punct	8	SENT_130	[p7l891t2512r982b2576],
8	o	NN	O	o	dep	6	SENT_130	[p7l891t2512r982b2576],
9	]	CD	NUMBER	]	num	8	SENT_130	[p7l891t2512r982b2576],

1	LLQ	NN	O	llq	_	0	SENT_131	[p7l80t2613r201b2667],
2	10.7	CD	NUMBER	10.7	num	1	SENT_131	[p7l1101t2613r1339b2665],
3	/	:	O	/	punct	4	SENT_131	[p7l1101t2613r1339b2665],
4	9.3	CD	NUMBER	9.3	dep	1	SENT_131	[p7l1101t2613r1339b2665],

1	ULQ	NN	O	ulq	_	0	SENT_132	[p7l80t2821r213b2875],
2	3.3	CD	NUMBER	3.3	num	1	SENT_132	[p7l1096t2821r1301b2872],
3	/	:	O	/	punct	4	SENT_132	[p7l1096t2821r1301b2872],
4	7.2	CD	NUMBER	7.2	dep	1	SENT_132	[p7l1096t2821r1301b2872],

1	Accuracy	NN	O	accuracy	_	0	SENT_133	[p7l7t3030r287b3095],
2	(	CD	NUMBER	(	num	4	SENT_133	[p7l316t3029r859b3095],
3	intraday/interday	JJ	O	intraday/interday	amod	4	SENT_133	[p7l316t3029r859b3095],
4	)	NN	O	)	dep	1	SENT_133	[p7l316t3029r859b3095],
5	[	CD	NUMBER	[	number	6	SENT_133	[p7l891t3030r982b3094],
6	°	CD	NUMBER	°	dep	4	SENT_133	[p7l891t3030r982b3094],
7	/	:	O	/	punct	8	SENT_133	[p7l891t3030r982b3094],
8	o	NN	O	o	dep	6	SENT_133	[p7l891t3030r982b3094],
9	]	CD	NUMBER	]	num	8	SENT_133	[p7l891t3030r982b3094],

1	LLQ	NN	O	llq	_	0	SENT_134	[p7l80t3131r201b3185],
2	9.0	CD	NUMBER	9.0	num	1	SENT_134	[p7l1097t3131r1339b3183],
3	/	:	O	/	punct	4	SENT_134	[p7l1097t3131r1339b3183],
4	10.8	CD	NUMBER	10.8	dep	1	SENT_134	[p7l1097t3131r1339b3183],

1	ULQ	NNP	O	ULQ	_	0	SENT_135	[p7l80t3339r213b3392],
2	-0.5	CD	NUMBER	-0.5	num	1	SENT_135	[p7l1094t3339r1339b3390],
3	/	:	O	/	punct	4	SENT_135	[p7l1094t3339r1339b3390],
4	3.3	CD	NUMBER	3.3	dep	1	SENT_135	[p7l1094t3339r1339b3390],

1	Valsartan	NNP	O	Valsartan	nsubj	12	SENT_136	[p7l8t3435r272b3483],
2	lrbesartana	NN	O	lrbesartana	nn	3	SENT_136	[p7l1108t3435r1412b3483],
3	Liquid-liquid	NN	O	liquid-liquid	dep	1	SENT_136	[p7l12t3527r343b3587],
4	(	CD	NUMBER	(	num	6	SENT_136	[p7l373t3526r797b3587],
5	hexane/diethyl	NN	O	hexane/diethyl	nn	6	SENT_136	[p7l373t3526r797b3587],
6	ether	NN	O	ether	dep	1	SENT_136	[p7l825t3527r980b3575],
7	:	:	O	:	_	0	SENT_136	[p7l825t3527r980b3575],
8	Liquid-liquid	JJ	O	liquid-liquid	amod	11	SENT_136	[p7l1107t3527r1439b3587],
9	(	CD	NUMBER	(	tmod	8	SENT_136	[p7l1469t3526r1938b3587],
10	methyl-tert-butyl	NN	O	methyl-tert-butyl	nn	11	SENT_136	[p7l1469t3526r1938b3587],
11	ether	NN	O	ether	dep	6	SENT_136	[p7l1967t3526r2153b3587],
12	)	VBD	O	)	_	0	SENT_136	[p7l1967t3526r2153b3587],
13	a	DT	O	a	det	14	SENT_136	[p7l1967t3526r2153b3587],
14	50/50	CD	NUMBER	50/50	dobj	12	SENT_136	[p7l9t3618r179b3667],
15	:	:	O	:	_	0	SENT_136	[p7l9t3618r179b3667],
16	v/v	CD	NUMBER	v/v	num	17	SENT_136	[p7l207t3618r305b3679],
17	)	CD	NUMBER	)	dep	14	SENT_136	[p7l207t3618r305b3679],

1	Methanol/0	NN	O	methanol/0	nn	3	SENT_137	[p8l11t78r429b126],
2	.2	NN	PERCENT	.2	nn	3	SENT_137	[p8l11t78r429b126],
3	%	NN	PERCENT	%	dep	11	SENT_137	[p8l11t78r429b126],
4	acetic	JJ	O	acetic	amod	5	SENT_137	[p8l456t79r619b126],
5	acid	NN	O	acid	dep	3	SENT_137	[p8l645t79r756b126],
6	(	NN	O	(	dep	11	SENT_137	[p8l11t172r185b232],
7	90/10	CD	NUMBER	90/10	num	6	SENT_137	[p8l11t172r185b232],
8	v/v	NN	O	v/v	nn	11	SENT_137	[p8l210t172r308b232],
9	)	CD	NUMBER	)	num	11	SENT_137	[p8l210t172r308b232],
10	CC8/3	NN	O	cc8/3	nn	11	SENT_137	[p8l10t267r186b315],
11	nucleosil	NN	O	nucleosil	_	0	SENT_137	[p8l213t268r453b315],
12	300-5	CD	NUMBER	300-5	num	13	SENT_137	[p8l482t269r654b315],
13	C4	NN	O	c4	dep	11	SENT_137	[p8l681t267r758b315],

1	0.3	CD	NUMBER	0.3	num	2	SENT_138	[p8l9t458r93b505],
2	APl4000	NN	O	apl4000	dep	16	SENT_138	[p8l8t552r249b600],
3	(	CD	NUMBER	(	num	6	SENT_138	[p8l277t552r504b612],
4	Applied	NNP	O	Applied	nn	6	SENT_138	[p8l277t552r504b612],
5	Biosystems	NNP	O	Biosystems	nn	6	SENT_138	[p8l534t552r889b612],
6	)	NN	O	)	dep	2	SENT_138	[p8l534t552r889b612],
7	;	:	O	;	_	0	SENT_138	[p8l534t552r889b612],
8	multiple	JJ	O	multiple	amod	9	SENT_138	[p8l11t647r224b706],
9	reaction	NN	O	reaction	dep	6	SENT_138	[p8l253t647r471b694],
10	monitoringnegative	JJ	O	monitoringnegative	amod	12	SENT_138	[p8l501t647r813b706, p8l11t741r245b800],
11	ion	NN	O	ion	nn	12	SENT_138	[p8l274t741r351b788],
12	mode	NN	O	mode	dep	9	SENT_138	[p8l381t741r534b788],
13	Q1	NN	O	q1	dep	16	SENT_138	[p8l9t835r80b885],
14	427.1	CD	NUMBER	427.1	num	13	SENT_138	[p8l116t837r261b882],
15	(	CD	NUMBER	(	num	16	SENT_138	[p8l300t835r493b895],
16	434.2	CD	NUMBER	434.2	dep	24	SENT_138	[p8l300t835r493b895],
17	)	NN	O	)	nn	19	SENT_138	[p8l300t835r493b895],
18	m/z	NN	O	m/z	nn	19	SENT_138	[p8l524t835r621b883],
19	Q3	NN	O	q3	dep	16	SENT_138	[p8l9t929r90b979],
20	193.0	CD	NUMBER	193.0	number	21	SENT_138	[p8l120t931r272b977],
21	(	CD	NUMBER	(	dep	19	SENT_138	[p8l300t929r493b989],
22	179.1	CD	NUMBER	179.1	num	24	SENT_138	[p8l300t929r493b989],
23	)	NN	O	)	nn	24	SENT_138	[p8l300t929r493b989],
24	m/z	NN	O	m/z	_	0	SENT_138	[p8l524t929r621b977],
25	Dwell	NNP	O	Dwell	nn	26	SENT_138	[p8l12t1025r159b1072],
26	time	NN	O	time	nsubj	28	SENT_138	[p8l185t1025r303b1072],
27	200	CD	NUMBER	200	num	26	SENT_138	[p8l329t1026r431b1072],
28	ms	VBZ	O	m	rcmod	24	SENT_138	[p8l460t1036r539b1072],
29	DP	NN	O	dp	nn	32	SENT_138	[p8l12t1119r93b1165],
30	90	CD	NUMBER	90	num	32	SENT_138	[p8l120t1120r187b1166],
31	V	NN	O	v	nn	32	SENT_138	[p8l212t1119r252b1165],
32	EP	NN	O	ep	dobj	28	SENT_138	[p8l12t1214r89b1260],
33	10	CD	NUMBER	10	num	34	SENT_138	[p8l120t1215r183b1261],
34	V	NN	O	v	dep	32	SENT_138	[p8l208t1214r249b1260],
35	CE	NN	O	ce	nn	38	SENT_138	[p8l10t1307r92b1355],
36	34	CD	NUMBER	34	num	38	SENT_138	[p8l120t1309r187b1355],
37	eV	NN	O	ev	nn	38	SENT_138	[p8l213t1308r288b1355],
38	CXP	NN	O	cxp	dep	45	SENT_138	[p8l10t1401r135b1449],
39	13	CD	NUMBER	13	dep	38	SENT_138	[p8l166t1403r229b1449],
40	(	NN	O	(	dep	45	SENT_138	[p8l257t1401r362b1461],
41	11	CD	NUMBER	11	num	40	SENT_138	[p8l257t1401r362b1461],
42	)	CD	NUMBER	)	num	45	SENT_138	[p8l257t1401r362b1461],
43	V	NN	O	v	nn	45	SENT_138	[p8l390t1402r430b1448],
44	Collision	NN	O	collision	nn	45	SENT_138	[p8l10t1495r244b1543],
45	gas	NN	O	gas	dep	48	SENT_138	[p8l272t1507r370b1556],
46	7	CD	NUMBER	7	num	47	SENT_138	[p8l397t1498r428b1542],
47	psi	NNS	O	psus	dep	45	SENT_138	[p8l456t1496r530b1555],
48	Curtain	NNP	O	Curtain	dep	52	SENT_138	[p8l10t1589r209b1637],
49	gas	NN	O	gas	nn	52	SENT_138	[p8l237t1601r335b1650],
50	15	CD	NUMBER	15	num	52	SENT_138	[p8l366t1591r428b1637],
51	psi	NN	O	psus	nn	52	SENT_138	[p8l456t1590r530b1649],
52	G81	NN	O	g81	dep	57	SENT_138	[p8l10t1683r123b1731],
53	60	CD	NUMBER	60	num	55	SENT_138	[p8l159t1685r226b1731],
54	psi	NN	O	psus	nn	55	SENT_138	[p8l253t1684r327b1743],
55	G82	NN	O	g82	dep	52	SENT_138	[p8l10t1777r132b1825],
56	50	CD	NUMBER	50	num	57	SENT_138	[p8l159t1779r226b1825],
57	psi	NNS	O	psus	dep	62	SENT_138	[p8l253t1778r327b1837],
58	Ion	NNP	O	Ion	nn	60	SENT_138	[p8l13t1872r92b1919],
59	spray	NN	O	spray	nn	60	SENT_138	[p8l120t1883r273b1931],
60	voltage	NN	O	voltage	dep	57	SENT_138	[p8l296t1872r499b1932],
61	4500	CD	NUMBER	4500	num	62	SENT_138	[p8l525t1873r663b1919],
62	V	NN	O	v	dep	32	SENT_138	[p8l689t1872r729b1918],
63	Temperature	NN	O	temperature	nn	66	SENT_138	[p8l8t1966r369b2025],
64	600	CD	NUMBER	600	num	66	SENT_138	[p8l396t1965r569b2013],
65	°	NN	O	°	nn	66	SENT_138	[p8l396t1965r569b2013],
66	C	NN	O	c	dep	62	SENT_138	[p8l396t1965r569b2013],

1	Acetonitrile/0	NN	O	acetonitrile/0	dep	114	SENT_139	[p8l1103t78r1578b126],
2	.2	NN	PERCENT	.2	dep	114	SENT_139	[p8l1103t78r1578b126],
3	%	NN	PERCENT	%	dep	114	SENT_139	[p8l1103t78r1578b126],
4	formic	JJ	O	formic	dep	114	SENT_139	[p8l1603t78r1775b126],
5	acid	NN	O	acid	dep	114	SENT_139	[p8l1800t79r1912b126],
6	(	NN	O	(	dep	114	SENT_139	[p8l1107t172r1280b232],
7	55/45	CD	NUMBER	55/45	dep	114	SENT_139	[p8l1107t172r1280b232],
8	v/v	NN	O	v/v	dep	114	SENT_139	[p8l1306t172r1430b232],
9	)	CD	NUMBER	)	dep	114	SENT_139	[p8l1306t172r1430b232],
10	a	DT	O	a	dep	114	SENT_139	[p8l1306t172r1430b232],
11	ZORBAX	NNP	MISC	ZORBAX	dep	114	SENT_139	[p8l1104t267r1363b315],
12	Eclipse	NNP	MISC	Eclipse	dep	114	SENT_139	[p8l1392t268r1590b327],
13	XDB-C18	NN	O	xdb-c18	dep	114	SENT_139	[p8l1615t267r1881b315],
14	4.6	CD	NUMBER	4.6	dep	114	SENT_139	[p8l1104t363r1241b409],
15	>	JJR	O	>	dep	114	SENT_139	[p8l1104t363r1241b409],
16	<	JJR	O	<	dep	114	SENT_139	[p8l1104t363r1241b409],
17	150	CD	NUMBER	150	dep	114	SENT_139	[p8l1264t363r1362b409],
18	mm	NN	O	mm	dep	114	SENT_139	[p8l1390t373r1505b417],
19	,	,	O	,	_	0	SENT_139	[p8l1390t373r1505b417],
20	5	CD	NUMBER	5	dep	114	SENT_139	[p8l1534t364r1565b409],
21	pa	NN	O	pa	dep	114	SENT_139	[p8l1592t364r1649b422],
22	Oa	NN	O	oa	dep	114	SENT_139	[p8l1104t458r1161b505],
23	APl4000	NN	O	apl4000	dep	114	SENT_139	[p8l1103t552r1345b600],
24	(	CD	NUMBER	(	dep	114	SENT_139	[p8l1373t552r1599b612],
25	Applied	NNP	O	Applied	dep	114	SENT_139	[p8l1373t552r1599b612],
26	Biosystems	NNP	O	Biosystems	dep	114	SENT_139	[p8l1629t552r1984b612],
27	)	NN	O	)	dep	114	SENT_139	[p8l1629t552r1984b612],
28	;	:	O	;	_	0	SENT_139	[p8l1629t552r1984b612],
29	multiple	JJ	O	multiple	dep	114	SENT_139	[p8l1106t647r1320b706],
30	reaction	NN	O	reaction	dep	114	SENT_139	[p8l1349t647r1567b694],
31	monitoringpositive	JJ	O	monitoringpositive	dep	114	SENT_139	[p8l1597t647r1909b706, p8l1106t741r1316b800],
32	ion	NN	O	ion	dep	114	SENT_139	[p8l1345t741r1422b788],
33	modea	NN	O	modea	dep	114	SENT_139	[p8l1452t741r1630b788],
34	Q1	NN	O	q1	dep	114	SENT_139	[p8l1105t835r1175b885],
35	423.1	CD	NUMBER	423.1	dep	114	SENT_139	[p8l1211t837r1382b891],
36	,	,	O	,	_	0	SENT_139	[p8l1211t837r1382b891],
37	437.2	CD	NUMBER	437.2	dep	114	SENT_139	[p8l1410t837r1566b883],
38	(	CD	NUMBER	(	dep	114	SENT_139	[p8l1595t835r1788b895],
39	429.0	CD	NUMBER	429.0	dep	114	SENT_139	[p8l1595t835r1788b895],
40	)	NN	O	)	dep	114	SENT_139	[p8l1595t835r1788b895],
41	m/z	NN	O	m/z	dep	114	SENT_139	[p8l1818t835r1915b883],
42	Q3	NN	O	q3	dep	114	SENT_139	[p8l1105t929r1186b979],
43	205.2	CD	NUMBER	205.2	dep	114	SENT_139	[p8l1211t931r1382b985],
44	,	,	O	,	_	0	SENT_139	[p8l1211t931r1382b985],
45	207.1	CD	NUMBER	207.1	dep	114	SENT_139	[p8l1411t931r1556b977],
46	(	CD	NUMBER	(	dep	114	SENT_139	[p8l1595t929r1788b989],
47	207.1	CD	NUMBER	207.1	dep	114	SENT_139	[p8l1595t929r1788b989],
48	)	NN	O	)	dep	114	SENT_139	[p8l1595t929r1788b989],
49	m/z	NN	O	m/z	dep	114	SENT_139	[p8l1818t929r1915b977],
50	Dwell	NNP	O	Dwell	dep	114	SENT_139	[p8l1107t1025r1254b1072],
51	time	NN	O	time	dep	114	SENT_139	[p8l1281t1025r1398b1072],
52	250	CD	NUMBER	250	dep	114	SENT_139	[p8l1424t1026r1527b1072],
53	ms	NNS	O	m	dep	114	SENT_139	[p8l1555t1036r1634b1072],
54	DP	NN	O	dp	dep	114	SENT_139	[p8l1107t1119r1188b1165],
55	51	CD	NUMBER	51	dep	114	SENT_139	[p8l1215t1120r1297b1174],
56	,	,	O	,	_	0	SENT_139	[p8l1215t1120r1297b1174],
57	61	CD	NUMBER	61	dep	114	SENT_139	[p8l1326t1120r1383b1166],
58	(	CD	NUMBER	(	dep	114	SENT_139	[p8l1421t1118r1526b1178],
59	71	CD	NUMBER	71	dep	114	SENT_139	[p8l1421t1118r1526b1178],
60	)	CD	NUMBER	)	dep	114	SENT_139	[p8l1421t1118r1526b1178],
61	V	NN	O	v	dep	114	SENT_139	[p8l1554t1119r1594b1165],
62	EP	NN	O	ep	dep	114	SENT_139	[p8l1108t1214r1185b1260],
63	10	CD	NUMBER	10	dep	114	SENT_139	[p8l1216t1215r1278b1261],
64	V	NN	O	v	dep	114	SENT_139	[p8l1304t1214r1344b1260],
65	CE	NN	O	ce	dep	114	SENT_139	[p8l1105t1307r1188b1355],
66	77	CD	NUMBER	77	dep	114	SENT_139	[p8l1215t1310r1297b1363],
67	,	,	O	,	_	0	SENT_139	[p8l1215t1310r1297b1363],
68	31	CD	NUMBER	31	dep	114	SENT_139	[p8l1326t1309r1383b1355],
69	(	CD	NUMBER	(	dep	114	SENT_139	[p8l1421t1307r1527b1367],
70	35	CD	NUMBER	35	dep	114	SENT_139	[p8l1421t1307r1527b1367],
71	)	NN	O	)	dep	114	SENT_139	[p8l1421t1307r1527b1367],
72	eV	NN	O	ev	dep	114	SENT_139	[p8l1555t1308r1630b1355],
73	CXP	NN	O	cxp	dep	114	SENT_139	[p8l1105t1401r1231b1449],
74	30	CD	NUMBER	30	dep	114	SENT_139	[p8l1258t1403r1339b1457],
75	,	,	O	,	_	0	SENT_139	[p8l1258t1403r1339b1457],
76	18	CD	NUMBER	18	dep	114	SENT_139	[p8l1373t1403r1435b1449],
77	(	CD	NUMBER	(	dep	114	SENT_139	[p8l1464t1401r1569b1461],
78	14	CD	NUMBER	14	dep	114	SENT_139	[p8l1464t1401r1569b1461],
79	)	CD	NUMBER	)	dep	114	SENT_139	[p8l1464t1401r1569b1461],
80	V	NN	O	v	dep	114	SENT_139	[p8l1596t1402r1637b1448],
81	Collision	NN	O	collision	dep	114	SENT_139	[p8l1105t1495r1339b1543],
82	gas	NN	O	gas	dep	114	SENT_139	[p8l1368t1507r1466b1556],
83	4	CD	NUMBER	4	dep	114	SENT_139	[p8l1492t1497r1538b1551],
84	,	,	O	,	_	0	SENT_139	[p8l1492t1497r1538b1551],
85	5	CD	NUMBER	5	dep	114	SENT_139	[p8l1568t1498r1599b1543],
86	(	NN	O	(	dep	114	SENT_139	[p8l1628t1495r1697b1555],
87	4	CD	NUMBER	4	dep	114	SENT_139	[p8l1628t1495r1697b1555],
88	)	CD	NUMBER	)	dep	114	SENT_139	[p8l1628t1495r1697b1555],
89	psi	NNS	O	psus	dep	114	SENT_139	[p8l1727t1496r1801b1555],
90	Curtain	NNP	O	Curtain	dep	114	SENT_139	[p8l1105t1589r1304b1637],
91	gas	NN	O	gas	dep	114	SENT_139	[p8l1333t1601r1431b1650],
92	10	CD	NUMBER	10	dep	114	SENT_139	[p8l1461t1591r1524b1637],
93	psi	NN	O	psus	dep	114	SENT_139	[p8l1552t1590r1626b1649],
94	G81	NN	O	g81	dep	114	SENT_139	[p8l1106t1683r1218b1731],
95	50	CD	NUMBER	50	dep	114	SENT_139	[p8l1254t1685r1321b1731],
96	psi	NNS	O	psus	dep	114	SENT_139	[p8l1349t1684r1423b1743],
97	G82	NN	O	g82	dep	114	SENT_139	[p8l1106t1777r1228b1825],
98	70	CD	NUMBER	70	dep	114	SENT_139	[p8l1255t1779r1336b1833],
99	,	,	O	,	_	0	SENT_139	[p8l1255t1779r1336b1833],
100	60	CD	NUMBER	60	dep	114	SENT_139	[p8l1366t1779r1432b1825],
101	(	CD	NUMBER	(	dep	114	SENT_139	[p8l1460t1777r1566b1837],
102	70	CD	NUMBER	70	dep	114	SENT_139	[p8l1460t1777r1566b1837],
103	)	NN	O	)	dep	114	SENT_139	[p8l1460t1777r1566b1837],
104	psi	NNS	O	psus	dep	114	SENT_139	[p8l1595t1778r1669b1837],
105	Ion	NNP	MISC	Ion	dep	114	SENT_139	[p8l1108t1872r1188b1919],
106	spray	NN	O	spray	dep	114	SENT_139	[p8l1215t1883r1368b1931],
107	voltage	NN	O	voltage	dep	114	SENT_139	[p8l1392t1872r1594b1932],
108	5000	CD	NUMBER	5000	dep	114	SENT_139	[p8l1621t1873r1759b1919],
109	V	NN	O	v	dep	114	SENT_139	[p8l1784t1872r1824b1918],
110	Temperature	NN	O	temperature	dep	114	SENT_139	[p8l1103t1966r1465b2025],
111	600	CD	NUMBER	600	dep	114	SENT_139	[p8l1492t1965r1690b2013],
112	°	NN	O	°	dep	114	SENT_139	[p8l1492t1965r1690b2013],
113	C	NN	O	c	dep	114	SENT_139	[p8l1492t1965r1690b2013],
114	‘	CD	NUMBER	‘	_	0	SENT_139	[p8l1492t1965r1690b2013],
115	?	.	O	?	_	0	SENT_139	[p8l1492t1965r1690b2013],

1	a	DT	O	a	_	0	SENT_140	[p8l6t3409r23b3428],
2	For	IN	O	for	dep	1	SENT_140	[p8l66t3403r114b3428],
3	both	DT	O	both	preconj	4	SENT_140	[p8l127t3403r188b3428],
4	losartan	NN	O	losartan	pobj	2	SENT_140	[p8l204t3403r318b3428],
5	and	CC	O	and	_	0	SENT_140	[p8l333t3403r386b3428],
6	EXP3174	NN	O	exp3174	conj_and	4	SENT_140	[p8l402t3403r547b3428],
7	.	.	O	.	_	0	SENT_140	[p8l402t3403r547b3428],

1	b	NN	O	b	_	0	SENT_141	[p8l6t3450r21b3475],
2	For	IN	O	for	dep	1	SENT_141	[p8l65t3450r113b3475],
3	losartan	NN	O	losartan	pobj	2	SENT_141	[p8l126t3450r249b3475],
4	.	.	O	.	_	0	SENT_141	[p8l126t3450r249b3475],

1	c	NN	O	c	_	0	SENT_142	[p8l6t3503r21b3522],
2	For	IN	O	for	dep	1	SENT_142	[p8l66t3497r114b3522],
3	EXP3174	NN	O	exp3174	pobj	2	SENT_142	[p8l128t3497r273b3522],
4	.	.	O	.	_	0	SENT_142	[p8l128t3497r273b3522],

1	CE	NN	O	ce	_	0	SENT_143	[p8l6t3542r50b3567],
2	=	JJ	O	=	amod	4	SENT_143	[p8l66t3553r84b3563],
3	collision	NN	O	collision	nn	4	SENT_143	[p8l100t3543r216b3567],
4	energy	NN	O	energy	dep	1	SENT_143	[p8l233t3549r340b3574],
5	;	:	O	;	_	0	SENT_143	[p8l233t3549r340b3574],
6	CXP	NN	O	cxp	dep	1	SENT_143	[p8l359t3542r425b3567],
7	=	JJ	O	=	amod	11	SENT_143	[p8l441t3553r459b3563],
8	collision	NN	O	collision	nn	11	SENT_143	[p8l475t3543r591b3567],
9	cell	NN	O	cell	nn	11	SENT_143	[p8l608t3543r655b3567],
10	exit	NN	O	exit	nn	11	SENT_143	[p8l673t3543r723b3567],
11	potential	NN	O	potential	dep	6	SENT_143	[p8l739t3543r870b3574],
12	;	:	O	;	_	0	SENT_143	[p8l739t3543r870b3574],
13	DP	NN	O	dp	dep	1	SENT_143	[p8l889t3543r932b3567],
14	=	JJ	O	=	amod	13	SENT_143	[p8l949t3553r966b3563],
15	declustering	VBG	O	decluster	partmod	13	SENT_143	[p8l983t3543r1160b3574],
16	potential	NN	O	potential	dobj	15	SENT_143	[p8l1178t3543r1309b3574],
17	;	:	O	;	_	0	SENT_143	[p8l1178t3543r1309b3574],
18	EP	NN	O	ep	dep	13	SENT_143	[p8l1328t3543r1369b3567],
19	=	JJ	O	=	amod	21	SENT_143	[p8l1386t3553r1403b3563],
20	entrance	NN	O	entrance	nn	21	SENT_143	[p8l1420t3544r1547b3567],
21	potential	NN	O	potential	dep	18	SENT_143	[p8l1564t3543r1695b3574],
22	;	:	O	;	_	0	SENT_143	[p8l1564t3543r1695b3574],
23	GS1	NN	O	gs1	dep	18	SENT_143	[p8l1713t3542r1773b3568],
24	=	JJ	O	=	amod	26	SENT_143	[p8l1794t3553r1812b3563],
25	nebulizer	NN	O	nebulizer	nn	26	SENT_143	[p8l1829t3543r1963b3567],
26	gas	NN	O	gas	dep	23	SENT_143	[p8l1978t3549r2037b3574],
27	;	:	O	;	_	0	SENT_143	[p8l1978t3549r2037b3574],
28	GS2	NN	O	gs2	dep	18	SENT_143	[p8l2055t3542r2119b3568],
29	=	JJ	O	=	amod	31	SENT_143	[p8l2137t3553r2154b3563],
30	turbo	NN	O	turbo	nn	31	SENT_143	[p8l6t3589r80b3613],
31	gas	NN	O	gas	dep	28	SENT_143	[p8l97t3595r157b3620],
32	;	:	O	;	_	0	SENT_143	[p8l97t3595r157b3620],
33	HPLC	NN	O	hplc	dep	18	SENT_143	[p8l172t3588r260b3613],
34	=	JJ	O	=	amod	37	SENT_143	[p8l273t3599r290b3609],
35	high-performance	JJ	O	high-performance	amod	37	SENT_143	[p8l304t3588r562b3620],
36	liquid	JJ	O	liquid	amod	37	SENT_143	[p8l577t3589r651b3620],
37	chromatography	NN	O	chromatography	dep	33	SENT_143	[p8l665t3589r911b3620],
38	;	:	O	;	_	0	SENT_143	[p8l665t3589r911b3620],
39	LLQ	NN	O	llq	npadvmod	40	SENT_143	[p8l927t3588r990b3614],
40	=	JJ	O	=	amod	42	SENT_143	[p8l1004t3599r1021b3609],
41	lower	JJR	O	lower	amod	42	SENT_143	[p8l1035t3589r1113b3613],
42	limit	NN	O	limit	dep	18	SENT_143	[p8l1126t3589r1183b3613],
43	of	IN	O	of	_	0	SENT_143	[p8l1195t3588r1222b3613],
44	quantification	NN	O	quantification	prep_of	42	SENT_143	[p8l1234t3588r1436b3620],
45	;	:	O	;	_	0	SENT_143	[p8l1234t3588r1436b3620],
46	MS	NN	O	m	dep	18	SENT_143	[p8l1452t3588r1499b3614],
47	=	JJ	O	=	amod	49	SENT_143	[p8l1512t3599r1530b3609],
48	mass	NN	O	mass	nn	49	SENT_143	[p8l1544t3595r1620b3613],
49	spectrometry	NN	O	spectrometry	dep	46	SENT_143	[p8l1633t3590r1832b3620],
50	;	:	O	;	_	0	SENT_143	[p8l1633t3590r1832b3620],
51	Q	NNP	O	Q	dep	18	SENT_143	[p8l1847t3588r1870b3614],
52	=	JJ	O	=	amod	53	SENT_143	[p8l1884t3599r1901b3609],
53	quadrupole	NN	O	quadrupole	dep	51	SENT_143	[p8l1914t3589r2086b3620],
54	;	:	O	;	_	0	SENT_143	[p8l1914t3589r2086b3620],
55	R	NN	O	r	dep	18	SENT_143	[p8l2102t3589r2123b3613],
56	=	JJ	O	=	amod	58	SENT_143	[p8l2137t3599r2154b3609],
57	correlation	NN	O	correlation	nn	58	SENT_143	[p8l6t3635r159b3660],
58	coefficient	NN	O	coefficient	dep	55	SENT_143	[p8l250t3635r406b3664],
59	;	:	O	;	_	0	SENT_143	[p8l250t3635r406b3664],
60	SPE	NN	O	spe	dep	18	SENT_143	[p8l7t3666r68b3690],
61	=	JJ	O	=	amod	64	SENT_143	[p8l81t3677r98b3686],
62	solid	JJ	O	solid	amod	64	SENT_143	[p8l111t3667r173b3690],
63	phase	NN	O	phase	nn	64	SENT_143	[p8l187t3667r271b3696],
64	extraction	NN	O	extraction	dep	60	SENT_143	[p8l284t3667r426b3694],
65	;	:	O	;	_	0	SENT_143	[p8l284t3667r426b3694],
66	ULQ	NN	O	ulq	nn	69	SENT_143	[p8l442t3666r505b3691],
67	=	JJ	O	=	amod	69	SENT_143	[p8l518t3677r535b3686],
68	upper	JJ	O	upper	amod	69	SENT_143	[p8l549t3672r628b3696],
69	limit	NN	O	limit	dep	18	SENT_143	[p8l641t3666r694b3690],
70	of	IN	O	of	_	0	SENT_143	[p8l707t3666r732b3690],
71	quantification	NN	O	quantification	prep_of	69	SENT_143	[p8l744t3666r936b3696],
72	.	.	O	.	_	0	SENT_143	[p8l744t3666r936b3696],

1	©	RB	O	©	advmod	2	SENT_144	[p9l6t46r24b63],
2	2008	CD	DATE	2008	_	0	SENT_144	[p9l33t44r87b63],
3	Adis	NNP	ORGANIZATION	Adis	nn	5	SENT_144	[p9l95t44r145b63],
4	Data	NNP	ORGANIZATION	Data	nn	5	SENT_144	[p9l155t44r213b63],
5	Information	NNP	ORGANIZATION	Information	dep	2	SENT_144	[p9l223t44r359b63],
6	BV	NN	ORGANIZATION	bv	dep	5	SENT_144	[p9l369t44r404b63],
7	.	.	O	.	_	0	SENT_144	[p9l369t44r404b63],

1	All	DT	O	all	det	2	SENT_145	[p9l414t44r441b63],
2	rights	NNS	O	rights	nsubj	3	SENT_145	[p9l451t44r512b68],
3	reserved	VBN	O	reserve	_	0	SENT_145	[p9l521t44r629b74],
4	.	.	O	.	_	0	SENT_145	[p9l521t44r629b74],

1	Clin	NNP	O	Clin	nn	4	SENT_146	[p9l1890t44r1933b63],
2	Ph	NN	O	ph	nn	4	SENT_146	[p9l1943t44r1970b63],
3	QQQQ	NN	O	qqqq	nn	4	SENT_146	[p9l1973t49r2036b63],
4	cokinet	NN	O	cokinet	dep	11	SENT_146	[p9l2038t44r2127b63],
5	2008	CD	DATE	2008	num	7	SENT_146	[p9l6t73r66b95],
6	;	:	O	;	_	0	SENT_146	[p9l6t73r66b95],
7	47	CD	NUMBER	47	dep	4	SENT_146	[p9l75t74r102b93],
8	(	CD	NUMBER	(	dep	11	SENT_146	[p9l112t74r141b96],
9	5	CD	NUMBER	5	num	11	SENT_146	[p9l112t74r141b96],
10	)	NN	O	)	nn	11	SENT_146	[p9l112t74r141b96],
11	Determinants	NNS	O	determinant	dep	14	SENT_146	[p9l153t69r352b94],
12	of	IN	O	of	_	0	SENT_146	[p9l364t68r393b94],
13	Torasemide	NNP	O	Torasemide	prep_of	11	SENT_146	[p9l403t68r576b94],
14	PK	NN	O	pk	_	0	SENT_146	[p9l587t69r631b93],
15	327	CD	NUMBER	327	num	14	SENT_146	[p9l6t104r56b128],

1	obtained	VBN	O	obtain	_	0	SENT_147	[p9l9t306r285b363],
2	directly	RB	O	directly	advmod	1	SENT_147	[p9l307t306r551b380],
3	from	IN	O	from	_	0	SENT_147	[p9l573t306r729b363],
4	the	DT	O	the	det	6	SENT_147	[p9l749t306r845b363],
5	observed	VBN	O	observe	amod	6	SENT_147	[p9l868t306r1158b363],
6	data	NNS	O	datum	prep_from	1	SENT_147	[p9l1179t306r1327b363],
7	.	.	O	.	_	0	SENT_147	[p9l1179t306r1327b363],

1	The	DT	O	the	det	2	SENT_148	[p9l1353t307r1476b363],
2	t1/2	NN	O	t1/2	nsubjpass	4	SENT_148	[p9l1497t315r1568b371],
3	was	VBD	O	be	auxpass	4	SENT_148	[p9l1589t324r1711b363],
4	calculated	VBN	O	calculate	_	0	SENT_148	[p9l1734t306r2061b363],
5	as	IN	O	as	_	0	SENT_148	[p9l2083t324r2144b363],
6	ln2/M	NN	O	ln2/m	prep_as	4	SENT_148	[p9l8t404r222b475],
7	,	,	O	,	_	0	SENT_148	[p9l8t404r222b475],
8	where	WRB	O	where	advmod	12	SENT_148	[p9l254t408r449b465],
9	7	CD	NUMBER	7	num	10	SENT_148	[p9l479t404r548b472],
10	»	NN	O	»	nsubj	12	SENT_148	[p9l479t404r548b472],
11	;	:	O	;	_	0	SENT_148	[p9l479t404r548b472],
12	denotes	VBZ	O	denote	rcmod	6	SENT_148	[p9l578t408r821b465],
13	the	DT	O	the	det	14	SENT_148	[p9l851t408r947b465],
14	time	NN	O	time	dobj	12	SENT_148	[p9l976t408r1118b465],
15	constant	JJ	O	constant	amod	14	SENT_148	[p9l1147t417r1415b465],
16	of	IN	O	of	_	0	SENT_148	[p9l1443t408r1513b465],
17	the	DT	O	the	det	19	SENT_148	[p9l1536t408r1633b465],
18	terminal	JJ	O	terminal	amod	19	SENT_148	[p9l1661t408r1929b465],
19	slope	NN	O	slope	prep_of	14	SENT_148	[p9l1960t408r2142b482],
20	.	.	O	.	_	0	SENT_148	[p9l1960t408r2142b482],

1	The	DT	O	the	det	2	SENT_149	[p9l8t508r132b565],
2	AUC24	NN	O	auc24	nsubjpass	6	SENT_149	[p9l152t509r451b581],
3	,	,	O	,	_	0	SENT_149	[p9l152t509r451b581],
4	ss	NN	O	ss	appos	2	SENT_149	[p9l152t509r451b581],
5	was	VBD	O	be	auxpass	6	SENT_149	[p9l474t526r595b565],
6	calculated	VBN	O	calculate	_	0	SENT_149	[p9l618t508r945b565],
7	using	VBG	O	use	xcomp	6	SENT_149	[p9l964t508r1137b582],
8	the	DT	O	the	det	11	SENT_149	[p9l1159t508r1255b565],
9	linear	JJ	O	linear	amod	11	SENT_149	[p9l1276t508r1460b565],
10	trapezoidal	JJ	O	trapezoidal	amod	11	SENT_149	[p9l1479t508r1837b582],
11	rule	NN	O	rule	dobj	7	SENT_149	[p9l1857t508r1998b565],
12	.	.	O	.	_	0	SENT_149	[p9l1857t508r1998b565],

1	The	DT	O	the	det	7	SENT_150	[p9l2022t508r2146b565],
2	apparent	JJ	O	apparent	amod	7	SENT_150	[p9l10t618r286b683],
3	oral	JJ	O	oral	amod	7	SENT_150	[p9l312t609r435b666],
4	clearance	NN	O	clearance	nn	7	SENT_150	[p9l462t609r765b666],
5	(	CD	NUMBER	(	num	7	SENT_150	[p9l795t610r1013b679],
6	CL/F	NN	O	cl/f	nn	7	SENT_150	[p9l795t610r1013b679],
7	)	NN	O	)	nsubjpass	9	SENT_150	[p9l795t610r1013b679],
8	was	VBD	O	be	auxpass	9	SENT_150	[p9l1043t627r1164b666],
9	calculated	VBN	O	calculate	_	0	SENT_150	[p9l1193t609r1520b666],
10	as	IN	O	as	_	0	SENT_150	[p9l1547t627r1609b666],
11	dose/AUC24	NN	O	dose/auc24	prep_as	9	SENT_150	[p9l1638t609r2125b682],
12	,	,	O	,	_	0	SENT_150	[p9l1638t609r2125b682],
13	Ss	NNS	O	ss	appos	11	SENT_150	[p9l1638t609r2125b682],
14	.	.	O	.	_	0	SENT_150	[p9l1638t609r2125b682],

1	Statistics	NNS	O	statistics	_	0	SENT_151	[p9l105t816r396b872],

1	The	DT	O	the	det	2	SENT_152	[p9l105t993r229b1050],
2	results	NNS	O	result	nsubjpass	4	SENT_152	[p9l253t993r461b1050],
3	are	VBP	O	be	auxpass	4	SENT_152	[p9l490t1011r584b1050],
4	expressed	VBN	O	express	_	0	SENT_152	[p9l610t993r928b1066],
5	as	IN	O	as	_	0	SENT_152	[p9l953t1011r1015b1050],
6	the	DT	O	the	det	7	SENT_152	[p9l1041t993r1138b1050],
7	mean	NN	O	mean	prep_as	4	SENT_152	[p9l1163t1011r1337b1050],
8	i	FW	O	i	dep	7	SENT_152	[p9l1361t996r1404b1049],
9	the	DT	O	the	det	11	SENT_152	[p9l1428t993r1525b1050],
10	standard	JJ	O	standard	amod	11	SENT_152	[p9l1552t993r1823b1050],
11	deviation	NN	O	deviation	dep	8	SENT_152	[p9l1848t993r2146b1050],
12	and	CC	O	and	_	0	SENT_152	[p9l10t1093r140b1160],
13	,	,	O	,	_	0	SENT_152	[p9l10t1093r140b1160],
14	for	IN	O	for	dep	7	SENT_152	[p9l164t1093r257b1150],
15	clarity	NN	O	clarity	pobj	14	SENT_152	[p9l277t1093r499b1167],
16	,	,	O	,	_	0	SENT_152	[p9l277t1093r499b1167],
17	as	IN	O	as	_	0	SENT_152	[p9l524t1111r586b1150],
18	the	DT	O	the	det	19	SENT_152	[p9l608t1093r705b1150],
19	mean	NN	O	mean	prep_as	14	SENT_152	[p9l726t1111r900b1150],
20	i	FW	O	i	dep	19	SENT_152	[p9l920t1096r963b1149],
21	the	DT	O	the	det	23	SENT_152	[p9l983t1093r1080b1150],
22	standard	JJ	O	standard	amod	23	SENT_152	[p9l1104t1093r1374b1150],
23	error	NN	O	error	dep	20	SENT_152	[p9l1395t1111r1551b1150],
24	of	IN	O	of	_	0	SENT_152	[p9l1571t1093r1641b1150],
25	the	DT	O	the	det	26	SENT_152	[p9l1656t1093r1752b1150],
26	mean	NN	O	mean	prep_of	14	SENT_152	[p9l1774t1111r1947b1150],
27	in	IN	O	in	_	0	SENT_152	[p9l1968t1093r2029b1149],
28	the	DT	O	the	det	29	SENT_152	[p9l2049t1093r2146b1150],
29	figures	NNS	O	figure	prep_in	26	SENT_152	[p9l8t1193r247b1267],
30	.	.	O	.	_	0	SENT_152	[p9l8t1193r247b1267],

1	The	DT	O	the	det	2	SENT_153	[p9l288t1193r411b1250],
2	contribution	NN	O	contribution	nsubjpass	19	SENT_153	[p9l450t1193r843b1250],
3	of	IN	O	of	_	0	SENT_153	[p9l881t1193r951b1250],
4	CYP2C9	NN	O	cyp2c9	nn	7	SENT_153	[p9l987t1194r1265b1250],
5	and	CC	O	and	_	0	SENT_153	[p9l1303t1193r1417b1250],
6	SLCOIBI	NN	O	slcoibus	nn	7	SENT_153	[p9l1453t1194r1774b1250],
7	SNPs	NNS	O	snp	prep_of	2	SENT_153	[p9l1819t1194r1993b1250],
8	and	CC	O	and	_	0	SENT_153	[p9l2033t1193r2147b1250],
9	gender	NN	O	gender	nsubjpass	19	SENT_153	[p9l9t1293r228b1367],
10	to	TO	O	to	_	0	SENT_153	[p9l262t1302r322b1350],
11	the	DT	O	the	det	12	SENT_153	[p9l358t1293r455b1350],
12	variability	NN	O	variability	prep_to	9	SENT_153	[p9l491t1293r822b1367],
13	in	IN	O	in	_	0	SENT_153	[p9l858t1293r918b1349],
14	the	DT	O	the	det	15	SENT_153	[p9l954t1293r1050b1350],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	12	SENT_153	[p9l1085t1293r1655b1366],
16	of	IN	O	of	_	0	SENT_153	[p9l1693t1293r1763b1350],
17	torasemide	NN	O	torasemide	prep_of	15	SENT_153	[p9l1793t1293r2146b1350],
18	was	VBD	O	be	auxpass	19	SENT_153	[p9l8t1411r130b1450],
19	investigated	VBN	O	investigate	_	0	SENT_153	[p9l163t1393r553b1467],
20	by	IN	O	by	_	0	SENT_153	[p9l583t1393r662b1467],
21	use	NN	O	use	agent	19	SENT_153	[p9l694t1411r800b1450],
22	of	IN	O	of	_	0	SENT_153	[p9l833t1393r903b1450],
23	factorial	JJ	O	factorial	amod	24	SENT_153	[p9l929t1393r1196b1450],
24	ANOVA	NNP	O	ANOVA	prep_of	21	SENT_153	[p9l1228t1394r1534b1450],
25	.	.	O	.	_	0	SENT_153	[p9l1228t1394r1534b1450],

1	Post	NNP	O	Post	nsubj	2	SENT_154	[p9l1569t1393r1856b1450],
2	—	VBD	O	—	_	0	SENT_154	[p9l1569t1393r1856b1450],
3	hoc	FW	O	hoc	dobj	2	SENT_154	[p9l1569t1393r1856b1450],
4	analysis	NN	O	analysis	nsubjpass	10	SENT_154	[p9l1889t1393r2144b1467],
5	with	IN	O	with	_	0	SENT_154	[p9l8t1493r150b1550],
6	the	DT	O	the	det	8	SENT_154	[p9l172t1493r268b1550],
7	Bonferroni	NNP	LOCATION	Bonferroni	nn	8	SENT_154	[p9l291t1493r644b1550],
8	test	NN	O	test	prep_with	4	SENT_154	[p9l667t1502r778b1550],
9	was	VBD	O	be	auxpass	10	SENT_154	[p9l799t1511r921b1550],
10	used	VBN	O	use	rcmod	3	SENT_154	[p9l945t1493r1092b1550],
11	to	TO	O	to	aux	12	SENT_154	[p9l1114t1502r1173b1550],
12	compare	VB	O	compare	xcomp	10	SENT_154	[p9l1197t1511r1473b1566],
13	CYP2C9	NN	O	cyp2c9	nn	14	SENT_154	[p9l1500t1494r1778b1550],
14	genotypes	NNS	O	genotype	dobj	12	SENT_154	[p9l1801t1502r2141b1567],
15	.	.	O	.	_	0	SENT_154	[p9l1801t1502r2141b1567],

1	The	DT	O	the	det	5	SENT_155	[p9l8t1593r132b1650],
2	CYP2C9	NN	O	cyp2c9	nn	5	SENT_155	[p9l166t1594r444b1651],
3	and	CC	O	and	_	0	SENT_155	[p9l476t1593r589b1650],
4	SLCOIBI	NN	O	slcoibus	nn	5	SENT_155	[p9l619t1594r940b1650],
5	SNPS	NNS	O	snp	nsubjpass	9	SENT_155	[p9l978t1594r1152b1650],
6	and	CC	O	and	_	0	SENT_155	[p9l1186t1593r1300b1650],
7	gender	NN	O	gender	conj_and	5	SENT_155	[p9l1330t1593r1550b1667],
8	were	VBD	O	be	auxpass	9	SENT_155	[p9l1579t1611r1733b1650],
9	put	VBN	O	put	_	0	SENT_155	[p9l1763t1602r1866b1667],
10	into	IN	O	into	_	0	SENT_155	[p9l1895t1593r2018b1650],
11	the	DT	O	the	det	12	SENT_155	[p9l2050t1593r2146b1650],
12	model	NN	O	model	prep_into	9	SENT_155	[p9l8t1693r208b1750],
13	as	IN	O	as	_	0	SENT_155	[p9l239t1711r300b1750],
14	independent	JJ	O	independent	amod	15	SENT_155	[p9l331t1693r726b1766],
15	variables	NNS	O	variable	prep_as	12	SENT_155	[p9l754t1693r1060b1750],
16	.	.	O	.	_	0	SENT_155	[p9l754t1693r1060b1750],

1	The	DT	O	the	det	2	SENT_156	[p9l1093t1693r1217b1750],
2	equality	NN	O	equality	nsubjpass	7	SENT_156	[p9l1246t1693r1504b1767],
3	of	IN	O	of	_	0	SENT_156	[p9l1534t1693r1604b1750],
4	group	NN	O	group	nn	5	SENT_156	[p9l1628t1711r1813b1767],
5	variances	NNS	O	variance	prep_of	2	SENT_156	[p9l1843t1693r2145b1750],
6	was	VBD	O	be	auxpass	7	SENT_156	[p9l8t1811r130b1850],
7	tested	VBN	O	test	_	0	SENT_156	[p9l172t1793r360b1850],
8	with	IN	O	with	_	0	SENT_156	[p9l401t1793r543b1850],
9	the	DT	O	the	det	11	SENT_156	[p9l583t1793r680b1850],
10	Levene	NNP	PERSON	Levene	nn	11	SENT_156	[p9l721t1795r957b1850],
11	statistic	NN	O	statistic	prep_with	7	SENT_156	[p9l1001t1793r1260b1850],
12	.	.	O	.	_	0	SENT_156	[p9l1001t1793r1260b1850],

1	Statistical	JJ	O	statistical	amod	2	SENT_157	[p9l1308t1793r1623b1850],
2	comparison	NN	O	comparison	nsubjpass	20	SENT_157	[p9l1664t1793r2040b1866],
3	of	IN	O	of	_	0	SENT_157	[p9l2082t1793r2152b1850],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_157	[p9l7t1893r545b1967],
5	variables	NNS	O	variable	prep_of	2	SENT_157	[p9l574t1893r863b1950],
6	of	IN	O	of	_	0	SENT_157	[p9l893t1893r963b1950],
7	noncarriers	NNS	O	noncarrier	prep_of	5	SENT_157	[p9l985t1893r1346b1950],
8	versus	CC	O	versus	prep	7	SENT_157	[p9l1376t1911r1579b1950],
9	homo/heterozygous	JJ	O	homo/heterozygous	amod	10	SENT_157	[p9l1608t1893r2144b1967, p9l9t2011r157b2067],
10	carriers	NNS	O	carrier	dep	8	SENT_157	[p9l186t1993r424b2050],
11	of	IN	O	of	_	0	SENT_157	[p9l453t1993r523b2050],
12	an	DT	O	a	det	13	SENT_157	[p9l545t2011r618b2050],
13	SNP	NN	O	snp	prep_of	10	SENT_157	[p9l646t1994r791b2050],
14	or	CC	O	or	_	0	SENT_157	[p9l817t2011r883b2050],
15	female	JJ	O	female	dep	8	SENT_157	[p9l908t1993r1126b2050],
16	versus	CC	O	versus	prep	15	SENT_157	[p9l1152t2011r1355b2050],
17	male	JJ	O	male	amod	18	SENT_157	[p9l1383t1993r1538b2050],
18	patients	NNS	O	patient	dep	16	SENT_157	[p9l1564t1993r1813b2066],
19	was	VBD	O	be	auxpass	20	SENT_157	[p9l1841t2011r1963b2050],
20	done	VBN	O	do	_	0	SENT_157	[p9l1992t1993r2146b2050],
21	by	IN	O	by	_	0	SENT_157	[p9l7t2093r86b2167],
22	use	NN	O	use	agent	20	SENT_157	[p9l106t2111r212b2150],
23	of	IN	O	of	_	0	SENT_157	[p9l234t2093r304b2150],
24	the	DT	O	the	det	25	SENT_157	[p9l318t2093r415b2150],
25	Mann	NNP	PERSON	Mann	prep_of	22	SENT_157	[p9l435t2093r928b2167],
26	.	.	O	.	_	0	SENT_157	[p9l435t2093r928b2167],

1	—	NN	O	—	_	0	SENT_158	[p9l435t2093r928b2167],
2	.	.	O	.	_	0	SENT_158	[p9l435t2093r928b2167],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_159	[p9l435t2093r928b2167],
2	U-test	NNP	O	U-test	_	0	SENT_159	[p9l948t2095r1161b2150],
3	.	.	O	.	_	0	SENT_159	[p9l948t2095r1161b2150],

1	Comparison	NN	O	comparison	nsubjpass	14	SENT_160	[p9l1186t2093r1579b2166],
2	of	IN	O	of	_	0	SENT_160	[p9l1601t2093r1670b2150],
3	the	DT	O	the	det	5	SENT_160	[p9l1685t2093r1781b2150],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_160	[p9l1801t2093r2144b2166, p9l7t2193r225b2250],
5	data	NNS	O	datum	prep_of	1	SENT_160	[p9l257t2193r391b2250],
6	of	IN	O	of	_	0	SENT_160	[p9l420t2193r490b2250],
7	torasemide	NN	O	torasemide	prep_of	5	SENT_160	[p9l515t2193r868b2250],
8	before	IN	O	before	_	0	SENT_160	[p9l897t2193r1103b2250],
9	and	CC	O	and	_	0	SENT_160	[p9l1135t2193r1248b2250],
10	during	IN	O	during	_	0	SENT_160	[p9l1279t2193r1486b2267],
11	ARB	NN	O	arb	nn	12	SENT_160	[p9l1517t2194r1677b2249],
12	comedication	NN	O	comedication	prep_during	7	SENT_160	[p9l1713t2193r2147b2250],
13	was	VBD	O	be	auxpass	14	SENT_160	[p9l8t2311r130b2350],
14	made	VBN	O	make	_	0	SENT_160	[p9l192t2293r365b2350],
15	with	IN	O	with	_	0	SENT_160	[p9l426t2293r568b2350],
16	the	DT	O	the	det	25	SENT_160	[p9l628t2293r724b2350],
17	nonparametric	JJ	O	nonparametric	amod	25	SENT_160	[p9l785t2293r1250b2366],
18	Wilcoxon	NNP	PERSON	Wilcoxon	nsubj	19	SENT_160	[p9l1310t2293r1629b2350],
19	matched	VBD	O	match	ccomp	17	SENT_160	[p9l1690t2293r2144b2366],
20	—	CD	NUMBER	—	num	21	SENT_160	[p9l1690t2293r2144b2366],
21	pairs	NNS	O	pair	nsubj	22	SENT_160	[p9l1690t2293r2144b2366],
22	signed	VBD	O	sign	ccomp	19	SENT_160	[p9l11t2393r418b2467],
23	—	CD	NUMBER	—	num	24	SENT_160	[p9l11t2393r418b2467],
24	ranks	NNS	O	rank	dobj	22	SENT_160	[p9l11t2393r418b2467],
25	test	NN	O	test	prep_with	14	SENT_160	[p9l443t2402r569b2450],
26	.	.	O	.	_	0	SENT_160	[p9l443t2402r569b2450],

1	Correlations	NNS	O	correlation	nsubjpass	3	SENT_161	[p9l597t2393r993b2450],
2	were	VBD	O	be	auxpass	3	SENT_161	[p9l1018t2411r1172b2450],
3	investigated	VBN	O	investigate	_	0	SENT_161	[p9l1195t2393r1586b2467],
4	with	IN	O	with	_	0	SENT_161	[p9l1608t2393r1750b2450],
5	the	DT	O	the	det	8	SENT_161	[p9l1772t2393r1869b2450],
6	Pearson	NNP	PERSON	Pearson	nn	8	SENT_161	[p9l1892t2395r2147b2450],
7	correlation	NN	O	correlation	nn	8	SENT_161	[p9l9t2493r357b2550],
8	test	NN	O	test	prep_with	3	SENT_161	[p9l384t2502r511b2550],
9	.	.	O	.	_	0	SENT_161	[p9l384t2502r511b2550],

1	The	DT	O	the	det	2	SENT_162	[p9l542t2493r666b2550],
2	impact	NN	O	impact	nsubjpass	10	SENT_162	[p9l694t2493r913b2567],
3	of	IN	O	of	_	0	SENT_162	[p9l941t2493r1011b2550],
4	CYPZC9	NN	O	cypzc9	nn	5	SENT_162	[p9l1037t2494r1315b2550],
5	genotypes	NNS	O	genotype	prep_of	2	SENT_162	[p9l1343t2502r1666b2567],
6	on	IN	O	on	_	0	SENT_162	[p9l1697t2511r1774b2550],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_162	[p9l1801t2493r2144b2566, p9l7t2593r225b2650],
8	parameters	NNS	O	parameter	prep_on	5	SENT_162	[p9l301t2602r654b2667],
9	was	VBD	O	be	auxpass	10	SENT_162	[p9l732t2611r854b2650],
10	analysed	VBN	O	analyse	_	0	SENT_162	[p9l933t2593r1214b2667],
11	with	IN	O	with	_	0	SENT_162	[p9l1290t2593r1432b2650],
12	the	DT	O	the	det	14	SENT_162	[p9l1508t2593r1604b2650],
13	nonparametric	JJ	O	nonparametric	amod	14	SENT_162	[p9l1681t2593r2145b2667],
14	Jonckheere	NNP	O	Jonckheere	prep_with	10	SENT_162	[p9l8t2693r669b2766],
15	.	.	O	.	_	0	SENT_162	[p9l8t2693r669b2766],

1	—	NN	O	—	_	0	SENT_163	[p9l8t2693r669b2766],
2	.	.	O	.	_	0	SENT_163	[p9l8t2693r669b2766],

1	Terpstra	NNP	PERSON	Terpstra	nn	3	SENT_164	[p9l8t2693r669b2766],
2	trend	NN	O	trend	nn	3	SENT_164	[p9l709t2693r874b2750],
3	test	NN	O	test	_	0	SENT_164	[p9l914t2702r1042b2760],
4	,	,	O	,	_	0	SENT_164	[p9l914t2702r1042b2760],
5	with	IN	O	with	_	0	SENT_164	[p9l1086t2693r1228b2750],
6	a	DT	O	a	det	8	SENT_164	[p9l1270t2711r1304b2750],
7	predefined	JJ	O	predefined	amod	8	SENT_164	[p9l1342t2693r1689b2766],
8	order	NN	O	order	prep_with	3	SENT_164	[p9l1730t2693r1899b2750],
9	of	IN	O	of	_	0	SENT_164	[p9l1940t2693r2010b2750],
10	genotypes	NNS	O	genotype	prep_of	8	SENT_164	[p9l2046t2711r2144b2767, p9l8t2802r256b2867],
11	as	IN	O	as	mark	12	SENT_164	[p9l288t2811r350b2850],
12	follows	VBZ	O	follow	dep	10	SENT_164	[p9l381t2793r639b2850],
13	:	:	O	:	_	0	SENT_164	[p9l381t2793r639b2850],
14	*	CD	NUMBER	*	num	15	SENT_164	[p9l677t2794r872b2860],
15	l	NN	O	l	dep	3	SENT_164	[p9l677t2794r872b2860],
16	/	:	O	/	punct	18	SENT_164	[p9l677t2794r872b2860],
17	*	CD	NUMBER	*	num	18	SENT_164	[p9l677t2794r872b2860],
18	l	NN	O	l	dep	15	SENT_164	[p9l677t2794r872b2860],
19	,	,	O	,	_	0	SENT_164	[p9l677t2794r872b2860],
20	*	NN	O	*	appos	18	SENT_164	[p9l908t2794r1104b2860],
21	1	CD	NUMBER	1	num	20	SENT_164	[p9l908t2794r1104b2860],
22	/	:	O	/	punct	24	SENT_164	[p9l908t2794r1104b2860],
23	*	CD	NUMBER	*	num	24	SENT_164	[p9l908t2794r1104b2860],
24	2	CD	NUMBER	2	dep	15	SENT_164	[p9l908t2794r1104b2860],
25	,	,	O	,	_	0	SENT_164	[p9l908t2794r1104b2860],
26	*	CD	NUMBER	*	num	27	SENT_164	[p9l1140t2794r1334b2850],
27	1	CD	NUMBER	1	appos	24	SENT_164	[p9l1140t2794r1334b2850],
28	/	:	O	/	punct	24	SENT_164	[p9l1140t2794r1334b2850],
29	*	CD	NUMBER	*	num	30	SENT_164	[p9l1140t2794r1334b2850],
30	3	CD	NUMBER	3	dep	15	SENT_164	[p9l1140t2794r1334b2850],
31	.	.	O	.	_	0	SENT_164	[p9l1140t2794r1334b2850],

1	The	DT	O	the	det	2	SENT_165	[p9l1367t2793r1491b2850],
2	data	NNS	O	datum	nsubjpass	4	SENT_165	[p9l1520t2793r1654b2850],
3	were	VBD	O	be	auxpass	4	SENT_165	[p9l1682t2811r1836b2850],
4	analysed	VBN	O	analyse	_	0	SENT_165	[p9l1867t2793r2147b2867],
5	with	IN	O	with	_	0	SENT_165	[p9l8t2893r150b2950],
6	SPSS	NN	ORGANIZATION	spss	prep_with	4	SENT_165	[p9l182t2894r354b2950],
7	14.0	CD	NUMBER	14.0	dep	13	SENT_165	[p9l396t2894r527b2950],
8	for	IN	O	for	_	0	SENT_165	[p9l558t2893r652b2950],
9	Windows	NNP	MISC	Windows	prep_for	7	SENT_165	[p9l679t2893r987b2950],
10	software	NN	O	software	dep	13	SENT_165	[p9l1022t2893r1296b2950],
11	(	CD	NUMBER	(	num	10	SENT_165	[p9l1329t2894r1527b2963],
12	SPSS	NNP	ORGANIZATION	SPSS	nn	13	SENT_165	[p9l1329t2894r1527b2963],
13	Inc.	NNP	ORGANIZATION	Inc.	dep	6	SENT_165	[p9l1561t2895r1700b2960],
14	,	,	O	,	_	0	SENT_165	[p9l1561t2895r1700b2960],
15	Chicago	NNP	LOCATION	Chicago	appos	13	SENT_165	[p9l1734t2893r2019b2967],
16	,	,	O	,	_	0	SENT_165	[p9l1734t2893r2019b2967],
17	IL	NN	LOCATION	il	appos	13	SENT_165	[p9l2052t2895r2143b2960],
18	,	,	O	,	_	0	SENT_165	[p9l2052t2895r2143b2960],
19	USA	NNP	LOCATION	USA	appos	13	SENT_165	[p9l8t2994r211b3063],
20	)	CD	NUMBER	)	num	19	SENT_165	[p9l8t2994r211b3063],
21	.	.	O	.	_	0	SENT_165	[p9l8t2994r211b3063],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_166	[p9l238t2993r554b3050],
2	significance	NN	O	significance	nsubjpass	4	SENT_166	[p9l578t2993r965b3067],
3	was	VBD	O	be	auxpass	4	SENT_166	[p9l987t3011r1109b3050],
4	accepted	VBN	O	accept	_	0	SENT_166	[p9l1134t2993r1414b3066],
5	for	IN	O	for	_	0	SENT_166	[p9l1435t2993r1529b3050],
6	values	NNS	O	value	prep_for	4	SENT_166	[p9l1549t2993r1752b3050],
7	of	IN	O	of	_	0	SENT_166	[p9l1776t2993r1846b3050],
8	p	NN	O	p	prep_of	6	SENT_166	[p9l1861t3011r1899b3067],
9	<	JJR	O	<	dep	10	SENT_166	[p9l1922t3007r1964b3049],
10	0.05	CD	NUMBER	0.05	advmod	4	SENT_166	[p9l1987t2993r2142b3050],
11	.	.	O	.	_	0	SENT_166	[p9l1987t2993r2142b3050],

1	Results	NNS	O	result	_	0	SENT_167	[p9l109t3195r365b3256],

1	Bciseline	NNP	O	Bciseline	nn	3	SENT_168	[p9l109t3403r390b3458],
2	Stecidy-State	NNP	O	Stecidy-State	nn	3	SENT_168	[p9l416t3402r867b3471],
3	Phormocokinetics	NNP	O	Phormocokinetics	_	0	SENT_168	[p9l897t3403r1521b3458],
4	of	IN	O	of	_	0	SENT_168	[p9l1547t3403r1615b3458],
5	Toroisemide	NNP	O	Toroisemide	prep_of	3	SENT_168	[p9l1637t3403r2041b3458],

1	The	DT	O	the	det	3	SENT_169	[p9l105t3580r229b3637],
2	baseline	NN	O	baseline	nn	3	SENT_169	[p9l279t3580r544b3637],
3	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	7	SENT_169	[p9l595t3580r1163b3653],
4	of	IN	O	of	_	0	SENT_169	[p9l1218t3580r1288b3637],
5	torasemide	NN	O	torasemide	prep_of	3	SENT_169	[p9l1334t3580r1687b3637],
6	are	VBP	O	be	auxpass	7	SENT_169	[p9l1741t3598r1836b3637],
7	summarized	VBN	O	summarize	_	0	SENT_169	[p9l1890t3598r2144b3637, p9l7t3680r168b3737],
8	in	IN	O	in	_	0	SENT_169	[p9l187t3680r248b3736],
9	table	NN	O	table	prep_in	7	SENT_169	[p9l267t3680r422b3737],
10	III	CD	NUMBER	iii	num	9	SENT_169	[p9l441t3682r536b3737],
11	.	.	O	.	_	0	SENT_169	[p9l441t3682r536b3737],

1	The	DT	O	the	det	3	SENT_170	[p9l559t3680r683b3737],
2	dose-adjusted	JJ	O	dose-adjusted	amod	3	SENT_170	[p9l703t3680r1146b3753],
3	AUC24	NN	O	auc24	dep	8	SENT_170	[p9l1165t3680r1464b3753],
4	,	,	O	,	_	0	SENT_170	[p9l1165t3680r1464b3753],
5	ss	NN	O	ss	dep	8	SENT_170	[p9l1165t3680r1464b3753],
6	and	CC	O	and	_	0	SENT_170	[p9l1486t3680r1600b3737],
7	Cmax	NN	PERSON	cmax	dep	8	SENT_170	[p9l1619t3680r1782b3744],
8	varied	VBD	O	vary	_	0	SENT_170	[p9l1801t3680r2002b3737],
9	4.1	CD	NUMBER	4.1	num	10	SENT_170	[p9l2020t3680r2144b3737, p10l8t21r137b78],
10	fold	NN	O	fold	nsubj	8	SENT_170	[p9l2020t3680r2144b3737, p10l8t21r137b78],

1	(	NN	O	(	_	0	SENT_171	[p10l186t21r556b91],
2	coefficient	NN	O	coefficient	dep	1	SENT_171	[p10l186t21r556b91],
3	of	IN	O	of	_	0	SENT_171	[p10l604t21r673b78],
4	variation	NN	O	variation	prep_of	2	SENT_171	[p10l716t21r1002b78],
5	[	NN	O	[	nn	6	SENT_171	[p10l1055t21r1208b89],
6	CV	NN	O	cv	dep	1	SENT_171	[p10l1055t21r1208b89],
7	]	CD	PERCENT	]	number	8	SENT_171	[p10l1055t21r1208b89],
8	37.4	CD	PERCENT	37.4	num	9	SENT_171	[p10l1263t21r1493b91],
9	%	NN	PERCENT	%	dep	6	SENT_171	[p10l1263t21r1493b91],
10	)	CD	NUMBER	)	dep	1	SENT_171	[p10l1263t21r1493b91],
11	and	CC	O	and	_	0	SENT_171	[p10l1544t21r1658b78],
12	3.4-fold	RB	O	3.4-fold	advmod	10	SENT_171	[p10l1707t21r1962b78],
13	(	CD	NUMBER	(	num	14	SENT_171	[p10l2012t21r2146b91],
14	CV	NN	O	cv	dep	1	SENT_171	[p10l2012t21r2146b91],
15	43.4	CD	PERCENT	43.4	num	16	SENT_171	[p10l8t120r259b190],
16	%	NN	PERCENT	%	dep	1	SENT_171	[p10l8t120r259b190],
17	)	CD	NUMBER	)	dep	16	SENT_171	[p10l8t120r259b190],
18	,	,	O	,	_	0	SENT_171	[p10l8t120r259b190],
19	respectively	RB	O	respectively	advmod	16	SENT_171	[p10l286t120r693b193],
20	,	,	O	,	_	0	SENT_171	[p10l286t120r693b193],
21	between	IN	O	between	_	0	SENT_171	[p10l720t120r989b177],
22	individual	JJ	O	individual	amod	23	SENT_171	[p10l1013t120r1340b177],
23	subjects	NNS	O	subject	prep_between	1	SENT_171	[p10l1367t120r1639b193],
24	.	.	O	.	_	0	SENT_171	[p10l1367t120r1639b193],

1	In	IN	O	in	_	0	SENT_172	[p10l1668t122r1733b176],
2	the	DT	O	the	det	6	SENT_172	[p10l1757t120r1854b177],
3	factorial	JJ	O	factorial	amod	6	SENT_172	[p10l1879t120r2146b177],
4	ANOVA	NNP	O	ANOVA	nn	6	SENT_172	[p10l8t220r298b277],
5	(	CD	NUMBER	(	num	6	SENT_172	[p10l348t220r528b290],
6	table	NN	O	table	prep_in	39	SENT_172	[p10l348t220r528b290],
7	IV	CD	NUMBER	iv	num	8	SENT_172	[p10l576t221r704b290],
8	)	NN	O	)	dep	6	SENT_172	[p10l576t221r704b290],
9	,	,	O	,	_	0	SENT_172	[p10l576t221r704b290],
10	the	DT	O	the	det	25	SENT_172	[p10l754t220r851b277],
11	CYP2C9	NN	O	cyp2c9	nn	14	SENT_172	[p10l903t220r1181b277],
12	genotype	NN	O	genotype	nn	14	SENT_172	[p10l1229t229r1522b293],
13	(	NN	O	(	nn	14	SENT_172	[p10l1573t221r1635b293],
14	p	NN	O	p	npadvmod	23	SENT_172	[p10l1573t221r1635b293],
15	=	JJ	O	=	amod	14	SENT_172	[p10l1685t244r1726b266],
16	0.002	CD	NUMBER	0.002	num	17	SENT_172	[p10l1775t220r1999b290],
17	)	NN	O	)	tmod	15	SENT_172	[p10l1775t220r1999b290],
18	,	,	O	,	_	0	SENT_172	[p10l1775t220r1999b290],
19	the	DT	O	the	det	22	SENT_172	[p10l2050t220r2146b277],
20	SLCOIBI	NNP	O	SLCOIBI	nn	22	SENT_172	[p10l8t321r328b377],
21	c.	NN	O	c.	nn	22	SENT_172	[p10l365t320r687b377],
22	521T	NN	O	521t	appos	17	SENT_172	[p10l365t320r687b377],
23	>	JJR	O	>	amod	25	SENT_172	[p10l365t320r687b377],
24	C	NN	O	c	nn	25	SENT_172	[p10l365t320r687b377],
25	SNP	NN	O	snp	conj_and	6	SENT_172	[p10l720t320r865b377],
26	(	CD	NUMBER	(	num	27	SENT_172	[p10l897t321r958b393],
27	p	NN	O	p	npadvmod	28	SENT_172	[p10l897t321r958b393],
28	<	JJR	O	<	amod	25	SENT_172	[p10l990t334r1032b376],
29	0.0001	CD	NUMBER	0.0001	num	30	SENT_172	[p10l1062t320r1307b390],
30	)	NN	O	)	dep	25	SENT_172	[p10l1062t320r1307b390],
31	and	CC	O	and	_	0	SENT_172	[p10l1340t320r1454b377],
32	gender	NN	O	gender	nn	34	SENT_172	[p10l1484t320r1703b393],
33	(	NN	O	(	nn	34	SENT_172	[p10l1734t321r1795b393],
34	p	NN	O	p	conj_and	6	SENT_172	[p10l1734t321r1795b393],
35	<	JJR	O	<	tmod	34	SENT_172	[p10l1827t334r1868b376],
36	0.0001	CD	NUMBER	0.0001	num	37	SENT_172	[p10l1899t320r2144b390],
37	)	NN	O	)	npadvmod	38	SENT_172	[p10l1899t320r2144b390],
38	independently	RB	O	independently	advmod	35	SENT_172	[p10l8t420r464b493],
39	predicted	VBD	O	predict	_	0	SENT_172	[p10l484t420r786b493],
40	the	DT	O	the	det	42	SENT_172	[p10l805t420r902b477],
41	dose-adjusted	JJ	O	dose-adjusted	amod	42	SENT_172	[p10l923t420r1367b493],
42	AUC24	NN	O	auc24	nsubj	39	SENT_172	[p10l1386t420r1686b493],
43	,	,	O	,	_	0	SENT_172	[p10l1386t420r1686b493],
44	ss	NN	O	ss	appos	42	SENT_172	[p10l1386t420r1686b493],
45	of	IN	O	of	_	0	SENT_172	[p10l1708t420r1778b477],
46	torasemide	NN	O	torasemide	prep_of	44	SENT_172	[p10l1793t420r2146b477],
47	(	CD	NUMBER	(	num	46	SENT_172	[p10l11t521r304b594],
48	adjusted	VBN	O	adjust	partmod	46	SENT_172	[p10l11t521r304b594],
49	multiple	JJ	O	multiple	amod	50	SENT_172	[p10l331t521r599b594],
50	r2	NN	O	r2	nsubj	53	SENT_172	[p10l627t516r684b577],
51	=	JJ	O	=	amod	53	SENT_172	[p10l714t545r756b567],
52	0.85	CD	NUMBER	0.85	number	51	SENT_172	[p10l785t521r967b591],
53	)	NN	O	)	xcomp	48	SENT_172	[p10l785t521r967b591],
54	.	.	O	.	_	0	SENT_172	[p10l785t521r967b591],

1	Post	NNP	O	Post	nsubj	2	SENT_173	[p10l999t521r1286b578],
2	—	VBD	O	—	_	0	SENT_173	[p10l999t521r1286b578],
3	hoc	FW	O	hoc	dobj	2	SENT_173	[p10l999t521r1286b578],
4	analysis	NN	O	analysis	nsubj	5	SENT_173	[p10l1316t521r1571b594],
5	revealed	VBD	O	reveal	rcmod	3	SENT_173	[p10l1600t521r1874b578],
6	that	IN	O	that	complm	52	SENT_173	[p10l1902t521r2023b578],
7	the	DT	O	the	det	9	SENT_173	[p10l2049t521r2146b578],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_173	[p10l12t620r290b677],
9	*	NN	O	*	dep	52	SENT_173	[p10l313t620r487b677],
10	1	CD	NUMBER	1	dep	9	SENT_173	[p10l313t620r487b677],
11	/	:	O	/	punct	9	SENT_173	[p10l313t620r487b677],
12	*	CD	NUMBER	*	num	13	SENT_173	[p10l313t620r487b677],
13	3	CD	NUMBER	3	dep	39	SENT_173	[p10l313t620r487b677],
14	genotype	NN	O	genotype	nn	16	SENT_173	[p10l511t629r805b693],
15	(	NN	O	(	nn	16	SENT_173	[p10l827t621r889b693],
16	p	NN	O	p	dep	13	SENT_173	[p10l827t621r889b693],
17	=	JJ	O	=	amod	16	SENT_173	[p10l910t644r951b666],
18	0.001	CD	NUMBER	0.001	tmod	17	SENT_173	[p10l971t620r1144b677],
19	vs	CC	O	vs	_	0	SENT_173	[p10l1171t638r1238b677],
20	CYP2C9	CD	NUMBER	cyp2c9	num	21	SENT_173	[p10l1263t621r1542b677],
21	*	NN	O	*	conj_vs	16	SENT_173	[p10l1564t620r1787b690],
22	1	CD	NUMBER	1	dep	21	SENT_173	[p10l1564t620r1787b690],
23	/	:	O	/	punct	26	SENT_173	[p10l1564t620r1787b690],
24	*	CD	NUMBER	*	num	26	SENT_173	[p10l1564t620r1787b690],
25	1	CD	NUMBER	1	num	26	SENT_173	[p10l1564t620r1787b690],
26	)	NN	O	)	dep	22	SENT_173	[p10l1564t620r1787b690],
27	,	,	O	,	_	0	SENT_173	[p10l1564t620r1787b690],
28	but	CC	O	but	_	0	SENT_173	[p10l1807t620r1912b677],
29	not	RB	O	not	_	0	SENT_173	[p10l1929t629r2032b677],
30	the	DT	O	the	det	32	SENT_173	[p10l2050t620r2146b677],
31	CYP2C9	NN	O	cyp2c9	nn	32	SENT_173	[p10l12t720r290b777],
32	*	NN	O	*	conj_negcc	26	SENT_173	[p10l325t720r502b777],
33	1	CD	NUMBER	1	dep	26	SENT_173	[p10l325t720r502b777],
34	/	:	O	/	punct	26	SENT_173	[p10l325t720r502b777],
35	*	CD	NUMBER	*	dep	39	SENT_173	[p10l325t720r502b777],
36	2	CD	NUMBER	2	num	39	SENT_173	[p10l325t720r502b777],
37	genotype	NN	O	genotype	nn	39	SENT_173	[p10l534t729r828b793],
38	(	NN	O	(	nn	39	SENT_173	[p10l862t721r924b793],
39	p	NN	O	p	dep	45	SENT_173	[p10l862t721r924b793],
40	=	JJ	O	=	amod	41	SENT_173	[p10l957t744r998b766],
41	0.911	CD	NUMBER	0.911	dep	39	SENT_173	[p10l1031t720r1203b778],
42	vs	CC	O	vs	_	0	SENT_173	[p10l1241t738r1309b777],
43	CYP2C9	CD	NUMBER	cyp2c9	num	44	SENT_173	[p10l1346t721r1624b777],
44	*	NN	O	*	dep	39	SENT_173	[p10l1658t720r1881b790],
45	1	CD	NUMBER	1	dep	9	SENT_173	[p10l1658t720r1881b790],
46	/	:	O	/	punct	45	SENT_173	[p10l1658t720r1881b790],
47	*	CD	NUMBER	*	num	48	SENT_173	[p10l1658t720r1881b790],
48	1	CD	NUMBER	1	dep	45	SENT_173	[p10l1658t720r1881b790],
49	)	NN	O	)	dep	48	SENT_173	[p10l1658t720r1881b790],
50	,	,	O	,	_	0	SENT_173	[p10l1658t720r1881b790],
51	significantly	RB	O	significantly	advmod	52	SENT_173	[p10l1917t720r2144b793, p10l9t820r203b893],
52	inﬂuenced	VBD	O	inﬂuenced	ccomp	5	SENT_173	[p10l236t820r577b877],
53	the	DT	O	the	det	55	SENT_173	[p10l608t820r705b877],
54	dose-corrected	JJ	O	dose-corrected	amod	55	SENT_173	[p10l738t820r1213b877],
55	AUC24	NN	O	auc24	dobj	52	SENT_173	[p10l1245t820r1544b893],
56	,	,	O	,	_	0	SENT_173	[p10l1245t820r1544b893],
57	ss	NN	O	ss	appos	55	SENT_173	[p10l1245t820r1544b893],
58	of	IN	O	of	_	0	SENT_173	[p10l1579t820r1648b877],
59	torasemide	NN	O	torasemide	prep_of	57	SENT_173	[p10l1675t820r2045b877],
60	.	.	O	.	_	0	SENT_173	[p10l1675t820r2045b877],

1	In	IN	O	in	_	0	SENT_174	[p10l2081t822r2146b876],
2	patients	NNS	O	patient	prep_in	32	SENT_174	[p10l7t920r256b993],
3	with	IN	O	with	_	0	SENT_174	[p10l296t920r437b977],
4	the	DT	O	the	det	6	SENT_174	[p10l475t920r571b977],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_174	[p10l613t921r892b977],
6	*	NN	O	*	prep_with	2	SENT_174	[p10l932t920r1107b977],
7	1	CD	NUMBER	1	nsubj	32	SENT_174	[p10l932t920r1107b977],
8	/	:	O	/	punct	11	SENT_174	[p10l932t920r1107b977],
9	*	CD	NUMBER	*	num	11	SENT_174	[p10l932t920r1107b977],
10	3	CD	NUMBER	3	num	11	SENT_174	[p10l932t920r1107b977],
11	genotype	NN	O	genotype	dep	7	SENT_174	[p10l1149t928r1460b993],
12	,	,	O	,	_	0	SENT_174	[p10l1149t928r1460b993],
13	the	DT	O	the	det	15	SENT_174	[p10l1501t920r1597b977],
14	mean	NN	O	mean	nn	15	SENT_174	[p10l1635t938r1809b977],
15	AUC24	NN	O	auc24	appos	11	SENT_174	[p10l1846t920r2145b993],
16	,	,	O	,	_	0	SENT_174	[p10l1846t920r2145b993],
17	ss	NN	O	ss	appos	11	SENT_174	[p10l1846t920r2145b993],
18	was	VBD	O	be	cop	32	SENT_174	[p10l8t1038r130b1077],
19	46	CD	PERCENT	46	num	20	SENT_174	[p10l160t1020r303b1077],
20	%	NN	PERCENT	%	npadvmod	21	SENT_174	[p10l160t1020r303b1077],
21	greater	JJR	O	greater	amod	32	SENT_174	[p10l336t1028r560b1093],
22	than	IN	O	than	mark	29	SENT_174	[p10l587t1020r724b1077],
23	in	IN	O	in	dep	29	SENT_174	[p10l753t1020r813b1076],
24	subjects	NNS	O	subject	pobj	23	SENT_174	[p10l845t1020r1099b1093],
25	with	IN	O	with	_	0	SENT_174	[p10l1130t1020r1272b1077],
26	the	DT	O	the	det	28	SENT_174	[p10l1300t1020r1396b1077],
27	reference	NN	O	reference	nn	28	SENT_174	[p10l1425t1020r1724b1077],
28	*	NN	O	*	prep_with	24	SENT_174	[p10l1758t1020r1928b1077],
29	1	CD	NUMBER	1	dep	21	SENT_174	[p10l1758t1020r1928b1077],
30	/	:	O	/	punct	29	SENT_174	[p10l1758t1020r1928b1077],
31	*	CD	NUMBER	*	number	32	SENT_174	[p10l1758t1020r1928b1077],
32	1	CD	NUMBER	1	_	0	SENT_174	[p10l1758t1020r1928b1077],
33	genotype	NN	O	genotype	nn	36	SENT_174	[p10l1965t1038r2144b1093, p10l8t1129r145b1193],
34	(	CD	NUMBER	(	num	36	SENT_174	[p10l190t1120r405b1193],
35	figure	NN	O	figure	nn	36	SENT_174	[p10l190t1120r405b1193],
36	1a	NN	O	1a	dep	32	SENT_174	[p10l455t1121r538b1187],
37	,	,	O	,	_	0	SENT_174	[p10l455t1121r538b1187],
38	table	NN	O	table	appos	32	SENT_174	[p10l583t1120r738b1177],
39	III	CD	NUMBER	iii	num	40	SENT_174	[p10l780t1121r902b1190],
40	)	NN	O	)	dep	38	SENT_174	[p10l780t1121r902b1190],
41	.	.	O	.	_	0	SENT_174	[p10l780t1121r902b1190],

1	Similarly	RB	O	similarly	_	0	SENT_175	[p10l950t1120r1265b1193],
2	,	,	O	,	_	0	SENT_175	[p10l950t1120r1265b1193],
3	comparison	NN	O	comparison	dep	4	SENT_175	[p10l1310t1120r1686b1193],
4	of	IN	O	of	dep	1	SENT_175	[p10l1729t1120r1798b1177],
5	the	DT	O	the	det	6	SENT_175	[p10l1834t1120r1931b1177],
6	mean	NN	O	mean	pobj	4	SENT_175	[p10l1973t1138r2146b1177],

1	©	RB	O	©	advmod	2	SENT_176	[p10l9t1320r43b1354],
2	2008	CD	DATE	2008	_	0	SENT_176	[p10l61t1317r166b1354],
3	Adis	NNP	PERSON	Adis	nn	5	SENT_176	[p10l183t1317r279b1354],
4	Dcrrcr	NNP	PERSON	Dcrrcr	nn	5	SENT_176	[p10l298t1317r411b1354],
5	Information	NNP	O	Information	dep	2	SENT_176	[p10l432t1317r695b1354],
6	BV	NN	O	bv	dep	5	SENT_176	[p10l715t1317r783b1354],
7	.	.	O	.	_	0	SENT_176	[p10l715t1317r783b1354],

1	All	DT	O	all	det	2	SENT_177	[p10l803t1317r855b1354],
2	rights	NNS	O	rights	nsubj	3	SENT_177	[p10l875t1317r994b1364],
3	reserved	VBN	O	reserve	_	0	SENT_177	[p10l1012t1317r1222b1354],
4	.	.	O	.	_	0	SENT_177	[p10l1012t1317r1222b1354],

1	.59	NN	NUMBER	.59	_	0	SENT_178	[p11l2059t3579r2105b3699],
2	.	.	O	.	_	0	SENT_178	[p11l2059t3579r2105b3699],

1	_	NN	O	_	nn	2	SENT_179	[p11l2056t3726r2105b3831],
2	o	NN	O	o	_	0	SENT_179	[p11l2056t3726r2105b3831],
3	:	:	O	:	_	0	SENT_179	[p11l2056t3726r2105b3831],
4	m	NN	O	m	dep	2	SENT_179	[p11l2056t3726r2105b3831],

1	Er	NNP	O	Er	_	0	SENT_180	[p11l1955t95r2006b223],
2	9	CD	NUMBER	9	num	1	SENT_180	[p11l1968t247r2005b311],
3	,	,	O	,	_	0	SENT_180	[p11l1968t247r2005b311],
4	mmod	NN	O	mmod	nn	5	SENT_180	[p11l1957t333r2005b495],
5	u	NN	O	u	dep	1	SENT_180	[p11l1978t518r1997b553],
6	Q	NNP	O	Q	nn	7	SENT_180	[p11l1968t576r2018b607],
7	Q	NNP	O	Q	dep	5	SENT_180	[p11l1957t631r2004b666],
8	,	,	O	,	_	0	SENT_180	[p11l1957t631r2004b666],
9	53	CD	NUMBER	53	dep	1	SENT_180	[p11l1955t692r2018b899],
10	-	:	O	-	_	0	SENT_180	[p11l1955t692r2018b899],
11	:	:	O	:	_	0	SENT_180	[p11l1955t692r2018b899],
12	$	$	MONEY	$	dep	13	SENT_180	[p11l1955t924r2018b1370],
13	s	PRP	MONEY	s	npadvmod	14	SENT_180	[p11l1955t924r2018b1370],
14	_	RB	O	_	dep	1	SENT_180	[p11l1955t924r2018b1370],
15	.	.	O	.	_	0	SENT_180	[p11l1955t924r2018b1370],

1	;	:	O	;	_	0	SENT_181	[p11l1955t924r2018b1370],
2	>	JJR	O	>	amod	8	SENT_181	[p11l1955t924r2018b1370],
3	-	:	O	-	_	0	SENT_181	[p11l1955t924r2018b1370],
4	§	NN	O	§	nn	5	SENT_181	[p11l1955t924r2018b1370],
5	_	NN	O	_	dep	6	SENT_181	[p11l1955t924r2018b1370],
6	>	JJR	O	>	dep	2	SENT_181	[p11l1955t924r2018b1370],
7	_	CD	NUMBER	_	num	8	SENT_181	[p11l1955t924r2018b1370],
8	Q	NNP	O	Q	nsubj	11	SENT_181	[p11l1955t924r2018b1370],
9	was	VBD	O	be	cop	11	SENT_181	[p11l1956t1396r2005b1533],
10	9	CD	NUMBER	9	num	11	SENT_181	[p11l1968t1559r2005b1623],
11	SQ	NN	O	sq	_	0	SENT_181	[p11l1957t1655r2005b1770],
12	v	LS	O	v	prep	11	SENT_181	[p11l1971t1794r2003b1827],
13	Q	NNP	O	Q	dep	12	SENT_181	[p11l1968t1851r2018b1882],
14	3	CD	NUMBER	3	num	13	SENT_181	[p11l1955t1907r2016b1977],
15	.	.	O	.	_	0	SENT_181	[p11l1957t2003r2014b2144],

1	mo.	NN	O	mo.	nn	2	SENT_182	[p11l1957t2003r2014b2144],
2	o	NN	O	o	nsubj	6	SENT_182	[p11l1957t2003r2014b2144],
3	v	LS	O	v	dep	6	SENT_182	[p11l1971t2168r2003b2201],
4	Q	NNP	O	Q	nn	6	SENT_182	[p11l1968t2225r2018b2256],
5	m	NN	O	m	nn	6	SENT_182	[p11l1955t2281r2016b2314],
6	E	NN	O	e	_	0	SENT_182	[p11l1956t2341r2014b2434],
7	2	CD	NUMBER	2	dobj	6	SENT_182	[p11l1968t2456r2005b2520],
8	,	,	O	,	_	0	SENT_182	[p11l1968t2456r2005b2520],
9	mod	NN	O	mod	dobj	6	SENT_182	[p11l1957t2542r2006b2667],
10	v	LS	O	v	prep	9	SENT_182	[p11l1971t2691r2003b2724],
11	Q	NNP	O	Q	nn	14	SENT_182	[p11l1968t2748r2018b2779],
12	H	NNP	O	H	nn	14	SENT_182	[p11l1956t2804r2016b2837],
13	EQQEQEQQQ	NNP	O	EQQEQEQQQ	nn	14	SENT_182	[p11l1956t2864r2018b3291],
14	EQQQQQQQQ	NNP	O	EQQQQQQQQ	dep	10	SENT_182	[p11l1956t3312r2018b3652],
15	£	CD	MONEY	£	number	16	SENT_182	[p11l1956t3678r2005b3834],
16	5	CD	MONEY	5	num	14	SENT_182	[p11l1956t3678r2005b3834],
17	;	:	O	;	_	0	SENT_182	[p11l1956t3678r2005b3834],
18	.	.	O	.	_	0	SENT_182	[p11l1855t88r1914b242],

1	m	NN	O	m	_	0	SENT_183	[p11l1855t88r1914b242],
2	*	CD	NUMBER	*	number	3	SENT_183	[p11l1855t88r1914b242],
3	\	CD	NUMBER	\	num	5	SENT_183	[p11l1855t88r1914b242],
4	F	NN	O	f	nn	5	SENT_183	[p11l1855t88r1914b242],
5	m	NN	O	m	npadvmod	6	SENT_183	[p11l1868t269r1906b333],
6	>	JJR	O	>	amod	7	SENT_183	[p11l1868t269r1906b333],
7	mod	NN	O	mod	dep	1	SENT_183	[p11l1857t358r1906b483],
8	v	LS	O	v	prep	7	SENT_183	[p11l1871t510r1904b543],
9	Q	NNP	O	Q	dep	8	SENT_183	[p11l1868t570r1919b601],
10	.	.	O	.	_	0	SENT_183	[p11l1856t629r1916b662],

1	_	NN	O	_	_	0	SENT_184	[p11l1856t629r1916b662],
2	.	.	O	.	_	0	SENT_184	[p11l1856t629r1916b662],

1	Qaeo	NNP	O	Qaeo	_	0	SENT_185	[p11l1855t691r1912b850],
2	9	CD	NUMBER	9	num	1	SENT_185	[p11l1856t877r1906b966],
3	:	:	O	:	_	0	SENT_185	[p11l1856t877r1906b966],
4	comm	NN	O	comm	dep	1	SENT_185	[p11l1856t993r1906b1151],
5	.	.	O	.	_	0	SENT_185	[p11l1856t993r1906b1151],

1	2	CD	NUMBER	2	_	0	SENT_186	[p11l1859t1180r1906b1232],
2	9	CD	NUMBER	9	dep	1	SENT_186	[p11l1856t1257r1906b1380],
3	:	:	O	:	_	0	SENT_186	[p11l1856t1257r1906b1380],
4	:	:	O	:	_	0	SENT_186	[p11l1856t1257r1906b1380],
5	n	NN	O	n	dep	1	SENT_186	[p11l1878t1405r1897b1439],
6	.85	CD	NUMBER	.85	number	7	SENT_186	[p11l1859t1464r1912b1592],
7	”	CD	NUMBER	”	dep	8	SENT_186	[p11l1855t1619r1914b1843],
8	m.	NN	NUMBER	m.	dep	5	SENT_186	[p11l1855t1619r1914b1843],
9	.	.	O	.	_	0	SENT_186	[p11l1855t1619r1914b1843],

1	__	SYM	O	__	_	0	SENT_187	[p11l1855t1619r1914b1843],
2	-	:	O	-	_	0	SENT_187	[p11l1855t1619r1914b1843],
3	.	.	O	.	_	0	SENT_187	[p11l1855t1619r1914b1843],

1	__	NN	O	__	nn	2	SENT_188	[p11l1855t1619r1914b1843],
2	m	NN	O	m	_	0	SENT_188	[p11l1855t1619r1914b1843],
3	;	:	O	;	_	0	SENT_188	[p11l1855t1619r1914b1843],
4	:	:	O	:	_	0	SENT_188	[p11l1856t1873r1906b2184],
5	o	NN	O	o	nn	6	SENT_188	[p11l1856t1873r1906b2184],
6	_	NN	O	_	dep	2	SENT_188	[p11l1856t1873r1906b2184],
7	.	.	O	.	_	0	SENT_188	[p11l1856t1873r1906b2184],

1	.	.	O	.	_	0	SENT_189	[p11l1856t1873r1906b2184],

1	mc_E	NN	O	mc_e	nn	6	SENT_190	[p11l1856t1873r1906b2184],
2	__	NN	O	__	nn	6	SENT_190	[p11l1856t1873r1906b2184],
3	m	NN	O	m	nn	6	SENT_190	[p11l1856t1873r1906b2184],
4	n	NN	O	n	nn	6	SENT_190	[p11l1878t2211r1897b2245],
5	«	NN	O	«	nn	6	SENT_190	[p11l1859t2271r1912b2336],
6	B	NN	O	b	_	0	SENT_190	[p11l1859t2271r1912b2336],
7	uotoqmcmh	JJ	O	uotoqmcmh	amod	11	SENT_190	[p11l1859t2364r1918b2698],
8	co_cm	NN	O	co_cm	nn	11	SENT_190	[p11l1856t2725r1906b2881],
9	o_cm9o	NN	O	o_cm9o	nn	11	SENT_190	[p11l1856t2907r1919b3121],
10	Qo	NN	O	qo	nn	11	SENT_190	[p11l1856t3145r1906b3332],
11	_	NN	O	_	dep	6	SENT_190	[p11l1856t3145r1906b3332],
12	:	:	O	:	_	0	SENT_190	[p11l1856t3145r1906b3332],
13	mo	NN	DURATION	mo	nn	14	SENT_190	[p11l1856t3145r1906b3332],
14	mS_om	NN	O	ms_om	dep	6	SENT_190	[p11l1856t3359r1906b3532],
15	n	NN	O	n	nn	16	SENT_190	[p11l1878t3558r1897b3592],
16	oo	NN	O	oo	dep	14	SENT_190	[p11l1855t3619r1906b3799],
17	.	.	O	.	_	0	SENT_190	[p11l1855t3619r1906b3799],

1	_	NN	O	_	dep	7	SENT_191	[p11l1855t3619r1906b3799],
2	m	NN	O	m	dep	1	SENT_191	[p11l1855t3619r1906b3799],
3	_	CD	NUMBER	_	num	4	SENT_191	[p11l1869t3829r1914b3834],
4	mEmm_n	NN	O	memm_n	dep	7	SENT_191	[p11l1757t83r1819b293],
5	_	NN	O	_	nn	7	SENT_191	[p11l1757t83r1819b293],
6	xmoa	NN	O	xmoa	nn	7	SENT_191	[p11l1757t333r1819b473],
7	n	NN	O	n	dep	13	SENT_191	[p11l1778t515r1797b549],
8	.850	CD	NUMBER	.850	num	9	SENT_191	[p11l1755t589r1812b740],
9	6o	NN	O	6o	dep	7	SENT_191	[p11l1756t784r1814b1084],
10	:	:	O	:	_	0	SENT_191	[p11l1756t784r1814b1084],
11	mQmo_o	NNP	O	mQmo_o	nn	13	SENT_191	[p11l1756t784r1814b1084],
12	_	CD	NUMBER	_	num	13	SENT_191	[p11l1756t1126r1806b1231],
13	mQo	NN	O	mqo	_	0	SENT_191	[p11l1756t1126r1806b1231],
14	.	.	O	.	_	0	SENT_191	[p11l1760t1270r1819b1530],

1	.	.	O	.	_	0	SENT_192	[p11l1760t1270r1819b1530],

1	coQmn_n_m	NN	O	coqmn_n_m	_	0	SENT_193	[p11l1760t1270r1819b1530],
2	"	''	O	"	punct	1	SENT_193	[p11l1755t1644r1806b1788],
3	.30	CD	NUMBER	.30	number	4	SENT_193	[p11l1755t1644r1806b1788],
4	“	CD	NUMBER	“	num	5	SENT_193	[p11l1760t1833r1814b1988],
5	Suﬁ	NN	O	suﬁ	npadvmod	6	SENT_193	[p11l1760t1833r1814b1988],
6	>	JJR	O	>	amod	1	SENT_193	[p11l1757t2027r1819b2220],
7	_	CD	NUMBER	_	num	8	SENT_193	[p11l1757t2027r1819b2220],
8	umw	NN	O	umw	dep	1	SENT_193	[p11l1757t2027r1819b2220],
9	_	NN	O	_	dep	8	SENT_193	[p11l1757t2027r1819b2220],
10	.	.	O	.	_	0	SENT_193	[p11l1757t2027r1819b2220],

1	m	NN	O	m	nn	4	SENT_194	[p11l1757t2027r1819b2220],
2	E	NN	O	e	nn	4	SENT_194	[p11l1760t2260r1806b2312],
3	_	NN	O	_	nn	4	SENT_194	[p11l1756t2354r1806b2560],
4	m	NN	O	m	_	0	SENT_194	[p11l1756t2354r1806b2560],
5	>	JJR	O	>	dep	4	SENT_194	[p11l1756t2354r1806b2560],
6	.	.	O	.	_	0	SENT_194	[p11l1756t2354r1806b2560],

1	_	RB	O	_	dep	4	SENT_195	[p11l1756t2354r1806b2560],
2	2c	JJ	O	2c	amod	4	SENT_195	[p11l1756t2354r1806b2560],
3	_	NN	O	_	nn	4	SENT_195	[p11l1756t2354r1806b2560],
4	m	NN	O	m	_	0	SENT_195	[p11l1756t2604r1819b2795],
5	:	:	O	:	_	0	SENT_195	[p11l1756t2604r1819b2795],
6	_	CD	NUMBER	_	num	7	SENT_195	[p11l1756t2604r1819b2795],
7	moU	NN	O	mou	npadvmod	8	SENT_195	[p11l1756t2604r1819b2795],
8	So	RB	O	so	dep	4	SENT_195	[p11l1757t2833r1806b3061],
9	;	:	O	;	_	0	SENT_195	[p11l1757t2833r1806b3061],
10	-	:	O	-	_	0	SENT_195	[p11l1757t2833r1806b3061],
11	vm	NN	O	vm	dep	8	SENT_195	[p11l1757t2833r1806b3061],
12	9	CD	NUMBER	9	dep	11	SENT_195	[p11l1756t3101r1806b3190],
13	:	:	O	:	_	0	SENT_195	[p11l1756t3101r1806b3190],
14	mczsv	NN	O	mczsv	nn	15	SENT_195	[p11l1756t3231r1819b3410],
15	m	NN	O	m	dep	12	SENT_195	[p11l1769t3450r1806b3609],
16	>	JJR	O	>	dep	17	SENT_195	[p11l1769t3450r1806b3609],
17	So	IN	O	so	rcmod	15	SENT_195	[p11l1769t3450r1806b3609],
18	mE	NN	O	me	nn	19	SENT_195	[p11l1756t3650r1806b3828],
19	__	NN	O	__	dep	15	SENT_195	[p11l1756t3650r1806b3828],
20	.	.	O	.	_	0	SENT_195	[p11l1756t3650r1806b3828],

1	-	:	O	-	_	0	SENT_196	[p11l1756t3650r1806b3828],
2	:	:	O	:	_	0	SENT_196	[p11l1756t3650r1806b3828],
3	.	.	O	.	_	0	SENT_196	[p11l1498t3044r1548b3340],

1	ow_2	NN	O	ow_2	_	0	SENT_197	[p11l1498t3044r1548b3340],
2	:	:	O	:	_	0	SENT_197	[p11l1498t3044r1548b3340],
3	m	NN	O	m	nn	5	SENT_197	[p11l1498t3044r1548b3340],
4	£	CD	NUMBER	£	num	5	SENT_197	[p11l1498t3044r1548b3340],
5	o	NN	O	o	dep	1	SENT_197	[p11l1498t3044r1548b3340],
6	_	CD	NUMBER	_	num	7	SENT_197	[p11l1498t3369r1560b3626],
7	oo	NN	O	oo	dep	5	SENT_197	[p11l1498t3369r1560b3626],
8	___	CD	NUMBER	___	num	10	SENT_197	[p11l1498t3369r1560b3626],
9	omQm	NN	O	omqm	nn	10	SENT_197	[p11l1498t3369r1560b3626],
10	mmo	NN	O	mmo	dep	5	SENT_197	[p11l1498t3654r1548b3834],
11	_	CD	NUMBER	_	dep	10	SENT_197	[p11l1498t3654r1548b3834],
12	:	:	O	:	_	0	SENT_197	[p11l1498t3654r1548b3834],
13	Q	NNP	O	Q	dep	1	SENT_197	[p11l1498t3654r1548b3834],

1	No.	NN	O	no.	_	0	SENT_198	[p11l1365t222r1414b343],
2	_	CD	NUMBER	_	dep	1	SENT_198	[p11l1365t222r1414b343],
3	.	.	O	.	_	0	SENT_198	[p11l1365t222r1414b343],

1	H	NN	O	h	nn	2	SENT_199	[p11l1369t373r1413b409],
2	mwm	NN	O	mwm	nsubj	3	SENT_199	[p11l1365t435r1414b561],
3	med	VBD	O	med	_	0	SENT_199	[p11l1365t753r1414b878],
4	H	NN	O	h	nn	14	SENT_199	[p11l1369t904r1413b940],
5	oQ_m	NN	O	oq_m	nn	14	SENT_199	[p11l1365t966r1414b1091],
6	H50	NN	O	h50	nn	14	SENT_199	[p11l1361t1425r1414b1543],
7	H	NN	O	h	nn	14	SENT_199	[p11l1369t1570r1413b1605],
8	mm	NN	O	mm	nn	14	SENT_199	[p11l1365t1631r1414b1720],
9	m.o	NN	O	m.o	nn	14	SENT_199	[p11l1365t1986r1414b2074],
10	H	NN	O	h	nn	14	SENT_199	[p11l1369t2100r1413b2136],
11	om	NN	O	om	nn	14	SENT_199	[p11l1365t2162r1414b2250],
12	Q.o	NN	O	q.o	nn	14	SENT_199	[p11l1365t2759r1414b2847],
13	H	NN	O	h	nn	14	SENT_199	[p11l1369t2873r1413b2909],
14	N.N	NN	O	n.n	dobj	3	SENT_199	[p11l1365t2935r1413b3023],
15	To	TO	O	to	_	0	SENT_199	[p11l1365t3289r1414b3378],
16	H	NN	O	h	nn	17	SENT_199	[p11l1369t3403r1413b3439],
17	©	NN	O	©	prep_to	14	SENT_199	[p11l1365t3465r1414b3554],
18	.	.	O	.	_	0	SENT_199	[p11l1365t3465r1414b3554],

1	N	NN	O	n	_	0	SENT_200	[p11l1365t3465r1414b3554],
2	M	NN	O	m	nn	5	SENT_200	[p11l1366t3820r1414b3834],
3	33	CD	NUMBER	33	num	5	SENT_200	[p11l1230t193r1284b343],
4	H	NN	O	h	nn	5	SENT_200	[p11l1240t373r1283b409],
5	o	NN	O	o	dep	1	SENT_200	[p11l1236t435r1284b561],
6	:	:	O	:	_	0	SENT_200	[p11l1236t435r1284b561],
7	»	CD	NUMBER	»	num	10	SENT_200	[p11l1236t435r1284b561],
8	mmo	NN	O	mmo	nn	10	SENT_200	[p11l1236t754r1284b878],
9	H	NN	O	h	nn	10	SENT_200	[p11l1240t904r1283b940],
10	Em	NN	O	em	dep	5	SENT_200	[p11l1236t965r1284b1091],
11	E	NN	O	e	nn	23	SENT_200	[p11l1236t1466r1283b1539],
12	H	NN	O	h	nn	23	SENT_200	[p11l1240t1570r1283b1605],
13	mm	NN	O	mm	nn	23	SENT_200	[p11l1236t1631r1284b1719],
14	Q.o	NN	O	q.o	nn	23	SENT_200	[p11l1236t1986r1284b2074],
15	H	NN	O	h	nn	23	SENT_200	[p11l1240t2100r1283b2136],
16	Q.m	NN	O	q.m	nn	23	SENT_200	[p11l1236t2162r1284b2251],
17	Q.o	NN	O	q.o	nn	23	SENT_200	[p11l1236t2759r1284b2847],
18	H	NN	O	h	nn	23	SENT_200	[p11l1240t2873r1283b2909],
19	mm	NN	O	mm	nn	23	SENT_200	[p11l1236t2935r1284b3023],
20	Q_o	NN	O	q_o	nn	23	SENT_200	[p11l1236t3290r1284b3378],
21	H	NN	O	h	nn	23	SENT_200	[p11l1240t3403r1283b3439],
22	ow	NN	O	ow	nn	23	SENT_200	[p11l1236t3465r1284b3553],
23	M	NN	O	m	dep	10	SENT_200	[p11l1236t3821r1283b3834],

1	6	CD	NUMBER	6	_	0	SENT_201	[p11l1104t185r1167b442],
2	.	.	O	.	_	0	SENT_201	[p11l1104t185r1167b442],

1	m	NN	O	m	_	0	SENT_202	[p11l1104t185r1167b442],
2	:	:	O	:	_	0	SENT_202	[p11l1104t185r1167b442],
3	m.e	VB	O	m.e	dep	1	SENT_202	[p11l1104t185r1167b442],
4	o.m	NN	O	o.m	dobj	3	SENT_202	[p11l1106t472r1155b561],
5	8	CD	NUMBER	8	num	4	SENT_202	[p11l1104t715r1167b973],
6	.	.	O	.	_	0	SENT_202	[p11l1104t715r1167b973],

1	m	NN	O	m	_	0	SENT_203	[p11l1104t715r1167b973],
2	:	:	O	:	_	0	SENT_203	[p11l1104t715r1167b973],
3	m.	VB	O	m.	dep	1	SENT_203	[p11l1104t715r1167b973],
4	ov	NN	O	ov	nn	8	SENT_203	[p11l1104t715r1167b973],
5	oe	NN	O	oe	nn	8	SENT_203	[p11l1106t1003r1155b1086],
6	a.m.e	NN	O	a.m.e	nn	8	SENT_203	[p11l1104t1399r1167b1601],
7	o.m	NN	O	o.m	nn	8	SENT_203	[p11l1106t1631r1155b1720],
8	Amumé	NN	O	amumé	dobj	3	SENT_203	[p11l1104t1930r1167b2132],
9	3	CD	NUMBER	3	num	10	SENT_203	[p11l1106t2162r1155b2246],
10	a-m	NN	O	a-m	dep	8	SENT_203	[p11l1104t2703r1167b2905],
11	.	.	O	.	_	0	SENT_203	[p11l1104t2703r1167b2905],

1	e	SYM	O	e	dep	2	SENT_204	[p11l1104t2703r1167b2905],
2	3	CD	NUMBER	3	dep	3	SENT_204	[p11l1106t2934r1155b3018],
3	a-m	NN	O	a-m	_	0	SENT_204	[p11l1104t3233r1167b3435],
4	.	.	O	.	_	0	SENT_204	[p11l1104t3233r1167b3435],

1	e	LS	O	e	dep	2	SENT_205	[p11l1104t3233r1167b3435],
2	me	PRP	O	I	_	0	SENT_205	[p11l1106t3465r1155b3549],
3	AmQwmv	NNP	O	AmQwmv	prep	2	SENT_205	[p11l1104t3764r1167b3834, p11l971t156r1025b311],
4	H	NNP	O	H	nn	5	SENT_205	[p11l980t336r1023b372],
5	mm	NN	O	mm	dep	3	SENT_205	[p11l976t398r1025b556],
6	?	.	O	?	_	0	SENT_205	[p11l976t398r1025b556],

1	m.	NN	O	m.	nn	4	SENT_206	[p11l976t753r1025b801],
2	5	CD	NUMBER	5	num	4	SENT_206	[p11l976t819r1025b878],
3	H	NN	O	h	nn	4	SENT_206	[p11l980t904r1023b940],
4	QNQ	NN	O	qnq	_	0	SENT_206	[p11l976t966r1025b1090],
5	Q5	NN	O	q5	nn	9	SENT_206	[p11l976t1381r1025b1507],
6	H	NN	O	h	nn	9	SENT_206	[p11l980t1532r1023b1568],
7	mam	NN	O	mam	nn	9	SENT_206	[p11l976t1594r1025b1719],
8	nmv	NN	O	nmv	nn	9	SENT_206	[p11l976t1875r1025b2001],
9	H	NN	O	h	dep	4	SENT_206	[p11l980t2026r1023b2062],
10	$	$	MONEY	$	amod	9	SENT_206	[p11l976t2087r1025b2246],
11	2	CD	MONEY	2	number	10	SENT_206	[p11l976t2087r1025b2246],
12	QB	NN	O	qb	nn	14	SENT_206	[p11l976t2648r1025b2773],
13	H	NN	O	h	nn	14	SENT_206	[p11l980t2799r1023b2835],
14	mm	NN	O	mm	dep	9	SENT_206	[p11l976t2861r1025b3019],
15	:	:	O	:	_	0	SENT_206	[p11l976t2861r1025b3019],
16	mom	NN	O	mom	nn	17	SENT_206	[p11l976t3179r1025b3304],
17	H	NN	O	h	dep	9	SENT_206	[p11l980t3329r1024b3365],
18	92	CD	NUMBER	92	dep	17	SENT_206	[p11l976t3391r1025b3549],
19	:	:	O	:	_	0	SENT_206	[p11l976t3391r1025b3549],
20	5	CD	PERCENT	5	num	21	SENT_206	[p11l976t3709r1025b3834],
21	%	NN	PERCENT	%	dep	9	SENT_206	[p11l976t3709r1025b3834],
22	8.2	CD	NUMBER	8.2	num	24	SENT_206	[p11l747t149r795b306],
23	H	NN	O	h	nn	24	SENT_206	[p11l750t336r794b372],
24	mm	NN	O	mm	dep	21	SENT_206	[p11l747t398r795b483],
25	.	.	O	.	_	0	SENT_206	[p11l747t398r795b483],

1	5	CD	NUMBER	5	number	2	SENT_207	[p11l747t501r794b561],
2	56	CD	NUMBER	56	_	0	SENT_207	[p11l747t716r795b841],
3	H	NN	O	h	prep	2	SENT_207	[p11l750t867r794b903],
4	2	CD	NUMBER	2	dep	3	SENT_207	[p11l747t928r795b1013],
5	.	.	O	.	_	0	SENT_207	[p11l747t928r795b1013],

1	E	NN	O	e	nn	9	SENT_208	[p11l747t1032r795b1091],
2	QNE	NN	O	qne	nn	9	SENT_208	[p11l747t1308r795b1465],
3	H	NN	O	h	nn	9	SENT_208	[p11l750t1495r794b1531],
4	mmwm	NN	O	mmwm	nn	9	SENT_208	[p11l747t1557r795b1719],
5	SQ	NN	O	sq	nn	9	SENT_208	[p11l747t1875r795b2000],
6	H	NN	O	h	nn	9	SENT_208	[p11l750t2026r794b2062],
7	«	CD	NUMBER	«	num	9	SENT_208	[p11l747t2087r795b2250],
8	Q8	NN	O	q8	nn	9	SENT_208	[p11l747t2087r795b2250],
9	K5	NN	O	k5	_	0	SENT_208	[p11l744t2580r795b2769],
10	:	:	O	:	_	0	SENT_208	[p11l744t2580r795b2769],
11	H	NN	O	h	nn	14	SENT_208	[p11l750t2799r794b2835],
12	8.3	CD	NUMBER	8.3	num	14	SENT_208	[p11l747t2861r795b3023],
13	Qmwm	NN	O	qmwm	nn	14	SENT_208	[p11l747t3148r795b3304],
14	H	NN	O	h	dep	9	SENT_208	[p11l750t3330r794b3365],
15	3.8	CD	NUMBER	3.8	num	16	SENT_208	[p11l747t3391r795b3553],
16	Quad	NN	O	quad	dep	14	SENT_208	[p11l747t3709r795b3834],
17	3	CD	NUMBER	3	dep	16	SENT_208	[p11l617t223r666b343],
18	:	:	O	:	_	0	SENT_208	[p11l617t223r666b343],
19	H	NN	O	h	nsubj	21	SENT_208	[p11l621t373r664b409],
20	can	MD	O	can	aux	21	SENT_208	[p11l617t435r666b560],
21	oi	VB	O	oi	dep	14	SENT_208	[p11l617t753r666b874],
22	H	NN	O	h	nn	23	SENT_208	[p11l621t904r664b940],
23	mxw	NN	O	mxw	dobj	21	SENT_208	[p11l617t965r666b1090],
24	3	CD	NUMBER	3	num	23	SENT_208	[p11l617t1382r666b1502],
25	:	:	O	:	_	0	SENT_208	[p11l617t1382r666b1502],
26	H	NN	O	h	nn	27	SENT_208	[p11l621t1532r664b1568],
27	wow	NN	O	wow	dep	9	SENT_208	[p11l617t1594r666b1719],
28	03	CD	NUMBER	03	num	31	SENT_208	[p11l617t1912r666b2033],
29	H	NN	O	h	nn	31	SENT_208	[p11l621t2063r664b2099],
30	mam	NN	O	mam	nn	31	SENT_208	[p11l617t2126r666b2250],
31	rum	NN	O	rum	dep	27	SENT_208	[p11l617t2695r664b2811],
32	H	NN	O	h	nn	34	SENT_208	[p11l621t2836r664b2872],
33	mxm	NN	O	mxm	nn	34	SENT_208	[p11l617t2898r666b3023],
34	mm	NN	O	mm	dep	27	SENT_208	[p11l617t3215r666b3336],
35	;	:	O	;	_	0	SENT_208	[p11l617t3215r666b3336],
36	H	NN	O	h	nn	37	SENT_208	[p11l621t3367r664b3402],
37	mam	NN	O	mam	dep	9	SENT_208	[p11l617t3428r666b3553],
38	no	DT	O	no	det	47	SENT_208	[p11l617t3747r666b3834],
39	Qmoewm	NN	O	qmoewm	nn	47	SENT_208	[p11l482t89r536b311],
40	H	NN	O	h	nn	47	SENT_208	[p11l491t336r534b372],
41	mxvm	NN	O	mxvm	nn	47	SENT_208	[p11l487t398r536b560],
42	NE	NN	O	ne	nn	47	SENT_208	[p11l487t717r534b841],
43	H	NN	O	h	nn	47	SENT_208	[p11l491t867r534b903],
44	m.	NN	O	m.	nn	47	SENT_208	[p11l487t929r536b1091],
45	Qmm	NN	O	qmm	nn	47	SENT_208	[p11l487t929r536b1091],
46	Hizm	NN	O	hizm	nn	47	SENT_208	[p11l483t1278r536b1470],
47	H	NN	O	h	dep	37	SENT_208	[p11l491t1495r534b1531],
48	ex	FW	O	ex	dep	37	SENT_208	[p11l487t1557r536b1720],
49	?	.	O	?	_	0	SENT_208	[p11l487t1557r536b1720],

1	3	CD	NUMBER	3	_	0	SENT_209	[p11l487t1838r536b1996],
2	:	:	O	:	_	0	SENT_209	[p11l487t1838r536b1996],
3	H	NN	O	h	nn	4	SENT_209	[p11l491t2026r534b2062],
4	mama	NN	O	mama	dep	1	SENT_209	[p11l487t2087r536b2250],
5	#	#	MONEY	#	number	6	SENT_209	[p11l483t2507r536b2659],
6	5	CD	MONEY	5	amod	4	SENT_209	[p11l483t2507r536b2659],
7	.	.	O	.	_	0	SENT_209	[p11l483t2507r536b2659],

1	Km	NN	O	km	nn	3	SENT_210	[p11l487t2677r534b2774],
2	H	NN	O	h	nn	3	SENT_210	[p11l491t2799r534b2835],
3	mwvm	NN	O	mwvm	_	0	SENT_210	[p11l487t2861r536b3023],
4	N.	NNP	O	N.	dep	3	SENT_210	[p11l488t3178r534b3226],
5	5	CD	NUMBER	5	num	4	SENT_210	[p11l487t3245r536b3304],
6	H	NN	O	h	nn	10	SENT_210	[p11l491t3329r534b3365],
7	m.	NN	O	m.	nn	10	SENT_210	[p11l487t3391r536b3439],
8	Sm	NN	O	sm	nn	10	SENT_210	[p11l487t3457r536b3553],
9	H.	NN	O	h.	nn	10	SENT_210	[p11l487t3672r534b3720],
10	E	NN	O	e	dep	3	SENT_210	[p11l487t3738r536b3830],
11	:	:	O	:	_	0	SENT_210	[p11l487t3738r536b3830],

1	|	NN	O	|	_	0	SENT_211	[p11l250t81r332b1093],
2	§	NN	O	§	dep	1	SENT_211	[p11l250t81r332b1093],
3	.	.	O	.	_	0	SENT_211	[p11l250t81r332b1093],

1	.	.	O	.	_	0	SENT_212	[p11l250t81r332b1093],

1	amQ	NN	O	amq	_	0	SENT_213	[p11l250t81r332b1093],
2	§	CD	NUMBER	§	num	3	SENT_213	[p11l250t1240r332b2252],
3	|	NN	O	|	dep	1	SENT_213	[p11l253t2399r332b3834],
4	.	.	O	.	_	0	SENT_213	[p11l253t2399r332b3834],

1	£	NN	O	£	_	0	SENT_214	[p11l8t86r57b199],
2	_	SYM	O	_	dep	3	SENT_214	[p11l8t86r57b199],
3	>>	CD	NUMBER	>>	rcmod	1	SENT_214	[p11l8t86r57b199],
4	:	:	O	:	_	0	SENT_214	[p11l8t227r57b540],
5	o	NN	O	o	dep	1	SENT_214	[p11l8t227r57b540],
6	:	:	O	:	_	0	SENT_214	[p11l8t227r57b540],
7	mo	NN	DURATION	mo	nn	9	SENT_214	[p11l8t227r57b540],
8	__	NN	O	__	nn	9	SENT_214	[p11l8t227r57b540],
9	uwE	NN	O	uwe	dep	5	SENT_214	[p11l8t227r57b540],
10	EQ9-mco	JJ	O	eq9-mco	amod	12	SENT_214	[p11l8t570r71b843],
11	_	NN	O	_	nn	12	SENT_214	[p11l8t570r71b843],
12	Qmuc	NN	O	qmuc	dep	9	SENT_214	[p11l8t869r57b1035],
13	:	:	O	:	_	0	SENT_214	[p11l8t869r57b1035],
14	m.	NN	O	m.	dep	9	SENT_214	[p11l8t1064r70b1292],
15	.	.	O	.	_	0	SENT_214	[p11l8t1064r70b1292],

1	cm	NN	O	cm	_	0	SENT_215	[p11l8t1064r70b1292],
2	_	NN	O	_	dep	1	SENT_215	[p11l8t1064r70b1292],
3	.	.	O	.	_	0	SENT_215	[p11l8t1064r70b1292],

1	.	.	O	.	_	0	SENT_216	[p11l8t1064r70b1292],

1	m.g	NN	O	m.g	_	0	SENT_217	[p11l8t1064r70b1292],
2	So	RB	O	so	dep	1	SENT_217	[p11l7t1317r70b1668],
3	.	.	O	.	_	0	SENT_217	[p11l7t1317r70b1668],

1	_	SYM	O	_	dep	5	SENT_218	[p11l7t1317r70b1668],
2	-	:	O	-	_	0	SENT_218	[p11l7t1317r70b1668],
3	>	JJR	O	>	amod	5	SENT_218	[p11l7t1317r70b1668],
4	Eo	NN	O	eo	nn	5	SENT_218	[p11l7t1317r70b1668],
5	>>	NN	O	>>	_	0	SENT_218	[p11l7t1317r70b1668],
6	.	.	O	.	_	0	SENT_218	[p11l7t1317r70b1668],

1	_	NN	O	_	_	0	SENT_219	[p11l7t1317r70b1668],
2	.	.	O	.	_	0	SENT_219	[p11l7t1317r70b1668],

1	.	.	O	.	_	0	SENT_220	[p11l8t1696r70b2153],

1	wE	NN	O	we	_	0	SENT_221	[p11l8t1696r70b2153],
2	.	.	O	.	_	0	SENT_221	[p11l8t1696r70b2153],

1	w	NN	O	w	_	0	SENT_222	[p11l8t1696r70b2153],
2	__	NN	O	__	dep	1	SENT_222	[p11l8t1696r70b2153],
3	.	.	O	.	_	0	SENT_222	[p11l8t1696r70b2153],

1	_	NNP	O	_	nn	4	SENT_223	[p11l8t1696r70b2153],
2	Q.	NNP	O	Q.	nn	4	SENT_223	[p11l8t1696r70b2153],
3	_	NNP	O	_	nn	4	SENT_223	[p11l8t1696r70b2153],
4	OE	NNP	O	OE	_	0	SENT_223	[p11l8t1696r70b2153],
5	>	JJR	O	>	dep	4	SENT_223	[p11l8t1696r70b2153],
6	_	CD	NUMBER	_	num	8	SENT_223	[p11l8t1696r70b2153],
7	OQ	NN	O	oq	nn	8	SENT_223	[p11l8t1696r70b2153],
8	momnio	NN	O	momnio	dep	5	SENT_223	[p11l7t2175r57b2431],
9	2	CD	NUMBER	2	num	10	SENT_223	[p11l11t2462r57b2515],
10	co	NN	O	co	dep	4	SENT_223	[p11l8t2542r57b2751],
11	=	JJ	O	=	amod	15	SENT_223	[p11l8t2542r57b2751],
12	m_9	NN	O	m_9	nn	15	SENT_223	[p11l8t2542r57b2751],
13	E	NN	O	e	nn	15	SENT_223	[p11l8t2782r56b2826],
14	wco	NN	O	wco	nn	15	SENT_223	[p11l8t2855r57b3150],
15	_	NN	O	_	dep	10	SENT_223	[p11l8t2855r57b3150],
16	.	.	O	.	_	0	SENT_223	[p11l8t2855r57b3150],

1	.	.	O	.	_	0	SENT_224	[p11l8t2855r57b3150],

1	_	NN	O	_	_	0	SENT_225	[p11l8t2855r57b3150],
2	ucoo	NN	O	ucoo	nn	3	SENT_225	[p11l8t2855r57b3150],
3	9m	NN	O	9m	dep	1	SENT_225	[p11l8t3176r70b3535],
4	.	.	O	.	_	0	SENT_225	[p11l8t3176r70b3535],

1	.	.	O	.	_	0	SENT_226	[p11l8t3176r70b3535],

1	m	NN	O	m	_	0	SENT_227	[p11l8t3176r70b3535],
2	-	:	O	-	_	0	SENT_227	[p11l8t3176r70b3535],
3	>	JJR	O	>	amod	5	SENT_227	[p11l8t3176r70b3535],
4	_	NN	O	_	nn	5	SENT_227	[p11l8t3176r70b3535],
5	umo	NN	O	umo	dep	1	SENT_227	[p11l8t3176r70b3535],
6	.	.	O	.	_	0	SENT_227	[p11l8t3176r70b3535],

1	.	.	O	.	_	0	SENT_228	[p11l8t3176r70b3535],

1	w	NN	O	w	_	0	SENT_229	[p11l8t3176r70b3535],
2	mc_S_o	NN	O	mc_s_o	nn	3	SENT_229	[p11l8t3562r71b3742],
3	mu	NN	O	mu	dep	1	SENT_229	[p11l8t3768r57b3834],

1	-	:	O	-	_	0	SENT_230	[p12l8t6r56b23],
2	=	JJ	O	=	amod	4	SENT_230	[p12l8t6r56b23],
3	U	NNP	O	U	nn	4	SENT_230	[p12l253t6r301b31],
4	)	NNP	O	)	_	0	SENT_230	[p12l253t6r301b31],
5	1	LS	NUMBER	1	dep	4	SENT_230	[p12l617t21r664b39],
6	-	:	O	-	_	0	SENT_230	[p12l617t21r664b39],
7	,	,	O	,	_	0	SENT_230	[p12l1107t6r1546b63],
8	_	CD	NUMBER	_	num	9	SENT_230	[p12l1107t6r1546b63],
9	(	CD	NUMBER	(	dep	4	SENT_230	[p12l1107t6r1546b63],
10	|	NN	O	|	prep	4	SENT_230	[p12l1107t6r1546b63],
11	3	CD	NUMBER	3	num	12	SENT_230	[p12l1107t6r1546b63],
12	“	NN	O	“	dep	10	SENT_230	[p12l1107t6r1546b63],
13	!	.	O	!	_	0	SENT_230	[p12l1107t6r1546b63],

1	‘	NN	O	‘	_	0	SENT_231	[p12l1107t6r1546b63],
2	*	CD	MONEY	*	num	3	SENT_231	[p12l1107t6r1546b63],
3	£	NN	MONEY	£	nsubj	8	SENT_231	[p12l1107t6r1546b63],
4	'	''	O	'	_	0	SENT_231	[p12l1107t6r1546b63],
5	o'q5	CD	NUMBER	o'q5	dep	8	SENT_231	[p12l1769t6r2104b48],
6	"	``	O	"	punct	8	SENT_231	[p12l1769t6r2104b48],
7	'	''	O	'	_	0	SENT_231	[p12l1769t6r2104b48],
8	~	NN	O	~	rcmod	1	SENT_231	[p12l1769t6r2104b48],
9	:	:	O	:	_	0	SENT_231	[p12l1769t6r2104b48],
10	E	NN	O	e	nn	11	SENT_231	[p12l20t31r56b78],
11	Q5	NN	O	q5	dep	1	SENT_231	[p12l250t32r794b105],
12	/	:	O	/	punct	24	SENT_231	[p12l250t32r794b105],
13	+	CC	O	+	_	0	SENT_231	[p12l250t32r794b105],
14	|	CD	NUMBER	|	num	16	SENT_231	[p12l250t32r794b105],
15	_	NN	O	_	nn	16	SENT_231	[p12l250t32r794b105],
16	H	NN	O	h	dep	24	SENT_231	[p12l250t32r794b105],
17	+	CC	O	+	_	0	SENT_231	[p12l250t32r794b105],
18	|	NN	O	|	dep	24	SENT_231	[p12l250t32r794b105],
19	+	CC	O	+	_	0	SENT_231	[p12l980t32r1023b68],
20	|	CD	NUMBER	|	num	21	SENT_231	[p12l980t32r1023b68],
21	_	NN	O	_	conj_+	18	SENT_231	[p12l1146t42r1547b82],
22	,	,	O	,	_	0	SENT_231	[p12l1146t42r1547b82],
23	_	NN	O	_	appos	21	SENT_231	[p12l1146t42r1547b82],
24	oD	NN	O	od	dep	11	SENT_231	[p12l1146t42r1547b82],
25	-	:	O	-	_	0	SENT_231	[p12l1756t29r2105b104],
26	.	.	O	.	_	0	SENT_231	[p12l1756t29r2105b104],

1	=	JJ	O	=	_	0	SENT_232	[p12l1756t29r2105b104],
2	.	.	O	.	_	0	SENT_232	[p12l1756t29r2105b104],

1	,	,	O	,	_	0	SENT_233	[p12l1756t29r2105b104],
2	,	,	O	,	_	0	SENT_233	[p12l1756t29r2105b104],
3	>	JJR	O	>	amod	4	SENT_233	[p12l1756t29r2105b104],
4	m	NN	O	m	nsubj	8	SENT_233	[p12l1756t29r2105b104],
5	CD	NNP	O	CD	prep	8	SENT_233	[p12l20t85r57b117],
6	N	NNP	O	N	nn	7	SENT_233	[p12l253t80r300b120],
7	Lo	NNP	O	Lo	dep	5	SENT_233	[p12l488t94r536b127],
8	co	VBD	O	co	_	0	SENT_233	[p12l747t94r795b127],
9	ooO	NN	O	ooo	dobj	8	SENT_233	[p12l976t85r1155b126],
10	U	NNP	O	U	nn	11	SENT_233	[p12l1497t90r1548b129],
11	)	NNP	O	)	dobj	8	SENT_233	[p12l1497t90r1548b129],
12	900	CD	NUMBER	900	dep	11	SENT_233	[p12l1769t74r2104b129],
13	.	.	O	.	_	0	SENT_233	[p12l1769t74r2104b129],

1	U	NNP	O	U	nsubj	3	SENT_234	[p12l20t121r57b151],
2	,	,	O	,	_	0	SENT_234	[p12l20t121r57b151],
3	,3	CD	NUMBER	,3	_	0	SENT_234	[p12l251t116r794b182],
4	_	CD	NUMBER	_	dobj	3	SENT_234	[p12l251t116r794b182],
5	:	:	O	:	_	0	SENT_234	[p12l251t116r794b182],
6	_	CD	NUMBER	_	dep	4	SENT_234	[p12l251t116r794b182],
7	Lo	NNP	O	Lo	dep	6	SENT_234	[p12l251t116r794b182],
8	_	CD	NUMBER	_	num	7	SENT_234	[p12l251t116r794b182],
9	,	,	O	,	_	0	SENT_234	[p12l251t116r794b182],
10	\	CD	NUMBER	\	appos	4	SENT_234	[p12l251t116r794b182],
11	,	,	O	,	_	0	SENT_234	[p12l251t116r794b182],
12	\	CD	NUMBER	\	num	13	SENT_234	[p12l251t116r794b182],
13	o_v	NN	O	o_v	dobj	3	SENT_234	[p12l976t106r1283b182],
14	+	CC	O	+	_	0	SENT_234	[p12l976t106r1283b182],
15	I	PRP	O	I	conj_+	13	SENT_234	[p12l976t106r1283b182],
16	+1	CD	NUMBER	+1	dep	15	SENT_234	[p12l1369t106r1413b142],
17	;	:	O	;	_	0	SENT_234	[p12l1760t124r2105b179],
18	_	CD	NUMBER	_	num	19	SENT_234	[p12l1760t124r2105b179],
19	-52.5	CD	NUMBER	-52.5	dep	22	SENT_234	[p12l1760t124r2105b179],
20	9	CD	NUMBER	9	number	21	SENT_234	[p12l20t154r57b207],
21	>	JJR	O	>	amod	19	SENT_234	[p12l251t157r795b226],
22	‘	CD	NUMBER	‘	dep	13	SENT_234	[p12l251t157r795b226],
23	:	:	O	:	_	0	SENT_234	[p12l251t157r795b226],
24	r	NN	O	r	dep	25	SENT_234	[p12l251t157r795b226],
25	\	CD	NUMBER	\	parataxis	3	SENT_234	[p12l251t157r795b226],
26	coo	NN	O	coo	nn	28	SENT_234	[p12l251t157r795b226],
27	'	''	O	'	_	0	SENT_234	[p12l251t157r795b226],
28	oO	NN	O	oo	dep	25	SENT_234	[p12l976t155r1547b219],
29	.	.	O	.	_	0	SENT_234	[p12l976t155r1547b219],
30	"	''	O	"	punct	3	SENT_234	[p12l976t155r1547b219],

1	.	.	O	.	_	0	SENT_235	[p12l976t155r1547b219],

1	°	NN	O	°	_	0	SENT_236	[p12l976t155r1547b219],
2	?	.	O	?	_	0	SENT_236	[p12l976t155r1547b219],

1	+	CC	O	+	nsubj	4	SENT_237	[p12l976t155r1547b219],
2	'	''	O	'	_	0	SENT_237	[p12l976t155r1547b219],
3	$	$	MONEY	$	dep	4	SENT_237	[p12l1769t156r2118b224],
4	n	NN	MONEY	n	_	0	SENT_237	[p12l1769t156r2118b224],
5	<	VBG	O	<	partmod	4	SENT_237	[p12l1769t156r2118b224],
6	Eo	NN	O	eo	dobj	5	SENT_237	[p12l1769t156r2118b224],
7	.	.	O	.	_	0	SENT_237	[p12l1769t156r2118b224],

1	2	CD	NUMBER	2	_	0	SENT_238	[p12l11t214r57b267],
2	Utecooooo	NN	ORGANIZATION	utecooooo	rcmod	1	SENT_238	[p12l250t206r795b256],
3	1	CD	NUMBER	1	dep	2	SENT_238	[p12l976t218r1547b257],
4	--	:	O	--	_	0	SENT_238	[p12l976t218r1547b257],
5	.	.	O	.	_	0	SENT_238	[p12l976t218r1547b257],

1	.	.	O	.	_	0	SENT_239	[p12l976t218r1547b257],

1	—	NN	O	—	_	0	SENT_240	[p12l976t218r1547b257],
2	.	.	O	.	_	0	SENT_240	[p12l976t218r1547b257],

1	OONC	NN	ORGANIZATION	oonc	nn	2	SENT_241	[p12l976t218r1547b257],
2	o	NN	O	o	_	0	SENT_241	[p12l1769t227r1806b257],
3	-5	CD	NUMBER	-5	dep	2	SENT_241	[p12l1956t217r2105b274],

1	cu	NN	O	cu	_	0	SENT_242	[p12l1510t253r1548b286],
2	com	NN	O	com	dep	1	SENT_242	[p12l1769t243r2005b292],
3	"	''	O	"	punct	2	SENT_242	[p12l7t290r57b343],

1	5	CD	NUMBER	5	num	3	SENT_243	[p12l7t290r57b343],
2	a3	NN	O	a3	nn	3	SENT_243	[p12l1510t291r1548b323],
3	o.	NN	O	o.	nsubj	4	SENT_243	[p12l1769t277r2104b331, p12l1510t329r1547b377],
4	_	NN	O	_	_	0	SENT_243	[p12l1769t277r2104b331, p12l1510t329r1547b377],
5	'	''	O	'	_	0	SENT_243	[p12l1769t277r2104b331, p12l1510t329r1547b377],
6	:	:	O	:	_	0	SENT_243	[p12l1769t277r2104b331, p12l1510t329r1547b377],
7	|	CD	NUMBER	|	dep	4	SENT_243	[p12l1769t277r2104b331, p12l1510t329r1547b377],
8	E	NN	O	e	prep	7	SENT_243	[p12l1769t277r2104b331, p12l1510t329r1547b377],
9	ooO	NN	O	ooo	dep	8	SENT_243	[p12l1768t320r2089b364],
10	'	''	O	'	_	0	SENT_243	[p12l1768t320r2089b364],
11	e	SYM	O	e	dep	7	SENT_243	[p12l20t369r57b418],
12	L0	FW	O	l0	nn	13	SENT_243	[p12l1858t342r2105b411],
13	‘	FW	O	‘	amod	14	SENT_243	[p12l1858t342r2105b411],
14	<	JJR	O	<	dep	7	SENT_243	[p12l1858t342r2105b411],
15	'	''	O	'	_	0	SENT_243	[p12l1858t342r2105b411],
16	5	CD	NUMBER	5	number	17	SENT_243	[p12l1858t342r2105b411],
17	°	CD	NUMBER	°	dep	4	SENT_243	[p12l1858t342r2105b411],
18	~	NN	O	~	nn	19	SENT_243	[p12l1858t342r2105b411],
19	’	NN	O	’	dep	17	SENT_243	[p12l1858t342r2105b411],
20	.	.	O	.	_	0	SENT_243	[p12l11t461r57b477],

1	.	.	O	.	_	0	SENT_244	[p12l11t461r57b477],

1	_	NN	O	_	_	0	SENT_245	[p12l11t461r57b477],
2	.	.	O	.	_	0	SENT_245	[p12l11t461r57b477],

1	S	NN	O	s	nn	2	SENT_246	[p12l1498t445r1547b474],
2	gn	NN	O	gn	_	0	SENT_246	[p12l1769t438r2105b491],
3	_	CD	NUMBER	_	num	5	SENT_246	[p12l1769t438r2105b491],
4	~	NN	O	~	nn	5	SENT_246	[p12l1769t438r2105b491],
5	«	NN	O	«	dep	2	SENT_246	[p12l1769t438r2105b491],
6	.	.	O	.	_	0	SENT_246	[p12l1769t438r2105b491],

1	—	NN	O	—	_	0	SENT_247	[p12l1769t438r2105b491],
2	.	.	O	.	_	0	SENT_247	[p12l1769t438r2105b491],

1	<	JJR	O	<	_	0	SENT_248	[p12l1769t438r2105b491],
2	D	NN	O	d	dep	1	SENT_248	[p12l1769t438r2105b491],

1	Q	NNP	O	Q	_	0	SENT_249	[p12l746t464r794b504],
2	4.0	CD	NUMBER	4.0	num	1	SENT_249	[p12l1502t479r1547b496, p12l20t481r57b513],
3	-	:	O	-	_	0	SENT_249	[p12l1502t479r1547b496, p12l20t481r57b513],
4	’	CD	NUMBER	’	dep	1	SENT_249	[p12l1502t479r1547b496, p12l20t481r57b513],

1	en	IN	O	en	_	0	SENT_250	[p12l1769t497r1806b526],
2	0-5	CD	NUMBER	0-5	number	3	SENT_250	[p12l1968t477r2104b522],
3	(	CD	NUMBER	(	num	4	SENT_250	[p12l20t572r57b605],
4	5	CD	NUMBER	5	prep_en	11	SENT_250	[p12l20t572r57b605],
5	"	``	O	"	punct	4	SENT_250	[p12l772t556r809b591],
6	1	CD	NUMBER	1	number	7	SENT_250	[p12l772t556r809b591],
7	(	CD	NUMBER	(	nn	10	SENT_250	[p12l1510t555r1548b588],
8	5	CD	NUMBER	5	num	9	SENT_250	[p12l1510t555r1548b588],
9	‘	NN	O	‘	dep	7	SENT_250	[p12l1756t544r2105b596],
10	E030	NN	O	e030	dep	4	SENT_250	[p12l1756t544r2105b596],
11	has	VBZ	O	have	_	0	SENT_250	[p12l20t607r135b634],
12	‘	CD	NUMBER	‘	dobj	11	SENT_250	[p12l763t597r801b624],
13	I	PRP	O	I	nsubj	14	SENT_250	[p12l763t597r801b624],
14	’	VBP	O	’	rcmod	12	SENT_250	[p12l763t597r801b624],
15	QOCE	NN	O	qoce	dobj	14	SENT_250	[p12l1769t580r2105b648],
16	(	CD	NUMBER	(	num	15	SENT_250	[p12l20t631r157b670],
17	BU	NN	O	bu	nn	20	SENT_250	[p12l20t631r157b670],
18	N	NN	O	n	nn	20	SENT_250	[p12l763t628r801b654],
19	U	NNP	O	U	nn	20	SENT_250	[p12l1498t617r1548b649],
20	Li	NNP	PERSON	Li	nsubj	11	SENT_250	[p12l1868t636r2004b654],

1	-1	CD	NUMBER	-1	_	0	SENT_251	[p12l111t710r156b727],
2	-	:	O	-	_	0	SENT_251	[p12l111t710r156b727],
3	:	:	O	:	_	0	SENT_251	[p12l111t710r156b727],
4	(	NN	O	(	nsubj	5	SENT_251	[p12l1510t690r1548b719],
5	D	NN	O	d	dep	1	SENT_251	[p12l1510t690r1548b719],
6	.	.	O	.	_	0	SENT_251	[p12l1756t687r2105b741],

1	—	NN	O	—	_	0	SENT_252	[p12l1756t687r2105b741],
2	.	.	O	.	_	0	SENT_252	[p12l1756t687r2105b741],

1	COha	NN	O	coha	_	0	SENT_253	[p12l1756t687r2105b741],
2	_	SYM	O	_	dep	1	SENT_253	[p12l1756t687r2105b741],
3	)	SYM	O	)	dep	1	SENT_253	[p12l1756t687r2105b741],

1	org	NN	O	org	nn	3	SENT_254	[p12l20t727r157b763],
2	3	CD	NUMBER	3	num	3	SENT_254	[p12l746t708r795b746],
3	(	NN	O	(	_	0	SENT_254	[p12l1510t723r1548b752],
4	1	CD	NUMBER	1	number	5	SENT_254	[p12l1510t723r1548b752],
5	)	CD	NUMBER	)	dep	3	SENT_254	[p12l1510t723r1548b752],
6	4-100	CD	NUMBER	4-100	num	7	SENT_254	[p12l1760t711r2005b763],
7	o	NN	O	o	dep	5	SENT_254	[p12l20t795r156b834],
8	)	CD	NUMBER	)	num	10	SENT_254	[p12l20t795r156b834],
9	:	:	O	:	_	0	SENT_254	[p12l20t795r156b834],
10	‘	CD	NUMBER	‘	dep	5	SENT_254	[p12l20t795r156b834],
11	:	:	O	:	_	0	SENT_254	[p12l20t795r156b834],
12	U	NNP	O	U	nn	13	SENT_254	[p12l498t791r549b822],
13	’	NNP	O	’	dep	5	SENT_254	[p12l498t791r549b822],
14	‘	NN	O	‘	nn	15	SENT_254	[p12l746t822r795b853],
15	C	NN	O	c	dep	13	SENT_254	[p12l746t822r795b853],
16	Q.	NNP	O	Q.	prep	3	SENT_254	[p12l1510t815r1560b847],
17	‘	CD	NUMBER	‘	num	19	SENT_254	[p12l1769t806r2105b857],
18	DOCUQ	NNP	O	DOCUQ	nn	19	SENT_254	[p12l1769t806r2105b857],
19	XS	NN	O	x	dep	16	SENT_254	[p12l8t833r157b877],
20	+	CC	O	+	_	0	SENT_254	[p12l8t833r157b877],
21	E	NN	O	e	nn	22	SENT_254	[p12l498t829r534b876],
22	G	NN	O	g	conj_+	19	SENT_254	[p12l758t858r795b890],
23	)	CD	NUMBER	)	num	24	SENT_254	[p12l758t858r795b890],
24	X	NN	O	x	dep	22	SENT_254	[p12l1511t851r1547b882],
25	-	:	O	-	_	0	SENT_254	[p12l1756t844r1806b876],
26	C	NN	O	c	dep	24	SENT_254	[p12l1756t844r1806b876],
27	_	SYM	O	_	dep	24	SENT_254	[p12l1997t861r2104b882],
28	-	:	O	-	_	0	SENT_254	[p12l1997t861r2104b882],
29	I-I	NN	O	i-i	nn	30	SENT_254	[p12l1997t861r2104b882],
30	O	NN	O	o	dep	31	SENT_254	[p12l20t905r156b949],
31	>	JJR	O	>	dep	16	SENT_254	[p12l20t905r156b949],
32	\	CD	NUMBER	\	number	33	SENT_254	[p12l485t934r536b955],
33	1	CD	NUMBER	1	dep	31	SENT_254	[p12l746t930r794b951],
34	,	,	O	,	_	0	SENT_254	[p12l1626t919r1806b957],
35	.	.	O	.	_	0	SENT_254	[p12l1626t919r1806b957],
36	'	''	O	'	_	0	SENT_254	[p12l1626t919r1806b957],

1	\	NN	O	\	_	0	SENT_255	[p12l1626t919r1806b957],
2	:	:	O	:	_	0	SENT_255	[p12l1626t919r1806b957],
3	-	:	O	-	_	0	SENT_255	[p12l1956t905r2119b948],
4	kc	NN	O	kc	dep	1	SENT_255	[p12l1956t905r2119b948],
5	)	CD	NUMBER	)	num	6	SENT_255	[p12l1956t905r2119b948],
6	o.E	NN	O	o.e	dep	4	SENT_255	[p12l20t942r156b986],
7	_	NN	O	_	dep	6	SENT_255	[p12l486t958r534b987],
8	c	NN	O	c	dobj	7	SENT_255	[p12l486t958r534b987],
9	cu	NN	O	cu	nn	10	SENT_255	[p12l758t957r795b990],
10	A	NN	O	a	rcmod	8	SENT_255	[p12l974t990r1037b1005],
11	Qq	NN	O	qq	dep	10	SENT_255	[p12l1510t946r1677b998],
12	;	:	O	;	_	0	SENT_255	[p12l1510t946r1677b998],
13	9	CD	NUMBER	9	dep	11	SENT_255	[p12l1856t936r2104b999],
14	-	:	O	-	_	0	SENT_255	[p12l1856t936r2104b999],
15	:	:	O	:	_	0	SENT_255	[p12l1856t936r2104b999],
16	.	.	O	.	_	0	SENT_255	[p12l1856t936r2104b999],

1	E	NN	O	e	nn	2	SENT_256	[p12l1856t936r2104b999],
2	Ea	NN	O	ea	_	0	SENT_256	[p12l20t986r157b1073],
3	»	SYM	O	»	dep	2	SENT_256	[p12l20t986r157b1073],
4	-	:	O	-	_	0	SENT_256	[p12l503t997r1038b1054],
5	~	NN	O	~	nn	6	SENT_256	[p12l503t997r1038b1054],
6	EA	NN	O	ea	dep	2	SENT_256	[p12l503t997r1038b1054],
7	<	JJR	O	<	dep	8	SENT_256	[p12l503t997r1038b1054],
8	=	JJ	O	=	amod	6	SENT_256	[p12l503t997r1038b1054],
9	v	LS	O	v	dep	6	SENT_256	[p12l503t997r1038b1054],
10	<	JJR	O	<	amod	12	SENT_256	[p12l1510t979r2105b1067],
11	=	JJ	O	=	amod	12	SENT_256	[p12l1510t979r2105b1067],
12	s2	NN	O	s2	dep	6	SENT_256	[p12l1510t979r2105b1067],
13	°	NN	O	°	dep	12	SENT_256	[p12l1510t979r2105b1067],
14	85	CD	NUMBER	85	number	13	SENT_256	[p12l1510t979r2105b1067],
15	*	CD	NUMBER	*	number	13	SENT_256	[p12l1510t979r2105b1067],
16	9	CD	NUMBER	9	number	13	SENT_256	[p12l1510t979r2105b1067],

1	;	:	O	;	_	0	SENT_257	[p12l120t1050r156b1068],
2	_	CD	NUMBER	_	dep	3	SENT_257	[p12l120t1050r156b1068],
3	L	NN	O	l	_	0	SENT_257	[p12l758t1048r794b1065],

1	am	VBP	O	be	cop	3	SENT_258	[p12l20t1075r157b1134],
2	23035	CD	NUMBER	23035	num	3	SENT_258	[p12l498t1049r1023b1128],
3	sea	NN	O	sea	_	0	SENT_258	[p12l1510t1051r2105b1131],
4	--	:	O	--	_	0	SENT_258	[p12l1510t1051r2105b1131],
5	98	CD	NUMBER	98	num	6	SENT_258	[p12l1510t1051r2105b1131],
6	n	NN	O	n	dep	3	SENT_258	[p12l8t1176r56b1213],
7	_	VBG	O	_	partmod	6	SENT_258	[p12l8t1176r56b1213],
8	4-4-C75	NN	O	4-4-c75	dobj	7	SENT_258	[p12l619t1149r1038b1209],
9	,	,	O	,	_	0	SENT_258	[p12l619t1149r1038b1209],
10	—	CD	NUMBER	—	num	11	SENT_258	[p12l1498t1175r1547b1181],
11	n.	NN	O	n.	npadvmod	12	SENT_258	[p12l1778t1150r2105b1208],
12	<	JJR	O	<	amod	8	SENT_258	[p12l1778t1150r2105b1208],
13	_	CD	NUMBER	_	num	15	SENT_258	[p12l1778t1150r2105b1208],
14	3o	NN	O	3o	nn	15	SENT_258	[p12l1778t1150r2105b1208],
15	}	NN	O	}	dep	7	SENT_258	[p12l485t1222r809b1268],
16	,	,	O	,	_	0	SENT_258	[p12l485t1222r809b1268],
17	D'	NN	O	d'	appos	15	SENT_258	[p12l485t1222r809b1268],
18	>	JJR	O	>	amod	19	SENT_258	[p12l485t1222r809b1268],
19	C	NN	O	c	dep	17	SENT_258	[p12l485t1222r809b1268],
20	)	CD	NUMBER	)	number	21	SENT_258	[p12l485t1222r809b1268],
21	3	CD	NUMBER	3	dep	19	SENT_258	[p12l974t1212r1038b1267],
22	,	,	O	,	_	0	SENT_258	[p12l974t1212r1038b1267],
23	.	.	O	.	_	0	SENT_258	[p12l974t1212r1038b1267],

1	_	NN	O	_	_	0	SENT_259	[p12l1364t1213r2104b1267],
2	:	:	O	:	_	0	SENT_259	[p12l1364t1213r2104b1267],
3	>	JJR	O	>	dep	1	SENT_259	[p12l1364t1213r2104b1267],
4	.	.	O	.	_	0	SENT_259	[p12l1364t1213r2104b1267],

1	<	JJR	O	<	_	0	SENT_260	[p12l1364t1213r2104b1267],
2	§	CD	NUMBER	§	dep	6	SENT_260	[p12l1364t1213r2104b1267],
3	m	NN	O	m	nn	6	SENT_260	[p12l1364t1213r2104b1267],
4	_	CD	NUMBER	_	num	6	SENT_260	[p12l1364t1213r2104b1267],
5	N	NN	O	n	nn	6	SENT_260	[p12l1364t1213r2104b1267],
6	EEE5	NN	O	eee5	dep	1	SENT_260	[p12l8t1260r301b1321],
7	<	JJR	O	<	amod	6	SENT_260	[p12l512t1236r1167b1338],
8	'	''	O	'	_	0	SENT_260	[p12l512t1236r1167b1338],
9	>	JJR	O	>	dobj	6	SENT_260	[p12l512t1236r1167b1338],
10	.	.	O	.	_	0	SENT_260	[p12l512t1236r1167b1338],
11	'	''	O	'	_	0	SENT_260	[p12l512t1236r1167b1338],

1	a	DT	O	a	_	0	SENT_261	[p12l512t1236r1167b1338],
2	'	''	O	'	_	0	SENT_261	[p12l512t1236r1167b1338],
3	>	JJR	O	>	dep	5	SENT_261	[p12l512t1236r1167b1338],
4	'	''	O	'	_	0	SENT_261	[p12l512t1236r1167b1338],
5	a	DT	O	a	rcmod	1	SENT_261	[p12l512t1236r1167b1338],
6	'	''	O	'	_	0	SENT_261	[p12l512t1236r1167b1338],
7	>	JJR	O	>	amod	8	SENT_261	[p12l512t1236r1167b1338],
8	QD	NN	O	qd	dobj	5	SENT_261	[p12l512t1236r1167b1338],
9	£	CD	NUMBER	£	number	10	SENT_261	[p12l512t1236r1167b1338],
10	L	NN	O	l	num	15	SENT_261	[p12l512t1236r1167b1338],
11	jq	NN	O	jq	nn	15	SENT_261	[p12l1363t1254r2105b1328],
12	)	NN	O	)	nn	15	SENT_261	[p12l1363t1254r2105b1328],
13	'	''	O	'	_	0	SENT_261	[p12l1363t1254r2105b1328],
14	C	NN	O	c	nn	15	SENT_261	[p12l1363t1254r2105b1328],
15	”	NN	O	”	dep	8	SENT_261	[p12l1363t1254r2105b1328],
16	!	.	O	!	_	0	SENT_261	[p12l1363t1254r2105b1328],

1	.	.	O	.	_	0	SENT_262	[p12l1363t1254r2105b1328],

1	*	NN	O	*	nn	2	SENT_263	[p12l1363t1254r2105b1328],
2	EO	NN	O	eo	_	0	SENT_263	[p12l1363t1254r2105b1328],
3	*	CD	NUMBER	*	number	4	SENT_263	[p12l1363t1254r2105b1328],
4	\	CD	NUMBER	\	num	6	SENT_263	[p12l1363t1254r2105b1328],
5	QCDE	NN	O	qcde	nn	6	SENT_263	[p12l19t1318r300b1372],
6	¢	NN	O	¢	npadvmod	7	SENT_263	[p12l503t1303r2104b1373],
7	<	JJR	O	<	amod	9	SENT_263	[p12l503t1303r2104b1373],
8	\	CD	NUMBER	\	amod	9	SENT_263	[p12l503t1303r2104b1373],
9	r	NN	O	r	rcmod	2	SENT_263	[p12l503t1303r2104b1373],
10	|	NN	O	|	prep	9	SENT_263	[p12l503t1303r2104b1373],
11	3	CD	NUMBER	3	dep	10	SENT_263	[p12l503t1303r2104b1373],
12	;	:	O	;	_	0	SENT_263	[p12l503t1303r2104b1373],
13	'	''	O	'	_	0	SENT_263	[p12l503t1303r2104b1373],
14	:	:	O	:	_	0	SENT_263	[p12l503t1303r2104b1373],
15	\	CD	MONEY	\	num	17	SENT_263	[p12l503t1303r2104b1373],
16	£	CD	MONEY	£	num	17	SENT_263	[p12l503t1303r2104b1373],
17	«	NN	O	«	dep	2	SENT_263	[p12l503t1303r2104b1373],
18	z	SYM	O	z	dep	19	SENT_263	[p12l503t1303r2104b1373],
19	~	FW	O	~	rcmod	17	SENT_263	[p12l503t1303r2104b1373],
20	"	``	O	"	punct	19	SENT_263	[p12l503t1303r2104b1373],
21	-	:	O	-	_	0	SENT_263	[p12l503t1303r2104b1373],
22	CGEGJVJ	NN	O	cgegjvj	dep	2	SENT_263	[p12l503t1303r2104b1373],
23	:	:	O	:	_	0	SENT_263	[p12l503t1303r2104b1373],
24	—	CD	NUMBER	—	num	25	SENT_263	[p12l8t1364r157b1393],
25	u	NN	O	u	dep	22	SENT_263	[p12l8t1364r157b1393],
26	:	:	O	:	_	0	SENT_263	[p12l8t1364r157b1393],
27	(	CD	NUMBER	(	number	29	SENT_263	[p12l263t1371r301b1404],
28	5	CD	NUMBER	5	number	29	SENT_263	[p12l263t1371r301b1404],
29	O	NN	O	o	amod	31	SENT_263	[p12l485t1359r886b1415],
30	>>	NN	O	>>	nn	31	SENT_263	[p12l485t1359r886b1415],
31	o	NN	O	o	dep	2	SENT_263	[p12l485t1359r886b1415],
32	>	JJR	O	>	npadvmod	33	SENT_263	[p12l1002t1362r1030b1387],
33	<	JJR	O	<	amod	31	SENT_263	[p12l1002t1362r1030b1387],
34	_	CD	NUMBER	_	dep	31	SENT_263	[p12l1235t1343r1906b1411],
35	:	:	O	:	_	0	SENT_263	[p12l1235t1343r1906b1411],
36	u	FW	O	u	dep	2	SENT_263	[p12l1235t1343r1906b1411],
37	_	FW	O	_	nn	38	SENT_263	[p12l1235t1343r1906b1411],
38	|	FW	O	|	amod	36	SENT_263	[p12l1235t1343r1906b1411],
39	.	.	O	.	_	0	SENT_263	[p12l1235t1343r1906b1411],

1	—	NN	O	—	_	0	SENT_264	[p12l1235t1343r1906b1411],
2	.	.	O	.	_	0	SENT_264	[p12l1235t1343r1906b1411],

1	§	NN	O	§	nn	2	SENT_265	[p12l1235t1343r1906b1411],
2	Qo	NN	O	qo	_	0	SENT_265	[p12l1235t1343r1906b1411],
3	€	CD	MONEY	€	number	4	SENT_265	[p12l8t1394r301b1467],
4	93 338033	CD	MONEY	93 338033	dep	2	SENT_265	[p12l486t1389r1414b1463],[p12l8t1394r301b1467],
5	”	CD	MONEY	”	num	6	SENT_265	[p12l486t1389r1414b1463],
6	)	NN	O	)	dep	4	SENT_265	[p12l486t1389r1414b1463],
7	:	:	O	:	_	0	SENT_265	[p12l1756t1382r2105b1471],
8	C.	NNP	O	C.	dep	4	SENT_265	[p12l1756t1382r2105b1471],
9	,	,	O	,	_	0	SENT_265	[p12l1756t1382r2105b1471],
10	c_L	NN	O	c_l	appos	8	SENT_265	[p12l1756t1382r2105b1471],
11	'	''	O	'	_	0	SENT_265	[p12l1756t1382r2105b1471],
12	°	CD	NUMBER	°	num	13	SENT_265	[p12l1756t1382r2105b1471],
13	N	NN	O	n	dep	2	SENT_265	[p12l1268t1448r1290b1463],
14	O	NN	O	o	nn	16	SENT_265	[p12l1868t1442r1906b1474],
15	C	NN	O	c	nn	16	SENT_265	[p12l2068t1440r2104b1469],
16	I-Sn	NN	O	i-sn	dep	13	SENT_265	[p12l8t1457r300b1509],
17	.	.	O	.	_	0	SENT_265	[p12l8t1457r300b1509],

1	<	JJR	O	<	_	0	SENT_266	[p12l486t1450r2105b1509],
2	Emm3-O	NN	O	emm3-o	dep	1	SENT_266	[p12l486t1450r2105b1509],
3	.	.	O	.	_	0	SENT_266	[p12l486t1450r2105b1509],

1	§	NN	O	§	_	0	SENT_267	[p12l486t1450r2105b1509],
2	30cts_o	CD	NUMBER	30cts_o	num	3	SENT_267	[p12l486t1450r2105b1509],
3	<	JJR	O	<	dep	1	SENT_267	[p12l486t1450r2105b1509],
4	o-i	CD	NUMBER	o-i	num	6	SENT_267	[p12l486t1450r2105b1509],
5	—	NN	O	—	nn	6	SENT_267	[p12l486t1450r2105b1509],
6	cts	NNS	O	ct	dep	1	SENT_267	[p12l486t1450r2105b1509],

1	Clin	NNP	O	Clin	nn	2	SENT_268	[p12l1389t1660r1475b1698],
2	Phoirmocokinet	NNP	O	Phoirmocokinet	_	0	SENT_268	[p12l1497t1660r1863b1698],
3	2008	CD	DATE	2008	num	2	SENT_268	[p12l1879t1660r1999b1701],
4	;	:	O	;	_	0	SENT_268	[p12l1879t1660r1999b1701],
5	47	CD	NUMBER	47	number	6	SENT_268	[p12l2018t1660r2070b1698],
6	(	CD	NUMBER	(	dep	2	SENT_268	[p12l2090t1660r2150b1704],
7	5	CD	NUMBER	5	num	8	SENT_268	[p12l2090t1660r2150b1704],
8	)	NN	O	)	dep	6	SENT_268	[p12l2090t1660r2150b1704],

1	328	CD	NUMBER	328	num	2	SENT_269	[p12l6t1778r54b1802],
2	Werner	NNP	O	Werner	_	0	SENT_269	[p12l6t1814r105b1838],
3	et	FW	O	et	dep	2	SENT_269	[p12l116t1816r139b1838],
4	all	DT	O	all	dep	3	SENT_269	[p12l149t1813r179b1838],
5	.	.	O	.	_	0	SENT_269	[p12l149t1813r179b1838],

1	Table	NNP	O	Table	_	0	SENT_270	[p12l8t2017r175b2065],
2	IV	CD	NUMBER	iv	dep	1	SENT_270	[p12l206t2017r278b2065],
3	.	.	O	.	_	0	SENT_270	[p12l206t2017r278b2065],

1	Factorial	JJ	O	factorial	amod	3	SENT_271	[p12l312t2017r552b2065],
2	ANOVA	NNP	O	ANOVA	nn	3	SENT_271	[p12l582t2016r808b2066],
3	p-values	NNS	O	p-value	dep	22	SENT_271	[p12l837t2017r1077b2078],
4	for	IN	O	for	_	0	SENT_271	[p12l1105t2017r1181b2065],
5	the	DT	O	the	det	6	SENT_271	[p12l1207t2017r1294b2065],
6	effect	NN	O	effect	prep_for	3	SENT_271	[p12l1324t2017r1479b2065],
7	of	IN	O	of	_	0	SENT_271	[p12l1508t2017r1559b2065],
8	genetic	JJ	O	genetic	amod	9	SENT_271	[p12l1587t2017r1793b2078],
9	factors	NNS	O	factor	prep_of	6	SENT_271	[p12l1821t2017r2012b2065],
10	and	CC	O	and	_	0	SENT_271	[p12l2042t2017r2145b2065],
11	gender	NN	O	gender	dep	22	SENT_271	[p12l10t2108r210b2168],
12	on	IN	O	on	_	0	SENT_271	[p12l234t2119r300b2155],
13	steady-state	JJ	O	steady-state	amod	14	SENT_271	[p12l329t2108r678b2168],
14	torasemide	NN	O	torasemide	prep_on	11	SENT_271	[p12l704t2108r1022b2155],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_271	[p12l1050t2108r1518b2168],
16	parametersa	NN	O	parametersa	dep	22	SENT_271	[p12l1545t2110r1893b2168],
17	Parameter	NN	O	parameter	nn	22	SENT_271	[p12l13t2237r311b2285],
18	CYP2C9	NN	O	cyp2c9	nn	22	SENT_271	[p12l782t2235r1032b2285],
19	SLCO1	NN	O	slco1	nn	22	SENT_271	[p12l1160t2235r1364b2285],
20	B1	NN	O	b1	nn	22	SENT_271	[p12l1372t2237r1444b2284],
21	c.	NN	O	c.	nn	22	SENT_271	[p12l1471t2235r1749b2285],
22	521T	NN	O	521t	dep	27	SENT_271	[p12l1471t2235r1749b2285],
23	>	JJR	O	>	dep	22	SENT_271	[p12l1471t2235r1749b2285],
24	C	NN	O	c	nn	27	SENT_271	[p12l1471t2235r1749b2285],
25	Gender	NN	O	gender	nn	27	SENT_271	[p12l1885t2236r2099b2285],
26	genotype	NN	O	genotype	nn	27	SENT_271	[p12l778t2331r1040b2389],
27	SNP	NN	O	snp	_	0	SENT_271	[p12l1157t2326r1285b2376],

1	AUC24	NN	O	auc24	nsubj	23	SENT_272	[p12l8t2438r287b2500],
2	,	,	O	,	_	0	SENT_272	[p12l8t2438r287b2500],
3	ss	VBP	O	ss	rcmod	1	SENT_272	[p12l8t2438r287b2500],
4	/	:	O	/	punct	5	SENT_272	[p12l8t2438r287b2500],
5	D	NN	O	d	dep	3	SENT_272	[p12l291t2439r330b2486],
6	0.002	CD	NUMBER	0.002	num	7	SENT_272	[p12l778t2440r936b2488],
7	<	JJR	O	<	nsubj	18	SENT_272	[p12l1156t2440r1379b2488],
8	0.0001	CD	NUMBER	0.0001	num	9	SENT_272	[p12l1156t2440r1379b2488],
9	<	JJR	O	<	npadvmod	14	SENT_272	[p12l1884t2440r2107b2488],
10	0.0001	CD	NUMBER	0.0001	npadvmod	11	SENT_272	[p12l1884t2440r2107b2488],
11	Bodyweight-normalized	JJ	O	bodyweight-normalized	amod	9	SENT_272	[p12l12t2530r678b2590],
12	0.003	CD	NUMBER	0.003	number	13	SENT_272	[p12l778t2530r936b2578],
13	0.001	CD	NUMBER	0.001	num	9	SENT_272	[p12l1192t2530r1341b2578],
14	<	JJR	O	<	amod	7	SENT_272	[p12l1884t2530r2107b2578],
15	0.0001	CD	NUMBER	0.0001	num	16	SENT_272	[p12l1884t2530r2107b2578],
16	AUC24	NN	O	auc24	dep	7	SENT_272	[p12l8t2618r287b2680],
17	,	,	O	,	_	0	SENT_272	[p12l8t2618r287b2680],
18	ss	VBP	O	ss	rcmod	5	SENT_272	[p12l8t2618r287b2680],
19	/	:	O	/	punct	5	SENT_272	[p12l8t2618r287b2680],
20	D	NN	O	d	nn	21	SENT_272	[p12l291t2619r330b2666],
21	Cmax	NN	O	cmax	dobj	3	SENT_272	[p12l10t2708r238b2770],
22	,	,	O	,	_	0	SENT_272	[p12l10t2708r238b2770],
23	ss	VBP	O	ss	dep	40	SENT_272	[p12l10t2708r238b2770],
24	/	:	O	/	punct	40	SENT_272	[p12l10t2708r238b2770],
25	D	NN	O	d	dep	34	SENT_272	[p12l241t2709r281b2756],
26	0.316	CD	NUMBER	0.316	num	25	SENT_272	[p12l778t2710r936b2758],
27	0.839	CD	NUMBER	0.839	num	29	SENT_272	[p12l1192t2711r1350b2758],
28	0.037	CD	NUMBER	0.037	num	29	SENT_272	[p12l1920t2710r2079b2758],
29	t1/2	NN	O	t1/2	dep	25	SENT_272	[p12l8t2803r68b2855],
30	0.988	CD	NUMBER	0.988	number	31	SENT_272	[p12l778t2801r936b2848],
31	0.073	CD	NUMBER	0.073	dep	29	SENT_272	[p12l1193t2801r1351b2848],
32	0.002	CD	NUMBER	0.002	num	33	SENT_272	[p12l1920t2800r2078b2848],
33	CL/F	NN	O	cl/f	dep	34	SENT_272	[p12l10t2890r146b2939],
34	0.173	CD	NUMBER	0.173	dep	40	SENT_272	[p12l778t2892r936b2939],
35	0.019	CD	NUMBER	0.019	number	36	SENT_272	[p12l1192t2891r1351b2939],
36	0.074	CD	NUMBER	0.074	dep	34	SENT_272	[p12l1920t2892r2078b2939],
37	a	DT	O	a	det	39	SENT_272	[p12l10t3013r42b3049],
38	Bold	JJ	MISC	bold	amod	39	SENT_272	[p12l125t3001r247b3049],
39	type	NN	O	type	dep	36	SENT_272	[p12l274t3004r394b3062],
40	indicates	VBZ	O	indicate	_	0	SENT_272	[p12l423t3001r673b3049],
41	a	DT	O	a	det	44	SENT_272	[p12l700t3013r732b3049],
42	statistically	RB	O	statistically	advmod	43	SENT_272	[p12l758t3001r1069b3062],
43	significant	JJ	O	significant	amod	44	SENT_272	[p12l1095t3000r1380b3062],
44	result	NN	O	result	dobj	40	SENT_272	[p12l1408t3001r1575b3049],
45	.	.	O	.	_	0	SENT_272	[p12l1408t3001r1575b3049],

1	AUC24	NN	O	auc24	_	0	SENT_273	[p12l9t3090r276b3153],
2	,	,	O	,	_	0	SENT_273	[p12l9t3090r276b3153],
3	ss	NN	O	ss	nn	5	SENT_273	[p12l9t3090r276b3153],
4	=	JJ	O	=	amod	5	SENT_273	[p12l298t3112r331b3131],
5	area	NN	O	area	appos	1	SENT_273	[p12l354t3103r480b3139],
6	under	IN	O	under	_	0	SENT_273	[p12l504t3091r666b3139],
7	the	DT	O	the	det	10	SENT_273	[p12l684t3091r772b3139],
8	plasma	NN	O	plasma	nn	10	SENT_273	[p12l796t3091r1000b3151],
9	concentration-time	NN	O	concentration-time	nn	10	SENT_273	[p12l1021t3091r1551b3139],
10	curve	NN	O	curve	prep_under	5	SENT_273	[p12l1573t3103r1727b3139],
11	during	IN	O	during	_	0	SENT_273	[p12l1750t3091r1925b3152],
12	the	DT	O	the	det	15	SENT_273	[p12l1947t3091r2034b3139],
13	24hour	JJ	O	24hour	amod	15	SENT_273	[p12l2056t3092r2146b3138, p12l11t3181r138b3229],
14	dosing	NN	O	dosing	nn	15	SENT_273	[p12l175t3181r361b3242],
15	interval	NN	O	interval	prep_during	10	SENT_273	[p12l405t3181r606b3229],
16	at	IN	O	at	_	0	SENT_273	[p12l648t3184r699b3229],
17	steady	JJ	O	steady	amod	18	SENT_273	[p12l738t3181r927b3242],
18	state	NN	O	state	prep_at	15	SENT_273	[p12l965t3184r1117b3237],
19	;	:	O	;	_	0	SENT_273	[p12l965t3184r1117b3237],
20	CLIF	NN	O	clif	dep	5	SENT_273	[p12l1161t3180r1301b3229],
21	=	JJ	O	=	amod	24	SENT_273	[p12l1341t3202r1374b3221],
22	apparent	JJ	O	apparent	amod	24	SENT_273	[p12l1415t3184r1668b3241],
23	oral	JJ	O	oral	amod	24	SENT_273	[p12l1707t3181r1809b3229],
24	clearance	NN	O	clearance	dep	20	SENT_273	[p12l1851t3181r2143b3237],
25	;	:	O	;	_	0	SENT_273	[p12l1851t3181r2143b3237],
26	Cmax	NNP	O	Cmax	dep	5	SENT_273	[p12l10t3270r229b3333],
27	,	,	O	,	_	0	SENT_273	[p12l10t3270r229b3333],
28	ss	NN	O	ss	appos	26	SENT_273	[p12l10t3270r229b3333],
29	=	JJ	O	=	amod	32	SENT_273	[p12l255t3292r289b3311],
30	peak	NN	O	peak	nn	32	SENT_273	[p12l317t3271r455b3331],
31	plasma	NN	O	plasma	nn	32	SENT_273	[p12l481t3271r686b3331],
32	concentration	NN	O	concentration	dep	28	SENT_273	[p12l712t3271r1096b3319],
33	at	IN	O	at	_	0	SENT_273	[p12l1125t3274r1176b3319],
34	steady	JJ	O	steady	amod	35	SENT_273	[p12l1202t3271r1390b3332],
35	state	NN	O	state	prep_at	32	SENT_273	[p12l1416t3274r1567b3327],
36	;	:	O	;	_	0	SENT_273	[p12l1416t3274r1567b3327],
37	CYP	NN	O	cyp	dep	5	SENT_273	[p12l1598t3270r1727b3319],
38	=	JJ	O	=	amod	40	SENT_273	[p12l1754t3292r1788b3311],
39	cytochrome	NN	O	cytochrome	nn	40	SENT_273	[p12l1815t3271r2146b3332],
40	P450	NN	O	p450	dep	37	SENT_273	[p12l13t3361r172b3417],
41	;	:	O	;	_	0	SENT_273	[p12l13t3361r172b3417],
42	D	NN	O	d	dep	5	SENT_273	[p12l227t3361r267b3408],
43	=	JJ	O	=	amod	44	SENT_273	[p12l316t3382r350b3401],
44	dose	NN	O	dose	dep	42	SENT_273	[p12l398t3361r550b3417],
45	;	:	O	;	_	0	SENT_273	[p12l398t3361r550b3417],
46	SLCO	NN	O	slco	nn	49	SENT_273	[p12l603t3360r778b3409],
47	=	JJ	O	=	amod	49	SENT_273	[p12l828t3382r861b3401],
48	solute	JJ	O	solute	amod	49	SENT_273	[p12l910t3361r1079b3409],
49	carrier	NN	O	carrier	dep	5	SENT_273	[p12l1128t3361r1310b3409],
50	organic	JJ	O	organic	amod	52	SENT_273	[p12l1357t3361r1566b3422],
51	anion	NN	O	anion	nn	52	SENT_273	[p12l1615t3361r1768b3409],
52	transporter	NN	O	transporter	dep	49	SENT_273	[p12l1817t3364r2143b3421],
53	;	:	O	;	_	0	SENT_273	[p12l1817t3364r2143b3421],
54	SNP	NN	O	snp	dep	5	SENT_273	[p12l10t3450r138b3499],
55	=	JJ	O	=	amod	58	SENT_273	[p12l166t3472r199b3491],
56	single	JJ	O	single	amod	58	SENT_273	[p12l226t3451r391b3512],
57	nucleotide	NN	O	nucleotide	nn	58	SENT_273	[p12l420t3451r710b3499],
58	polymorphism	NN	O	polymorphism	dep	54	SENT_273	[p12l738t3451r1151b3512],
59	;	:	O	;	_	0	SENT_273	[p12l738t3451r1151b3512],
60	t1/2	NN	O	t1/2	dep	5	SENT_273	[p12l1180t3454r1243b3505],
61	=	JJ	O	=	amod	63	SENT_273	[p12l1269t3472r1303b3491],
62	elimination	NN	O	elimination	nn	63	SENT_273	[p12l1330t3451r1634b3499],
63	half-life	NN	O	half-life	dep	60	SENT_273	[p12l1665t3451r1883b3499],
64	.	.	O	.	_	0	SENT_273	[p12l1665t3451r1883b3499],

1	plasma	NN	O	plasma	_	0	SENT_274	[p12l8t3683r237b3756],
2	concentration-time	NN	O	concentration-time	nn	3	SENT_274	[p12l316t3683r926b3739],
3	curves	NNS	O	curve	dep	1	SENT_274	[p12l1006t3700r1213b3739],
4	for	IN	O	for	_	0	SENT_274	[p12l1295t3683r1389b3739],
5	the	DT	O	the	det	6	SENT_274	[p12l1467t3683r1563b3739],
6	effect	NN	O	effect	prep_for	3	SENT_274	[p12l1644t3683r1827b3739],
7	of	IN	O	of	_	0	SENT_274	[p12l1906t3682r1976b3739],
8	the	DT	O	the	prep_of	6	SENT_274	[p12l2050t3683r2147b3739],

1	SLCOIBI	NNP	PERSON	SLCOIBI	nsubj	2	SENT_275	[p13l9t21r329b78],
2	c.	VBD	O	c.	_	0	SENT_275	[p13l354t20r677b78],
3	521T	CD	NUMBER	521t	num	6	SENT_275	[p13l354t20r677b78],
4	>	JJR	O	>	amod	6	SENT_275	[p13l354t20r677b78],
5	C	NN	O	c	nn	6	SENT_275	[p13l354t20r677b78],
6	SNP	NN	O	snp	dobj	2	SENT_275	[p13l699t21r844b78],
7	(	CD	NUMBER	(	num	10	SENT_275	[p13l865t21r1081b94],
8	figure	NN	O	figure	nn	10	SENT_275	[p13l865t21r1081b94],
9	lb	NN	O	lb	nn	10	SENT_275	[p13l1107t21r1203b90],
10	)	NN	O	)	nsubj	17	SENT_275	[p13l1107t21r1203b90],
11	or	CC	O	or	_	0	SENT_275	[p13l1225t38r1291b77],
12	gender	NN	O	gender	nn	15	SENT_275	[p13l1309t21r1528b94],
13	(	CD	NUMBER	(	num	15	SENT_275	[p13l1547t21r1763b94],
14	figure	NN	O	figure	nn	15	SENT_275	[p13l1547t21r1763b94],
15	1c	NN	O	1c	conj_or	10	SENT_275	[p13l1789t21r1881b90],
16	)	CD	NUMBER	)	dep	15	SENT_275	[p13l1789t21r1881b90],
17	demonstrated	VBD	O	demonstrate	dep	2	SENT_275	[p13l1902t21r2145b77, p13l11t122r223b178],
18	a	DT	O	a	det	21	SENT_275	[p13l243t139r277b178],
19	38	CD	PERCENT	38	number	20	SENT_275	[p13l296t122r437b179],
20	%	NN	PERCENT	%	amod	21	SENT_275	[p13l296t122r437b179],
21	increase	NN	O	increase	dobj	17	SENT_275	[p13l459t122r723b178],
22	in	IN	O	in	_	0	SENT_275	[p13l742t122r803b178],
23	the	DT	O	the	det	24	SENT_275	[p13l822t122r918b178],
24	AUC24	NN	O	auc24	prep_in	21	SENT_275	[p13l937t122r1237b194],
25	,	,	O	,	_	0	SENT_275	[p13l937t122r1237b194],
26	ss	NN	O	ss	conj_and	21	SENT_275	[p13l937t122r1237b194],
27	in	IN	O	in	_	0	SENT_275	[p13l1257t122r1318b178],
28	patients	NNS	O	patient	prep_in	26	SENT_275	[p13l1336t122r1585b195],
29	heterozygous	JJ	O	heterozygous	amod	26	SENT_275	[p13l1605t122r2034b195],
30	for	IN	O	for	_	0	SENT_275	[p13l2055t122r2149b178],
31	the	DT	O	the	det	34	SENT_275	[p13l8t223r105b279],
32	SLCOIBI	NNP	O	SLCOIBI	nn	34	SENT_275	[p13l142t223r463b280],
33	c.	NN	O	c.	nn	34	SENT_275	[p13l506t222r829b280],
34	521T	NN	O	521t	prep_for	29	SENT_275	[p13l506t222r829b280],
35	>	JJR	O	>	amod	37	SENT_275	[p13l506t222r829b280],
36	C	NN	O	c	nn	37	SENT_275	[p13l506t222r829b280],
37	SNP	NN	ORGANIZATION	snp	dep	21	SENT_275	[p13l870t223r1015b280],
38	compared	VBN	O	compare	prep	37	SENT_275	[p13l1052t223r1370b296],
39	with	IN	O	with	pcomp	38	SENT_275	[p13l1406t223r1548b280],
40	patients	NNS	O	patient	pobj	39	SENT_275	[p13l1584t223r1833b296],
41	with	IN	O	with	_	0	SENT_275	[p13l1872t223r2014b279],
42	the	DT	O	the	det	44	SENT_275	[p13l2051t223r2147b279],
43	reference	NN	O	reference	nn	44	SENT_275	[p13l8t324r308b380],
44	genotype	NN	O	genotype	prep_with	40	SENT_275	[p13l332t332r644b397],
45	,	,	O	,	_	0	SENT_275	[p13l332t332r644b397],
46	and	CC	O	and	_	0	SENT_275	[p13l671t324r785b380],
47	a	DT	O	a	det	50	SENT_275	[p13l809t341r843b380],
48	52	CD	PERCENT	52	number	49	SENT_275	[p13l866t323r1008b381],
49	%	NN	PERCENT	%	amod	50	SENT_275	[p13l866t323r1008b381],
50	increase	NN	O	increase	dobj	17	SENT_275	[p13l1034t324r1297b380],
51	in	IN	O	in	_	0	SENT_275	[p13l1321t324r1382b380],
52	women	NNS	O	woman	prep_in	50	SENT_275	[p13l1405t341r1641b380],
53	compared	VBN	O	compare	_	0	SENT_275	[p13l1665t324r1983b397],
54	with	IN	O	with	prepc_compared_with	52	SENT_275	[p13l2006t324r2147b381],
55	men	NNS	O	man	pobj	52	SENT_275	[p13l9t442r162b481],
56	.	.	O	.	_	0	SENT_275	[p13l9t442r162b481],

1	The	DT	O	the	det	3	SENT_276	[p13l187t425r311b481],
2	dose-corrected	JJ	O	dose-corrected	amod	3	SENT_276	[p13l333t425r808b481],
3	Cmax	NN	O	cmax	nsubjpass	9	SENT_276	[p13l829t425r1057b497],
4	,	,	O	,	_	0	SENT_276	[p13l829t425r1057b497],
5	ss	NN	O	ss	appos	3	SENT_276	[p13l829t425r1057b497],
6	of	IN	O	of	_	0	SENT_276	[p13l1080t425r1150b481],
7	torasemide	NN	O	torasemide	prep_of	5	SENT_276	[p13l1165t425r1519b481],
8	was	VBD	O	be	auxpass	9	SENT_276	[p13l1541t442r1662b482],
9	predicted	VBN	O	predict	_	0	SENT_276	[p13l1684t425r1985b498],
10	only	RB	O	only	advmod	9	SENT_276	[p13l2006t425r2146b498],
11	by	IN	O	by	_	0	SENT_276	[p13l7t526r87b599],
12	female	JJ	O	female	amod	15	SENT_276	[p13l126t526r344b582],
13	gender	NN	O	gender	nn	15	SENT_276	[p13l384t526r603b599],
14	(	NN	O	(	nn	15	SENT_276	[p13l643t526r705b599],
15	p	NN	O	p	prep_by	10	SENT_276	[p13l643t526r705b599],
16	=	JJ	O	=	amod	18	SENT_276	[p13l746t549r788b572],
17	0.037	CD	NUMBER	0.037	tmod	16	SENT_276	[p13l828t526r1051b595],
18	)	NN	O	)	dobj	9	SENT_276	[p13l828t526r1051b595],
19	,	,	O	,	_	0	SENT_276	[p13l828t526r1051b595],
20	whereas	IN	O	whereas	mark	53	SENT_276	[p13l1094t526r1355b583],
21	the	DT	O	the	det	25	SENT_276	[p13l1396t526r1492b582],
22	CYP2C9	NN	O	cyp2c9	nn	25	SENT_276	[p13l1535t526r1814b583],
23	genotype	NN	O	genotype	nn	25	SENT_276	[p13l1853t534r2146b599],
24	(	NN	O	(	nn	25	SENT_276	[p13l11t627r73b700],
25	p	NN	O	p	nsubj	53	SENT_276	[p13l11t627r73b700],
26	=	JJ	O	=	amod	40	SENT_276	[p13l108t650r149b673],
27	0.316	CD	NUMBER	0.316	number	28	SENT_276	[p13l183t626r388b696],
28	)	CD	NUMBER	)	amod	40	SENT_276	[p13l183t626r388b696],
29	or	CC	O	or	_	0	SENT_276	[p13l424t644r490b683],
30	heterozygosity	NN	O	heterozygosity	npadvmod	36	SENT_276	[p13l520t627r995b700],
31	for	IN	O	for	_	0	SENT_276	[p13l1029t627r1123b683],
32	the	DT	O	the	det	35	SENT_276	[p13l1154t627r1250b683],
33	SLCOIBI	NNP	O	SLCOIBI	nn	35	SENT_276	[p13l1284t627r1604b684],
34	c.	NN	O	c.	nn	35	SENT_276	[p13l1644t626r1966b684],
35	521T	NN	O	521t	prep_for	30	SENT_276	[p13l1644t626r1966b684],
36	>	JJR	O	>	amod	40	SENT_276	[p13l1644t626r1966b684],
37	C	NN	O	c	nn	40	SENT_276	[p13l1644t626r1966b684],
38	SNP	NN	O	snp	nn	40	SENT_276	[p13l2003t627r2147b684],
39	(	CD	NUMBER	(	num	40	SENT_276	[p13l11t728r73b801],
40	p	NN	O	p	dep	25	SENT_276	[p13l11t728r73b801],
41	=	JJ	O	=	amod	43	SENT_276	[p13l106t751r147b774],
42	0.839	CD	NUMBER	0.839	num	43	SENT_276	[p13l180t728r384b797],
43	)	NN	O	)	nsubj	44	SENT_276	[p13l180t728r384b797],
44	had	VBD	O	have	rcmod	40	SENT_276	[p13l417t728r533b784],
45	no	DT	O	no	det	47	SENT_276	[p13l564t745r642b784],
46	significant	JJ	O	significant	amod	47	SENT_276	[p13l676t728r1015b801],
47	impact	NN	O	impact	dobj	44	SENT_276	[p13l1045t728r1265b801],
48	on	IN	O	on	_	0	SENT_276	[p13l1295t745r1374b784],
49	the	DT	O	the	det	51	SENT_276	[p13l1404t728r1501b784],
50	torasemide	NN	O	torasemide	nn	51	SENT_276	[p13l1532t728r1886b784],
51	CmaX	NN	O	cmax	prep_on	47	SENT_276	[p13l1918t728r2146b800],
52	,	,	O	,	_	0	SENT_276	[p13l1918t728r2146b800],
53	ss	VBP	O	ss	advcl	9	SENT_276	[p13l1918t728r2146b800],
54	(	RB	O	(	advmod	55	SENT_276	[p13l11t829r304b903],
55	adjusted	VBN	O	adjust	amod	57	SENT_276	[p13l11t829r304b903],
56	multiple	JJ	O	multiple	amod	57	SENT_276	[p13l330t829r598b903],
57	r2	NN	O	r2	nsubj	60	SENT_276	[p13l624t825r682b885],
58	=	JJ	O	=	amod	60	SENT_276	[p13l710t853r751b876],
59	0.40	CD	NUMBER	0.40	num	60	SENT_276	[p13l779t830r961b899],
60	)	NN	O	)	xcomp	53	SENT_276	[p13l779t830r961b899],
61	.	.	O	.	_	0	SENT_276	[p13l779t830r961b899],

1	Impact	NN	O	impact	_	0	SENT_277	[p13l110t1050r361b1118],
2	of	IN	O	of	_	0	SENT_277	[p13l386t1050r454b1105],
3	Angiotensin	NN	O	angiotensin	nn	7	SENT_277	[p13l477t1050r886b1120],
4	II	CD	NUMBER	ii	num	7	SENT_277	[p13l917t1050r940b1104],
5	Receptor	NN	O	receptor	nn	7	SENT_277	[p13l972t1050r1297b1118],
6	Blocker	NN	O	blocker	nn	7	SENT_277	[p13l1325t1050r1577b1105],
7	Comedicotion	NN	O	comedicotion	prep_of	1	SENT_277	[p13l1602t1049r2111b1105],
8	on	IN	O	on	_	0	SENT_277	[p13l107t1166r193b1208],
9	Phormocokinetics	NNS	O	phormocokinetic	prep_on	1	SENT_277	[p13l224t1153r848b1208],
10	of	IN	O	of	_	0	SENT_277	[p13l875t1153r943b1208],
11	Torosemide	NN	O	torosemide	prep_of	9	SENT_277	[p13l965t1153r1369b1208],

1	There	EX	O	there	expl	2	SENT_278	[p13l106t1342r292b1399],
2	were	VBD	O	be	_	0	SENT_278	[p13l342t1360r496b1399],
3	no	DT	O	no	det	4	SENT_278	[p13l545t1360r623b1399],
4	patients	NNS	O	patient	nsubj	2	SENT_278	[p13l671t1342r921b1415],
5	with	IN	O	with	_	0	SENT_278	[p13l972t1342r1114b1399],
6	the	DT	O	the	det	10	SENT_278	[p13l1162t1342r1259b1399],
7	CYP2C9	NN	O	cyp2c9	nn	10	SENT_278	[p13l1311t1343r1666b1399],
8	*	NN	O	*	nn	10	SENT_278	[p13l1311t1343r1666b1399],
9	3	CD	NUMBER	3	num	10	SENT_278	[p13l1311t1343r1666b1399],
10	allele	NN	O	allele	prep_with	4	SENT_278	[p13l1720t1342r1892b1399],
11	in	IN	O	in	_	0	SENT_278	[p13l1941t1342r2002b1398],
12	the	DT	O	the	det	14	SENT_278	[p13l2050t1342r2147b1399],
13	losartan	NN	O	losartan	nn	14	SENT_278	[p13l9t1443r263b1500],
14	group	NN	O	group	prep_in	2	SENT_278	[p13l292t1461r495b1517],
15	,	,	O	,	_	0	SENT_278	[p13l292t1461r495b1517],
16	whereas	IN	O	whereas	mark	23	SENT_278	[p13l527t1443r788b1500],
17	five	CD	NUMBER	five	num	18	SENT_278	[p13l819t1443r942b1500],
18	patients	NNS	O	patient	nsubj	23	SENT_278	[p13l969t1443r1218b1517],
19	in	IN	O	in	_	0	SENT_278	[p13l1249t1443r1309b1499],
20	the	DT	O	the	det	22	SENT_278	[p13l1337t1443r1434b1500],
21	irbesartan	NN	O	irbesartan	nn	22	SENT_278	[p13l1463t1443r1780b1500],
22	group	NN	O	group	prep_in	18	SENT_278	[p13l1809t1461r1994b1517],
23	carried	VBD	O	carry	advcl	2	SENT_278	[p13l2024t1461r2145b1500, p13l8t1544r133b1601],
24	this	DT	O	this	det	25	SENT_278	[p13l164t1544r277b1601],
25	allele	NN	O	allele	dobj	23	SENT_278	[p13l312t1544r500b1601],
26	.	.	O	.	_	0	SENT_278	[p13l312t1544r500b1601],

1	This	DT	O	this	det	3	SENT_279	[p13l535t1544r675b1601],
2	unbalanced	JJ	O	unbalanced	amod	3	SENT_279	[p13l708t1544r1076b1601],
3	distribution	NN	O	distribution	nsubj	8	SENT_279	[p13l1108t1544r1479b1601],
4	of	IN	O	of	_	0	SENT_279	[p13l1511t1544r1581b1601],
5	the	DT	O	the	det	7	SENT_279	[p13l1607t1544r1703b1601],
6	polymorphic	JJ	O	polymorphic	amod	7	SENT_279	[p13l1734t1544r2146b1618],
7	alleles	NNS	O	allele	prep_of	3	SENT_279	[p13l10t1645r212b1702],
8	contributed	VBD	O	contribute	_	0	SENT_279	[p13l271t1645r638b1702],
9	to	TO	O	to	_	0	SENT_279	[p13l693t1654r753b1702],
10	different	JJ	O	different	amod	12	SENT_279	[p13l811t1645r1089b1702],
11	baseline	NN	O	baseline	nn	12	SENT_279	[p13l1143t1645r1407b1702],
12	AUC24	NN	O	auc24	prep_to	8	SENT_279	[p13l1464t1646r1763b1718],
13	,	,	O	,	_	0	SENT_279	[p13l1464t1646r1763b1718],
14	ss	NN	O	ss	nn	15	SENT_279	[p13l1464t1646r1763b1718],
15	values	NNS	O	value	appos	12	SENT_279	[p13l1821t1645r2024b1702],
16	of	IN	O	of	_	0	SENT_279	[p13l2083t1645r2153b1702],
17	torasemide	NN	O	torasemide	prep_of	15	SENT_279	[p13l9t1746r362b1803],
18	in	IN	O	in	_	0	SENT_279	[p13l389t1746r450b1802],
19	the	DT	O	the	det	21	SENT_279	[p13l476t1746r573b1803],
20	two	CD	NUMBER	two	num	21	SENT_279	[p13l600t1755r718b1803],
21	groups	NNS	O	group	prep_in	8	SENT_279	[p13l747t1764r962b1820],
22	(	CD	NUMBER	(	num	23	SENT_279	[p13l993t1746r1209b1820],
23	figure	NN	O	figure	dep	8	SENT_279	[p13l993t1746r1209b1820],
24	2	CD	NUMBER	2	num	25	SENT_279	[p13l1237t1747r1317b1816],
25	)	NN	O	)	dep	23	SENT_279	[p13l1237t1747r1317b1816],
26	.	.	O	.	_	0	SENT_279	[p13l1237t1747r1317b1816],

1	The	DT	O	the	det	2	SENT_280	[p13l106t1846r229b1903],
2	AUC24	NN	O	auc24	nsubj	11	SENT_280	[p13l250t1847r549b1919],
3	,	,	O	,	_	0	SENT_280	[p13l250t1847r549b1919],
4	ss	NN	O	ss	appos	2	SENT_280	[p13l250t1847r549b1919],
5	of	IN	O	of	_	0	SENT_280	[p13l572t1846r642b1903],
6	losartan	NN	O	losartan	prep_of	4	SENT_280	[p13l657t1846r912b1903],
7	and	CC	O	and	_	0	SENT_280	[p13l934t1846r1047b1903],
8	its	PRP$	O	its	poss	10	SENT_280	[p13l1067t1846r1140b1903],
9	metabolite	NN	O	metabolite	nn	10	SENT_280	[p13l1162t1846r1502b1903],
10	EXP3174	NN	O	exp3174	prep_of	4	SENT_280	[p13l1523t1847r1835b1903],
11	averaged	VBD	O	average	_	0	SENT_280	[p13l1858t1846r2148b1920],
12	1468	CD	DATE	1468	dobj	11	SENT_280	[p13l16t1947r165b2004],
13	i	FW	O	i	dep	12	SENT_280	[p13l187t1950r230b2003],
14	751	CD	NUMBER	751	num	17	SENT_280	[p13l249t1947r361b2004],
15	ug	NN	O	ug	nn	17	SENT_280	[p13l388t1962r471b2021],
16	o	NN	O	o	nn	17	SENT_280	[p13l496t1972r520b1996],
17	h/L	NN	O	h/l	dep	12	SENT_280	[p13l544t1947r655b2004],
18	and	CC	O	and	_	0	SENT_280	[p13l675t1947r789b2004],
19	13	CD	NUMBER	13	number	20	SENT_280	[p13l816t1948r882b2004],
20	374	CD	NUMBER	374	conj_and	12	SENT_280	[p13l911t1948r1028b2004],
21	i	FW	O	i	dep	20	SENT_280	[p13l1047t1950r1090b2003],
22	5759	CD	DATE	5759	num	25	SENT_280	[p13l1110t1947r1266b2005],
23	ug	NN	O	ug	nn	25	SENT_280	[p13l1289t1962r1372b2021],
24	o	NN	O	o	nn	25	SENT_280	[p13l1397t1972r1421b1996],
25	h/L	NN	O	h/l	dep	20	SENT_280	[p13l1444t1947r1573b2014],
26	,	,	O	,	_	0	SENT_280	[p13l1444t1947r1573b2014],
27	respectively	RB	O	respectively	advmod	11	SENT_280	[p13l1594t1947r2000b2021],
28	.	.	O	.	_	0	SENT_280	[p13l1594t1947r2000b2021],

1	The	DT	O	the	det	2	SENT_281	[p13l2023t1947r2147b2004],
2	AUC24	NN	O	auc24	nsubj	9	SENT_281	[p13l8t2050r308b2122],
3	,	,	O	,	_	0	SENT_281	[p13l8t2050r308b2122],
4	sS	NN	O	ss	appos	2	SENT_281	[p13l8t2050r308b2122],
5	of	IN	O	of	_	0	SENT_281	[p13l343t2049r412b2106],
6	losartan	NN	O	losartan	prep_of	4	SENT_281	[p13l440t2049r694b2106],
7	and	CC	O	and	_	0	SENT_281	[p13l729t2049r842b2106],
8	EXP3174	NN	O	exp3174	prep_of	4	SENT_281	[p13l874t2050r1187b2106],
9	varied	VBD	O	vary	_	0	SENT_281	[p13l1221t2049r1421b2106],
10	5.6	CD	NUMBER	5.6	number	11	SENT_281	[p13l1455t2049r1711b2106],
11	—	CD	NUMBER	—	num	14	SENT_281	[p13l1455t2049r1711b2106],
12	fold	JJ	O	fold	amod	14	SENT_281	[p13l1455t2049r1711b2106],
13	(	NN	O	(	nn	14	SENT_281	[p13l1745t2050r1880b2119],
14	CV	NN	O	cv	dobj	9	SENT_281	[p13l1745t2050r1880b2119],
15	51.2	CD	PERCENT	51.2	number	16	SENT_281	[p13l1914t2049r2145b2119],
16	%	NN	PERCENT	%	amod	14	SENT_281	[p13l1914t2049r2145b2119],
17	)	CD	NUMBER	)	dep	14	SENT_281	[p13l1914t2049r2145b2119],
18	and	CC	O	and	_	0	SENT_281	[p13l10t2149r124b2206],
19	3.5	CD	NUMBER	3.5	number	20	SENT_281	[p13l170t2149r426b2206],
20	—	CD	NUMBER	—	num	23	SENT_281	[p13l170t2149r426b2206],
21	fold	JJ	O	fold	amod	23	SENT_281	[p13l170t2149r426b2206],
22	(	NN	O	(	nn	23	SENT_281	[p13l472t2150r607b2219],
23	CV	NN	O	cv	dobj	9	SENT_281	[p13l472t2150r607b2219],
24	43.1	CD	PERCENT	43.1	number	25	SENT_281	[p13l652t2150r904b2219],
25	%	NN	PERCENT	%	amod	23	SENT_281	[p13l652t2150r904b2219],
26	)	CD	NUMBER	)	tmod	9	SENT_281	[p13l652t2150r904b2219],
27	,	,	O	,	_	0	SENT_281	[p13l652t2150r904b2219],
28	respectively	RB	O	respectively	advmod	9	SENT_281	[p13l951t2149r1357b2223],
29	.	.	O	.	_	0	SENT_281	[p13l951t2149r1357b2223],

1	The	DT	O	the	det	5	SENT_282	[p13l1407t2149r1530b2206],
2	mean	NN	O	mean	nn	5	SENT_282	[p13l1575t2167r1749b2206],
3	torasemide	NN	O	torasemide	nn	5	SENT_282	[p13l1794t2149r2147b2206],
4	plasma	NN	O	plasma	nn	5	SENT_282	[p13l8t2251r238b2324],
5	concentration	NN	O	concentration	nsubj	17	SENT_282	[p13l299t2250r908b2307],
6	—	CD	NUMBER	—	num	8	SENT_282	[p13l299t2250r908b2307],
7	time	NN	O	time	nn	8	SENT_282	[p13l299t2250r908b2307],
8	curves	NNS	O	curve	dep	5	SENT_282	[p13l971t2268r1178b2307],
9	before	IN	O	before	_	0	SENT_282	[p13l1240t2250r1446b2307],
10	and	CC	O	and	_	0	SENT_282	[p13l1510t2250r1624b2307],
11	after	IN	O	after	_	0	SENT_282	[p13l1687t2250r1833b2307],
12	losartan	NN	O	losartan	nn	13	SENT_282	[p13l1893t2250r2147b2307],
13	comedication	NN	O	comedication	prep_before	8	SENT_282	[p13l9t2351r443b2408],
14	were	VBD	O	be	cop	17	SENT_282	[p13l470t2369r625b2408],
15	essentially	RB	O	essentially	advmod	17	SENT_282	[p13l652t2351r991b2425],
16	the	DT	O	the	det	17	SENT_282	[p13l1018t2351r1115b2408],
17	same	JJ	O	same	_	0	SENT_282	[p13l1144t2369r1322b2408],
18	.	.	O	.	_	0	SENT_282	[p13l1144t2369r1322b2408],

1	Accordingly	RB	O	accordingly	advmod	24	SENT_283	[p13l1353t2351r1773b2425],
2	,	,	O	,	_	0	SENT_283	[p13l1353t2351r1773b2425],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_283	[p13l1802t2351r2145b2425, p13l8t2452r225b2509],
4	parameters	NNS	O	parameter	nsubjpass	24	SENT_283	[p13l256t2461r609b2526],
5	for	IN	O	for	_	0	SENT_283	[p13l641t2452r735b2509],
6	torasemide	NN	O	torasemide	prep_for	4	SENT_283	[p13l763t2452r1117b2509],
7	such	JJ	O	such	_	0	SENT_283	[p13l1150t2452r1294b2509],
8	as	IN	O	as	_	0	SENT_283	[p13l1325t2470r1387b2509],
9	the	DT	O	the	det	10	SENT_283	[p13l1419t2452r1515b2509],
10	AUC24	NN	O	auc24	prep_such_as	6	SENT_283	[p13l1546t2453r1864b2525],
11	,	,	O	,	_	0	SENT_283	[p13l1546t2453r1864b2525],
12	Ss	NNP	O	Ss	prep_such_as	6	SENT_283	[p13l1546t2453r1864b2525],
13	,	,	O	,	_	0	SENT_283	[p13l1546t2453r1864b2525],
14	Cmams	NNP	O	Cmams	prep_such_as	6	SENT_283	[p13l1898t2453r2144b2525],
15	,	,	O	,	_	0	SENT_283	[p13l1898t2453r2144b2525],
16	tmax	NN	O	tmax	prep_such_as	6	SENT_283	[p13l9t2562r158b2620],
17	,	,	O	,	_	0	SENT_283	[p13l9t2562r158b2620],
18	t1/2	NN	O	t1/2	conj_and	10	SENT_283	[p13l202t2562r273b2618],
19	and	CC	O	and	_	0	SENT_283	[p13l315t2553r429b2610],
20	CLH3	NN	O	clh3	conj_and	10	SENT_283	[p13l470t2554r639b2610],
21	were	VBD	O	be	auxpass	24	SENT_283	[p13l680t2571r835b2610],
22	not	RB	O	not	neg	24	SENT_283	[p13l876t2562r979b2610],
23	significantly	RB	O	significantly	advmod	24	SENT_283	[p13l1022t2553r1421b2627],
24	changed	VBN	O	change	_	0	SENT_283	[p13l1464t2553r1732b2627],
25	by	IN	O	by	_	0	SENT_283	[p13l1771t2553r1851b2627],
26	losartan	NN	O	losartan	nn	28	SENT_283	[p13l1893t2553r2147b2610],
27	(	CD	NUMBER	(	num	28	SENT_283	[p13l11t2654r226b2728],
28	figure	NN	O	figure	agent	24	SENT_283	[p13l11t2654r226b2728],
29	2	CD	NUMBER	2	num	28	SENT_283	[p13l247t2655r302b2721],
30	,	,	O	,	_	0	SENT_283	[p13l247t2655r302b2721],
31	table	NN	O	table	nn	33	SENT_283	[p13l324t2654r479b2711],
32	V	NN	O	v	nn	33	SENT_283	[p13l499t2655r598b2724],
33	)	NN	O	)	dobj	24	SENT_283	[p13l499t2655r598b2724],
34	.	.	O	.	_	0	SENT_283	[p13l499t2655r598b2724],

1	A	DT	O	a	det	3	SENT_284	[p13l622t2655r679b2710],
2	significant	JJ	O	significant	amod	3	SENT_284	[p13l701t2654r1039b2728],
3	correlation	NN	O	correlation	nsubjpass	5	SENT_284	[p13l1058t2654r1407b2711],
4	was	VBD	O	be	auxpass	5	SENT_284	[p13l1426t2672r1548b2711],
5	observed	VBN	O	observe	_	0	SENT_284	[p13l1570t2654r1860b2711],
6	between	IN	O	between	_	0	SENT_284	[p13l1878t2654r2147b2711],
7	the	DT	O	the	det	8	SENT_284	[p13l8t2756r105b2813],
8	AUC24	NN	O	auc24	prep_between	5	SENT_284	[p13l139t2757r438b2829],
9	,	,	O	,	_	0	SENT_284	[p13l139t2757r438b2829],
10	sS	NN	O	ss	nn	11	SENT_284	[p13l139t2757r438b2829],
11	values	NNS	O	value	appos	8	SENT_284	[p13l473t2756r676b2813],
12	of	IN	O	of	_	0	SENT_284	[p13l712t2756r782b2813],
13	torasemide	NN	O	torasemide	dep	15	SENT_284	[p13l809t2756r1162b2813],
14	(	CD	NUMBER	(	num	13	SENT_284	[p13l1199t2756r1587b2826],
15	determined	VBN	O	determine	amod	23	SENT_284	[p13l1199t2756r1587b2826],
16	at	IN	O	at	_	0	SENT_284	[p13l1621t2765r1676b2813],
17	baseline	NN	O	baseline	nn	18	SENT_284	[p13l1707t2756r1997b2826],
18	)	NN	O	)	prep_at	15	SENT_284	[p13l1707t2756r1997b2826],
19	and	CC	O	and	_	0	SENT_284	[p13l2034t2756r2148b2813],
20	losartan	NN	O	losartan	nn	22	SENT_284	[p13l9t2856r263b2913],
21	(	CD	NUMBER	(	num	22	SENT_284	[p13l292t2857r572b2926],
22	Pearson	NNP	PERSON	Pearson	prep_at	15	SENT_284	[p13l292t2857r572b2926],
23	r	NN	O	r	prep_of	11	SENT_284	[p13l597t2874r624b2912],
24	=	JJ	O	=	amod	23	SENT_284	[p13l651t2880r692b2903],
25	0.61	CD	NUMBER	0.61	tmod	24	SENT_284	[p13l721t2856r877b2923],
26	,	,	O	,	_	0	SENT_284	[p13l721t2856r877b2923],
27	p	NN	O	p	appos	23	SENT_284	[p13l906t2874r944b2930],
28	=	JJ	O	=	amod	30	SENT_284	[p13l973t2880r1015b2903],
29	0.034	CD	NUMBER	0.034	tmod	28	SENT_284	[p13l1043t2857r1267b2926],
30	)	NN	O	)	dep	27	SENT_284	[p13l1043t2857r1267b2926],
31	,	,	O	,	_	0	SENT_284	[p13l1043t2857r1267b2926],
32	whereas	IN	O	whereas	mark	35	SENT_284	[p13l1297t2856r1558b2913],
33	a	DT	O	a	det	34	SENT_284	[p13l1588t2874r1622b2913],
34	correlation	NN	O	correlation	nsubj	35	SENT_284	[p13l1648t2856r1997b2913],
35	was	VBD	O	be	dep	23	SENT_284	[p13l2024t2874r2145b2913],

1	©	RB	O	©	advmod	2	SENT_285	[p13l10t3057r43b3091],
2	2008	CD	DATE	2008	_	0	SENT_285	[p13l62t3053r167b3091],
3	Adis	NNP	ORGANIZATION	Adis	nn	5	SENT_285	[p13l184t3053r280b3091],
4	Data	NNP	ORGANIZATION	Data	nn	5	SENT_285	[p13l299t3053r412b3091],
5	Information	NNP	ORGANIZATION	Information	dep	2	SENT_285	[p13l433t3053r695b3091],
6	BV	NN	ORGANIZATION	bv	dep	5	SENT_285	[p13l716t3053r784b3090],
7	.	.	O	.	_	0	SENT_285	[p13l716t3053r784b3090],

1	All	DT	O	all	det	2	SENT_286	[p13l804t3053r856b3090],
2	rights	NNS	O	rights	nsubj	3	SENT_286	[p13l876t3053r994b3100],
3	reserved	VBN	O	reserve	_	0	SENT_286	[p13l1013t3053r1222b3091],
4	.	.	O	.	_	0	SENT_286	[p13l1013t3053r1222b3091],

1	a	DT	O	a	_	0	SENT_287	[p13l435t3134r464b3166],

1	Torasemide	NNP	O	Torasemide	_	0	SENT_288	[p14l186t2436r228b2734],
2	plasma	NN	O	plasma	nn	3	SENT_288	[p14l186t2235r239b2415],
3	concentration	NN	O	concentration	dep	1	SENT_288	[p14l186t1880r228b2217],
4	(	CD	NUMBER	(	num	6	SENT_288	[p14l185t1619r240b1857],
5	pg/L/mg	NN	O	pg/l/mg	nn	6	SENT_288	[p14l185t1619r240b1857],
6	)	NN	O	)	dep	1	SENT_288	[p14l185t1619r240b1857],

1	O	NN	O	o	nn	3	SENT_289	[p14l1064t217r1110b263],
2	CYP2C9	NN	O	cyp2c9	nn	3	SENT_289	[p14l1157t220r1376b263],
3	*	NN	O	*	dep	14	SENT_289	[p14l1391t220r1501b263],
4	1	CD	NUMBER	1	dep	3	SENT_289	[p14l1391t220r1501b263],
5	/	:	O	/	punct	13	SENT_289	[p14l1391t220r1501b263],
6	*	CD	NUMBER	*	number	7	SENT_289	[p14l1391t220r1501b263],
7	1	CD	NUMBER	1	num	9	SENT_289	[p14l1391t220r1501b263],
8	(	NN	O	(	nn	9	SENT_289	[p14l1531t220r1575b274],
9	n	NN	O	n	dep	13	SENT_289	[p14l1531t220r1575b274],
10	=	JJ	O	=	amod	9	SENT_289	[p14l1596t220r1722b274],
11	15	CD	NUMBER	15	number	12	SENT_289	[p14l1596t220r1722b274],
12	)	CD	NUMBER	)	dep	10	SENT_289	[p14l1596t220r1722b274],
13	I	PRP	O	I	dep	4	SENT_289	[p14l1065t293r1106b333],
14	CYP2C9	VBP	O	cyp2c9	_	0	SENT_289	[p14l1157t289r1376b333],
15	*	CD	NUMBER	*	number	16	SENT_289	[p14l1391t289r1509b333],
16	1	CD	NUMBER	1	dobj	14	SENT_289	[p14l1391t289r1509b333],
17	/	:	O	/	punct	26	SENT_289	[p14l1391t289r1509b333],
18	*	CD	NUMBER	*	number	19	SENT_289	[p14l1391t289r1509b333],
19	2	CD	NUMBER	2	num	26	SENT_289	[p14l1391t289r1509b333],
20	(	NN	O	(	nn	26	SENT_289	[p14l1531t289r1575b344],
21	n	NN	O	n	nn	26	SENT_289	[p14l1531t289r1575b344],
22	=	JJ	O	=	amod	26	SENT_289	[p14l1596t309r1626b325],
23	4	CD	NUMBER	4	number	24	SENT_289	[p14l1644t289r1690b344],
24	)	CD	NUMBER	)	num	26	SENT_289	[p14l1644t289r1690b344],
25	V	NN	O	v	nn	26	SENT_289	[p14l1063t362r1111b410],
26	CYP2C9	NN	O	cyp2c9	dep	16	SENT_289	[p14l1157t358r1376b402],
27	*	NN	O	*	dep	26	SENT_289	[p14l1390t358r1510b402],
28	1	CD	NUMBER	1	dep	26	SENT_289	[p14l1390t358r1510b402],
29	/	:	O	/	punct	26	SENT_289	[p14l1390t358r1510b402],
30	*	CD	NUMBER	*	number	31	SENT_289	[p14l1390t358r1510b402],
31	3	CD	NUMBER	3	num	33	SENT_289	[p14l1390t358r1510b402],
32	(	NN	O	(	nn	33	SENT_289	[p14l1531t358r1575b413],
33	n	NN	O	n	npadvmod	34	SENT_289	[p14l1531t358r1575b413],
34	=	JJ	O	=	amod	16	SENT_289	[p14l1596t378r1626b394],
35	5	CD	NUMBER	5	num	36	SENT_289	[p14l1645t358r1690b412],
36	)	NN	O	)	nsubj	14	SENT_289	[p14l1645t358r1690b412],

1	O	NN	O	o	nn	4	SENT_290	[p14l1065t1762r1111b1809],
2	SLCO1B1	NN	O	slco1b1	nn	4	SENT_290	[p14l1157t1765r1406b1809],
3	c.	NN	O	c.	nn	4	SENT_290	[p14l1426t1766r1633b1809],
4	521TT	NN	O	521tt	_	0	SENT_290	[p14l1426t1766r1633b1809],
5	(	CD	NUMBER	(	num	6	SENT_290	[p14l1653t1765r1697b1820],
6	n	NN	O	n	dep	4	SENT_290	[p14l1653t1765r1697b1820],
7	=	JJ	O	=	quantmod	9	SENT_290	[p14l1718t1765r1844b1820],
8	13	CD	NUMBER	13	number	9	SENT_290	[p14l1718t1765r1844b1820],
9	)	CD	NUMBER	)	num	14	SENT_290	[p14l1718t1765r1844b1820],
10	O	NN	O	o	nn	14	SENT_290	[p14l1065t1833r1111b1880],
11	SLCO1B1c	NN	O	slco1b1c	nn	14	SENT_290	[p14l1157t1835r1637b1878],
12	.521	CD	NUMBER	.521	num	14	SENT_290	[p14l1157t1835r1637b1878],
13	TC	NN	O	tc	nn	14	SENT_290	[p14l1157t1835r1637b1878],
14	(	NN	O	(	dep	6	SENT_290	[p14l1659t1835r1703b1889],
15	n	NN	O	n	nn	17	SENT_290	[p14l1659t1835r1703b1889],
16	:11	CD	NUMBER	:11	num	17	SENT_290	[p14l1724t1835r1850b1889],
17	)	NN	O	)	dep	4	SENT_290	[p14l1724t1835r1850b1889],

1	o	NN	O	o	nn	2	SENT_291	[p15l1066t220r1112b267],
2	Women	NNS	O	woman	dep	3	SENT_291	[p15l1154t224r1346b267],
3	(	VBP	O	(	_	0	SENT_291	[p15l1369t224r1413b278],
4	n	NN	O	n	nsubj	5	SENT_291	[p15l1369t224r1413b278],
5	=	JJ	O	=	ccomp	3	SENT_291	[p15l1434t243r1463b260],
6	7	CD	NUMBER	7	num	7	SENT_291	[p15l1483t224r1528b278],
7	)	CD	NUMBER	)	iobj	5	SENT_291	[p15l1483t224r1528b278],
8	A	DT	O	a	det	11	SENT_291	[p15l1065t292r1113b339],
9	Men	NN	O	man	nn	11	SENT_291	[p15l1157t294r1260b336],
10	(	NN	O	(	nn	11	SENT_291	[p15l1283t293r1327b347],
11	n	NN	O	n	dobj	5	SENT_291	[p15l1283t293r1327b347],
12	=	JJ	O	=	amod	11	SENT_291	[p15l1348t312r1378b329],
13	17	CD	NUMBER	17	num	14	SENT_291	[p15l1401t293r1474b347],
14	)	NN	O	)	nsubj	3	SENT_291	[p15l1401t293r1474b347],

1	O	NN	O	o	_	0	SENT_292	[p15l371t1186r399b1228],

1	Time	NNP	O	Time	_	0	SENT_293	[p15l1112t1382r1236b1424],
2	(	CD	NUMBER	(	num	3	SENT_293	[p15l1258t1381r1320b1435],
3	h	NN	O	h	dep	1	SENT_293	[p15l1258t1381r1320b1435],
4	)	CD	NUMBER	)	dep	1	SENT_293	[p15l1258t1381r1320b1435],

1	Fig	NN	O	fig	_	0	SENT_294	[p15l9t1466r116b1528],
2	.	.	O	.	_	0	SENT_294	[p15l9t1466r116b1528],

1	1	LS	NUMBER	1	_	0	SENT_295	[p15l148t1467r194b1514],
2	.	.	O	.	_	0	SENT_295	[p15l148t1467r194b1514],

1	Mean	NN	O	mean	nsubj	20	SENT_296	[p15l226t1467r381b1515],
2	i	FW	O	i	dep	1	SENT_296	[p15l409t1472r444b1514],
3	standard	JJ	O	standard	amod	4	SENT_296	[p15l470t1467r718b1515],
4	error	NN	O	error	dep	1	SENT_296	[p15l748t1479r883b1515],
5	of	IN	O	of	_	0	SENT_296	[p15l909t1466r961b1515],
6	the	DT	O	the	det	11	SENT_296	[p15l986t1467r1074b1515],
7	mean	NN	O	mean	nn	11	SENT_296	[p15l1104t1479r1259b1515],
8	dose-normalized	JJ	O	dose-normalized	amod	11	SENT_296	[p15l1289t1467r1765b1515],
9	plasma	NN	O	plasma	nn	11	SENT_296	[p15l1795t1467r2001b1528],
10	concentration-time	NN	O	concentration-time	nn	11	SENT_296	[p15l2028t1479r2150b1515, p15l6t1555r432b1603],
11	curves	NNS	O	curve	prep_of	4	SENT_296	[p15l457t1567r645b1603],
12	of	IN	O	of	_	0	SENT_296	[p15l670t1554r721b1603],
13	torasemide	NN	O	torasemide	prep_of	11	SENT_296	[p15l743t1555r1063b1603],
14	after	IN	O	after	_	0	SENT_296	[p15l1088t1554r1216b1603],
15	oral	JJ	O	oral	amod	16	SENT_296	[p15l1239t1555r1341b1603],
16	administration	NN	O	administration	prep_after	13	SENT_296	[p15l1368t1555r1767b1603],
17	in	IN	O	in	_	0	SENT_296	[p15l1796t1555r1839b1602],
18	relation	NN	O	relation	prep_in	16	SENT_296	[p15l1869t1555r2074b1603],
19	to	TO	O	to	aux	20	SENT_296	[p15l2099t1558r2150b1603],
20	(	VB	O	(	purpcl	29	SENT_296	[p15l8t1642r79b1703],
21	a	DT	O	a	det	22	SENT_296	[p15l8t1642r79b1703],
22	)	NN	O	)	nsubj	25	SENT_296	[p15l8t1642r79b1703],
23	the	DT	O	the	det	25	SENT_296	[p15l118t1643r206b1691],
24	CYP2C9	NN	O	cyp2c9	nn	25	SENT_296	[p15l250t1641r500b1691],
25	genotype	NN	O	genotype	xcomp	20	SENT_296	[p15l533t1646r812b1704],
26	,	,	O	,	_	0	SENT_296	[p15l533t1646r812b1704],
27	(	NN	O	(	nn	28	SENT_296	[p15l856t1642r931b1703],
28	b	NN	O	b	nsubj	29	SENT_296	[p15l856t1642r931b1703],
29	)	VBD	O	)	_	0	SENT_296	[p15l856t1642r931b1703],
30	the	DT	O	the	det	33	SENT_296	[p15l970t1643r1058b1691],
31	SLCO1B1	NN	O	slco1b1	nn	33	SENT_296	[p15l1100t1641r1385b1691],
32	c.	NN	O	c.	nn	33	SENT_296	[p15l1424t1641r1704b1691],
33	521T	NN	O	521t	dep	41	SENT_296	[p15l1424t1641r1704b1691],
34	>	JJR	O	>	amod	36	SENT_296	[p15l1424t1641r1704b1691],
35	C	NN	O	c	nn	36	SENT_296	[p15l1424t1641r1704b1691],
36	genotype	NN	O	genotype	dep	33	SENT_296	[p15l1744t1646r2007b1704],
37	and	CC	O	and	_	0	SENT_296	[p15l2046t1643r2149b1691],
38	(	NN	O	(	nn	39	SENT_296	[p15l8t1730r79b1792],
39	c	NN	O	c	conj_and	41	SENT_296	[p15l8t1730r79b1792],
40	)	CD	NUMBER	)	num	41	SENT_296	[p15l8t1730r79b1792],
41	gender	NN	O	gender	dobj	29	SENT_296	[p15l119t1731r320b1793],
42	in	IN	O	in	_	0	SENT_296	[p15l357t1731r400b1779],
43	patients	NNS	O	patient	prep_in	41	SENT_296	[p15l441t1731r663b1792],
44	with	IN	O	with	_	0	SENT_296	[p15l700t1731r811b1779],
45	arterial	JJ	O	arterial	amod	46	SENT_296	[p15l851t1731r1043b1780],
46	hypertension	NN	O	hypertension	prep_with	43	SENT_296	[p15l1085t1731r1450b1793],
47	or	CC	O	or	_	0	SENT_296	[p15l1490t1743r1546b1779],
48	heart	NN	O	heart	nn	49	SENT_296	[p15l1583t1731r1726b1780],
49	failure	NN	O	failure	conj_or	41	SENT_296	[p15l1761t1730r1936b1780],
50	during	IN	O	during	_	0	SENT_296	[p15l1974t1731r2149b1793],
51	steady-state	JJ	O	steady-state	amod	52	SENT_296	[p15l6t1819r356b1881],
52	conditions	NNS	O	condition	prep_during	29	SENT_296	[p15l386t1819r690b1868],
53	.	.	O	.	_	0	SENT_296	[p15l386t1819r690b1868],

1	CYP	NN	O	cyp	_	0	SENT_297	[p15l723t1818r852b1868],
2	=	JJ	O	=	amod	4	SENT_297	[p15l882t1841r915b1860],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_297	[p15l944t1819r1277b1881],
4	P450	NN	O	p450	dep	1	SENT_297	[p15l1310t1819r1469b1876],
5	;	:	O	;	_	0	SENT_297	[p15l1310t1819r1469b1876],
6	SLCO	NN	O	slco	nn	9	SENT_297	[p15l1502t1818r1678b1868],
7	=	JJ	O	=	amod	9	SENT_297	[p15l1708t1841r1742b1860],
8	solute	JJ	O	solute	amod	9	SENT_297	[p15l1771t1820r1940b1868],
9	carrier	NN	O	carrier	dep	1	SENT_297	[p15l1970t1820r2153b1868],
10	organic	JJ	O	organic	amod	12	SENT_297	[p15l6t1907r216b1965],
11	anion	NN	O	anion	nn	12	SENT_297	[p15l242t1907r395b1956],
12	transporter	NN	O	transporter	dep	9	SENT_297	[p15l423t1911r750b1965],
13	.	.	O	.	_	0	SENT_297	[p15l423t1911r750b1965],

1	Clin	NNP	O	Clin	nn	2	SENT_298	[p15l1406t2112r1491b2149],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_298	[p15l1511t2112r1870b2150],
3	2008	CD	DATE	2008	num	2	SENT_298	[p15l1886t2112r2003b2152],
4	;	:	O	;	_	0	SENT_298	[p15l1886t2112r2003b2152],
5	47	CD	NUMBER	47	number	6	SENT_298	[p15l2021t2112r2072b2149],
6	(	CD	NUMBER	(	dep	2	SENT_298	[p15l2092t2112r2150b2155],
7	5	CD	NUMBER	5	num	8	SENT_298	[p15l2092t2112r2150b2155],
8	)	NN	O	)	dep	6	SENT_298	[p15l2092t2112r2150b2155],

1	Determinants	NNS	O	determinant	_	0	SENT_299	[p15l6t2231r206b2255],
2	of	IN	O	of	_	0	SENT_299	[p15l218t2230r247b2255],
3	Torasemide	NNP	O	Torasemide	prep_of	1	SENT_299	[p15l257t2230r430b2255],
4	PK	NN	O	pk	dep	1	SENT_299	[p15l441t2231r485b2255],
5	329	CD	NUMBER	329	num	4	SENT_299	[p15l6t2266r54b2290],

1	missing	VBG	O	miss	_	0	SENT_300	[p15l8t2468r257b2541],
2	between	IN	O	between	_	0	SENT_300	[p15l286t2468r555b2525],
3	the	DT	O	the	det	4	SENT_300	[p15l584t2468r680b2525],
4	AUC24	NN	O	auc24	prep_between	1	SENT_300	[p15l709t2468r1009b2541],
5	,	,	O	,	_	0	SENT_300	[p15l709t2468r1009b2541],
6	ss	NN	O	ss	nn	7	SENT_300	[p15l709t2468r1009b2541],
7	values	NNS	O	value	appos	4	SENT_300	[p15l1039t2468r1242b2525],
8	of	IN	O	of	_	0	SENT_300	[p15l1273t2468r1343b2525],
9	losartan	NN	O	losartan	prep_of	7	SENT_300	[p15l1366t2468r1621b2525],
10	and	CC	O	and	_	0	SENT_300	[p15l1651t2468r1765b2525],
11	torasemide	NN	O	torasemide	prep_of	7	SENT_300	[p15l1793t2468r2146b2525],
12	during	IN	O	during	_	0	SENT_300	[p15l9t2568r217b2641],
13	ARB	NN	O	arb	nn	14	SENT_300	[p15l239t2569r399b2624],
14	comedication	NN	O	comedication	prep_during	1	SENT_300	[p15l426t2568r876b2625],
15	.	.	O	.	_	0	SENT_300	[p15l426t2568r876b2625],

1	There	EX	O	there	expl	2	SENT_301	[p15l903t2568r1089b2625],
2	was	VBD	O	be	_	0	SENT_301	[p15l1112t2586r1233b2625],
3	also	RB	O	also	advmod	2	SENT_301	[p15l1259t2568r1384b2625],
4	no	DT	O	no	det	5	SENT_301	[p15l1407t2586r1485b2625],
5	correlation	NN	O	correlation	nsubj	2	SENT_301	[p15l1509t2568r1857b2625],
6	between	IN	O	between	_	0	SENT_301	[p15l1878t2568r2147b2625],
7	the	DT	O	the	det	8	SENT_301	[p15l8t2668r104b2725],
8	AUC24	NN	O	auc24	prep_between	5	SENT_301	[p15l131t2668r431b2741],
9	,	,	O	,	_	0	SENT_301	[p15l131t2668r431b2741],
10	ss	NN	O	ss	nn	11	SENT_301	[p15l131t2668r431b2741],
11	Values	NNS	O	value	appos	8	SENT_301	[p15l459t2668r662b2725],
12	of	IN	O	of	_	0	SENT_301	[p15l691t2668r761b2725],
13	EXP3l74	NN	O	exp3l74	prep_of	11	SENT_301	[p15l782t2668r1094b2725],
14	and	CC	O	and	_	0	SENT_301	[p15l1123t2668r1237b2725],
15	torasemide	NN	O	torasemide	conj_and	13	SENT_301	[p15l1263t2668r1633b2725],
16	.	.	O	.	_	0	SENT_301	[p15l1263t2668r1633b2725],

1	The	DT	O	the	det	2	SENT_302	[p15l106t2768r229b2825],
2	AUC24	NN	O	auc24	nsubj	9	SENT_302	[p15l256t2769r556b2841],
3	,	,	O	,	_	0	SENT_302	[p15l256t2769r556b2841],
4	sg	NN	O	sg	appos	2	SENT_302	[p15l256t2769r556b2841],
5	of	IN	O	of	_	0	SENT_302	[p15l585t2768r655b2825],
6	irbesartan	NN	O	irbesartan	prep_of	4	SENT_302	[p15l676t2768r994b2825],
7	was	VBD	O	be	cop	9	SENT_302	[p15l1021t2786r1143b2825],
8	29	CD	NUMBER	29	num	9	SENT_302	[p15l1173t2769r1249b2826],
9	304	CD	NUMBER	304	_	0	SENT_302	[p15l1276t2769r1392b2825],
10	i	FW	O	i	dep	9	SENT_302	[p15l1419t2771r1463b2824],
11	12	CD	NUMBER	12	num	12	SENT_302	[p15l1497t2769r1567b2824],
12	597	CD	NUMBER	597	dep	10	SENT_302	[p15l1592t2768r1707b2826],
13	ug	NN	O	ug	nn	15	SENT_302	[p15l1738t2783r1821b2842],
14	o	NN	O	o	nn	15	SENT_302	[p15l1846t2793r1870b2817],
15	h/L	NN	O	h/l	dep	10	SENT_302	[p15l1894t2768r2005b2825],
16	and	CC	O	and	_	0	SENT_302	[p15l2034t2768r2148b2825],
17	Varied	VBD	O	vary	conj_and	9	SENT_302	[p15l9t2869r209b2926],
18	4.7	CD	NUMBER	4.7	number	19	SENT_302	[p15l237t2869r495b2926],
19	—	CD	NUMBER	—	nsubj	20	SENT_302	[p15l237t2869r495b2926],
20	fold	JJ	O	fold	ccomp	17	SENT_302	[p15l237t2869r495b2926],
21	(	NN	O	(	nn	22	SENT_302	[p15l526t2870r660b2939],
22	CV	NN	O	cv	iobj	20	SENT_302	[p15l526t2870r660b2939],
23	43.0	CD	PERCENT	43.0	num	24	SENT_302	[p15l690t2870r940b2939],
24	%	NN	PERCENT	%	dobj	20	SENT_302	[p15l690t2870r940b2939],
25	)	CD	NUMBER	)	dobj	9	SENT_302	[p15l690t2870r940b2939],
26	.	.	O	.	_	0	SENT_302	[p15l690t2870r940b2939],

1	Coadministration	NN	O	coadministration	nsubj	6	SENT_303	[p15l975t2869r1535b2926],
2	of	IN	O	of	_	0	SENT_303	[p15l1565t2869r1634b2926],
3	irbesartan	NN	O	irbesartan	prep_of	1	SENT_303	[p15l1658t2869r1976b2926],
4	with	IN	O	with	_	0	SENT_303	[p15l2005t2869r2147b2926],
5	torasemide	NN	O	torasemide	prep_with	3	SENT_303	[p15l8t2968r361b3025],
6	yielded	VBD	O	yield	_	0	SENT_303	[p15l385t2968r622b3042],
7	a	DT	O	a	det	13	SENT_303	[p15l646t2986r679b3025],
8	moderate	JJ	O	moderate	amod	13	SENT_303	[p15l701t2968r1000b3025],
9	but	CC	O	but	_	0	SENT_303	[p15l1022t2968r1126b3025],
10	significant	JJ	O	significant	conj_but	8	SENT_303	[p15l1150t2968r1489b3042],
11	13	CD	PERCENT	13	number	12	SENT_303	[p15l1519t2969r1654b3025],
12	%	NN	PERCENT	%	amod	13	SENT_303	[p15l1519t2969r1654b3025],
13	increase	NN	O	increase	dobj	6	SENT_303	[p15l1680t2968r1943b3025],
14	in	IN	O	in	_	0	SENT_303	[p15l1967t2968r2028b3024],
15	the	DT	O	the	det	16	SENT_303	[p15l2050t2968r2147b3025],
16	AUC24	NN	O	auc24	prep_in	13	SENT_303	[p15l8t3069r307b3141],
17	,	,	O	,	_	0	SENT_303	[p15l8t3069r307b3141],
18	ss	NN	O	ss	appos	16	SENT_303	[p15l8t3069r307b3141],
19	of	IN	O	of	_	0	SENT_303	[p15l339t3068r409b3125],
20	torasemide	NN	O	torasemide	nn	22	SENT_303	[p15l432t3068r786b3125],
21	(	NN	O	(	nn	22	SENT_303	[p15l818t3069r880b3141],
22	p	NN	O	p	prep_of	18	SENT_303	[p15l818t3069r880b3141],
23	=	JJ	O	=	amod	22	SENT_303	[p15l911t3092r952b3114],
24	0.002	CD	NUMBER	0.002	tmod	23	SENT_303	[p15l983t3069r1182b3135],
25	;	:	O	;	_	0	SENT_303	[p15l983t3069r1182b3135],
26	table	NN	O	table	dep	18	SENT_303	[p15l1215t3068r1370b3125],
27	VI	NNP	O	VI	nn	28	SENT_303	[p15l1399t3069r1525b3138],
28	)	NNP	O	)	dep	26	SENT_303	[p15l1399t3069r1525b3138],
29	.	.	O	.	_	0	SENT_303	[p15l1399t3069r1525b3138],

1	This	DT	O	this	det	2	SENT_304	[p15l1559t3068r1699b3125],
2	increase	NN	O	increase	nsubjpass	4	SENT_304	[p15l1730t3068r1993b3125],
3	was	VBD	O	be	auxpass	4	SENT_304	[p15l2023t3086r2145b3125],
4	observed	VBN	O	observe	_	0	SENT_304	[p15l9t3168r299b3225],
5	in	IN	O	in	_	0	SENT_304	[p15l326t3168r387b3224],
6	each	DT	O	each	det	8	SENT_304	[p15l415t3168r561b3225],
7	individual	JJ	O	individual	amod	8	SENT_304	[p15l587t3168r914b3225],
8	patient	NN	O	patient	prep_in	4	SENT_304	[p15l940t3168r1177b3241],
9	,	,	O	,	_	0	SENT_304	[p15l940t3168r1177b3241],
10	with	IN	O	with	_	0	SENT_304	[p15l1208t3168r1349b3225],
11	a	DT	O	a	det	13	SENT_304	[p15l1378t3186r1411b3225],
12	maximum	JJ	O	maximum	amod	13	SENT_304	[p15l1437t3168r1765b3225],
13	increase	NN	O	increase	prep_with	8	SENT_304	[p15l1791t3168r2054b3225],
14	of	IN	O	of	_	0	SENT_304	[p15l2083t3168r2152b3225],
15	46	CD	PERCENT	46	num	16	SENT_304	[p15l8t3268r151b3325],
16	%	NN	PERCENT	%	prep_of	13	SENT_304	[p15l8t3268r151b3325],
17	(	CD	NUMBER	(	num	18	SENT_304	[p15l190t3268r405b3342],
18	figure	NN	O	figure	dep	8	SENT_304	[p15l190t3268r405b3342],
19	2	CD	NUMBER	2	num	20	SENT_304	[p15l440t3269r520b3338],
20	)	NN	O	)	dep	18	SENT_304	[p15l440t3269r520b3338],
21	.	.	O	.	_	0	SENT_304	[p15l440t3269r520b3338],

1	Accordingly	RB	O	accordingly	advmod	7	SENT_305	[p15l557t3268r978b3342],
2	,	,	O	,	_	0	SENT_305	[p15l557t3268r978b3342],
3	the	DT	O	the	det	4	SENT_305	[p15l1014t3268r1110b3325],
4	t1/2	NN	O	t1/2	nsubj	7	SENT_305	[p15l1143t3277r1214b3333],
5	of	IN	O	of	_	0	SENT_305	[p15l1248t3268r1317b3325],
6	torasemide	NN	O	torasemide	prep_of	4	SENT_305	[p15l1345t3268r1698b3325],
7	increased	VBN	O	increase	_	0	SENT_305	[p15l1731t3268r2036b3325],
8	by	IN	O	by	_	0	SENT_305	[p15l2067t3268r2146b3342],
9	17	CD	PERCENT	17	num	10	SENT_305	[p15l16t3369r151b3425],
10	%	NN	PERCENT	%	prep_by	7	SENT_305	[p15l16t3369r151b3425],
11	(	CD	NUMBER	(	num	12	SENT_305	[p15l179t3369r241b3441],
12	p	NN	O	p	dobj	7	SENT_305	[p15l179t3369r241b3441],
13	=	JJ	O	=	rcmod	12	SENT_305	[p15l266t3392r307b3414],
14	0.021	CD	NUMBER	0.021	number	15	SENT_305	[p15l331t3369r535b3438],
15	)	CD	NUMBER	)	dep	13	SENT_305	[p15l331t3369r535b3438],
16	whereas	IN	O	whereas	mark	19	SENT_305	[p15l560t3368r821b3425],
17	the	DT	O	the	det	18	SENT_305	[p15l846t3368r942b3425],
18	CL/F	NN	O	cl/f	nsubj	19	SENT_305	[p15l965t3369r1134b3425],
19	decreased	VBN	O	decrease	dep	13	SENT_305	[p15l1157t3368r1474b3425],
20	by	IN	O	by	_	0	SENT_305	[p15l1495t3368r1574b3442],
21	12	CD	PERCENT	12	num	22	SENT_305	[p15l1605t3369r1740b3425],
22	%	NN	PERCENT	%	prep_by	19	SENT_305	[p15l1605t3369r1740b3425],
23	(	CD	NUMBER	(	num	24	SENT_305	[p15l1768t3369r1830b3442],
24	p	NN	O	p	dep	22	SENT_305	[p15l1768t3369r1830b3442],
25	=	JJ	O	=	amod	27	SENT_305	[p15l1854t3392r1896b3414],
26	0.002	CD	NUMBER	0.002	tmod	25	SENT_305	[p15l1919t3369r2142b3438],
27	)	NN	O	)	dobj	19	SENT_305	[p15l1919t3369r2142b3438],
28	.	.	O	.	_	0	SENT_305	[p15l1919t3369r2142b3438],

1	Irbesartan	NNP	O	Irbesartan	nsubj	5	SENT_306	[p15l8t3468r330b3525],
2	did	VBD	O	do	aux	5	SENT_306	[p15l369t3468r470b3525],
3	not	RB	O	not	neg	5	SENT_306	[p15l508t3477r611b3525],
4	significantly	RB	O	significantly	advmod	5	SENT_306	[p15l650t3468r1050b3542],
5	change	VB	O	change	_	0	SENT_306	[p15l1090t3468r1316b3542],
6	the	DT	O	the	det	7	SENT_306	[p15l1355t3468r1451b3525],
7	Cmax	NNP	O	Cmax	dobj	5	SENT_306	[p15l1491t3469r1719b3541],
8	,	,	O	,	_	0	SENT_306	[p15l1491t3469r1719b3541],
9	ss	NN	O	ss	appos	7	SENT_306	[p15l1491t3469r1719b3541],
10	and	CC	O	and	_	0	SENT_306	[p15l1760t3468r1874b3525],
11	tmax	NN	O	tmax	conj_and	9	SENT_306	[p15l1911t3477r2043b3532],
12	of	IN	O	of	_	0	SENT_306	[p15l2083t3468r2152b3525],
13	torasemide	NN	O	torasemide	prep_of	9	SENT_306	[p15l8t3568r378b3625],
14	.	.	O	.	_	0	SENT_306	[p15l8t3568r378b3625],

1	The	DT	O	the	det	2	SENT_307	[p15l421t3568r544b3625],
2	AUC24	NN	O	auc24	_	0	SENT_307	[p15l583t3569r882b3641],
3	,	,	O	,	_	0	SENT_307	[p15l583t3569r882b3641],
4	ss	NN	O	ss	nn	5	SENT_307	[p15l583t3569r882b3641],
5	values	NNS	O	value	appos	2	SENT_307	[p15l923t3568r1125b3625],
6	of	IN	O	of	_	0	SENT_307	[p15l1167t3568r1237b3625],
7	torasemide	NN	O	torasemide	prep_of	5	SENT_307	[p15l1270t3568r1623b3625],
8	(	CD	NUMBER	(	num	7	SENT_307	[p15l1665t3568r2053b3638],
9	determined	VBN	O	determine	conj_and	9	SENT_307	[p15l1665t3568r2053b3638],
10	at	IN	O	at	_	0	SENT_307	[p15l2092t3577r2148b3625],
11	baseline	NN	O	baseline	prep_at	9	SENT_307	[p15l7t3668r271b3725],
12	and	CC	O	and	_	0	SENT_307	[p15l307t3668r420b3725],
13	during	IN	O	during	_	0	SENT_307	[p15l454t3668r662b3742],
14	ARB	NN	O	arb	nn	16	SENT_307	[p15l696t3669r856b3724],
15	comedication	NN	O	comedication	nn	16	SENT_307	[p15l894t3668r1353b3738],
16	)	NN	O	)	prep_during	9	SENT_307	[p15l894t3668r1353b3738],
17	significantly	RB	O	significantly	advmod	18	SENT_307	[p15l1391t3668r1791b3742],
18	correlated	VBD	O	correlate	partmod	16	SENT_307	[p15l1826t3668r2148b3725],
19	with	IN	O	with	_	0	SENT_307	[p16l9t20r150b77],
20	the	DT	O	the	det	22	SENT_307	[p16l189t20r285b77],
21	corresponding	JJ	O	corresponding	amod	22	SENT_307	[p16l324t20r785b94],
22	AUC24	NN	O	auc24	prep_with	18	SENT_307	[p16l823t21r1123b93],
23	,	,	O	,	_	0	SENT_307	[p16l823t21r1123b93],
24	ss	NN	O	ss	nn	25	SENT_307	[p16l823t21r1123b93],
25	values	NNS	O	value	appos	22	SENT_307	[p16l1163t20r1366b77],
26	of	IN	O	of	_	0	SENT_307	[p16l1407t20r1477b77],
27	irbesartan	NN	O	irbesartan	nn	30	SENT_307	[p16l1510t20r1827b77],
28	(	CD	NUMBER	(	num	30	SENT_307	[p16l1868t21r2147b90],
29	Pearson	NNP	PERSON	Pearson	nn	30	SENT_307	[p16l1868t21r2147b90],
30	r	NN	O	r	prep_of	25	SENT_307	[p16l7t137r34b175],
31	=	JJ	O	=	amod	5	SENT_307	[p16l60t143r102b165],
32	0.69	CD	NUMBER	0.69	tmod	31	SENT_307	[p16l130t119r286b186],
33	,	,	O	,	_	0	SENT_307	[p16l130t119r286b186],
34	p	NN	O	p	conj_and	5	SENT_307	[p16l315t137r354b193],
35	=	JJ	O	=	amod	34	SENT_307	[p16l382t143r424b165],
36	0.013	CD	NUMBER	0.013	tmod	35	SENT_307	[p16l452t120r650b186],
37	;	:	O	;	_	0	SENT_307	[p16l452t120r650b186],
38	and	CC	O	and	_	0	SENT_307	[p16l682t119r796b176],
39	r	NN	O	r	appos	2	SENT_307	[p16l821t137r848b175],
40	=	JJ	O	=	amod	39	SENT_307	[p16l874t143r916b165],
41	0.75	CD	NUMBER	0.75	tmod	40	SENT_307	[p16l944t119r1100b186],
42	,	,	O	,	_	0	SENT_307	[p16l944t119r1100b186],
43	p	NN	O	p	appos	5	SENT_307	[p16l1129t137r1167b193],
44	=	JJ	O	=	amod	43	SENT_307	[p16l1196t143r1237b165],
45	0.005	CD	NUMBER	0.005	tmod	44	SENT_307	[p16l1265t119r1464b186],
46	;	:	O	;	_	0	SENT_307	[p16l1265t119r1464b186],
47	respectively	RB	O	respectively	advmod	48	SENT_307	[p16l1493t119r1927b193],
48	)	CD	NUMBER	)	dep	5	SENT_307	[p16l1493t119r1927b193],
49	.	.	O	.	_	0	SENT_307	[p16l1493t119r1927b193],

1	Fifteen	CD	NUMBER	fifteen	nsubj	5	SENT_308	[p16l105t219r333b276],
2	of	IN	O	of	_	0	SENT_308	[p16l355t219r425b276],
3	the	DT	O	the	det	4	SENT_308	[p16l440t219r536b276],
4	patients	NNS	O	patient	prep_of	1	SENT_308	[p16l556t219r805b293],
5	received	VBD	O	receive	_	0	SENT_308	[p16l827t219r1101b276],
6	the	DT	O	the	det	8	SENT_308	[p16l1121t219r1218b276],
7	lipid	NN	O	lipid	nn	8	SENT_308	[p16l1239t219r1699b293],
8	—	NN	O	—	dobj	5	SENT_308	[p16l1239t219r1699b293],
9	lowering	VBG	O	lower	xcomp	5	SENT_308	[p16l1239t219r1699b293],
10	drug	NN	O	drug	nn	11	SENT_308	[p16l1722t219r1867b293],
11	atorvastatin	NN	O	atorvastatin	dobj	9	SENT_308	[p16l1890t228r2145b276, p16l8t319r166b376],
12	.	.	O	.	_	0	SENT_308	[p16l1890t228r2145b276, p16l8t319r166b376],

1	The	DT	O	the	det	4	SENT_309	[p16l191t320r314b376],
2	baseline	NN	O	baseline	nn	4	SENT_309	[p16l333t319r598b376],
3	torasemide	NN	O	torasemide	nn	4	SENT_309	[p16l618t319r971b376],
4	AUC24	NN	O	auc24	nsubj	8	SENT_309	[p16l992t320r1291b392],
5	,	,	O	,	_	0	SENT_309	[p16l992t320r1291b392],
6	ss	NN	O	ss	appos	4	SENT_309	[p16l992t320r1291b392],
7	was	VBD	O	be	cop	8	SENT_309	[p16l1313t337r1434b376],
8	4026	CD	NUMBER	4026	_	0	SENT_309	[p16l1456t319r1615b376],
9	i	FW	O	i	dep	8	SENT_309	[p16l1636t322r1679b375],
10	1676	CD	DATE	1676	num	13	SENT_309	[p16l1707t319r1857b376],
11	ug	NN	O	ug	nn	13	SENT_309	[p16l1880t334r1963b393],
12	o	NN	O	o	nn	13	SENT_309	[p16l1988t344r2012b368],
13	h/L	NN	O	h/l	dobj	9	SENT_309	[p16l2036t319r2147b376],
14	in	IN	O	in	_	0	SENT_309	[p16l8t419r69b475],
15	those	DT	O	those	prep_in	13	SENT_309	[p16l90t419r259b476],
16	receiving	VBG	O	receive	xcomp	9	SENT_309	[p16l280t419r579b493],
17	atorvastatin	NN	O	atorvastatin	dobj	16	SENT_309	[p16l603t419r978b476],
18	compared	VBN	O	compare	_	0	SENT_309	[p16l1000t419r1318b493],
19	with	IN	O	with	prepc_compared_with	16	SENT_309	[p16l1339t419r1481b476],
20	4337	CD	NUMBER	4337	nsubj	31	SENT_309	[p16l1502t420r1659b476],
21	i	FW	O	i	dep	20	SENT_309	[p16l1683t422r1726b475],
22	2072	CD	DATE	2072	num	23	SENT_309	[p16l1748t420r1906b476],
23	ug	NN	O	ug	nn	27	SENT_309	[p16l1930t434r2012b493],
24	-	:	O	-	_	0	SENT_309	[p16l2038t444r2062b468],
25	h	NN	O	h	dep	23	SENT_309	[p16l2085t419r2149b476],
26	/	:	O	/	punct	25	SENT_309	[p16l2085t419r2149b476],
27	L	NN	O	l	dep	20	SENT_309	[p16l8t521r56b575],
28	in	IN	O	in	_	0	SENT_309	[p16l92t519r153b575],
29	those	DT	O	those	prep_in	27	SENT_309	[p16l189t519r358b576],
30	not	RB	O	not	neg	31	SENT_309	[p16l394t528r497b576],
31	receiving	VBG	O	receive	pcomp	16	SENT_309	[p16l531t519r830b593],
32	atorvastatin	NN	O	atorvastatin	nn	34	SENT_309	[p16l869t519r1244b576],
33	(	NN	O	(	nn	34	SENT_309	[p16l1282t519r1633b589],
34	difference	NN	O	difference	dobj	31	SENT_309	[p16l1282t519r1633b589],
35	not	RB	O	not	prep	31	SENT_309	[p16l1669t528r1772b576],
36	significant	JJ	O	significant	amod	40	SENT_309	[p16l1809t519r2148b593],
37	[	NN	O	[	nn	40	SENT_309	[p16l14t620r207b689],
38	NS	NN	O	n	nn	40	SENT_309	[p16l14t620r207b689],
39	]	CD	NUMBER	]	num	40	SENT_309	[p16l14t620r207b689],
40	)	NN	O	)	pobj	35	SENT_309	[p16l14t620r207b689],
41	.	.	O	.	_	0	SENT_309	[p16l14t620r207b689],

1	In	IN	O	in	_	0	SENT_310	[p16l239t621r304b675],
2	the	DT	O	the	det	4	SENT_310	[p16l332t619r429b676],
3	losartan	NN	O	losartan	nn	4	SENT_310	[p16l457t619r712b676],
4	group	NN	O	group	prep_in	10	SENT_310	[p16l741t637r944b693],
5	,	,	O	,	_	0	SENT_310	[p16l741t637r944b693],
6	the	DT	O	the	det	7	SENT_310	[p16l975t619r1072b676],
7	AUC	NN	O	auc	nsubj	10	SENT_310	[p16l1100t620r1267b676],
8	of	IN	O	of	_	0	SENT_310	[p16l1298t619r1368b676],
9	torasemide	NN	O	torasemide	prep_of	7	SENT_310	[p16l1390t619r1743b676],
10	changed	VBN	O	change	_	0	SENT_310	[p16l1773t619r2040b693],
11	by	IN	O	by	_	0	SENT_310	[p16l2067t619r2146b693],
12	1	CD	NUMBER	1	prep_by	10	SENT_310	[p16l16t720r39b775],
13	i	FW	O	i	dobj	10	SENT_310	[p16l70t722r114b775],
14	2	CD	PERCENT	2	number	15	SENT_310	[p16l139t720r240b776],
15	%	NN	PERCENT	%	amod	13	SENT_310	[p16l139t720r240b776],
16	in	IN	O	in	_	0	SENT_310	[p16l268t719r329b775],
17	six	CD	NUMBER	six	num	18	SENT_310	[p16l356t719r445b776],
18	patients	NNS	O	patient	prep_in	10	SENT_310	[p16l469t719r718b793],
19	receiving	VBG	O	receive	partmod	18	SENT_310	[p16l744t719r1043b793],
20	atorvastatin	NN	O	atorvastatin	nn	21	SENT_310	[p16l1070t719r1445b776],
21	comedication	NN	O	comedication	dobj	19	SENT_310	[p16l1470t719r1904b776],
22	and	CC	O	and	_	0	SENT_310	[p16l1930t719r2044b776],
23	by	IN	O	by	advmod	21	SENT_310	[p16l2067t719r2146b793],
24	7	CD	NUMBER	7	pobj	23	SENT_310	[p16l9t821r44b876],
25	i	FW	O	i	conj_and	21	SENT_310	[p16l71t822r114b875],
26	2	CD	PERCENT	2	number	27	SENT_310	[p16l140t820r242b876],
27	%	NN	PERCENT	%	amod	25	SENT_310	[p16l140t820r242b876],
28	(	CD	NUMBER	(	num	30	SENT_310	[p16l273t820r423b889],
29	NS	NN	O	n	nn	30	SENT_310	[p16l273t820r423b889],
30	)	NN	O	)	dep	25	SENT_310	[p16l273t820r423b889],
31	in	IN	O	in	_	0	SENT_310	[p16l451t819r512b875],
32	the	DT	O	the	det	35	SENT_310	[p16l537t819r633b876],
33	other	JJ	O	other	amod	35	SENT_310	[p16l660t819r825b876],
34	six	CD	NUMBER	six	num	35	SENT_310	[p16l852t819r941b876],
35	patients	NNS	O	patient	prep_in	19	SENT_310	[p16l965t819r1233b893],
36	.	.	O	.	_	0	SENT_310	[p16l965t819r1233b893],

1	In	IN	O	in	_	0	SENT_311	[p16l1262t821r1328b875],
2	the	DT	O	the	det	4	SENT_311	[p16l1353t819r1449b876],
3	irbesartan	NN	O	irbesartan	nn	4	SENT_311	[p16l1475t819r1792b876],
4	group	NN	O	group	prep_in	10	SENT_311	[p16l1818t837r2022b893],
5	,	,	O	,	_	0	SENT_311	[p16l1818t837r2022b893],
6	the	DT	O	the	det	7	SENT_311	[p16l2050t819r2146b876],
7	AUC	NN	O	auc	nsubj	10	SENT_311	[p16l8t920r175b976],
8	of	IN	O	of	_	0	SENT_311	[p16l202t919r272b976],
9	torasemide	NN	O	torasemide	prep_of	7	SENT_311	[p16l290t919r644b976],
10	changed	VBN	O	change	_	0	SENT_311	[p16l669t919r937b993],
11	by	IN	O	by	_	0	SENT_311	[p16l959t919r1039b993],
12	16	CD	NUMBER	16	prep_by	10	SENT_311	[p16l1071t919r1141b976],
13	i	FW	O	i	dobj	10	SENT_311	[p16l1166t922r1209b975],
14	14	CD	PERCENT	14	number	15	SENT_311	[p16l1240t920r1376b976],
15	%	NN	PERCENT	%	amod	13	SENT_311	[p16l1240t920r1376b976],
16	in	IN	O	in	_	0	SENT_311	[p16l1403t919r1464b975],
17	nine	CD	NUMBER	nine	num	18	SENT_311	[p16l1488t919r1625b976],
18	patients	NNS	O	patient	prep_in	10	SENT_311	[p16l1649t919r1898b993],
19	receiving	VBG	O	receive	partmod	18	SENT_311	[p16l1923t919r2144b976, p16l8t1019r108b1093],
20	atorvastatin	NN	O	atorvastatin	nn	21	SENT_311	[p16l137t1019r512b1076],
21	comedication	NN	O	comedication	dobj	19	SENT_311	[p16l538t1019r973b1076],
22	and	CC	O	and	_	0	SENT_311	[p16l1001t1019r1114b1076],
23	by	IN	O	by	advmod	21	SENT_311	[p16l1139t1019r1218b1093],
24	11	CD	NUMBER	11	pobj	23	SENT_311	[p16l1253t1020r1316b1075],
25	i	FW	O	i	conj_and	21	SENT_311	[p16l1349t1022r1393b1075],
26	18	CD	PERCENT	18	number	27	SENT_311	[p16l1426t1020r1561b1076],
27	%	NN	PERCENT	%	amod	25	SENT_311	[p16l1426t1020r1561b1076],
28	(	CD	NUMBER	(	num	30	SENT_311	[p16l1593t1020r1744b1089],
29	NS	NN	O	n	nn	30	SENT_311	[p16l1593t1020r1744b1089],
30	)	NN	O	)	dep	25	SENT_311	[p16l1593t1020r1744b1089],
31	in	IN	O	in	_	0	SENT_311	[p16l1772t1019r1833b1075],
32	the	DT	O	the	det	35	SENT_311	[p16l1859t1019r1956b1076],
33	other	JJ	O	other	amod	35	SENT_311	[p16l1983t1019r2148b1076],
34	three	CD	NUMBER	three	num	35	SENT_311	[p16l8t1119r168b1176],
35	patients	NNS	O	patient	prep_in	19	SENT_311	[p16l194t1119r461b1193],
36	.	.	O	.	_	0	SENT_311	[p16l194t1119r461b1193],

1	Discussion	NN	O	discussion	_	0	SENT_312	[p16l109t1339r504b1401],

1	This	DT	O	this	det	2	SENT_313	[p16l105t1547r245b1604],
2	study	NN	O	study	nsubj	3	SENT_313	[p16l278t1547r448b1621],
3	shows	VBZ	O	show	_	0	SENT_313	[p16l480t1547r676b1604],
4	that	IN	O	that	complm	11	SENT_313	[p16l706t1547r827b1604],
5	the	DT	O	the	det	7	SENT_313	[p16l853t1547r950b1604],
6	CYP2C9	NN	O	cyp2c9	nn	7	SENT_313	[p16l983t1548r1337b1605],
7	*	NN	O	*	nsubj	11	SENT_313	[p16l983t1548r1337b1605],
8	3	CD	NUMBER	3	dep	7	SENT_313	[p16l983t1548r1337b1605],
9	and	CC	O	and	_	0	SENT_313	[p16l1371t1547r1485b1604],
10	SLCOIBI	NNP	O	SLCOIBI	nsubj	11	SENT_313	[p16l1513t1548r1833b1605],
11	c.	VBP	O	c.	ccomp	3	SENT_313	[p16l1868t1547r2145b1604],
12	521TC	NN	O	521tc	nn	13	SENT_313	[p16l1868t1547r2145b1604],
13	alleles	NNS	O	allele	nsubj	21	SENT_313	[p16l10t1648r211b1705],
14	and	CC	O	and	_	0	SENT_313	[p16l277t1648r391b1705],
15	female	JJ	O	female	amod	16	SENT_313	[p16l453t1648r671b1705],
16	gender	NN	O	gender	conj_and	13	SENT_313	[p16l734t1648r953b1722],
17	are	VBP	O	be	cop	21	SENT_313	[p16l1016t1666r1110b1705],
18	significant	JJ	O	significant	amod	21	SENT_313	[p16l1176t1648r1514b1722],
19	and	CC	O	and	_	0	SENT_313	[p16l1577t1648r1691b1705],
20	independent	JJ	O	independent	conj_and	18	SENT_313	[p16l1753t1648r2148b1722],
21	predictors	NNS	O	predictor	ccomp	11	SENT_313	[p16l7t1749r328b1823],
22	of	IN	O	of	_	0	SENT_313	[p16l367t1749r437b1806],
23	the	DT	O	the	det	24	SENT_313	[p16l467t1749r564b1806],
24	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	21	SENT_313	[p16l599t1749r1168b1823],
25	of	IN	O	of	_	0	SENT_313	[p16l1207t1749r1276b1806],
26	torasemide	NN	O	torasemide	prep_of	24	SENT_313	[p16l1307t1749r1676b1806],
27	.	.	O	.	_	0	SENT_313	[p16l1307t1749r1676b1806],

1	Our	PRP$	O	we	poss	2	SENT_314	[p16l1718t1750r1842b1806],
2	study	NN	O	study	nsubj	11	SENT_314	[p16l1879t1749r2049b1823],
3	in	IN	O	in	_	0	SENT_314	[p16l2086t1749r2147b1805],
4	patients	NNS	O	patient	prep_in	2	SENT_314	[p16l7t1850r256b1924],
5	undergoing	VBG	O	undergo	partmod	4	SENT_314	[p16l286t1850r653b1924],
6	long	JJ	O	long	amod	10	SENT_314	[p16l683t1850r1001b1924],
7	—	NN	O	—	nn	10	SENT_314	[p16l683t1850r1001b1924],
8	term	NN	O	term	nn	10	SENT_314	[p16l683t1850r1001b1924],
9	torasemide	NN	O	torasemide	nn	10	SENT_314	[p16l1029t1850r1382b1907],
10	treatment	NN	O	treatment	dobj	5	SENT_314	[p16l1411t1859r1717b1907],
11	extends	VBZ	O	extend	_	0	SENT_314	[p16l1745t1850r1988b1907],
12	previous	JJ	O	previous	amod	13	SENT_314	[p16l2017t1868r2144b1924, p16l8t1952r180b2009],
13	findings	NNS	O	finding	dobj	11	SENT_314	[p16l203t1952r464b2026],
14	from	IN	O	from	_	0	SENT_314	[p16l488t1952r643b2009],
15	single	JJ	O	single	amod	18	SENT_314	[p16l666t1952r1030b2026],
16	—	NN	O	—	nn	18	SENT_314	[p16l666t1952r1030b2026],
17	dose	NN	O	dose	nn	18	SENT_314	[p16l666t1952r1030b2026],
18	studies	NNS	O	study	prep_from	11	SENT_314	[p16l1054t1952r1272b2009],
19	in	IN	O	in	_	0	SENT_314	[p16l1295t1952r1356b2008],
20	healthy	JJ	O	healthy	amod	21	SENT_314	[p16l1377t1952r1613b2026],
21	volunteers	NNS	O	volunteer	prep_in	18	SENT_314	[p16l1635t1945r2144b2009],
22	.	.	O	.	_	0	SENT_314	[p16l1635t1945r2144b2009],

1	“	NN	O	“	nsubj	8	SENT_315	[p16l1635t1945r2144b2009],
2	8	CD	NUMBER	8	num	3	SENT_315	[p16l1635t1945r2144b2009],
3	’	NN	O	’	dep	1	SENT_315	[p16l1635t1945r2144b2009],
4	19	CD	NUMBER	19	number	5	SENT_315	[p16l1635t1945r2144b2009],
5	]	CD	NUMBER	]	dep	1	SENT_315	[p16l1635t1945r2144b2009],
6	Those	DT	O	those	det	7	SENT_315	[p16l8t2052r204b2109],
7	studies	NNS	O	study	dep	5	SENT_315	[p16l238t2052r457b2109],
8	indicated	VBD	O	indicate	_	0	SENT_315	[p16l490t2052r786b2109],
9	that	IN	O	that	complm	25	SENT_315	[p16l816t2052r937b2109],
10	among	IN	O	among	_	0	SENT_315	[p16l969t2070r1185b2126],
11	the	DT	O	the	det	13	SENT_315	[p16l1217t2052r1314b2109],
12	genetic	JJ	O	genetic	amod	13	SENT_315	[p16l1346t2052r1576b2126],
13	variations	NNS	O	variation	prep_among	25	SENT_315	[p16l1609t2052r1924b2109],
14	in	IN	O	in	_	0	SENT_315	[p16l1958t2052r2019b2108],
15	the	DT	O	the	det	19	SENT_315	[p16l2050t2052r2146b2109],
16	four	CD	NUMBER	four	num	19	SENT_315	[p16l9t2153r142b2210],
17	C	NN	O	c	nn	19	SENT_315	[p16l174t2155r225b2211],
18	YP2C	NN	O	yp2c	nn	19	SENT_315	[p16l229t2154r414b2211],
19	genes	NNS	O	gene	prep_in	13	SENT_315	[p16l441t2171r640b2227],
20	,	,	O	,	_	0	SENT_315	[p16l441t2171r640b2227],
21	the	DT	O	the	det	22	SENT_315	[p16l672t2153r769b2210],
22	biotransformation	NN	O	biotransformation	nsubj	25	SENT_315	[p16l797t2153r1377b2210],
23	of	IN	O	of	_	0	SENT_315	[p16l1407t2153r1477b2210],
24	torasemide	NN	O	torasemide	prep_of	22	SENT_315	[p16l1500t2153r1854b2210],
25	depends	VBZ	O	depend	ccomp	8	SENT_315	[p16l1884t2153r2145b2227],
26	on	IN	O	on	_	0	SENT_315	[p16l9t2273r87b2312],
27	the	DT	O	the	det	29	SENT_315	[p16l114t2255r210b2312],
28	CYP2C9	NN	O	cyp2c9	nn	29	SENT_315	[p16l241t2256r596b2312],
29	*	NN	O	*	prep_on	25	SENT_315	[p16l241t2256r596b2312],
30	3	CD	NUMBER	3	num	31	SENT_315	[p16l241t2256r596b2312],
31	variant	NN	O	variant	nn	29	SENT_315	[p16l627t2255r867b2322],
32	,	,	O	,	_	0	SENT_315	[p16l627t2255r867b2322],
33	i.e.	FW	O	i.e.	dep	29	SENT_315	[p16l896t2255r989b2312],
34	the	DT	O	the	det	38	SENT_315	[p16l1020t2255r1116b2312],
35	CYP2C9	NN	O	cyp2c9	nn	38	SENT_315	[p16l1147t2256r1502b2312],
36	*	NN	O	*	nn	38	SENT_315	[p16l1147t2256r1502b2312],
37	3	CD	NUMBER	3	num	38	SENT_315	[p16l1147t2256r1502b2312],
38	allele	NN	O	allele	nsubj	39	SENT_315	[p16l1535t2255r1706b2312],
39	determines	VBZ	O	determine	rcmod	29	SENT_315	[p16l1734t2255r2084b2312],
40	a	DT	O	a	det	43	SENT_315	[p16l2115t2273r2148b2312],
41	poor	JJ	O	poor	amod	43	SENT_315	[p16l7t2374r156b2430],
42	metabolizer	NN	O	metabolizer	nn	43	SENT_315	[p16l182t2356r565b2413],
43	phenotype	NN	O	phenotype	dobj	39	SENT_315	[p16l590t2349r1033b2430],
44	.	.	O	.	_	0	SENT_315	[p16l590t2349r1033b2430],

1	[	NN	O	[	dep	13	SENT_316	[p16l590t2349r1033b2430],
2	19	CD	NUMBER	19	num	1	SENT_316	[p16l590t2349r1033b2430],
3	]	CD	NUMBER	]	dep	13	SENT_316	[p16l590t2349r1033b2430],
4	Whether	IN	O	whether	dep	13	SENT_316	[p16l1063t2356r1342b2413],
5	the	DT	O	the	det	7	SENT_316	[p16l1368t2356r1465b2413],
6	interindividual	JJ	O	interindividual	amod	7	SENT_316	[p16l1493t2356r1968b2413],
7	variability	NN	O	variability	nsubjpass	13	SENT_316	[p16l1996t2356r2144b2413, p16l10t2456r212b2530],
8	of	IN	O	of	_	0	SENT_316	[p16l246t2456r316b2513],
9	torasemide	NN	O	torasemide	nn	10	SENT_316	[p16l342t2456r695b2513],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	7	SENT_316	[p16l726t2456r1295b2530],
11	is	VBZ	O	be	auxpass	13	SENT_316	[p16l1329t2456r1378b2513],
12	fully	RB	O	fully	advmod	13	SENT_316	[p16l1412t2456r1562b2530],
13	explained	VBN	O	explain	ccomp	24	SENT_316	[p16l1595t2456r1908b2530],
14	by	IN	O	by	_	0	SENT_316	[p16l1938t2457r2018b2530],
15	the	DT	O	the	det	19	SENT_316	[p16l2050t2456r2146b2513],
16	CYP2C9	NN	O	cyp2c9	nn	19	SENT_316	[p16l12t2559r367b2615],
17	*	NN	O	*	nn	19	SENT_316	[p16l12t2559r367b2615],
18	3	CD	NUMBER	3	num	19	SENT_316	[p16l12t2559r367b2615],
19	allele	NN	O	allele	agent	13	SENT_316	[p16l399t2558r588b2625],
20	,	,	O	,	_	0	SENT_316	[p16l399t2558r588b2625],
21	however	RB	O	however	advmod	24	SENT_316	[p16l617t2558r912b2625],
22	,	,	O	,	_	0	SENT_316	[p16l617t2558r912b2625],
23	remained	VBD	O	remain	cop	24	SENT_316	[p16l941t2558r1242b2615],
24	unclear	JJ	O	unclear	_	0	SENT_316	[p16l1267t2558r1520b2615],
25	.	.	O	.	_	0	SENT_316	[p16l1267t2558r1520b2615],

1	We	PRP	O	we	nsubj	2	SENT_317	[p16l104t2660r215b2715],
2	provide	VBP	O	provide	_	0	SENT_317	[p16l237t2659r483b2732],
3	evidence	NN	O	evidence	dobj	2	SENT_317	[p16l506t2659r791b2715],
4	that	IN	O	that	complm	27	SENT_317	[p16l813t2659r934b2715],
5	at	IN	O	at	quantmod	7	SENT_317	[p16l956t2667r1012b2715],
6	least	JJS	O	least	mwe	5	SENT_317	[p16l1033t2659r1180b2715],
7	two	CD	NUMBER	two	num	9	SENT_317	[p16l1201t2667r1319b2715],
8	additional	JJ	O	additional	amod	9	SENT_317	[p16l1344t2659r1664b2715],
9	factors	NNS	O	factor	nsubj	27	SENT_317	[p16l1686t2658r1922b2725],
10	,	,	O	,	_	0	SENT_317	[p16l1686t2658r1922b2725],
11	namely	RB	O	namely	advmod	12	SENT_317	[p16l1947t2676r2145b2715, p16l8t2760r68b2833],
12	gender	NN	O	gender	appos	9	SENT_317	[p16l91t2760r310b2833],
13	and	CC	O	and	_	0	SENT_317	[p16l332t2760r445b2816],
14	the	DT	O	the	det	15	SENT_317	[p16l466t2760r562b2816],
15	presence	NN	O	presence	appos	9	SENT_317	[p16l583t2777r865b2833],
16	of	IN	O	of	_	0	SENT_317	[p16l888t2759r957b2816],
17	at	IN	O	at	quantmod	19	SENT_317	[p16l975t2768r1030b2816],
18	least	JJS	O	least	mwe	17	SENT_317	[p16l1051t2760r1198b2816],
19	one	CD	NUMBER	one	prep_of	15	SENT_317	[p16l1219t2777r1333b2816],
20	SLCOIBI	NNP	O	SLCOIBI	nn	23	SENT_317	[p16l1354t2760r1675b2817],
21	c.	NN	O	c.	nn	23	SENT_317	[p16l1703t2759r1930b2817],
22	521C	NN	O	521c	nn	23	SENT_317	[p16l1703t2759r1930b2817],
23	allele	NN	O	allele	dep	19	SENT_317	[p16l1955t2760r2144b2826],
24	,	,	O	,	_	0	SENT_317	[p16l1955t2760r2144b2826],
25	are	VBP	O	be	cop	27	SENT_317	[p16l10t2878r105b2917],
26	significant	JJ	O	significant	amod	27	SENT_317	[p16l144t2860r483b2934],
27	determinants	NNS	O	determinant	ccomp	2	SENT_317	[p16l519t2861r933b2917],
28	of	IN	O	of	_	0	SENT_317	[p16l972t2861r1042b2917],
29	interindividual	JJ	O	interindividual	amod	30	SENT_317	[p16l1073t2861r1548b2917],
30	variability	NN	O	variability	prep_of	27	SENT_317	[p16l1585t2861r1915b2934],
31	in	IN	O	in	_	0	SENT_317	[p16l1953t2861r2013b2917],
32	the	DT	O	the	det	33	SENT_317	[p16l2050t2861r2146b2917],
33	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	30	SENT_317	[p16l7t2962r576b3035],
34	of	IN	O	of	_	0	SENT_317	[p16l610t2962r680b3018],
35	torasemide	NN	O	torasemide	prep_of	33	SENT_317	[p16l705t2962r1075b3018],
36	.	.	O	.	_	0	SENT_317	[p16l705t2962r1075b3018],

1	The	DT	O	the	det	4	SENT_318	[p16l1110t2962r1233b3018],
2	SLCOIBI	NNP	O	SLCOIBI	nn	4	SENT_318	[p16l1265t2962r1585b3019],
3	c.	NN	O	c.	nn	4	SENT_318	[p16l1622t2961r1945b3019],
4	521T	NN	O	521t	nsubjpass	10	SENT_318	[p16l1622t2961r1945b3019],
5	>	JJR	O	>	amod	7	SENT_318	[p16l1622t2961r1945b3019],
6	C	NN	O	c	nn	7	SENT_318	[p16l1622t2961r1945b3019],
7	polymorphism	NN	O	polymorphism	dep	4	SENT_318	[p16l1977t2962r2144b3035, p16l8t3063r336b3136],
8	has	VBZ	O	have	aux	10	SENT_318	[p16l380t3063r484b3119],
9	been	VBN	O	be	auxpass	10	SENT_318	[p16l531t3063r683b3119],
10	associated	VBN	O	associate	_	0	SENT_318	[p16l730t3063r1060b3119],
11	with	IN	O	with	_	0	SENT_318	[p16l1105t3063r1247b3119],
12	functional	JJ	O	functional	amod	13	SENT_318	[p16l1292t3062r1618b3119],
13	impairment	NN	O	impairment	prep_with	10	SENT_318	[p16l1664t3063r2037b3136],
14	of	IN	O	of	_	0	SENT_318	[p16l2082t3062r2152b3119],
15	OATP1B1	NN	O	oatp1b1	prep_of	13	SENT_318	[p16l10t3157r459b3221],
16	.	.	O	.	_	0	SENT_318	[p16l10t3157r459b3221],

1	”	NN	O	”	_	0	SENT_319	[p16l10t3157r459b3221],
2	2	CD	NUMBER	2	number	3	SENT_319	[p16l10t3157r459b3221],
3	]	CD	NUMBER	]	num	5	SENT_319	[p16l10t3157r459b3221],
4	Our	PRP$	O	we	poss	5	SENT_319	[p16l496t3165r620b3221],
5	observation	NN	O	observation	dep	1	SENT_319	[p16l651t3164r1027b3221],
6	that	IN	O	that	complm	13	SENT_319	[p16l1058t3164r1179b3221],
7	the	DT	O	the	det	8	SENT_319	[p16l1210t3164r1306b3221],
8	AUC	NN	O	auc	nsubjpass	13	SENT_319	[p16l1339t3165r1506b3221],
9	of	IN	O	of	_	0	SENT_319	[p16l1541t3164r1611b3221],
10	torasemide	NN	O	torasemide	prep_of	8	SENT_319	[p16l1637t3164r1990b3221],
11	was	VBD	O	be	auxpass	13	SENT_319	[p16l2023t3182r2145b3221],
12	significantly	RB	O	significantly	advmod	13	SENT_319	[p16l11t3264r411b3338],
13	increased	VBN	O	increase	dep	1	SENT_319	[p16l451t3265r755b3321],
14	in	IN	O	in	_	0	SENT_319	[p16l794t3265r855b3321],
15	patients	NNS	O	patient	prep_in	13	SENT_319	[p16l893t3265r1143b3338],
16	with	IN	O	with	_	0	SENT_319	[p16l1184t3265r1326b3321],
17	the	DT	O	the	det	20	SENT_319	[p16l1365t3265r1461b3321],
18	SLCOIBI	NNP	O	SLCOIBI	nn	20	SENT_319	[p16l1502t3265r1822b3322],
19	c.	NN	O	c.	nn	20	SENT_319	[p16l1868t3264r2145b3322],
20	521TC	NN	O	521tc	prep_with	15	SENT_319	[p16l1868t3264r2145b3322],

1	©	RB	O	©	advmod	2	SENT_320	[p16l9t3465r43b3499],
2	2008	CD	DATE	2008	_	0	SENT_320	[p16l61t3461r166b3499],
3	Adis	NNP	PERSON	Adis	nn	4	SENT_320	[p16l183t3462r280b3499],
4	Doria	NNP	PERSON	Doria	dep	2	SENT_320	[p16l299t3462r412b3499],
5	lnformciiion	NN	O	lnformciiion	nn	6	SENT_320	[p16l432t3462r695b3499],
6	BV	NN	O	bv	dep	4	SENT_320	[p16l716t3462r784b3498],
7	.	.	O	.	_	0	SENT_320	[p16l716t3462r784b3498],

1	All	DT	O	all	det	2	SENT_321	[p16l803t3462r856b3498],
2	rights	NNS	O	rights	nsubj	3	SENT_321	[p16l876t3462r994b3509],
3	reserved	VBN	O	reserve	_	0	SENT_321	[p16l1012t3462r1222b3499],
4	.	.	O	.	_	0	SENT_321	[p16l1012t3462r1222b3499],

1	3	CD	NUMBER	3	_	0	SENT_322	[p17l229t123r284b168],
2	,	,	O	,	_	0	SENT_322	[p17l229t123r284b168],
3	3	CD	NUMBER	3	num	6	SENT_322	[p17l464t90r493b122],
4	‘	NN	O	‘	nn	6	SENT_322	[p17l464t90r493b122],
5	NS	NN	O	n	nn	6	SENT_322	[p17l736t108r808b152],
6	p	NN	O	p	appos	1	SENT_322	[p17l1542t110r1774b163],
7	=	JJ	O	=	amod	9	SENT_322	[p17l1542t110r1774b163],
8	0.002	CD	NUMBER	0.002	tmod	7	SENT_322	[p17l1542t110r1774b163],
9	E	NN	O	e	dep	6	SENT_322	[p17l240t173r272b214],
10	1200	CD	DATE	1200	num	11	SENT_322	[p17l320t155r439b196],
11	re	NN	O	re	dep	6	SENT_322	[p17l614t171r925b199],
12	:	:	O	:	_	0	SENT_322	[p17l614t171r925b199],
13	1200	CD	DATE	1200	dep	1	SENT_322	[p17l1194t155r1313b196],
14	in	IN	O	in	prep	13	SENT_322	[p17l1500t171r1814b199],
15	:	:	O	:	_	0	SENT_322	[p17l1500t171r1814b199],
16	J	NNP	O	J	nn	18	SENT_322	[p17l229t216r273b260],
17	E	NNP	O	E	nn	18	SENT_322	[p17l229t263r273b309],
18	o	NN	O	o	dep	1	SENT_322	[p17l244t330r265b351],
19	1000	CD	DATE	1000	num	21	SENT_322	[p17l320t324r439b365],
20	1000	CD	DATE	1000	num	21	SENT_322	[p17l1194t324r1313b365],
21	C5	NN	O	c5	dep	18	SENT_322	[p17l240t372r284b399],
22	)	CD	NUMBER	)	number	23	SENT_322	[p17l240t372r284b399],
23	:1	CD	NUMBER	:1	num	24	SENT_322	[p17l242t401r284b432],
24	\	NN	O	\	dep	21	SENT_322	[p17l229t436r283b449],
25	.	.	O	.	_	0	SENT_322	[p17l229t436r283b449],

1	/	:	O	/	punct	2	SENT_323	[p17l229t436r283b449],
2	Ojjm-O	NN	O	ojjm-o	_	0	SENT_323	[p17l1487t422r1827b473],
3	Q	NNP	O	Q	dep	2	SENT_323	[p17l229t471r286b544],
4	“	CD	NUMBER	“	num	3	SENT_323	[p17l229t471r286b544],
5	,	,	O	,	_	0	SENT_323	[p17l229t471r286b544],
6	800	CD	NUMBER	800	number	7	SENT_323	[p17l348t489r439b530],
7	800	CD	NUMBER	800	appos	3	SENT_323	[p17l1222t489r1313b530],

1	<	JJR	O	<	_	0	SENT_324	[p17l230t667r273b741],
2	3	CD	NUMBER	3	dep	1	SENT_324	[p17l230t667r273b741],
3	:	:	O	:	_	0	SENT_324	[p17l230t667r273b741],
4	600	CD	NUMBER	600	number	5	SENT_324	[p17l348t656r439b698],
5	600	CD	NUMBER	600	num	8	SENT_324	[p17l1222t656r1313b698],
6	CD	NNP	O	CD	nn	8	SENT_324	[p17l240t760r272b787],
7	79	CD	NUMBER	79	num	8	SENT_324	[p17l230t792r272b830],
8	E	NN	O	e	dep	1	SENT_324	[p17l240t837r272b910],
9	400	CD	NUMBER	400	number	10	SENT_324	[p17l347t821r439b863],
10	400	CD	NUMBER	400	num	8	SENT_324	[p17l1221t821r1313b863],
11	E	NN	O	e	dep	8	SENT_324	[p17l240t914r272b987],
12	'	''	O	'	_	0	SENT_324	[p17l230t993r272b1057],
13	3	CD	NUMBER	3	number	14	SENT_324	[p17l230t993r272b1057],
14	200	CD	NUMBER	200	dep	1	SENT_324	[p17l348t990r439b1031],
15	200	CD	NUMBER	200	dep	14	SENT_324	[p17l1221t990r1313b1031],

1	Baseline	NN	O	baseline	_	0	SENT_325	[p17l511t1048r722b1091],
2	Losartan	NNP	O	Losartan	nn	3	SENT_325	[p17l806t1048r1020b1091],
3	Baseline	NNP	O	Baseline	dep	1	SENT_325	[p17l1399t1048r1611b1091],
4	irbesartan	NN	O	irbesartan	dep	1	SENT_325	[p17l1685t1048r1932b1091],

1	Fig	NN	O	fig	_	0	SENT_326	[p17l12t1149r119b1210],
2	.	.	O	.	_	0	SENT_326	[p17l12t1149r119b1210],

1	2	LS	NUMBER	2	_	0	SENT_327	[p17l142t1150r190b1197],
2	.	.	O	.	_	0	SENT_327	[p17l142t1150r190b1197],

1	Changes	NNS	O	change	nsubj	11	SENT_328	[p17l214t1148r470b1211],
2	in	IN	O	in	_	0	SENT_328	[p17l493t1149r536b1197],
3	the	DT	O	the	det	6	SENT_328	[p17l558t1149r645b1197],
4	torasemide	NN	O	torasemide	nn	6	SENT_328	[p17l666t1149r983b1197],
5	dose-normalized	JJ	O	dose-normalized	amod	6	SENT_328	[p17l1005t1149r1480b1197],
6	area	NN	O	area	prep_in	1	SENT_328	[p17l1503t1161r1629b1197],
7	under	IN	O	under	_	0	SENT_328	[p17l1652t1149r1814b1197],
8	the	DT	O	the	det	10	SENT_328	[p17l1832t1149r1920b1197],
9	plasma	NN	O	plasma	nn	10	SENT_328	[p17l1943t1149r2147b1210],
10	concentration-time	NN	O	concentration-time	prep_under	6	SENT_328	[p17l9t1234r539b1282],
11	curve	NN	O	curve	_	0	SENT_328	[p17l562t1246r716b1282],
12	during	IN	O	during	_	0	SENT_328	[p17l739t1234r914b1295],
13	the	DT	O	the	det	16	SENT_328	[p17l937t1234r1024b1282],
14	24-hour	JJ	DURATION	24-hour	amod	16	SENT_328	[p17l1046t1234r1269b1282],
15	dosing	NN	O	dosing	nn	16	SENT_328	[p17l1289t1234r1475b1295],
16	interval	NN	O	interval	prep_during	11	SENT_328	[p17l1501t1234r1702b1282],
17	at	IN	O	at	_	0	SENT_328	[p17l1727t1237r1778b1282],
18	steady	JJ	O	steady	amod	21	SENT_328	[p17l1800t1234r1988b1295],
19	state	NN	O	state	nn	21	SENT_328	[p17l2010t1237r2146b1282],
20	(	CD	NUMBER	(	num	21	SENT_328	[p17l12t1317r372b1379],
21	AUC24	NN	O	auc24	prep_at	11	SENT_328	[p17l12t1317r372b1379],
22	,	,	O	,	_	0	SENT_328	[p17l12t1317r372b1379],
23	ss/D	NN	O	ss/d	dep	11	SENT_328	[p17l12t1317r372b1379],
24	)	CD	NUMBER	)	num	23	SENT_328	[p17l12t1317r372b1379],
25	when	WRB	O	when	advmod	29	SENT_328	[p17l395t1319r545b1367],
26	patients	NNS	O	patient	nsubjpass	29	SENT_328	[p17l570t1319r791b1379],
27	were	VBD	O	be	auxpass	29	SENT_328	[p17l812t1330r949b1367],
28	additionally	RB	O	additionally	advmod	29	SENT_328	[p17l971t1319r1293b1379],
29	treated	VBN	O	treat	dep	23	SENT_328	[p17l1312t1319r1510b1367],
30	with	IN	O	with	_	0	SENT_328	[p17l1531t1319r1642b1366],
31	either	CC	O	either	preconj	32	SENT_328	[p17l1665t1319r1825b1367],
32	losartan	NN	O	losartan	prep_with	29	SENT_328	[p17l1847t1319r2069b1367],
33	or	CC	O	or	_	0	SENT_328	[p17l2093t1330r2149b1366],
34	irbesartan	NN	O	irbesartan	prep_with	29	SENT_328	[p17l12t1402r292b1450],
35	for	IN	O	for	_	0	SENT_328	[p17l324t1401r400b1450],
36	3	CD	DURATION	3	num	37	SENT_328	[p17l430t1403r462b1450],
37	days	NNS	NUMBER	day	prep_for	29	SENT_328	[p17l494t1402r627b1463],
38	compared	VBN	O	compare	_	0	SENT_328	[p17l659t1402r942b1462],
39	with	IN	O	with	prepc_compared_with	37	SENT_328	[p17l974t1402r1085b1449],
40	baseline	NN	O	baseline	pobj	37	SENT_328	[p17l1120t1402r1371b1450],
41	.	.	O	.	_	0	SENT_328	[p17l1120t1402r1371b1450],

1	The	DT	O	the	det	3	SENT_329	[p17l1405t1402r1514b1450],
2	red	JJ	O	red	amod	3	SENT_329	[p17l1549t1402r1635b1450],
3	circles	NNS	O	circle	nsubj	6	SENT_329	[p17l1668t1402r1848b1450],
4	and	CC	O	and	_	0	SENT_329	[p17l1881t1402r1983b1450],
5	lines	NNS	O	line	conj_and	3	SENT_329	[p17l2019t1402r2146b1450],
6	indicate	VBP	O	indicate	_	0	SENT_329	[p17l12t1487r229b1535],
7	the	DT	O	the	det	9	SENT_329	[p17l254t1487r341b1535],
8	average	JJ	O	average	amod	9	SENT_329	[p17l369t1498r599b1548],
9	changes	NNS	O	change	dobj	6	SENT_329	[p17l625t1487r882b1548],
10	.	.	O	.	_	0	SENT_329	[p17l625t1487r882b1548],

1	NS	NN	O	n	dep	5	SENT_330	[p17l914t1486r998b1535],
2	=	JJ	O	=	amod	1	SENT_330	[p17l1025t1508r1058b1526],
3	statistically	RB	O	statistically	advmod	5	SENT_330	[p17l1085t1487r1396b1547],
4	not	RB	O	not	neg	5	SENT_330	[p17l1424t1490r1509b1535],
5	significant	JJ	O	significant	_	0	SENT_330	[p17l1534t1486r1834b1548],
6	.	.	O	.	_	0	SENT_330	[p17l1534t1486r1834b1548],

1	genotype	NN	O	genotype	nsubj	3	SENT_331	[p17l10t1703r303b1767],
2	therefore	RB	O	therefore	advmod	3	SENT_331	[p17l329t1694r619b1751],
3	suggests	VBZ	O	suggest	_	0	SENT_331	[p17l648t1703r916b1767],
4	that	IN	O	that	complm	11	SENT_331	[p17l944t1694r1064b1751],
5	OATP1B1-mediated	JJ	O	oatp1b1-mediated	amod	6	SENT_331	[p17l1090t1694r1759b1751],
6	hepatic	JJ	O	hepatic	amod	7	SENT_331	[p17l1783t1694r2014b1767],
7	uptake	NN	O	uptake	nsubj	11	SENT_331	[p17l2041t1712r2145b1767, p17l8t1795r141b1852],
8	of	IN	O	of	_	0	SENT_331	[p17l176t1795r246b1852],
9	torasemide	NN	O	torasemide	prep_of	7	SENT_331	[p17l274t1795r628b1852],
10	is	VBZ	O	be	cop	11	SENT_331	[p17l662t1795r712b1852],
11	important	JJ	O	important	ccomp	3	SENT_331	[p17l748t1795r1062b1868],
12	for	IN	O	for	_	0	SENT_331	[p17l1095t1795r1189b1852],
13	its	PRP$	O	its	poss	14	SENT_331	[p17l1221t1795r1294b1852],
14	elimination	NN	O	elimination	prep_for	11	SENT_331	[p17l1330t1795r1697b1852],
15	by	IN	O	by	_	0	SENT_331	[p17l1729t1795r1808b1868],
16	CYP	NN	O	cyp	npadvmod	18	SENT_331	[p17l1844t1795r2145b1852, p17l10t1896r214b1969],
17	—	CD	NUMBER	—	num	16	SENT_331	[p17l1844t1795r2145b1852, p17l10t1896r214b1969],
18	catalysed	JJ	O	catalysed	amod	19	SENT_331	[p17l1844t1795r2145b1852, p17l10t1896r214b1969],
19	biotransformation	NN	O	biotransformation	prep_by	11	SENT_331	[p17l247t1896r843b1953],
20	.	.	O	.	_	0	SENT_331	[p17l247t1896r843b1953],

1	Our	PRP$	O	we	poss	2	SENT_332	[p17l884t1897r1008b1953],
2	findings	NNS	O	finding	nsubj	3	SENT_332	[p17l1041t1896r1303b1969],
3	are	VBP	O	be	_	0	SENT_332	[p17l1341t1914r1436b1953],
4	in	IN	O	in	_	0	SENT_332	[p17l1471t1896r1532b1952],
5	agreement	NN	O	agreement	prep_in	3	SENT_332	[p17l1568t1904r1903b1969],
6	with	IN	O	with	_	0	SENT_332	[p17l1937t1896r2079b1953],
7	a	DT	O	a	det	10	SENT_332	[p17l2115t1914r2148b1953],
8	recently	RB	DATE	recently	advmod	9	SENT_332	[p17l8t1997r267b2070],
9	published	VBN	O	publish	amod	10	SENT_332	[p17l307t1997r621b2070],
10	study	NN	O	study	prep_with	3	SENT_332	[p17l664t1997r852b2070],
11	,	,	O	,	_	0	SENT_332	[p17l664t1997r852b2070],
12	in	IN	O	in	_	0	SENT_332	[p17l895t1997r956b2053],
13	which	WDT	O	which	rel	32	SENT_332	[p17l996t1997r1192b2054],
14	a	DT	O	a	det	16	SENT_332	[p17l1234t2015r1267b2054],
15	significant	JJ	O	significant	amod	16	SENT_332	[p17l1309t1997r1647b2070],
16	impact	NN	O	impact	nsubjpass	32	SENT_332	[p17l1686t1997r1906b2070],
17	of	IN	O	of	_	0	SENT_332	[p17l1946t1997r2016b2054],
18	the	DT	O	the	det	24	SENT_332	[p17l2051t1997r2147b2054],
19	OAT	NN	O	oat	nn	24	SENT_332	[p17l12t2099r167b2155],
20	P	NN	O	p	nn	24	SENT_332	[p17l160t2099r244b2154],
21	]	NN	O	]	nn	24	SENT_332	[p17l160t2099r244b2154],
22	B	NN	O	b	nn	24	SENT_332	[p17l250t2099r334b2154],
23	]	CD	NUMBER	]	num	24	SENT_332	[p17l250t2099r334b2154],
24	genotype	NN	O	genotype	prep_of	16	SENT_332	[p17l360t2107r653b2171],
25	on	IN	O	on	_	0	SENT_332	[p17l674t2116r752b2155],
26	torasemide	NN	O	torasemide	nn	27	SENT_332	[p17l771t2098r1125b2155],
27	CL/F	NN	O	cl/f	prep_on	16	SENT_332	[p17l1145t2098r1314b2155],
28	in	IN	O	in	_	0	SENT_332	[p17l1333t2098r1394b2154],
29	healthy	JJ	O	healthy	amod	30	SENT_332	[p17l1412t2098r1649b2171],
30	volunteers	NNS	O	volunteer	prep_in	27	SENT_332	[p17l1669t2098r2002b2155],
31	was	VBD	O	be	auxpass	32	SENT_332	[p17l2024t2116r2145b2155],
32	reported	VBN	O	report	rcmod	10	SENT_332	[p17l8t2192r383b2273],
33	.	.	O	.	_	0	SENT_332	[p17l8t2192r383b2273],

1	[	NN	O	[	nn	3	SENT_333	[p17l8t2192r383b2273],
2	33	CD	NUMBER	33	num	3	SENT_333	[p17l8t2192r383b2273],
3	]	NN	O	]	nsubj	6	SENT_333	[p17l8t2192r383b2273],
4	This	DT	O	this	det	5	SENT_333	[p17l420t2200r560b2257],
5	finding	NN	O	finding	dep	3	SENT_333	[p17l597t2200r828b2273],
6	is	VBZ	O	be	_	0	SENT_333	[p17l863t2200r913b2257],
7	of	IN	O	of	_	0	SENT_333	[p17l950t2200r1020b2257],
8	considerable	JJ	O	considerable	amod	9	SENT_333	[p17l1049t2200r1456b2257],
9	interest	NN	O	interest	prep_of	6	SENT_333	[p17l1491t2200r1729b2257],
10	because	IN	O	because	mark	19	SENT_333	[p17l1761t2200r2015b2257],
11	the	DT	O	the	det	12	SENT_333	[p17l2050t2200r2147b2257],
12	mechanism	NN	O	mechanism	nsubj	19	SENT_333	[p17l9t2300r377b2357],
13	of	IN	O	of	_	0	SENT_333	[p17l410t2300r479b2357],
14	hepatic	JJ	O	hepatic	amod	15	SENT_333	[p17l507t2300r738b2373],
15	uptake	NN	O	uptake	prep_of	12	SENT_333	[p17l772t2300r986b2373],
16	of	IN	O	of	_	0	SENT_333	[p17l1021t2300r1090b2357],
17	torasemide	NN	O	torasemide	prep_of	15	SENT_333	[p17l1118t2300r1471b2357],
18	was	VBD	O	be	cop	19	SENT_333	[p17l1505t2318r1627b2357],
19	unclear	JJ	O	unclear	advcl	6	SENT_333	[p17l1661t2300r1915b2357],
20	.	.	O	.	_	0	SENT_333	[p17l1661t2300r1915b2357],

1	In	IN	O	in	_	0	SENT_334	[p17l1952t2302r2017b2356],
2	the	DT	O	the	det	3	SENT_334	[p17l2050t2300r2147b2357],
3	kidney	NN	O	kidney	prep_in	11	SENT_334	[p17l8t2401r244b2474],
4	,	,	O	,	_	0	SENT_334	[p17l8t2401r244b2474],
5	the	DT	O	the	det	8	SENT_334	[p17l273t2401r370b2458],
6	luminally	RB	O	luminally	advmod	7	SENT_334	[p17l396t2401r704b2474],
7	expressed	VBN	O	express	amod	8	SENT_334	[p17l732t2401r1049b2474],
8	OAT4	NN	O	oat4	nsubjpass	11	SENT_334	[p17l1076t2401r1279b2458],
9	has	VBZ	O	have	aux	11	SENT_334	[p17l1305t2401r1410b2458],
10	been	VBN	O	be	auxpass	11	SENT_334	[p17l1437t2401r1589b2458],
11	suggested	VBN	O	suggest	_	0	SENT_334	[p17l1618t2401r1933b2474],
12	as	IN	O	as	_	0	SENT_334	[p17l1960t2419r2022b2458],
13	the	DT	O	the	det	15	SENT_334	[p17l2050t2401r2146b2458],
14	major	JJ	O	major	amod	15	SENT_334	[p17l8t2502r197b2575],
15	mechanism	NN	O	mechanism	prep_as	11	SENT_334	[p17l219t2502r588b2559],
16	of	IN	O	of	_	0	SENT_334	[p17l612t2502r682b2559],
17	active	JJ	O	active	amod	19	SENT_334	[p17l702t2502r891b2559],
18	renal	JJ	O	renal	amod	19	SENT_334	[p17l915t2502r1076b2559],
19	excretion	NN	O	excretion	prep_of	15	SENT_334	[p17l1101t2502r1400b2559],
20	of	IN	O	of	_	0	SENT_334	[p17l1425t2502r1494b2559],
21	torasemide	NN	O	torasemide	prep_of	19	SENT_334	[p17l1513t2502r1884b2569],
22	,	,	O	,	_	0	SENT_334	[p17l1513t2502r1884b2569],
23	While	IN	O	while	mark	34	SENT_334	[p17l1911t2502r2089b2559],
24	a	DT	O	a	det	27	SENT_334	[p17l2115t2520r2148b2559],
25	corresponding	JJ	O	corresponding	amod	27	SENT_334	[p17l9t2603r469b2676],
26	uptake	NN	O	uptake	nn	27	SENT_334	[p17l497t2603r711b2676],
27	transporter	NN	O	transporter	nsubjpass	34	SENT_334	[p17l738t2612r1088b2676],
28	in	IN	O	in	_	0	SENT_334	[p17l1114t2603r1175b2659],
29	the	DT	O	the	det	30	SENT_334	[p17l1202t2603r1298b2660],
30	liver	NN	O	liver	prep_in	27	SENT_334	[p17l1326t2603r1473b2660],
31	has	VBZ	O	have	aux	34	SENT_334	[p17l1498t2603r1602b2660],
32	not	RB	O	not	neg	34	SENT_334	[p17l1631t2612r1734b2660],
33	been	VBN	O	be	auxpass	34	SENT_334	[p17l1759t2603r1911b2660],
34	identified	VBN	O	identify	dep	11	SENT_334	[p17l1938t2603r2145b2660, p17l9t2704r148b2761],
35	.	.	O	.	_	0	SENT_334	[p17l1938t2603r2145b2660, p17l9t2704r148b2761],

1	It	PRP	O	it	nsubj	3	SENT_335	[p17l179t2706r228b2761],
2	is	VBZ	O	be	cop	3	SENT_335	[p17l253t2704r303b2761],
3	tempting	JJ	O	tempting	_	0	SENT_335	[p17l332t2704r617b2777],
4	to	TO	O	to	aux	5	SENT_335	[p17l644t2713r704b2761],
5	speculate	VB	O	speculate	xcomp	3	SENT_335	[p17l735t2704r1031b2777],
6	that	IN	O	that	complm	25	SENT_335	[p17l1058t2704r1179b2761],
7	in	IN	O	in	_	0	SENT_335	[p17l1205t2704r1265b2760],
8	patients	NNS	O	patient	prep_in	25	SENT_335	[p17l1291t2704r1540b2777],
9	with	IN	O	with	_	0	SENT_335	[p17l1569t2704r1711b2761],
10	the	DT	O	the	det	15	SENT_335	[p17l1737t2704r1834b2761],
11	homozygous	JJ	O	homozygous	amod	15	SENT_335	[p17l1861t2704r2145b2777, p17l9t2823r157b2878],
12	SLCOIBI	NNP	O	SLCOIBI	nn	15	SENT_335	[p17l228t2806r549b2862],
13	c.	NN	O	c.	nn	15	SENT_335	[p17l624t2805r905b2862],
14	521CC	NN	O	521cc	nn	15	SENT_335	[p17l624t2805r905b2862],
15	genotype	NN	O	genotype	prep_with	8	SENT_335	[p17l976t2814r1288b2878],
16	,	,	O	,	_	0	SENT_335	[p17l976t2814r1288b2878],
17	nonrenal	JJ	O	nonrenal	amod	18	SENT_335	[p17l1359t2805r1640b2862],
18	clearance	NN	O	clearance	nsubj	25	SENT_335	[p17l1710t2805r2013b2862],
19	of	IN	O	of	_	0	SENT_335	[p17l2083t2805r2152b2862],
20	torasemide	NN	O	torasemide	prep_of	18	SENT_335	[p17l8t2906r362b2963],
21	might	MD	O	might	aux	25	SENT_335	[p17l397t2906r585b2979],
22	be	VB	O	be	cop	25	SENT_335	[p17l617t2906r692b2963],
23	even	RB	O	even	advmod	25	SENT_335	[p17l728t2924r879b2963],
24	more	RBR	O	more	advmod	25	SENT_335	[p17l913t2924r1078b2963],
25	affected	JJ	O	affected	ccomp	5	SENT_335	[p17l1114t2906r1372b2963],
26	than	IN	O	than	prep	25	SENT_335	[p17l1406t2906r1544b2963],
27	in	IN	O	in	pcomp	26	SENT_335	[p17l1579t2906r1640b2962],
28	carriers	NNS	O	carrier	pobj	27	SENT_335	[p17l1675t2906r1913b2963],
29	of	IN	O	of	_	0	SENT_335	[p17l1951t2906r2021b2963],
30	the	DT	O	the	det	32	SENT_335	[p17l2050t2906r2146b2963],
31	heterozygous	JJ	O	heterozygous	amod	32	SENT_335	[p17l8t3007r436b3080],
32	genotype	NN	O	genotype	prep_of	28	SENT_335	[p17l460t3015r770b3080],
33	.	.	O	.	_	0	SENT_335	[p17l460t3015r770b3080],

1	Our	PRP$	O	we	poss	3	SENT_336	[p17l795t3008r920b3064],
2	study	NN	O	study	nn	3	SENT_336	[p17l941t3007r1111b3080],
3	population	NN	O	population	nsubj	20	SENT_336	[p17l1131t3007r1477b3080],
4	(	CD	NUMBER	(	num	6	SENT_336	[p17l1499t3007r1718b3077],
5	allelic	JJ	O	allelic	amod	6	SENT_336	[p17l1499t3007r1718b3077],
6	frequency	NN	O	frequency	nsubj	9	SENT_336	[p17l1740t3007r2061b3080],
7	of	IN	O	of	_	0	SENT_336	[p17l2083t3007r2152b3064],
8	SLCOIBI	NNP	O	SLCOIBI	prep_of	6	SENT_336	[p17l9t3109r329b3165],
9	c.	VBP	O	c.	rcmod	3	SENT_336	[p17l367t3108r613b3165],
10	521C	NN	O	521c	dobj	9	SENT_336	[p17l367t3108r613b3165],
11	:	:	O	:	_	0	SENT_336	[p17l367t3108r613b3165],
12	23	CD	PERCENT	23	num	13	SENT_336	[p17l651t3108r840b3178],
13	%	NN	PERCENT	%	dep	10	SENT_336	[p17l651t3108r840b3178],
14	)	CD	NUMBER	)	dep	13	SENT_336	[p17l651t3108r840b3178],
15	,	,	O	,	_	0	SENT_336	[p17l651t3108r840b3178],
16	however	RB	O	however	advmod	13	SENT_336	[p17l874t3108r1168b3175],
17	,	,	O	,	_	0	SENT_336	[p17l874t3108r1168b3175],
18	did	VBD	O	do	aux	20	SENT_336	[p17l1203t3108r1305b3165],
19	not	RB	O	not	neg	20	SENT_336	[p17l1335t3117r1438b3165],
20	include	VB	O	include	_	0	SENT_336	[p17l1467t3108r1704b3165],
21	homozygous	JJ	O	homozygous	amod	22	SENT_336	[p17l1734t3108r2145b3181],
22	carriers	NNS	O	carrier	dobj	20	SENT_336	[p17l9t3209r247b3266],
23	of	IN	O	of	_	0	SENT_336	[p17l270t3209r340b3266],
24	the	DT	O	the	det	28	SENT_336	[p17l354t3209r451b3266],
25	SLCOIBI	NNP	O	SLCOIBI	nn	28	SENT_336	[p17l471t3210r792b3266],
26	c.	NN	O	c.	nn	28	SENT_336	[p17l818t3209r1100b3266],
27	521CC	NN	O	521cc	nn	28	SENT_336	[p17l818t3209r1100b3266],
28	variant	NN	O	variant	prep_of	22	SENT_336	[p17l1122t3209r1346b3266],
29	to	TO	O	to	aux	30	SENT_336	[p17l1364t3218r1424b3266],
30	prove	VB	O	prove	xcomp	20	SENT_336	[p17l1444t3227r1627b3282],
31	this	DT	O	this	det	32	SENT_336	[p17l1647t3209r1760b3266],
32	hypothesis	NN	O	hypothesis	dobj	30	SENT_336	[p17l1782t3209r2143b3282],
33	.	.	O	.	_	0	SENT_336	[p17l1782t3209r2143b3282],

1	Previous	JJ	O	previous	amod	2	SENT_337	[p17l8t3310r288b3367],
2	studies	NNS	O	study	nsubj	5	SENT_337	[p17l319t3310r538b3367],
3	have	VBP	O	have	aux	5	SENT_337	[p17l566t3310r717b3367],
4	clearly	RB	O	clearly	advmod	5	SENT_337	[p17l745t3310r962b3383],
5	indicated	VBN	O	indicate	_	0	SENT_337	[p17l990t3310r1286b3367],
6	an	DT	O	a	det	8	SENT_337	[p17l1313t3328r1386b3367],
7	important	JJ	O	important	amod	8	SENT_337	[p17l1413t3310r1727b3383],
8	contribution	NN	O	contribution	nn	16	SENT_337	[p17l1754t3310r2147b3367],
9	of	IN	O	of	_	0	SENT_337	[p17l9t3411r79b3468],
10	the	DT	O	the	det	13	SENT_337	[p17l108t3411r205b3468],
11	SLCOIBI	NNP	O	SLCOIBI	nn	13	SENT_337	[p17l240t3412r561b3468],
12	c.	NN	O	c.	nn	13	SENT_337	[p17l602t3411r925b3468],
13	52lT	NN	O	52lt	prep_of	8	SENT_337	[p17l602t3411r925b3468],
14	>	JJR	O	>	dep	15	SENT_337	[p17l602t3411r925b3468],
15	C	NN	O	c	amod	16	SENT_337	[p17l602t3411r925b3468],
16	polymorphism	NN	O	polymorphism	dobj	5	SENT_337	[p17l960t3411r1433b3484],
17	to	TO	O	to	_	0	SENT_337	[p17l1466t3420r1526b3468],
18	the	DT	O	the	det	19	SENT_337	[p17l1562t3411r1658b3468],
19	disposition	NN	O	disposition	prep_to	5	SENT_337	[p17l1694t3411r2047b3484],
20	of	IN	O	of	_	0	SENT_337	[p17l2083t3411r2153b3468],
21	pravastatin	NN	O	pravastatin	prep_of	19	SENT_337	[p17l7t3512r379b3585],
22	,	,	O	,	_	0	SENT_337	[p17l7t3512r379b3585],
23	rosuvastatin	NN	O	rosuvastatin	nn	27	SENT_337	[p17l417t3512r825b3579],
24	,	,	O	,	_	0	SENT_337	[p17l417t3512r825b3579],
25	pitavastatin	NN	O	pitavastatin	nn	31	SENT_337	[p17l862t3512r1252b3585],
26	,	,	O	,	_	0	SENT_337	[p17l862t3512r1252b3585],
27	fexofenadine	NN	O	fexofenadine	nn	31	SENT_337	[p17l1291t3512r1711b3569],
28	and	CC	O	and	_	0	SENT_337	[p17l1749t3512r1862b3569],
29	repagli	JJ	O	repagli	conj_and	27	SENT_337	[p17l1896t3512r2145b3585],
30	—	NN	O	—	nn	31	SENT_337	[p17l1896t3512r2145b3585],
31	nide	NN	O	nide	appos	21	SENT_337	[p17l8t3606r225b3670],
32	.	.	O	.	_	0	SENT_337	[p17l8t3606r225b3670],

1	[	NN	O	[	_	0	SENT_338	[p17l8t3606r225b3670],
2	8	CD	NUMBER	8	num	3	SENT_338	[p17l8t3606r225b3670],
3	]	NN	O	]	dep	1	SENT_338	[p17l8t3606r225b3670],

1	Interestingly	RB	O	interestingly	advmod	5	SENT_339	[p17l106t3714r531b3787],
2	,	,	O	,	_	0	SENT_339	[p17l106t3714r531b3787],
3	our	PRP$	O	we	poss	4	SENT_339	[p17l560t3731r667b3770],
4	data	NNS	O	datum	nsubj	5	SENT_339	[p17l692t3714r825b3770],
5	indicate	VBP	O	indicate	_	0	SENT_339	[p17l849t3714r1103b3770],
6	the	DT	O	the	det	7	SENT_339	[p17l1129t3714r1226b3770],
7	presence	NN	O	presence	dobj	5	SENT_339	[p17l1251t3731r1533b3787],
8	of	IN	O	of	_	0	SENT_339	[p17l1560t3714r1630b3770],
9	gender-specific	JJ	O	gender-specific	amod	10	SENT_339	[p17l1651t3714r2146b3787],
10	differences	NNS	O	difference	prep_of	7	SENT_339	[p18l9t21r364b77],
11	in	IN	O	in	_	0	SENT_339	[p18l406t21r467b77],
12	torasemide	NN	O	torasemide	nn	13	SENT_339	[p18l506t21r860b77],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	10	SENT_339	[p18l898t21r1485b94],
14	.	.	O	.	_	0	SENT_339	[p18l898t21r1485b94],

1	The	DT	O	the	det	2	SENT_340	[p18l1529t21r1653b77],
2	AUC24	NN	O	auc24	nsubjpass	10	SENT_340	[p18l1692t21r1992b93],
3	,	,	O	,	_	0	SENT_340	[p18l1692t21r1992b93],
4	ss	NN	O	ss	conj_and	2	SENT_340	[p18l1692t21r1992b93],
5	and	CC	O	and	_	0	SENT_340	[p18l2034t21r2148b77],
6	Cmax	NN	O	cmax	conj_and	2	SENT_340	[p18l9t122r238b194],
7	,	,	O	,	_	0	SENT_340	[p18l9t122r238b194],
8	gs	NNS	O	g	appos	2	SENT_340	[p18l9t122r238b194],
9	were	VBD	O	be	auxpass	10	SENT_340	[p18l258t139r412b179],
10	increased	VBN	O	increase	_	0	SENT_340	[p18l431t122r736b178],
11	by	IN	O	by	dep	10	SENT_340	[p18l753t122r832b195],
12	about	IN	O	about	_	0	SENT_340	[p18l853t122r1030b178],
13	40-50	CD	PERCENT	40-50	num	14	SENT_340	[p18l1047t121r1312b179],
14	%	NN	PERCENT	%	prep_about	10	SENT_340	[p18l1047t121r1312b179],
15	in	IN	O	in	_	0	SENT_340	[p18l1335t122r1395b178],
16	women	NNS	O	woman	prep_in	14	SENT_340	[p18l1414t139r1651b178],
17	compared	VBN	O	compare	_	0	SENT_340	[p18l1670t122r1987b195],
18	with	IN	O	with	prepc_compared_with	10	SENT_340	[p18l2006t122r2147b179],
19	men	NNS	O	man	pobj	10	SENT_340	[p18l9t240r162b279],
20	.	.	O	.	_	0	SENT_340	[p18l9t240r162b279],

1	Our	PRP$	O	we	poss	2	SENT_341	[p18l192t223r316b280],
2	study	NN	O	study	nsubjpass	6	SENT_341	[p18l341t223r511b296],
3	was	VBD	O	be	auxpass	6	SENT_341	[p18l536t240r658b279],
4	not	RB	O	not	neg	6	SENT_341	[p18l684t231r787b279],
5	primarily	RB	O	primarily	advmod	6	SENT_341	[p18l809t222r1109b296],
6	designed	VBN	O	design	_	0	SENT_341	[p18l1134t223r1420b296],
7	to	TO	O	to	aux	8	SENT_341	[p18l1443t231r1503b279],
8	investigate	VB	O	investigate	xcomp	6	SENT_341	[p18l1528t223r1877b296],
9	genderrelated	JJ	O	genderrelated	amod	10	SENT_341	[p18l1903t223r2145b296, p18l8t324r227b380],
10	differences	NNS	O	difference	dobj	8	SENT_341	[p18l249t324r623b390],
11	,	,	O	,	_	0	SENT_341	[p18l249t324r623b390],
12	and	CC	O	and	_	0	SENT_341	[p18l649t324r763b380],
13	the	DT	O	the	det	15	SENT_341	[p18l783t324r880b380],
14	small	JJ	O	small	amod	15	SENT_341	[p18l904t324r1074b380],
15	number	NN	O	number	nsubj	24	SENT_341	[p18l1096t324r1343b380],
16	of	IN	O	of	_	0	SENT_341	[p18l1363t323r1433b380],
17	female	JJ	O	female	amod	18	SENT_341	[p18l1449t324r1667b380],
18	patients	NNS	O	patient	prep_of	15	SENT_341	[p18l1687t324r1936b397],
19	in	IN	O	in	_	0	SENT_341	[p18l1959t324r2020b380],
20	our	PRP$	O	we	poss	21	SENT_341	[p18l2042t341r2149b380],
21	study	NN	O	study	prep_in	18	SENT_341	[p18l11t425r181b498],
22	does	VBZ	O	do	aux	24	SENT_341	[p18l202t425r346b481],
23	not	RB	O	not	neg	24	SENT_341	[p18l367t433r469b481],
24	allow	VB	O	allow	conj_and	6	SENT_341	[p18l489t425r664b481],
25	a	DT	O	a	det	27	SENT_341	[p18l686t442r719b481],
26	final	JJ	O	final	amod	27	SENT_341	[p18l738t425r883b481],
27	estimation	NN	O	estimation	dobj	24	SENT_341	[p18l903t425r1238b481],
28	of	IN	O	of	_	0	SENT_341	[p18l1258t424r1328b481],
29	the	DT	O	the	det	30	SENT_341	[p18l1342t425r1439b481],
30	magnitude	NN	O	magnitude	prep_of	27	SENT_341	[p18l1458t425r1798b498],
31	of	IN	O	of	_	0	SENT_341	[p18l1818t425r1888b481],
32	genderrelated	JJ	O	genderrelated	amod	33	SENT_341	[p18l1903t425r2144b498, p18l8t526r228b582],
33	changes	NNS	O	change	prep_of	30	SENT_341	[p18l258t526r514b599],
34	in	IN	O	in	_	0	SENT_341	[p18l546t526r607b582],
35	torasemide	NN	O	torasemide	nn	36	SENT_341	[p18l637t526r990b582],
36	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	24	SENT_341	[p18l1020t525r1607b599],
37	.	.	O	.	_	0	SENT_341	[p18l1020t525r1607b599],

1	In	IN	O	in	_	0	SENT_342	[p18l1641t527r1706b582],
2	addition	NN	O	addition	prep_in	8	SENT_342	[p18l1738t526r2017b593],
3	,	,	O	,	_	0	SENT_342	[p18l1738t526r2017b593],
4	the	DT	O	the	det	5	SENT_342	[p18l2051t526r2147b582],
5	differences	NNS	O	difference	nsubjpass	8	SENT_342	[p18l9t627r364b683],
6	may	MD	O	may	aux	8	SENT_342	[p18l400t644r537b700],
7	be	VB	O	be	auxpass	8	SENT_342	[p18l569t627r645b683],
8	attributed	VBN	O	attribute	_	0	SENT_342	[p18l680t627r988b683],
9	at	IN	O	at	advmod	8	SENT_342	[p18l1022t635r1078b683],
10	least	JJS	O	least	pobj	9	SENT_342	[p18l1111t627r1258b683],
11	in	IN	O	in	_	0	SENT_342	[p18l1290t627r1351b683],
12	part	NN	O	part	prep_in	8	SENT_342	[p18l1384t635r1510b700],
13	to	TO	O	to	_	0	SENT_342	[p18l1542t635r1602b683],
14	the	DT	O	the	det	15	SENT_342	[p18l1636t627r1733b683],
15	presence	NN	O	presence	prep_to	8	SENT_342	[p18l1766t644r2047b700],
16	of	IN	O	of	_	0	SENT_342	[p18l2082t626r2152b683],
17	more	JJR	O	more	amod	18	SENT_342	[p18l9t745r173b784],
18	carriers	NNS	O	carrier	prep_of	15	SENT_342	[p18l210t728r449b784],
19	of	IN	O	of	_	0	SENT_342	[p18l489t728r558b784],
20	the	DT	O	the	det	22	SENT_342	[p18l590t728r686b784],
21	CYP2C9	NN	O	cyp2c9	nn	22	SENT_342	[p18l728t728r1082b785],
22	*	NN	O	*	prep_of	18	SENT_342	[p18l728t728r1082b785],
23	3	CD	NUMBER	3	num	24	SENT_342	[p18l728t728r1082b785],
24	allele	NN	O	allele	nsubj	32	SENT_342	[p18l1125t728r1296b784],
25	among	IN	O	among	_	0	SENT_342	[p18l1335t745r1551b801],
26	the	DT	O	the	det	27	SENT_342	[p18l1589t728r1686b784],
27	females	NNS	O	female	prep_among	24	SENT_342	[p18l1723t728r1971b784],
28	than	IN	O	than	advmod	32	SENT_342	[p18l2010t728r2147b784],
29	among	IN	O	among	_	0	SENT_342	[p18l10t846r226b902],
30	the	DT	O	the	det	31	SENT_342	[p18l254t829r351b885],
31	males	NNS	O	male	prep_among	28	SENT_342	[p18l379t829r564b885],
32	(	VBP	O	(	rcmod	22	SENT_342	[p18l596t829r764b898],
33	29	CD	PERCENT	29	num	34	SENT_342	[p18l596t829r764b898],
34	%	NN	PERCENT	%	dobj	32	SENT_342	[p18l596t829r764b898],
35	vs	CC	O	vs	_	0	SENT_342	[p18l795t846r863b886],
36	18	CD	PERCENT	18	num	37	SENT_342	[p18l900t829r1082b898],
37	%	NN	PERCENT	%	conj_vs	34	SENT_342	[p18l900t829r1082b898],
38	)	CD	NUMBER	)	dep	37	SENT_342	[p18l900t829r1082b898],
39	.	.	O	.	_	0	SENT_342	[p18l900t829r1082b898],

1	In	IN	O	in	_	0	SENT_343	[p18l1114t830r1179b885],
2	animal	NN	O	animal	nn	3	SENT_343	[p18l1209t829r1425b885],
3	models	NNS	O	model	prep_in	24	SENT_343	[p18l1453t829r1703b895],
4	,	,	O	,	_	0	SENT_343	[p18l1453t829r1703b895],
5	an	DT	O	a	det	6	SENT_343	[p18l1735t846r1808b885],
6	impact	NN	O	impact	nsubjpass	24	SENT_343	[p18l1835t829r2055b902],
7	of	IN	O	of	_	0	SENT_343	[p18l2083t828r2152b885],
8	gender	NN	O	gender	prep_of	6	SENT_343	[p18l10t930r229b1003],
9	on	IN	O	on	_	0	SENT_343	[p18l247t947r325b986],
10	the	DT	O	the	det	11	SENT_343	[p18l345t930r441b986],
11	expression	NN	O	expression	prep_on	8	SENT_343	[p18l462t930r806b1003],
12	of	IN	O	of	_	0	SENT_343	[p18l826t930r896b986],
13	proteins	NNS	O	protein	prep_of	11	SENT_343	[p18l909t930r1167b1003],
14	involved	VBN	O	involve	partmod	13	SENT_343	[p18l1189t930r1471b986],
15	in	IN	O	in	_	0	SENT_343	[p18l1490t930r1551b986],
16	the	DT	O	the	det	17	SENT_343	[p18l1570t930r1667b986],
17	metabolism	NN	O	metabolism	prep_in	14	SENT_343	[p18l1686t930r2064b986],
18	or	CC	O	or	_	0	SENT_343	[p18l2083t947r2149b986],
19	excretion	NN	O	excretion	prep_in	14	SENT_343	[p18l9t1031r308b1087],
20	of	IN	O	of	_	0	SENT_343	[p18l343t1031r413b1087],
21	torasemide	NN	O	torasemide	prep_of	17	SENT_343	[p18l441t1031r794b1087],
22	has	VBZ	O	have	aux	24	SENT_343	[p18l828t1031r933b1087],
23	been	VBN	O	be	auxpass	24	SENT_343	[p18l967t1031r1120b1087],
24	described	VBN	O	describe	_	0	SENT_343	[p18l1154t1031r1462b1087],
25	for	IN	O	for	_	0	SENT_343	[p18l1496t1031r1590b1087],
26	members	NNS	O	member	prep_for	24	SENT_343	[p18l1622t1031r1915b1087],
27	of	IN	O	of	_	0	SENT_343	[p18l1952t1030r2022b1087],
28	the	DT	O	the	prep_of	26	SENT_343	[p18l2050t1031r2146b1087],

1	Clin	NN	O	clin	_	0	SENT_344	[p18l1405t1227r1489b1265],
2	Phc1rmoCokine	NN	O	phc1rmocokine	dep	1	SENT_344	[p18l1509t1227r1999b1268],
3	’	CD	NUMBER	’	num	4	SENT_344	[p18l1509t1227r1999b1268],
4	r2008	NN	O	r2008	dep	2	SENT_344	[p18l1509t1227r1999b1268],
5	,	,	O	,	_	0	SENT_344	[p18l1509t1227r1999b1268],
6	'	''	DATE	'	_	0	SENT_344	[p18l1509t1227r1999b1268],
7	47	CD	DATE	47	number	8	SENT_344	[p18l2018t1228r2068b1264],
8	(	CD	NUMBER	(	dep	1	SENT_344	[p18l2088t1228r2146b1270],
9	5	CD	NUMBER	5	num	10	SENT_344	[p18l2088t1228r2146b1270],
10	)	NN	O	)	dep	8	SENT_344	[p18l2088t1228r2146b1270],

1	330	CD	NUMBER	330	num	2	SENT_345	[p18l6t1344r54b1368],
2	Werner	NNP	O	Werner	_	0	SENT_345	[p18l6t1380r105b1404],
3	et	FW	O	et	dep	2	SENT_345	[p18l116t1382r139b1404],
4	all	DT	O	all	dep	3	SENT_345	[p18l149t1379r179b1404],
5	.	.	O	.	_	0	SENT_345	[p18l149t1379r179b1404],

1	OAT	NN	O	oat	nn	2	SENT_346	[p18l10t1591r173b1647],
2	family	NN	O	family	_	0	SENT_346	[p18l208t1583r523b1664],
3	,	,	O	,	_	0	SENT_346	[p18l208t1583r523b1664],
4	[	CD	NUMBER	[	number	5	SENT_346	[p18l208t1583r523b1664],
5	34	CD	NUMBER	34	num	6	SENT_346	[p18l208t1583r523b1664],
6	]	NN	O	]	appos	2	SENT_346	[p18l208t1583r523b1664],
7	which	WDT	O	which	nsubj	8	SENT_346	[p18l562t1590r758b1647],
8	mediate	VBP	O	mediate	rcmod	6	SENT_346	[p18l792t1590r1046b1647],
9	renal	JJ	O	renal	amod	10	SENT_346	[p18l1081t1591r1241b1647],
10	excretion	NN	O	excretion	dobj	8	SENT_346	[p18l1277t1590r1576b1647],
11	of	IN	O	of	_	0	SENT_346	[p18l1612t1590r1681b1647],
12	torasemide	NN	O	torasemide	prep_of	10	SENT_346	[p18l1711t1582r2144b1647],
13	.	.	O	.	_	0	SENT_346	[p18l1711t1582r2144b1647],

1	[	NN	O	[	nsubj	12	SENT_347	[p18l1711t1582r2144b1647],
2	6	CD	NUMBER	6	number	3	SENT_347	[p18l1711t1582r2144b1647],
3	]	CD	NUMBER	]	dep	1	SENT_347	[p18l1711t1582r2144b1647],
4	Furthermore	RB	O	furthermore	advmod	3	SENT_347	[p18l8t1692r429b1758],
5	,	,	O	,	_	0	SENT_347	[p18l8t1692r429b1758],
6	Cerrutti	NNP	O	Cerrutti	appos	1	SENT_347	[p18l462t1692r710b1749],
7	et	FW	O	et	dep	6	SENT_347	[p18l741t1700r797b1748],
8	al.	FW	O	al.	nn	9	SENT_347	[p18l827t1684r988b1748],
9	[	FW	O	[	dep	6	SENT_347	[p18l827t1684r988b1748],
10	35	CD	NUMBER	35	num	11	SENT_347	[p18l827t1684r988b1748],
11	]	NN	O	]	dep	9	SENT_347	[p18l827t1684r988b1748],
12	evaluated	VBD	O	evaluate	_	0	SENT_347	[p18l1021t1692r1329b1749],
13	the	DT	O	the	det	14	SENT_347	[p18l1357t1692r1454b1748],
14	pharmacokinetics	NNS	O	pharmacokinetic	dobj	12	SENT_347	[p18l1482t1692r2051b1765],
15	of	IN	O	of	_	0	SENT_347	[p18l2083t1692r2152b1748],
16	para	NN	O	para	npadvmod	18	SENT_347	[p18l7t1792r644b1865],
17	—	CD	NUMBER	—	num	16	SENT_347	[p18l7t1792r644b1865],
18	aminohippuric	JJ	O	aminohippuric	amod	19	SENT_347	[p18l7t1792r644b1865],
19	acid	NN	O	acid	prep_of	14	SENT_347	[p18l689t1792r837b1859],
20	,	,	O	,	_	0	SENT_347	[p18l689t1792r837b1859],
21	the	DT	O	the	det	23	SENT_347	[p18l882t1792r978b1849],
22	reference	NN	O	reference	nn	23	SENT_347	[p18l1019t1792r1319b1849],
23	substance	NN	O	substance	conj_and	14	SENT_347	[p18l1364t1792r1674b1849],
24	for	IN	O	for	_	0	SENT_347	[p18l1716t1792r1809b1849],
25	the	DT	O	the	det	28	SENT_347	[p18l1849t1792r1946b1849],
26	renal	JJ	O	renal	amod	28	SENT_347	[p18l1987t1792r2147b1849],
27	OAT	NN	O	oat	nn	28	SENT_347	[p18l10t1893r173b1949],
28	systems	NNS	O	system	prep_for	23	SENT_347	[p18l213t1901r482b1966],
29	,	,	O	,	_	0	SENT_347	[p18l213t1901r482b1966],
30	and	CC	O	and	_	0	SENT_347	[p18l525t1892r638b1949],
31	the	DT	O	the	det	32	SENT_347	[p18l675t1892r772b1949],
32	loop	NN	O	loop	conj_and	14	SENT_347	[p18l810t1892r951b1966],
33	diuretic	JJ	O	diuretic	amod	37	SENT_347	[p18l990t1892r1233b1949],
34	furosemide	NN	O	furosemide	nn	37	SENT_347	[p18l1273t1892r1635b1949],
35	(	NN	O	(	nn	37	SENT_347	[p18l1675t1892r2046b1962],
36	frusemide	NN	O	frusemide	nn	37	SENT_347	[p18l1675t1892r2046b1962],
37	)	NN	O	)	dep	32	SENT_347	[p18l1675t1892r2046b1962],
38	in	IN	O	in	_	0	SENT_347	[p18l2086t1892r2147b1948],
39	rats	NNS	O	rat	prep_in	12	SENT_347	[p18l8t2002r139b2050],
40	.	.	O	.	_	0	SENT_347	[p18l8t2002r139b2050],

1	They	PRP	O	they	nsubj	2	SENT_348	[p18l163t1994r326b2067],
2	demonstrated	VBD	O	demonstrate	_	0	SENT_348	[p18l346t1994r781b2050],
3	a	DT	O	a	det	5	SENT_348	[p18l801t2012r834b2050],
4	higher	JJR	O	higher	amod	5	SENT_348	[p18l851t1994r1058b2067],
5	AUC	NN	O	auc	dobj	2	SENT_348	[p18l1075t1994r1243b2051],
6	and	CC	O	and	_	0	SENT_348	[p18l1265t1994r1379b2050],
7	lower	JJR	O	lower	amod	8	SENT_348	[p18l1397t1994r1581b2051],
8	clearance	NN	O	clearance	dobj	2	SENT_348	[p18l1599t1994r1902b2050],
9	of	IN	O	of	prep	8	SENT_348	[p18l1922t1994r1992b2050],
10	both	CC	O	both	preconj	5	SENT_348	[p18l2004t1994r2147b2050],
11	substances	NNS	O	substance	conj_and	5	SENT_348	[p18l11t2095r351b2152],
12	in	IN	O	in	_	0	SENT_348	[p18l372t2095r433b2151],
13	female	JJ	O	female	amod	14	SENT_348	[p18l452t2095r670b2152],
14	rats	NNS	O	rat	prep_in	11	SENT_348	[p18l688t2104r820b2152],
15	.	.	O	.	_	0	SENT_348	[p18l688t2104r820b2152],

1	A	DT	O	a	det	3	SENT_349	[p18l843t2096r900b2151],
2	few	JJ	O	few	amod	3	SENT_349	[p18l919t2095r1037b2152],
3	reports	NNS	O	report	nsubjpass	8	SENT_349	[p18l1056t2104r1278b2168],
4	have	VBP	O	have	aux	8	SENT_349	[p18l1298t2095r1449b2152],
5	so	RB	O	so	advmod	6	SENT_349	[p18l1471t2113r1537b2152],
6	far	RB	O	far	advmod	8	SENT_349	[p18l1558t2095r1647b2152],
7	been	VBN	O	be	auxpass	8	SENT_349	[p18l1663t2095r1815b2152],
8	published	VBN	O	publish	_	0	SENT_349	[p18l1833t2095r2148b2168],
9	on	IN	O	on	_	0	SENT_349	[p18l10t2213r87b2252],
10	gender	NN	O	gender	nn	11	SENT_349	[p18l122t2195r341b2269],
11	differences	NNS	O	difference	prep_on	8	SENT_349	[p18l373t2195r728b2252],
12	in	IN	O	in	_	0	SENT_349	[p18l764t2195r825b2251],
13	the	DT	O	the	det	17	SENT_349	[p18l858t2195r954b2252],
14	CYP2C9	NN	O	cyp2c9	nn	17	SENT_349	[p18l989t2195r1640b2269],
15	—	NN	O	—	nn	17	SENT_349	[p18l989t2195r1640b2269],
16	dependent	JJ	O	dependent	amod	17	SENT_349	[p18l989t2195r1640b2269],
17	metabolism	NN	O	metabolism	prep_in	8	SENT_349	[p18l1672t2195r2050b2252],
18	of	IN	O	of	_	0	SENT_349	[p18l2083t2195r2153b2252],
19	drugs	NNS	O	drug	prep_of	17	SENT_349	[p18l9t2298r204b2371],
20	,	,	O	,	_	0	SENT_349	[p18l9t2298r204b2371],
21	with	IN	O	with	_	0	SENT_349	[p18l251t2298r393b2355],
22	negative	JJ	O	negative	amod	23	SENT_349	[p18l437t2298r709b2371],
23	results	NNS	O	result	prep_with	8	SENT_349	[p18l753t2290r1136b2354],
24	.	.	O	.	_	0	SENT_349	[p18l753t2290r1136b2354],

1	[	NN	O	[	nn	3	SENT_350	[p18l753t2290r1136b2354],
2	36	CD	NUMBER	36	num	3	SENT_350	[p18l753t2290r1136b2354],
3	’	NN	O	’	nsubj	33	SENT_350	[p18l753t2290r1136b2354],
4	37	CD	NUMBER	37	number	5	SENT_350	[p18l753t2290r1136b2354],
5	]	CD	NUMBER	]	dep	3	SENT_350	[p18l753t2290r1136b2354],
6	According	VBG	O	accord	_	0	SENT_350	[p18l1184t2298r1523b2371],
7	to	TO	O	to	prepc_according_to	30	SENT_350	[p18l1568t2306r1628b2354],
8	data	NNS	O	datum	pobj	30	SENT_350	[p18l1674t2298r1808b2354],
9	from	IN	O	from	_	0	SENT_350	[p18l1851t2298r2007b2354],
10	the	DT	O	the	det	17	SENT_350	[p18l2050t2298r2147b2354],
11	German	JJ	O	german	amod	17	SENT_350	[p18l10t2399r268b2455],
12	Pharmacovigilance	NNP	O	Pharmacovigilance	nn	13	SENT_350	[p18l293t2398r912b2472],
13	Project	NNP	O	Project	tmod	11	SENT_350	[p18l937t2398r1182b2472],
14	,	,	O	,	_	0	SENT_350	[p18l937t2398r1182b2472],
15	the	DT	O	the	det	16	SENT_350	[p18l1211t2398r1307b2455],
16	majority	NN	O	majority	appos	13	SENT_350	[p18l1333t2398r1605b2472],
17	(	NN	O	(	prep_from	8	SENT_350	[p18l1633t2398r1828b2468],
18	75	CD	PERCENT	75	number	19	SENT_350	[p18l1633t2398r1828b2468],
19	%	NN	PERCENT	%	amod	17	SENT_350	[p18l1633t2398r1828b2468],
20	)	CD	NUMBER	)	nsubj	30	SENT_350	[p18l1633t2398r1828b2468],
21	of	IN	O	of	_	0	SENT_350	[p18l1857t2398r1927b2455],
22	hospital	NN	O	hospital	nn	23	SENT_350	[p18l1946t2398r2145b2472, p18l8t2498r87b2555],
23	admissions	NNS	O	admission	prep_of	20	SENT_350	[p18l122t2498r476b2555],
24	caused	VBN	O	cause	partmod	23	SENT_350	[p18l512t2499r730b2555],
25	by	IN	O	by	_	0	SENT_350	[p18l761t2498r841b2572],
26	torasemide	NN	O	torasemide	nn	28	SENT_350	[p18l874t2498r1228b2555],
27	adverse	JJ	O	adverse	amod	28	SENT_350	[p18l1262t2498r1506b2555],
28	reactions	NNS	O	reaction	agent	24	SENT_350	[p18l1538t2498r1828b2555],
29	have	VBP	O	have	aux	30	SENT_350	[p18l1862t2498r2013b2555],
30	occurred	VBN	O	occur	rcmod	3	SENT_350	[p18l2047t2516r2145b2555, p18l9t2600r214b2656],
31	in	IN	O	in	_	0	SENT_350	[p18l238t2600r299b2656],
32	women	NNS	O	woman	prep_in	30	SENT_350	[p18l323t2618r560b2657],
33	(	VBP	O	(	_	0	SENT_350	[p18l586t2600r946b2669],
34	Thiirmann	NNP	ORGANIZATION	Thiirmann	nn	35	SENT_350	[p18l586t2600r946b2669],
35	PA	NN	ORGANIZATION	pa	dobj	33	SENT_350	[p18l970t2600r1089b2667],
36	,	,	O	,	_	0	SENT_350	[p18l970t2600r1089b2667],
37	personal	JJ	O	personal	amod	39	SENT_350	[p18l1115t2600r1389b2673],
38	communication	NN	O	communication	nn	39	SENT_350	[p18l1414t2600r1959b2669],
39	)	NN	O	)	appos	35	SENT_350	[p18l1414t2600r1959b2669],
40	.	.	O	.	_	0	SENT_350	[p18l1414t2600r1959b2669],

1	Considering	VBG	O	consider	_	0	SENT_351	[p18l1988t2600r2145b2657, p18l11t2701r267b2775],
2	the	DT	O	the	det	4	SENT_351	[p18l287t2701r384b2758],
3	higher	JJR	O	higher	amod	4	SENT_351	[p18l402t2701r610b2775],
4	frequency	NN	O	frequency	prep_considering	27	SENT_351	[p18l628t2701r949b2775],
5	of	IN	O	of	_	0	SENT_351	[p18l970t2701r1039b2758],
6	torasemide	NN	O	torasemide	nn	9	SENT_351	[p18l1053t2701r1407b2758],
7	adverse	JJ	O	adverse	amod	9	SENT_351	[p18l1428t2701r1671b2758],
8	drug	NN	O	drug	nn	9	SENT_351	[p18l1692t2701r1837b2775],
9	reactions	NNS	O	reaction	prep_of	4	SENT_351	[p18l1856t2701r2145b2758],
10	in	IN	O	in	_	0	SENT_351	[p18l9t2801r69b2857],
11	female	JJ	O	female	amod	12	SENT_351	[p18l95t2801r314b2858],
12	patients	NNS	O	patient	prep_in	4	SENT_351	[p18l339t2801r607b2875],
13	,	,	O	,	_	0	SENT_351	[p18l339t2801r607b2875],
14	the	DT	O	the	det	15	SENT_351	[p18l636t2801r732b2858],
15	reassessment	NN	O	reassessment	nsubj	27	SENT_351	[p18l758t2810r1181b2858],
16	of	IN	O	of	_	0	SENT_351	[p18l1207t2801r1277b2858],
17	gender	NN	O	gender	nn	20	SENT_351	[p18l1298t2801r1764b2875],
18	—	NN	O	—	nn	20	SENT_351	[p18l1298t2801r1764b2875],
19	related	JJ	O	related	amod	20	SENT_351	[p18l1298t2801r1764b2875],
20	differences	NNS	O	difference	prep_of	15	SENT_351	[p18l1790t2801r2145b2858],
21	in	IN	O	in	_	0	SENT_351	[p18l9t2903r69b2959],
22	torasemide	NN	O	torasemide	nn	23	SENT_351	[p18l103t2903r456b2959],
23	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	15	SENT_351	[p18l490t2903r1059b2976],
24	is	VBZ	O	be	cop	27	SENT_351	[p18l1095t2903r1145b2959],
25	an	DT	O	a	det	27	SENT_351	[p18l1182t2921r1255b2959],
26	important	JJ	O	important	amod	27	SENT_351	[p18l1289t2903r1603b2976],
27	topic	NN	O	topic	_	0	SENT_351	[p18l1636t2903r1794b2976],
28	for	IN	O	for	_	0	SENT_351	[p18l1830t2903r1923b2959],
29	future	JJ	DATE	future	amod	30	SENT_351	[p18l1956t2903r2147b2959],
30	studies	NNS	O	study	prep_for	27	SENT_351	[p18l11t3004r248b3060],
31	.	.	O	.	_	0	SENT_351	[p18l11t3004r248b3060],

1	In	FW	O	in	nn	2	SENT_352	[p18l104t3106r170b3160],
2	vitro	FW	O	vitro	amod	3	SENT_352	[p18l223t3106r372b3160],
3	studies	NNS	O	study	nsubj	5	SENT_352	[p18l427t3104r646b3160],
4	have	VBP	O	have	aux	5	SENT_352	[p18l698t3104r849b3160],
5	shown	VBN	O	show	_	0	SENT_352	[p18l903t3104r1110b3160],
6	that	IN	O	that	complm	12	SENT_352	[p18l1161t3104r1282b3160],
7	the	DT	O	the	det	9	SENT_352	[p18l1331t3104r1428b3160],
8	ARBs	NNS	MISC	arb	nn	9	SENT_352	[p18l1479t3104r1674b3160],
9	losartan	NN	O	losartan	nsubj	12	SENT_352	[p18l1727t3104r1982b3160],
10	and	CC	O	and	_	0	SENT_352	[p18l2034t3104r2148b3160],
11	irbesartan	NN	O	irbesartan	conj_and	9	SENT_352	[p18l8t3205r326b3261],
12	inhibit	VBP	O	inhibit	ccomp	5	SENT_352	[p18l350t3205r561b3261],
13	CYP2C9	NN	O	cyp2c9	dobj	12	SENT_352	[p18l585t3197r980b3262],
14	.	.	O	.	_	0	SENT_352	[p18l585t3197r980b3262],

1	[	NN	O	[	nsubjpass	7	SENT_353	[p18l585t3197r980b3262],
2	21	CD	NUMBER	21	number	3	SENT_353	[p18l585t3197r980b3262],
3	]	CD	NUMBER	]	num	1	SENT_353	[p18l585t3197r980b3262],
4	Because	IN	O	because	_	0	SENT_353	[p18l1008t3206r1275b3261],
5	torasemide	NN	O	torasemide	prep_because	1	SENT_353	[p18l1299t3205r1653b3261],
6	is	VBZ	O	be	auxpass	7	SENT_353	[p18l1677t3205r1727b3261],
7	metabolized	VBN	O	metabolize	dep	18	SENT_353	[p18l1753t3205r2148b3261],
8	by	IN	O	by	_	0	SENT_353	[p18l7t3306r87b3380],
9	CYP2C9	NN	O	cyp2c9	agent	7	SENT_353	[p18l132t3298r528b3373],
10	,	,	O	,	_	0	SENT_353	[p18l132t3298r528b3373],
11	”	CD	NUMBER	”	number	12	SENT_353	[p18l132t3298r528b3373],
12	5	CD	NUMBER	5	num	14	SENT_353	[p18l132t3298r528b3373],
13	]	NN	O	]	nn	14	SENT_353	[p18l132t3298r528b3373],
14	losartan	NN	O	losartan	nsubj	18	SENT_353	[p18l574t3306r829b3363],
15	and	CC	O	and	_	0	SENT_353	[p18l874t3306r987b3363],
16	irbesartan	NN	O	irbesartan	nsubj	18	SENT_353	[p18l1030t3306r1348b3363],
17	may	MD	O	may	aux	18	SENT_353	[p18l1391t3324r1528b3380],
18	interfere	VB	O	interfere	_	0	SENT_353	[p18l1572t3306r1844b3363],
19	with	IN	O	with	_	0	SENT_353	[p18l1888t3306r2030b3363],
20	its	PRP$	O	its	poss	21	SENT_353	[p18l2073t3306r2145b3363],
21	metabolism	NN	O	metabolism	prep_with	18	SENT_353	[p18l9t3407r401b3463],
22	.	.	O	.	_	0	SENT_353	[p18l9t3407r401b3463],

1	Our	PRP$	O	we	poss	2	SENT_354	[p18l448t3407r572b3464],
2	study	NN	O	study	nsubj	3	SENT_354	[p18l614t3407r784b3480],
3	provides	VBZ	O	provide	_	0	SENT_354	[p18l825t3407r1101b3480],
4	the	DT	O	the	det	6	SENT_354	[p18l1144t3407r1240b3463],
5	first	JJ	ORDINAL	first	amod	6	SENT_354	[p18l1282t3407r1412b3463],
6	data	NNS	O	datum	dobj	3	SENT_354	[p18l1452t3407r1586b3463],
7	that	WDT	O	that	nsubj	8	SENT_354	[p18l1625t3407r1746b3463],
8	predict	VBP	O	predict	rcmod	6	SENT_354	[p18l1785t3407r2010b3480],
9	the	DT	O	the	det	11	SENT_354	[p18l2050t3407r2147b3463],
10	clinical	JJ	O	clinical	amod	11	SENT_354	[p18l9t3508r245b3565],
11	significance	NN	O	significance	dobj	8	SENT_354	[p18l292t3508r679b3581],
12	of	IN	O	of	_	0	SENT_354	[p18l724t3508r794b3565],
13	this	DT	O	this	det	14	SENT_354	[p18l833t3508r946b3565],
14	interaction	NN	O	interaction	prep_of	11	SENT_354	[p18l992t3508r1353b3565],
15	.	.	O	.	_	0	SENT_354	[p18l992t3508r1353b3565],

1	These	DT	O	these	det	2	SENT_355	[p18l1402t3508r1593b3565],
2	data	NNS	O	datum	nsubj	3	SENT_355	[p18l1638t3508r1772b3565],
3	show	VBP	O	show	_	0	SENT_355	[p18l1817t3508r1983b3565],
4	that	IN	O	that	_	0	SENT_355	[p18l2028t3508r2148b3565],
5	administration	NN	O	administration	prep_that	3	SENT_355	[p18l10t3608r475b3665],
6	of	IN	O	of	_	0	SENT_355	[p18l537t3608r607b3665],
7	oral	JJ	O	oral	amod	12	SENT_355	[p18l665t3608r787b3665],
8	losartan	NN	O	losartan	nn	12	SENT_355	[p18l849t3608r1103b3665],
9	(	NN	O	(	nn	12	SENT_355	[p18l1168t3609r1311b3678],
10	100	CD	NUMBER	100	num	12	SENT_355	[p18l1168t3609r1311b3678],
11	mg/day	JJ	O	mg/day	amod	12	SENT_355	[p18l1373t3608r1638b3682],
12	)	NN	O	)	prep_of	5	SENT_355	[p18l1373t3608r1638b3682],
13	or	CC	O	or	_	0	SENT_355	[p18l1704t3626r1770b3665],
14	irbesartan	NN	O	irbesartan	nn	15	SENT_355	[p18l1830t3608r2147b3665],
15	(	NN	O	(	prep_of	5	SENT_355	[p18l11t3709r154b3779],
16	150	CD	NUMBER	150	num	18	SENT_355	[p18l11t3709r154b3779],
17	mg/day	JJ	O	mg/day	amod	18	SENT_355	[p18l188t3710r453b3783],
18	)	NN	O	)	dobj	3	SENT_355	[p18l188t3710r453b3783],
19	in	IN	O	in	_	0	SENT_355	[p18l489t3710r549b3766],
20	patients	NNS	O	patient	prep_in	18	SENT_355	[p18l581t3710r830b3783],
21	already	RB	O	already	advmod	3	SENT_355	[p18l867t3710r1101b3783],
22	on	IN	O	on	_	0	SENT_355	[p18l1135t3727r1213b3766],
23	long	JJ	O	long	amod	27	SENT_355	[p18l1246t3710r1564b3783],
24	—	JJ	O	—	amod	27	SENT_355	[p18l1246t3710r1564b3783],
25	term	NN	O	term	nn	27	SENT_355	[p18l1246t3710r1564b3783],
26	torasemide	NN	O	torasemide	nn	27	SENT_355	[p18l1596t3709r1950b3766],
27	medication	NN	O	medication	prep_on	3	SENT_355	[p18l1983t3710r2145b3766, p19l9t21r227b78],

1	does	VBZ	O	do	aux	4	SENT_356	[p19l259t21r403b78],
2	not	RB	O	not	neg	4	SENT_356	[p19l437t30r539b78],
3	critically	RB	O	critically	advmod	4	SENT_356	[p19l570t21r855b94],
4	impair	VB	O	impair	_	0	SENT_356	[p19l888t21r1098b94],
5	metabolism	NN	O	metabolism	nsubj	4	SENT_356	[p19l1129t21r1506b78],
6	and	CC	O	and	_	0	SENT_356	[p19l1538t21r1652b78],
7	elimination	NN	O	elimination	nsubj	4	SENT_356	[p19l1684t21r2050b78],
8	of	IN	O	of	prep	4	SENT_356	[p19l2083t21r2153b78],

1	Table	NNP	O	Table	nn	3	SENT_357	[p19l8t224r175b272],
2	V.	NNP	O	V.	nn	3	SENT_357	[p19l234t224r290b271],
3	Changes	NNS	O	change	_	0	SENT_357	[p19l353t223r608b285],
4	in	IN	O	in	_	0	SENT_357	[p19l670t224r713b271],
5	steady-state	JJ	O	steady-state	amod	7	SENT_357	[p19l774t224r1124b284],
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_357	[p19l1185t224r1653b284],
7	parameters	NNS	O	parameter	prep_in	3	SENT_357	[p19l1714t227r2036b284],
8	of	IN	O	of	_	0	SENT_357	[p19l2096t223r2148b272],
9	torasemide	NN	O	torasemide	prep_of	3	SENT_357	[p19l8t314r326b362],
10	when	WRB	O	when	advmod	14	SENT_357	[p19l347t314r497b362],
11	patients	NNS	O	patient	nsubjpass	14	SENT_357	[p19l522t314r744b374],
12	were	VBD	O	be	auxpass	14	SENT_357	[p19l764t325r902b362],
13	additionally	RB	O	additionally	advmod	14	SENT_357	[p19l924t314r1245b374],
14	treated	VBN	O	treat	dep	3	SENT_357	[p19l1264t314r1462b362],
15	with	IN	O	with	_	0	SENT_357	[p19l1484t314r1595b361],
16	losartan	NN	O	losartan	prep_with	14	SENT_357	[p19l1620t314r1843b362],
17	for	IN	O	for	_	0	SENT_357	[p19l1865t313r1940b362],
18	3	CD	DURATION	3	num	19	SENT_357	[p19l1960t315r1992b362],
19	days	NNS	NUMBER	day	prep_for	16	SENT_357	[p19l2014t314r2146b374],
20	compared	VBN	O	compare	_	0	SENT_357	[p19l9t403r292b463],
21	with	IN	O	with	prepc_compared_with	14	SENT_357	[p19l319t403r430b450],
22	baselinea	NN	O	baselinea	pobj	14	SENT_357	[p19l460t403r721b451],

1	Parameter	NNP	O	Parameter	nn	2	SENT_358	[p19l13t533r311b581],
2	Baseline	NNP	O	Baseline	_	0	SENT_358	[p19l924t533r1166b581],
3	With	IN	O	with	dep	2	SENT_358	[p19l1402t533r1526b580],
4	p-Valueb	NN	O	p-valueb	pobj	3	SENT_358	[p19l1885t527r2128b593],

1	(	NN	O	(	_	0	SENT_359	[p19l924t621r1146b682],
2	without	IN	O	without	dep	1	SENT_359	[p19l924t621r1146b682],
3	losartan	NN	O	losartan	nn	5	SENT_359	[p19l1405t622r1628b670],
4	losartan	NN	O	losartan	nn	5	SENT_359	[p19l924t682r1168b744],
5	)	NN	O	)	pobj	2	SENT_359	[p19l924t682r1168b744],

1	Cmax	NNP	O	Cmax	_	0	SENT_360	[p19l10t795r281b856],
2	,	,	O	,	_	0	SENT_360	[p19l10t795r281b856],
3	ss/D	NN	O	ss/d	nn	6	SENT_360	[p19l10t795r281b856],
4	(	CD	NUMBER	(	num	6	SENT_360	[p19l310t795r581b857],
5	ug/L/mg	NN	O	ug/l/mg	nn	6	SENT_360	[p19l310t795r581b857],
6	)	NN	O	)	appos	1	SENT_360	[p19l310t795r581b857],
7	951	CD	NUMBER	951	dep	6	SENT_360	[p19l922t797r1015b844],
8	i	FW	O	i	dep	16	SENT_360	[p19l1051t801r1086b843],
9	320	CD	NUMBER	320	number	10	SENT_360	[p19l1111t797r1215b844],
10	861	CD	NUMBER	861	dep	8	SENT_360	[p19l1403t797r1496b844],
11	i	FW	O	i	dep	10	SENT_360	[p19l1532t801r1567b843],
12	298	CD	NUMBER	298	num	13	SENT_360	[p19l1591t797r1696b844],
13	NS	NN	O	n	dep	16	SENT_360	[p19l1886t795r1969b844],
14	tmax	NN	O	tmax	nn	16	SENT_360	[p19l8t889r123b940],
15	(	CD	NUMBER	(	num	16	SENT_360	[p19l150t885r246b946],
16	h	NN	O	h	dep	21	SENT_360	[p19l150t885r246b946],
17	)	CD	NUMBER	)	number	18	SENT_360	[p19l150t885r246b946],
18	°	CD	NUMBER	°	dep	16	SENT_360	[p19l150t885r246b946],
19	1.0	CD	NUMBER	1.0	num	20	SENT_360	[p19l926t887r1008b934],
20	(	CD	NUMBER	(	dep	18	SENT_360	[p19l1037t885r1288b946],
21	o.	NN	O	o.	dep	23	SENT_360	[p19l1037t885r1288b946],
22	5	CD	NUMBER	5	num	21	SENT_360	[p19l1037t885r1288b946],
23	—	NN	O	—	dep	1	SENT_360	[p19l1037t885r1288b946],
24	2	CD	NUMBER	2	num	23	SENT_360	[p19l1037t885r1288b946],
25	.	.	O	.	_	0	SENT_360	[p19l1037t885r1288b946],

1	o	NN	O	o	_	0	SENT_361	[p19l1037t885r1288b946],
2	)	CD	NUMBER	)	number	3	SENT_361	[p19l1037t885r1288b946],
3	1.5	CD	NUMBER	1.5	dep	1	SENT_361	[p19l1407t887r1488b934],
4	(	CD	NUMBER	(	num	5	SENT_361	[p19l1518t885r1769b946],
5	o.	NN	O	o.	dep	3	SENT_361	[p19l1518t885r1769b946],
6	5	CD	NUMBER	5	num	7	SENT_361	[p19l1518t885r1769b946],
7	—	NN	O	—	dep	1	SENT_361	[p19l1518t885r1769b946],
8	4	CD	NUMBER	4	dep	7	SENT_361	[p19l1518t885r1769b946],
9	.	.	O	.	_	0	SENT_361	[p19l1518t885r1769b946],

1	o	NN	O	o	nn	4	SENT_362	[p19l1518t885r1769b946],
2	)	CD	NUMBER	)	num	4	SENT_362	[p19l1518t885r1769b946],
3	NS	NN	O	n	nn	4	SENT_362	[p19l1886t885r1969b934],
4	AUC24	NN	O	auc24	nsubjpass	65	SENT_362	[p19l8t973r330b1034],
5	,	,	O	,	_	0	SENT_362	[p19l8t973r330b1034],
6	ss/D	NN	O	ss/d	nn	9	SENT_362	[p19l8t973r330b1034],
7	(	CD	NUMBER	(	num	9	SENT_362	[p19l360t973r448b1035],
8	ug	NN	O	ug	nn	9	SENT_362	[p19l360t973r448b1035],
9	o	NN	O	o	dep	23	SENT_362	[p19l470t990r494b1014],
10	h/L/mg	NN	O	h/l/mg	dep	9	SENT_362	[p19l517t973r729b1035],
11	)	CD	NUMBER	)	number	12	SENT_362	[p19l517t973r729b1035],
12	355.3	CD	NUMBER	355.3	num	13	SENT_362	[p19l922t975r1080b1022],
13	J	NN	O	j	dep	10	SENT_362	[p19l1105t979r1140b1021],
14	;	:	O	;	_	0	SENT_362	[p19l1105t979r1140b1021],
15	85.0	CD	NUMBER	85.0	number	16	SENT_362	[p19l1165t975r1287b1022],
16	364.1	CD	NUMBER	364.1	dep	10	SENT_362	[p19l1403t975r1551b1022],
17	J	NN	O	j	dep	16	SENT_362	[p19l1586t979r1621b1021],
18	;	:	O	;	_	0	SENT_362	[p19l1586t979r1621b1021],
19	97.3	CD	NUMBER	97.3	num	20	SENT_362	[p19l1647t975r1768b1022],
20	NS	NN	O	n	dep	10	SENT_362	[p19l1886t973r1969b1022],
21	Bodyweight-normalized	JJ	O	bodyweight-normalized	amod	20	SENT_362	[p19l12t1063r678b1124],
22	30.26	CD	NUMBER	30.26	dep	23	SENT_362	[p19l922t1064r1080b1111],
23	i	FW	O	i	dep	26	SENT_362	[p19l1105t1068r1140b1110],
24	7.67	CD	NUMBER	7.67	num	25	SENT_362	[p19l1165t1064r1287b1111],
25	31.01	CD	NUMBER	31.01	dep	23	SENT_362	[p19l1403t1064r1551b1111],
26	i	FW	O	i	dep	35	SENT_362	[p19l1586t1068r1621b1110],
27	8.33	CD	NUMBER	8.33	num	29	SENT_362	[p19l1646t1064r1768b1111],
28	NS	NN	O	n	nn	29	SENT_362	[p19l1886t1062r1969b1111],
29	AUC24	NN	O	auc24	dep	26	SENT_362	[p19l8t1151r330b1212],
30	,	,	O	,	_	0	SENT_362	[p19l8t1151r330b1212],
31	ss/D	NN	O	ss/d	nn	34	SENT_362	[p19l8t1151r330b1212],
32	(	CD	NUMBER	(	num	34	SENT_362	[p19l360t1151r448b1213],
33	pg	NN	O	pg	nn	34	SENT_362	[p19l360t1151r448b1213],
34	o	NN	O	o	appos	29	SENT_362	[p19l470t1168r494b1191],
35	h/L/mg	NN	O	h/l/mg	dep	4	SENT_362	[p19l517t1151r816b1213],
36	/	:	O	/	punct	35	SENT_362	[p19l517t1151r816b1213],
37	kg	NN	O	kg	nn	39	SENT_362	[p19l517t1151r816b1213],
38	)	NN	O	)	nn	39	SENT_362	[p19l517t1151r816b1213],
39	tr/2	NN	O	tr/2	dep	44	SENT_362	[p19l8t1245r68b1296],
40	(	CD	NUMBER	(	num	41	SENT_362	[p19l96t1241r167b1302],
41	h	NN	O	h	dep	39	SENT_362	[p19l96t1241r167b1302],
42	)	CD	NUMBER	)	dep	41	SENT_362	[p19l96t1241r167b1302],
43	3.1	CD	NUMBER	3.1	dep	44	SENT_362	[p19l922t1243r997b1290],
44	i	FW	O	i	dep	49	SENT_362	[p19l1033t1247r1068b1289],
45	1.0	CD	NUMBER	1.0	number	46	SENT_362	[p19l1097t1243r1179b1290],
46	3.5	CD	NUMBER	3.5	dep	44	SENT_362	[p19l1402t1243r1488b1290],
47	i	FW	O	i	dep	46	SENT_362	[p19l1514t1247r1549b1289],
48	1.2	CD	NUMBER	1.2	num	49	SENT_362	[p19l1578t1243r1659b1289],
49	NS	NN	O	n	dep	50	SENT_362	[p19l1886t1241r1969b1290],
50	CL/F	NN	O	cl/f	dep	52	SENT_362	[p19l10t1329r146b1378],
51	(	CD	NUMBER	(	num	50	SENT_362	[p19l175t1329r300b1390],
52	Uh	NN	O	uh	dep	54	SENT_362	[p19l175t1329r300b1390],
53	)	CD	NUMBER	)	num	52	SENT_362	[p19l175t1329r300b1390],
54	3.0	CD	NUMBER	3.0	dep	55	SENT_362	[p19l922t1331r1008b1378],
55	i	FW	O	i	dep	60	SENT_362	[p19l1033t1335r1068b1377],
56	0.8	CD	NUMBER	0.8	number	57	SENT_362	[p19l1093t1331r1179b1378],
57	2.9	CD	NUMBER	2.9	dep	55	SENT_362	[p19l1402t1331r1488b1378],
58	i	FW	O	i	dep	57	SENT_362	[p19l1514t1335r1549b1377],
59	0.7	CD	NUMBER	0.7	num	60	SENT_362	[p19l1574t1331r1660b1378],
60	NS	NN	O	n	dep	35	SENT_362	[p19l1886t1329r1969b1378],
61	a	DT	O	a	predet	63	SENT_362	[p19l10t1452r42b1488],
62	The	DT	O	the	det	63	SENT_362	[p19l122t1440r230b1488],
63	values	NNS	O	value	nsubjpass	65	SENT_362	[p19l256t1440r441b1488],
64	are	VBP	O	be	auxpass	65	SENT_362	[p19l468t1452r557b1488],
65	expressed	VBN	O	express	_	0	SENT_362	[p19l585t1440r878b1500],
66	as	IN	O	as	_	0	SENT_362	[p19l906t1452r971b1488],
67	the	DT	O	the	det	70	SENT_362	[p19l996t1440r1083b1488],
68	mean	JJ	O	mean	amod	70	SENT_362	[p19l1112t1452r1267b1488],
69	ir	JJ	O	ir	amod	70	SENT_362	[p19l1294t1445r1329b1487],
70	SD	NN	O	sd	prep_as	65	SENT_362	[p19l1355t1439r1439b1488],
71	unless	IN	O	unless	mark	72	SENT_362	[p19l1469t1440r1650b1488],
72	specified	VBN	O	specify	advcl	65	SENT_362	[p19l1676t1440r1927b1500],
73	otherwise	RB	O	otherwise	advmod	72	SENT_362	[p19l123t1529r411b1578],
74	.	.	O	.	_	0	SENT_362	[p19l123t1529r411b1578],

1	b	NN	O	b	nn	3	SENT_363	[p19l11t1619r41b1667],
2	Statistical	JJ	O	statistical	amod	3	SENT_363	[p19l124t1618r395b1668],
3	significance	NN	O	significance	nsubjpass	5	SENT_363	[p19l423t1619r758b1680],
4	was	VBD	O	be	auxpass	5	SENT_363	[p19l784t1631r896b1667],
5	tested	VBN	O	test	_	0	SENT_363	[p19l922t1619r1094b1667],
6	by	IN	O	by	_	0	SENT_363	[p19l1124t1619r1188b1680],
7	use	NN	O	use	agent	5	SENT_363	[p19l1216t1631r1314b1667],
8	of	IN	O	of	_	0	SENT_363	[p19l1341t1619r1392b1667],
9	the	DT	O	the	det	11	SENT_363	[p19l1416t1619r1504b1667],
10	Wilcoxon	NNP	O	Wilcoxon	nn	11	SENT_363	[p19l1530t1619r1788b1667],
11	matchedpairs	NNS	O	matchedpair	prep_of	7	SENT_363	[p19l1818t1619r2082b1667, p19l124t1709r259b1769],

1	signed-ranks	JJ	O	signed-ranks	amod	2	SENT_364	[p19l286t1709r653b1769],
2	test	NN	O	test	_	0	SENT_364	[p19l679t1712r796b1756],
3	.	.	O	.	_	0	SENT_364	[p19l679t1712r796b1756],

1	c	NN	O	c	_	0	SENT_365	[p19l9t1808r38b1845],
2	Median	JJ	MISC	median	amod	5	SENT_365	[p19l125t1797r330b1845],
3	(	NN	O	(	nn	5	SENT_365	[p19l360t1796r578b1858],
4	range	NN	O	range	nn	5	SENT_365	[p19l360t1796r578b1858],
5	)	NN	O	)	dep	1	SENT_365	[p19l360t1796r578b1858],
6	.	.	O	.	_	0	SENT_365	[p19l360t1796r578b1858],

1	AUC24	NN	O	auc24	nsubj	10	SENT_366	[p19l9t1885r276b1947],
2	,	,	O	,	_	0	SENT_366	[p19l9t1885r276b1947],
3	ss	NN	O	ss	nn	5	SENT_366	[p19l9t1885r276b1947],
4	=	JJ	O	=	amod	5	SENT_366	[p19l298t1907r331b1925],
5	area	NN	O	area	appos	1	SENT_366	[p19l354t1897r480b1934],
6	under	IN	O	under	_	0	SENT_366	[p19l504t1886r666b1934],
7	the	DT	O	the	det	9	SENT_366	[p19l684t1886r772b1934],
8	plasma	NN	O	plasma	nn	9	SENT_366	[p19l796t1886r1000b1946],
9	concentration-time	NN	O	concentration-time	prep_under	5	SENT_366	[p19l1021t1886r1551b1934],
10	curve	NN	O	curve	_	0	SENT_366	[p19l1573t1897r1727b1934],
11	during	IN	O	during	_	0	SENT_366	[p19l1750t1886r1925b1947],
12	the	DT	O	the	det	15	SENT_366	[p19l1947t1886r2034b1934],
13	24hour	JJ	O	24hour	amod	15	SENT_366	[p19l2056t1887r2146b1933, p19l11t1975r138b2023],
14	dosing	NN	O	dosing	nn	15	SENT_366	[p19l175t1975r361b2036],
15	interval	NN	O	interval	prep_during	10	SENT_366	[p19l405t1975r606b2023],
16	at	IN	O	at	_	0	SENT_366	[p19l648t1978r699b2023],
17	steady	JJ	O	steady	amod	18	SENT_366	[p19l738t1975r927b2035],
18	state	NN	O	state	prep_at	15	SENT_366	[p19l965t1978r1117b2031],
19	;	:	O	;	_	0	SENT_366	[p19l965t1978r1117b2031],
20	CL/F	NN	O	cl/f	dep	15	SENT_366	[p19l1161t1974r1301b2023],
21	=	JJ	O	=	amod	24	SENT_366	[p19l1341t1996r1374b2014],
22	apparent	JJ	O	apparent	amod	24	SENT_366	[p19l1415t1978r1668b2035],
23	oral	JJ	O	oral	amod	24	SENT_366	[p19l1707t1975r1809b2023],
24	clearance	NN	O	clearance	dep	20	SENT_366	[p19l1851t1975r2143b2031],
25	;	:	O	;	_	0	SENT_366	[p19l1851t1975r2143b2031],
26	Cmax	NNP	O	Cmax	dep	15	SENT_366	[p19l10t2063r229b2125],
27	,	,	O	,	_	0	SENT_366	[p19l10t2063r229b2125],
28	ss	NN	O	ss	appos	26	SENT_366	[p19l10t2063r229b2125],
29	=	JJ	O	=	amod	32	SENT_366	[p19l254t2085r287b2103],
30	peak	NN	O	peak	nn	32	SENT_366	[p19l314t2064r451b2124],
31	plasma	NN	O	plasma	nn	32	SENT_366	[p19l476t2064r680b2124],
32	concentration	NN	O	concentration	dep	28	SENT_366	[p19l704t2064r1088b2112],
33	at	IN	O	at	_	0	SENT_366	[p19l1115t2067r1166b2112],
34	steady	JJ	O	steady	amod	35	SENT_366	[p19l1190t2064r1379b2124],
35	state	NN	O	state	prep_at	32	SENT_366	[p19l1403t2067r1554b2120],
36	;	:	O	;	_	0	SENT_366	[p19l1403t2067r1554b2120],
37	D	NN	O	d	dep	15	SENT_366	[p19l1585t2064r1626b2111],
38	=	JJ	O	=	amod	39	SENT_366	[p19l1651t2085r1684b2103],
39	dose	NN	O	dose	dep	37	SENT_366	[p19l1710t2064r1861b2120],
40	;	:	O	;	_	0	SENT_366	[p19l1710t2064r1861b2120],
41	NS	NN	O	n	dep	15	SENT_366	[p19l1892t2063r1976b2112],
42	=	JJ	O	=	amod	41	SENT_366	[p19l2001t2085r2035b2103],
43	not	RB	O	not	neg	44	SENT_366	[p19l2062t2067r2147b2112],
44	significant	JJ	O	significant	amod	41	SENT_366	[p19l9t2152r309b2214],
45	;	:	O	;	_	0	SENT_366	[p19l9t2152r309b2214],
46	t1/2	NN	O	t1/2	dep	15	SENT_366	[p19l337t2156r401b2207],
47	=	JJ	O	=	amod	49	SENT_366	[p19l427t2174r460b2192],
48	elimination	NN	O	elimination	nn	49	SENT_366	[p19l488t2153r792b2201],
49	half-life	NN	O	half-life	dep	46	SENT_366	[p19l822t2152r1040b2209],
50	;	:	O	;	_	0	SENT_366	[p19l822t2152r1040b2209],
51	tmax	NN	O	tmax	dep	15	SENT_366	[p19l1068t2156r1193b2207],
52	=	JJ	O	=	amod	53	SENT_366	[p19l1218t2174r1252b2192],
53	time	NN	O	time	tmod	51	SENT_366	[p19l1277t2153r1397b2201],
54	to	TO	O	to	aux	55	SENT_366	[p19l1423t2156r1474b2201],
55	reach	VB	O	reach	infmod	15	SENT_366	[p19l1504t2153r1657b2201],
56	the	DT	O	the	det	57	SENT_366	[p19l1684t2153r1772b2201],
57	Cmax	NNP	O	Cmax	dobj	55	SENT_366	[p19l1799t2152r1954b2207],
58	.	.	O	.	_	0	SENT_366	[p19l1799t2152r1954b2207],

1	©	RB	O	©	advmod	2	SENT_367	[p19l10t2383r43b2417],
2	2008	CD	DATE	2008	_	0	SENT_367	[p19l62t2379r167b2417],
3	Adis	NNP	PERSON	Adis	nn	4	SENT_367	[p19l184t2379r280b2417],
4	Dofo	NNP	PERSON	Dofo	dep	2	SENT_367	[p19l299t2379r412b2417],
5	lnformclfion	NN	O	lnformclfion	nn	6	SENT_367	[p19l433t2379r695b2417],
6	BV	NN	O	bv	dep	4	SENT_367	[p19l716t2379r784b2416],
7	.	.	O	.	_	0	SENT_367	[p19l716t2379r784b2416],

1	All	DT	O	all	det	2	SENT_368	[p19l804t2379r856b2416],
2	righfs	NNS	O	righf	nsubj	3	SENT_368	[p19l876t2379r994b2426],
3	reserved	VBN	O	reserve	_	0	SENT_368	[p19l1013t2379r1222b2417],
4	.	.	O	.	_	0	SENT_368	[p19l1013t2379r1222b2417],

1	Table	NNP	O	Table	nn	2	SENT_369	[p19l7t2574r175b2622],
2	VI	NNP	O	VI	_	0	SENT_369	[p19l231t2574r305b2621],
3	.	.	O	.	_	0	SENT_369	[p19l231t2574r305b2621],

1	Changes	NNS	O	change	_	0	SENT_370	[p19l365t2573r620b2635],
2	in	IN	O	in	_	0	SENT_370	[p19l680t2574r722b2622],
3	steady-state	JJ	O	steady-state	amod	5	SENT_370	[p19l781t2574r1130b2635],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_370	[p19l1190t2574r1657b2635],
5	parameters	NNS	O	parameter	prep_in	1	SENT_370	[p19l1716t2578r2038b2635],
6	of	IN	O	of	_	0	SENT_370	[p19l2095t2574r2147b2622],
7	torasemide	NN	O	torasemide	prep_of	1	SENT_370	[p19l8t2663r325b2711],
8	when	WRB	O	when	advmod	12	SENT_370	[p19l365t2664r515b2711],
9	patients	NNS	O	patient	nsubjpass	12	SENT_370	[p19l559t2664r781b2724],
10	were	VBD	O	be	auxpass	12	SENT_370	[p19l820t2675r957b2711],
11	additionally	RB	O	additionally	advmod	12	SENT_370	[p19l998t2663r1320b2724],
12	treated	VBN	O	treat	dep	1	SENT_370	[p19l1358t2663r1556b2711],
13	with	IN	O	with	_	0	SENT_370	[p19l1596t2663r1707b2711],
14	irbesartan	NN	O	irbesartan	prep_with	12	SENT_370	[p19l1751t2663r2032b2711],
15	for	IN	O	for	_	0	SENT_370	[p19l2073t2663r2148b2711],
16	3	CD	DURATION	3	num	17	SENT_370	[p19l9t2754r41b2801],
17	days	NNS	NUMBER	day	prep_for	14	SENT_370	[p19l67t2753r201b2813],
18	compared	VBN	O	compare	_	0	SENT_370	[p19l227t2753r510b2813],
19	with	IN	O	with	prepc_compared_with	12	SENT_370	[p19l537t2753r648b2800],
20	baselinea	NN	O	baselinea	pobj	12	SENT_370	[p19l678t2753r939b2800],

1	Parameter	NNP	O	Parameter	nn	2	SENT_371	[p19l12t2882r310b2930],
2	Baseline	NNP	O	Baseline	_	0	SENT_371	[p19l903t2882r1145b2930],
3	With	IN	O	with	dep	2	SENT_371	[p19l1401t2882r1526b2929],
4	p-Value	NN	O	p-value	pobj	3	SENT_371	[p19l1905t2882r2123b2942],

1	(	NN	O	(	_	0	SENT_372	[p19l902t2970r1124b3031],
2	without	IN	O	without	dep	1	SENT_372	[p19l902t2970r1124b3031],
3	irbesartan	NN	O	irbesartan	nn	5	SENT_372	[p19l1404t2971r1684b3019],
4	irbesartan	NN	O	irbesartan	nn	5	SENT_372	[p19l902t3059r1204b3120],
5	)	NN	O	)	pobj	2	SENT_372	[p19l902t3059r1204b3120],

1	Cmax	NNP	O	Cmax	_	0	SENT_373	[p19l9t3170r280b3232],
2	,	,	O	,	_	0	SENT_373	[p19l9t3170r280b3232],
3	ss/D	NN	O	ss/d	nn	5	SENT_373	[p19l9t3170r280b3232],
4	(	CD	NUMBER	(	num	5	SENT_373	[p19l310t3170r580b3233],
5	ug/L/mg	NN	O	ug/l/mg	appos	1	SENT_373	[p19l310t3170r580b3233],
6	)	CD	NUMBER	)	num	8	SENT_373	[p19l310t3170r580b3233],
7	104.9	CD	NUMBER	104.9	num	8	SENT_373	[p19l904t3172r1058b3220],
8	ir	NN	O	ir	dep	17	SENT_373	[p19l1083t3176r1119b3218],
9	57.3	CD	NUMBER	57.3	number	10	SENT_373	[p19l1144t3173r1266b3220],
10	114.2	CD	NUMBER	114.2	dep	8	SENT_373	[p19l1406t3172r1559b3219],
11	i	FW	O	i	dep	10	SENT_373	[p19l1585t3176r1620b3218],
12	44.6	CD	NUMBER	44.6	num	13	SENT_373	[p19l1645t3172r1767b3220],
13	NS	NN	O	n	dep	17	SENT_373	[p19l1906t3170r1989b3220],
14	tmax	NN	O	tmax	nn	17	SENT_373	[p19l8t3264r122b3315],
15	(	CD	NUMBER	(	num	17	SENT_373	[p19l150t3255r247b3321],
16	h	NN	O	h	nn	17	SENT_373	[p19l150t3255r247b3321],
17	)	NN	O	)	dep	21	SENT_373	[p19l150t3255r247b3321],
18	b	NN	O	b	prep	17	SENT_373	[p19l150t3255r247b3321],
19	1.0	CD	NUMBER	1.0	num	20	SENT_373	[p19l904t3261r986b3309],
20	(	CD	NUMBER	(	dep	18	SENT_373	[p19l1015t3259r1267b3321],
21	o.	NN	O	o.	dep	23	SENT_373	[p19l1015t3259r1267b3321],
22	5	CD	NUMBER	5	num	21	SENT_373	[p19l1015t3259r1267b3321],
23	—	NN	O	—	dep	1	SENT_373	[p19l1015t3259r1267b3321],
24	2	CD	NUMBER	2	num	23	SENT_373	[p19l1015t3259r1267b3321],
25	.	.	O	.	_	0	SENT_373	[p19l1015t3259r1267b3321],

1	o	NN	O	o	_	0	SENT_374	[p19l1015t3259r1267b3321],
2	)	CD	NUMBER	)	number	3	SENT_374	[p19l1015t3259r1267b3321],
3	2.0	CD	NUMBER	2.0	dep	1	SENT_374	[p19l1401t3261r1488b3309],
4	(	CD	NUMBER	(	num	5	SENT_374	[p19l1517t3259r1768b3321],
5	o.	NN	O	o.	dep	3	SENT_374	[p19l1517t3259r1768b3321],
6	5	CD	NUMBER	5	num	7	SENT_374	[p19l1517t3259r1768b3321],
7	—	NN	O	—	dep	1	SENT_374	[p19l1517t3259r1768b3321],
8	4	CD	NUMBER	4	dep	7	SENT_374	[p19l1517t3259r1768b3321],
9	.	.	O	.	_	0	SENT_374	[p19l1517t3259r1768b3321],

1	o	NN	O	o	dep	13	SENT_375	[p19l1517t3259r1768b3321],
2	)	CD	NUMBER	)	num	4	SENT_375	[p19l1517t3259r1768b3321],
3	NS	NN	O	n	nn	4	SENT_375	[p19l1907t3259r1989b3309],
4	AUC24	NN	O	auc24	dep	1	SENT_375	[p19l8t3348r330b3410],
5	,	,	O	,	_	0	SENT_375	[p19l8t3348r330b3410],
6	ss/D	NN	O	ss/d	nn	9	SENT_375	[p19l8t3348r330b3410],
7	(	CD	NUMBER	(	num	9	SENT_375	[p19l359t3348r447b3411],
8	ug	NN	O	ug	nn	9	SENT_375	[p19l359t3348r447b3411],
9	o	NN	O	o	appos	4	SENT_375	[p19l469t3365r493b3389],
10	h/L/mg	NN	O	h/l/mg	dep	13	SENT_375	[p19l517t3348r728b3410],
11	)	CD	NUMBER	)	num	10	SENT_375	[p19l517t3348r728b3410],
12	473.3	CD	NUMBER	473.3	num	13	SENT_375	[p19l899t3350r1058b3398],
13	ir	NN	O	ir	dep	18	SENT_375	[p19l1083t3354r1119b3396],
14	229.5	CD	NUMBER	229.5	number	15	SENT_375	[p19l1143t3350r1302b3398],
15	535.5	CD	NUMBER	535.5	dep	13	SENT_375	[p19l1402t3351r1560b3398],
16	i	FW	O	i	dep	15	SENT_375	[p19l1585t3354r1620b3396],
17	246.7	CD	NUMBER	246.7	num	18	SENT_375	[p19l1645t3350r1804b3398],
18	0.002	CD	NUMBER	0.002	dep	24	SENT_375	[p19l1904t3350r2061b3398],
19	Bodyweight-normalized	JJ	O	bodyweight-normalized	amod	21	SENT_375	[p19l11t3439r678b3499],
20	38.06	CD	NUMBER	38.06	tmod	19	SENT_375	[p19l900t3440r1058b3487],
21	ir	NN	O	ir	dep	18	SENT_375	[p19l1083t3443r1119b3485],
22	14.75	CD	NUMBER	14.75	num	23	SENT_375	[p19l1148t3440r1302b3487],
23	43.05	CD	NUMBER	43.05	dep	21	SENT_375	[p19l1401t3439r1560b3487],
24	i	FW	O	i	dep	33	SENT_375	[p19l1585t3443r1620b3485],
25	15.62	CD	NUMBER	15.62	number	26	SENT_375	[p19l1650t3439r1803b3487],
26	0.005	CD	NUMBER	0.005	num	27	SENT_375	[p19l1904t3440r2062b3487],
27	AUC24	NN	O	auc24	dep	24	SENT_375	[p19l8t3526r330b3588],
28	,	,	O	,	_	0	SENT_375	[p19l8t3526r330b3588],
29	ss/D	NN	O	ss/d	nn	32	SENT_375	[p19l8t3526r330b3588],
30	(	CD	NUMBER	(	num	32	SENT_375	[p19l359t3526r447b3589],
31	pg	NN	O	pg	nn	32	SENT_375	[p19l359t3526r447b3589],
32	o	NN	O	o	appos	27	SENT_375	[p19l469t3543r493b3567],
33	h/L/mg	NN	O	h/l/mg	_	0	SENT_375	[p19l517t3526r815b3588],
34	/	:	O	/	punct	33	SENT_375	[p19l517t3526r815b3588],
35	kg	NN	O	kg	nn	37	SENT_375	[p19l517t3526r815b3588],
36	)	NN	O	)	nn	37	SENT_375	[p19l517t3526r815b3588],
37	t1/2	NN	O	t1/2	dep	53	SENT_375	[p19l7t3620r67b3671],
38	(	CD	NUMBER	(	num	39	SENT_375	[p19l95t3616r166b3677],
39	h	NN	O	h	dep	37	SENT_375	[p19l95t3616r166b3677],
40	)	CD	NUMBER	)	number	41	SENT_375	[p19l95t3616r166b3677],
41	3.5	CD	NUMBER	3.5	num	42	SENT_375	[p19l900t3618r986b3665],
42	ir	NN	O	ir	dep	39	SENT_375	[p19l1011t3621r1047b3663],
43	1.2	CD	NUMBER	1.2	number	44	SENT_375	[p19l1076t3617r1157b3663],
44	4.1	CD	NUMBER	4.1	num	42	SENT_375	[p19l1401t3617r1478b3663],
45	i	FW	O	i	dep	39	SENT_375	[p19l1513t3621r1548b3663],
46	2.0	CD	NUMBER	2.0	number	47	SENT_375	[p19l1573t3618r1659b3665],
47	0.021	CD	NUMBER	0.021	num	48	SENT_375	[p19l1904t3617r2052b3665],
48	CL/F	NN	O	cl/f	dep	45	SENT_375	[p19l9t3704r146b3754],
49	(	CD	NUMBER	(	num	50	SENT_375	[p19l174t3704r299b3766],
50	L/h	NN	O	l/h	dep	53	SENT_375	[p19l174t3704r299b3766],
51	)	CD	NUMBER	)	number	52	SENT_375	[p19l174t3704r299b3766],
52	2.5	CD	NUMBER	2.5	num	53	SENT_375	[p19l900t3707r986b3754],
53	ir	NN	O	ir	dep	57	SENT_375	[p19l1011t3710r1047b3752],
54	0.8	CD	NUMBER	0.8	number	55	SENT_375	[p19l1072t3706r1157b3754],
55	2	CD	NUMBER	2	amod	53	SENT_375	[p19l1401t3707r1433b3752],
56	2	CD	NUMBER	2	dep	53	SENT_375	[p19l1456t3707r1487b3752],
57	i	FW	O	i	dep	60	SENT_375	[p19l1513t3710r1548b3752],
58	o	NN	O	o	dep	57	SENT_375	[p19l1573t3706r1605b3754],
59	7	CD	NUMBER	7	num	60	SENT_375	[p19l1627t3707r1660b3752],
60	0.002	CD	NUMBER	0.002	dep	33	SENT_375	[p19l1904t3706r2061b3754],

1	a	DT	O	a	predet	3	SENT_376	[p20l9t38r41b74],
2	The	DT	O	the	det	3	SENT_376	[p20l121t26r230b74],
3	values	NNS	O	value	nsubjpass	5	SENT_376	[p20l255t26r440b74],
4	are	VBP	O	be	auxpass	5	SENT_376	[p20l467t38r556b74],
5	expressed	VBN	O	express	_	0	SENT_376	[p20l584t26r877b87],
6	as	IN	O	as	_	0	SENT_376	[p20l906t38r970b74],
7	the	DT	O	the	det	10	SENT_376	[p20l995t26r1083b74],
8	mean	NN	O	mean	amod	10	SENT_376	[p20l1111t38r1266b74],
9	i	FW	O	i	dep	8	SENT_376	[p20l1293t31r1328b73],
10	SD	NN	O	sd	prep_as	5	SENT_376	[p20l1354t25r1438b75],
11	unless	IN	O	unless	mark	12	SENT_376	[p20l1468t26r1649b74],
12	specified	VBN	O	specify	dep	10	SENT_376	[p20l1676t26r1926b87],
13	otherwise	RB	O	otherwise	advmod	12	SENT_376	[p20l122t116r411b164],
14	.	.	O	.	_	0	SENT_376	[p20l122t116r411b164],

1	b	NN	O	b	_	0	SENT_377	[p20l10t205r41b253],
2	Median	JJ	MISC	median	amod	5	SENT_377	[p20l125t205r329b253],
3	(	NN	O	(	nn	5	SENT_377	[p20l360t204r577b266],
4	range	NN	O	range	nn	5	SENT_377	[p20l360t204r577b266],
5	)	NN	O	)	dep	1	SENT_377	[p20l360t204r577b266],
6	.	.	O	.	_	0	SENT_377	[p20l360t204r577b266],

1	AUC24	NN	O	auc24	nsubj	10	SENT_378	[p20l8t293r276b355],
2	,	,	O	,	_	0	SENT_378	[p20l8t293r276b355],
3	ss	NN	O	ss	nn	5	SENT_378	[p20l8t293r276b355],
4	=	JJ	O	=	amod	5	SENT_378	[p20l298t315r331b333],
5	area	NN	O	area	appos	1	SENT_378	[p20l353t305r480b342],
6	under	IN	O	under	_	0	SENT_378	[p20l503t294r665b342],
7	the	DT	O	the	det	9	SENT_378	[p20l684t294r771b342],
8	plasma	NN	O	plasma	nn	9	SENT_378	[p20l795t294r999b354],
9	concentration-time	NN	O	concentration-time	prep_under	5	SENT_378	[p20l1020t294r1550b342],
10	curve	NN	O	curve	_	0	SENT_378	[p20l1572t305r1727b342],
11	during	IN	O	during	_	0	SENT_378	[p20l1749t294r1924b355],
12	the	DT	O	the	det	15	SENT_378	[p20l1946t294r2033b342],
13	24hour	JJ	O	24hour	amod	15	SENT_378	[p20l2055t295r2145b341, p20l11t383r137b431],
14	dosing	NN	O	dosing	nn	15	SENT_378	[p20l175t383r360b444],
15	interval	NN	O	interval	prep_during	10	SENT_378	[p20l404t383r605b431],
16	at	IN	O	at	_	0	SENT_378	[p20l647t386r698b431],
17	steady	JJ	O	steady	amod	18	SENT_378	[p20l738t383r926b443],
18	state	NN	O	state	prep_at	15	SENT_378	[p20l965t386r1116b439],
19	;	:	O	;	_	0	SENT_378	[p20l965t386r1116b439],
20	CLIF	NN	O	clif	dep	15	SENT_378	[p20l1160t382r1301b431],
21	=	JJ	O	=	amod	24	SENT_378	[p20l1340t404r1374b422],
22	apparent	JJ	O	apparent	amod	24	SENT_378	[p20l1414t386r1667b443],
23	oral	JJ	O	oral	amod	24	SENT_378	[p20l1706t383r1808b431],
24	clearance	NN	O	clearance	dep	20	SENT_378	[p20l1850t383r2142b439],
25	;	:	O	;	_	0	SENT_378	[p20l1850t383r2142b439],
26	Cmax	NNP	O	Cmax	dep	15	SENT_378	[p20l10t471r228b534],
27	,	,	O	,	_	0	SENT_378	[p20l10t471r228b534],
28	ss	NN	O	ss	appos	26	SENT_378	[p20l10t471r228b534],
29	=	JJ	O	=	amod	32	SENT_378	[p20l253t493r286b511],
30	peak	NN	O	peak	nn	32	SENT_378	[p20l313t472r450b532],
31	plasma	NN	O	plasma	nn	32	SENT_378	[p20l475t472r679b532],
32	concentration	NN	O	concentration	dep	28	SENT_378	[p20l704t472r1087b520],
33	at	IN	O	at	_	0	SENT_378	[p20l1115t475r1166b520],
34	steady	JJ	O	steady	amod	35	SENT_378	[p20l1190t472r1378b532],
35	state	NN	O	state	prep_at	32	SENT_378	[p20l1402t475r1554b528],
36	;	:	O	;	_	0	SENT_378	[p20l1402t475r1554b528],
37	D	NN	O	d	dep	15	SENT_378	[p20l1585t472r1625b519],
38	=	JJ	O	=	amod	39	SENT_378	[p20l1651t493r1684b511],
39	dose	NN	O	dose	dep	37	SENT_378	[p20l1709t472r1861b528],
40	;	:	O	;	_	0	SENT_378	[p20l1709t472r1861b528],
41	NS	NN	O	n	dep	15	SENT_378	[p20l1891t471r1975b520],
42	=	JJ	O	=	amod	41	SENT_378	[p20l2001t493r2034b511],
43	not	RB	O	not	neg	44	SENT_378	[p20l2061t475r2146b520],
44	significant	JJ	O	significant	amod	41	SENT_378	[p20l9t560r308b622],
45	;	:	O	;	_	0	SENT_378	[p20l9t560r308b622],
46	t1/2	NN	O	t1/2	dep	15	SENT_378	[p20l336t564r400b615],
47	=	JJ	O	=	amod	49	SENT_378	[p20l426t582r460b600],
48	elimination	NN	O	elimination	nn	49	SENT_378	[p20l487t561r791b609],
49	half-life	NN	O	half-life	dep	46	SENT_378	[p20l821t560r1039b617],
50	;	:	O	;	_	0	SENT_378	[p20l821t560r1039b617],
51	tmax	NN	O	tmax	dep	15	SENT_378	[p20l1068t564r1192b615],
52	=	JJ	O	=	amod	53	SENT_378	[p20l1218t582r1251b600],
53	time	NN	O	time	tmod	51	SENT_378	[p20l1277t561r1396b609],
54	to	TO	O	to	aux	55	SENT_378	[p20l1422t564r1474b609],
55	reach	VB	O	reach	infmod	15	SENT_378	[p20l1503t561r1657b609],
56	the	DT	O	the	det	57	SENT_378	[p20l1684t561r1771b609],
57	Cmax	NNP	O	Cmax	dobj	55	SENT_378	[p20l1799t560r1954b615],
58	.	.	O	.	_	0	SENT_378	[p20l1799t560r1954b615],

1	torasemide	NN	O	torasemide	_	0	SENT_379	[p20l8t792r378b849],
2	.	.	O	.	_	0	SENT_379	[p20l8t792r378b849],

1	While	IN	O	while	mark	5	SENT_380	[p20l407t792r604b849],
2	losartan	NN	O	losartan	nsubj	5	SENT_380	[p20l631t792r885b849],
3	did	VBD	O	do	aux	5	SENT_380	[p20l913t792r1014b849],
4	not	RB	O	not	neg	5	SENT_380	[p20l1040t801r1143b849],
5	change	VB	O	change	advcl	13	SENT_380	[p20l1169t792r1395b866],
6	torasemide	NN	O	torasemide	nn	7	SENT_380	[p20l1422t792r1775b849],
7	pharmacokinetics	NNS	O	pharmacokinetic	dobj	5	SENT_380	[p20l1801t792r2144b866, p20l7t894r256b950],
8	at	IN	O	at	advmod	5	SENT_380	[p20l289t902r345b950],
9	all	DT	O	all	pobj	8	SENT_380	[p20l375t894r469b961],
10	,	,	O	,	_	0	SENT_380	[p20l375t894r469b961],
11	irbesartan	NN	O	irbesartan	nsubj	13	SENT_380	[p20l502t894r820b950],
12	moderately	RB	O	moderately	advmod	13	SENT_380	[p20l849t894r1211b967],
13	increased	VBD	O	increase	_	0	SENT_380	[p20l1241t894r1546b950],
14	the	DT	O	the	det	15	SENT_380	[p20l1575t894r1671b950],
15	AUC24	NN	O	auc24	dobj	13	SENT_380	[p20l1701t894r2000b966],
16	,	,	O	,	_	0	SENT_380	[p20l1701t894r2000b966],
17	ss	NN	O	ss	conj_and	15	SENT_380	[p20l1701t894r2000b966],
18	and	CC	O	and	_	0	SENT_380	[p20l2033t894r2147b950],
19	the	DT	O	the	det	20	SENT_380	[p20l8t994r104b1051],
20	t1/2	NN	O	t1/2	dobj	13	SENT_380	[p20l148t1003r219b1059],
21	of	IN	O	of	_	0	SENT_380	[p20l263t994r333b1051],
22	torasemide	NN	O	torasemide	prep_of	20	SENT_380	[p20l371t994r724b1051],
23	by	IN	O	by	_	0	SENT_380	[p20l767t994r846b1068],
24	about	RB	O	about	quantmod	25	SENT_380	[p20l892t994r1070b1051],
25	13	CD	PERCENT	13	num	26	SENT_380	[p20l1120t995r1274b1051],
26	%	NN	PERCENT	%	prep_by	13	SENT_380	[p20l1120t995r1274b1051],
27	.	.	O	.	_	0	SENT_380	[p20l1120t995r1274b1051],

1	Our	PRP$	O	we	poss	2	SENT_381	[p20l1324t995r1448b1051],
2	study	NN	O	study	nsubj	7	SENT_381	[p20l1493t994r1662b1068],
3	performed	VBN	O	perform	partmod	2	SENT_381	[p20l1706t994r2043b1068],
4	in	IN	O	in	_	0	SENT_381	[p20l2086t994r2147b1050],
5	patients	NNS	O	patient	prep_in	3	SENT_381	[p20l7t1096r256b1169],
6	therefore	RB	O	therefore	advmod	7	SENT_381	[p20l299t1096r588b1152],
7	suggests	VBZ	O	suggest	_	0	SENT_381	[p20l633t1105r901b1169],
8	that	IN	O	that	complm	13	SENT_381	[p20l943t1096r1064b1152],
9	the	DT	O	the	det	10	SENT_381	[p20l1103t1096r1199b1152],
10	risk	NN	O	risk	nsubj	25	SENT_381	[p20l1240t1096r1362b1152],
11	of	IN	O	of	_	0	SENT_381	[p20l1402t1096r1472b1152],
12	torasemide	NN	O	torasemide	prep_of	10	SENT_381	[p20l1507t1096r1860b1152],
13	toxicity	NN	O	toxicity	ccomp	7	SENT_381	[p20l1901t1096r2146b1169],
14	(	CD	NUMBER	(	num	15	SENT_381	[p20l11t1210r446b1284],
15	hypotension	NN	O	hypotension	dobj	13	SENT_381	[p20l11t1210r446b1284],
16	,	,	O	,	_	0	SENT_381	[p20l11t1210r446b1284],
17	nausea	NN	O	nausea	appos	15	SENT_381	[p20l477t1228r713b1277],
18	,	,	O	,	_	0	SENT_381	[p20l477t1228r713b1277],
19	dizziness	NN	O	dizziness	appos	15	SENT_381	[p20l744t1210r1055b1277],
20	,	,	O	,	_	0	SENT_381	[p20l744t1210r1055b1277],
21	muscle	NN	O	muscle	nn	22	SENT_381	[p20l1086t1210r1313b1267],
22	cramps	NNS	O	cramp	appos	15	SENT_381	[p20l1342t1228r1590b1284],
23	,	,	O	,	_	0	SENT_381	[p20l1342t1228r1590b1284],
24	and	CC	O	and	_	0	SENT_381	[p20l1622t1210r1736b1267],
25	increases	VBZ	O	increase	ccomp	7	SENT_381	[p20l1763t1210r2056b1267],
26	in	IN	O	in	_	0	SENT_381	[p20l2086t1210r2146b1266],
27	serum	NN	O	serum	prep_in	25	SENT_381	[p20l11t1330r205b1368],
28	uric	JJ	O	uric	amod	29	SENT_381	[p20l248t1312r371b1368],
29	acid	NN	O	acid	dobj	25	SENT_381	[p20l419t1312r551b1368],
30	and	CC	O	and	_	0	SENT_381	[p20l597t1312r711b1368],
31	creatinine	NN	O	creatinine	nn	32	SENT_381	[p20l756t1312r1097b1381],
32	)	NN	O	)	dobj	25	SENT_381	[p20l756t1312r1097b1381],
33	is	VBZ	O	be	auxpass	36	SENT_381	[p20l1145t1312r1195b1368],
34	not	RB	O	not	neg	36	SENT_381	[p20l1242t1321r1344b1368],
35	critically	RB	O	critically	advmod	36	SENT_381	[p20l1389t1312r1673b1385],
36	enhanced	VBN	O	enhance	rcmod	29	SENT_381	[p20l1720t1312r2024b1368],
37	by	IN	O	by	_	0	SENT_381	[p20l2067t1312r2146b1385],
38	pharmacokinetic	JJ	O	pharmacokinetic	amod	42	SENT_381	[p20l7t1412r545b1486],
39	drug	NN	O	drug	nn	42	SENT_381	[p20l579t1412r900b1486],
40	—	NN	O	—	nn	42	SENT_381	[p20l579t1412r900b1486],
41	drug	NN	O	drug	nn	42	SENT_381	[p20l579t1412r900b1486],
42	interactions	NNS	O	interaction	agent	36	SENT_381	[p20l933t1412r1307b1469],
43	with	IN	O	with	_	0	SENT_381	[p20l1342t1412r1484b1469],
44	losartan	NN	O	losartan	prep_with	42	SENT_381	[p20l1516t1412r1771b1469],
45	or	CC	O	or	_	0	SENT_381	[p20l1804t1430r1870b1469],
46	irbesartan	NN	O	irbesartan	prep_with	42	SENT_381	[p20l1901t1412r2144b1469, p20l8t1523r121b1570],
47	.	.	O	.	_	0	SENT_381	[p20l1901t1412r2144b1469, p20l8t1523r121b1570],

1	However	RB	O	however	advmod	7	SENT_382	[p20l145t1515r458b1581],
2	,	,	O	,	_	0	SENT_382	[p20l145t1515r458b1581],
3	the	DT	O	the	det	5	SENT_382	[p20l481t1514r577b1570],
4	present	JJ	DATE	present	amod	5	SENT_382	[p20l597t1523r831b1587],
5	study	NN	O	study	nsubj	7	SENT_382	[p20l853t1514r1023b1587],
6	again	RB	O	again	advmod	7	SENT_382	[p20l1046t1514r1218b1587],
7	highlights	VBZ	O	highlight	_	0	SENT_382	[p20l1238t1514r1559b1587],
8	the	DT	O	the	det	9	SENT_382	[p20l1581t1514r1677b1570],
9	importance	NN	O	importance	dobj	7	SENT_382	[p20l1698t1514r2060b1587],
10	of	IN	O	of	_	0	SENT_382	[p20l2082t1514r2152b1570],
11	the	DT	O	the	det	15	SENT_382	[p20l8t1615r104b1672],
12	CYP2C9	NN	O	cyp2c9	nn	15	SENT_382	[p20l157t1616r511b1672],
13	*	NN	O	*	nn	15	SENT_382	[p20l157t1616r511b1672],
14	3	CD	NUMBER	3	num	15	SENT_382	[p20l157t1616r511b1672],
15	variant	NN	O	variant	prep_of	9	SENT_382	[p20l564t1615r804b1682],
16	,	,	O	,	_	0	SENT_382	[p20l564t1615r804b1682],
17	which	WDT	O	which	nsubjpass	20	SENT_382	[p20l856t1615r1051b1672],
18	is	VBZ	O	be	auxpass	20	SENT_382	[p20l1099t1615r1149b1672],
19	also	RB	O	also	advmod	20	SENT_382	[p20l1201t1615r1327b1672],
20	known	VBN	O	know	rcmod	15	SENT_382	[p20l1375t1615r1594b1672],
21	to	TO	O	to	aux	22	SENT_382	[p20l1643t1624r1702b1672],
22	affect	VB	O	affect	xcomp	20	SENT_382	[p20l1753t1615r1935b1672],
23	other	JJ	O	other	amod	25	SENT_382	[p20l1983t1615r2148b1672],
24	CYP2C9	NN	O	cyp2c9	nn	25	SENT_382	[p20l9t1716r297b1773],
25	substrates	NNS	O	substrate	dobj	22	SENT_382	[p20l328t1716r660b1783],
26	,	,	O	,	_	0	SENT_382	[p20l328t1716r660b1783],
27	e.g.	FW	O	e.g.	appos	25	SENT_382	[p20l691t1734r801b1789],
28	warfarin	NN	O	warfarin	dep	27	SENT_382	[p20l832t1716r1120b1773],
29	.	.	O	.	_	0	SENT_382	[p20l832t1716r1120b1773],

1	A	DT	O	a	det	3	SENT_383	[p20l1151t1716r1208b1772],
2	recent	JJ	O	recent	amod	3	SENT_383	[p20l1234t1724r1432b1772],
3	investigation	NN	O	investigation	nsubj	4	SENT_383	[p20l1457t1716r1874b1789],
4	demonstrated	VBD	O	demonstrate	_	0	SENT_383	[p20l1902t1716r2144b1772, p20l11t1817r222b1873],
5	for	IN	O	for	_	0	SENT_383	[p20l252t1816r346b1873],
6	the	DT	O	the	det	8	SENT_383	[p20l374t1816r471b1873],
7	first	JJ	ORDINAL	first	amod	8	SENT_383	[p20l501t1816r631b1873],
8	time	NN	O	time	prep_for	4	SENT_383	[p20l659t1816r801b1873],
9	that	IN	O	that	complm	16	SENT_383	[p20l831t1816r952b1873],
10	CYP2C9	NN	O	cyp2c9	nsubj	18	SENT_383	[p20l982t1817r1269b1874],
11	genotype-guided	JJ	O	genotype-guided	amod	13	SENT_383	[p20l1302t1816r1845b1890],
12	warfarin	NN	O	warfarin	nn	13	SENT_383	[p20l1875t1816r2147b1873],
13	therapy	NN	O	therapy	dep	10	SENT_383	[p20l8t1918r248b1991],
14	is	VBZ	O	be	cop	16	SENT_383	[p20l283t1918r333b1974],
15	more	RBR	O	more	advmod	16	SENT_383	[p20l369t1936r532b1974],
16	efficient	JJ	O	efficient	ccomp	4	SENT_383	[p20l568t1918r836b1974],
17	and	CC	O	and	_	0	SENT_383	[p20l870t1918r984b1974],
18	safer	JJR	O	safer	conj_and	16	SENT_383	[p20l1020t1918r1174b1974],
19	then	RB	O	then	prep	16	SENT_383	[p20l1207t1918r1344b1974],
20	standard	JJ	O	standard	amod	21	SENT_383	[p20l1381t1918r1651b1974],
21	dosing	NN	O	dosing	pobj	19	SENT_383	[p20l1686t1918r1898b1991],
22	of	IN	O	of	_	0	SENT_383	[p20l1934t1918r2003b1974],
23	this	DT	O	this	det	24	SENT_383	[p20l2032t1918r2145b1974],
24	drug	NN	O	drug	prep_of	21	SENT_383	[p20l9t2012r260b2094],
25	.	.	O	.	_	0	SENT_383	[p20l9t2012r260b2094],

1	[	NN	O	[	_	0	SENT_384	[p20l9t2012r260b2094],
2	38	CD	NUMBER	38	num	3	SENT_384	[p20l9t2012r260b2094],
3	]	NN	O	]	dep	1	SENT_384	[p20l9t2012r260b2094],

1	In	FW	O	in	nn	3	SENT_385	[p20l103t2123r169b2177],
2	vitro	FW	O	vitro	nn	3	SENT_385	[p20l213t2123r363b2177],
3	studies	NNS	O	study	nsubj	9	SENT_385	[p20l409t2121r628b2177],
4	in	IN	O	in	_	0	SENT_385	[p20l672t2121r733b2176],
5	human	JJ	O	human	amod	7	SENT_385	[p20l775t2121r995b2177],
6	liver	NN	O	liver	nn	7	SENT_385	[p20l1037t2121r1185b2177],
7	microsomes	NNS	O	microsome	prep_in	3	SENT_385	[p20l1226t2121r1614b2177],
8	have	VBP	O	have	aux	9	SENT_385	[p20l1657t2121r1809b2177],
9	indicated	VBN	O	indicate	_	0	SENT_385	[p20l1851t2121r2147b2177],
10	that	IN	O	that	complm	18	SENT_385	[p20l8t2220r128b2277],
11	losartan	NN	O	losartan	nsubj	18	SENT_385	[p20l173t2220r427b2277],
12	and	CC	O	and	_	0	SENT_385	[p20l474t2220r588b2277],
13	irbesartan	NN	O	irbesartan	nsubj	18	SENT_385	[p20l633t2220r950b2277],
14	are	VBP	O	be	cop	18	SENT_385	[p20l997t2238r1092b2277],
15	the	DT	O	the	det	18	SENT_385	[p20l1138t2220r1234b2277],
16	most	RBS	O	most	advmod	17	SENT_385	[p20l1280t2229r1437b2277],
17	potent	JJ	O	potent	amod	18	SENT_385	[p20l1480t2229r1683b2294],
18	inhibitors	NNS	O	inhibitor	ccomp	9	SENT_385	[p20l1727t2220r2034b2277],
19	of	IN	O	of	_	0	SENT_385	[p20l2082t2220r2152b2277],
20	CYP2C9-mediated	JJ	O	cyp2c9-mediated	amod	21	SENT_385	[p20l9t2322r623b2379],
21	methylhydroxylation	NN	O	methylhydroxylation	prep_of	18	SENT_385	[p20l642t2322r1320b2395],
22	of	IN	O	of	_	0	SENT_385	[p20l1341t2322r1411b2378],
23	tolbutamide	NN	O	tolbutamide	prep_of	21	SENT_385	[p20l1425t2322r1809b2378],
24	compared	VBN	O	compare	_	0	SENT_385	[p20l1830t2322r2147b2395],
25	with	IN	O	with	prepc_compared_with	18	SENT_385	[p20l8t2423r150b2480],
26	other	JJ	O	other	amod	27	SENT_385	[p20l202t2423r367b2480],
27	ARBs	NNS	MISC	arb	pobj	18	SENT_385	[p20l416t2424r611b2480],
28	such	JJ	O	such	_	0	SENT_385	[p20l667t2423r810b2480],
29	as	IN	O	as	_	0	SENT_385	[p20l863t2441r924b2480],
30	valsartan	NN	O	valsartan	nn	33	SENT_385	[p20l978t2423r1285b2490],
31	,	,	O	,	_	0	SENT_385	[p20l978t2423r1285b2490],
32	candesartan	NN	O	candesartan	prep_such_as	27	SENT_385	[p20l1340t2423r1720b2480],
33	cilexetil	NN	O	cilexetil	prep_such_as	27	SENT_385	[p20l1772t2423r2030b2480],
34	or	CC	O	or	_	0	SENT_385	[p20l2082t2441r2148b2480],
35	eprosartan	NN	O	eprosartan	prep_such_as	27	SENT_385	[p20l9t2517r450b2598],
36	.	.	O	.	_	0	SENT_385	[p20l9t2517r450b2598],

1	[	NN	O	[	tmod	22	SENT_386	[p20l9t2517r450b2598],
2	2	CD	NUMBER	2	num	3	SENT_386	[p20l9t2517r450b2598],
3	”	CD	NUMBER	”	dep	1	SENT_386	[p20l9t2517r450b2598],
4	In	IN	O	in	_	0	SENT_386	[p20l474t2526r539b2581],
5	addition	NN	O	addition	_	0	SENT_386	[p20l562t2525r824b2581],
6	to	TO	O	to	_	0	SENT_386	[p20l844t2533r904b2581],
7	the	DT	O	the	det	8	SENT_386	[p20l926t2525r1022b2581],
8	affinity	NN	O	affinity	prep_in_addition_to	22	SENT_386	[p20l1046t2525r1280b2598],
9	of	IN	O	of	_	0	SENT_386	[p20l1302t2525r1372b2581],
10	the	DT	O	the	det	11	SENT_386	[p20l1387t2525r1484b2581],
11	ARBs	NNS	MISC	arb	prep_of	8	SENT_386	[p20l1505t2525r1700b2581],
12	for	IN	O	for	_	0	SENT_386	[p20l1723t2525r1816b2581],
13	CYP2C9	NN	O	cyp2c9	prep_for	11	SENT_386	[p20l1836t2525r2143b2592],
14	,	,	O	,	_	0	SENT_386	[p20l1836t2525r2143b2592],
15	the	DT	O	the	det	16	SENT_386	[p20l8t2624r104b2681],
16	concentration	NN	O	concentration	nsubj	22	SENT_386	[p20l134t2624r573b2681],
17	at	IN	O	at	_	0	SENT_386	[p20l602t2633r658b2681],
18	the	DT	O	the	det	21	SENT_386	[p20l685t2625r782b2681],
19	enzyme	NN	O	enzyme	nn	21	SENT_386	[p20l811t2642r1060b2698],
20	active	JJ	O	active	amod	21	SENT_386	[p20l1091t2624r1280b2681],
21	site	NN	O	site	prep_at	16	SENT_386	[p20l1312t2624r1419b2681],
22	determines	VBZ	O	determine	_	0	SENT_386	[p20l1448t2624r1799b2681],
23	the	DT	O	the	det	25	SENT_386	[p20l1830t2624r1926b2681],
24	actual	JJ	O	actual	amod	25	SENT_386	[p20l1957t2624r2146b2681],
25	inhibition	NN	O	inhibition	dobj	22	SENT_386	[p20l8t2726r321b2782],
26	in	FW	O	in	prep	25	SENT_386	[p20l357t2728r414b2782],
27	vivo	FW	O	vivo	pobj	26	SENT_386	[p20l449t2728r597b2783],
28	.	.	O	.	_	0	SENT_386	[p20l449t2728r597b2783],

1	The	DT	O	the	det	4	SENT_387	[p20l635t2726r758b2782],
2	peak	NN	O	peak	nn	4	SENT_387	[p20l790t2726r944b2799],
3	plasma	NN	O	plasma	nn	4	SENT_387	[p20l975t2726r1204b2799],
4	concentrations	NNS	O	concentration	nsubj	12	SENT_387	[p20l1237t2726r1705b2782],
5	in	IN	O	in	_	0	SENT_387	[p20l1740t2726r1801b2782],
6	our	PRP$	O	we	poss	7	SENT_387	[p20l1835t2744r1942b2782],
7	study	NN	O	study	prep_in	4	SENT_387	[p20l1976t2726r2146b2799],
8	were	VBD	O	be	cop	12	SENT_387	[p20l8t2844r163b2883],
9	up	RB	O	up	quantmod	11	SENT_387	[p20l183t2844r262b2900],
10	to	TO	O	to	dep	11	SENT_387	[p20l283t2835r343b2883],
11	21.4	CD	NUMBER	21.4	num	12	SENT_387	[p20l366t2827r504b2883],
12	umol/L	NN	O	umol/l	_	0	SENT_387	[p20l527t2826r768b2900],
13	for	IN	O	for	_	0	SENT_387	[p20l789t2826r882b2883],
14	irbesartan	NN	O	irbesartan	prep_for	12	SENT_387	[p20l902t2826r1219b2883],
15	and	CC	O	and	_	0	SENT_387	[p20l1242t2826r1355b2883],
16	3.2	CD	NUMBER	3.2	num	17	SENT_387	[p20l1377t2827r1474b2883],
17	umol/L	NN	O	umol/l	conj_and	12	SENT_387	[p20l1497t2826r1738b2900],
18	for	IN	O	for	_	0	SENT_387	[p20l1759t2826r1852b2883],
19	losartan	NN	O	losartan	prep_for	17	SENT_387	[p20l1872t2826r2143b2893],
20	,	,	O	,	_	0	SENT_387	[p20l1872t2826r2143b2893],
21	but	CC	O	but	_	0	SENT_387	[p20l7t2928r110b2984],
22	hepatic	JJ	O	hepatic	amod	23	SENT_387	[p20l150t2928r381b3001],
23	concentrations	NNS	O	concentration	nsubjpass	31	SENT_387	[p20l425t2928r893b2984],
24	at	IN	O	at	_	0	SENT_387	[p20l938t2937r994b2984],
25	the	DT	O	the	det	28	SENT_387	[p20l1034t2928r1130b2984],
26	enzyme	NN	O	enzyme	nn	28	SENT_387	[p20l1173t2946r1422b3001],
27	active	JJ	O	active	amod	28	SENT_387	[p20l1465t2928r1655b2985],
28	site	NN	O	site	prep_at	23	SENT_387	[p20l1699t2928r1806b2984],
29	were	VBD	O	be	auxpass	31	SENT_387	[p20l1849t2946r2003b2985],
30	not	RB	O	not	neg	31	SENT_387	[p20l2045t2937r2148b2984],
31	known	VBN	O	know	conj_but	12	SENT_387	[p20l7t3028r243b3085],
32	.	.	O	.	_	0	SENT_387	[p20l7t3028r243b3085],

1	This	DT	O	this	det	2	SENT_388	[p20l289t3028r429b3085],
2	study	NN	O	study	nsubj	3	SENT_388	[p20l475t3028r645b3102],
3	suggests	VBZ	O	suggest	_	0	SENT_388	[p20l691t3037r959b3102],
4	that	IN	O	that	complm	10	SENT_388	[p20l1003t3028r1123b3085],
5	effective	JJ	O	effective	amod	7	SENT_388	[p20l1165t3028r1445b3085],
6	inhibitor	NN	O	inhibitor	nn	7	SENT_388	[p20l1488t3028r1766b3085],
7	concentrations	NNS	O	concentration	nsubjpass	10	SENT_388	[p20l1807t3037r2144b3085, p20l8t3130r161b3186],
8	are	VBP	O	be	auxpass	10	SENT_388	[p20l203t3148r297b3186],
9	not	RB	O	not	neg	10	SENT_388	[p20l336t3138r438b3186],
10	attained	VBN	O	attain	ccomp	3	SENT_388	[p20l477t3130r730b3186],
11	with	IN	O	with	_	0	SENT_388	[p20l768t3130r910b3187],
12	the	DT	O	the	det	13	SENT_388	[p20l948t3130r1044b3186],
13	doses	NNS	O	dose	prep_with	10	SENT_388	[p20l1083t3130r1259b3186],
14	of	IN	O	of	_	0	SENT_388	[p20l1299t3130r1369b3186],
15	losartan	NN	O	losartan	nn	16	SENT_388	[p20l1402t3130r1656b3186],
16	(	NN	O	(	prep_of	13	SENT_388	[p20l1697t3130r1840b3200],
17	100	CD	NUMBER	100	num	19	SENT_388	[p20l1697t3130r1840b3200],
18	mg/day	JJ	O	mg/day	amod	19	SENT_388	[p20l1878t3130r2144b3203],
19	)	NN	O	)	dep	16	SENT_388	[p20l1878t3130r2144b3203],
20	and	CC	O	and	_	0	SENT_388	[p20l10t3230r123b3287],
21	irbesartan	NN	O	irbesartan	nn	22	SENT_388	[p20l164t3230r482b3287],
22	(	NN	O	(	prep_of	13	SENT_388	[p20l526t3230r670b3300],
23	150	CD	NUMBER	150	num	25	SENT_388	[p20l526t3230r670b3300],
24	mg/day	JJ	O	mg/day	amod	25	SENT_388	[p20l712t3230r977b3304],
25	)	NN	O	)	dep	22	SENT_388	[p20l712t3230r977b3304],
26	used	VBN	O	use	partmod	13	SENT_388	[p20l1021t3231r1168b3287],
27	in	IN	O	in	_	0	SENT_388	[p20l1210t3230r1270b3286],
28	our	PRP$	O	we	poss	30	SENT_388	[p20l1313t3248r1419b3287],
29	study	NN	O	study	nn	30	SENT_388	[p20l1462t3230r1632b3304],
30	protocol	NN	O	protocol	prep_in	26	SENT_388	[p20l1674t3230r1959b3304],
31	.	.	O	.	_	0	SENT_388	[p20l1674t3230r1959b3304],

1	This	DT	O	this	_	0	SENT_389	[p20l2005t3230r2144b3287],

1	Clin	NNP	O	Clin	nn	2	SENT_390	[p20l1404t3427r1488b3465],
2	Phdrmocokinet	NNP	O	Phdrmocokinet	_	0	SENT_390	[p20l1509t3427r1866b3465],
3	2008	CD	DATE	2008	num	2	SENT_390	[p20l1882t3427r1999b3467],
4	;	:	O	;	_	0	SENT_390	[p20l1882t3427r1999b3467],
5	47	CD	NUMBER	47	number	6	SENT_390	[p20l2017t3427r2068b3464],
6	(	CD	NUMBER	(	dep	2	SENT_390	[p20l2088t3427r2145b3470],
7	5	CD	NUMBER	5	num	8	SENT_390	[p20l2088t3427r2145b3470],
8	)	NN	O	)	dep	6	SENT_390	[p20l2088t3427r2145b3470],

1	Determinants	NNS	O	determinant	_	0	SENT_391	[p20l6t3546r206b3570],
2	of	IN	O	of	_	0	SENT_391	[p20l218t3545r247b3570],
3	Torasemide	NNP	O	Torasemide	prep_of	1	SENT_391	[p20l257t3545r430b3570],
4	PK	NN	O	pk	dep	1	SENT_391	[p20l441t3546r485b3570],
5	331	CD	NUMBER	331	num	4	SENT_391	[p20l6t3581r53b3605],

1	might	MD	O	might	aux	3	SENT_392	[p21l8t81r196b154],
2	be	VB	O	be	cop	3	SENT_392	[p21l230t81r305b137],
3	related	JJ	O	related	ccomp	20	SENT_392	[p21l341t81r577b147],
4	,	,	O	,	_	0	SENT_392	[p21l341t81r577b147],
5	at	IN	O	at	advmod	20	SENT_392	[p21l618t89r674b137],
6	least	JJS	O	least	pobj	5	SENT_392	[p21l710t81r857b137],
7	in	IN	O	in	_	0	SENT_392	[p21l892t81r953b137],
8	part	NN	O	part	prep_in	5	SENT_392	[p21l988t89r1130b154],
9	,	,	O	,	_	0	SENT_392	[p21l988t89r1130b154],
10	to	TO	O	to	_	0	SENT_392	[p21l1170t89r1230b137],
11	the	DT	O	the	det	16	SENT_392	[p21l1267t81r1364b137],
12	relatively	RB	O	relatively	advmod	13	SENT_392	[p21l1399t81r1703b154],
13	high	JJ	O	high	amod	16	SENT_392	[p21l1740t81r1883b154],
14	plasma	NN	O	plasma	nn	16	SENT_392	[p21l1918t81r2147b154],
15	protein	NN	O	protein	nn	16	SENT_392	[p21l7t182r236b255],
16	binding	NN	O	binding	prep_to	20	SENT_392	[p21l284t182r530b255],
17	of	IN	O	of	_	0	SENT_392	[p21l583t182r652b238],
18	the	DT	O	the	det	19	SENT_392	[p21l697t182r794b238],
19	ARBs	NNS	MISC	arb	prep_of	16	SENT_392	[p21l844t182r1038b238],
20	(	VBP	O	(	_	0	SENT_392	[p21l1093t182r1346b255],
21	plasma	NN	O	plasma	nn	23	SENT_392	[p21l1093t182r1346b255],
22	free	JJ	O	free	amod	23	SENT_392	[p21l1396t182r1519b238],
23	fraction	NN	O	fraction	dobj	20	SENT_392	[p21l1570t182r1836b238],
24	:	:	O	:	_	0	SENT_392	[p21l1570t182r1836b238],
25	losartan	NN	O	losartan	dep	23	SENT_392	[p21l1892t182r2147b238],
26	1.3	CD	PERCENT	1.3	number	27	SENT_392	[p21l16t284r192b350],
27	%	NN	PERCENT	%	amod	25	SENT_392	[p21l16t284r192b350],
28	,	,	O	,	_	0	SENT_392	[p21l16t284r192b350],
29	EXP3l74	NN	O	exp3l74	appos	23	SENT_392	[p21l228t284r540b340],
30	0.2	CD	PERCENT	0.2	number	31	SENT_392	[p21l575t284r758b350],
31	%	NN	PERCENT	%	amod	29	SENT_392	[p21l575t284r758b350],
32	,	,	O	,	_	0	SENT_392	[p21l575t284r758b350],
33	irbesartan	NN	O	irbesartan	appos	23	SENT_392	[p21l794t283r1112b340],
34	l0	CD	PERCENT	l0	num	35	SENT_392	[p21l1153t276r1425b353],
35	%	NN	PERCENT	%	dep	33	SENT_392	[p21l1153t276r1425b353],
36	)	CD	NUMBER	)	nsubj	20	SENT_392	[p21l1153t276r1425b353],
37	,	,	O	,	_	0	SENT_392	[p21l1153t276r1425b353],
38	[	CD	NUMBER	[	number	39	SENT_392	[p21l1153t276r1425b353],
39	39	CD	NUMBER	39	num	40	SENT_392	[p21l1153t276r1425b353],
40	]	NN	O	]	appos	36	SENT_392	[p21l1153t276r1425b353],
41	resulting	VBG	O	result	partmod	40	SENT_392	[p21l1461t283r1742b357],
42	in	IN	O	in	_	0	SENT_392	[p21l1776t283r1837b339],
43	low	JJ	O	low	amod	45	SENT_392	[p21l1870t284r1989b341],
44	free	JJ	O	free	amod	45	SENT_392	[p21l2023t283r2146b340],
45	concentrations	NNS	O	concentration	prep_in	41	SENT_392	[p21l9t384r477b440],
46	able	JJ	O	able	amod	45	SENT_392	[p21l530t384r661b440],
47	to	TO	O	to	aux	48	SENT_392	[p21l711t392r771b440],
48	penetrate	VB	O	penetrate	xcomp	46	SENT_392	[p21l821t392r1116b457],
49	liver	NN	O	liver	nn	51	SENT_392	[p21l1166t384r1314b440],
50	cell	NN	O	cell	nn	51	SENT_392	[p21l1363t384r1477b440],
51	membranes	NNS	O	membrane	dobj	48	SENT_392	[p21l1527t384r1915b440],
52	.	.	O	.	_	0	SENT_392	[p21l1527t384r1915b440],

1	Since	IN	O	since	_	0	SENT_393	[p21l1971t384r2146b441],
2	ARBs	NNS	O	arb	prep_since	10	SENT_393	[p21l8t486r202b542],
3	(	CD	NUMBER	(	num	4	SENT_393	[p21l235t486r635b555],
4	telmisartan	NN	O	telmisartan	dep	2	SENT_393	[p21l235t486r635b555],
5	,	,	O	,	_	0	SENT_393	[p21l235t486r635b555],
6	Valsartan	NNP	O	Valsartan	nsubjpass	10	SENT_393	[p21l667t486r981b555],
7	)	CD	NUMBER	)	num	6	SENT_393	[p21l667t486r981b555],
8	have	VBP	O	have	aux	10	SENT_393	[p21l1012t486r1163b542],
9	been	VBN	O	be	auxpass	10	SENT_393	[p21l1191t486r1343b542],
10	shown	VBN	O	show	_	0	SENT_393	[p21l1374t486r1581b542],
11	to	TO	O	to	aux	16	SENT_393	[p21l1609t494r1669b542],
12	be	VB	O	be	cop	16	SENT_393	[p21l1698t486r1773b542],
13	OATPlBl	JJ	O	oatplbl	amod	16	SENT_393	[p21l1803t486r2139b542],
14	and/or	NN	O	and/or	nn	16	SENT_393	[p21l10t586r214b643],
15	OATPlB3	NN	O	oatplb3	nn	16	SENT_393	[p21l251t587r590b643],
16	substrates	NNS	O	substrate	xcomp	10	SENT_393	[p21l633t579r1121b653],
17	,	,	O	,	_	0	SENT_393	[p21l633t579r1121b653],
18	[	CD	NUMBER	[	number	19	SENT_393	[p21l633t579r1121b653],
19	23	CD	NUMBER	23	appos	16	SENT_393	[p21l633t579r1121b653],
20	’	NN	O	’	nn	23	SENT_393	[p21l633t579r1121b653],
21	24	CD	NUMBER	24	num	23	SENT_393	[p21l633t579r1121b653],
22	]	NN	O	]	nn	23	SENT_393	[p21l633t579r1121b653],
23	inhibition	NN	O	inhibition	nsubj	37	SENT_393	[p21l1161t586r1475b643],
24	of	IN	O	of	_	0	SENT_393	[p21l1512t586r1582b643],
25	OATP	NN	O	oatp	prep_of	23	SENT_393	[p21l1614t586r2147b643],
26	—	CD	NUMBER	—	num	25	SENT_393	[p21l1614t586r2147b643],
27	mediated	VBN	O	mediate	partmod	25	SENT_393	[p21l1614t586r2147b643],
28	torasemide	NN	O	torasemide	nn	29	SENT_393	[p21l8t687r361b743],
29	uptake	NN	O	uptake	dobj	27	SENT_393	[p21l381t687r595b760],
30	into	IN	O	into	_	0	SENT_393	[p21l615t687r738b743],
31	the	DT	O	the	det	32	SENT_393	[p21l759t687r856b743],
32	liver	NN	O	liver	prep_into	27	SENT_393	[p21l876t687r1024b743],
33	might	MD	O	might	aux	37	SENT_393	[p21l1042t687r1230b760],
34	be	VB	O	be	cop	37	SENT_393	[p21l1248t687r1323b743],
35	an	DT	O	a	det	37	SENT_393	[p21l1345t704r1417b743],
36	additional	JJ	O	additional	amod	37	SENT_393	[p21l1439t687r1759b743],
37	mechanism	NN	O	mechanism	rcmod	19	SENT_393	[p21l1780t687r2148b743],
38	of	IN	O	of	_	0	SENT_393	[p21l9t788r78b844],
39	the	DT	O	the	det	41	SENT_393	[p21l101t788r198b844],
40	drug	NN	O	drug	nn	41	SENT_393	[p21l228t788r373b861],
41	interaction	NN	O	interaction	prep_of	37	SENT_393	[p21l402t788r747b844],
42	between	IN	O	between	_	0	SENT_393	[p21l774t788r1044b844],
43	torasemide	NN	O	torasemide	prep_between	41	SENT_393	[p21l1072t788r1425b844],
44	and	CC	O	and	_	0	SENT_393	[p21l1456t788r1570b844],
45	irbesartan	NN	O	irbesartan	conj_and	43	SENT_393	[p21l1598t788r1931b844],
46	.	.	O	.	_	0	SENT_393	[p21l1598t788r1931b844],

1	However	RB	O	however	advmod	11	SENT_394	[p21l1964t789r2144b845, p21l9t906r162b956],
2	,	,	O	,	_	0	SENT_394	[p21l1964t789r2144b845, p21l9t906r162b956],
3	to	TO	O	to	_	0	SENT_394	[p21l185t897r245b945],
4	the	DT	O	the	det	5	SENT_394	[p21l265t889r361b945],
5	best	JJS	O	best	prep_to	11	SENT_394	[p21l380t889r510b945],
6	of	IN	O	of	_	0	SENT_394	[p21l529t889r599b945],
7	our	PRP$	O	we	poss	8	SENT_394	[p21l614t906r720b945],
8	knowledge	NN	O	knowledge	prep_of	5	SENT_394	[p21l737t889r1109b962],
9	,	,	O	,	_	0	SENT_394	[p21l737t889r1109b962],
10	there	EX	O	there	expl	11	SENT_394	[p21l1131t889r1290b945],
11	are	VBP	O	be	_	0	SENT_394	[p21l1311t906r1406b945],
12	currently	RB	DATE	currently	advmod	11	SENT_394	[p21l1426t889r1716b962],
13	no	DT	O	no	det	15	SENT_394	[p21l1735t906r1813b945],
14	published	VBN	O	publish	amod	15	SENT_394	[p21l1833t889r2147b962],
15	data	NNS	O	datum	nsubj	11	SENT_394	[p21l9t990r142b1046],
16	indicating	VBG	O	indicate	partmod	15	SENT_394	[p21l162t990r483b1063],
17	whether	IN	O	whether	complm	23	SENT_394	[p21l505t990r765b1046],
18	irbesartan	NN	O	irbesartan	nsubj	23	SENT_394	[p21l785t990r1102b1046],
19	is	VBZ	O	be	cop	23	SENT_394	[p21l1123t990r1173b1046],
20	a	DT	O	a	det	23	SENT_394	[p21l1197t1007r1231b1046],
21	substrate	JJ	O	substrate	amod	23	SENT_394	[p21l1253t990r1536b1046],
22	and/or	NN	O	and/or	nn	23	SENT_394	[p21l1559t990r1764b1047],
23	inhibitor	NN	O	inhibitor	ccomp	16	SENT_394	[p21l1783t990r2062b1046],
24	of	IN	O	of	_	0	SENT_394	[p21l2082t990r2152b1046],
25	OATPlBl	NN	O	oatplbl	prep_of	23	SENT_394	[p21l9t1091r368b1148],
26	.	.	O	.	_	0	SENT_394	[p21l9t1091r368b1148],

1	The	DT	O	the	det	2	SENT_395	[p21l399t1091r522b1147],
2	lack	NN	O	lack	nsubj	17	SENT_395	[p21l549t1091r683b1147],
3	of	IN	O	of	_	0	SENT_395	[p21l708t1090r778b1147],
4	clinically	RB	O	clinically	advmod	5	SENT_395	[p21l799t1091r1097b1164],
5	relevant	JJ	O	relevant	amod	7	SENT_395	[p21l1123t1091r1384b1147],
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_395	[p21l1408t1091r1946b1164],
7	interactions	NNS	O	interaction	prep_of	2	SENT_395	[p21l1973t1091r2144b1147, p21l10t1192r233b1248],
8	of	IN	O	of	_	0	SENT_395	[p21l261t1192r331b1248],
9	torasemide	NN	O	torasemide	prep_of	7	SENT_395	[p21l350t1192r704b1248],
10	with	IN	O	with	_	0	SENT_395	[p21l730t1192r871b1249],
11	losartan	NN	O	losartan	prep_with	9	SENT_395	[p21l896t1192r1151b1248],
12	and	CC	O	and	_	0	SENT_395	[p21l1177t1192r1291b1248],
13	irbesartan	NN	O	irbesartan	conj_and	11	SENT_395	[p21l1315t1192r1633b1248],
14	at	IN	O	at	_	0	SENT_395	[p21l1659t1200r1715b1248],
15	higher	JJR	O	higher	amod	16	SENT_395	[p21l1738t1192r1945b1265],
16	doses	NNS	O	dose	prep_at	7	SENT_395	[p21l1970t1192r2145b1248],
17	remains	VBZ	O	remain	_	0	SENT_395	[p21l7t1293r260b1349],
18	to	TO	O	to	aux	20	SENT_395	[p21l289t1301r349b1349],
19	be	VB	O	be	auxpass	20	SENT_395	[p21l375t1293r450b1349],
20	established	VBN	O	establish	xcomp	17	SENT_395	[p21l478t1293r852b1349],
21	.	.	O	.	_	0	SENT_395	[p21l478t1293r852b1349],

1	Conclusion	NN	O	conclusion	_	0	SENT_396	[p21l106t1495r540b1557],

1	This	DT	O	this	det	2	SENT_397	[p21l105t1695r245b1751],
2	study	NN	O	study	nsubj	3	SENT_397	[p21l283t1695r454b1768],
3	shows	VBZ	O	show	_	0	SENT_397	[p21l491t1695r686b1752],
4	that	IN	O	that	complm	7	SENT_397	[p21l722t1695r842b1751],
5	irbesartan	NN	O	irbesartan	nn	6	SENT_397	[p21l875t1695r1193b1751],
6	comedication	NN	O	comedication	nsubj	7	SENT_397	[p21l1227t1695r1661b1751],
7	has	VBZ	O	have	ccomp	3	SENT_397	[p21l1694t1695r1798b1751],
8	minor	JJ	O	minor	amod	9	SENT_397	[p21l1834t1695r2027b1751],
9	effects	NNS	O	effect	dobj	7	SENT_397	[p21l2059t1695r2144b1751, p21l8t1796r157b1852],
10	on	IN	O	on	_	0	SENT_397	[p21l180t1814r258b1852],
11	torasemide	NN	O	torasemide	nn	12	SENT_397	[p21l278t1796r632b1852],
12	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	9	SENT_397	[p21l651t1796r1238b1869],
13	.	.	O	.	_	0	SENT_397	[p21l651t1796r1238b1869],

1	However	RB	O	however	advmod	23	SENT_398	[p21l1263t1797r1575b1863],
2	,	,	O	,	_	0	SENT_398	[p21l1263t1797r1575b1863],
3	gender	NN	O	gender	nsubj	23	SENT_398	[p21l1600t1796r1819b1869],
4	as	RB	O	as	_	0	SENT_398	[p21l1839t1814r1901b1852],
5	well	RB	O	well	_	0	SENT_398	[p21l1924t1796r2061b1853],
6	as	IN	O	as	_	0	SENT_398	[p21l2083t1814r2145b1852],
7	the	DT	O	the	det	12	SENT_398	[p21l8t1898r104b1954],
8	CYP2C9	NN	O	cyp2c9	nn	12	SENT_398	[p21l140t1898r495b1954],
9	*	NN	O	*	nn	12	SENT_398	[p21l140t1898r495b1954],
10	3	CD	NUMBER	3	num	12	SENT_398	[p21l140t1898r495b1954],
11	allelic	JJ	O	allelic	amod	12	SENT_398	[p21l532t1898r725b1954],
12	variant	NN	O	variant	nsubj	23	SENT_398	[p21l757t1898r981b1954],
13	and	CC	O	and	_	0	SENT_398	[p21l1013t1898r1127b1954],
14	the	DT	O	the	det	17	SENT_398	[p21l1157t1898r1254b1954],
15	SLCOIBI	NNP	O	SLCOIBI	nn	17	SENT_398	[p21l1286t1898r1606b1954],
16	c.	NN	O	c.	nn	17	SENT_398	[p21l1645t1898r1967b1954],
17	52lT	NN	O	52lt	conj_and	3	SENT_398	[p21l1645t1898r1967b1954],
18	>	JJR	O	>	amod	20	SENT_398	[p21l1645t1898r1967b1954],
19	C	NN	O	c	nn	20	SENT_398	[p21l1645t1898r1967b1954],
20	SNP	NN	ORGANIZATION	snp	dep	17	SENT_398	[p21l2002t1898r2147b1954],
21	are	VBP	O	be	cop	23	SENT_398	[p21l10t2016r104b2054],
22	significant	JJ	O	significant	amod	23	SENT_398	[p21l144t1998r482b2071],
23	determinants	NNS	O	determinant	_	0	SENT_398	[p21l519t1998r933b2054],
24	of	IN	O	of	_	0	SENT_398	[p21l972t1998r1042b2054],
25	interindividual	JJ	O	interindividual	amod	26	SENT_398	[p21l1073t1998r1548b2055],
26	variability	NN	O	variability	prep_of	23	SENT_398	[p21l1585t1998r1915b2071],
27	in	IN	O	in	_	0	SENT_398	[p21l1952t1998r2013b2054],
28	the	DT	O	the	det	29	SENT_398	[p21l2050t1998r2146b2054],
29	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	26	SENT_398	[p21l7t2099r576b2172],
30	of	IN	O	of	_	0	SENT_398	[p21l605t2099r675b2155],
31	torasemide	NN	O	torasemide	prep_of	29	SENT_398	[p21l696t2099r1066b2155],
32	.	.	O	.	_	0	SENT_398	[p21l696t2099r1066b2155],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_399	[p21l105t2316r894b2395],

1	This	DT	O	this	det	2	SENT_400	[p21l105t2504r224b2552],
2	work	NN	O	work	nsubjpass	4	SENT_400	[p21l261t2504r401b2552],
3	was	VBD	O	be	auxpass	4	SENT_400	[p21l435t2519r538b2552],
4	supported	VBN	O	support	_	0	SENT_400	[p21l576t2504r845b2566],
5	in	IN	O	in	_	0	SENT_400	[p21l879t2504r931b2551],
6	part	NN	O	part	prep_in	4	SENT_400	[p21l964t2511r1071b2566],
7	by	IN	O	by	_	0	SENT_400	[p21l1104t2504r1171b2566],
8	grant	NN	O	grant	nn	9	SENT_400	[p21l1207t2511r1347b2566],
9	no.	NN	O	no.	agent	4	SENT_400	[p21l1380t2519r1461b2552],
10	.	.	O	.	_	0	SENT_400	[p21l1380t2519r1461b2552],

1	Ko	NNP	O	Ko	_	0	SENT_401	[p21l1501t2505r1581b2552],
2	2120	CD	DATE	2120	num	1	SENT_401	[p21l1617t2504r1773b2552],
3	/	:	O	/	punct	4	SENT_401	[p21l1617t2504r1773b2552],
4	1-3	CD	NUMBER	1-3	dep	1	SENT_401	[p21l1780t2504r1860b2552],
5	from	IN	O	from	_	0	SENT_401	[p21l1898t2504r2031b2552],
6	the	DT	O	the	det	8	SENT_401	[p21l2064t2504r2146b2552],
7	Deutsche	NNP	ORGANIZATION	Deutsche	nn	8	SENT_401	[p21l8t2589r262b2637],
8	Forschungsgemeinschaft	NNP	ORGANIZATION	Forschungsgemeinschaft	prep_from	4	SENT_401	[p21l305t2588r1002b2651],
9	.	.	O	.	_	0	SENT_401	[p21l305t2588r1002b2651],

1	The	DT	O	the	det	2	SENT_402	[p21l1048t2589r1154b2637],
2	authors	NNS	O	author	nsubj	3	SENT_402	[p21l1198t2589r1396b2637],
3	thank	VBP	O	thank	_	0	SENT_402	[p21l1440t2589r1593b2637],
4	Daniel	NNP	PERSON	Daniel	nn	5	SENT_402	[p21l1634t2588r1816b2637],
5	Auge	NNP	PERSON	Auge	dobj	3	SENT_402	[p21l1859t2589r2006b2651],
6	and	CC	O	and	_	0	SENT_402	[p21l2051t2589r2147b2637],
7	Dr	NNP	O	Dr	nn	9	SENT_402	[p21l8t2675r80b2721],
8	Ligia	NNP	PERSON	Ligia	nn	9	SENT_402	[p21l95t2673r241b2735],
9	Chialda	NNP	PERSON	Chialda	dobj	3	SENT_402	[p21l258t2673r470b2722],
10	for	IN	O	for	_	0	SENT_402	[p21l487t2673r567b2721],
11	skilled	JJ	O	skilled	amod	12	SENT_402	[p21l585t2673r765b2721],
12	determination	NN	O	determination	prep_for	9	SENT_402	[p21l783t2673r1163b2721],
13	of	IN	O	of	_	0	SENT_402	[p21l1182t2673r1241b2721],
14	plasma	NN	O	plasma	nn	16	SENT_402	[p21l1253t2673r1448b2735],
15	drug	NN	O	drug	nn	16	SENT_402	[p21l1465t2673r1588b2735],
16	concentrations	NNS	O	concentration	prep_of	12	SENT_402	[p21l1607t2673r2021b2721],
17	.	.	O	.	_	0	SENT_402	[p21l1607t2673r2021b2721],

1	The	DT	O	the	det	2	SENT_403	[p21l2041t2673r2146b2721],
2	authors	NNS	O	author	nsubj	3	SENT_403	[p21l9t2758r207b2806],
3	have	VBP	O	have	_	0	SENT_403	[p21l227t2758r356b2806],
4	no	DT	O	no	det	5	SENT_403	[p21l375t2773r441b2806],
5	conﬂicts	NNS	O	conﬂicts	dobj	3	SENT_403	[p21l461t2758r695b2806],
6	of	IN	O	of	_	0	SENT_403	[p21l716t2758r776b2806],
7	interest	NN	O	interest	prep_of	5	SENT_403	[p21l790t2758r992b2806],
8	that	WDT	O	that	nsubj	11	SENT_403	[p21l1010t2758r1113b2806],
9	are	VBP	O	be	cop	11	SENT_403	[p21l1132t2773r1213b2806],
10	directly	RB	O	directly	advmod	11	SENT_403	[p21l1233t2758r1440b2820],
11	relevant	JJ	O	relevant	rcmod	5	SENT_403	[p21l1459t2758r1681b2806],
12	to	TO	O	to	_	0	SENT_403	[p21l1699t2766r1750b2806],
13	the	DT	O	the	det	14	SENT_403	[p21l1770t2758r1852b2806],
14	content	NN	O	content	prep_to	11	SENT_403	[p21l1872t2766r2073b2806],
15	of	IN	O	of	_	0	SENT_403	[p21l2092t2758r2151b2806],
16	this	DT	O	this	det	17	SENT_403	[p21l8t2843r104b2891],
17	study	NN	O	study	prep_of	14	SENT_403	[p21l130t2843r289b2905],
18	.	.	O	.	_	0	SENT_403	[p21l130t2843r289b2905],

1	References	NNS	O	reference	_	0	SENT_404	[p21l150t3051r583b3114],

1	1	LS	NUMBER	1	_	0	SENT_405	[p21l74t3154r109b3196],
2	.	.	O	.	_	0	SENT_405	[p21l74t3154r109b3196],

1	Hunt	NNP	O	Hunt	nn	2	SENT_406	[p21l144t3155r265b3196],
2	SA	NNP	O	SA	_	0	SENT_406	[p21l282t3154r370b3203],
3	,	,	O	,	_	0	SENT_406	[p21l282t3154r370b3203],
4	Abraham	NNP	PERSON	Abraham	nn	5	SENT_406	[p21l388t3153r614b3196],
5	WT	NNP	O	WT	appos	2	SENT_406	[p21l628t3155r735b3203],
6	,	,	O	,	_	0	SENT_406	[p21l628t3155r735b3203],
7	Chin	NNP	O	Chin	nn	8	SENT_406	[p21l754t3153r870b3196],
8	MH	NNP	O	MH	appos	2	SENT_406	[p21l886t3155r996b3203],
9	,	,	O	,	_	0	SENT_406	[p21l886t3155r996b3203],
10	et	FW	O	et	nn	11	SENT_406	[p21l1015t3160r1057b3196],
11	al.	FW	O	al.	appos	2	SENT_406	[p21l1074t3153r1127b3196],
12	.	.	O	.	_	0	SENT_406	[p21l1074t3153r1127b3196],

1	ACC/AHA	NNP	O	ACC/AHA	nsubj	4	SENT_407	[p21l1147t3154r1418b3196],
2	2005	CD	DATE	2005	num	3	SENT_407	[p21l1436t3153r1552b3196],
3	guideline	NN	O	guideline	dep	1	SENT_407	[p21l1572t3153r1795b3208],
4	update	VBP	O	update	_	0	SENT_407	[p21l1812t3153r1972b3208],
5	for	IN	O	for	_	0	SENT_407	[p21l1989t3153r2059b3196],
6	the	DT	O	the	det	7	SENT_407	[p21l2074t3154r2147b3196],
7	diagnosis	NN	O	diagnosis	prep_for	4	SENT_407	[p21l227t3228r453b3283],
8	and	CC	O	and	_	0	SENT_407	[p21l475t3228r560b3270],
9	management	NN	O	management	conj_and	7	SENT_407	[p21l578t3235r888b3283],
10	of	IN	O	of	_	0	SENT_407	[p21l907t3228r960b3270],
11	chronic	JJ	O	chronic	amod	13	SENT_407	[p21l975t3228r1154b3270],
12	heart	NN	O	heart	nn	13	SENT_407	[p21l1173t3228r1295b3270],
13	failure	NN	O	failure	prep_of	7	SENT_407	[p21l1313t3228r1469b3270],
14	in	IN	O	in	_	0	SENT_407	[p21l1488t3228r1534b3270],
15	the	DT	O	the	det	16	SENT_407	[p21l1553t3228r1625b3270],
16	adult	NN	O	adult	prep_in	13	SENT_407	[p21l1646t3228r1777b3270],
17	:	:	O	:	_	0	SENT_407	[p21l1646t3228r1777b3270],
18	a	DT	O	a	det	19	SENT_407	[p21l1801t3241r1826b3270],
19	report	NN	O	report	nsubj	33	SENT_407	[p21l1843t3235r1989b3283],
20	of	IN	O	of	_	0	SENT_407	[p21l2007t3228r2060b3270],
21	the	DT	O	the	det	23	SENT_407	[p21l2074t3228r2146b3270],
22	American	NNP	ORGANIZATION	American	nn	23	SENT_407	[p21l227t3303r465b3345],
23	College	NNP	ORGANIZATION	College	prep_of	19	SENT_407	[p21l489t3303r675b3358],
24	of	IN	ORGANIZATION	of	_	0	SENT_407	[p21l699t3303r752b3345],
25	Cardiology/American	NNP	ORGANIZATION	Cardiology/American	nn	29	SENT_407	[p21l772t3303r1300b3358],
26	Heart	NNP	ORGANIZATION	Heart	nn	29	SENT_407	[p21l1323t3304r1457b3345],
27	Association	NNP	ORGANIZATION	Association	nn	29	SENT_407	[p21l1479t3303r1765b3345],
28	Task	NNP	ORGANIZATION	Task	nn	29	SENT_407	[p21l1788t3303r1906b3345],
29	Force	NNP	ORGANIZATION	Force	prep_of	23	SENT_407	[p21l1927t3304r2065b3345],
30	on	IN	O	on	_	0	SENT_407	[p21l2089t3316r2147b3345],
31	Practice	NNP	O	Practice	nn	32	SENT_407	[p21l227t3378r420b3420],
32	Guidelines	NNS	O	guideline	prep_on	29	SENT_407	[p21l439t3378r698b3420],
33	(	VBP	O	(	parataxis	4	SENT_407	[p21l719t3378r924b3433],
34	Writing	VBG	ORGANIZATION	write	xcomp	33	SENT_407	[p21l719t3378r924b3433],
35	Committee	NNP	ORGANIZATION	Committee	dobj	34	SENT_407	[p21l942t3378r1210b3420],
36	to	TO	O	to	_	0	SENT_407	[p21l1228t3384r1273b3420],
37	Update	NNP	O	Update	prep_to	35	SENT_407	[p21l1290t3378r1464b3433],
38	the	DT	O	the	det	40	SENT_407	[p21l1482t3378r1554b3420],
39	2001	CD	DATE	2001	num	40	SENT_407	[p21l1573t3378r1686b3420],
40	Guidelines	NNS	O	guideline	nsubj	71	SENT_407	[p21l1709t3378r1969b3420],
41	for	IN	O	for	_	0	SENT_407	[p21l1988t3378r2058b3420],
42	the	DT	O	the	det	43	SENT_407	[p21l2074t3378r2146b3420],
43	Evaluation	NN	O	evaluation	prep_for	40	SENT_407	[p21l226t3455r488b3498],
44	and	CC	O	and	_	0	SENT_407	[p21l506t3455r591b3498],
45	Management	NN	O	management	conj_and	43	SENT_407	[p21l607t3456r924b3510],
46	of	IN	O	of	_	0	SENT_407	[p21l940t3455r992b3498],
47	Heart	NNP	O	Heart	nn	49	SENT_407	[p21l1005t3456r1139b3498],
48	Failure	NN	O	failure	nn	49	SENT_407	[p21l1154t3455r1358b3508],
49	)	NN	O	)	prep_of	43	SENT_407	[p21l1154t3455r1358b3508],
50	:	:	O	:	_	0	SENT_407	[p21l1154t3455r1358b3508],
51	developed	VBN	O	develop	partmod	40	SENT_407	[p21l1379t3455r1627b3510],
52	in	IN	O	in	_	0	SENT_407	[p21l1643t3455r1689b3497],
53	collaboration	NN	O	collaboration	prep_in	51	SENT_407	[p21l1705t3455r2024b3498],
54	with	IN	O	with	_	0	SENT_407	[p21l2041t3455r2147b3498],
55	the	DT	O	the	det	57	SENT_407	[p21l227t3532r299b3574],
56	American	NNP	ORGANIZATION	American	nn	57	SENT_407	[p21l325t3532r563b3574],
57	College	NNP	ORGANIZATION	College	prep_with	51	SENT_407	[p21l590t3532r776b3587],
58	of	IN	ORGANIZATION	of	_	0	SENT_407	[p21l803t3532r856b3574],
59	Chest	NN	ORGANIZATION	chest	nn	60	SENT_407	[p21l878t3532r1015b3575],
60	Physicians	NNP	ORGANIZATION	Physicians	prep_of	57	SENT_407	[p21l1040t3532r1298b3587],
61	and	CC	O	and	_	0	SENT_407	[p21l1326t3532r1412b3574],
62	the	DT	O	the	det	64	SENT_407	[p21l1437t3532r1509b3574],
63	International	NNP	ORGANIZATION	International	nn	64	SENT_407	[p21l1536t3532r1844b3574],
64	Society	NNP	ORGANIZATION	Society	prep_with	51	SENT_407	[p21l1872t3532r2051b3587],
65	for	IN	ORGANIZATION	for	_	0	SENT_407	[p21l2078t3532r2148b3574],
66	Heart	NNP	ORGANIZATION	Heart	prep_for	64	SENT_407	[p21l227t3609r361b3650],
67	and	CC	O	and	_	0	SENT_407	[p21l395t3607r480b3650],
68	Lung	NN	O	lung	nn	69	SENT_407	[p21l513t3609r640b3662],
69	Transplantation	NN	O	transplantation	prep_for	64	SENT_407	[p21l674t3607r1067b3662],
70	:	:	O	:	_	0	SENT_407	[p21l674t3607r1067b3662],
71	endorsed	VBN	O	endorse	rcmod	35	SENT_407	[p21l1105t3607r1323b3650],
72	by	IN	O	by	_	0	SENT_407	[p21l1356t3607r1415b3662],
73	the	DT	O	the	det	76	SENT_407	[p21l1449t3607r1522b3650],
74	Heart	NNP	ORGANIZATION	Heart	nn	76	SENT_407	[p21l1555t3609r1690b3650],
75	Rhythm	NNP	ORGANIZATION	Rhythm	nn	76	SENT_407	[p21l1723t3607r1918b3662],
76	Society	NNP	ORGANIZATION	Society	prep_by	71	SENT_407	[p21l1952t3607r2144b3662],
77	.	.	O	.	_	0	SENT_407	[p21l1952t3607r2144b3662],

1	Circulation	NN	O	circulation	_	0	SENT_408	[p21l227t3683r499b3726],
2	2005	CD	DATE	2005	num	1	SENT_408	[p21l519t3683r653b3734],
3	;	:	O	;	_	0	SENT_408	[p21l519t3683r653b3734],
4	112	CD	NUMBER	112	dep	1	SENT_408	[p21l681t3684r778b3726],
5	:	:	O	:	_	0	SENT_408	[p21l681t3684r778b3726],
6	e154-235	NN	O	e154-235	dep	4	SENT_408	[p21l802t3683r1027b3726],

1	Swedberg	NNP	PERSON	Swedberg	nn	2	SENT_409	[p22l146t19r385b74],
2	K	NNP	PERSON	K	_	0	SENT_409	[p22l403t20r458b69],
3	,	,	O	,	_	0	SENT_409	[p22l403t20r458b69],
4	Cleland	NNP	PERSON	Cleland	nn	5	SENT_409	[p22l477t19r664b62],
5	J	NNP	PERSON	J	appos	2	SENT_409	[p22l679t20r715b69],
6	,	,	O	,	_	0	SENT_409	[p22l679t20r715b69],
7	Dargie	NNP	PERSON	Dargie	nn	8	SENT_409	[p22l733t19r897b74],
8	H	NNP	O	H	appos	2	SENT_409	[p22l913t20r969b69],
9	,	,	O	,	_	0	SENT_409	[p22l913t20r969b69],
10	et	FW	O	et	nn	11	SENT_409	[p22l988t26r1030b61],
11	al.	FW	O	al.	appos	2	SENT_409	[p22l1047t19r1100b61],
12	.	.	O	.	_	0	SENT_409	[p22l1047t19r1100b61],

1	Guidelines	NNS	O	guideline	_	0	SENT_410	[p22l1120t19r1380b62],
2	for	IN	O	for	_	0	SENT_410	[p22l1398t19r1468b61],
3	the	DT	O	the	det	4	SENT_410	[p22l1483t19r1556b61],
4	diagnosis	NN	O	diagnosis	prep_for	1	SENT_410	[p22l1573t19r1799b74],
5	and	CC	O	and	_	0	SENT_410	[p22l1817t19r1903b61],
6	treatment	NN	O	treatment	prep_for	1	SENT_410	[p22l1919t26r2148b61],
7	of	IN	O	of	_	0	SENT_410	[p22l227t94r280b136],
8	chronic	JJ	O	chronic	amod	10	SENT_410	[p22l295t94r474b136],
9	heart	NN	O	heart	nn	10	SENT_410	[p22l494t94r615b136],
10	failure	NN	O	failure	prep_of	4	SENT_410	[p22l633t94r802b136],
11	:	:	O	:	_	0	SENT_410	[p22l633t94r802b136],
12	executive	NN	O	executive	nn	14	SENT_410	[p22l826t94r1057b136],
13	summary	NN	O	summary	nn	14	SENT_410	[p22l1078t107r1300b149],
14	(	NN	O	(	dep	1	SENT_410	[p22l1322t94r1500b149],
15	update	VBP	O	update	dep	14	SENT_410	[p22l1322t94r1500b149],
16	2005	CD	DATE	2005	num	17	SENT_410	[p22l1520t94r1672b146],
17	)	CD	NUMBER	)	dobj	15	SENT_410	[p22l1520t94r1672b146],
18	:	:	O	:	_	0	SENT_410	[p22l1520t94r1672b146],
19	the	DT	O	the	det	21	SENT_410	[p22l1695t94r1767b136],
20	Task	NNP	O	Task	nn	21	SENT_410	[p22l1787t94r1904b136],
21	Force	NNP	O	Force	dep	14	SENT_410	[p22l1922t95r2059b136],
22	for	IN	O	for	_	0	SENT_410	[p22l2078t94r2148b136],
23	the	DT	O	the	det	24	SENT_410	[p22l227t171r299b214],
24	Diagnosis	NN	O	diagnosis	prep_for	21	SENT_410	[p22l316t171r557b226],
25	and	CC	O	and	_	0	SENT_410	[p22l577t171r662b214],
26	Treatment	NN	O	treatment	prep_for	21	SENT_410	[p22l679t172r928b214],
27	of	IN	O	of	_	0	SENT_410	[p22l945t171r998b214],
28	Chronic	JJ	O	chronic	amod	30	SENT_410	[p22l1011t171r1204b214],
29	Heart	NNP	O	Heart	nn	30	SENT_410	[p22l1222t172r1357b214],
30	Failure	NN	O	failure	prep_of	24	SENT_410	[p22l1373t171r1543b214],
31	of	IN	O	of	_	0	SENT_410	[p22l1562t171r1614b214],
32	the	DT	O	the	det	34	SENT_410	[p22l1627t171r1700b214],
33	European	JJ	ORGANIZATION	european	amod	34	SENT_410	[p22l1717t172r1949b226],
34	Society	NNP	ORGANIZATION	Society	prep_of	21	SENT_410	[p22l1968t171r2146b226],
35	of	IN	ORGANIZATION	of	_	0	SENT_410	[p22l227t247r280b289],
36	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	34	SENT_410	[p22l296t247r579b301],
37	.	.	O	.	_	0	SENT_410	[p22l296t247r579b301],

1	Eur	NNP	O	Eur	nn	3	SENT_411	[p22l602t248r690b289],
2	Heart	NNP	O	Heart	nn	3	SENT_411	[p22l709t248r843b289],
3	J	NNP	O	J	_	0	SENT_411	[p22l862t248r884b289],
4	2005	CD	DATE	2005	num	3	SENT_411	[p22l905t246r1038b296],
5	;	:	O	;	_	0	SENT_411	[p22l905t246r1038b296],
6	26	CD	NUMBER	26	num	8	SENT_411	[p22l1062t247r1133b289],
7	:	:	O	:	_	0	SENT_411	[p22l1062t247r1133b289],
8	1115-40	CD	NUMBER	1115-40	dep	3	SENT_411	[p22l1163t247r1357b289],

1	.	.	O	.	_	0	SENT_412	[p22l102t358r109b365],

1	European	JJ	ORGANIZATION	european	amod	2	SENT_413	[p22l144t324r376b378],
2	Society	NNP	ORGANIZATION	Society	_	0	SENT_413	[p22l406t323r584b378],
3	of	IN	ORGANIZATION	of	_	0	SENT_413	[p22l614t323r666b365],
4	Hypertension-European	NNP	ORGANIZATION	Hypertension-European	nn	5	SENT_413	[p22l690t323r1270b378],
5	Society	NNP	ORGANIZATION	Society	prep_of	2	SENT_413	[p22l1300t323r1479b378],
6	of	IN	ORGANIZATION	of	_	0	SENT_413	[p22l1508t323r1560b365],
7	Cardiology	NNP	ORGANIZATION	Cardiology	nn	9	SENT_413	[p22l1585t323r1856b378],
8	Guidelines	NNS	ORGANIZATION	guideline	dep	9	SENT_413	[p22l1886t323r2145b366],
9	Committee	NNP	ORGANIZATION	Committee	prep_of	2	SENT_413	[p22l227t398r507b441],
10	.	.	O	.	_	0	SENT_413	[p22l227t398r507b441],

1	2003	CD	DATE	2003	_	0	SENT_414	[p22l529t399r645b441],
2	European	JJ	ORGANIZATION	european	amod	3	SENT_414	[p22l665t400r897b453],
3	Society	NNP	ORGANIZATION	Society	dep	1	SENT_414	[p22l916t398r1094b453],
4	of	IN	ORGANIZATION	of	_	0	SENT_414	[p22l1113t398r1165b441],
5	Hypertension-European	NNP	ORGANIZATION	Hypertension-European	nn	6	SENT_414	[p22l1179t398r1758b453],
6	Society	NNP	ORGANIZATION	Society	prep_of	3	SENT_414	[p22l1777t398r1956b453],
7	of	IN	ORGANIZATION	of	_	0	SENT_414	[p22l1975t398r2027b441],
8	Cardiology	NNP	ORGANIZATION	Cardiology	nn	9	SENT_414	[p22l2041t399r2145b441, p22l227t473r410b528],
9	guidelines	NNS	O	guideline	prep_of	6	SENT_414	[p22l436t473r682b528],
10	for	IN	O	for	_	0	SENT_414	[p22l708t473r778b516],
11	the	DT	O	the	det	12	SENT_414	[p22l801t473r874b516],
12	management	NN	O	management	prep_for	9	SENT_414	[p22l898t480r1208b528],
13	of	IN	O	of	_	0	SENT_414	[p22l1233t473r1285b516],
14	arterial	JJ	O	arterial	amod	15	SENT_414	[p22l1306t473r1475b516],
15	hypertension	NN	O	hypertension	prep_of	12	SENT_414	[p22l1500t473r1825b528],
16	.	.	O	.	_	0	SENT_414	[p22l1500t473r1825b528],

1	J	NN	O	j	nn	2	SENT_415	[p22l1852t475r1874b516],
2	Hypertens	NNS	O	hyperten	_	0	SENT_415	[p22l1899t475r2145b528],
3	2003	CD	DATE	2003	dep	2	SENT_415	[p22l227t550r361b600],
4	;	:	O	;	_	0	SENT_415	[p22l227t550r361b600],
5	21	CD	NUMBER	21	dep	2	SENT_415	[p22l384t550r455b592],
6	:	:	O	:	_	0	SENT_415	[p22l384t550r455b592],
7	1011-53	CD	NUMBER	1011-53	dep	5	SENT_415	[p22l485t549r677b592],

1	Uchida	NNP	PERSON	Uchida	nn	2	SENT_416	[p22l144t624r319b667],
2	T	NN	O	t	_	0	SENT_416	[p22l353t625r401b674],
3	,	,	O	,	_	0	SENT_416	[p22l353t625r401b674],
4	Yamanaga	NNP	PERSON	Yamanaga	nn	5	SENT_416	[p22l439t625r698b679],
5	K	NNP	PERSON	K	appos	2	SENT_416	[p22l733t625r787b674],
6	,	,	O	,	_	0	SENT_416	[p22l733t625r787b674],
7	Nishikawa	NNP	PERSON	Nishikawa	nn	8	SENT_416	[p22l824t624r1084b666],
8	M	NNP	O	M	appos	2	SENT_416	[p22l1117t625r1183b674],
9	,	,	O	,	_	0	SENT_416	[p22l1117t625r1183b674],
10	et	FW	O	et	nn	11	SENT_416	[p22l1221t631r1263b666],
11	al.	FW	O	al.	appos	2	SENT_416	[p22l1298t624r1351b666],
12	.	.	O	.	_	0	SENT_416	[p22l1298t624r1351b666],

1	Anti-aldosteronergic	JJ	O	anti-aldosteronergic	amod	2	SENT_417	[p22l1390t624r1890b679],
2	effect	NN	O	effect	_	0	SENT_417	[p22l1926t624r2064b666],
3	of	IN	O	of	_	0	SENT_417	[p22l2098t624r2151b666],
4	torasemide	NN	O	torasemide	prep_of	2	SENT_417	[p22l227t700r504b743],
5	.	.	O	.	_	0	SENT_417	[p22l227t700r504b743],

1	Eur	NNP	MISC	Eur	nn	3	SENT_418	[p22l527t701r614b743],
2	J	NNP	O	J	nn	3	SENT_418	[p22l633t701r655b743],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_418	[p22l675t700r933b743],
4	1991	CD	DATE	1991	num	3	SENT_418	[p22l959t700r1088b750],
5	;	:	O	;	_	0	SENT_418	[p22l959t700r1088b750],
6	205	CD	NUMBER	205	num	8	SENT_418	[p22l1111t700r1212b743],
7	:	:	O	:	_	0	SENT_418	[p22l1111t700r1212b743],
8	145-50	CD	NUMBER	145-50	dep	3	SENT_418	[p22l1242t700r1407b743],

1	.	.	O	.	_	0	SENT_419	[p22l102t810r109b817],

1	Knauf	NN	PERSON	knauf	nn	2	SENT_420	[p22l145t775r299b817],
2	H	NN	PERSON	h	_	0	SENT_420	[p22l329t776r384b825],
3	,	,	O	,	_	0	SENT_420	[p22l329t776r384b825],
4	Mutschler	NNP	PERSON	Mutschler	nn	5	SENT_420	[p22l420t775r667b817],
5	E.	NNP	PERSON	E.	appos	2	SENT_420	[p22l700t776r748b817],
6	Clinical	JJ	PERSON	clinical	amod	7	SENT_420	[p22l785t775r975b817],
7	pharmacokinetics	NNS	O	pharmacokinetic	dep	5	SENT_420	[p22l1009t775r1436b830],
8	and	CC	O	and	_	0	SENT_420	[p22l1473t775r1558b817],
9	pharmacodynamics	NNS	O	pharmacodynamic	dep	5	SENT_420	[p22l1591t775r2062b830],
10	of	IN	O	of	_	0	SENT_420	[p22l2099t775r2151b817],
11	torasemide	NN	O	torasemide	prep_of	7	SENT_420	[p22l227t851r504b894],
12	.	.	O	.	_	0	SENT_420	[p22l227t851r504b894],

1	Clin	NNP	O	Clin	nn	2	SENT_421	[p22l528t851r630b894],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_421	[p22l650t851r1014b894],
3	1998	CD	DATE	1998	num	2	SENT_421	[p22l1039t851r1167b901],
4	;	:	O	;	_	0	SENT_421	[p22l1039t851r1167b901],
5	34	CD	NUMBER	34	num	7	SENT_421	[p22l1191t851r1262b894],
6	:	:	O	:	_	0	SENT_421	[p22l1191t851r1262b894],
7	1-24	CD	NUMBER	1-24	dep	2	SENT_421	[p22l1292t851r1395b893],

1	.	.	O	.	_	0	SENT_422	[p22l102t963r109b971],

1	Vormfelde	NNP	O	Vormfelde	nn	2	SENT_423	[p22l144t928r406b971],
2	SV	NNP	O	SV	_	0	SENT_423	[p22l423t928r510b978],
3	,	,	O	,	_	0	SENT_423	[p22l423t928r510b978],
4	Schirmer	NNP	PERSON	Schirmer	nn	5	SENT_423	[p22l529t928r751b971],
5	M	NNP	O	M	appos	2	SENT_423	[p22l764t929r830b978],
6	,	,	O	,	_	0	SENT_423	[p22l764t929r830b978],
7	Hagos	NNP	PERSON	Hagos	nn	8	SENT_423	[p22l848t929r1000b983],
8	Y	NN	PERSON	y	appos	2	SENT_423	[p22l1017t929r1072b978],
9	,	,	O	,	_	0	SENT_423	[p22l1017t929r1072b978],
10	et	FW	O	et	nn	11	SENT_423	[p22l1090t935r1132b971],
11	al.	FW	O	al.	appos	2	SENT_423	[p22l1148t928r1201b971],
12	.	.	O	.	_	0	SENT_423	[p22l1148t928r1201b971],

1	T	NN	O	t	nn	2	SENT_424	[p22l1219t929r1255b970],
2	orsemide	NN	O	orsemide	_	0	SENT_424	[p22l1257t928r1478b971],
3	renal	JJ	O	renal	amod	4	SENT_424	[p22l1492t928r1613b971],
4	clearance	NN	O	clearance	dep	2	SENT_424	[p22l1629t928r1856b971],
5	and	CC	O	and	_	0	SENT_424	[p22l1873t928r1958b971],
6	genetic	JJ	O	genetic	amod	7	SENT_424	[p22l1974t928r2146b983],
7	Variation	NN	O	variation	dep	2	SENT_424	[p22l227t1005r441b1047],
8	in	IN	O	in	_	0	SENT_424	[p22l474t1005r520b1047],
9	luminal	JJ	O	luminal	amod	14	SENT_424	[p22l553t1005r736b1047],
10	and	CC	O	and	_	0	SENT_424	[p22l771t1005r856b1047],
11	basolateral	JJ	O	basolateral	conj_and	9	SENT_424	[p22l888t1005r1150b1047],
12	organic	JJ	O	organic	amod	14	SENT_424	[p22l1184t1005r1363b1060],
13	anion	NN	O	anion	nn	14	SENT_424	[p22l1398t1005r1530b1047],
14	transporters	NNS	O	transporter	prep_in	4	SENT_424	[p22l1563t1011r1861b1060],
15	.	.	O	.	_	0	SENT_424	[p22l1563t1011r1861b1060],

1	Br	NN	O	br	nn	3	SENT_425	[p22l1897t1006r1957b1047],
2	J	NN	O	j	nn	3	SENT_425	[p22l1988t1006r2011b1048],
3	Clin	NN	O	clin	_	0	SENT_425	[p22l2045t1005r2147b1048],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_425	[p22l226t1081r485b1124],
5	2006	CD	DATE	2006	num	4	SENT_425	[p22l506t1081r639b1132],
6	;	:	O	;	_	0	SENT_425	[p22l506t1081r639b1132],
7	62	CD	NUMBER	62	dep	3	SENT_425	[p22l663t1081r734b1124],
8	:	:	O	:	_	0	SENT_425	[p22l663t1081r734b1124],
9	323-35	CD	NUMBER	323-35	dep	7	SENT_425	[p22l759t1081r926b1124],

1	©	RB	O	©	advmod	2	SENT_426	[p22l9t1269r43b1303],
2	2008	CD	DATE	2008	_	0	SENT_426	[p22l61t1265r166b1303],
3	Adis	NNP	ORGANIZATION	Adis	nn	5	SENT_426	[p22l183t1265r279b1303],
4	Data	NNP	ORGANIZATION	Data	nn	5	SENT_426	[p22l298t1265r411b1303],
5	Information	NNP	ORGANIZATION	Information	dep	2	SENT_426	[p22l432t1265r695b1303],
6	BV	NN	ORGANIZATION	bv	dep	5	SENT_426	[p22l715t1265r783b1302],
7	.	.	O	.	_	0	SENT_426	[p22l715t1265r783b1302],

1	All	DT	O	all	det	2	SENT_427	[p22l803t1265r855b1302],
2	rights	NNS	O	rights	nsubj	3	SENT_427	[p22l875t1265r994b1312],
3	reserved	VBN	O	reserve	_	0	SENT_427	[p22l1012t1265r1222b1303],
4	.	.	O	.	_	0	SENT_427	[p22l1012t1265r1222b1303],

1	7	CD	NUMBER	7	_	0	SENT_428	[p22l37t1339r78b1380],
2	.	.	O	.	_	0	SENT_428	[p22l37t1339r78b1380],

1	Hagos	NNP	PERSON	Hagos	nn	2	SENT_429	[p22l114t1339r269b1393],
2	Y	NN	PERSON	y	_	0	SENT_429	[p22l294t1339r350b1388],
3	,	,	O	,	_	0	SENT_429	[p22l294t1339r350b1388],
4	Bahn	NNP	PERSON	Bahn	nn	5	SENT_429	[p22l376t1338r505b1380],
5	A	NNP	O	A	appos	2	SENT_429	[p22l529t1338r585b1388],
6	,	,	O	,	_	0	SENT_429	[p22l529t1338r585b1388],
7	Vormfelde	NNP	O	Vormfelde	nn	8	SENT_429	[p22l611t1338r876b1380],
8	SV	NNP	O	SV	appos	2	SENT_429	[p22l902t1338r991b1388],
9	,	,	O	,	_	0	SENT_429	[p22l902t1338r991b1388],
10	et	FW	O	et	nn	11	SENT_429	[p22l1017t1344r1061b1380],
11	al.	FW	O	al.	appos	2	SENT_429	[p22l1085t1338r1139b1380],
12	.	.	O	.	_	0	SENT_429	[p22l1085t1338r1139b1380],

1	Torasemide	NNP	O	Torasemide	nn	2	SENT_430	[p22l1166t1338r1455b1380],
2	transport	NN	O	transport	nsubj	7	SENT_430	[p22l1480t1344r1698b1393],
3	by	IN	O	by	_	0	SENT_430	[p22l1721t1338r1781b1393],
4	organic	JJ	O	organic	amod	6	SENT_430	[p22l1806t1338r1988b1393],
5	anion	NN	O	anion	nn	6	SENT_430	[p22l2014t1338r2148b1380],
6	transporters	NNS	O	transporter	prep_by	2	SENT_430	[p22l198t1422r486b1471],
7	contributes	VBZ	O	contribute	_	0	SENT_430	[p22l506t1416r776b1458],
8	to	TO	O	to	_	0	SENT_430	[p22l796t1422r841b1458],
9	hyperuricemia	NN	O	hyperuricemia	prep_to	7	SENT_430	[p22l859t1416r1227b1471],
10	.	.	O	.	_	0	SENT_430	[p22l859t1416r1227b1471],

1	J	NNP	O	J	nn	4	SENT_431	[p22l1247t1417r1270b1459],
2	Am	NNP	O	Am	nn	4	SENT_431	[p22l1288t1416r1379b1458],
3	Soc	NNP	O	Soc	nn	4	SENT_431	[p22l1398t1416r1486b1459],
4	Nephrol	NNP	O	Nephrol	_	0	SENT_431	[p22l1504t1416r1705b1471],
5	2007	CD	DATE	2007	num	4	SENT_431	[p22l1725t1416r1860b1466],
6	;	:	O	;	_	0	SENT_431	[p22l1725t1416r1860b1466],
7	18	CD	NUMBER	18	num	9	SENT_431	[p22l1886t1416r1953b1459],
8	:	:	O	:	_	0	SENT_431	[p22l1886t1416r1953b1459],
9	3101-9	CD	NUMBER	3101-9	dep	4	SENT_431	[p22l1977t1416r2147b1459],
10	Konig	NNP	PERSON	Konig	nn	11	SENT_431	[p22l115t1494r266b1550],
11	J	NNP	PERSON	J	dep	4	SENT_431	[p22l299t1495r335b1545],
12	,	,	O	,	_	0	SENT_431	[p22l299t1495r335b1545],
13	Seithel	NNP	O	Seithel	nn	14	SENT_431	[p22l371t1494r539b1537],
14	A	NNP	O	A	appos	4	SENT_431	[p22l571t1494r628b1545],
15	,	,	O	,	_	0	SENT_431	[p22l571t1494r628b1545],
16	Gradhand	NNP	O	Gradhand	nn	17	SENT_431	[p22l663t1494r905b1537],
17	U	NNP	O	U	appos	4	SENT_431	[p22l936t1495r993b1545],
18	,	,	O	,	_	0	SENT_431	[p22l936t1495r993b1545],
19	et	FW	O	et	nn	20	SENT_431	[p22l1028t1501r1071b1537],
20	al.	FW	O	al.	appos	4	SENT_431	[p22l1103t1494r1158b1537],
21	.	.	O	.	_	0	SENT_431	[p22l1103t1494r1158b1537],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_432	[p22l1193t1494r1674b1550],
2	of	IN	O	of	_	0	SENT_432	[p22l1708t1494r1761b1537],
3	human	JJ	O	human	amod	4	SENT_432	[p22l1789t1494r1956b1537],
4	OATP	NN	O	oatp	prep_of	1	SENT_432	[p22l1989t1494r2148b1537],

1	transporters	NNS	O	transporter	_	0	SENT_433	[p22l198t1579r500b1627],
2	.	.	O	.	_	0	SENT_433	[p22l198t1579r500b1627],

1	Naunyn	NNP	O	Naunyn	nn	4	SENT_434	[p22l523t1573r717b1627],
2	Schmiedebergs	NNP	O	Schmiedebergs	nn	4	SENT_434	[p22l739t1572r1112b1627],
3	Arch	NNP	O	Arch	nn	4	SENT_434	[p22l1133t1572r1255b1615],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_434	[p22l1275t1572r1538b1615],
5	2006	CD	DATE	2006	num	4	SENT_434	[p22l1559t1572r1695b1622],
6	;	:	O	;	_	0	SENT_434	[p22l1559t1572r1695b1622],
7	372	CD	NUMBER	372	num	9	SENT_434	[p22l1719t1572r1821b1615],
8	:	:	O	:	_	0	SENT_434	[p22l1719t1572r1821b1615],
9	432-43	CD	NUMBER	432-43	dep	4	SENT_434	[p22l1845t1572r2016b1615],

1	Konig	NNP	PERSON	Konig	nn	2	SENT_435	[p22l115t1650r266b1706],
2	J	NNP	PERSON	J	_	0	SENT_435	[p22l288t1652r324b1701],
3	,	,	O	,	_	0	SENT_435	[p22l288t1652r324b1701],
4	Cui	NNP	PERSON	Cui	nn	5	SENT_435	[p22l348t1650r434b1693],
5	Y	NN	PERSON	y	appos	2	SENT_435	[p22l456t1652r512b1701],
6	,	,	O	,	_	0	SENT_435	[p22l456t1652r512b1701],
7	Nies	NNPS	PERSON	Nies	appos	2	SENT_435	[p22l536t1650r646b1693],
8	AT	IN	O	at	amod	7	SENT_435	[p22l669t1651r762b1701],
9	,	,	O	,	_	0	SENT_435	[p22l669t1651r762b1701],
10	et	FW	O	et	nn	11	SENT_435	[p22l787t1657r830b1693],
11	al.	FW	O	al.	appos	2	SENT_435	[p22l852t1651r906b1693],
12	.	.	O	.	_	0	SENT_435	[p22l852t1651r906b1693],

1	Localization	NN	O	localization	nn	4	SENT_436	[p22l930t1650r1238b1693],
2	and	CC	O	and	_	0	SENT_436	[p22l1260t1650r1347b1693],
3	genomic	JJ	O	genomic	nn	4	SENT_436	[p22l1368t1650r1578b1706],
4	organization	NN	O	organization	_	0	SENT_436	[p22l1601t1650r1907b1706],
5	of	IN	O	of	_	0	SENT_436	[p22l1929t1650r1982b1693],
6	a	DT	O	a	det	10	SENT_436	[p22l2001t1664r2027b1693],
7	new	JJ	O	new	amod	10	SENT_436	[p22l2047t1664r2147b1693],
8	hepatocellular	JJ	O	hepatocellular	amod	10	SENT_436	[p22l197t1728r547b1784],
9	organic	JJ	O	organic	amod	10	SENT_436	[p22l564t1728r746b1784],
10	anion	NN	O	anion	prep_of	4	SENT_436	[p22l766t1728r901b1771],
11	transporting	VBG	O	transport	partmod	10	SENT_436	[p22l918t1728r1215b1784],
12	polypeptide	NN	O	polypeptide	dobj	11	SENT_436	[p22l1233t1728r1535b1784],
13	.	.	O	.	_	0	SENT_436	[p22l1233t1728r1535b1784],

1	J	NNP	O	J	nn	3	SENT_437	[p22l1556t1729r1579b1771],
2	Biol	NNP	O	Biol	nn	3	SENT_437	[p22l1596t1728r1701b1771],
3	Chem	NNP	O	Chem	_	0	SENT_437	[p22l1720t1728r1866b1771],
4	2000	CD	DATE	2000	num	3	SENT_437	[p22l1884t1729r2020b1779],
5	;	:	O	;	_	0	SENT_437	[p22l1884t1729r2020b1779],
6	275	CD	NUMBER	275	num	8	SENT_437	[p22l2041t1728r2144b1771],
7	:	:	O	:	_	0	SENT_437	[p22l2041t1728r2144b1771],
8	23161-8	CD	NUMBER	23161-8	dep	3	SENT_437	[p22l198t1805r400b1848],

1	Konig	NNP	PERSON	Konig	nn	2	SENT_438	[p22l115t1883r266b1938],
2	J	NNP	PERSON	J	_	0	SENT_438	[p22l299t1884r335b1933],
3	,	,	O	,	_	0	SENT_438	[p22l299t1884r335b1933],
4	Cui	NNP	PERSON	Cui	nn	5	SENT_438	[p22l371t1883r457b1926],
5	Y	NN	PERSON	y	appos	2	SENT_438	[p22l491t1884r547b1933],
6	,	,	O	,	_	0	SENT_438	[p22l491t1884r547b1933],
7	Nies	NNPS	PERSON	Nies	appos	2	SENT_438	[p22l582t1883r692b1926],
8	AT	IN	O	at	amod	7	SENT_438	[p22l727t1883r820b1933],
9	,	,	O	,	_	0	SENT_438	[p22l727t1883r820b1933],
10	et	FW	O	et	nn	11	SENT_438	[p22l856t1889r900b1925],
11	al.	FW	O	al.	appos	2	SENT_438	[p22l933t1883r987b1925],
12	.	.	O	.	_	0	SENT_438	[p22l933t1883r987b1925],

1	A	DT	O	a	det	5	SENT_439	[p22l1022t1883r1066b1925],
2	novel	JJ	O	novel	amod	5	SENT_439	[p22l1098t1883r1234b1925],
3	human	JJ	O	human	amod	5	SENT_439	[p22l1266t1883r1433b1925],
4	organic	JJ	O	organic	amod	5	SENT_439	[p22l1467t1883r1649b1938],
5	anion	NN	O	anion	_	0	SENT_439	[p22l1684t1883r1818b1925],
6	transporting	VBG	O	transport	partmod	5	SENT_439	[p22l1851t1883r2147b1938],
7	polypeptide	NN	O	polypeptide	dobj	6	SENT_439	[p22l197t1961r487b2017],
8	localized	JJ	O	localized	amod	7	SENT_439	[p22l512t1961r733b2004],
9	to	TO	O	to	_	0	SENT_439	[p22l757t1968r803b2004],
10	the	DT	O	the	det	13	SENT_439	[p22l827t1961r901b2004],
11	basolateral	JJ	O	basolateral	amod	13	SENT_439	[p22l924t1961r1191b2004],
12	hepatocyte	NN	O	hepatocyte	nn	13	SENT_439	[p22l1214t1961r1480b2017],
13	membrane	NN	O	membrane	prep_to	8	SENT_439	[p22l1505t1961r1776b2004],
14	.	.	O	.	_	0	SENT_439	[p22l1505t1961r1776b2004],

1	Am	NNP	O	Am	nn	5	SENT_440	[p22l1803t1962r1895b2004],
2	J	NNP	O	J	nn	5	SENT_440	[p22l1918t1963r1941b2004],
3	Physiol	NNP	O	Physiol	nn	5	SENT_440	[p22l1964t1961r2148b2017],
4	Gastrointest	NNP	O	Gastrointest	nn	5	SENT_440	[p22l199t2039r495b2082],
5	Liver	NN	O	liver	_	0	SENT_440	[p22l514t2039r648b2082],
6	Physiol	NNP	O	Physiol	dep	5	SENT_440	[p22l667t2039r851b2095],
7	2000	CD	DATE	2000	num	6	SENT_440	[p22l872t2040r1008b2090],
8	;	:	O	;	_	0	SENT_440	[p22l872t2040r1008b2090],
9	278	CD	NUMBER	278	dep	5	SENT_440	[p22l1031t2040r1134b2082],
10	:	:	O	:	_	0	SENT_440	[p22l1031t2040r1134b2082],
11	G156-64	NN	O	g156-64	dep	9	SENT_440	[p22l1160t2039r1376b2082],

1	Hsiang	NN	PERSON	hsiang	nn	2	SENT_441	[p22l114t2117r287b2172],
2	B	NN	PERSON	b	_	0	SENT_441	[p22l307t2118r359b2167],
3	,	,	O	,	_	0	SENT_441	[p22l307t2118r359b2167],
4	Zhu	NNP	PERSON	Zhu	nn	5	SENT_441	[p22l381t2117r479b2159],
5	Y	NN	PERSON	y	appos	2	SENT_441	[p22l499t2118r555b2167],
6	,	,	O	,	_	0	SENT_441	[p22l499t2118r555b2167],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_441	[p22l575t2118r721b2172],
8	Z	NNP	O	Z	appos	2	SENT_441	[p22l741t2118r791b2167],
9	,	,	O	,	_	0	SENT_441	[p22l741t2118r791b2167],
10	et	FW	O	et	nn	11	SENT_441	[p22l813t2123r856b2159],
11	al.	FW	O	al.	appos	2	SENT_441	[p22l876t2117r930b2159],
12	.	.	O	.	_	0	SENT_441	[p22l876t2117r930b2159],

1	A	DT	O	a	det	6	SENT_442	[p22l952t2117r995b2159],
2	novel	JJ	O	novel	amod	6	SENT_442	[p22l1015t2117r1150b2159],
3	human	JJ	O	human	amod	6	SENT_442	[p22l1169t2117r1336b2159],
4	hepatic	JJ	O	hepatic	amod	6	SENT_442	[p22l1355t2117r1531b2172],
5	organic	JJ	O	organic	amod	6	SENT_442	[p22l1552t2117r1734b2172],
6	anion	NN	O	anion	_	0	SENT_442	[p22l1756t2117r1890b2159],
7	transporting	VBG	O	transport	partmod	6	SENT_442	[p22l1910t2123r2146b2172, p22l198t2195r274b2250],
8	polypeptide	NN	O	polypeptide	dobj	7	SENT_442	[p22l306t2195r596b2250],
9	(	CD	NUMBER	(	num	10	SENT_442	[p22l631t2195r874b2247],
10	OATP2	NN	O	oatp2	dep	6	SENT_442	[p22l631t2195r874b2247],
11	)	CD	NUMBER	)	dep	10	SENT_442	[p22l631t2195r874b2247],
12	:	:	O	:	_	0	SENT_442	[p22l631t2195r874b2247],
13	identification	NN	O	identification	dep	6	SENT_442	[p22l910t2195r1238b2237],
14	of	IN	O	of	_	0	SENT_442	[p22l1271t2195r1324b2237],
15	a	DT	O	a	det	19	SENT_442	[p22l1353t2208r1378b2237],
16	liver-specific	JJ	O	liver-specific	amod	19	SENT_442	[p22l1410t2195r1733b2250],
17	human	JJ	O	human	amod	19	SENT_442	[p22l1765t2195r1933b2237],
18	organic	JJ	O	organic	amod	19	SENT_442	[p22l1965t2195r2147b2250],
19	anion	NN	O	anion	prep_of	13	SENT_442	[p22l199t2273r333b2316],
20	transporting	VBG	O	transport	partmod	19	SENT_442	[p22l361t2273r658b2329],
21	polypeptide	NN	O	polypeptide	dobj	20	SENT_442	[p22l685t2273r976b2329],
22	and	CC	O	and	_	0	SENT_442	[p22l1005t2274r1092b2316],
23	identification	NN	O	identification	conj_and	21	SENT_442	[p22l1119t2273r1447b2316],
24	of	IN	O	of	_	0	SENT_442	[p22l1476t2273r1529b2316],
25	rat	NN	O	rat	nn	31	SENT_442	[p22l1552t2280r1617b2316],
26	and	CC	O	and	_	0	SENT_442	[p22l1646t2273r1732b2316],
27	human	JJ	O	human	conj_and	25	SENT_442	[p22l1759t2274r1927b2316],
28	hydroxymethylglutaryl-CoA	NN	O	hydroxymethylglutaryl-coa	nn	31	SENT_442	[p22l1954t2273r2146b2329, p22l198t2351r728b2407],
29	reductase	NN	O	reductase	nn	31	SENT_442	[p22l746t2351r978b2394],
30	inhibitor	NN	O	inhibitor	nn	31	SENT_442	[p22l997t2351r1210b2394],
31	transporters	NNS	O	transporter	prep_of	21	SENT_442	[p22l1228t2358r1530b2407],
32	.	.	O	.	_	0	SENT_442	[p22l1228t2358r1530b2407],

1	J	NNP	O	J	nn	3	SENT_443	[p22l1552t2352r1574b2394],
2	Biol	NNP	O	Biol	nn	3	SENT_443	[p22l1593t2351r1698b2394],
3	Chem	NNP	O	Chem	_	0	SENT_443	[p22l1718t2351r1864b2394],
4	1999	CD	DATE	1999	num	3	SENT_443	[p22l1888t2352r2019b2402],
5	;	:	O	;	_	0	SENT_443	[p22l1888t2352r2019b2402],
6	274	CD	NUMBER	274	num	8	SENT_443	[p22l2041t2352r2144b2394],
7	:	:	O	:	_	0	SENT_443	[p22l2041t2352r2144b2394],
8	37161-8	CD	NUMBER	37161-8	dep	3	SENT_443	[p22l199t2428r400b2471],

1	Tirona	NNP	O	Tirona	nn	2	SENT_444	[p22l114t2506r278b2548],
2	RG	NNP	O	RG	_	0	SENT_444	[p22l295t2506r392b2556],
3	,	,	O	,	_	0	SENT_444	[p22l295t2506r392b2556],
4	Leake	NNP	PERSON	Leake	nn	5	SENT_444	[p22l411t2506r561b2548],
5	BF	NNP	O	BF	appos	2	SENT_444	[p22l578t2507r666b2556],
6	,	,	O	,	_	0	SENT_444	[p22l578t2507r666b2556],
7	Merino	NNP	O	Merino	nn	8	SENT_444	[p22l685t2506r865b2548],
8	G	NNP	O	G	appos	2	SENT_444	[p22l885t2506r940b2556],
9	,	,	O	,	_	0	SENT_444	[p22l885t2506r940b2556],
10	et	FW	O	et	nn	11	SENT_444	[p22l960t2512r1003b2548],
11	al.	FW	O	al.	appos	2	SENT_444	[p22l1021t2506r1075b2548],
12	.	.	O	.	_	0	SENT_444	[p22l1021t2506r1075b2548],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_445	[p22l1096t2506r1481b2561],
2	in	IN	O	in	_	0	SENT_445	[p22l1500t2506r1546b2548],
3	OATP-C	NN	O	oatp-c	prep_in	1	SENT_445	[p22l1565t2506r1798b2549],
4	:	:	O	:	_	0	SENT_445	[p22l1565t2506r1798b2549],
5	identification	NN	O	identification	dep	1	SENT_445	[p22l1821t2506r2148b2548],
6	of	IN	O	of	_	0	SENT_445	[p22l198t2584r252b2627],
7	multiple	JJ	O	multiple	amod	9	SENT_445	[p22l276t2584r480b2640],
8	allelic	JJ	O	allelic	amod	9	SENT_445	[p22l510t2584r657b2627],
9	Variants	NNS	O	variant	prep_of	5	SENT_445	[p22l687t2584r880b2627],
10	associated	VBN	O	associate	partmod	9	SENT_445	[p22l911t2584r1162b2627],
11	with	IN	O	with	_	0	SENT_445	[p22l1191t2584r1299b2627],
12	altered	JJ	O	altered	amod	14	SENT_445	[p22l1329t2584r1494b2627],
13	transport	NN	O	transport	nn	14	SENT_445	[p22l1522t2591r1741b2640],
14	activity	NN	O	activity	prep_with	10	SENT_445	[p22l1770t2584r1952b2640],
15	among	IN	O	among	_	0	SENT_445	[p22l1983t2598r2147b2640],
16	European	JJ	MISC	european	prep_among	14	SENT_445	[p22l197t2663r452b2718],
17	-	:	O	-	_	0	SENT_445	[p22l197t2663r452b2718],
18	and	CC	O	and	_	0	SENT_445	[p22l475t2662r562b2705],
19	African-Americans	NNPS	MISC	African-Americans	dep	1	SENT_445	[p22l581t2662r1069b2705],
20	.	.	O	.	_	0	SENT_445	[p22l581t2662r1069b2705],

1	J	NNP	O	J	nn	3	SENT_446	[p22l1092t2663r1114b2705],
2	Biol	NNP	O	Biol	nn	3	SENT_446	[p22l1135t2662r1239b2705],
3	Chem	NNP	O	Chem	_	0	SENT_446	[p22l1260t2662r1407b2705],
4	2001	CD	DATE	2001	num	3	SENT_446	[p22l1427t2663r1562b2713],
5	;	:	O	;	_	0	SENT_446	[p22l1427t2663r1562b2713],
6	276	CD	NUMBER	276	num	8	SENT_446	[p22l1586t2662r1689b2705],
7	:	:	O	:	_	0	SENT_446	[p22l1586t2662r1689b2705],
8	35669-75	CD	NUMBER	35669-75	dep	3	SENT_446	[p22l1715t2662r1946b2706],

1	Niemi	NNP	PERSON	Niemi	nn	2	SENT_447	[p22l114t2740r266b2783],
2	M	NNP	O	M	_	0	SENT_447	[p22l297t2741r363b2790],
3	,	,	O	,	_	0	SENT_447	[p22l297t2741r363b2790],
4	Kivisto	NNP	ORGANIZATION	Kivisto	nn	5	SENT_447	[p22l397t2740r576b2783],
5	KT	NNP	ORGANIZATION	KT	appos	2	SENT_447	[p22l608t2741r700b2791],
6	,	,	O	,	_	0	SENT_447	[p22l608t2741r700b2791],
7	Hofmann	NNP	PERSON	Hofmann	nn	8	SENT_447	[p22l733t2740r965b2783],
8	U	NNP	O	U	appos	2	SENT_447	[p22l994t2741r1051b2790],
9	,	,	O	,	_	0	SENT_447	[p22l994t2741r1051b2790],
10	et	FW	O	et	nn	11	SENT_447	[p22l1084t2747r1127b2783],
11	al.	FW	O	al.	appos	2	SENT_447	[p22l1158t2740r1212b2783],
12	.	.	O	.	_	0	SENT_447	[p22l1158t2740r1212b2783],

1	Fexofenadine	NN	O	fexofenadine	nn	2	SENT_448	[p22l1245t2740r1579b2783],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	4	SENT_448	[p22l1609t2740r2043b2795],
3	are	VBP	O	be	auxpass	4	SENT_448	[p22l2076t2753r2147b2783],
4	associated	VBN	O	associate	_	0	SENT_448	[p22l199t2818r450b2860],
5	with	IN	O	with	_	0	SENT_448	[p22l468t2818r576b2860],
6	a	DT	O	a	det	7	SENT_448	[p22l596t2831r621b2860],
7	polymorphism	NN	O	polymorphism	prep_with	4	SENT_448	[p22l637t2818r998b2873],
8	of	IN	O	of	_	0	SENT_448	[p22l1016t2818r1069b2860],
9	the	DT	O	the	det	12	SENT_448	[p22l1083t2818r1157b2860],
10	SLCO1B1	NN	O	slco1b1	nn	12	SENT_448	[p22l1177t2818r1429b2861],
11	gene	NN	O	gene	nn	12	SENT_448	[p22l1453t2831r1568b2873],
12	(	NN	O	(	prep_of	7	SENT_448	[p22l1588t2818r1831b2873],
13	encoding	VBG	O	encode	xcomp	4	SENT_448	[p22l1588t2818r1831b2873],
14	OATP1B1	NN	O	oatp1b1	nn	15	SENT_448	[p22l1850t2818r2145b2870],
15	)	NN	O	)	dobj	13	SENT_448	[p22l1850t2818r2145b2870],
16	.	.	O	.	_	0	SENT_448	[p22l1850t2818r2145b2870],

1	Br	NN	O	br	nn	3	SENT_449	[p22l198t2896r259b2937],
2	J	NN	O	j	nn	3	SENT_449	[p22l278t2896r301b2938],
3	Clin	NN	O	clin	_	0	SENT_449	[p22l321t2895r425b2938],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_449	[p22l445t2895r708b2937],
5	2005	CD	DATE	2005	num	4	SENT_449	[p22l729t2894r865b2945],
6	;	:	O	;	_	0	SENT_449	[p22l729t2894r865b2945],
7	59	CD	NUMBER	59	dep	3	SENT_449	[p22l889t2895r961b2938],
8	:	:	O	:	_	0	SENT_449	[p22l889t2895r961b2938],
9	602-4	CD	NUMBER	602-4	dep	7	SENT_449	[p22l986t2895r1127b2938],

1	Niemi	NNP	PERSON	Niemi	nn	2	SENT_450	[p22l114t2973r266b3016],
2	M	NNP	O	M	_	0	SENT_450	[p22l284t2974r350b3024],
3	,	,	O	,	_	0	SENT_450	[p22l284t2974r350b3024],
4	Schaeffeler	NNP	O	Schaeffeler	nn	5	SENT_450	[p22l372t2973r651b3016],
5	E	NNP	O	E	appos	2	SENT_450	[p22l666t2974r716b3024],
6	,	,	O	,	_	0	SENT_450	[p22l666t2974r716b3024],
7	Lang	NNP	PERSON	Lang	nn	8	SENT_450	[p22l735t2974r860b3029],
8	T	NN	O	t	appos	2	SENT_450	[p22l878t2974r927b3024],
9	,	,	O	,	_	0	SENT_450	[p22l878t2974r927b3024],
10	et	FW	O	et	nn	11	SENT_450	[p22l947t2980r991b3016],
11	al.	FW	O	al.	appos	2	SENT_450	[p22l1008t2973r1062b3016],
12	.	.	O	.	_	0	SENT_450	[p22l1008t2973r1062b3016],

1	High	JJ	O	high	amod	4	SENT_451	[p22l1082t2973r1204b3029],
2	plasma	NN	O	plasma	nn	4	SENT_451	[p22l1221t2973r1396b3029],
3	pravastatin	NN	O	pravastatin	nn	4	SENT_451	[p22l1411t2973r1682b3029],
4	concentrations	NNS	O	concentration	nsubjpass	6	SENT_451	[p22l1699t2973r2056b3016],
5	are	VBP	O	be	auxpass	6	SENT_451	[p22l2076t2987r2148b3016],
6	associated	VBN	O	associate	_	0	SENT_451	[p22l199t3051r450b3094],
7	with	IN	O	with	_	0	SENT_451	[p22l478t3051r586b3094],
8	single	JJ	O	single	amod	10	SENT_451	[p22l615t3051r758b3107],
9	nucleotide	NN	O	nucleotide	nn	10	SENT_451	[p22l786t3051r1041b3094],
10	polymorphisms	NNS	O	polymorphism	prep_with	6	SENT_451	[p22l1068t3051r1450b3107],
11	and	CC	O	and	_	0	SENT_451	[p22l1481t3051r1567b3094],
12	haplotypes	NNS	O	haplotype	conj_and	10	SENT_451	[p22l1593t3051r1859b3107],
13	of	IN	O	of	_	0	SENT_451	[p22l1888t3051r1942b3094],
14	organic	JJ	O	organic	amod	15	SENT_451	[p22l1965t3051r2147b3107],
15	anion	NN	O	anion	prep_of	10	SENT_451	[p22l199t3129r333b3172],
16	transporting	VBG	O	transport	xcomp	6	SENT_451	[p22l367t3129r663b3184],
17	polypeptide-C	NN	O	polypeptide-c	nn	19	SENT_451	[p22l696t3129r1047b3184],
18	(	CD	NUMBER	(	num	19	SENT_451	[p22l1083t3129r1337b3182],
19	OATP	NN	O	oatp	dobj	16	SENT_451	[p22l1083t3129r1337b3182],
20	.	.	O	.	_	0	SENT_451	[p22l1083t3129r1337b3182],

1	—	NN	O	—	_	0	SENT_452	[p22l1083t3129r1337b3182],
2	.	.	O	.	_	0	SENT_452	[p22l1083t3129r1337b3182],

1	C	NN	O	c	_	0	SENT_453	[p22l1083t3129r1337b3182],
2	,	,	O	,	_	0	SENT_453	[p22l1083t3129r1337b3182],
3	SLCO1B1	NN	O	slco1b1	nn	4	SENT_453	[p22l1374t3129r1664b3182],
4	)	NN	O	)	appos	1	SENT_453	[p22l1374t3129r1664b3182],
5	.	.	O	.	_	0	SENT_453	[p22l1374t3129r1664b3182],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_454	[p22l1700t3129r2147b3184],
2	2004	CD	DATE	2004	num	1	SENT_454	[p22l199t3206r334b3256],
3	;	:	O	;	_	0	SENT_454	[p22l199t3206r334b3256],
4	14	CD	NUMBER	14	num	6	SENT_454	[p22l363t3206r430b3248],
5	:	:	O	:	_	0	SENT_454	[p22l363t3206r430b3248],
6	429-40	CD	NUMBER	429-40	dep	1	SENT_454	[p22l454t3206r627b3249],

1	Miners	NNP	O	Miners	nn	2	SENT_455	[p22l114t3284r286b3327],
2	JO	NNP	O	JO	_	0	SENT_455	[p22l316t3285r397b3335],
3	,	,	O	,	_	0	SENT_455	[p22l316t3285r397b3335],
4	Rees	NNP	ORGANIZATION	Rees	nn	5	SENT_455	[p22l428t3286r545b3327],
5	DL	NNP	ORGANIZATION	DL	appos	2	SENT_455	[p22l575t3286r669b3335],
6	,	,	O	,	_	0	SENT_455	[p22l575t3286r669b3335],
7	Valente	NNP	PERSON	Valente	nn	8	SENT_455	[p22l700t3285r890b3327],
8	L	NNP	O	L	appos	2	SENT_455	[p22l919t3286r969b3335],
9	,	,	O	,	_	0	SENT_455	[p22l919t3286r969b3335],
10	et	FW	O	et	nn	11	SENT_455	[p22l1000t3291r1043b3327],
11	al.	FW	O	al.	appos	2	SENT_455	[p22l1073t3284r1127b3327],
12	.	.	O	.	_	0	SENT_455	[p22l1073t3284r1127b3327],

1	Human	JJ	O	human	amod	3	SENT_456	[p22l1159t3286r1339b3327],
2	hepatic	JJ	O	hepatic	amod	3	SENT_456	[p22l1367t3284r1544b3340],
3	cytochrome	NN	O	cytochrome	nsubj	6	SENT_456	[p22l1574t3284r1863b3340],
4	P450	NN	O	p450	nn	5	SENT_456	[p22l1892t3284r2018b3327],
5	2C9	NN	O	2c9	dep	3	SENT_456	[p22l2047t3285r2146b3328],
6	catalyzes	VBZ	O	catalyze	_	0	SENT_456	[p22l198t3362r421b3418],
7	the	DT	O	the	det	9	SENT_456	[p22l440t3362r514b3405],
8	rate-lirniting	JJ	O	rate-lirniting	amod	9	SENT_456	[p22l531t3362r838b3418],
9	pathway	NN	O	pathway	dobj	6	SENT_456	[p22l856t3362r1064b3418],
10	of	IN	O	of	_	0	SENT_456	[p22l1083t3362r1136b3405],
11	torsemide	NN	O	torsemide	nn	12	SENT_456	[p22l1150t3362r1392b3405],
12	metabolism	NN	O	metabolism	prep_of	9	SENT_456	[p22l1410t3362r1709b3405],
13	.	.	O	.	_	0	SENT_456	[p22l1410t3362r1709b3405],

1	J	NNP	O	J	nn	4	SENT_457	[p22l1729t3363r1752b3405],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_457	[p22l1770t3362r2032b3405],
3	Exp	NNP	O	Exp	nn	4	SENT_457	[p22l2050t3363r2147b3418],
4	Ther	NNP	O	Ther	_	0	SENT_457	[p22l198t3439r314b3482],
5	1995	CD	DATE	1995	num	4	SENT_457	[p22l339t3439r469b3490],
6	;	:	O	;	_	0	SENT_457	[p22l339t3439r469b3490],
7	272	CD	NUMBER	272	num	9	SENT_457	[p22l493t3439r596b3482],
8	:	:	O	:	_	0	SENT_457	[p22l493t3439r596b3482],
9	1076-81	CD	NUMBER	1076-81	dep	4	SENT_457	[p22l626t3439r819b3482],

1	Miners	NNS	O	miner	_	0	SENT_458	[p22l114t3517r286b3560],
2	J	NNP	O	J	nn	3	SENT_458	[p22l301t3518r324b3560],
3	O	NNP	O	O	dep	1	SENT_458	[p22l326t3517r382b3567],
4	,	,	O	,	_	0	SENT_458	[p22l326t3517r382b3567],
5	Coulter	NNP	PERSON	Coulter	nn	6	SENT_458	[p22l398t3517r583b3560],
6	S	NNP	O	S	appos	3	SENT_458	[p22l597t3517r642b3567],
7	,	,	O	,	_	0	SENT_458	[p22l597t3517r642b3567],
8	Birkett	NNP	PERSON	Birkett	nn	9	SENT_458	[p22l657t3517r828b3560],
9	DJ	NNP	O	DJ	appos	3	SENT_458	[p22l841t3518r922b3567],
10	,	,	O	,	_	0	SENT_458	[p22l841t3518r922b3567],
11	et	FW	O	et	nn	12	SENT_458	[p22l938t3524r982b3560],
12	al.	FW	O	al.	appos	3	SENT_458	[p22l996t3517r1050b3560],
13	.	.	O	.	_	0	SENT_458	[p22l996t3517r1050b3560],

1	Torsemide	NNP	O	Torsemide	nn	2	SENT_459	[p22l1067t3517r1330b3560],
2	metabolism	NN	O	metabolism	_	0	SENT_459	[p22l1344t3517r1631b3560],
3	by	IN	O	by	_	0	SENT_459	[p22l1644t3517r1704b3572],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_459	[p22l1719t3517r1939b3560],
5	Variants	NNS	O	variant	prep_by	2	SENT_459	[p22l1954t3517r2147b3560],
6	and	CC	O	and	_	0	SENT_459	[p22l199t3595r286b3637],
7	other	JJ	O	other	amod	11	SENT_459	[p22l300t3595r426b3637],
8	human	JJ	O	human	amod	11	SENT_459	[p22l439t3595r606b3637],
9	CYP2C	NN	O	cyp2c	nn	11	SENT_459	[p22l621t3595r809b3638],
10	subfamily	NN	O	subfamily	nn	11	SENT_459	[p22l827t3595r1070b3650],
11	enzymes	NNS	O	enzyme	prep_by	2	SENT_459	[p22l1085t3608r1312b3650],
12	.	.	O	.	_	0	SENT_459	[p22l1085t3608r1312b3650],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_460	[p22l1329t3595r1776b3650],
2	2000	CD	DATE	2000	num	1	SENT_460	[p22l1792t3595r1928b3645],
3	;	:	O	;	_	0	SENT_460	[p22l1792t3595r1928b3645],
4	10	CD	NUMBER	10	num	6	SENT_460	[p22l1951t3595r2018b3638],
5	:	:	O	:	_	0	SENT_460	[p22l1951t3595r2018b3638],
6	26770	CD	NUMBER	26770	dep	1	SENT_460	[p22l2037t3595r2146b3638, p22l198t3675r257b3718],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_461	[p22l114t3719r205b3761],
2	CR	NN	O	cr	_	0	SENT_461	[p22l236t3718r329b3768],
3	,	,	O	,	_	0	SENT_461	[p22l236t3718r329b3768],
4	Goldstein	NNP	PERSON	Goldstein	nn	5	SENT_461	[p22l363t3718r600b3761],
5	JA	NNP	O	JA	appos	2	SENT_461	[p22l630t3718r711b3769],
6	,	,	O	,	_	0	SENT_461	[p22l630t3718r711b3769],
7	Pieper	NNP	PERSON	Pieper	nn	8	SENT_461	[p22l743t3718r901b3774],
8	JA	NNP	O	JA	appos	5	SENT_461	[p22l929t3719r1009b3761],
9	.	.	O	.	_	0	SENT_461	[p22l929t3719r1009b3761],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_462	[p22l1043t3718r1346b3774],
2	P	NN	O	p	_	0	SENT_462	[p22l1376t3719r1409b3760],
3	450	CD	NUMBER	450	num	5	SENT_462	[p22l1439t3718r1530b3761],
4	2C9	NN	O	2c9	nn	5	SENT_462	[p22l1561t3718r1661b3761],
5	polymorphisms	NNS	O	polymorphism	dep	2	SENT_462	[p22l1691t3718r2088b3774],
6	:	:	O	:	_	0	SENT_462	[p22l1691t3718r2088b3774],
7	a	DT	O	a	det	9	SENT_462	[p22l2123t3732r2149b3761],
8	comprehensive	JJ	O	comprehensive	amod	9	SENT_462	[p23l198t18r570b73],
9	review	NN	O	review	dep	2	SENT_462	[p23l586t18r752b61],
10	of	IN	O	of	_	0	SENT_462	[p23l770t18r823b61],
11	the	DT	O	the	det	12	SENT_462	[p23l835t18r909b61],
12	in-vitro	FW	O	in-vitro	prep_of	9	SENT_462	[p23l927t20r1108b61],
13	and	CC	O	and	_	0	SENT_462	[p23l1127t18r1213b61],
14	human	JJ	O	human	amod	15	SENT_462	[p23l1229t18r1396b61],
15	data	NNS	O	datum	conj_and	12	SENT_462	[p23l1413t18r1525b61],
16	.	.	O	.	_	0	SENT_462	[p23l1413t18r1525b61],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_463	[p23l1545t18r1991b73],
2	2002	CD	DATE	2002	num	1	SENT_463	[p23l2010t18r2145b68],
3	;	:	O	;	_	0	SENT_463	[p23l2010t18r2145b68],
4	12	CD	NUMBER	12	num	6	SENT_463	[p23l204t95r271b137],
5	:	:	O	:	_	0	SENT_463	[p23l204t95r271b137],
6	251-63	CD	NUMBER	251-63	dep	1	SENT_463	[p23l296t94r466b137],

1	18	CD	NUMBER	18	_	0	SENT_464	[p23l12t174r78b216],
2	.	.	O	.	_	0	SENT_464	[p23l12t174r78b216],

1	Vormfelde	NNP	O	Vormfelde	nn	2	SENT_465	[p23l114t173r380b216],
2	SV	NNP	O	SV	_	0	SENT_465	[p23l411t174r500b224],
3	,	,	O	,	_	0	SENT_465	[p23l411t174r500b224],
4	Engelhardt	NNP	PERSON	Engelhardt	nn	5	SENT_465	[p23l532t173r803b229],
5	S	NNP	PERSON	S	conj_and	2	SENT_465	[p23l833t174r877b224],
6	,	,	O	,	_	0	SENT_465	[p23l833t174r877b224],
7	Zirk	NNP	O	Zirk	nn	10	SENT_465	[p23l909t173r1015b216],
8	A.	NNP	O	A.	nn	10	SENT_465	[p23l1043t174r1098b216],
9	CYP2C9	NNP	O	CYP2C9	nn	10	SENT_465	[p23l1132t174r1352b217],
10	polymorphisms	NNS	O	polymorphism	conj_and	2	SENT_465	[p23l1382t173r1764b229],
11	and	CC	O	and	_	0	SENT_465	[p23l1796t173r1883b216],
12	the	DT	O	the	det	14	SENT_465	[p23l1912t174r1986b216],
13	interindividual	JJ	O	interindividual	amod	14	SENT_465	[p23l2016t173r2146b216, p23l198t251r446b294],
14	variability	NN	O	variability	conj_and	2	SENT_465	[p23l468t251r720b307],
15	in	IN	O	in	_	0	SENT_465	[p23l741t251r788b293],
16	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	14	SENT_465	[p23l809t251r1242b307],
17	and	CC	O	and	_	0	SENT_465	[p23l1266t251r1353b294],
18	pharmacodynarnics	NNS	O	pharmacodynarnic	prep_in	14	SENT_465	[p23l1373t251r1851b307],
19	of	IN	O	of	_	0	SENT_465	[p23l1874t251r1928b294],
20	the	DT	O	the	det	24	SENT_465	[p23l1945t251r2018b294],
21	loop	NN	O	loop	nn	24	SENT_465	[p23l2040t251r2147b307],
22	diuretic	JJ	O	diuretic	amod	24	SENT_465	[p23l198t329r384b372],
23	drug	NN	O	drug	nn	24	SENT_465	[p23l405t329r516b385],
24	torsemide	NN	O	torsemide	prep_of	16	SENT_465	[p23l537t329r791b372],
25	.	.	O	.	_	0	SENT_465	[p23l537t329r791b372],

1	Clin	NNP	O	Clin	nn	3	SENT_466	[p23l815t329r919b372],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_466	[p23l939t329r1202b372],
3	Ther	NNP	O	Ther	_	0	SENT_466	[p23l1222t329r1338b372],
4	2004	CD	DATE	2004	num	3	SENT_466	[p23l1358t329r1494b379],
5	;	:	O	;	_	0	SENT_466	[p23l1358t329r1494b379],
6	76	CD	NUMBER	76	num	8	SENT_466	[p23l1517t329r1590b372],
7	:	:	O	:	_	0	SENT_466	[p23l1517t329r1590b372],
8	557-66	CD	NUMBER	557-66	dep	3	SENT_466	[p23l1615t329r1786b372],

1	19	CD	NUMBER	19	_	0	SENT_467	[p23l12t406r78b449],
2	.	.	O	.	_	0	SENT_467	[p23l12t406r78b449],

1	Vormfelde	NNP	O	Vormfelde	nn	2	SENT_468	[p23l114t406r380b448],
2	SV	NNP	O	SV	_	0	SENT_468	[p23l396t406r485b456],
3	,	,	O	,	_	0	SENT_468	[p23l396t406r485b456],
4	Schirmer	NNP	PERSON	Schirmer	nn	5	SENT_468	[p23l503t406r728b449],
5	M	NNP	O	M	appos	2	SENT_468	[p23l740t407r807b456],
6	,	,	O	,	_	0	SENT_468	[p23l740t407r807b456],
7	Toliat	NNP	O	Toliat	appos	2	SENT_468	[p23l824t406r983b456],
8	,	,	O	,	_	0	SENT_468	[p23l824t406r983b456],
9	et	FW	O	et	nn	10	SENT_468	[p23l1000t412r1044b448],
10	al.	FW	O	al.	appos	2	SENT_468	[p23l1058t406r1112b448],
11	.	.	O	.	_	0	SENT_468	[p23l1058t406r1112b448],

1	Genetic	JJ	O	genetic	amod	2	SENT_469	[p23l1131t406r1319b449],
2	variation	NN	O	variation	_	0	SENT_469	[p23l1335t406r1553b448],
3	at	IN	O	at	_	0	SENT_469	[p23l1568t412r1611b448],
4	the	DT	O	the	det	6	SENT_469	[p23l1624t406r1698b448],
5	CYP2C	NN	O	cyp2c	nn	6	SENT_469	[p23l1713t406r1902b449],
6	locus	NN	O	locus	prep_at	2	SENT_469	[p23l1918t406r2045b448],
7	and	CC	O	and	_	0	SENT_469	[p23l2062t406r2149b448],
8	its	PRP$	O	its	poss	9	SENT_469	[p23l198t484r253b526],
9	association	NN	O	association	prep_at	2	SENT_469	[p23l271t484r543b526],
10	with	IN	O	with	_	0	SENT_469	[p23l559t484r666b527],
11	torsemide	NN	O	torsemide	nn	12	SENT_469	[p23l682t484r924b526],
12	biotransformation	NN	O	biotransformation	prep_with	2	SENT_469	[p23l939t484r1393b526],
13	.	.	O	.	_	0	SENT_469	[p23l939t484r1393b526],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	_	0	SENT_470	[p23l1411t484r1892b539],
2	J	NNP	O	J	dep	1	SENT_470	[p23l1909t485r1932b527],
3	2006	CD	DATE	2006	num	2	SENT_470	[p23l1948t484r2084b534],
4	;	:	O	;	_	0	SENT_470	[p23l1948t484r2084b534],
5	7	CD	NUMBER	7	dep	1	SENT_470	[p23l2102t485r2144b526],
6	:	:	O	:	_	0	SENT_470	[p23l2102t485r2144b526],
7	200-1	CD	NUMBER	200-1	num	8	SENT_470	[p23l198t563r335b606],
8	1	CD	NUMBER	1	dep	5	SENT_470	[p23l348t563r366b605],

1	20	CD	NUMBER	20	_	0	SENT_471	[p23l7t641r78b684],
2	.	.	O	.	_	0	SENT_471	[p23l7t641r78b684],

1	Yasar	NNP	PERSON	Yasar	nn	2	SENT_472	[p23l115t642r258b684],
2	U	NNP	PERSON	U	_	0	SENT_472	[p23l285t642r341b692],
3	,	,	O	,	_	0	SENT_472	[p23l285t642r341b692],
4	Tybring	NNP	O	Tybring	nn	5	SENT_472	[p23l373t641r569b697],
5	G	NNP	O	G	appos	2	SENT_472	[p23l600t641r655b692],
6	,	,	O	,	_	0	SENT_472	[p23l600t641r655b692],
7	Hidestrand	NNP	O	Hidestrand	nn	8	SENT_472	[p23l686t641r956b684],
8	M	NNP	O	M	appos	2	SENT_472	[p23l984t642r1051b691],
9	,	,	O	,	_	0	SENT_472	[p23l984t642r1051b691],
10	et	FW	O	et	nn	11	SENT_472	[p23l1082t648r1126b684],
11	al.	FW	O	al.	appos	2	SENT_472	[p23l1155t641r1209b684],
12	.	.	O	.	_	0	SENT_472	[p23l1155t641r1209b684],

1	Role	NN	O	role	_	0	SENT_473	[p23l1241t641r1356b684],
2	of	IN	O	of	_	0	SENT_473	[p23l1386t641r1439b684],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_473	[p23l1465t641r1684b685],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_473	[p23l1713t641r2074b697],
5	in	IN	O	in	_	0	SENT_473	[p23l2102t641r2148b683],
6	losartan	NN	O	losartan	nn	7	SENT_473	[p23l198t719r392b762],
7	oxidation	NN	O	oxidation	prep_in	1	SENT_473	[p23l412t719r656b762],
8	.	.	O	.	_	0	SENT_473	[p23l412t719r656b762],

1	Drug	NN	O	drug	nn	3	SENT_474	[p23l679t720r804b775],
2	Metab	NNP	O	Metab	nn	3	SENT_474	[p23l824t719r980b762],
3	Dispos	NNP	O	Dispos	_	0	SENT_474	[p23l1001t719r1170b775],
4	2001	CD	DATE	2001	num	3	SENT_474	[p23l1192t719r1328b769],
5	;	:	O	;	_	0	SENT_474	[p23l1192t719r1328b769],
6	29	CD	NUMBER	29	num	8	SENT_474	[p23l1351t719r1424b763],
7	:	:	O	:	_	0	SENT_474	[p23l1351t719r1424b763],
8	1051-6	CD	NUMBER	1051-6	dep	3	SENT_474	[p23l1454t719r1620b762],

1	21	CD	NUMBER	21	_	0	SENT_475	[p23l7t797r78b839],
2	.	.	O	.	_	0	SENT_475	[p23l7t797r78b839],

1	Taavitsainen	NN	PERSON	taavitsainen	nn	2	SENT_476	[p23l114t797r428b839],
2	P	NN	PERSON	p	_	0	SENT_476	[p23l457t798r503b847],
3	,	,	O	,	_	0	SENT_476	[p23l457t798r503b847],
4	Kiukaanniemi	NNP	ORGANIZATION	Kiukaanniemi	nn	5	SENT_476	[p23l535t797r882b839],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_476	[p23l912t798r968b847],
6	,	,	O	,	_	0	SENT_476	[p23l912t798r968b847],
7	Pelkonen	NNP	O	Pelkonen	nn	8	SENT_476	[p23l999t797r1227b839],
8	O.	NNP	O	O.	appos	2	SENT_476	[p23l1257t797r1311b840],
9	In	FW	O	in	nn	12	SENT_476	[p23l1342t798r1393b839],
10	vitro	FW	O	vitro	nn	12	SENT_476	[p23l1423t798r1536b840],
11	inhibition	NN	O	inhibition	nn	12	SENT_476	[p23l1567t797r1805b839],
12	screening	NN	O	screening	dep	8	SENT_476	[p23l1836t797r2069b852],
13	of	IN	O	of	_	0	SENT_476	[p23l2099t797r2152b839],
14	human	JJ	O	human	amod	17	SENT_476	[p23l197t876r364b918],
15	hepatic	JJ	O	hepatic	amod	17	SENT_476	[p23l380t875r556b931],
16	P450	NN	O	p450	nn	17	SENT_476	[p23l574t875r699b918],
17	enzymes	NNS	O	enzyme	prep_of	12	SENT_476	[p23l717t889r929b931],
18	by	IN	O	by	_	0	SENT_476	[p23l946t875r1007b931],
19	five	CD	NUMBER	five	num	22	SENT_476	[p23l1024t875r1118b918],
20	angiotensin-II	NN	O	angiotensin-ii	nn	22	SENT_476	[p23l1136t875r1480b931],
21	receptor	NN	O	receptor	nn	22	SENT_476	[p23l1495t882r1698b931],
22	antagonists	NNS	O	antagonist	prep_by	17	SENT_476	[p23l1715t875r2002b931],
23	.	.	O	.	_	0	SENT_476	[p23l1715t875r2002b931],

1	Eur	NNP	O	Eur	nn	4	SENT_477	[p23l2021t877r2111b918],
2	J	NNP	O	J	nn	4	SENT_477	[p23l2125t877r2148b918],
3	Clin	NNP	O	Clin	nn	4	SENT_477	[p23l198t952r303b995],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_477	[p23l322t952r585b995],
5	2000	CD	DATE	2000	num	4	SENT_477	[p23l606t953r742b1003],
6	;	:	O	;	_	0	SENT_477	[p23l606t953r742b1003],
7	56	CD	NUMBER	56	num	9	SENT_477	[p23l766t952r838b995],
8	:	:	O	:	_	0	SENT_477	[p23l766t952r838b995],
9	135-40	CD	NUMBER	135-40	dep	4	SENT_477	[p23l868t952r1035b995],

1	22	CD	NUMBER	22	_	0	SENT_478	[p23l7t1030r78b1073],
2	.	.	O	.	_	0	SENT_478	[p23l7t1030r78b1073],

1	Fischer	NNP	O	Fischer	nn	2	SENT_479	[p23l114t1030r296b1073],
2	TL	NNP	O	TL	_	0	SENT_479	[p23l318t1031r405b1080],
3	,	,	O	,	_	0	SENT_479	[p23l318t1031r405b1080],
4	Pieper	NNP	PERSON	Pieper	nn	5	SENT_479	[p23l431t1030r588b1085],
5	JA	NNP	O	JA	appos	2	SENT_479	[p23l610t1030r691b1080],
6	,	,	O	,	_	0	SENT_479	[p23l610t1030r691b1080],
7	Graff	NNP	PERSON	Graff	nn	8	SENT_479	[p23l718t1030r853b1073],
8	DW	NNP	O	DW	appos	2	SENT_479	[p23l872t1031r987b1080],
9	,	,	O	,	_	0	SENT_479	[p23l872t1031r987b1080],
10	et	FW	O	et	nn	11	SENT_479	[p23l1013t1036r1056b1073],
11	al.	FW	O	al.	appos	2	SENT_479	[p23l1080t1030r1134b1073],
12	.	.	O	.	_	0	SENT_479	[p23l1080t1030r1134b1073],

1	Evaluation	NN	O	evaluation	_	0	SENT_480	[p23l1160t1030r1427b1073],
2	of	IN	O	of	_	0	SENT_480	[p23l1451t1030r1505b1073],
3	potential	JJ	O	potential	amod	8	SENT_480	[p23l1523t1030r1738b1085],
4	losartan	NN	O	losartan	nn	8	SENT_480	[p23l1762t1030r2146b1085, p23l198t1108r292b1150],
5	—	NN	O	—	nn	8	SENT_480	[p23l1762t1030r2146b1085, p23l198t1108r292b1150],
6	phenytoin	NN	O	phenytoin	nn	8	SENT_480	[p23l1762t1030r2146b1085, p23l198t1108r292b1150],
7	drug	NN	O	drug	nn	8	SENT_480	[p23l319t1108r429b1163],
8	interactions	NNS	O	interaction	prep_of	1	SENT_480	[p23l456t1108r741b1150],
9	in	IN	O	in	_	0	SENT_480	[p23l769t1108r815b1150],
10	healthy	JJ	O	healthy	amod	11	SENT_480	[p23l841t1108r1021b1163],
11	volunteers	NNS	O	volunteer	prep_in	8	SENT_480	[p23l1048t1108r1315b1150],
12	.	.	O	.	_	0	SENT_480	[p23l1048t1108r1315b1150],

1	Clin	NNP	O	Clin	nn	3	SENT_481	[p23l1345t1108r1449b1151],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_481	[p23l1476t1108r1738b1150],
3	Ther	NNP	O	Ther	_	0	SENT_481	[p23l1764t1108r1880b1150],
4	2002	CD	DATE	2002	num	3	SENT_481	[p23l1907t1108r2042b1158],
5	;	:	O	;	_	0	SENT_481	[p23l1907t1108r2042b1158],
6	72	CD	NUMBER	72	num	8	SENT_481	[p23l2071t1108r2144b1150],
7	:	:	O	:	_	0	SENT_481	[p23l2071t1108r2144b1150],
8	238-46	CD	NUMBER	238-46	dep	3	SENT_481	[p23l198t1185r370b1228],

1	23	CD	NUMBER	23	_	0	SENT_482	[p23l7t1264r78b1306],
2	.	.	O	.	_	0	SENT_482	[p23l7t1264r78b1306],

1	Ishiguro	NNP	PERSON	Ishiguro	nn	2	SENT_483	[p23l114t1263r318b1319],
2	N	NNP	O	N	_	0	SENT_483	[p23l335t1264r391b1314],
3	,	,	O	,	_	0	SENT_483	[p23l335t1264r391b1314],
4	Maeda	NNP	PERSON	Maeda	nn	5	SENT_483	[p23l410t1263r578b1306],
5	K	NNP	PERSON	K	appos	2	SENT_483	[p23l595t1264r650b1314],
6	,	,	O	,	_	0	SENT_483	[p23l595t1264r650b1314],
7	Kishimoto	NNP	PERSON	Kishimoto	nn	8	SENT_483	[p23l670t1263r928b1306],
8	W	NNP	O	W	appos	2	SENT_483	[p23l945t1264r1015b1314],
9	,	,	O	,	_	0	SENT_483	[p23l945t1264r1015b1314],
10	et	FW	O	et	nn	11	SENT_483	[p23l1035t1270r1079b1306],
11	al.	FW	O	al.	appos	2	SENT_483	[p23l1096t1263r1150b1306],
12	.	.	O	.	_	0	SENT_483	[p23l1096t1263r1150b1306],

1	Predominant	JJ	O	predominant	amod	2	SENT_484	[p23l1170t1263r1485b1306],
2	contribution	NN	O	contribution	_	0	SENT_484	[p23l1502t1263r1802b1306],
3	of	IN	O	of	_	0	SENT_484	[p23l1819t1263r1872b1306],
4	OATP1B3	NN	O	oatp1b3	prep_of	2	SENT_484	[p23l1886t1264r2145b1306],
5	to	TO	O	to	_	0	SENT_484	[p23l198t1348r243b1384],
6	the	DT	O	the	det	8	SENT_484	[p23l268t1341r341b1384],
7	hepatic	JJ	O	hepatic	amod	8	SENT_484	[p23l364t1341r540b1397],
8	uptake	NN	O	uptake	prep_to	2	SENT_484	[p23l565t1341r728b1397],
9	of	IN	O	of	_	0	SENT_484	[p23l752t1341r806b1384],
10	telmisartan	NN	O	telmisartan	prep_of	8	SENT_484	[p23l825t1341r1111b1392],
11	,	,	O	,	_	0	SENT_484	[p23l825t1341r1111b1392],
12	an	DT	O	a	det	16	SENT_484	[p23l1138t1355r1193b1384],
13	angiotensin	NN	O	angiotensin	nn	16	SENT_484	[p23l1218t1341r1500b1397],
14	II	CD	NUMBER	ii	num	16	SENT_484	[p23l1523t1342r1563b1383],
15	receptor	NN	O	receptor	nn	16	SENT_484	[p23l1586t1347r1788b1397],
16	antagonist	NN	O	antagonist	appos	10	SENT_484	[p23l1812t1341r2076b1397],
17	,	,	O	,	_	0	SENT_484	[p23l1812t1341r2076b1397],
18	in	IN	O	in	_	0	SENT_484	[p23l2102t1341r2148b1383],
19	humans	NNS	O	human	prep_in	2	SENT_484	[p23l197t1419r400b1462],
20	.	.	O	.	_	0	SENT_484	[p23l197t1419r400b1462],

1	Drug	NN	O	drug	nn	3	SENT_485	[p23l424t1420r548b1474],
2	Metab	NNP	O	Metab	nn	3	SENT_485	[p23l569t1419r725b1462],
3	Dispos	NNP	O	Dispos	_	0	SENT_485	[p23l745t1419r914b1474],
4	2006	CD	DATE	2006	num	3	SENT_485	[p23l937t1419r1072b1469],
5	;	:	O	;	_	0	SENT_485	[p23l937t1419r1072b1469],
6	34	CD	NUMBER	34	num	8	SENT_485	[p23l1097t1419r1168b1462],
7	:	:	O	:	_	0	SENT_485	[p23l1097t1419r1168b1462],
8	1109-15	CD	NUMBER	1109-15	dep	3	SENT_485	[p23l1198t1419r1394b1462],

1	24	CD	NUMBER	24	_	0	SENT_486	[p23l7t1498r78b1540],
2	.	.	O	.	_	0	SENT_486	[p23l7t1498r78b1540],

1	Yamashiro	NNP	PERSON	Yamashiro	nn	2	SENT_487	[p23l114t1497r383b1540],
2	W	NNP	O	W	_	0	SENT_487	[p23l417t1499r488b1548],
3	,	,	O	,	_	0	SENT_487	[p23l417t1499r488b1548],
4	Maeda	NNP	PERSON	Maeda	nn	5	SENT_487	[p23l525t1497r693b1540],
5	K	NNP	PERSON	K	appos	2	SENT_487	[p23l727t1499r782b1548],
6	,	,	O	,	_	0	SENT_487	[p23l727t1499r782b1548],
7	Hirouchi	NNP	O	Hirouchi	nn	8	SENT_487	[p23l820t1497r1037b1540],
8	M	NNP	O	M	appos	2	SENT_487	[p23l1072t1499r1139b1548],
9	,	,	O	,	_	0	SENT_487	[p23l1072t1499r1139b1548],
10	et	FW	O	et	nn	11	SENT_487	[p23l1176t1504r1220b1540],
11	al.	FW	O	al.	appos	2	SENT_487	[p23l1255t1497r1309b1540],
12	.	.	O	.	_	0	SENT_487	[p23l1255t1497r1309b1540],

1	Involvement	NN	O	involvement	_	0	SENT_488	[p23l1347t1497r1658b1540],
2	of	IN	O	of	_	0	SENT_488	[p23l1693t1497r1746b1540],
3	transporters	NNS	O	transporter	prep_of	1	SENT_488	[p23l1777t1504r2065b1553],
4	in	IN	O	in	_	0	SENT_488	[p23l2102t1497r2148b1540],
5	the	DT	O	the	det	7	SENT_488	[p23l198t1575r271b1618],
6	hepatic	JJ	O	hepatic	amod	7	SENT_488	[p23l292t1575r468b1631],
7	uptake	NN	O	uptake	prep_in	3	SENT_488	[p23l490t1575r653b1631],
8	and	CC	O	and	_	0	SENT_488	[p23l676t1575r762b1618],
9	biliary	JJ	O	biliary	amod	10	SENT_488	[p23l783t1575r942b1631],
10	excretion	NN	O	excretion	conj_and	3	SENT_488	[p23l965t1575r1192b1618],
11	of	IN	O	of	_	0	SENT_488	[p23l1214t1575r1267b1618],
12	valsartan	NN	O	valsartan	prep_of	10	SENT_488	[p23l1285t1575r1519b1626],
13	,	,	O	,	_	0	SENT_488	[p23l1285t1575r1519b1626],
14	a	DT	O	a	det	16	SENT_488	[p23l1544t1589r1569b1618],
15	selective	JJ	O	selective	amod	16	SENT_488	[p23l1591t1575r1803b1618],
16	antagonist	NN	O	antagonist	appos	1	SENT_488	[p23l1826t1575r2078b1631],
17	of	IN	O	of	_	0	SENT_488	[p23l2099t1575r2152b1618],
18	the	DT	O	the	det	21	SENT_488	[p23l198t1653r271b1696],
19	angiotensin	NN	O	angiotensin	nn	21	SENT_488	[p23l301t1653r583b1709],
20	II	CD	NUMBER	ii	num	21	SENT_488	[p23l611t1654r651b1695],
21	AT1-receptor	NN	O	at1-receptor	prep_of	16	SENT_488	[p23l679t1654r1027b1709],
22	,	,	O	,	_	0	SENT_488	[p23l679t1654r1027b1709],
23	in	IN	O	in	_	0	SENT_488	[p23l1058t1653r1104b1695],
24	humans	NNS	O	human	prep_in	1	SENT_488	[p23l1132t1653r1335b1696],
25	.	.	O	.	_	0	SENT_488	[p23l1132t1653r1335b1696],

1	Drug	NN	O	drug	nn	3	SENT_489	[p23l1367t1654r1491b1709],
2	Metab	NNP	O	Metab	nn	3	SENT_489	[p23l1520t1653r1676b1696],
3	Dispos	NNP	O	Dispos	_	0	SENT_489	[p23l1705t1653r1873b1709],
4	2006	CD	DATE	2006	num	3	SENT_489	[p23l1904t1653r2040b1704],
5	;	:	O	;	_	0	SENT_489	[p23l1904t1653r2040b1704],
6	34	CD	NUMBER	34	num	8	SENT_489	[p23l2073t1654r2144b1696],
7	:	:	O	:	_	0	SENT_489	[p23l2073t1654r2144b1696],
8	1247-54	CD	NUMBER	1247-54	dep	3	SENT_489	[p23l203t1730r402b1773],

1	25	CD	NUMBER	25	_	0	SENT_490	[p23l7t1808r78b1851],
2	.	.	O	.	_	0	SENT_490	[p23l7t1808r78b1851],

1	Neuvonen	NNP	O	Neuvonen	nn	2	SENT_491	[p23l114t1809r366b1851],
2	PJ	NNP	O	PJ	_	0	SENT_491	[p23l407t1809r477b1858],
3	,	,	O	,	_	0	SENT_491	[p23l407t1809r477b1858],
4	Niemi	NNP	PERSON	Niemi	nn	5	SENT_491	[p23l520t1808r672b1851],
5	M	NNP	O	M	appos	2	SENT_491	[p23l714t1809r780b1858],
6	,	,	O	,	_	0	SENT_491	[p23l714t1809r780b1858],
7	Backman	NNP	PERSON	Backman	nn	8	SENT_491	[p23l823t1808r1055b1851],
8	JT	NNP	O	JT	appos	5	SENT_491	[p23l1095t1809r1168b1851],
9	.	.	O	.	_	0	SENT_491	[p23l1095t1809r1168b1851],

1	Drug	NN	O	drug	nn	2	SENT_492	[p23l1212t1809r1337b1863],
2	interactions	NNS	O	interaction	_	0	SENT_492	[p23l1378t1808r1663b1851],
3	with	IN	O	with	_	0	SENT_492	[p23l1706t1808r1814b1851],
4	lipid	NN	O	lipid	nn	5	SENT_492	[p23l1855t1808r2146b1863, p23l198t1886r274b1941],
5	—	NN	O	—	prep_with	2	SENT_492	[p23l1855t1808r2146b1863, p23l198t1886r274b1941],
6	lowering	VBG	O	lower	partmod	5	SENT_492	[p23l1855t1808r2146b1863, p23l198t1886r274b1941],
7	drugs	NNS	O	drug	dobj	6	SENT_492	[p23l295t1886r443b1941],
8	:	:	O	:	_	0	SENT_492	[p23l295t1886r443b1941],
9	mechanisms	NNS	O	mechanism	dep	2	SENT_492	[p23l468t1886r770b1928],
10	and	CC	O	and	_	0	SENT_492	[p23l793t1886r880b1928],
11	clinical	JJ	O	clinical	amod	12	SENT_492	[p23l899t1886r1079b1928],
12	relevance	NN	O	relevance	conj_and	9	SENT_492	[p23l1098t1886r1347b1929],
13	.	.	O	.	_	0	SENT_492	[p23l1098t1886r1347b1929],

1	Clin	NNP	O	Clin	nn	3	SENT_493	[p23l1370t1886r1474b1929],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_493	[p23l1494t1886r1757b1928],
3	Ther	NNP	O	Ther	_	0	SENT_493	[p23l1777t1886r1893b1928],
4	2006	CD	DATE	2006	num	3	SENT_493	[p23l1913t1885r2048b1936],
5	;	:	O	;	_	0	SENT_493	[p23l1913t1885r2048b1936],
6	80	CD	NUMBER	80	num	8	SENT_493	[p23l2073t1886r2144b1929],
7	:	:	O	:	_	0	SENT_493	[p23l2073t1886r2144b1929],
8	565-81	CD	NUMBER	565-81	dep	3	SENT_493	[p23l199t1962r366b2005],

1	26	CD	NUMBER	26	_	0	SENT_494	[p23l7t2041r78b2084],
2	.	.	O	.	_	0	SENT_494	[p23l7t2041r78b2084],

1	Kassler	NNP	PERSON	Kassler	_	0	SENT_495	[p23l115t2041r444b2084],
2	.	.	O	.	_	0	SENT_495	[p23l115t2041r444b2084],

1	—	NN	O	—	_	0	SENT_496	[p23l115t2041r444b2084],
2	.	.	O	.	_	0	SENT_496	[p23l115t2041r444b2084],

1	Taub	NNP	ORGANIZATION	Taub	nn	2	SENT_497	[p23l115t2041r444b2084],
2	K	NNP	ORGANIZATION	K	_	0	SENT_497	[p23l480t2042r535b2091],
3	,	,	O	,	_	0	SENT_497	[p23l480t2042r535b2091],
4	Littlejohn	NNP	PERSON	Littlejohn	nn	5	SENT_497	[p23l570t2041r813b2097],
5	T	NN	O	t	appos	2	SENT_497	[p23l846t2042r896b2092],
6	,	,	O	,	_	0	SENT_497	[p23l846t2042r896b2092],
7	Elliott	NNP	PERSON	Elliott	nn	8	SENT_497	[p23l931t2041r1085b2084],
8	W	NNP	O	W	appos	2	SENT_497	[p23l1117t2042r1188b2092],
9	,	,	O	,	_	0	SENT_497	[p23l1117t2042r1188b2092],
10	et	FW	O	et	nn	11	SENT_497	[p23l1224t2048r1267b2084],
11	al.	FW	O	al.	appos	2	SENT_497	[p23l1301t2041r1355b2084],
12	.	.	O	.	_	0	SENT_497	[p23l1301t2041r1355b2084],

1	Comparative	JJ	O	comparative	amod	2	SENT_498	[p23l1393t2041r1709b2097],
2	efficacy	NN	O	efficacy	_	0	SENT_498	[p23l1743t2041r1939b2097],
3	of	IN	O	of	_	0	SENT_498	[p23l1974t2041r2028b2084],
4	two	CD	NUMBER	two	num	5	SENT_498	[p23l2057t2047r2147b2084],
5	angiotensin	NN	O	angiotensin	prep_of	2	SENT_498	[p23l199t2119r481b2174],
6	II	CD	NUMBER	ii	num	8	SENT_498	[p23l498t2120r537b2161],
7	receptor	NN	O	receptor	nn	8	SENT_498	[p23l553t2126r756b2174],
8	antagonists	NNS	O	antagonist	dep	2	SENT_498	[p23l773t2119r1061b2174],
9	,	,	O	,	_	0	SENT_498	[p23l773t2119r1061b2174],
10	irbesartan	NN	O	irbesartan	appos	8	SENT_498	[p23l1080t2119r1322b2162],
11	and	CC	O	and	_	0	SENT_498	[p23l1340t2119r1427b2162],
12	losartan	NN	O	losartan	conj_and	10	SENT_498	[p23l1443t2119r1637b2162],
13	in	IN	O	in	_	0	SENT_498	[p23l1654t2119r1700b2161],
14	mild-to-moderate	JJ	O	mild-to-moderate	amod	15	SENT_498	[p23l1717t2119r2148b2162],
15	hypertension	NN	O	hypertension	prep_in	10	SENT_498	[p23l197t2197r527b2252],
16	.	.	O	.	_	0	SENT_498	[p23l197t2197r527b2252],

1	Irbesartan/Losartan	NNP	O	Irbesartan/Losartan	nn	2	SENT_499	[p23l553t2197r1032b2240],
2	Study	NNP	O	Study	_	0	SENT_499	[p23l1056t2197r1196b2252],
3	Investigators	NNS	O	investigator	dep	2	SENT_499	[p23l1220t2197r1549b2252],
4	.	.	O	.	_	0	SENT_499	[p23l1220t2197r1549b2252],

1	Am	VBP	O	be	dep	3	SENT_500	[p23l1575t2197r1667b2239],
2	J	NN	O	j	nn	3	SENT_500	[p23l1689t2198r1711b2240],
3	Hypertens	NNS	O	hyperten	_	0	SENT_500	[p23l1734t2198r1985b2252],
4	1998	CD	DATE	1998	dep	3	SENT_500	[p23l2015t2197r2145b2247],
5	;	:	O	;	_	0	SENT_500	[p23l2015t2197r2145b2247],
6	11	CD	NUMBER	11	num	8	SENT_500	[p23l204t2275r271b2317],
7	:	:	O	:	_	0	SENT_500	[p23l204t2275r271b2317],
8	445-53	CD	NUMBER	445-53	dep	4	SENT_500	[p23l295t2274r465b2317],

1	Clin	NNP	O	Clin	nn	2	SENT_501	[p23l1394t2460r1479b2497],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_501	[p23l1500t2460r1863b2498],
3	2008	CD	DATE	2008	num	2	SENT_501	[p23l1879t2460r1998b2500],
4	;	:	O	;	_	0	SENT_501	[p23l1879t2460r1998b2500],
5	47	CD	NUMBER	47	number	6	SENT_501	[p23l2016t2460r2068b2497],
6	(	CD	NUMBER	(	dep	2	SENT_501	[p23l2088t2460r2147b2503],
7	5	CD	NUMBER	5	num	8	SENT_501	[p23l2088t2460r2147b2503],
8	)	NN	O	)	dep	6	SENT_501	[p23l2088t2460r2147b2503],

1	332	CD	NUMBER	332	num	2	SENT_502	[p23l6t2577r54b2601],
2	Werner	NNP	O	Werner	_	0	SENT_502	[p23l6t2617r106b2641],
3	et	FW	O	et	dep	2	SENT_502	[p23l116t2619r140b2641],
4	111	CD	NUMBER	111	dep	3	SENT_502	[p23l150t2616r180b2641],
5	.	.	O	.	_	0	SENT_502	[p23l150t2616r180b2641],

1	27	CD	NUMBER	27	_	0	SENT_503	[p23l37t2819r108b2862],
2	.	.	O	.	_	0	SENT_503	[p23l37t2819r108b2862],

1	Schupp	NNP	PERSON	Schupp	nn	2	SENT_504	[p23l144t2819r323b2875],
2	M	NNP	O	M	_	0	SENT_504	[p23l343t2820r409b2870],
3	,	,	O	,	_	0	SENT_504	[p23l343t2820r409b2870],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_504	[p23l431t2820r520b2862],
5	LD	NNP	O	LD	appos	2	SENT_504	[p23l540t2820r633b2870],
6	,	,	O	,	_	0	SENT_504	[p23l540t2820r633b2870],
7	Frost	NNP	PERSON	Frost	nn	8	SENT_504	[p23l654t2820r779b2862],
8	N	NNP	O	N	appos	2	SENT_504	[p23l798t2820r853b2870],
9	,	,	O	,	_	0	SENT_504	[p23l798t2820r853b2870],
10	et	FW	O	et	nn	11	SENT_504	[p23l876t2826r918b2862],
11	al.	FW	O	al.	appos	2	SENT_504	[p23l938t2819r991b2862],
12	.	.	O	.	_	0	SENT_504	[p23l938t2819r991b2862],

1	Regulation	NN	O	regulation	_	0	SENT_505	[p23l1014t2819r1280b2875],
2	of	IN	O	of	_	0	SENT_505	[p23l1300t2819r1353b2862],
3	peroxisome	NN	O	peroxisome	prep_of	1	SENT_505	[p23l1367t2819r1650b2875],
4	proliferatoractivated	JJ	O	proliferatoractivated	amod	7	SENT_505	[p23l1670t2819r2147b2875, p23l226t2896r282b2939],
5	receptor	NN	O	receptor	nn	7	SENT_505	[p23l306t2902r505b2951],
6	gamma	NN	O	gamma	nn	7	SENT_505	[p23l530t2909r708b2951],
7	activity	NN	O	activity	dep	1	SENT_505	[p23l733t2896r913b2951],
8	by	IN	O	by	_	0	SENT_505	[p23l938t2896r997b2951],
9	losartan	NN	O	losartan	nn	10	SENT_505	[p23l1023t2896r1214b2939],
10	metabolites	NNS	O	metabolite	prep_by	7	SENT_505	[p23l1239t2896r1531b2939],
11	.	.	O	.	_	0	SENT_505	[p23l1239t2896r1531b2939],

1	Hypertension	NN	O	hypertension	_	0	SENT_506	[p23l1559t2896r1886b2951],
2	2006	CD	DATE	2006	num	1	SENT_506	[p23l1912t2896r2046b2946],
3	;	:	O	;	_	0	SENT_506	[p23l1912t2896r2046b2946],
4	47	CD	NUMBER	47	num	6	SENT_506	[p23l2073t2896r2145b2939],
5	:	:	O	:	_	0	SENT_506	[p23l2073t2896r2145b2939],
6	586-9	CD	NUMBER	586-9	dep	1	SENT_506	[p23l226t2971r364b3015],

1	28	CD	NUMBER	28	_	0	SENT_507	[p23l37t3049r108b3092],
2	.	.	O	.	_	0	SENT_507	[p23l37t3049r108b3092],

1	Polinko	NNP	O	Polinko	nn	2	SENT_508	[p23l142t3049r330b3091],
2	M	NNP	O	M	_	0	SENT_508	[p23l354t3050r420b3099],
3	,	,	O	,	_	0	SENT_508	[p23l354t3050r420b3099],
4	Riffel	NNP	PERSON	Riffel	nn	5	SENT_508	[p23l445t3049r585b3091],
5	K	NNP	PERSON	K	appos	2	SENT_508	[p23l609t3050r664b3099],
6	,	,	O	,	_	0	SENT_508	[p23l609t3050r664b3099],
7	Song	NN	O	song	nn	8	SENT_508	[p23l691t3049r812b3104],
8	H	NN	O	h	appos	2	SENT_508	[p23l836t3050r891b3099],
9	,	,	O	,	_	0	SENT_508	[p23l836t3050r891b3099],
10	et	FW	O	et	nn	11	SENT_508	[p23l917t3055r960b3091],
11	al.	FW	O	al.	appos	2	SENT_508	[p23l984t3049r1037b3091],
12	.	.	O	.	_	0	SENT_508	[p23l984t3049r1037b3091],

1	Simultaneous	JJ	O	simultaneous	amod	2	SENT_509	[p23l1065t3049r1392b3092],
2	determination	NN	O	determination	_	0	SENT_509	[p23l1417t3049r1753b3091],
3	of	IN	O	of	_	0	SENT_509	[p23l1777t3049r1829b3091],
4	losartan	NN	O	losartan	prep_of	2	SENT_509	[p23l1849t3049r2040b3091],
5	and	CC	O	and	_	0	SENT_509	[p23l2064t3049r2149b3091],
6	EXP3l74	NN	O	exp3l74	prep_of	2	SENT_509	[p23l225t3127r460b3169],
7	in	IN	O	in	_	0	SENT_509	[p23l481t3126r527b3169],
8	human	JJ	O	human	amod	9	SENT_509	[p23l546t3126r711b3169],
9	plasma	NN	O	plasma	prep_in	2	SENT_509	[p23l730t3127r903b3182],
10	and	CC	O	and	_	0	SENT_509	[p23l923t3127r1009b3169],
11	urine	NN	O	urine	conj_and	9	SENT_509	[p23l1028t3126r1152b3169],
12	utilizing	VBG	O	utilize	partmod	2	SENT_509	[p23l1172t3126r1373b3182],
13	liquid	JJ	O	liquid	amod	16	SENT_509	[p23l1394t3126r1535b3182],
14	chromatography/tandem	NN	O	chromatography/tandem	nn	16	SENT_509	[p23l1555t3126r2150b3182],
15	mass	NN	O	mass	nn	16	SENT_509	[p23l225t3217r344b3246],
16	spectrometry	NN	O	spectrometry	dobj	12	SENT_509	[p23l368t3210r694b3259],
17	.	.	O	.	_	0	SENT_509	[p23l368t3210r694b3259],

1	J	NNP	O	J	nn	4	SENT_510	[p23l717t3204r739b3246],
2	Pharm	NNP	O	Pharm	nn	4	SENT_510	[p23l759t3203r917b3246],
3	Biomed	NNP	O	Biomed	nn	4	SENT_510	[p23l936t3203r1128b3246],
4	Anal	NNP	O	Anal	_	0	SENT_510	[p23l1148t3203r1264b3246],
5	2003	CD	DATE	2003	num	4	SENT_510	[p23l1285t3204r1419b3254],
6	;	:	O	;	_	0	SENT_510	[p23l1285t3204r1419b3254],
7	33	CD	NUMBER	33	num	9	SENT_510	[p23l1443t3204r1514b3246],
8	:	:	O	:	_	0	SENT_510	[p23l1443t3204r1514b3246],
9	73-84	CD	NUMBER	73-84	dep	4	SENT_510	[p23l1538t3204r1677b3246],

1	29	CD	NUMBER	29	_	0	SENT_511	[p23l37t3281r108b3324],
2	.	.	O	.	_	0	SENT_511	[p23l37t3281r108b3324],

1	Grothusen	NN	MISC	grothusen	nn	2	SENT_512	[p23l144t3280r395b3323],
2	C	NN	O	c	_	0	SENT_512	[p23l418t3281r469b3331],
3	,	,	O	,	_	0	SENT_512	[p23l418t3281r469b3331],
4	Umbreen	NNP	O	Umbreen	nn	5	SENT_512	[p23l493t3280r719b3323],
5	S	NNP	O	S	appos	2	SENT_512	[p23l742t3281r786b3331],
6	,	,	O	,	_	0	SENT_512	[p23l742t3281r786b3331],
7	Konrad	NNP	PERSON	Konrad	appos	2	SENT_512	[p23l811t3280r991b3323],
8	I	PRP	PERSON	I	dep	7	SENT_512	[p23l1013t3281r1045b3331],
9	,	,	O	,	_	0	SENT_512	[p23l1013t3281r1045b3331],
10	et	FW	O	et	nn	11	SENT_512	[p23l1070t3287r1112b3323],
11	al.	FW	O	al.	appos	2	SENT_512	[p23l1135t3280r1188b3323],
12	.	.	O	.	_	0	SENT_512	[p23l1135t3280r1188b3323],

1	EXP3179	NN	O	exp3179	nsubj	2	SENT_513	[p23l1213t3281r1447b3324],
2	inhibits	VBZ	O	inhibit	_	0	SENT_513	[p23l1470t3280r1650b3323],
3	collagen-dependent	JJ	O	collagen-dependent	amod	5	SENT_513	[p23l1674t3280r2150b3336],
4	platelet	NN	O	platelet	nn	5	SENT_513	[p23l224t3357r404b3413],
5	activation	NN	O	activation	dobj	2	SENT_513	[p23l428t3357r666b3400],
6	via	IN	O	via	_	0	SENT_513	[p23l691t3357r764b3400],
7	glycoprotein	NN	O	glycoprotein	nn	8	SENT_513	[p23l788t3357r1094b3413],
8	receptor-VI	NN	O	receptor-vi	prep_via	5	SENT_513	[p23l1117t3358r1401b3413],
9	independent	JJ	O	independent	amod	8	SENT_513	[p23l1425t3357r1722b3413],
10	of	IN	O	of	_	0	SENT_513	[p23l1746t3357r1799b3400],
11	ATl-receptor	NN	O	atl-receptor	nn	12	SENT_513	[p23l1819t3357r2150b3413],
12	antagonism	NN	O	antagonism	prep_of	8	SENT_513	[p23l226t3434r517b3489],
13	:	:	O	:	_	0	SENT_513	[p23l226t3434r517b3489],
14	potential	JJ	O	potential	amod	15	SENT_513	[p23l542t3434r754b3489],
15	impact	NN	O	impact	dep	5	SENT_513	[p23l776t3434r941b3489],
16	on	IN	O	on	_	0	SENT_513	[p23l963t3447r1022b3477],
17	atherothrombosis	NN	O	atherothrombosis	prep_on	15	SENT_513	[p23l1044t3434r1477b3477],
18	.	.	O	.	_	0	SENT_513	[p23l1044t3434r1477b3477],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_514	[p23l1502t3434r1792b3477],
2	Thromb	NNP	O	Thromb	nn	4	SENT_514	[p23l1813t3434r2006b3477],
3	Vasc	NNP	O	Vasc	nn	4	SENT_514	[p23l2029t3435r2148b3477],
4	Biol	NNP	O	Biol	_	0	SENT_514	[p23l225t3510r328b3552],
5	2007	CD	DATE	2007	num	4	SENT_514	[p23l349t3510r483b3560],
6	;	:	O	;	_	0	SENT_514	[p23l349t3510r483b3560],
7	27	CD	NUMBER	27	num	9	SENT_514	[p23l506t3510r578b3552],
8	:	:	O	:	_	0	SENT_514	[p23l506t3510r578b3552],
9	1184-90	CD	NUMBER	1184-90	dep	4	SENT_514	[p23l607t3510r803b3553],

1	30	CD	NUMBER	30	_	0	SENT_515	[p23l38t3587r108b3630],
2	.	.	O	.	_	0	SENT_515	[p23l38t3587r108b3630],

1	US	NNP	LOCATION	US	nn	3	SENT_516	[p23l142t3587r216b3630],
2	FDA	NNP	ORGANIZATION	FDA	nn	3	SENT_516	[p23l232t3587r353b3629],
3	Center	NNP	ORGANIZATION	Center	_	0	SENT_516	[p23l368t3587r529b3630],
4	for	IN	ORGANIZATION	for	_	0	SENT_516	[p23l542t3587r612b3630],
5	Drug	NNP	ORGANIZATION	Drug	nn	6	SENT_516	[p23l625t3588r748b3642],
6	Evaluation	NN	ORGANIZATION	evaluation	prep_for	3	SENT_516	[p23l762t3587r1025b3630],
7	and	CC	ORGANIZATION	and	_	0	SENT_516	[p23l1040t3587r1125b3630],
8	Research	NN	ORGANIZATION	research	nn	11	SENT_516	[p23l1139t3587r1361b3630],
9	(	CD	NUMBER	(	num	11	SENT_516	[p23l1376t3587r1588b3640],
10	CDER	NN	O	cder	nn	11	SENT_516	[p23l1376t3587r1588b3640],
11	)	NN	O	)	conj_and	6	SENT_516	[p23l1376t3587r1588b3640],
12	.	.	O	.	_	0	SENT_516	[p23l1376t3587r1588b3640],

1	Guidance	NN	O	guidance	_	0	SENT_517	[p23l1606t3587r1836b3630],
2	for	IN	O	for	_	0	SENT_517	[p23l1851t3587r1921b3630],
3	industry	NN	O	industry	prep_for	1	SENT_517	[p23l1934t3587r2145b3642],
4	:	:	O	:	_	0	SENT_517	[p23l1934t3587r2145b3642],
5	bioanalytical	JJ	O	bioanalytical	amod	7	SENT_517	[p23l224t3664r538b3719],
6	method	NN	O	method	nn	7	SENT_517	[p23l560t3664r741b3706],
7	validation	NN	O	validation	dep	1	SENT_517	[p23l762t3664r1004b3706],
8	[	CD	NUMBER	[	dep	7	SENT_517	[p23l1030t3664r1229b3715],
9	online	NN	O	online	prep	8	SENT_517	[p23l1030t3664r1229b3715],
10	]	NN	O	]	dep	9	SENT_517	[p23l1030t3664r1229b3715],
11	.	.	O	.	_	0	SENT_517	[p23l1030t3664r1229b3715],

1	Rockville	NNP	LOCATION	Rockville	_	0	SENT_518	[p23l1253t3664r1488b3706],
2	(	CD	NUMBER	(	num	4	SENT_518	[p23l1511t3664r1660b3717],
3	MD	NN	O	md	nn	4	SENT_518	[p23l1511t3664r1660b3717],
4	)	NN	O	)	dep	1	SENT_518	[p23l1511t3664r1660b3717],
5	:	:	O	:	_	0	SENT_518	[p23l1511t3664r1660b3717],
6	CDER	NN	O	cder	dep	1	SENT_518	[p23l1686t3664r1859b3714],
7	,	,	O	,	_	0	SENT_518	[p23l1686t3664r1859b3714],
8	2001	CD	DATE	2001	num	9	SENT_518	[p23l1883t3664r1997b3707],
9	May	NNP	DATE	May	appos	6	SENT_518	[p23l2023t3665r2146b3719],
10	.	.	O	.	_	0	SENT_518	[p23l2023t3665r2146b3719],

1	Available	JJ	O	available	_	0	SENT_519	[p23l225t3741r460b3784],
2	from	IN	O	from	_	0	SENT_519	[p23l504t3741r622b3784],
3	URL	NN	O	url	prep_from	1	SENT_519	[p23l664t3743r797b3784],
4	:	:	O	:	_	0	SENT_519	[p23l664t3743r797b3784],
5	http://www.fda.gov/cder/guidance/4252fnl.htm	NN	O	http://www.fda.gov/cder/guidance/4252fnl.htm	dep	1	SENT_519	[p23l844t3741r1997b3797],
6	[	CD	NUMBER	[	num	5	SENT_519	[p23l2043t3742r2147b3793, p24l226t17r383b60],
7	Accessed	VBN	O	access	partmod	5	SENT_519	[p23l2043t3742r2147b3793, p24l226t17r383b60],

1	2008	CD	DATE	2008	_	0	SENT_520	[p24l403t18r520b60],
2	Mar	NNP	DATE	Mar	dep	1	SENT_520	[p24l542t18r644b60],
3	26	CD	DATE	26	num	2	SENT_520	[p24l663t17r738b69],
4	]	CD	NUMBER	]	dep	1	SENT_520	[p24l663t17r738b69],

1	31	CD	NUMBER	31	_	0	SENT_521	[p24l38t95r108b137],
2	.	.	O	.	_	0	SENT_521	[p24l38t95r108b137],

1	Werner	NNP	PERSON	Werner	nn	2	SENT_522	[p24l142t95r325b137],
2	U	NNP	PERSON	U	_	0	SENT_522	[p24l353t95r408b145],
3	,	,	O	,	_	0	SENT_522	[p24l353t95r408b145],
4	Werner	NNP	PERSON	Werner	nn	5	SENT_522	[p24l439t95r622b137],
5	D	NNP	PERSON	D	appos	2	SENT_522	[p24l649t95r705b145],
6	,	,	O	,	_	0	SENT_522	[p24l649t95r705b145],
7	Pahl	NNP	PERSON	Pahl	nn	8	SENT_522	[p24l736t94r843b137],
8	A	NNP	O	A	appos	2	SENT_522	[p24l872t95r927b145],
9	,	,	O	,	_	0	SENT_522	[p24l872t95r927b145],
10	et	FW	O	et	nn	11	SENT_522	[p24l959t101r1002b137],
11	al.	FW	O	al.	appos	2	SENT_522	[p24l1032t94r1085b137],
12	.	.	O	.	_	0	SENT_522	[p24l1032t94r1085b137],

1	Investigation	NN	O	investigation	_	0	SENT_523	[p24l1117t94r1434b150],
2	of	IN	O	of	_	0	SENT_523	[p24l1463t94r1516b137],
3	the	DT	O	the	det	4	SENT_523	[p24l1541t94r1613b137],
4	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	1	SENT_523	[p24l1642t94r2069b150],
5	of	IN	O	of	_	0	SENT_523	[p24l2100t94r2153b137],
6	celecoxib	NN	O	celecoxib	prep_of	4	SENT_523	[p24l226t171r456b214],
7	by	IN	O	by	_	0	SENT_523	[p24l479t171r538b227],
8	liquid	JJ	O	liquid	amod	10	SENT_523	[p24l562t171r703b227],
9	chromatography-mass	JJ	O	chromatography-mass	amod	10	SENT_523	[p24l725t171r1264b227],
10	spectrometry	NN	O	spectrometry	prep_by	1	SENT_523	[p24l1290t178r1616b227],
11	.	.	O	.	_	0	SENT_523	[p24l1290t178r1616b227],

1	Biomed	NNP	O	Biomed	nn	2	SENT_524	[p24l1642t171r1834b214],
2	Chromatogr	NNP	O	Chromatogr	_	0	SENT_524	[p24l1857t171r2150b227],
3	2002	CD	DATE	2002	num	2	SENT_524	[p24l226t247r360b297],
4	;	:	O	;	_	0	SENT_524	[p24l226t247r360b297],
5	16	CD	NUMBER	16	num	7	SENT_524	[p24l388t247r454b290],
6	:	:	O	:	_	0	SENT_524	[p24l388t247r454b290],
7	56-60	CD	NUMBER	56-60	dep	2	SENT_524	[p24l479t247r618b290],

1	32	CD	NUMBER	32	_	0	SENT_525	[p24l38t324r108b367],
2	.	.	O	.	_	0	SENT_525	[p24l38t324r108b367],

1	Egger	NNP	ORGANIZATION	Egger	nn	2	SENT_526	[p24l142t325r288b379],
2	T	NN	ORGANIZATION	t	_	0	SENT_526	[p24l302t325r351b374],
3	,	,	O	,	_	0	SENT_526	[p24l302t325r351b374],
4	Dormann	NNP	PERSON	Dormann	nn	5	SENT_526	[p24l369t325r598b367],
5	H	NNP	PERSON	H	appos	2	SENT_526	[p24l613t325r669b374],
6	,	,	O	,	_	0	SENT_526	[p24l613t325r669b374],
7	Ahne	NNP	O	Ahne	nn	8	SENT_526	[p24l687t324r816b367],
8	G	NNP	O	G	appos	2	SENT_526	[p24l834t324r888b374],
9	,	,	O	,	_	0	SENT_526	[p24l834t324r888b374],
10	et	FW	O	et	nn	11	SENT_526	[p24l907t330r949b367],
11	al.	FW	O	al.	appos	2	SENT_526	[p24l965t324r1019b367],
12	.	.	O	.	_	0	SENT_526	[p24l965t324r1019b367],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_527	[p24l1038t324r1337b379],
2	P450	NN	O	p450	nn	3	SENT_527	[p24l1353t324r1476b367],
3	polymorphisms	NNS	O	polymorphism	nsubj	13	SENT_527	[p24l1492t324r1869b379],
4	in	IN	O	in	_	0	SENT_527	[p24l1886t324r1932b366],
5	geriatric	JJ	O	geriatric	amod	6	SENT_527	[p24l1948t324r2148b379],
6	patients	NNS	O	patient	prep_in	3	SENT_527	[p24l224t401r426b456],
7	:	:	O	:	_	0	SENT_527	[p24l224t401r426b456],
8	impact	NN	O	impact	dep	6	SENT_527	[p24l450t401r615b456],
9	on	IN	O	on	_	0	SENT_527	[p24l635t414r693b444],
10	adverse	JJ	O	adverse	amod	12	SENT_527	[p24l714t401r897b444],
11	drug	NN	O	drug	nn	12	SENT_527	[p24l918t401r1027b456],
12	reactions	NNS	O	reaction	prep_on	8	SENT_527	[p24l1046t401r1264b444],
13	—	VBP	O	—	_	0	SENT_527	[p24l1284t427r1315b431],
14	a	DT	O	a	det	16	SENT_527	[p24l1335t414r1360b444],
15	pilot	NN	O	pilot	nn	16	SENT_527	[p24l1378t401r1490b456],
16	study	NN	O	study	dobj	13	SENT_527	[p24l1511t401r1651b456],
17	.	.	O	.	_	0	SENT_527	[p24l1511t401r1651b456],

1	Drugs	NNS	O	drug	_	0	SENT_528	[p24l1674t402r1820b456],
2	Aging	JJ	O	aging	amod	3	SENT_528	[p24l1841t401r1991b456],
3	2005	CD	DATE	2005	dep	1	SENT_528	[p24l2013t401r2146b451],
4	;	:	O	;	_	0	SENT_528	[p24l2013t401r2146b451],
5	22	CD	NUMBER	22	dep	1	SENT_528	[p24l226t477r297b519],
6	:	:	O	:	_	0	SENT_528	[p24l226t477r297b519],
7	265-72	CD	NUMBER	265-72	dep	5	SENT_528	[p24l322t477r492b519],

1	33	CD	NUMBER	33	_	0	SENT_529	[p24l38t554r108b597],
2	.	.	O	.	_	0	SENT_529	[p24l38t554r108b597],

1	Vormfelde	NNP	O	Vormfelde	nn	2	SENT_530	[p24l143t554r405b596],
2	SV	NNP	O	SV	_	0	SENT_530	[p24l422t554r510b604],
3	,	,	O	,	_	0	SENT_530	[p24l422t554r510b604],
4	Toliat	NNP	PERSON	Toliat	nn	5	SENT_530	[p24l527t554r672b596],
5	MR	NN	PERSON	mr	appos	2	SENT_530	[p24l686t555r792b604],
6	,	,	O	,	_	0	SENT_530	[p24l686t555r792b604],
7	Schirmer	NNP	PERSON	Schirmer	nn	8	SENT_530	[p24l812t554r1033b597],
8	M	NNP	O	M	appos	2	SENT_530	[p24l1047t555r1113b604],
9	,	,	O	,	_	0	SENT_530	[p24l1047t555r1113b604],
10	et	FW	O	et	nn	11	SENT_530	[p24l1131t560r1173b596],
11	al.	FW	O	al.	appos	2	SENT_530	[p24l1189t554r1242b596],
12	.	.	O	.	_	0	SENT_530	[p24l1189t554r1242b596],

1	The	DT	O	the	det	3	SENT_531	[p24l1260t554r1353b596],
2	polymorphisms	NNS	O	polymorphism	nn	3	SENT_531	[p24l1368t554r1745b609],
3	Asn120Asp	NN	O	asn120asp	nsubj	15	SENT_531	[p24l1761t554r2047b609],
4	and	CC	O	and	_	0	SENT_531	[p24l2064t554r2150b596],
5	Vall74Ala	NN	O	vall74alum	conj_and	3	SENT_531	[p24l225t631r492b674],
6	in	IN	O	in	_	0	SENT_531	[p24l515t631r561b673],
7	OATPlBl	NN	O	oatplbl	prep_in	3	SENT_531	[p24l586t631r839b674],
8	and	CC	O	and	_	0	SENT_531	[p24l870t631r955b673],
9	the	DT	O	the	det	11	SENT_531	[p24l979t631r1051b673],
10	CAP2C9	NN	O	cap2c9	nn	11	SENT_531	[p24l1076t631r1293b674],
11	allele	NN	O	allele	prep_in	3	SENT_531	[p24l1320t631r1507b674],
12	*	CD	NUMBER	*	num	13	SENT_531	[p24l1320t631r1507b674],
13	3	CD	NUMBER	3	npadvmod	14	SENT_531	[p24l1320t631r1507b674],
14	independently	RB	O	independently	advmod	15	SENT_531	[p24l1534t631r1877b686],
15	affect	VB	O	affect	_	0	SENT_531	[p24l1903t631r2040b673],
16	torsemide	NN	O	torsemide	nn	17	SENT_531	[p24l2063t637r2147b673, p24l227t708r396b751],
17	pharmacokinetics	NNS	O	pharmacokinetic	dobj	15	SENT_531	[p24l414t708r842b764],
18	and	CC	O	and	_	0	SENT_531	[p24l864t708r949b751],
19	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	17	SENT_531	[p24l967t708r1452b764],
20	.	.	O	.	_	0	SENT_531	[p24l967t708r1452b764],

1	Clin	NNP	O	Clin	nn	3	SENT_532	[p24l1475t708r1578b751],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_532	[p24l1596t708r1855b751],
3	Ther	NNP	O	Ther	_	0	SENT_532	[p24l1875t709r2000b751],
4	.	.	O	.	_	0	SENT_532	[p24l1875t709r2000b751],

1	Epub	NNP	O	Epub	_	0	SENT_533	[p24l2022t709r2148b764],
2	2007	CD	DATE	2007	dep	1	SENT_533	[p24l226t785r344b827],
3	Nov	NNP	DATE	Nov	tmod	2	SENT_533	[p24l365t785r468b827],
4	28	CD	DATE	28	num	3	SENT_533	[p24l489t785r546b827],

1	©	RB	O	©	amod	4	SENT_534	[p24l7t977r41b1011],
2	2008	CD	DATE	2008	tmod	1	SENT_534	[p24l60t973r164b1011],
3	Adis	NNP	PERSON	Adis	nn	4	SENT_534	[p24l181t974r278b1011],
4	Do1	NN	O	do1	_	0	SENT_534	[p24l297t974r411b1011],
5	’	CD	NUMBER	’	num	6	SENT_534	[p24l297t974r411b1011],
6	ro1	NN	O	ro1	dep	4	SENT_534	[p24l297t974r411b1011],
7	Information	NN	O	information	nn	8	SENT_534	[p24l431t974r695b1011],
8	BV	NN	O	bv	dep	6	SENT_534	[p24l715t974r783b1010],
9	.	.	O	.	_	0	SENT_534	[p24l715t974r783b1010],

1	All	DT	O	all	det	2	SENT_535	[p24l803t974r855b1010],
2	rights	NNS	O	rights	nsubj	3	SENT_535	[p24l875t974r994b1021],
3	reserved	VBN	O	reserve	_	0	SENT_535	[p24l1012t974r1222b1011],
4	.	.	O	.	_	0	SENT_535	[p24l1012t974r1222b1011],

1	34	CD	NUMBER	34	_	0	SENT_536	[p24l38t1045r108b1088],
2	.	.	O	.	_	0	SENT_536	[p24l38t1045r108b1088],

1	Buist	NNP	ORGANIZATION	Buist	nn	2	SENT_537	[p24l144t1045r272b1088],
2	SC	NNP	ORGANIZATION	SC	_	0	SENT_537	[p24l289t1045r373b1096],
3	,	,	O	,	_	0	SENT_537	[p24l289t1045r373b1096],
4	Klaassen	NNP	PERSON	Klaassen	nn	5	SENT_537	[p24l393t1045r611b1088],
5	CD	NNP	O	CD	appos	2	SENT_537	[p24l627t1045r722b1088],
6	.	.	O	.	_	0	SENT_537	[p24l627t1045r722b1088],

1	Rat	NN	O	rat	nn	4	SENT_538	[p24l741t1046r825b1088],
2	and	CC	O	and	_	0	SENT_538	[p24l842t1045r928b1088],
3	mouse	NN	O	mouse	conj_and	1	SENT_538	[p24l944t1059r1101b1088],
4	differences	NNS	O	difference	_	0	SENT_538	[p24l1118t1045r1386b1088],
5	in	IN	O	in	_	0	SENT_538	[p24l1404t1045r1450b1087],
6	gender-predominant	JJ	O	gender-predominant	amod	7	SENT_538	[p24l1466t1045r1960b1101],
7	expression	NN	O	expression	prep_in	4	SENT_538	[p24l1976t1059r2151b1101, p24l228t1122r326b1164],
8	of	IN	O	of	_	0	SENT_538	[p24l357t1122r410b1164],
9	organic	JJ	O	organic	amod	13	SENT_538	[p24l437t1122r617b1177],
10	anion	NN	O	anion	nn	13	SENT_538	[p24l649t1122r782b1164],
11	transporter	NN	O	transporter	nn	13	SENT_538	[p24l812t1128r1077b1177],
12	(	CD	NUMBER	(	num	13	SENT_538	[p24l1108t1122r1308b1174],
13	Oatl-3	NN	O	oatl-3	prep_of	7	SENT_538	[p24l1108t1122r1308b1174],
14	;	:	O	;	_	0	SENT_538	[p24l1108t1122r1308b1174],
15	Slc22a6-8	NN	O	slc22a6-8	dep	4	SENT_538	[p24l1343t1122r1606b1174],
16	)	CD	NUMBER	)	num	18	SENT_538	[p24l1343t1122r1606b1174],
17	mRNA	NN	O	mrna	nn	18	SENT_538	[p24l1638t1122r1813b1164],
18	levels	NNS	O	level	dep	15	SENT_538	[p24l1843t1122r1996b1165],
19	.	.	O	.	_	0	SENT_538	[p24l1843t1122r1996b1165],

1	Drug	NN	O	drug	nn	3	SENT_539	[p24l2029t1123r2153b1177],
2	Metab	NNP	O	Metab	nn	3	SENT_539	[p24l226t1200r379b1242],
3	Dispos	NNP	O	Dispos	_	0	SENT_539	[p24l400t1199r567b1255],
4	2004	CD	DATE	2004	num	3	SENT_539	[p24l589t1200r723b1250],
5	;	:	O	;	_	0	SENT_539	[p24l589t1200r723b1250],
6	32	CD	NUMBER	32	num	8	SENT_539	[p24l747t1200r818b1242],
7	:	:	O	:	_	0	SENT_539	[p24l747t1200r818b1242],
8	620-5	CD	NUMBER	620-5	dep	3	SENT_539	[p24l843t1199r980b1242],

1	35	CD	NUMBER	35	_	0	SENT_540	[p24l38t1276r108b1319],
2	.	.	O	.	_	0	SENT_540	[p24l38t1276r108b1319],

1	Cerrutti	NNP	ORGANIZATION	Cerrutti	nn	2	SENT_541	[p24l144t1276r331b1319],
2	IA	NNP	ORGANIZATION	IA	_	0	SENT_541	[p24l354t1277r433b1327],
3	,	,	O	,	_	0	SENT_541	[p24l354t1277r433b1327],
4	Quaglia	NNP	PERSON	Quaglia	nn	5	SENT_541	[p24l459t1276r650b1332],
5	NB	NN	O	nb	appos	2	SENT_541	[p24l671t1277r768b1327],
6	,	,	O	,	_	0	SENT_541	[p24l671t1277r768b1327],
7	Brandoni	NNP	LOCATION	Brandoni	nn	8	SENT_541	[p24l792t1276r1017b1319],
8	A	NNP	O	A	appos	2	SENT_541	[p24l1040t1277r1096b1327],
9	,	,	O	,	_	0	SENT_541	[p24l1040t1277r1096b1327],
10	et	FW	O	et	nn	11	SENT_541	[p24l1121t1283r1164b1319],
11	al.	FW	O	al.	appos	2	SENT_541	[p24l1186t1276r1240b1319],
12	.	.	O	.	_	0	SENT_541	[p24l1186t1276r1240b1319],

1	Effects	NNS	O	effect	nsubj	9	SENT_542	[p24l1265t1276r1435b1319],
2	of	IN	O	of	_	0	SENT_542	[p24l1459t1276r1512b1319],
3	gender	NN	O	gender	prep_of	1	SENT_542	[p24l1531t1276r1696b1332],
4	on	IN	O	on	_	0	SENT_542	[p24l1718t1290r1776b1319],
5	the	DT	O	the	det	6	SENT_542	[p24l1798t1276r1871b1319],
6	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	3	SENT_542	[p24l1893t1276r2151b1332, p24l225t1353r413b1396],
7	of	IN	O	of	_	0	SENT_542	[p24l435t1353r488b1396],
8	drugs	NNS	O	drug	prep_of	6	SENT_542	[p24l504t1353r636b1408],
9	secreted	VBN	O	secrete	_	0	SENT_542	[p24l659t1353r856b1396],
10	by	IN	O	by	_	0	SENT_542	[p24l875t1353r934b1408],
11	the	DT	O	the	det	14	SENT_542	[p24l955t1353r1027b1396],
12	renal	JJ	O	renal	amod	14	SENT_542	[p24l1047t1353r1168b1396],
13	organic	JJ	O	organic	amod	14	SENT_542	[p24l1189t1353r1369b1408],
14	anions	NNS	O	anion	prep_by	9	SENT_542	[p24l1391t1353r1546b1396],
15	transport	NN	O	transport	nn	16	SENT_542	[p24l1567t1359r1784b1408],
16	systems	NNS	O	system	dobj	9	SENT_542	[p24l1805t1359r1993b1408],
17	in	IN	O	in	_	0	SENT_542	[p24l2014t1353r2060b1395],
18	the	DT	O	the	det	19	SENT_542	[p24l2080t1353r2153b1396],
19	rat	NN	O	rat	prep_in	16	SENT_542	[p24l225t1436r301b1472],
20	.	.	O	.	_	0	SENT_542	[p24l225t1436r301b1472],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_543	[p24l324t1429r583b1472],
2	Res	NNP	O	Res	_	0	SENT_543	[p24l603t1431r692b1472],
3	2002	CD	DATE	2002	num	2	SENT_543	[p24l714t1430r848b1480],
4	;	:	O	;	_	0	SENT_543	[p24l714t1430r848b1480],
5	45	CD	NUMBER	45	num	7	SENT_543	[p24l870t1429r943b1472],
6	:	:	O	:	_	0	SENT_543	[p24l870t1429r943b1472],
7	107-12	CD	NUMBER	107-12	dep	2	SENT_543	[p24l973t1430r1137b1472],

1	36	CD	NUMBER	36	_	0	SENT_544	[p24l38t1506r108b1549],
2	.	.	O	.	_	0	SENT_544	[p24l38t1506r108b1549],

1	Schwartz	NNP	PERSON	Schwartz	nn	5	SENT_545	[p24l145t1506r368b1549],
2	J	NNP	O	J	nn	5	SENT_545	[p24l383t1507r406b1549],
3	B.	NNP	O	B.	nn	5	SENT_545	[p24l407t1507r458b1549],
4	The	NNP	O	The	nn	5	SENT_545	[p24l477t1506r570b1549],
5	inﬂuence	NN	O	inﬂuence	_	0	SENT_545	[p24l585t1506r810b1549],
6	of	IN	O	of	_	0	SENT_545	[p24l826t1506r879b1549],
7	sex	NN	O	sex	prep_of	5	SENT_545	[p24l892t1520r969b1549],
8	on	IN	O	on	_	0	SENT_545	[p24l985t1520r1044b1549],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	5	SENT_545	[p24l1058t1506r1500b1562],
10	.	.	O	.	_	0	SENT_545	[p24l1058t1506r1500b1562],

1	Clin	NNP	O	Clin	nn	2	SENT_546	[p24l1518t1506r1622b1549],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_546	[p24l1636t1506r2002b1549],
3	2003	CD	DATE	2003	num	2	SENT_546	[p24l2016t1507r2150b1557],
4	;	:	O	;	_	0	SENT_546	[p24l2016t1507r2150b1557],

1	37	CD	NUMBER	37	_	0	SENT_547	[p24l38t1659r108b1702],
2	.	.	O	.	_	0	SENT_547	[p24l38t1659r108b1702],

1	Tanaka	NNP	PERSON	Tanaka	nn	2	SENT_548	[p24l143t1659r323b1702],
2	E.	NNP	O	E.	_	0	SENT_548	[p24l336t1660r384b1702],
3	Gender-related	JJ	MISC	gender-related	amod	4	SENT_548	[p24l404t1659r768b1702],
4	differences	NNS	O	difference	dep	2	SENT_548	[p24l784t1659r1051b1702],
5	in	IN	O	in	_	0	SENT_548	[p24l1068t1659r1114b1701],
6	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	4	SENT_548	[p24l1129t1659r1557b1714],
7	and	CC	O	and	_	0	SENT_548	[p24l1576t1659r1661b1702],
8	their	PRP$	O	they	poss	10	SENT_548	[p24l1676t1659r1788b1702],
9	clinical	JJ	O	clinical	amod	10	SENT_548	[p24l1802t1659r1980b1702],
10	significance	NN	O	significance	prep_in	4	SENT_548	[p24l1998t1659r2151b1714, p24l226t1735r392b1778],
11	.	.	O	.	_	0	SENT_548	[p24l1998t1659r2151b1714, p24l226t1735r392b1778],

1	J	NNP	O	J	nn	4	SENT_549	[p24l415t1737r437b1778],
2	Clin	NNP	O	Clin	nn	4	SENT_549	[p24l458t1735r561b1778],
3	Pharm	NNP	O	Pharm	nn	4	SENT_549	[p24l581t1736r740b1778],
4	Ther	NNP	O	Ther	_	0	SENT_549	[p24l759t1735r874b1778],
5	1999	CD	DATE	1999	num	4	SENT_549	[p24l898t1736r1027b1786],
6	;	:	O	;	_	0	SENT_549	[p24l898t1736r1027b1786],
7	24	CD	NUMBER	24	num	9	SENT_549	[p24l1050t1736r1122b1778],
8	:	:	O	:	_	0	SENT_549	[p24l1050t1736r1122b1778],
9	339-46	CD	NUMBER	339-46	dep	4	SENT_549	[p24l1148t1735r1316b1779],

1	38	CD	NUMBER	38	_	0	SENT_550	[p24l38t1813r108b1855],
2	.	.	O	.	_	0	SENT_550	[p24l38t1813r108b1855],

1	Caraco	NNP	ORGANIZATION	Caraco	nn	2	SENT_551	[p24l144t1813r314b1855],
2	Y	NN	ORGANIZATION	y	nsubj	13	SENT_551	[p24l331t1813r386b1863],
3	,	,	O	,	_	0	SENT_551	[p24l331t1813r386b1863],
4	Blotnick	NN	PERSON	blotnick	nn	5	SENT_551	[p24l404t1812r614b1855],
5	S	NN	PERSON	s	appos	2	SENT_551	[p24l630t1813r674b1863],
6	,	,	O	,	_	0	SENT_551	[p24l630t1813r674b1863],
7	Muszkat	NNP	PERSON	Muszkat	nn	11	SENT_551	[p24l692t1812r901b1855],
8	M.	NNP	PERSON	M.	nn	11	SENT_551	[p24l916t1813r981b1855],
9	CYP2C9	NNP	PERSON	CYP2C9	nn	11	SENT_551	[p24l1001t1813r1217b1856],
10	genotype-guided	JJ	O	genotype-guided	amod	11	SENT_551	[p24l1236t1812r1644b1868],
11	warfarin	NN	O	warfarin	appos	2	SENT_551	[p24l1660t1812r1865b1855],
12	prescribing	VBG	O	prescribe	partmod	11	SENT_551	[p24l1880t1812r2152b1868],
13	enhances	VBZ	O	enhance	_	0	SENT_551	[p24l226t1889r447b1932],
14	the	DT	O	the	det	15	SENT_551	[p24l467t1889r540b1932],
15	efficacy	NN	O	efficacy	dobj	13	SENT_551	[p24l560t1889r754b1945],
16	and	CC	O	and	_	0	SENT_551	[p24l775t1889r861b1932],
17	safety	NN	O	safety	conj_and	15	SENT_551	[p24l882t1889r1023b1945],
18	of	IN	O	of	_	0	SENT_551	[p24l1044t1889r1096b1932],
19	anticoagulation	NN	O	anticoagulation	prep_of	15	SENT_551	[p24l1113t1889r1499b1945],
20	:	:	O	:	_	0	SENT_551	[p24l1113t1889r1499b1945],
21	a	DT	O	a	det	22	SENT_551	[p24l1524t1903r1549b1932],
22	prospective	JJ	O	prospective	dep	15	SENT_551	[p24l1567t1889r1847b1945],
23	randomized	VBN	O	randomize	partmod	22	SENT_551	[p24l1866t1889r2154b1932],
24	controlled	JJ	O	controlled	amod	25	SENT_551	[p24l226t1966r472b2008],
25	study	NN	O	study	dobj	23	SENT_551	[p24l494t1966r634b2021],
26	.	.	O	.	_	0	SENT_551	[p24l494t1966r634b2021],

1	Clin	NNP	O	Clin	nn	3	SENT_552	[p24l658t1966r761b2009],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_552	[p24l781t1966r1040b2008],
3	Ther	NNP	O	Ther	_	0	SENT_552	[p24l1061t1966r1175b2008],
4	2008	CD	DATE	2008	num	3	SENT_552	[p24l1195t1966r1329b2016],
5	;	:	O	;	_	0	SENT_552	[p24l1195t1966r1329b2016],
6	83	CD	NUMBER	83	num	8	SENT_552	[p24l1354t1966r1424b2009],
7	:	:	O	:	_	0	SENT_552	[p24l1354t1966r1424b2009],
8	460-70	CD	NUMBER	460-70	dep	3	SENT_552	[p24l1448t1966r1619b2009],

1	39	CD	NUMBER	39	_	0	SENT_553	[p24l38t2043r108b2086],
2	.	.	O	.	_	0	SENT_553	[p24l38t2043r108b2086],

1	Brunner	NNP	PERSON	Brunner	nn	2	SENT_554	[p24l143t2044r343b2085],
2	HR	NNP	DURATION	HR	_	0	SENT_554	[p24l357t2044r453b2085],
3	.	.	O	.	_	0	SENT_554	[p24l357t2044r453b2085],

1	The	DT	O	the	det	6	SENT_555	[p24l472t2043r565b2085],
2	new	JJ	O	new	amod	6	SENT_555	[p24l581t2056r681b2085],
3	angiotensin	NN	O	angiotensin	nn	6	SENT_555	[p24l699t2043r977b2098],
4	II	CD	NUMBER	ii	num	6	SENT_555	[p24l993t2044r1033b2085],
5	receptor	NN	O	receptor	nn	6	SENT_555	[p24l1048t2049r1248b2098],
6	antagonist	NN	O	antagonist	_	0	SENT_555	[p24l1264t2043r1525b2098],
7	,	,	O	,	_	0	SENT_555	[p24l1264t2043r1525b2098],
8	irbesartan	NN	O	irbesartan	appos	6	SENT_555	[p24l1544t2043r1796b2085],
9	:	:	O	:	_	0	SENT_555	[p24l1544t2043r1796b2085],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	13	SENT_555	[p24l1815t2043r2151b2098, p24l226t2120r311b2163],
11	and	CC	O	and	_	0	SENT_555	[p24l338t2120r424b2163],
12	pharmacodynamic	JJ	O	pharmacodynamic	amod	13	SENT_555	[p24l447t2120r896b2176],
13	considerations	NNS	O	consideration	dep	8	SENT_555	[p24l922t2120r1285b2163],
14	.	.	O	.	_	0	SENT_555	[p24l922t2120r1285b2163],

1	Am	VBP	O	be	dep	3	SENT_556	[p24l1312t2121r1403b2162],
2	J	NN	O	j	nn	3	SENT_556	[p24l1426t2121r1448b2163],
3	Hypertens	NNS	O	hyperten	_	0	SENT_556	[p24l1473t2121r1721b2176],
4	1997	CD	DATE	1997	dep	3	SENT_556	[p24l1752t2121r1881b2171],
5	;	:	O	;	_	0	SENT_556	[p24l1752t2121r1881b2171],
6	10	CD	NUMBER	10	num	8	SENT_556	[p24l1914t2121r1980b2163],
7	:	:	O	:	_	0	SENT_556	[p24l1914t2121r1980b2163],
8	311S317S	CD	NUMBER	311s317s	dep	4	SENT_556	[p24l2011t2121r2151b2163, p24l228t2196r347b2239],

1	Correspondence	NN	O	correspondence	_	0	SENT_557	[p24l7t2446r491b2512],
2	:	:	O	:	_	0	SENT_557	[p24l7t2446r491b2512],
3	Dr	NNP	O	Dr	nn	5	SENT_557	[p24l514t2448r588b2494],
4	Dierk	NNP	PERSON	Dierk	nn	5	SENT_557	[p24l609t2446r756b2494],
5	Werner	NNP	PERSON	Werner	dep	1	SENT_557	[p24l778t2448r987b2503],
6	,	,	O	,	_	0	SENT_557	[p24l778t2448r987b2503],
7	Department	NNP	ORGANIZATION	Department	appos	1	SENT_557	[p24l1008t2448r1354b2512],
8	of	IN	ORGANIZATION	of	_	0	SENT_557	[p24l1374t2446r1430b2495],
9	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	7	SENT_557	[p24l1449t2446r1787b2512],
10	,	,	O	,	_	0	SENT_557	[p24l1449t2446r1787b2512],
11	HeliosHospital	NNP	O	HeliosHospital	nn	12	SENT_557	[p24l1808t2446r2153b2495, p24l6t2528r135b2593],
12	Schwerin	NNP	LOCATION	Schwerin	appos	1	SENT_557	[p24l157t2528r439b2585],
13	,	,	O	,	_	0	SENT_557	[p24l157t2528r439b2585],
14	Wismarsche	NNP	ORGANIZATION	Wismarsche	nn	15	SENT_557	[p24l461t2528r812b2577],
15	Strasse	NNP	ORGANIZATION	Strasse	appos	1	SENT_557	[p24l835t2529r1032b2577],
16	393	CD	NUMBER	393	num	15	SENT_557	[p24l1054t2530r1165b2585],
17	,	,	O	,	_	0	SENT_557	[p24l1054t2530r1165b2585],
18	19055	CD	NUMBER	19055	num	15	SENT_557	[p24l1190t2530r1347b2577],
19	Schwerin	NNP	LOCATION	Schwerin	nn	21	SENT_557	[p24l1370t2528r1652b2585],
20	,	,	O	,	_	0	SENT_557	[p24l1370t2528r1652b2585],
21	Germany	NNP	LOCATION	Germany	dep	15	SENT_557	[p24l1675t2529r1957b2593],
22	.	.	O	.	_	0	SENT_557	[p24l1675t2529r1957b2593],

1	E-mail	NN	O	e-mail	_	0	SENT_558	[p24l7t2612r207b2660],
2	:	:	O	:	_	0	SENT_558	[p24l7t2612r207b2660],
3	dierk.werner@arcor.de	NN	O	dierk.werner@arcor.de	dep	1	SENT_558	[p24l233t2612r887b2661],

1	Clin	NNP	O	Clin	nn	2	SENT_559	[p24l1408t2808r1492b2846],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_559	[p24l1513t2809r1871b2846],
3	2008	CD	DATE	2008	num	2	SENT_559	[p24l1887t2808r2005b2849],
4	;	:	O	;	_	0	SENT_559	[p24l1887t2808r2005b2849],
5	47	CD	NUMBER	47	number	6	SENT_559	[p24l2023t2809r2074b2845],
6	(	CD	NUMBER	(	dep	2	SENT_559	[p24l2094t2809r2152b2851],
7	5	CD	NUMBER	5	num	8	SENT_559	[p24l2094t2809r2152b2851],
8	)	NN	O	)	dep	6	SENT_559	[p24l2094t2809r2152b2851],

